13. 多発性硬化症／視神経脊髄炎 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 3,685 / 薬物数 : 1,932 - (DrugBank : 355) / 標的遺伝子数 : 263 - 標的パスウェイ数 : 237
薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
0,5 MG fingolimod
Novartis Pharmaceuticals
2016 Phase 4 NCT02575365 Turkey
0.25 MG RPC1063
Celgene International II Sàrl (CIS II)
2014 Phase 2;Phase 3 EUCTR2012-002714-40-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Receptos, Inc.
2014 Phase 2;Phase 3 EUCTR2012-002714-40-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-IT Belgium;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Israel;Italy;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-GR Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-ES Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
0.25MG RPC1063
CELGENE INTERNATIONAL II SàRL
2016 Phase 3 EUCTR2015-002500-91-IT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Celgene International II Sàrl (CIS II)
2017 Phase 3 EUCTR2015-002500-91-SE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-PT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-PL Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-LV Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-LT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-EE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-GR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Receptos, Inc.
2015 Phase 3 EUCTR2015-002500-91-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
0.5 MG RPC1063
Celgene International II Sàrl (CIS II)
2014 Phase 2;Phase 3 EUCTR2012-002714-40-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Receptos, Inc.
2014 Phase 2;Phase 3 EUCTR2012-002714-40-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-IT Belgium;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Israel;Italy;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-GR Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-ES Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
0.5MG RPC1063
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Receptos, Inc.
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
0.9% chloride injection sodium
Institute of Psychiatry and Neurology, Warsaw
2022 Phase 2/Phase 3 NCT05961644 Poland
1 - andrographis paniculata P/ST extract
Universidad Austral de Chile
2012 Phase 1/Phase 2 NCT02280876 Chile
1 MG RPC1063
Celgene International II Sàrl (CIS II)
2014 Phase 2;Phase 3 EUCTR2012-002714-40-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Receptos, Inc.
2014 Phase 2;Phase 3 EUCTR2012-002714-40-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-IT Belgium;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Israel;Italy;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-GR Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-ES Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
1% steroid cream
University of Nebraska
2010 Phase 4 NCT00988988 United States
1-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-YL)OXY]-3-pyridinyl}-2-pyrrolidinone
GlaxoSmithKline Research & Development Ltd
2013 - EUCTR2012-003627-38-SE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-003627-38-GB Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 - EUCTR2012-003627-38-DE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 - EUCTR2012-003627-38-CZ Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-003627-38-BG Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
1.0MG RPC1063
CELGENE INTERNATIONAL II SàRL
2016 Phase 3 EUCTR2015-002500-91-IT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Celgene International II Sàrl (CIS II)
2017 Phase 3 EUCTR2015-002500-91-SE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-PT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-PL Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-LV Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-LT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-EE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-GR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Receptos, Inc.
2015 Phase 3 EUCTR2015-002500-91-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
10000IU vitamin D
University College Dublin
2012 Phase 1/Phase 2 NCT01728922 Ireland
11C-acetate
department of neurology, Osaka university school of medicine
2015 - JPRN-UMIN000018154 Japan
11C-BMS-986196
Bristol-Myers Squibb
2021 Phase 1 NCT05064436 United Kingdom;United States
11C-MC1
National Institute of Mental Health (NIMH)
2022 Phase 2 NCT05062083 United States
11C-PBR28
Massachusetts General Hospital
2020 Phase 4 NCT04230174 -
11C-PIB
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
2009 - EUCTR2008-004174-40-FR France
11C-PS13
National Institute of Mental Health (NIMH)
2022 Phase 2 NCT05062083 United States
13-PCV booster
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States
18F-DPA-714 and 18F-FDG
Assistance Publique - Hôpitaux de Paris
2012 - NCT02305264 France
18F-OP-801
Ashvattha Therapeutics, Inc.
2023 Phase 1/Phase 2 NCT05395624 United States
18F-PM-PBB3
Chang Gung Memorial Hospital
2020 Phase 1/Phase 2 NCT04242056 -
19 NOR vitamin D
University of Wisconsin, Madison
1998 Phase 1 NCT01257958 United States
2 - excipients
Universidad Austral de Chile
2012 Phase 1/Phase 2 NCT02280876 Chile
2 MA transcranial direct current stimulation
University of Iowa
2022 - NCT04391023 United States
2-(2-(2-amino-9H-purin-9-YL)ethyl)-1,3-propanediol diacetate ester
Queen Mary University London
2019 Phase 2 EUCTR2019-000169-19-GB United Kingdom
2-CDA
MERCK KGAA
2018 Phase 4 EUCTR2017-002631-42-IT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
Merck KGaA
2018 Phase 4 EUCTR2017-002632-17-SK Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-SE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-PT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-NO Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-NL Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-LT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-HU Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Ireland;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-GR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-GB Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-FR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-FI Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-ES Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-DK Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-CZ Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-BE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-AT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-FR Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-CZ Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-AT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
Merck Serono International S.A.
2008 - EUCTR2007-000381-20-NL Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2008 - EUCTR2007-000381-20-GR Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2007 Phase 3 EUCTR2007-000381-20-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lithuania;Netherlands;Portugal;United Kingdom
Merck Serono S.A. - Geneva
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - EUCTR2007-000381-20-PT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2008 - EUCTR2007-000381-20-LV Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-000381-20-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-EE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-DK Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-000381-20-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2007-000381-20-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2007-000381-20-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2-CDA, 2-chloro-2'-deoxy-ß-D-adenosine
MERCK SERONO SA
2011 Phase 3 EUCTR2009-017978-21-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Finland;Georgia;Germany;Greece;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Portugal;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States Minor Outlying Islands
2-CDA, 2-chloro-2?-deoxy-ß-D-adenosine
Merck Serono S.A. - Geneva
2011 Phase 3 EUCTR2009-017978-21-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2-CDA, 2-chloro-2’-deoxy-ß-D-adenosine
Merck Serono S.A. - Geneva
2012 Phase 3 EUCTR2009-017978-21-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2012 Phase 3 EUCTR2009-017978-21-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2012 Phase 3 EUCTR2009-017978-21-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-SE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-LV Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 - EUCTR2009-017978-21-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-DK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 - EUCTR2009-017978-21-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2010 Phase 3 EUCTR2009-017978-21-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2-chloro-2'-deoxyadenosine, 2CDA
Merck Serono International S.A.
2006 - EUCTR2004-005148-28-LT Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-FI Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-EE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-DK Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-CZ Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Merck Serono International, a branch of Laboratoires Serono S.A.
2005 Phase 3 EUCTR2004-005148-28-GB Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom
Merck Serono International, a branch of Laboratories Serono S.A.
2005 - EUCTR2004-005148-28-DE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Serono International S.A.
2006 Phase 3 EUCTR2004-005148-28-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom
2006 - EUCTR2004-005148-28-LV Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-AT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2-chloro-2?-deoxy-ß-D-adenosine
Merck Serono International
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2-chloro-2’-deoxy-ß-D-adenosine
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
Merck Serono S.A. - Geneva
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
20 MG GA
Teva Pharmaceutical Industries, Ltd.
2007 - EUCTR2006-002037-20-EE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-LV Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-LT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-HU Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-GB Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 Phase 3 EUCTR2006-002037-20-FI Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-DE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-BE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
20 MG mitoq
VA Office of Research and Development
2020 Phase 1/Phase 2 NCT04267926 United States
200106 or EMD 28162
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-LT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
20MG/0.5ML GA
Teva Pharmaceutical Industries Ltd.
2012 - EUCTR2011-005550-57-PL Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 - EUCTR2011-005550-57-LV Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 - EUCTR2011-005550-57-GR Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Greece;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 - EUCTR2011-005550-57-EE Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 - EUCTR2011-005550-57-BG Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
20MG/0.5ML glatiramer acetate
Teva Pharmaceutical Industries Ltd.
2012 - EUCTR2011-005550-57-PL Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 - EUCTR2011-005550-57-LV Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 - EUCTR2011-005550-57-GR Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Greece;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 - EUCTR2011-005550-57-EE Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 - EUCTR2011-005550-57-BG Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
23-PPV
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
23-valent pneumococcal polysaccharide vaccine
Biogen
2015 Phase 2 NCT02097849 United States
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
25(OH)D3
Tehran University of Medical Sciences
2022 Phase 4 NCT05340985 -
25OH-vitamin D
Charité - Universitätsmedizin Berlin
2011 Phase 2 EUCTR2011-002785-20-DE Germany
2b3-201
BBB-Therapeutics B.V.
2013 Phase 1 NCT02048358 Netherlands
3 MG melatonin
Providence Health & Services
2018 Early Phase 1 NCT03498131 United States
3,4-diaminopyridine
Assistance Publique - Hôpitaux de Paris
2005 Phase 3 NCT00190268 France
University of Aarhus
2006 Phase 2 NCT00342381 Denmark
4 MA transcranial direct current stimulation
University of Iowa
2022 - NCT04391023 United States
4-aminopyridine
Acorda Therapeutics
2003 Phase 2 NCT00053417 Canada;United States
Coordinación de Investigación en Salud, Mexico
2014 Phase 2 NCT02280096 Mexico
IRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO
2016 Phase 4 EUCTR2014-004650-34-IT Italy
4-AP
Acorda Therapeutics
2003 Phase 2 NCT00053417 Canada;United States
IRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO
2016 Phase 4 EUCTR2014-004650-34-IT Italy
4.5 MG naltrexone
University of California, San Francisco
2007 Phase 3 NCT00501696 United States
40 MG GA
Teva Pharmaceutical Industries Ltd.
2010 Phase 3 EUCTR2009-018084-27-IT Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Lithuania;United Kingdom
Teva Pharmaceutical Industries, Ltd.
2010 Phase 3 EUCTR2009-018084-27-LT Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-HU Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-GB Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-EE Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-DE Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-CZ Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-BG Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2007 - EUCTR2006-002037-20-EE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-LV Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-LT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-HU Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-GB Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 Phase 3 EUCTR2006-002037-20-FI Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-DE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-BE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Teva Pharmaceuticals Industries Ltd.
2006 - EUCTR2006-002037-20-IT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
40 MG glatiramer acetate
Teva Pharmaceutical Industries Ltd.
2010 Phase 3 EUCTR2009-018084-27-IT Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Lithuania;United Kingdom
Teva Pharmaceutical Industries, Ltd.
2010 Phase 3 EUCTR2009-018084-27-LT Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-HU Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-GB Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-EE Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-DE Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-CZ Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-BG Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2007 - EUCTR2006-002037-20-EE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-LV Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-LT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-HU Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-GB Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 Phase 3 EUCTR2006-002037-20-FI Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-DE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-BE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
40 MG glatiramer acetato
Teva Pharmaceuticals Industries Ltd.
2006 - EUCTR2006-002037-20-IT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
40MG OF mitoq
VA Office of Research and Development
2020 Phase 1/Phase 2 NCT04267926 United States
5 MG melatonin
Providence Health & Services
2018 Early Phase 1 NCT03498131 United States
5000IU vitamin D
University College Dublin
2012 Phase 1/Phase 2 NCT01728922 Ireland
52069.00.01
Philipps-Universität Marburg
2010 Phase 4 EUCTR2009-011088-35-DE Germany
6 months weight resistance and balance program
University of Nebraska
2013 - NCT01816100 United States
89 ZR-DF-crefmirlimab
National Institute of Neurological Disorders and Stroke (NINDS)
2023 Phase 1 NCT05849467 United States
9060X
Allergan
2008 - EUCTR2006-006299-39-NL France;Netherlands
2008 Phase 3 EUCTR2006-006299-39-FR France;Netherlands
Allergan Ltd.
2013 - EUCTR2012-000957-30-PT Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2013 - EUCTR2012-000957-30-GB Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2012 - EUCTR2012-000957-30-CZ Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2012 - EUCTR2012-000957-30-BE Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
95% pure ecgc capsules 200MG
Louisiana State University Health Sciences Center in New Orleans
2015 Phase 2 NCT02011451 United States
A4I antagonist
Hoffmann-La Roche
2007 Phase 2 NCT00104143 Bulgaria;Canada;Czech Republic;Finland;Germany;Poland;Russian Federation;Slovakia;Spain;United Kingdom;United States
AB1010
AB SCIENCE
2022 Phase 3 EUCTR2021-000639-30-IT Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
AB Science
2022 Phase 3 EUCTR2021-000639-30-NO Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000639-30-GR Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000639-30-ES Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000639-30-DE Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000639-30-BG Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-000639-30-FR Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-003735-32-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Colombia;Germany;Greece;Italy;Mexico;Slovakia;Spain;Switzerland;United Kingdom
2015 Phase 3 EUCTR2012-003735-32-GR Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom
2015 Phase 3 EUCTR2010-021219-17-BG Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
2013 - EUCTR2010-021219-17-PL Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain
2013 Phase 3 EUCTR2010-021219-17-GR Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey
2012 Phase 3 EUCTR2010-021219-17-SK Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-021219-17-ES Bulgaria;Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;United States
2011 Phase 3 EUCTR2010-021219-17-DE Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
ABA-101
Abata Therapeutics
2024 Phase 1 NCT06566261 United States
Abatacept
Bristol-Myers Squibb
2001 Phase 2 NCT00035529 United States
National Institute of Allergy and Infectious Diseases (NIAID)
2010 Phase 2 NCT01116427 Canada;United States
Abobotulinumtoxin A
Neurology Center of New England P.C.
2018 Phase 3 NCT03585569 United States
ABP 692
Amgen
2025 Phase 3 NCT06700343 Georgia;Serbia;Switzerland;United States
ABR-215062
TEVA
2005 - EUCTR2004-003943-28-IT Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
Teva Pharmaceutical Industries Ldt
2005 Phase 2 EUCTR2005-004334-41-IT Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
ABR-215062 sodium salt
Teva Pharmaceutical Industries Ltd
2010 Phase 3 EUCTR2009-015815-42-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain
2010 Phase 3 EUCTR2009-015815-42-PL Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-LT Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-EE Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-CZ Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-BG Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-012989-30-SE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012989-30-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012989-30-BG Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012989-30-AT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-NL Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-LT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-HU Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-GB Austria;Bulgaria;Canada;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2009-012989-30-EE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 - EUCTR2009-011234-99-DE Germany
2008 - EUCTR2007-003226-19-PT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2007-003226-19-LT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2007-003226-19-BG Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-SE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-NL Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-LV Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-HU Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-GB Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 Phase 3 EUCTR2007-003226-19-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 Phase 3 EUCTR2007-003226-19-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-EE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-DE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-AT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-GB Czech Republic;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-DE Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-CZ Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
2005 Phase 2 EUCTR2005-004334-41-HU Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
2005 - EUCTR2004-003943-28-HU Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 Phase 2 EUCTR2004-003943-28-GB Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 Phase 2 EUCTR2004-003943-28-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 - EUCTR2004-003943-28-DE Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 - EUCTR2004-003943-28-CZ Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
ABT-555
AbbVie
2016 Phase 1 NCT02601885 United States
2015 Phase 1 NCT02606630 United Kingdom
ABT-874/human monoclonal antibody against IL-12
AbbVie (prior sponsor, Abbott)
2004 Phase 2 NCT00086671 Canada;Germany;Netherlands;United Kingdom;United States
ABX-1431 HCL
Abide Therapeutics
2017 Phase 1 NCT03138421 United Kingdom
Acetaminophen tablet 650MG
Columbia University
2019 Phase 3 NCT03824938 United States
Acetazolamide
The University of Texas Health Science Center, Houston
2016 Phase 2 NCT02466074 United States
Acetylsalicylic acid
Biogen
2014 Phase 4 NCT02090413 Ireland;United Kingdom
Biogen Idec Research Limited
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom
Columbia University
2017 Early Phase 1 NCT03051646 United States
Aciclovir
Genzyme, a Sanofi Company
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain
Aclasta 5 MG infusionslösung
Novartis Pharma GmbH
2010 - EUCTR2009-011888-37-DE Germany
Aclasta 5MG solution FOR infusion
North Bristol Trust
2009 - EUCTR2008-005304-93-GB United Kingdom
ACT
Janssen-Cilag International NV
2023 Phase 3 EUCTR2020-004431-24-BE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
ACT-1
Actelion Pharmaceuticals Ltd
2015 Phase 3 EUCTR2012-000540-10-LV Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-GR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FI Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-CZ Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
ACT-128800
ACTELION Pharmaceuticals Ltd
2010 Phase 2 EUCTR2009-011470-15-PL Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-NL Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-HU Australia;Austria;Bulgaria;Canada;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-GB Austria;Bulgaria;Canada;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-FI Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-011470-15-ES Austria;Bulgaria;Czech Republic;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2010 Phase 2 EUCTR2009-011470-15-DE Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-CZ Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-BG Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-AT Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
ACTELION Pharmaceuticals Ltd.
2010 Phase 2 EUCTR2009-011470-15-SE Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Actelion Pharmaceuticals Ltd
2015 Phase 3 EUCTR2012-000540-10-SE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-PT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-PL Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LV Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-HU Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-HR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-GR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FI Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-ES Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-DE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-CZ Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-IT Austria;Bulgaria;Czech Republic;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2010 Phase 2 EUCTR2008-006786-92-FR Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 - EUCTR2008-006786-92-SE Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 - EUCTR2008-006786-92-PL Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 - EUCTR2008-006786-92-NL Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 - EUCTR2008-006786-92-HU Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 - EUCTR2008-006786-92-GB Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 - EUCTR2008-006786-92-FI Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 Phase 2 EUCTR2008-006786-92-ES Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 Phase 2 EUCTR2008-006786-92-CZ Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 - EUCTR2008-006786-92-BG Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 Phase 2 EUCTR2008-006786-92-BE Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 - EUCTR2008-006786-92-AT Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
Actelion Pharmaceuticals Ltd.
2019 Phase 3 EUCTR2012-000541-12-HR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Mexico;Poland;Portugal;Russian Federation;Spain;Switzerland;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-RO Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-PT Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-LV Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-HU Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-HR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-GR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-GB Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-FI Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-CZ Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-BG Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2012-000541-12-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2017 Phase 3 EUCTR2016-004719-10-SE Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2016-004719-10-PL Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2016-004719-10-LT Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2016-004719-10-ES Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2012-000541-12-PL Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2017 Phase 3 EUCTR2012-000541-12-FR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2017 Phase 3 EUCTR2012-000541-12-FI Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2017 Phase 3 EUCTR2012-000541-12-BG Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-PT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-HU Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-GR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-ES Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-DK Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-DE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-CZ Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-AT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2009 - EUCTR2008-006786-92-IT Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
ACT-128800 dose 1
Actelion
2009 Phase 2 NCT01006265 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
ACT-128800 dose 2
Actelion
2009 Phase 2 NCT01006265 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
ACT-128800 dose 3
Actelion
2009 Phase 2 NCT01006265 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Acth
Neurologique Foundation, Inc.
2009 Phase 2/Phase 3 NCT00947895 United States
Providence Health & Services
2015 Phase 3 NCT02315872 United States
University of Colorado, Denver
2013 Phase 4 NCT01838174 United States
University of Minnesota
2014 Phase 2 NCT01950234 United States
University of Southern California
2009 Phase 1 NCT01049451 United States
Weill Medical College of Cornell University
2016 Phase 4 NCT02446886 United States
Acthar
Elliot Frohman
2009 Phase 4 NCT00854750 United States
OhioHealth
2014 - NCT02258217 United States
University of Chicago
2016 Phase 4 NCT03021317 -
Weill Medical College of Cornell University
2016 Phase 4 NCT02446886 United States
Acthar GEL
Aaron Miller
2013 - NCT01900093 United States
Tanner Foundation for Multiple Sclerosis
2013 - NCT01906684 United States
The University of Texas Health Science Center, Houston
2013 Phase 4 NCT01888354 United States
University of Colorado, Denver
2013 Phase 4 NCT01838174 United States
Activated charcoal
Sanofi
2023 Phase 3 NCT06141473 Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
Active control
Biogen
2014 Phase 1 NCT02201849 United States
Acyclovir
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 1 NCT02583594 Spain
2014 Phase 1 NCT02282826 Germany
Sanofi
2016 Phase 1 NCT02977533 Germany
AD26.COV2.S
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States
Adderall XR
Sarah Morrow
2016 Phase 2/Phase 3 NCT02676739 Canada
Adderall XR 10 MG
London Health Sciences Centre
2012 Phase 2/Phase 3 NCT01667484 Canada
Adderall XR 5MG
London Health Sciences Centre
2012 Phase 2/Phase 3 NCT01667484 Canada
Adenosine
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Adezunap
Apurano Pharmaceuticals GmbH
2023 Phase 3 NCT06072001 Germany
2023 Phase 3 NCT06071949 Germany
Adherence counseling
Biogen
2015 Phase 4 NCT02343159 United States
Adipose tissue-derived mesenchymal stromal cells
Rennes University Hospital
2025 Phase 1 NCT06592703 France
Adrenocorticotropic hormone
State University of New York at Buffalo
2013 Phase 3 NCT02290444 United States
Weill Medical College of Cornell University
2016 Phase 4 NCT02446886 United States
ADS-5102
Adamas Pharmaceuticals, Inc.
2015 Phase 2 NCT02471222 United States
ADS-5102, 137 MG
Adamas Pharmaceuticals, Inc.
2018 Phase 3 NCT03436199 Canada;United States
ADS-5102, 274 MG
Adamas Pharmaceuticals, Inc.
2018 Phase 3 NCT03567057 Canada;United States
2018 Phase 3 NCT03436199 Canada;United States
Aerobic training
Istituto Auxologico Italiano
2016 - NCT06051019 -
Aert, (R)-baclofen
Osmotica Pharmaceutical US LLC
2018 Phase 3 EUCTR2017-004101-40-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004101-40-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004101-40-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
Agee cream
University of Nebraska
2010 Phase 4 NCT00988988 United States
Ahsc
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany
Aimspro
Daval International Limited
2008 Phase 2 EUCTR2006-006872-39-GB United Kingdom
AIN
NOVARTIS FARMA
2013 - EUCTR2012-004019-29-IT Argentina;Canada;Colombia;Finland;Germany;Italy;Japan;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
AIN457
NOVARTIS FARMA
2013 - EUCTR2012-004019-29-IT Argentina;Canada;Colombia;Finland;Germany;Italy;Japan;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
Novartis Farmacéutica, S.A.
2013 - EUCTR2012-004019-29-ES Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
Novartis Pharma AG
2013 - EUCTR2012-004019-29-SE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 - EUCTR2012-004019-29-PT Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 - EUCTR2012-004019-29-PL Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 - EUCTR2012-004019-29-FI Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 - EUCTR2012-004019-29-DE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 Phase 2 EUCTR2012-004019-29-CZ Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 Phase 2 EUCTR2012-004019-29-BE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
Novartis Pharma K.K.
2013 Phase 2 JPRN-jRCT2080222132 -
Novartis Pharma Services AG
2012 - EUCTR2011-001629-25-CZ Czech Republic;Russian Federation;Ukraine
2009 Phase 2 EUCTR2009-011626-34-SE Czech Republic;Sweden
2009 - EUCTR2009-011626-34-CZ Czech Republic;Russian Federation;Serbia;Sweden;Ukraine
Novartis Pharmaceuticals
2013 Phase 2 NCT01874340 Belgium;Canada;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2012 Phase 2 NCT01433250 Czech Republic;Russian Federation;Ukraine
2009 Phase 2 NCT01051817 Czech Republic;Russian Federation;Serbia;Sweden;Ukraine
Albuterol
National Institute of Allergy and Infectious Diseases (NIAID)
2001 - NCT00039988 United States
Alcohol wipes VS. NO alcohol wipes
Teva Neuroscience, Inc.
2004 Phase 4 NCT00220922 United States
Alemtuzumab
Biogen
2021 - NCT05688436 United States
Cambridge University Hospitals NHS Foundation Trust
2012 Phase 1/Phase 2 NCT01712945 United Kingdom
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom
Central Texas Neurology Consultants
2011 Phase 3 NCT01333358 -
GENZYME CORPORATION
2017 Phase 3 EUCTR2016-003100-30-IT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
Genzyme Corporation
2017 Phase 3 EUCTR2016-003100-30-PT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-NO Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-NL Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-GR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-GB Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-ES Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-DE Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-BE Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-AT Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 3;Phase 4 EUCTR2013-003884-71-NL Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3;Phase 4 EUCTR2013-003884-71-DK Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3;Phase 4 EUCTR2013-003884-71-BE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2015 Phase 3 EUCTR2009-010788-18-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2014 Phase 4 EUCTR2014-000092-62-NL Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-FR Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-ES Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-BE Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 3;Phase 4 EUCTR2013-003884-71-IT Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3;Phase 4 EUCTR2013-003884-71-HR Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2014 Phase 3;Phase 4 EUCTR2013-003884-71-ES Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3;Phase 4 EUCTR2013-003884-71-DE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2014 Phase 3;Phase 4 EUCTR2013-003884-71-CZ Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2009-010788-18-IT Austria;Belgium;Czech Republic;Denmark;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-010788-18-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-010788-18-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-010788-18-ES Austria;Belgium;Czech Republic;Denmark;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-010788-18-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-010788-18-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-010788-18-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-010788-18-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 - EUCTR2009-010788-18-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-010788-18-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-NL Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-IT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-001162-32-CZ Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-AT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001161-14-SE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 - EUCTR2007-001161-14-PL Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 Phase 3 EUCTR2007-001161-14-FR Czech Republic;France;Germany;Poland;Sweden;United Kingdom
2008 - EUCTR2007-001161-14-DE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 - EUCTR2007-001161-14-CZ Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2007 Phase 3 EUCTR2007-001162-32-GB Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2007 - EUCTR2007-001161-14-GB Czech Republic;France;Germany;Poland;Sweden;United Kingdom
- Phase 3 EUCTR2016-003100-30-PL Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-Outside-EU/EEA Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-FR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-BG Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
Genzyme GmbH
2016 Phase 3 EUCTR2016-000464-42-DE Germany
Genzyme, a Sanofi Company
2015 - NCT03774914 Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
2009 Phase 3 NCT00930553 Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2007 Phase 3 NCT00530348 Argentina;Australia;Brazil;Canada;Croatia;Czech Republic;Former Serbia and Montenegro;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;United States
Glostrup University Hospital, Copenhagen
2017 - NCT03193086 Denmark
Hadassah Medical Organization
2015 - NCT02529839 -
Haukeland University Hospital
2018 Phase 3 NCT03477500 Denmark;Netherlands;Norway;Sweden
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
Queen Mary University of London
2022 - NCT06310343 United Kingdom
2017 - NCT03250169 United Kingdom
R&D Addenbrookes Hospital
2008 Phase 2 EUCTR2005-002305-23-GB United Kingdom
Seah Lim M.D.
2012 Phase 2 NCT01679041 United States
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University Hospital Muenster
2015 Phase 4 NCT02419378 Germany
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany
University of Aarhus
2017 - NCT03806387 Denmark
University of British Columbia
2003 - NCT06705608 -
University of Chicago
2011 Phase 4 NCT01395316 -
University of Texas Southwestern Medical Center
2018 Phase 4 NCT03135249 United States
Universitätsklinikum Hamburg-Eppendorf
2021 Phase 2 NCT04971005 Germany
Universitätsklinikum Münster
2014 Phase 4 EUCTR2014-000709-10-DE Germany
Alemtuzumab 12 MG
Genzyme, a Sanofi Company
2007 Phase 3 NCT00548405 Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2002 Phase 2 NCT00050778 Croatia;Poland;Russian Federation;United Kingdom;United States
Alemtuzumab 24 MG
Genzyme, a Sanofi Company
2007 Phase 3 NCT00548405 Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2002 Phase 2 NCT00050778 Croatia;Poland;Russian Federation;United Kingdom;United States
Alemtuzumab GZ402673
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 1 NCT02583594 Spain
2015 Phase 4 NCT02255656 Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain
Alemtuzumab immunotherapy
Samuel Forrester Hunter, MD, PhD
2012 Phase 1 NCT01624714 United States
Alemtuzumab injection
Maritime Neurology
2016 - NCT04633967 Canada
University Hospital Muenster
2017 - NCT04082260 Germany
Alfuzosin
Capital District Health Authority, Canada
2007 Phase 2/Phase 3 NCT00688948 Canada
Alks 8700
Alkermes, Inc.
2019 Phase 3 EUCTR2017-001294-16-DE Germany;Poland;United States
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States
Biogen
2017 Phase 3 NCT03093324 Germany;Poland;United States
Alks 8700 delayed release (DR) capsule
Alkermes, Inc.
2016 Phase 3 EUCTR2015-005160-41-ES Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2016 Phase 3 EUCTR2015-005160-41-BG Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2016 Phase 3 EUCTR2015-005160-41-BE Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
Biogen Idec Research Limited
2016 Phase 3 EUCTR2015-005160-41-PL Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2016 Phase 3 EUCTR2015-005160-41-DE Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
ALL patients IN THE study will BE treated with ocrelizumab
Providence Health & Services
2020 - NCT05081700 United States
Allogeneic fecal microbiota
St. Petersburg State Pavlov Medical University
2019 Phase 1 NCT04203017 Russian Federation
Allogeneic human umbilical cord tissue-derived mesenchymal stem cells
Genesis Limited
2015 Phase 1/Phase 2 NCT02418325 Trinidad and Tobago
Novo Cellular Medicine Institute LLP
2015 Phase 1/Phase 2 NCT02587715 Trinidad and Tobago
Allogeneic umbilical cord mesenchymal stem cells
Ever Supreme Bio Technology Co., Ltd.
2023 Phase 1/Phase 2 NCT05532943 Taiwan
Allogenic placenta derived mesenchymal stem cells
Tehran University of Medical Sciences
2019 Phase 1 NCT06360861 Iran, Islamic Republic of
Allorx
The Foundation for Orthopaedics and Regenerative Medicine
2021 Phase 1 NCT05003388 Antigua and Barbuda;Argentina;Greece;Mexico
Alpha lipoic acid
Rebecca Spain
2018 Phase 1 NCT03493841 United States
University of Iowa
2010 Phase 1 NCT01381354 United States
Alpha-lipoic acid
National Center for Complementary and Integrative Health (NCCIH)
1999 Phase 1/Phase 2 NCT00010842 United States
Alpha1-antitrypsin
Stanford University
2014 Phase 1 NCT02087813 United States
Altri farmaci DEL sistema nervoso
GLAXO SMITHKLINE
2004 - EUCTR2004-000374-31-IT Italy
ALXN1210
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 3 EUCTR2019-003352-37-IT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
Alexion Pharmaceuticals, Inc.
2022 Phase 2;Phase 3 EUCTR2021-006075-42-FR Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2022 Phase 2;Phase 3 EUCTR2021-006075-42-ES Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2020 Phase 3 EUCTR2019-003352-37-PL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-NL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-ES Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-DK Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-DE Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-AT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
- Phase 2;Phase 3 EUCTR2021-006075-42-DE Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Amantadine
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
2011 - EUCTR2010-023678-38-IT Italy
Johns Hopkins University
2017 Phase 3 NCT03185065 United States
Amantadine hydrochloride
Fundación para la Inv. Biomédica Hospital Clínico San Carlos
2022 Phase 4 EUCTR2021-004868-95-ES Spain
Amantadine hydrochloride 100 MG (milligrams) oral capsule
Hospital San Carlos, Madrid
2022 Phase 3 NCT05809414 Spain
Amantadine level
Fundación para la Inv. Biomédica Hospital Clínico San Carlos
2022 Phase 4 EUCTR2021-004868-95-ES Spain
American ginseng extract HT-1001
Oregon Health and Science University
2005 Phase 2 NCT00754832 United States
Amiloride
UCL
2014 Phase 2 EUCTR2012-005394-31-GB United Kingdom
University College, London
2014 Phase 2 NCT01910259 United Kingdom
University of Oxford
2013 Phase 2 NCT01802489 United Kingdom
Amiloride hydrochloride
Oxford Racliffe NHS Trust
2008 - EUCTR2007-004051-11-GB United Kingdom
Amiloride hydrochloride, 2 H2O
Universitätsklinik für Neurologie, Medizinische Universität Wien
2013 - EUCTR2012-005113-39-AT Austria
Amilostad HCT tablets
Universitätsklinik für Neurologie, Medizinische Universität Wien
2013 - EUCTR2012-005113-39-AT Austria
Amniotic fluid or placental CD117 stem cells
Wake Forest University Health Sciences
2026 Phase 1/Phase 2 NCT06841068 United States
Ampyra
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
2011 - EUCTR2010-023678-38-IT Italy
MGH Institute of Health Professions
2024 Phase 4 NCT06136728 United States
Amyvid radiopharmaceutical
Brain Health Alliance
2024 Early Phase 1 NCT04390009 United States
AN100226
BIOGEN IDEC LTD
2011 - EUCTR2010-024000-10-IT Belgium;Germany;Italy;Spain
Biogen Idec Limited
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain
Biogen Idec Ltd.
2004 - EUCTR2004-000047-18-SE Sweden
AN100226, BG00002
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-002145-11-IT Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
Biogen Idec Limited
2012 Phase 3 EUCTR2010-021978-11-IE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2012 - EUCTR2010-021978-11-BE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-SE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-PL Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-GB Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-FI Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-ES Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-DK Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-DE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Iraq;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-CZ Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-002145-11-NL Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-FR Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-ES Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-DE Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2015 - EUCTR2013-005586-39-DE Germany;Italy;United States
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2013 - EUCTR2012-005082-13-IT Italy
Anakinra
National Institute of Neurological Disorders and Stroke (NINDS)
2019 Phase 1/Phase 2 NCT04025554 United States
Androgel 1 % topical GEL
University of California, Los Angeles
2018 Phase 2 NCT03000127 United States
Androgel 10 grams OF GEL containing 100 MG OF testosterone
University of California, Los Angeles
2002 Phase 1/Phase 2 NCT00405353 United States
Andrographolides
Innobioscience SpA
2014 Phase 1/Phase 2 NCT02273635 Chile
Anesthetic topical adhesive synera
Brown, Theodore R., M.D., MPH
2013 Phase 4 NCT01834586 United States
ANK-700
Anokion SA
2020 Phase 1 NCT04602390 United States
Anti LP40 antibody, subclass IGG4 LA294
Eli Lilly and Company
2010 - EUCTR2008-007459-28-BG Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-HU Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 Phase 2 EUCTR2008-007459-28-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-DK Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-DE Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-CZ Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-BE Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
ANTI-aquaporin-4 antibody
Pontificia Universidade Católica do Rio Grande do Sul
2017 - NCT03087136 Brazil
ANTI-baffr cart
Tianjin Medical University General Hospital
2024 Phase 1/Phase 2 NCT06561009 -
ANTI-CD20 antibody
Heinrich-Heine University, Duesseldorf
2021 - NCT06586177 Germany
ANTI-CD20 MAB
Kyverna Therapeutics
2024 Phase 2 NCT06384976 United States
ANTI-CD20 monoclonal antibody
Region Stockholm
2025 - NCT06711354 -
ANTI-CD20 MS treatment
Washington University School of Medicine
2024 - NCT06591429 United States
ANTI-CD25 humanized monoclonal antibody
PDL BioPharma, Inc.
2005 Phase 2 NCT00109161 Canada;United States
Protein Design Labs, Inc.
2006 - EUCTR2005-001567-55-DE Germany;Spain;United Kingdom
2005 Phase 2 EUCTR2005-001567-55-GB Austria;Germany;Spain;United Kingdom
2005 Phase 2 EUCTR2005-001567-55-ES Austria;Germany;Spain;United Kingdom
2005 - EUCTR2005-001567-55-AT Austria;Germany;Spain;United Kingdom
ANTI-CD52 monoclonal antibody
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom
ANTI-mullerian hormone (AMH) level
University Hospital, Bordeaux
2023 - NCT05754593 France
ANTI-myelin oligodendrocyte glycoprotein
Pontificia Universidade Católica do Rio Grande do Sul
2017 - NCT03087136 Brazil
ANTI-thymocyte globulin
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States
Anticholinergic medication
Wellspect HealthCare
2009 - NCT00913510 Belgium;France;Germany;Netherlands;United Kingdom
Anticuerpo monoclonal ANTI-lingo-1 humano
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-ES Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
Antihistamine
Genentech, Inc.
2016 Phase 3 NCT02688985 Canada;Germany;Sweden;United States
Hoffmann-La Roche
2020 Phase 3 NCT04548999 Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 NCT04544436 Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Antimycotic
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy
Antithymocyte
Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
2006 - EUCTR2006-002562-19-IT Italy
Antithymocyte immunoglobulin
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
Anxiety
Ankara Yildirim Beyazit University
2019 - NCT04408742 Turkey
Anxiety/depression and work and activities
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France
Apitox - pure honeybee toxin
Apimeds, Inc.
2019 Phase 3 NCT03710655 -
Arbaclofen
RVL Pharmaceuticals, Inc.
2026 Phase 3 NCT05179577 -
2013 Phase 3 NCT01844232 Russian Federation;Ukraine;United States
2012 Phase 3 NCT01743651 Russian Federation;Ukraine;United States
Arbaclofen ER tablets
RVL Pharmaceuticals, Inc.
2016 Phase 3 NCT02869425 United States
Arbaclofen extended release tablets
Osmotica Pharmaceutical US LLC
2018 Phase 3 EUCTR2017-004101-40-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004101-40-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004101-40-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
Arbaclofen placarbil
XenoPort, Inc.
2011 Phase 3 NCT01360489 United States
Arbaclofen placarbil 15 MG BID
XenoPort, Inc.
2011 Phase 3 NCT01359566 United States
Arbaclofen placarbil 30 MG BID
XenoPort, Inc.
2011 Phase 3 NCT01359566 United States
Arbaclofen placarbil 45 MG BID
XenoPort, Inc.
2011 Phase 3 NCT01359566 United States
Aricept
OSPEDALE S. RAFFAELE
2008 - EUCTR2008-001940-38-IT Italy
Aricept 10 MG filmdragerade tabletter
Neurology Unit
2005 - EUCTR2005-003410-15-SE Sweden
Aricept 5 MG filmdragerade tabletter
Neurology Unit
2005 - EUCTR2005-003410-15-SE Sweden
ARM 1 - GEH120714 (18F) injection
GE Healthcare
2013 Phase 1 NCT01738347 Canada;United States
Armodafinil
University of Missouri, Kansas City
2009 Phase 2/Phase 3 NCT00981084 United States
ARN-6039
Arrien Pharmaceuticals
2016 Phase 1 NCT03237832 -
Arzerra
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD.
2012 - EUCTR2011-002333-19-IT Canada;Czech Republic;Germany;Italy;Netherlands;Russian Federation;Spain;United States
GlaxoSmithKline Research and Development Limited
2012 - EUCTR2011-002333-19-CZ Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
2011 - EUCTR2011-002333-19-NL Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
2011 Phase 2 EUCTR2011-002333-19-DK Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
GlaxoSmithKline SA
2011 Phase 2 EUCTR2011-002333-19-ES Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
Novartis Farmacéutica S.A.
2020 Phase 3 EUCTR2019-001341-40-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States
Novartis Farmacéutica, S.A
2019 Phase 3 EUCTR2017-004703-51-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
Novartis Farmacéutica, S.A.
2018 Phase 2 EUCTR2017-004702-17-ES Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2016 Phase 3 EUCTR2015-005419-33-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-ES Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2016 Phase 3 EUCTR2015-005419-33-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
Novartis Pharma AG
2020 Phase 3 EUCTR2019-001341-40-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-NO Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 2 EUCTR2017-004702-17-PL Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 3 EUCTR2017-004703-51-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 2 EUCTR2017-004702-17-LV Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-LT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-EE Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-CZ Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-BG Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-AT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2017 Phase 3 EUCTR2015-005418-31-FR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HU Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BE Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-NL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-CZ Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-PL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GB Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-EE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BG Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Arzerra - 100 MG - concentrato PER soluzione PER infusione - USO endovenoso - flacone(vetro) - 5 ML(20MG/ML) 3 flaconi
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
Arzerra - 1000 MG - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino (vetro) - 50 ML (20 MG/ML) 1 flaconcino + 2 KIT DI prolunga
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
ASA
Biogen
2014 Phase 4 NCT02090413 Ireland;United Kingdom
Biogen Idec Research Limited
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom
ASB-683699
GLAXO SMITHKLINE
2004 - EUCTR2004-000374-31-IT Italy
Aspirin
Mayo Clinic
2007 Phase 3 NCT00467584 United States
Aspirin 650MG oral capsule
Columbia University
2019 Phase 3 NCT03824938 United States
Assessment OF disability
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France
Assessment OF impact OF MS ON cognition
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France
AT-home natalizumab treated MS patient
Nantes University Hospital
2021 - NCT04777539 France
ATA188
Atara Biotherapeutics
2017 Phase 1/Phase 2 NCT03283826 Australia;Canada;United States
Atacicept
EMD Serono
2008 Phase 2 NCT00642902 Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Lebanon;Lithuania;Netherlands;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Merck Serono Geneva- an affiliate of Merck KGaA, Darmstadt Germany
2008 - EUCTR2007-003936-50-SE Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Merck Serono International
2009 - EUCTR2008-005021-11-SE Belgium;Czech Republic;France;Sweden
2009 Phase 2 EUCTR2008-005021-11-FR Belgium;Czech Republic;France;Sweden
2009 Phase 2 EUCTR2008-005021-11-CZ Belgium;Czech Republic;France;Sweden
Merck Serono International S.A.
2008 - EUCTR2007-003936-50-NL Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2008 Phase 2 EUCTR2007-003936-50-FR Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2008 Phase 2 EUCTR2007-003936-50-ES Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Merck Serono S.A. - Geneva
2008 - EUCTR2007-003936-50-GB Australia;Austria;Canada;Czech Republic;France;Lebanon;Lithuania;Netherlands;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-003936-50-AT Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Merck Serono SA - Geneva, An affiliate of Merck KGaA, Darmstadt, Germany
2009 - EUCTR2008-005021-11-BE Belgium;Czech Republic;France;Sweden
Merck Serono SA - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2008 - EUCTR2007-003936-50-CZ Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2008 - EUCTR2007-003936-50-BE Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Merck Serono SA-Geneva
2008 - EUCTR2007-003936-50-LT Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Atacicept 150 MG
EMD Serono
2009 Phase 2 NCT00853762 Australia;Belgium;Canada;Czech Republic;France;Germany;Lebanon;Lithuania;Netherlands;New Caledonia;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Atacicept 25 MG
EMD Serono
2009 Phase 2 NCT00853762 Australia;Belgium;Canada;Czech Republic;France;Germany;Lebanon;Lithuania;Netherlands;New Caledonia;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Atacicept 75 MG
EMD Serono
2009 Phase 2 NCT00853762 Australia;Belgium;Canada;Czech Republic;France;Germany;Lebanon;Lithuania;Netherlands;New Caledonia;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
ATG
Baylor College of Medicine
1999 Phase 2 NCT00040482 United States
ATL1102
Antisense Therapeutics Ltd.
2007 Phase 2 EUCTR2006-004736-79-SK Czech Republic;Slovakia
2007 - EUCTR2006-004736-79-CZ Czech Republic
Atomoxetine
Icahn School of Medicine at Mount Sinai
2017 Phase 2 NCT03091400 United States
Atorvastatin
DR DIMENSIONE RICERCA
2005 - EUCTR2005-001009-25-IT Italy
National Institute of Allergy and Infectious Diseases (NIAID)
2005 Phase 2 NCT00094172 Canada;United States
Sun Yat-sen University
2006 - NCT00818103 China
University Hospital Inselspital, Berne
2005 Phase 2 NCT00942591 Switzerland
ATX-MS-1467
Apitope Technology (Bristol) Ltd.
2010 Phase 1 NCT01097668 Russian Federation;United Kingdom
Merck KGaA
2014 Phase 2 NCT01973491 Germany
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation
Aubagio
Actelion Pharmaceuticals Ltd
2015 Phase 3 EUCTR2012-000540-10-SE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-PT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-PL Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LV Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-HU Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-HR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-GR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FI Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-ES Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-DE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-CZ Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Centre Hospitalier Universitaire de Nice
2017 Phase 3 NCT03122652 France;Germany;Martinique;Sweden;Switzerland;Turkey;United Kingdom
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-001168-28-IT Austria;Bulgaria;Denmark;Finland;France;Greece;Italy;Netherlands;United States
2021 Phase 3 EUCTR2019-004857-10-IT Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-001168-28-GR Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-DK Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-BG Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2019-004857-10-NL Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2021 Phase 3 EUCTR2019-004857-10-HU Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2021 Phase 3 EUCTR2019-004857-10-DE Algeria;Argentina;China;Dominican Republic;Egypt;Finland;France;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
2020 Phase 3 EUCTR2020-001168-28-FR Austria;Bulgaria;Denmark;Finland;France;Greece;Italy;Netherlands;United States
2020 Phase 3 EUCTR2019-004857-10-FI Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
GENZYME CORPORATION
2022 Phase 3 EUCTR2020-000644-55-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
Genzyme Corporation
2022 Phase 3 EUCTR2020-000644-55-EE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NO Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HR Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-BE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-RO Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2014 Phase 4 EUCTR2013-001439-34-IT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States
2014 Phase 4 EUCTR2013-001439-34-GR Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 Phase 4 EUCTR2013-001439-34-GB Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-DE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-BE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-AT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-SE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-FI Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-ES Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
MS Centrum, Department of Neurology, Sshlgrenska University Hospital
2018 Phase 4 EUCTR2016-004414-10-SE Sweden
Merck Healthcare KGaA
2022 Phase 3 EUCTR2019-004980-36-CZ Belarus;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-SI Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-RO Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-SK Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PL Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-NO Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LV Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-GR Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-ES Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-DE Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-BG Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
NOVARTIS PHARMA AG
2022 Phase 3 EUCTR2020-005929-89-IT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Japan;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-IT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Guatemala;Hong Kong;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
Novartis Farmacéutica S.A.
2022 Phase 3 EUCTR2020-005929-89-ES Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-ES Slovakia;Spain
Novartis Farmacéutica, S.A.
2016 Phase 3 EUCTR2015-005419-33-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-ES Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2016 Phase 3 EUCTR2015-005419-33-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
Novartis Pharma AG
2023 Phase 3 EUCTR2020-005899-36-LT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2023 Phase 3 EUCTR2020-005899-36-DK Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2023 Phase 3 EUCTR2020-005899-36-AT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;Finland;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SK Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SI Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-RO Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Türkiye;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-PT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-PL Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Türkiye;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-HR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-GR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-FR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-EE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-BG Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-SK Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-NL Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-LV Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-HR Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-BG Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-BE Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-FR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HU Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BE Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-NL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-CZ Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-PL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GB Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-EE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BG Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Turku University Hospital
2017 Phase 4 EUCTR2016-003622-16-FI Finland
Aubagio - 14 MG - compressa rivestita CON film - USO orale - bister (ALU/ALU) perforato monodose - 10 X 1 compressa
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Aubagio - 14 MG - compressa rivestita CON film - USO orale - blister (ALU/ALU) - 28 compresse
UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
2016 Phase 4 EUCTR2016-001515-20-IT Italy
Aubagio 14 MG FILM-coated tablets
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2019-004857-10-PT Algeria;Argentina;China;Dominican Republic;Egypt;Finland;France;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
Aubagio 14MG TBL FLM
Fakultní nemocnice Ostrava
2023 Phase 4 EUCTR2022-004331-23-CZ Czech Republic
2021 Phase 4 EUCTR2021-003195-13-CZ Czech Republic
Autologous adipose derived mesenchymal cells
American CryoStem Corporation
2014 Phase 1 NCT02326935 Cayman Islands
Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved
Banc de Sang i Teixits
2014 - EUCTR2012-000734-19-ES Spain
Autologous bone marrow transplantation
Hadassah Medical Organization
2015 - NCT02529839 -
Autologous bone marrow-derived mononuclear stem cells
Genesis Limited
2015 Phase 1/Phase 2 NCT02418351 India;Trinidad and Tobago
Novo Cellular Medicine Institute LLP
2015 Phase 1/Phase 2 NCT02587806 India;Trinidad and Tobago
Autologous CD4+T cells stimulated and expanded EX vivo BY A MOG peptide modified BY THE introduction OF A thioreductase motif into THE flanking residues OF THE T cell epitope
Imcyse SA
2015 Phase 1/Phase 2 NCT02427776 Belgium
Autologous HB-admscs
Hope Biosciences
2025 Phase 2 NCT06800404 United States
Autologous hematopoietic stem cell
Makati Medical Center
2015 Phase 1 NCT03113162 Philippines
Autologous hematopoietic stem cell transplant
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States
Autologous hematopoietic stem cell transplantation
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
National Institute of Allergy and Infectious Diseases (NIAID)
2019 Phase 3 NCT04047628 United Kingdom;United States
Scripps Health
2023 - NCT05482542 United States
Universitätsklinikum Hamburg-Eppendorf
2021 Phase 2 NCT04971005 Germany
Autologous hematopoietic stem cells
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany
Autologous mesenchymal cell product
Imperial College London
2012 Phase 2 EUCTR2012-002357-35-GB United Kingdom
Autologous mesenchymal stem cell transplantation
The Cleveland Clinic
2011 Phase 1 NCT00813969 United States
Autologous mesenchymal stem cells
Albert Saiz
2010 Phase 2 NCT01228266 Spain
Antonio Uccelli
2012 Phase 1/Phase 2 NCT01854957 Italy
Karolinska Institutet
2013 Phase 1/Phase 2 NCT01730547 Sweden
2012 Phase 1 NCT03778333 Sweden
Tianjin Medical University General Hospital
2013 Phase 2 NCT02249676 China
University of Jordan
2012 Phase 1/Phase 2 NCT01895439 Jordan
Autologous myelin-derived peptide-pulsed tolerogenic dendritic cells
Antwerp University Hospital
2023 Phase 2 EUCTR2022-003465-38-BE Belgium;Spain
Autologous stem cell transplantation
Northwestern Memorial Hospital
2001 Phase 1 NCT00017628 United States
Autologous stem cells
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States
2017 Phase 3 NCT03342638 United States
Autologous T-lymphocytes
ImCyse S.A
2014 Phase 1;Phase 2 EUCTR2014-001081-99-BE Belgium
AV605
Avigen Inc
2007 - EUCTR2007-001031-63-DE Germany
2007 Phase 2 EUCTR2007-001031-63-CZ Czech Republic;Germany
Avonex
BIOGEN IDEC LTD
2010 - EUCTR2009-012500-11-IT Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
BIOGEN-DOMPE` SRL
2010 - EUCTR2009-017003-28-IT Italy
Bayer
2024 - NCT06053749 Finland;Sweden
Biocad
2017 Phase 2/Phase 3 NCT02744222 Russian Federation
Biogen
2023 - NCT05658497 Germany;Ireland;Spain;Switzerland;United States
2013 Phase 2 NCT01864148 Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
Biogen Idec
2010 Phase 3 NCT01181115 China
2010 - EUCTR2009-017490-38-DE Germany;Spain
2002 Phase 4 NCT00913666 -
1999 Phase 4 NCT00915460 -
Biogen Idec Ltd
2010 - EUCTR2009-012500-11-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-GR Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012500-11-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012500-11-FR Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012500-11-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-003098-42-CZ Czech Republic
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2017 Phase 3 EUCTR2013-002318-11-FR Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom
2016 - EUCTR2013-002318-11-ES Argentina;Belgium;Canada;Croatia;Czech Republic;Denmark;France;Hungary;Israel;Italy;Poland;Portugal;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom
2016 Phase 3 EUCTR2013-002318-11-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Türkiye;United Kingdom;United States
2015 Phase 3 EUCTR2013-002318-11-PL Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-SE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-IT Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3 EUCTR2013-002318-11-HU Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom
2014 Phase 3 EUCTR2013-002318-11-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-DK Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-CZ Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-IT Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-HU Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-GB Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-ES Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-CZ Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
- Phase 3 EUCTR2013-002318-11-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland
EMD Serono
1999 Phase 3 NCT00292266 -
EMD Serono Research & Development Institute, Inc.
2019 Phase 3 NCT04032171 Germany;United States
2019 Phase 3 NCT04032158 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
F.Hoffmann-La Roche Ltd.
2008 - EUCTR2007-006338-32-IT Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Russian Federation;Spain;Switzerland;Ukraine;United Kingdom;United States
Genentech, Inc.
2008 Phase 2 NCT00676715 Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-SK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
ISTITUTO C. MONDINO
2007 - EUCTR2008-007162-32-IT Italy
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
MedImmune LLC
2012 - EUCTR2011-005475-16-GB Austria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
Medizinische Universität Innsbruck
2014 - EUCTR2012-005450-30-SE Austria;Sweden
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden
Merck Healthcare KGaA
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
Merck KGaA
2014 - EUCTR2013-003126-83-HU Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-GR Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-ES Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-DE Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
Neurognostics
2006 - NCT00398528 United States
Novartis Farma
2013 Phase 3 EUCTR2011-005677-23-IT Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Farmaceutica S.A.
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-FR Austria;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Pharma Services AG
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
2006 - EUCTR2006-000704-17-PT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
PD Dr. Marcus Müller
2015 Phase 1 NCT02364986 Germany
Receptos, Inc.
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-IT Belgium;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Israel;Italy;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-GR Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-ES Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
Saint Francis Care
2012 - NCT01641120 United States
State University of New York at Buffalo
2005 - NCT00463710 United States
Teva Branded Pharmaceutical Products R&D, Inc.
2014 Phase 3 NCT01975298 Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2008 Phase 3 NCT00605215 Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Israel;Italy;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Montenegro;North Macedonia;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
Teva Pharmaceutical Industries, Ltd.
2014 - EUCTR2013-002082-19-NL Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2014 - EUCTR2013-002082-19-ES Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-SE Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 EUCTR2013-002082-19-GB Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-FI Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-DK Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 EUCTR2013-002082-19-BE Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
Trio Medicines Ltd.
2001 Phase 1 NCT01863069 United Kingdom
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
University of California, San Francisco
2006 Phase 2 NCT00501943 United States
Avonex (interferon BETA-1A), biogen idec LTD
Bayer
2016 - NCT02749396 Finland
Avonex - 30 MCG (6 milioni UI) polvere E solvente PER soluzione iniettabile 4 flaconi CON dispositivo bioset + 4 siringhe preriempite USO intramuscolare
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Avonex 30 microgram/0.5 ML solution FOR injection
Teva Pharmaceutical Industries Ltd
2008 Phase 3 EUCTR2007-005450-23-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Slovakia;Spain
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-DE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-CZ Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-BG Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
Avonex 30 microgramos/0,5 ML (interferóN beta - 1A) solucióN inyectable
Biogen Idec Ltd
2010 Phase 3 EUCTR2009-012500-11-ES Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
Avonex 30 microgramos/0.5 ML solucióN para inyeccióN
Teva Pharmaceutical Industries Ltd
2008 - EUCTR2007-005450-23-ES Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
Avonex 30 µG/0,5 ML solution FOR injection
Università degli Studi Aldo Moro
2019 Phase 3 EUCTR2017-005129-18-IT Italy
Avonex and topamax
Multiple Sclerosis Institute
2004 Phase 2 NCT00217295 United States
Avonex IM 4SIR 30MCG/0,5ML 4AG
Universita di Firenze
2006 Phase 3 EUCTR2006-004937-13-IT Italy
Avonex prefilled syringe VIA manual IM injection
Biogen
2009 Phase 3 NCT00828204 United States
Avonex*IM 4SIR 30MCG/0,5ML+4AG
TEVA ITALIA srl
2008 - EUCTR2007-005450-23-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
Avonex/betaseron/copaxone/rebif
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom
Avonex/zocor
University of North Carolina
2004 Phase 4 NCT00146068 United States
AVP-923
Avanir Pharmaceuticals
2011 Phase 2 NCT01324232 Argentina;Czech Republic;Czechia;Germany;Poland;Spain;United Kingdom;United States
2002 Phase 3 NCT00050232 United States
Avanir Pharmaceuticals, Inc.
2012 - EUCTR2011-002178-22-PL Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2012 Phase 2 EUCTR2011-002178-22-GB Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2012 - EUCTR2011-002178-22-CZ Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2011 Phase 2 EUCTR2011-002178-22-ES Argentina;Bulgaria;Czech Republic;Poland;Spain;United Kingdom;United States
Azathioprine
First Affiliated Hospital of Guangxi Medical University
2020 Phase 4 NCT05896605 China
Hoffmann-La Roche
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Isfahan University of Medical Sciences
2015 Phase 2/Phase 3 NCT03002038 Iran, Islamic Republic of
The Ophthalmology Department of the Chinese Peoples Liberation Army Hospital
2019 Phase 4 ChiCTR1900025744 China
2014 - ChiCTR-ICR-15007177 China
Tianjin Medical University General Hospital
2017 Phase 2/Phase 3 NCT03350633 China
Universita di Firenze
2006 Phase 3 EUCTR2006-004937-13-IT Italy
Azatioprina HEX. 50CPR 50MG BL
Universita di Firenze
2006 Phase 3 EUCTR2006-004937-13-IT Italy
Azithromycin
National Center for Research Resources (NCRR)
2001 Phase 2 NCT00043264 United States
B001
Shanghai Jiaolian Drug Research and Development Co., Ltd
2024 Phase 2/Phase 3 NCT06413654 China
B001 injection
Shanghai Pharmaceuticals Holding Co., Ltd
2022 Early Phase 1 NCT05145361 China
Bacille calmette-guerin vaccine
S. Andrea Hospital
2019 Phase 2 NCT03888924 Italy
Bacille OF calmette-guerin
S. Andrea Hospital
2001 Phase 2/Phase 3 NCT00202410 Italy
Baclofen
DAIICHI SANKYO COMPANY, LIMITED
2005 Phase 4 JPRN-jRCT1080220031 -
RVL Pharmaceuticals, Inc.
2012 Phase 3 NCT01743651 Russian Federation;Ukraine;United States
Baclofen 20 MG
IMPAX Laboratories, Inc.
2007 - EUCTR2007-000236-16-LV Estonia;Latvia
2007 - EUCTR2007-000236-16-EE Estonia;Latvia
Baclofen ER capsules (GRS) 10 MG
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States
Baclofen ER capsules (GRS) 20 MG
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States
Baclofen ER capsules (GRS) 30MG
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States
Baclofen ER capsules (GRS) 40MG
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States
Baclofen ER capsules (GRS) 50 MG
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States
Baclofen IR
Impax Laboratories, LLC
2009 Phase 2 NCT00914290 United States
Baclofen tablets USP 10 MG
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States
BAF312
NOVARTIS FARMA
2010 - EUCTR2009-014392-51-IT Finland;Germany;Hungary;Italy;Poland;Spain
2009 - EUCTR2008-008719-25-IT Finland;Germany;Hungary;Italy;Spain
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Novartis Farmacéutica, S.A
2009 - EUCTR2008-008719-25-ES Finland;Germany;Hungary;Italy;Spain
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-RO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Novartis Pharma K.K.
2014 Phase 3 JPRN-jRCT2080222397 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;United Kingdom;United States
Novartis Pharma Services AG
2010 Phase 2 EUCTR2009-014392-51-PL Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States
2010 Phase 2 EUCTR2009-014392-51-HU Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States
2010 Phase 2 EUCTR2009-014392-51-FI Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States
2010 - EUCTR2009-014392-51-DE Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States
2009 - EUCTR2008-008719-25-HU Finland;Germany;Hungary;Italy;Spain
2009 - EUCTR2008-008719-25-FI Finland;Germany;Hungary;Italy;Spain
- - EUCTR2008-008719-25-DE Finland;Germany;Hungary;Italy;Spain
Novartis Pharmaceuticals
2021 Phase 4 NCT04792567 Germany
2012 Phase 3 NCT01665144 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 2 NCT01185821 Canada;Finland;Germany;Hungary;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;Turkey;United States
2009 Phase 2 NCT00879658 Canada;Finland;Germany;Hungary;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;Turkey;United States
BAF312 0,25 MG tablet
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands
BAF312 1 MG tablet
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands
BAF312 4 MG tablet
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands
BAF312 hemifumarate
NOVARTIS FARMA
2012 Phase 3 EUCTR2012-003056-36-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2011-006043-30-NL Netherlands
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
BAF312A
NOVARTIS FARMA
2012 Phase 3 EUCTR2012-003056-36-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Bafiertam
Banner Life Sciences LLC
2019 Phase 1 NCT04022473 United States
BAL
McMaster University
2024 - NCT06461741 Canada
Balance exercise program using exoskeleton device
East Kent Hospitals University NHS Foundation Trust
2017 Phase 1 NCT05102682 United Kingdom
Balance exercises
Marmara University
2023 - NCT06075472 Turkey
October 6 University
2017 - NCT03670459 Egypt
Balance exercises with stroboscopic glasses
Halic University
2024 - NCT06387043 Turkey
Balance exercises with virtual reality glasses
Halic University
2024 - NCT06387043 Turkey
Balance exercises with visual-based metaphor training
Halic University
2024 - NCT06387043 Turkey
Balance platform therapy
University Hospital of Ferrara
2017 - NCT03353974 Italy
Balance targeted exercises
University of Miami
2023 - NCT06159361 United States
Balance trainer balance exercises
Biruni University
2016 - NCT03436927 -
Balance training
Istituto Auxologico Italiano
2016 - NCT06051019 -
Riphah International University
2024 - NCT06845722 Pakistan
University of Aarhus
2016 - NCT02870023 Denmark
University of Iowa
2022 - NCT04391023 United States
Wayne State University
2020 - NCT03404388 United States
Baminercept
Biogen Idec
2010 Phase 1/Phase 2 NCT01181089 Canada;United Kingdom
Baricitinib
Tianjin Medical University General Hospital
2023 Phase 1/Phase 2 NCT05792462 China
Baseline treatment
Hoffmann-La Roche
2014 Phase 3 NCT02028884 France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States
BAT4406F
Bio-Thera Solutions
2020 Phase 1 NCT04146285 China
BAT4406F injection
Bio-Thera Solutions
2023 Phase 2 NCT06044350 China
BAY 79-4998
Bayer Vital GmbH
2006 - EUCTR2006-002361-39-DE Germany
BAY86-5046
Bayer
2024 - NCT06053749 Finland;Sweden
2016 - NCT02652091 United States
2012 - NCT01706055 Poland
2012 - NCT01491100 Albania;Algeria;Argentina;Belgium;Bosnia and Herzegovina;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Jordan;Kazakhstan;Lebanon;Mexico;Netherlands;Poland;Portugal;Saudi Arabia;Syrian Arab Republic;Tunisia;Turkey
2012 - NCT01436838 China
2011 - NCT01071694 Korea, Republic of
2010 - NCT01076595 France
2010 - NCT01031459 Canada;United States
2009 - NCT03408093 -
2009 - NCT00963833 Austria;Belgium;Finland;Germany;Israel;Italy;Portugal;United Kingdom
2009 - NCT00902135 Germany
2008 - NCT01414816 Korea, Republic of
2008 - NCT01184833 Poland
2008 - NCT00787657 Argentina;Bahrain;Belgium;Bosnia and Herzegovina;Canada;China;Colombia;Czech Republic;Egypt;Estonia;France;Germany;Iran, Islamic Republic of;Israel;Italy;Jordan;Korea, Republic of;Kuwait;Lebanon;Libyan Arab Jamahiriya;Mexico;Netherlands;New Zealand;Norway;Pakistan;Portugal;Saudi Arabia;Singapore;Slovakia;Slovenia;Sweden;Syrian Arab Republic;Taiwan;United Arab Emirates;United Kingdom;Venezuela
2007 - NCT01235455 Portugal
2007 - NCT00928967 France
2007 - NCT00873340 Colombia
2007 - NCT00544037 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2007 - NCT00461396 United States
2007 Phase 3 NCT00459667 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States
2006 - NCT00882453 Australia;Austria;Bahrain;Belgium;Canada;Colombia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Indonesia;Israel;Italy;Jordan;Kazakhstan;Korea, Republic of;Kuwait;Lebanon;Mexico;Netherlands;Norway;Oman;Portugal;Slovenia;Spain;Sweden;Switzerland;Taiwan;Thailand;United Arab Emirates;United Kingdom
2006 Phase 3 NCT00370071 China
2005 Phase 3 NCT00313976 Denmark;Sweden
2005 - NCT00206635 Canada;United Kingdom;United States
2004 - NCT01233245 Czech Republic;France;Germany;Iran, Islamic Republic of;Israel;Italy;Jordan;Korea, Republic of;Lebanon;Netherlands;Portugal;Saudi Arabia;Spain;Taiwan;Turkey
2003 Phase 2 NCT00235989 United States
2003 Phase 3 NCT00099502 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States
2002 Phase 2 NCT00893217 United States
2002 Phase 3 NCT00185211 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
Bayer AG
2017 Phase 4 EUCTR2017-001176-31-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
Bayer HealthCare AG
2013 - EUCTR2012-005262-35-SI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-IT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
- - EUCTR2014-004613-93-Outside-EU/EEA China
BAY86-5046_interferon-BETA-1B
Bayer
2007 - NCT01158183 United States
Bazedoxifene acetate
Riley Bove, MD
2019 Phase 2 NCT04002934 United States
BBR 2778
Fondation Charcot Stichting
2009 Phase 1;Phase 2 EUCTR2007-003086-40-BE Belgium;France
2008 - EUCTR2007-003086-40-FR France
BCD-054 180 MCG
Biocad
2017 Phase 2/Phase 3 NCT02744222 Russian Federation
BCD-054 240 MCG
Biocad
2017 Phase 2/Phase 3 NCT02744222 Russian Federation
BCD-063
Biocad
2013 Phase 3 NCT02753088 -
BCD-132
Biocad
2021 Phase 3 NCT05385744 Russian Federation
2018 Phase 1 NCT03551275 Russian Federation
BCD-132, 125 MG
Biocad
2019 Phase 2 NCT04056897 Russian Federation
BCD-132, 500 MG
Biocad
2019 Phase 2 NCT04056897 Russian Federation
BCG20-0134
BTG International Ltd
2009 - EUCTR2009-011585-28-FR Belgium;France;Germany;Spain
2009 - EUCTR2009-011585-28-DE Belgium;European Union;France;Germany;Russian Federation;Spain
2009 Phase 2 EUCTR2009-011585-28-BE Belgium;European Union;France;Germany;Russian Federation;Spain
Beam regimen
Makati Medical Center
2015 Phase 1 NCT03113162 Philippines
Beetainterferoni -1A
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
Belimumab
Johns Hopkins University
2021 Phase 2 NCT04767698 United States
Tianjin Medical University General Hospital
2021 Phase 1/Phase 2 NCT05154734 China
Berg balance scale
Gazi University
2018 - NCT03584672 -
BETA-1B interferoni
Schering Oy
2006 - EUCTR2005-005211-21-FI Finland
BETA-alanine
Hasselt University
2019 - NCT03803800 Belgium
BETA-alanine supplementation
Hasselt University
2017 - NCT03418376 Belgium
BETA-carotene
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece
BETA-interferon
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
Betacarotene
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece
Betaconnect
Bayer
2019 - NCT03808142 Germany
2014 - NCT02247310 Austria;Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Czechia;France;Greece;Hungary;Italy;Netherlands;Spain;Switzerland
Betaconnect AUTO-injector
Bayer
2017 - NCT03134573 Germany
2014 - NCT02121444 Germany
Betaconnect autoinjector
Bayer
2015 - NCT02486640 Germany
Betaconnect device
Bayer
2016 - NCT02652091 United States
Betaferon
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy
Bayer
2014 - NCT02247310 Austria;Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Czechia;France;Greece;Hungary;Italy;Netherlands;Spain;Switzerland
2014 - NCT02121444 Germany
2012 - NCT01766063 Germany
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Medical University Innsbruck
2009 - EUCTR2009-013284-19-AT Austria
Medizinische Universität Innsbruck
2014 - EUCTR2012-005450-30-SE Austria;Sweden
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden
NURON BIOTECH INC.
2012 - EUCTR2011-002683-24-IT Belarus;Bulgaria;Hungary;Italy;Russian Federation;Spain
Nuron Biotech, Inc.
2012 - EUCTR2011-002683-24-HU Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine
2012 - EUCTR2011-002683-24-ES Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Poland;Russian Federation;Spain;Ukraine
2012 - EUCTR2011-002683-24-BG Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine
Ospedale Regionale di Lugano
2013 - EUCTR2012-004040-30-AT Austria;Switzerland
Pfenex, Inc
2015 Phase 1 NCT02474134 Australia
Schering Nordiska AB
2006 - EUCTR2005-001540-23-SE Denmark;Sweden
2005 Phase 3 EUCTR2005-001540-23-DK Denmark;Sweden
Schering Oy
2006 - EUCTR2005-005211-21-FI Finland
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
Betaferon - 15 flaconcini 0.25 MG + 15 flaconcini 2 ML
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Betaferon 250 MCG
SCHERING
2007 - EUCTR2006-005270-47-IT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Betaferon 250 microgram/ML
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Betaferon 250 microgram/ML, powder and solvent FOR solution FOR injection
Bayer AG
2017 Phase 4 EUCTR2017-001176-31-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
Bayer HealthCare AG
2013 - EUCTR2012-005262-35-SI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-IT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
Betaferon 250 microgramos
Schering AG
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Betaferon 250MCG
Schering AG
2007 - EUCTR2006-005270-47-IE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Betaferon 250µG
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Schering AG
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Betaferon 500 MCG
SCHERING
2007 - EUCTR2006-005270-47-IT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Betaferon 500 µG
Schering AG
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Betaferon 500MCG
Schering AG
2007 - EUCTR2006-005270-47-IE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom
Betaferon 500µG
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Schering AG
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Betaferon SC 15F 0,25MG 15SIR
Universita di Firenze
2006 Phase 3 EUCTR2006-004937-13-IT Italy
Betaferon, BAY86-5046
Bayer
2019 - NCT03808142 Germany
2017 - NCT03134573 Germany
2015 - NCT02486640 Germany
2010 - NCT01354665 Poland
2008 - NCT03577977 Russian Federation
Betaferon/betaseron
Bayer
2011 - NCT01071694 Korea, Republic of
2006 Phase 4 NCT00317941 France
2005 Phase 3 NCT00313976 Denmark;Sweden
2003 Phase 4 NCT00206648 Canada;United States
2003 Phase 3 NCT00099502 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States
Betaseron
Bayer
2024 - NCT06053749 Finland;Sweden
2020 - NCT04356339 United States
2016 - NCT02652091 United States
2012 - NCT01706055 Poland
2012 - NCT01491100 Albania;Algeria;Argentina;Belgium;Bosnia and Herzegovina;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Jordan;Kazakhstan;Lebanon;Mexico;Netherlands;Poland;Portugal;Saudi Arabia;Syrian Arab Republic;Tunisia;Turkey
2012 - NCT01436838 China
2010 - NCT01076595 France
2010 - NCT01031459 Canada;United States
2009 - NCT03408093 -
2009 - NCT00963833 Austria;Belgium;Finland;Germany;Israel;Italy;Portugal;United Kingdom
2009 - NCT00902135 Germany
2008 - NCT03577977 Russian Federation
2008 - NCT01414816 Korea, Republic of
2008 - NCT01184833 Poland
2008 - NCT00787657 Argentina;Bahrain;Belgium;Bosnia and Herzegovina;Canada;China;Colombia;Czech Republic;Egypt;Estonia;France;Germany;Iran, Islamic Republic of;Israel;Italy;Jordan;Korea, Republic of;Kuwait;Lebanon;Libyan Arab Jamahiriya;Mexico;Netherlands;New Zealand;Norway;Pakistan;Portugal;Saudi Arabia;Singapore;Slovakia;Slovenia;Sweden;Syrian Arab Republic;Taiwan;United Arab Emirates;United Kingdom;Venezuela
2007 - NCT01235455 Portugal
2007 - NCT00928967 France
2007 - NCT00873340 Colombia
2007 - NCT00544037 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2007 - NCT00461396 United States
2007 Phase 3 NCT00459667 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States
2006 - NCT00882453 Australia;Austria;Bahrain;Belgium;Canada;Colombia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Indonesia;Israel;Italy;Jordan;Kazakhstan;Korea, Republic of;Kuwait;Lebanon;Mexico;Netherlands;Norway;Oman;Portugal;Slovenia;Spain;Sweden;Switzerland;Taiwan;Thailand;United Arab Emirates;United Kingdom
2006 Phase 3 NCT00370071 China
2005 - NCT00206635 Canada;United Kingdom;United States
2004 - NCT01233245 Czech Republic;France;Germany;Iran, Islamic Republic of;Israel;Italy;Jordan;Korea, Republic of;Lebanon;Netherlands;Portugal;Saudi Arabia;Spain;Taiwan;Turkey
2003 Phase 2 NCT00235989 United States
2002 Phase 2 NCT00893217 United States
2002 Phase 3 NCT00185211 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
Bayer HealthCare AG
- - EUCTR2014-004613-93-Outside-EU/EEA China
Rutgers, The State University of New Jersey
2007 - NCT00468182 United States
Stuart D Cook MD
2003 Phase 4 NCT00176592 United States
Teva Pharmaceutical Industries
2004 Phase 4 NCT00202995 Canada;United States
Betaseron (interferon BETA-1B, BAY86-5046), bayer healthcare AG
Bayer
2016 - NCT02749396 Finland
Bevacizumab
Johns Hopkins University
2013 Phase 1 NCT01777412 United States
Bexarotene
Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge
2015 Phase 2 EUCTR2014-003145-99-GB United Kingdom
Bexsero
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
BG-12 120
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States
BG00002
BIOGEN IDEC LTD
2011 - EUCTR2010-024000-10-IT Belgium;Germany;Italy;Spain
2007 - EUCTR2005-004061-41-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2007 - EUCTR2005-004061-41-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom
2006 - EUCTR2005-004061-41-IT Australia;Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-IE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Spain;Sweden;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
Biogen
2010 Phase 2/Phase 3 NCT01440101 China;Japan
2010 Phase 3 NCT01058005 Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States
2009 Phase 4 NCT00871780 Belgium;Mexico;Poland;Romania;Saudi Arabia;Ukraine;Venezuela
2008 Phase 4 NCT00536120 United States
2006 Phase 2 NCT00516893 United States
2006 Phase 3 NCT00306592 Canada;United States
Biogen Idec
2012 Phase 4 NCT02142205 Russian Federation
Biogen Idec International GmbH
2010 Phase 4 EUCTR2009-009503-19-BE Belgium
Biogen Idec Limited
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-002145-11-GB Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany
BG00012
BIOGEN IDEC LTD
2010 Phase 3 EUCTR2008-004753-14-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom
2008 - EUCTR2006-003696-12-IT Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
BIOGEN IDEC RESEARCH LIMITED
2015 Phase 3 EUCTR2014-005624-98-IT Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
Biogen
2013 Phase 4 NCT01873417 United States
2009 Phase 1 NCT00837785 Germany;United Kingdom
2007 Phase 3 NCT00451451 Australia;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Costa Rica;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Ireland;Israel;Italy;Kazakhstan;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;New Zealand;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States
2007 Phase 3 NCT00420212 Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Guatemala;India;Israel;Italy;Kazakhstan;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Virgin Islands (U.S.)
2004 Phase 2 NCT00168701 Czech Republic;Czechia;Germany;Hungary;Netherlands;Poland;Russian Federation;Sweden;Switzerland;Turkey;United Kingdom
Biogen Idec Inc.
2004 - EUCTR2004-000663-99-SE Hungary;Sweden
2004 - EUCTR2004-000663-99-HU Hungary;Sweden
2004 - EUCTR2004-000663-99-CZ Czech Republic;Hungary;Sweden
Biogen Idec Italia S.r.l.
2015 - EUCTR2015-000303-21-IT Italy
2013 Phase 3 EUCTR2013-001422-25-IT Italy
Biogen Idec Limited
2010 Phase 3 EUCTR2008-004753-14-BG Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-SK Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-LV Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-IE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-GB Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-EE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-CZ Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-BE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-AT Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
Biogen Idec LtD.
2007 Phase 3 EUCTR2006-003696-12-SK Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Slovakia;Sweden;United Kingdom
Biogen Idec Ltd.
2010 Phase 3 EUCTR2008-004753-14-NL Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2008-004753-14-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom
2009 Phase 3 EUCTR2008-004753-14-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom
2009 Phase 3 EUCTR2008-004753-14-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom
2009 Phase 3 EUCTR2008-004753-14-DE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 - EUCTR2006-003696-12-BG Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2008 - EUCTR2006-003697-10-BG Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2008 - EUCTR2006-003696-12-NL Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2008 - EUCTR2006-003696-12-DE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 - EUCTR2006-003697-10-LV Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-IE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-GR Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 Phase 3 EUCTR2006-003697-10-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-EE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-DE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-CZ Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 Phase 3 EUCTR2006-003697-10-BE Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003696-12-SE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 - EUCTR2006-003696-12-GR Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 Phase 3 EUCTR2006-003696-12-GB Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Slovakia;Sweden;United Kingdom
2007 - EUCTR2006-003696-12-CZ Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 - EUCTR2006-003696-12-BE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 - EUCTR2006-003696-12-AT Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2017 Phase 3 EUCTR2013-002318-11-FR Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-003282-29-LV Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-003282-29-DE Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-003282-29-CZ Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-003282-29-BG Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-003282-29-BE Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-001973-42-PL Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States
2016 Phase 3 EUCTR2015-001973-42-LT Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States
2016 Phase 3 EUCTR2015-001973-42-HR Austria;Belgium;Bulgaria;Canada;Croatia;Kuwait;Lithuania;Poland;Slovakia;Sweden;Turkey;United States
2016 Phase 3 EUCTR2015-001973-42-BG Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States
2016 Phase 3 EUCTR2014-005624-98-AT Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
2016 - EUCTR2013-002318-11-ES Argentina;Belgium;Canada;Croatia;Czech Republic;Denmark;France;Hungary;Israel;Italy;Poland;Portugal;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom
2016 Phase 3 EUCTR2013-002318-11-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Türkiye;United Kingdom;United States
2015 Phase 3 EUCTR2015-001973-42-BE Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Kuwait;Lithuania;Poland;Turkey;United States
2015 - EUCTR2014-005624-98-HU Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
2015 Phase 2 EUCTR2014-005003-24-PL Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom
2015 Phase 2 EUCTR2014-005003-24-LV Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom
2015 Phase 2 EUCTR2014-005003-24-DE Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom
2015 Phase 2 EUCTR2014-005003-24-CZ Australia;Belgium;Bulgaria;Czech Republic;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United States
2015 Phase 2 EUCTR2014-005003-24-BG Australia;Belgium;Bulgaria;Czech Republic;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Poland;Turkey;United Kingdom;United States
2015 Phase 2 EUCTR2014-005003-24-BE Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom
2015 Phase 3 EUCTR2014-004562-22-IT Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 - EUCTR2014-004562-22-HU Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 Phase 3 EUCTR2014-004562-22-DE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 Phase 3 EUCTR2014-004562-22-CZ Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 Phase 3 EUCTR2014-004562-22-BE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 - EUCTR2014-003021-18-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 Phase 3 EUCTR2014-003021-18-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 Phase 3 EUCTR2013-002318-11-PL Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2015 - EUCTR2013-001025-53-ES Denmark;Finland;Netherlands;Norway;Spain;United Kingdom
2015 Phase 4 EUCTR2013-001025-53-DK Denmark;Finland;Netherlands;Norway;Spain;United Kingdom
2014 Phase 3 EUCTR2013-004533-32-PL Czech Republic;Japan;Korea, Republic of;Poland;Taiwan
2014 Phase 3 EUCTR2013-004533-32-CZ Czech Republic;Japan;Korea, Republic of;Poland;Taiwan
2014 Phase 3 EUCTR2013-002318-11-SE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-IT Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3 EUCTR2013-002318-11-HU Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom
2014 Phase 3 EUCTR2013-002318-11-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-DK Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-CZ Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom
2014 Phase 4 EUCTR2013-001656-35-SK Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-SI Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-PT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-IT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-HU Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-FR Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-ES Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-CZ Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-BE Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-AT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 - EUCTR2013-001486-17-DE Germany
- Phase 3 EUCTR2013-002318-11-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
- Phase 3 EUCTR2014-005624-98-EE Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
Multiple Sclerosis Center of Northeastern New York
2015 Phase 4 NCT02683863 United States
BG9418
Biogen
2009 Phase 3 NCT00828204 United States
2008 Phase 3 NCT00784836 United States
Biogen Idec
2004 - NCT00168714 United States
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
BGC20-0134
BTG International Ltd
2009 - EUCTR2009-011585-28-FR Belgium;France;Germany;Spain
2009 - EUCTR2009-011585-28-ES Belgium;France;Germany;Spain
2009 - EUCTR2009-011585-28-DE Belgium;European Union;France;Germany;Russian Federation;Spain
2009 Phase 2 EUCTR2009-011585-28-BE Belgium;European Union;France;Germany;Russian Federation;Spain
BGG492
Novartis Pharmaceuticals
2016 Phase 2 NCT01649050 Germany;Russian Federation
BHT-3009
Bayhill Therapeutics
2006 - EUCTR2005-001340-22-CZ Czech Republic;Finland;United Kingdom
2005 Phase 2 EUCTR2005-001340-22-SK Czech Republic;Finland;Slovakia;United Kingdom
2005 - EUCTR2005-001340-22-GB Czech Republic;Finland;United Kingdom
2005 - EUCTR2005-001340-22-FI Czech Republic;Finland;United Kingdom
BHT-3009 0.5 MG
Bayhill Therapeutics
2006 Phase 2 NCT00382629 -
BHT-3009 1.5 MG
Bayhill Therapeutics
2006 Phase 2 NCT00382629 -
BHT-3009-01
Bayhill Therapeutics
2004 Phase 1 NCT00103974 Canada;United States
BIIB017
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Biogen
2019 Phase 3 NCT03958877 Argentina;Australia;Belgium;Bulgaria;Croatia;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2013 Phase 3 NCT01939002 United States
2009 Phase 3 NCT00906399 Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Biogen Idec
2014 Phase 4 NCT02234869 -
Biogen Idec LTD
2009 - EUCTR2008-006333-27-LV Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom
Biogen Idec Limited
2012 Phase 3 EUCTR2010-024477-39-GR Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2010-024477-39-GB Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2012 - EUCTR2010-024477-39-CZ Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-LV Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-ES Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-EE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-024477-39-DE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-024477-39-BG Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-BE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2010 - EUCTR2008-006333-27-GR Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom
2010 - EUCTR2008-006333-27-CZ Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-NL Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-006333-27-GB Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-006333-27-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom
2009 - EUCTR2008-006333-27-EE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-BG Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-BE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
- - EUCTR2008-006333-27-DE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
Johns Hopkins University
2010 Phase 3 NCT01337427 United States
BIIB017 (peginterferon BETA-1A) autoinjector
Biogen Idec
2012 Phase 1 NCT01610310 United States
BIIB019
BIOGEN IDEC RESEARCH LIMITED
2017 Phase 3 EUCTR2016-002820-10-IT Canada;Denmark;France;Germany;Italy;United Kingdom;United States
BIOGEN IDEC RESEARCH LTD
2013 Phase 3 EUCTR2012-003176-39-IT Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Biogen
2013 Phase 3 NCT01797965 Argentina;Australia;Brazil;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States
2010 Phase 3 NCT01064401 Argentina;Australia;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Egypt;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 NCT01051349 Czech Republic;Czechia;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2010 Phase 2 EUCTR2009-015318-23-GB Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2009 Phase 2 NCT00870740 Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2008 Phase 2 NCT00390221 Australia;Czech Republic;Former Serbia and Montenegro;Germany;Hungary;India;Poland;Russian Federation;Sweden;Turkey;Ukraine;United Kingdom
Biogen Idec Limited
2011 - EUCTR2010-023856-97-PL Czech Republic;Hungary;Poland;Russian Federation;United States
2011 - EUCTR2010-023856-97-HU Czech Republic;Hungary;Poland;Russian Federation;United States
2011 - EUCTR2010-023856-97-CZ Czech Republic;Hungary;Poland;United States
Biogen Idec Ltd
2010 - EUCTR2009-012500-11-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012500-11-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012500-11-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Biogen Idec Ltd.
2011 Phase 2 EUCTR2009-015318-23-DE Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2010 Phase 2 EUCTR2009-015318-23-HU Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2010 Phase 2 EUCTR2009-015318-23-CZ Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2009 - EUCTR2008-005559-46-HU Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 Phase 2 EUCTR2008-005559-46-GB Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 - EUCTR2008-005559-46-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 - EUCTR2008-005559-46-CZ Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2008 - EUCTR2006-001161-42-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Sweden;Ukraine;United Kingdom
Biogen Idec Research Limited
2017 Phase 3 EUCTR2016-002820-10-GB Canada;Denmark;France;Germany;Italy;United Kingdom;United States
2017 Phase 3 EUCTR2016-002820-10-DE Canada;Germany;Italy;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-PL Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-GR Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-FR Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 - EUCTR2012-003176-39-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-ES Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
BIIB033
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 2 EUCTR2017-001224-22-IT Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Biogen
2017 Phase 2 NCT03222973 Australia;Belgium;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
2016 Phase 1 NCT02833142 United States
2016 Phase 1 NCT02641041 United Kingdom
2013 Phase 2 NCT01864148 Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2010 Phase 1 NCT01244139 United States
Biogen Idec Research Limited
2018 Phase 2 EUCTR2017-001224-22-PL Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 2 EUCTR2017-001224-22-NL Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 2 EUCTR2017-001224-22-DE Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 2 EUCTR2017-001224-22-BE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2017 Phase 2 EUCTR2017-001224-22-HU Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2017 Phase 2 EUCTR2017-001224-22-ES Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2017 Phase 2 EUCTR2017-001224-22-CZ Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-IT Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-HU Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-GB Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-ES Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-CZ Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
BIIB033 (ANTI-lingo) - EV substance code SUB118957
Biogen Idec Research Limited
2017 Phase 2 EUCTR2017-001224-22-GB Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
BIIB041
BIOGEN IDEC RESEARCH LTD
2012 - EUCTR2012-000368-90-IT Belgium;Canada;Italy;Netherlands;Switzerland;United Kingdom
2012 - EUCTR2011-003507-38-IT Australia;Denmark;Italy;Netherlands;Portugal;United Kingdom
Biogen
2013 Phase 3 NCT01917019 Japan
2012 Phase 2 NCT01597297 Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
Biogen Idec
2010 Phase 3 NCT01235221 Canada
Biogen Idec Research Limited
2015 Phase 3 EUCTR2013-003600-40-NL Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 - EUCTR2013-003600-40-LT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 - EUCTR2013-003600-40-IT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-GB Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States
2014 - EUCTR2013-003600-40-FI Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-CZ Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-BG Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2012 - EUCTR2012-000368-90-NL Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 - EUCTR2012-000368-90-GB Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 Phase 2 EUCTR2012-000368-90-BE Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-PT Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-NL Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 Phase 4 EUCTR2011-003507-38-GB Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-DK Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 Phase 4 EUCTR2011-003507-38-BE Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
Cliniques Universitaires Saint-Luc, Neurologie
2013 Phase 3 EUCTR2012-005076-34-BE Belgium
BIIB061
Biogen
2021 Phase 2 NCT04079088 -
2015 Phase 1 NCT02521545 United States
BIIB091
Biogen
2023 Phase 2 NCT05798520 Bulgaria;Czechia;Germany;Italy;Poland;Puerto Rico;Romania;Spain;Switzerland;United States
BIIB133
Biogen Idec Research Limited
2020 Phase 2 EUCTR2019-001967-58-PL Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States
2020 Phase 2 EUCTR2019-001967-58-FR Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States
Biobanking with genetic analysis
University Hospital, Lille
2020 - NCT04334031 France
Biological samples
Centre Hospitalier Régional d'Orléans
2021 Phase 4 NCT04952766 France
Biospecimen collection
National Cancer Institute (NCI)
2019 Phase 1 NCT03816345 Canada;United States
Biotin
MEDDAY Pharmaceuticals SA
2014 Phase 3 EUCTR2013-002112-27-GB France;United Kingdom
MEDDAY SAS
- Phase 3 EUCTR2013-002113-35-FR France
- Phase 3 EUCTR2013-002112-27-FR France;United Kingdom
University Hospital, Clermont-Ferrand
2018 - NCT03552211 France
Birt 2584 XX
BOEHRINGER ING.
2006 - EUCTR2005-005985-35-IT Czech Republic;Italy;Netherlands
Boehringer Ingelheim
2006 Phase 2 EUCTR2005-005985-35-NL Czech Republic;Netherlands
Boehringer Ingelheim Ltd
2006 - EUCTR2005-005985-35-CZ Czech Republic;Italy;Netherlands
Birt 2584XX
BOEHRINGER ING.
2006 - EUCTR2005-005985-35-IT Czech Republic;Italy;Netherlands
Bisacodyl
David Levinthal
2016 Phase 2 NCT02609607 United States
Blood sample
Biogen Idec
2011 Phase 4 NCT01556685 Colombia;Mexico
Centre Hospitalier Régional d'Orléans
2023 - NCT05746845 France
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France
University Hospital, Bordeaux
2021 - NCT04798651 France
Blood samples
University Hospital, Bordeaux
2014 - NCT02142764 France
Blood sampling
Centre Hospitalier Universitaire de Nimes
2013 Phase 3 NCT01817166 France;Martinique
Rennes University Hospital
2021 - NCT04697407 France
Sohag University
2021 - NCT05196425 Egypt
Blood tests
Amgen
2024 Phase 4 NCT06180278 China;Czechia;Hong Kong;Hungary;Korea, Republic of;Poland;Thailand;United States
Bmmnc
Chaitanya Hospital, Pune
2014 Phase 1/Phase 2 NCT01883661 India
BMS-986368
Celgene
2025 Phase 2 NCT06782490 Australia;Canada;Czechia;Germany;Poland;Puerto Rico;United States
BMS-986374
Bristol-Myers Squibb
2024 Phase 4 NCT06396039 China
BNT162
Novartis Pharmaceuticals
2021 Phase 4 NCT04792567 Germany
BNT162b2, bivalent
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States
Bodybio balance OIL
Terry L. Wahls
2022 - NCT05007483 United States
Bodybio PC
Terry L. Wahls
2022 - NCT05007483 United States
Bone marrow autologous mesenchymal stem cells transplantation
Germans Trias i Pujol Hospital
2013 Phase 1/Phase 2 NCT02035514 Spain
Borage OIL 20% GLA
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece
Bortezomib
Tianjin Medical University General Hospital
2015 Phase 2 NCT02893111 China
Boswelan
University Medical Center Eppendorf
- Phase 2 EUCTR2009-014724-32-DE Germany
Universitätsklinikum Hamburg-Eppendorf
2011 Phase 2 NCT01450124 Germany
Boswellia serrata extract PS0201BO capsules
University Medical Center Eppendorf
- Phase 2 EUCTR2009-014724-32-DE Germany
Botox
ALLERGAN
2008 - EUCTR2007-000192-42-IT France;Germany;Italy;Netherlands;Portugal;Spain;United Kingdom
Allergan
2008 - EUCTR2006-006299-39-NL France;Netherlands
2008 Phase 3 EUCTR2006-006299-39-FR France;Netherlands
Allergan Ltd.
2013 - EUCTR2012-000957-30-PT Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2013 - EUCTR2012-000957-30-GB Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2012 - EUCTR2012-000957-30-CZ Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2012 - EUCTR2012-000957-30-BE Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
Centre Hospitalier Universitaire de Lille
2022 Phase 3 EUCTR2022-000259-35-FR France
Krajská nemocnice Liberec, a.s.
2010 Phase 3 EUCTR2009-012431-15-CZ Czech Republic
Botox 100 UNT injection
Brigitte Schürch
2021 Phase 4 NCT04819360 Switzerland
Botulinum toxin
ALLERGAN
2008 - EUCTR2007-000192-42-IT France;Germany;Italy;Netherlands;Portugal;Spain;United Kingdom
Botulinum toxin A
Centre Hospitalier Universitaire de Lille
2022 Phase 3 EUCTR2022-000259-35-FR France
Sunnybrook Health Sciences Centre
2006 Phase 3 NCT01091727 Canada
Botulinum toxin A - haemagglutinin complex
Ipsen Innovation
2016 Phase 3 EUCTR2015-003471-30-RO Canada;Czech Republic;Czechia;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-PT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-PL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-NL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-IT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-CZ Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-000507-44-LT Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-FR Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-ES Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-DE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-BE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
Botulinum toxin type A
Allergan
2008 - EUCTR2006-006299-39-NL France;Netherlands
2008 Phase 3 EUCTR2006-006299-39-FR France;Netherlands
Allergan Ltd.
2013 - EUCTR2012-000957-30-PT Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2013 - EUCTR2012-000957-30-GB Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2012 - EUCTR2012-000957-30-CZ Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2012 - EUCTR2012-000957-30-BE Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
Aránzazu Vázquez Doce
2018 Phase 3 EUCTR2018-003231-30-ES Spain
IPSEN INNOVATION
2012 - EUCTR2010-023210-31-IT Austria;Czech Republic;Germany;Italy;Lithuania
Ipsen
2016 Phase 3 NCT02660359 Argentina;Australia;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 NCT02660138 Canada;Czech Republic;Czechia;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Turkey;United States
2011 Phase 2 NCT01357980 Austria;Czech Republic;Czechia;France;Germany;Italy;Poland
Krajská nemocnice Liberec, a.s.
2010 Phase 3 EUCTR2009-012431-15-CZ Czech Republic
Melbourne Health
2008 Phase 3 NCT01018485 Australia
University of Manitoba
2013 Phase 2 NCT01911377 Canada
Botulinum toxin type A 200U
Allergan
2009 Phase 3 NCT00876447 Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Czechia;France;Germany;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Singapore;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Botulinum toxin type A 300U
Allergan
2009 Phase 3 NCT00876447 Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Czechia;France;Germany;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Singapore;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Bouchard belgian dark chocolate probiotic napolitains, containing bifidobacterium longum
Columbia University
2024 - NCT06475183 United States
Brimonidine tartrate
Biogen
2016 Phase 4 NCT02568111 -
Bryostatin 1
Robert Fox
2024 Phase 1 NCT06190912 United States
BX-1
Bionorica SE
2020 Phase 3 EUCTR2018-000001-23-CZ Czech Republic;Hungary;Spain
2019 Phase 3 NCT03756974 Czechia;Germany;Hungary;Poland;Spain
2018 Phase 3 EUCTR2018-000001-23-HU Czech Republic;Hungary;Spain
2018 Phase 3 EUCTR2018-000001-23-ES Czech Republic;Hungary;Spain
C-11 ER176 radiotracer
Mayo Clinic
2023 Phase 2 NCT05805839 United States
C105
Cognition Pharmaceuticals, LLC
2006 Phase 2 NCT00529581 United States
C11 pittsburgh compound B
Mayo Clinic
2023 Phase 2 NCT05805839 United States
Caffeine
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States
Calcio
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy
Calcium and vitamin D combination
Novartis
2010 Phase 3 NCT01166178 Germany
Calcium carbonate
University Hospital of North Norway
2008 Phase 4 NCT00785473 Norway
Calcium levofolinate
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy
Calculus bovis
Tongji Hospital
2024 - NCT06474520 China
Cannabidiol
ALMIRALL PRODESFARMA
2011 - EUCTR2011-002258-30-IT Italy
Almirall Hermal GmbH
2016 Phase 4 EUCTR2015-004451-40-AT Austria;Czech Republic
GW Pharma Limited
2022 Phase 3 EUCTR2020-004306-58-LT Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom
2021 Phase 3 EUCTR2020-003271-18-CZ Czech Republic;Czechia;Poland;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-GB Poland;United Kingdom
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-PL Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
2020 Phase 3 EUCTR2019-002623-14-GB Czech Republic;Poland;Romania;United Kingdom;United States
2020 Phase 3 EUCTR2019-002623-14-CZ Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
2007 Phase 3 EUCTR2006-005910-11-CZ Czech Republic;Germany;Italy;Spain;United Kingdom
2006 Phase 3 EUCTR2005-005265-11-GB Czech Republic;France;United Kingdom
2006 Phase 3 EUCTR2005-005265-11-FR Czech Republic;France;United Kingdom
2006 - EUCTR2005-005265-11-CZ Czech Republic;France;United Kingdom
2005 Phase 3 EUCTR2004-002509-63-GB Czech Republic;United Kingdom
2005 - EUCTR2004-002509-63-CZ Czech Republic;United Kingdom
GW Pharma Ltd.
2011 - EUCTR2011-000926-31-CZ Czech Republic
2008 Phase 3 EUCTR2006-005910-11-GB Czech Republic;Germany;Italy;Spain;United Kingdom
2008 - EUCTR2006-005910-11-DE Germany;Italy;Spain;United Kingdom
2007 - EUCTR2007-002138-13-GB United Kingdom
JOSE MANUEL GARCIA DOMINGUEZ
2013 - EUCTR2011-000985-36-ES Spain
Tiffany J. Braley, MD, MS
2022 Phase 2 NCT05269628 United States
Cannabidiol / dronabinol capsule 5 MG+2,5 MG
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark
Cannabidiol capsule 5 MG
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark
Cannabis
AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
2004 - EUCTR2005-000393-47-IT Italy
Centre hospitalier de l'Université de Montréal (CHUM)
2022 Phase 2 NCT05092191 Canada
Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research)
2006 Phase 3 EUCTR2005-005263-29-GB United Kingdom
Cannabis, medical
OMNI Medical Services, LLC
2018 Phase 2 NCT03944447 United States
Cannador
Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research)
2006 Phase 3 EUCTR2005-005263-29-GB United Kingdom
Capacity OF muscular oxygen extraction
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France
Caprylic triglyceride
University of Miami
2013 - NCT01848327 United States
Carbamazepine
Stine Maarbjerg, MD PhD
2012 - NCT04371575 -
Carbidopa
University of Miami
2018 Phase 1 NCT03266965 United States
Carbone vegetale polvere
NOVARTIS PHARMA AG
2022 Phase 3 EUCTR2020-005929-89-IT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Japan;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-IT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Guatemala;Hong Kong;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
Cardiopulmonary evaluation
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France
Carmustina
FONDAZIONE ITALIANA SCLEROSI MULTIPLA ONLUS
2023 Phase 2 EUCTR2022-002654-95-IT Italy
Carmustine
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States
Carnosine, capsulle, 2 G/DAY, 8 weeks
University of Novi Sad, Faculty of Sport and Physical Education
2019 - NCT03995810 Serbia
Cawthorne cooksey exercises
October 6 University
2017 - NCT03670459 Egypt
CBD
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark
Almirall Hermal GmbH
2016 Phase 4 EUCTR2015-004451-40-AT Austria;Czech Republic
GW Pharma Limited
2022 Phase 3 EUCTR2020-004306-58-LT Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom
2021 Phase 3 EUCTR2020-003271-18-CZ Czech Republic;Czechia;Poland;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-GB Poland;United Kingdom
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-PL Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
2020 Phase 3 EUCTR2019-002623-14-GB Czech Republic;Poland;Romania;United Kingdom;United States
2020 Phase 3 EUCTR2019-002623-14-CZ Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
Tiffany J. Braley, MD, MS
2022 Phase 2 NCT05269628 United States
University of Calgary
2024 Phase 2 NCT06261489 -
CC-97540
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
2024 Phase 1 NCT06220201 Belgium;France;Germany;Italy;Spain;United Kingdom;United States
CCI-779
Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
2005 - EUCTR2005-000171-18-FI Finland
Wyeth is now a wholly owned subsidiary of Pfizer
2003 Phase 2 NCT00228397 -
CD20/BCMA-directed CAR-T cells
RenJi Hospital
2024 Phase 1 NCT06249438 China
CDP323
UCB Pharma
2008 Phase 1/Phase 2 NCT00726648 United Kingdom
2007 Phase 2 NCT00484536 Belgium;Canada;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;United States
2007 - EUCTR2006-002204-33-FI Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
2007 Phase 2 EUCTR2006-002204-33-ES Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
UCB Pharma S.A.
2007 - EUCTR2006-002204-33-SE Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
2007 - EUCTR2006-002204-33-NL Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
2007 - EUCTR2006-002204-33-HU Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
2007 Phase 2 EUCTR2006-002204-33-GB Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
2007 Phase 2 EUCTR2006-002204-33-FR Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
2007 - EUCTR2006-002204-33-DE Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
2007 - EUCTR2006-002204-33-BE Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
Celecoxib
National Institute of Mental Health (NIMH)
2022 Phase 2 NCT05062083 United States
Cell suspension containing dendritic cells
Antwerp University Hospital
2023 Phase 2 EUCTR2022-003465-38-BE Belgium;Spain
Cellcept
Aaron Boster
2006 Phase 0 NCT00618527 United States
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
University of Texas Southwestern Medical Center
2006 Phase 2 NCT00324506 United States
2004 Phase 2/Phase 3 NCT00223301 United States
Cellular therapy with EBV specific autologous CTL infusion
Nantes University Hospital
2021 Phase 1 NCT02912897 France
Ceralifimod
Merck KGaA
2014 - EUCTR2013-003126-83-HU Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-GR Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-ES Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-DE Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Ceralifmod
Merck KGaA
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Cerebro-spinal fluid
University Hospital, Bordeaux
2021 - NCT04798651 France
Ceterizine
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 1 NCT02583594 Spain
Cetirizina mylan generics
Biogen Idec Italia S.r.l.
2015 - EUCTR2013-001055-12-IT Italy
Cetirizine
Genzyme, a Sanofi Company
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain
Icahn School of Medicine at Mount Sinai
2014 Phase 1/Phase 2 NCT02865018 United States
Cetirizine hydrochloride
Biogen Idec Italia S.r.l.
2015 - EUCTR2013-001055-12-IT Italy
Cetrizine
Providence Health & Services
2020 Phase 3 NCT04175834 United States
CGP 77116
National Institute of Neurological Disorders and Stroke (NINDS)
1998 Phase 2 NCT00001781 United States
Charcoal
Sanofi
2013 Phase 3 NCT01863888 Belgium;Germany;Netherlands
Cholecalciferol
Academic MS Center Limburg
2014 Phase 2 NCT02096133 Netherlands
Johns Hopkins University
2010 Phase 1 NCT01024777 United States
Merck KGaA
2009 Phase 2 NCT01198132 France
University Hospital of North Norway
2008 Phase 4 NCT00785473 Norway
Cholecalciferol, vitamin D3
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-LT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-DE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
2011 - EUCTR2010-020328-23-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Cholestyramine
Sanofi
2023 Phase 3 NCT06141473 Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
2014 Phase 1 NCT02046629 China
2013 Phase 3 NCT01863888 Belgium;Germany;Netherlands
CHR-1103 / GBR500
Genzyme Corporation
2015 Phase 2 EUCTR2014-003265-19-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-SE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-DE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
Cianocobalamina
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy
CIC using lofric primo
Wellspect HealthCare
2009 - NCT00913510 Belgium;France;Germany;Netherlands;United Kingdom
Circadin
North Bristol NHS Trust
2013 Phase 2 EUCTR2012-004183-21-GB United Kingdom
Cisapride
2010 Phase 4 EUCTR2010-023996-25-BE Belgium
Citalopram
Novartis Pharmaceuticals
2011 Phase 4 NCT01436643 Germany
Citarabina
FONDAZIONE ITALIANA SCLEROSI MULTIPLA ONLUS
2023 Phase 2 EUCTR2022-002654-95-IT Italy
Citochine ED immunomodulatori
TEVA
2005 - EUCTR2004-003943-28-IT Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
CLA
Universität Münster
2023 - NCT05920018 Germany
Cladribina
MERCK KGAA
2021 Phase 4 EUCTR2020-003995-42-IT Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003874-30-IT Austria;Czech Republic;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain
2019 Phase 4 EUCTR2019-000069-19-IT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2018 Phase 4 EUCTR2017-002632-17-IT Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Ireland;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-IT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
MERCK SERONO SA
2008 - EUCTR2007-000381-20-IT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
Cladribina oral
Serono International, S.A.
2007 - EUCTR2006-003366-33-ES Italy;Spain
Cladribine
Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital
2019 Phase 3 EUCTR2019-001505-24-NO Norway
EMD Serono
2008 Phase 3 NCT00725985 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;India;Italy;Korea, Republic of;Lebanon;Macedonia, The Former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
EMD Serono Research & Development Institute, Inc.
2019 - NCT03933215 United States
2008 Phase 3 NCT00641537 Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;Former Serbia and Montenegro;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2006 Phase 2 NCT00436826 Italy;Russian Federation;Spain;United States
Fakultní nemocnice Ostrava
2021 Phase 4 EUCTR2021-003195-13-CZ Czech Republic
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-SE Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
MERCK SERONO INTERNATIONAL SA
2008 - EUCTR2006-003366-33-IT Italy;Spain
MERCK SERONO SA
2009 - EUCTR2008-003706-33-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2007-000381-20-IT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2005 - EUCTR2004-005148-28-IT Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2019 Phase 1 NCT04086225 Germany;Poland
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2019 - NCT04934800 Austria;Greece;Italy;Norway;Poland;Portugal;Switzerland
Merck KGaA
2018 Phase 4 EUCTR2017-002632-17-SK Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-SE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-PT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-NO Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-NL Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-LT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-HU Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Ireland;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-GR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-GB Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-FR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-FI Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-ES Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-DK Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-CZ Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-BE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-AT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-FR Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-CZ Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-AT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2008 Phase 1 NCT00938366 -
Merck KGaA, Darmstadt, Germany
2019 Phase 1 NCT03745144 Germany;Poland
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
Merck Serono International S.A.
2008 - EUCTR2007-000381-20-NL Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2008 - EUCTR2007-000381-20-GR Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2007 Phase 3 EUCTR2007-000381-20-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lithuania;Netherlands;Portugal;United Kingdom
2006 - EUCTR2004-005148-28-LT Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-FI Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-EE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-DK Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-CZ Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Merck Serono International, a branch of Laboratoires Serono S.A.
2005 Phase 3 EUCTR2004-005148-28-GB Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom
Merck Serono International, a branch of Laboratories Serono S.A.
2005 - EUCTR2004-005148-28-DE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Merck Serono S.A. - Geneva
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - EUCTR2007-000381-20-PT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2008 - EUCTR2007-000381-20-LV Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-000381-20-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-EE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-DK Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-000381-20-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2007-000381-20-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2007-000381-20-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
Oslo University Hospital
2019 Phase 3 NCT04121403 Norway
Queen Mary University of London
2021 Phase 2/Phase 3 NCT04695080 United Kingdom
2020 Phase 2 EUCTR2018-005038-39-GB United Kingdom
Serono International S.A.
2006 Phase 3 EUCTR2004-005148-28-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom
2006 - EUCTR2004-005148-28-LV Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-AT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Serono International, S.A.
2007 - EUCTR2006-003366-33-ES Italy;Spain
University Hospital, Strasbourg, France
2025 - NCT06887426 France
University of Texas Southwestern Medical Center
2020 Phase 4 NCT04178005 United States
Washington University School of Medicine
2019 Phase 4 NCT03963375 United States
Westfälische Wilhelms-Universität Münster c/o Universitätsklinikum Münster, Geschäftsbereich Recht u. Drittmittel
2019 Phase 4 EUCTR2018-004557-24-DE Germany
Cladribine 10 MG oral tablet
Pontificia Universidade Católica do Rio Grande do Sul
2021 Phase 4 NCT05902429 Brazil
Cladribine 3.5 MG/KG
EMD Serono
2005 Phase 3 NCT00213135 Canada;Switzerland
Cladribine 5.25 MG/KG
EMD Serono
2005 Phase 3 NCT00213135 Canada;Switzerland
Cladribine oral tablet
Claudio Gobbi
2020 - NCT04640818 Switzerland
Cladribine pill
Haukeland University Hospital
2018 Phase 3 NCT03477500 Denmark;Netherlands;Norway;Sweden
Cladribine subcutaneous injection
Institute of Psychiatry and Neurology, Warsaw
2022 Phase 2/Phase 3 NCT05961644 Poland
Cladribine tablet
MERCK SERONO SA
2011 Phase 3 EUCTR2009-017978-21-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Finland;Georgia;Germany;Greece;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Portugal;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States Minor Outlying Islands
Cladribine tablets
EMD Serono Research & Development Institute, Inc.
2019 - NCT03933202 United States
Keith Edwards, M.D.
2020 Phase 4 NCT04550455 United States
MERCK KGAA
2021 Phase 4 EUCTR2020-003995-42-IT Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003874-30-IT Austria;Czech Republic;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain
Merck Healthcare KGaA
2021 Phase 4 EUCTR2020-003995-42-PL Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-HU Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-CZ Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-AT Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003874-30-SK Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-HU Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-FR Austria;Czech Republic;Denmark;France;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-DK Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-CZ Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2020 Phase 4 EUCTR2020-003995-42-FI Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2020 Phase 4 EUCTR2020-003995-42-DE Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2020 Phase 4 EUCTR2020-003874-30-AT Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
Merck KGaA
2020 Phase 4 EUCTR2019-000069-19-RO Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-SE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-PT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-PL Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-LT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-HR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-ES Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-EE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-CZ Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-BG Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-BE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
Merck Serono S.A. - Geneva
2012 Phase 3 EUCTR2009-017978-21-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2012 Phase 3 EUCTR2009-017978-21-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2012 Phase 3 EUCTR2009-017978-21-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-SE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-LV Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 - EUCTR2009-017978-21-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-DK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 - EUCTR2009-017978-21-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2010 Phase 3 EUCTR2009-017978-21-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Merck, S.L.
2019 Phase 4 EUCTR2019-000069-19-AT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
Classic, progressive endurance training
Hasselt University
2019 - NCT03803800 Belgium
Clemastine
University of California, San Francisco
2014 Phase 2 NCT02040298 United States
Clemastine fumarate
Amsterdam UMC, location VUmc
2022 Phase 3 NCT05338450 Netherlands
Amsterdam University Medical Center
2022 Phase 3 EUCTR2021-003677-66-NL Netherlands
National Institute of Allergy and Infectious Diseases (NIAID)
2017 Phase 1/Phase 2 NCT03109288 United States
University of California, San Francisco
2024 Phase 1/Phase 2 NCT06065670 United States
2023 Phase 1/Phase 2 NCT05359653 United States
Clemastine milstein 1 MG, tabletten
Amsterdam University Medical Center
2022 Phase 3 EUCTR2021-003677-66-NL Netherlands
Clinical and neurological evaluation
Biogen Idec
2011 Phase 4 NCT01556685 Colombia;Mexico
Clinical assessment
University Hospital, Bordeaux
2023 - NCT05754593 France
Clinican CBD 10% OIL
Wageningen Research Stichting
2024 Phase 2 EUCTR2022-002372-36-NL Netherlands
Clostridium botulinum toxin type A
Ipsen Innovation
2016 Phase 3 EUCTR2015-003471-30-RO Canada;Czech Republic;Czechia;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-PT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-PL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-NL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-IT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-CZ Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-000507-44-LT Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-FR Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-ES Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-DE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-BE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2012 - EUCTR2010-023210-31-LT Austria;Czech Republic;Germany;Italy;Lithuania
2012 - EUCTR2010-023210-31-DE Austria;Czech Republic;Germany;Italy;Lithuania
2012 - EUCTR2010-023210-31-CZ Austria;Czech Republic;Germany;Italy;Lithuania
2012 - EUCTR2010-023210-31-AT Austria;Czech Republic;Germany;Italy;Lithuania
CLS12311
Cellerys AG
2023 Phase 1;Phase 2 EUCTR2022-000801-28-IT Czech Republic;Czechia;Germany;Italy;Switzerland
2023 Phase 1;Phase 2 EUCTR2022-000801-28-CZ Czech Republic;Czechia;Germany;Italy;Switzerland
CLS12311 high
Cellerys AG
2024 Phase 1/Phase 2 NCT06430671 Czech Republic;Czechia;Germany;Italy;Switzerland
CLS12311 LOW
Cellerys AG
2024 Phase 1/Phase 2 NCT06430671 Czech Republic;Czechia;Germany;Italy;Switzerland
CLS12311 medium
Cellerys AG
2024 Phase 1/Phase 2 NCT06430671 Czech Republic;Czechia;Germany;Italy;Switzerland
CNM-AU8
Clene Nanomedicine
2020 Phase 2/Phase 3 NCT04626921 Australia;Canada;United States
2019 - NCT04081714 United States
2018 Phase 2 NCT03536559 Australia;Canada;United States
CNP-MS-0601
Bionorica research GmbH
2007 Phase 3 EUCTR2006-004255-38-DK Austria;Denmark;Germany
2007 - EUCTR2006-004255-38-DE Austria;Germany
2007 - EUCTR2006-004255-38-AT Austria;Germany
Cnto 1275
Centocor, Inc.
2004 Phase 2 NCT00207727 Australia;Canada;Czech Republic;Hungary;Poland;United Kingdom;United States
CO-14
PEPTIMMUNE Inc
2008 - EUCTR2007-007759-15-HU Hungary
Coconut OIL
University of Iowa
2010 Phase 1 NCT01381354 United States
Coconut OIL and epigallocatechin gallate
Fundación Universidad Católica de Valencia San Vicente Mártir
2018 Phase 2 NCT03740295 Spain
Coduse balance training and step square exercises
Lama Saad El-Din Mahmoud
2020 - NCT04528121 Egypt
Coenzyme Q
University of Iowa
2010 Phase 1 NCT01381354 United States
Colecalciferol
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy
Charité - Universitätsmedizin Berlin
2011 Phase 2 EUCTR2011-002785-20-DE Germany
Javier Olascoaga Urtaza
2013 Phase 2 EUCTR2012-004602-97-ES Spain
MERCK SERONO SA
2011 - EUCTR2010-020328-23-IT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
MERCK SERONO s.a.s
2009 - EUCTR2009-013695-46-FR France
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
University of Turku
2008 Phase 2/Phase 3 NCT01432704 -
2008 Phase 4 NCT01339676 Finland
Colestiramina
NOVARTIS PHARMA AG
2022 Phase 3 EUCTR2020-005929-89-IT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Japan;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-IT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Guatemala;Hong Kong;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
Comirnaty konzentrat ZUR herstellung einer injektionsdispersion
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany
Complement protein C5 inhibitor
Tianjin Medical University General Hospital
2024 Phase 2 NCT06673394 -
Continued ocrelizumab
Johns Hopkins University
2021 Phase 2 NCT04767698 United States
Conventional balance training
Lama Saad El-Din Mahmoud
2020 - NCT04528121 Egypt
COP-1/copolymer-1
TEVA Pharmaceutical Industries Ltd.
2007 - EUCTR2004-000463-94-HU Hungary;Italy
2004 - EUCTR2004-000462-13-HU Hungary;Italy
Copaxone
Amphia Ziekenhuis
2009 - EUCTR2009-013129-41-NL Netherlands
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Bayer
2003 Phase 3 NCT00099502 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States
Biogen Idec
2010 - EUCTR2009-017490-38-DE Germany;Spain
Biogen Idec Limited
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Biogen Idec Ltd.
2008 - EUCTR2006-003697-10-BG Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-LV Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-IE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-GR Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 Phase 3 EUCTR2006-003697-10-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-EE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-DE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-CZ Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 Phase 3 EUCTR2006-003697-10-BE Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
FONDAZIONE DON CARLO GNOCCHI ONLUS
2011 - EUCTR2011-000150-31-IT Italy
Glostrup Hospital, Dep. of Neurology
2009 - EUCTR2006-001827-21-DK Denmark
ISTITUTO C. MONDINO
2007 - EUCTR2008-007162-32-IT Italy
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Merck KGaA
2014 - EUCTR2013-002283-25-PL Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-GR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 Phase 2 EUCTR2013-002283-25-GB Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-ES Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-BG Bulgaria;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2013-002283-25-IT Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-HU Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-FI Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-CZ Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
Merck Serono S.A. - Geneva
2010 - EUCTR2009-016087-37-GB France;Ireland;Italy;Spain;United Kingdom
2009 - EUCTR2009-016087-37-ES France;Ireland;Italy;Spain;United Kingdom
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy
Nancy Hammond, MD
2007 - NCT00490906 United States
Neurognostics
2006 - NCT00398528 United States
Novartis Pharma Services AG
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
Peptimmune Inc.
2010 Phase 2 EUCTR2009-012716-40-SK Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 Phase 2 EUCTR2009-012716-40-PL Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 - EUCTR2009-012716-40-FR Bulgaria;Czech Republic;Estonia;France;Germany;Poland
2010 Phase 2 EUCTR2009-012716-40-DE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 Phase 2 EUCTR2009-012716-40-CZ Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 - EUCTR2009-012716-40-BG Bulgaria;Czech Republic;Estonia;France;Germany;Poland
2009 - EUCTR2009-012716-40-EE Bulgaria;Czech Republic;Estonia;France;Germany;Poland
Philipps-Universität Marburg
2010 Phase 4 EUCTR2009-011088-35-DE Germany
SYNTHON BV
2011 - EUCTR2011-000888-27-IT Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Romania;Russian Federation;Ukraine;United Kingdom;United States
Stuart D Cook MD
2003 Phase 4 NCT00176592 United States
Synthon BV
2012 - EUCTR2011-000888-27-GR Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 - EUCTR2011-000888-27-DE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 NCT01489254 Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Italy;Kazakhstan;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;South Africa;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2011-000888-27-RO Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-GB Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-EE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-CZ Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-BG Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
TAKEDA PHARMACEUTICAL COMPANY LTD.
2015 - JPRN-jRCT1080223004 Japan
Teva Branded Pharmaceutical Products R&D, Inc.
2015 Phase 4 NCT02499900 Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Puerto Rico;Russian Federation;Spain;Turkey;United States
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University at Buffalo
2007 - NCT00937157 United States
University of California, Los Angeles
2007 Phase 2 NCT00451204 Canada;United States
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands
Copaxone - 20 MG/ML soluzione iniettabile 28 siringhe preriempite
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
Copaxone - 20 MG/ML soluzione iniettabile IN siringhe preriempite 30 siringhe
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
2015 Phase 4 EUCTR2015-000922-12-IT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
Copaxone - 40 MG/ML soluzione iniettabile IN
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
Copaxone - 40 MG/ML soluzione iniettabile IN siringa preriempita 12 siringhe preriempite DA 1 ML CON AGO
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
2015 Phase 4 EUCTR2015-000922-12-IT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
Copaxone 20 MG
EMD Serono
2013 Phase 2 NCT01963611 Bulgaria;Croatia;Czech Republic;Finland;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
Copaxone 20 MG/ML
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Teva Pharmaceutical Industries, Ltd
2016 Phase 4 EUCTR2015-000922-12-PL Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-FR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-ES Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-DE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-BE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-IE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-HR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-FI Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-AT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
Copaxone 20 MG/ML solucióN inyectable EN jeringa precargada
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Copaxone 20 MG/ML solucióN para inyeccióN EN jeringa precargada
Teva Pharmaceutical Industries, Ltd.
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Copaxone 20 MG/ML solution FOR injection, PRE-filled syringe
Teva Pharmaceutical Industries, Ltd.
2007 - EUCTR2006-002037-20-EE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-LV Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-LT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-HU Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-GB Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 Phase 3 EUCTR2006-002037-20-FI Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-DE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-BE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Copaxone 20 MG/ML, solution FOR injection, PRE-filled syringes
Teva Pharmaceutical Industries, Ltd.
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Copaxone 20MG/ML solution FOR injection, PRE-filled syringe
Teva Pharmaceutical Industries, Ltd.
2006 - EUCTR2006-002037-20-LT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Copaxone 40 MG/ML
Teva Pharmaceutical Industries, Ltd
2016 Phase 4 EUCTR2015-000922-12-PL Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-FR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-ES Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-DE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-BE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-IE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-HR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-FI Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-AT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
Copaxone 40 MG/ML solution FOR injection, PRE-filled syringe
Università degli Studi Aldo Moro
2019 Phase 3 EUCTR2017-005129-18-IT Italy
Copaxone*SC 28SIR 20MG/ML
Teva Pharmaceuticals Industries Ltd.
2006 - EUCTR2006-002037-20-IT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Copaxone-teva
Biocad
2013 Phase 3 NCT02753088 -
Copolymer 1
National Center for Research Resources (NCRR)
1991 Phase 3 NCT00004814 -
Core stability
Ankara Yildirim Beyazit University
2016 - NCT03566251 Turkey
Corticosteroid
The Affiliated Hospital of Guangdong Medical University
2024 Phase 3 ChiCTR2400087660 China
University of New Mexico
2019 Phase 1/Phase 2 NCT03752307 United States
Corticosteroids & tancart19/20
Chinese PLA General Hospital
2018 Phase 1 NCT03605238 China
Covid-19 vaccination
Sheba Medical Center
2021 - NCT05075499 Israel
Covid-19 vaccine
Novartis Pharmaceuticals
2021 - NCT04847596 Puerto Rico;United States
Covid19 vaccine
Yale University
2021 - NCT05286242 United States
Cranberry
Rennes University Hospital
2006 Phase 3 NCT00280592 France
Creatine
University of Iowa
2010 Phase 1 NCT01381354 United States
Cryopreserved myelin-derived peptide-loaded tolerogenic dendritic cells
Antwerp University Hospital
2023 Phase 2 EUCTR2022-003465-38-BE Belgium;Spain
CS-0777 tablets
Daiichi Sankyo Inc.
2008 Phase 1 NCT00616733 United States
CSF sampling
Rennes University Hospital
2021 - NCT04697407 France
CT-P53
Celltrion
2024 Phase 3 NCT05906992 Poland
CT103A cells
Tongji Hospital
2020 Early Phase 1 NCT04561557 China
Curcumin
Merck KGaA, Darmstadt, Germany
2012 Phase 2 NCT01514370 Italy
CYB704
Sandoz
2025 Phase 3 NCT06847724 -
Cyclophosfamide
Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
2006 - EUCTR2006-002562-19-IT Italy
Cyclophosphamide
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
Baylor College of Medicine
1999 Phase 2 NCT00040482 United States
Bruce Cree
2024 Phase 1 NCT06451159 United States
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States
Hadassah Medical Organization
2015 - NCT02529839 -
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-SE Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
Indapta Therapeutics, INC.
2026 Phase 1 NCT06677710 United States
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
2024 Phase 1 NCT06220201 Belgium;France;Germany;Italy;Spain;United Kingdom;United States
Northwestern Memorial Hospital
2001 Phase 1 NCT00017628 United States
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States
2017 Phase 3 NCT03342638 United States
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy
Seah Lim M.D.
2012 Phase 2 NCT01679041 United States
Stony Brook University
2003 Phase 2 NCT00296205 United States
University Hospital, Bordeaux
2005 Phase 3 NCT00241254 France
Cyclophosphamide and ATG
Haukeland University Hospital
2018 Phase 3 NCT03477500 Denmark;Netherlands;Norway;Sweden
Cyclophosphamide and fludarabine
Tongji Hospital
2020 Early Phase 1 NCT04561557 China
Cyclophosphamide monohydrate
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom
Uppsala l?ns landsting
2011 Phase 2 EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States
Cyclophosphamide/ATG
Scripps Health
2023 - NCT05482542 United States
Cyclophosphamide/glatiramer acetate
Johns Hopkins University
2010 Phase 2 NCT00939549 United States
Cyclophosphamide/rituximab
Scripps Health
2023 - NCT05482542 United States
Cymbalta
Eli Lilly and Company
2008 - EUCTR2008-002560-34-BE Belgium
Cytarabine
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States
Cytolytic CD4+ T cells
ImCyse S.A
2014 Phase 1;Phase 2 EUCTR2014-001081-99-BE Belgium
Cápsulas DE laquinimod 0.6 MG
Teva Pharmaceutical Industries Ltd
2008 - EUCTR2007-005450-23-ES Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
Células madre mesenquimales
Fundació Clínic per a la Recerca Biomèdica
- - EUCTR2009-016442-74-ES Spain
D mannose
University College, London
2015 Phase 1 NCT02490046 United Kingdom
D-aspartate
Merck KGaA, Darmstadt, Germany
2018 Phase 2 NCT03387046 Germany;Italy
D-biotin
MEDDAY PHARMACEUTICALS
2017 Phase 3 EUCTR2016-000700-29-IT Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
MEDDAY PHARMACEUTICALS SA
2018 Phase 3 EUCTR2016-000700-29-PL Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2016-000700-29-HU Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2016-000700-29-BE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-000700-29-SE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-000700-29-ES Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Poland;Spain;Sweden;United Kingdom;United States
2017 Phase 3 EUCTR2016-000700-29-DE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-000700-29-CZ Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
D-biotina
MEDDAY PHARMACEUTICALS
2017 Phase 3 EUCTR2016-000700-29-IT Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
DAC HYP
BIOGEN IDEC RESEARCH LIMITED
2017 Phase 3 EUCTR2016-002820-10-IT Canada;Denmark;France;Germany;Italy;United Kingdom;United States
Biogen Idec Research Limited
2017 Phase 3 EUCTR2016-002820-10-GB Canada;Denmark;France;Germany;Italy;United Kingdom;United States
2017 Phase 3 EUCTR2016-002820-10-DE Canada;Germany;Italy;United Kingdom;United States
DAC-HYP
National Institute of Neurological Disorders and Stroke (NINDS)
2010 Phase 1 NCT01143441 United States
Daclizumab
BIOGEN IDEC RESEARCH LIMITED
2017 Phase 3 EUCTR2016-002820-10-IT Canada;Denmark;France;Germany;Italy;United Kingdom;United States
Biogen
2017 Phase 3 NCT02881567 Canada;France;Germany;Italy;Puerto Rico;United Kingdom;United States
2013 Phase 3 NCT01797965 Argentina;Australia;Brazil;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States
2010 Phase 2 NCT01051349 Czech Republic;Czechia;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
Biogen Idec Research Limited
2017 Phase 3 EUCTR2016-002820-10-GB Canada;Denmark;France;Germany;Italy;United Kingdom;United States
2017 Phase 3 EUCTR2016-002820-10-DE Canada;Germany;Italy;United Kingdom;United States
National Institute of Neurological Disorders and Stroke (NINDS)
2003 Phase 2 NCT00071838 United States
PDL BioPharma, Inc.
2005 Phase 2 NCT00109161 Canada;United States
Protein Design Labs, Inc.
2006 - EUCTR2005-001567-55-DE Germany;Spain;United Kingdom
2005 Phase 2 EUCTR2005-001567-55-GB Austria;Germany;Spain;United Kingdom
2005 Phase 2 EUCTR2005-001567-55-ES Austria;Germany;Spain;United Kingdom
2005 - EUCTR2005-001567-55-AT Austria;Germany;Spain;United Kingdom
Daclizumab high yield process
Biogen
2010 Phase 3 NCT01064401 Argentina;Australia;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Egypt;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 2 NCT00870740 Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2008 Phase 2 NCT00390221 Australia;Czech Republic;Former Serbia and Montenegro;Germany;Hungary;India;Poland;Russian Federation;Sweden;Turkey;Ukraine;United Kingdom
Biogen Idec Ltd.
2011 Phase 2 EUCTR2009-015318-23-DE Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2010 Phase 2 EUCTR2009-015318-23-HU Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2010 Phase 2 EUCTR2009-015318-23-CZ Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
Daclizumab HYP
BIOGEN IDEC LTD
2010 - EUCTR2009-012500-11-IT Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
Daclizumab HYP (DAC HYP
BIOGEN IDEC RESEARCH LTD
2013 Phase 3 EUCTR2012-003176-39-IT Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Biogen
2013 Phase 3 EUCTR2012-003176-39-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-015318-23-GB Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
Biogen Idec Limited
2011 - EUCTR2010-023856-97-PL Czech Republic;Hungary;Poland;Russian Federation;United States
2011 - EUCTR2010-023856-97-HU Czech Republic;Hungary;Poland;Russian Federation;United States
2011 - EUCTR2010-023856-97-CZ Czech Republic;Hungary;Poland;United States
Biogen Idec Ltd
2010 - EUCTR2009-012500-11-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-GR Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012500-11-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012500-11-FR Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012500-11-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012500-11-ES Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-012500-11-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2006 Phase 2 EUCTR2006-001161-42-GB Czech Republic;Germany;Hungary;Sweden;United Kingdom
Biogen Idec Ltd.
2011 Phase 2 EUCTR2009-015318-23-DE Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2010 Phase 2 EUCTR2009-015318-23-HU Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2010 Phase 2 EUCTR2009-015318-23-CZ Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2009 - EUCTR2008-005559-46-HU Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 Phase 2 EUCTR2008-005559-46-GB Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 - EUCTR2008-005559-46-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 - EUCTR2008-005559-46-CZ Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2008 - EUCTR2006-001161-42-HU Germany;Hungary;Sweden;United Kingdom
2008 - EUCTR2006-001161-42-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Sweden;Ukraine;United Kingdom
2006 - EUCTR2006-001161-42-SE Germany;Hungary;Sweden;United Kingdom
2006 - EUCTR2006-001161-42-CZ Czech Republic;Germany;Hungary;Sweden;United Kingdom
Biogen Idec Research Limited
2013 Phase 3 EUCTR2012-003176-39-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-PL Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-GR Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-FR Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 - EUCTR2012-003176-39-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-ES Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Daclizumab HYP (DAC HYP)
Biogen Idec Ltd
2012 Phase 3 EUCTR2009-012500-11-SI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Daclizumab with greek suufix
Biogen Idec Ltd.
2009 - EUCTR2008-005559-46-HU Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 Phase 2 EUCTR2008-005559-46-GB Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 - EUCTR2008-005559-46-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 - EUCTR2008-005559-46-CZ Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
Dalfampridine
Johns Hopkins University
2014 Phase 2 NCT02166346 United States
Oregon Health and Science University
2011 Phase 2 NCT01444300 United States
State University of New York at Buffalo
2011 Phase 2/Phase 3 NCT02006160 United States
VA Office of Research and Development
2015 Phase 2 NCT02391961 United States
Washington University School of Medicine
2011 Phase 2/Phase 3 NCT01337986 United States
Dalfampridine ER
Brown, Theodore R., M.D., MPH
2010 Phase 4 NCT01356940 United States
Dalfampridine ER, 10 MG oral tablet, extended release
Ain Shams University
2021 - NCT05730738 Egypt
Dalfampridine plus physical therapy
MGH Institute of Health Professions
2024 Phase 4 NCT06136728 United States
Dalfampridine-ER 10MG
Acorda Therapeutics
2011 Phase 3 NCT01328379 United States
Dalfampridine-ER 5MG
Acorda Therapeutics
2011 Phase 3 NCT01328379 United States
Dantrolene
National Institute of Allergy and Infectious Diseases (NIAID)
2017 Phase 1/Phase 2 NCT03109288 United States
Dapirolizumab pegol
Biogen Idec Research Limited
2020 Phase 2 EUCTR2019-001967-58-PL Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States
2020 Phase 2 EUCTR2019-001967-58-FR Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States
Daratumumab
Tianjin Medical University General Hospital
2022 Phase 2/Phase 3 NCT05403138 China
Darifenacin
Bayer
2007 Phase 2 NCT00845338 Germany
Bayer Vital GmbH
2006 - EUCTR2006-002361-39-DE Germany
DC-TAB
Delta Crystallon B.V.
2012 - EUCTR2011-004475-36-BG Bulgaria
Dekristol 20000 IE
Merja Soilu Häninen
2007 - EUCTR2007-001958-99-FI Finland
Dekristol® 400-tabletten
Charité - Universitätsmedizin Berlin
2011 Phase 2 EUCTR2011-002785-20-DE Germany
Delta-9-tetrahydrocannabinol
ALMIRALL PRODESFARMA
2011 - EUCTR2011-002258-30-IT Italy
Almirall Hermal GmbH
2016 Phase 4 EUCTR2015-004451-40-AT Austria;Czech Republic
Bionorica research GmbH
2007 Phase 3 EUCTR2006-004255-38-DK Austria;Denmark;Germany
2007 - EUCTR2006-004255-38-DE Austria;Germany
2007 - EUCTR2006-004255-38-AT Austria;Germany
GW Pharma Limited
2022 Phase 3 EUCTR2020-004306-58-LT Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom
2021 Phase 3 EUCTR2020-003271-18-CZ Czech Republic;Czechia;Poland;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-GB Poland;United Kingdom
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-PL Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
2020 Phase 3 EUCTR2019-002623-14-GB Czech Republic;Poland;Romania;United Kingdom;United States
2020 Phase 3 EUCTR2019-002623-14-CZ Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
2007 Phase 3 EUCTR2006-005910-11-CZ Czech Republic;Germany;Italy;Spain;United Kingdom
2006 Phase 3 EUCTR2005-005265-11-GB Czech Republic;France;United Kingdom
2006 Phase 3 EUCTR2005-005265-11-FR Czech Republic;France;United Kingdom
2006 - EUCTR2005-005265-11-CZ Czech Republic;France;United Kingdom
2005 Phase 3 EUCTR2004-002509-63-GB Czech Republic;United Kingdom
2005 - EUCTR2004-002509-63-CZ Czech Republic;United Kingdom
GW Pharma Ltd.
2011 - EUCTR2011-000926-31-CZ Czech Republic
2008 Phase 3 EUCTR2006-005910-11-GB Czech Republic;Germany;Italy;Spain;United Kingdom
2008 - EUCTR2006-005910-11-DE Germany;Italy;Spain;United Kingdom
2007 - EUCTR2007-002138-13-GB United Kingdom
Demestril septem
OSPEDALI CIVILI DI LIONE
2007 - EUCTR2006-005460-30-IT Italy
Desloratadine given orally
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Australia;Brazil;Canada;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
Determination OF calcium intake BY A dietician interview
Centre Hospitalier Universitaire de Nimes
2016 - NCT02636829 France
Dexamethason
Department of Neurology UMCG
2006 - EUCTR2006-003113-40-NL Netherlands
Dexamethasone
Department of Neurology UMCG
2006 - EUCTR2006-003113-40-NL Netherlands
Dexamethasone given orally
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Australia;Brazil;Canada;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
Dexamethasone soduim phosphate
Hadassah Medical Organization
2008 Phase 1 NCT00674141 Israel
Dexchlorpheniramine
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 1 NCT02583594 Spain
Dexrazoxane
PD Dr. Andrew Chan
2012 Phase 2 NCT01627938 Germany
Dextromethorphan
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States
Dextromethorphan hydrobromide
Avanir Pharmaceuticals, Inc.
2012 - EUCTR2011-002178-22-PL Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2012 Phase 2 EUCTR2011-002178-22-GB Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2012 - EUCTR2011-002178-22-CZ Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
Dextromethorphan hydrobromide 20 MG and quinidine sulfate 10 MG
Avanir Pharmaceuticals
2007 Phase 3 NCT00573443 Argentina;Brazil;United States
Dextromethorphan hydrobromide 30 MG and quinidine sulfate 10 MG
Avanir Pharmaceuticals
2007 Phase 3 NCT00573443 Argentina;Brazil;United States
Dextromethorphan/quinidine
Avanir Pharmaceuticals, Inc.
2012 - EUCTR2011-002178-22-PL Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2012 Phase 2 EUCTR2011-002178-22-GB Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2012 - EUCTR2011-002178-22-CZ Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
Dextrometorfano hidrobromuro
Avanir Pharmaceuticals, Inc.
2011 Phase 2 EUCTR2011-002178-22-ES Argentina;Bulgaria;Czech Republic;Poland;Spain;United Kingdom;United States
Dextrometorfano/quinidina
Avanir Pharmaceuticals, Inc.
2011 Phase 2 EUCTR2011-002178-22-ES Argentina;Bulgaria;Czech Republic;Poland;Spain;United Kingdom;United States
Diazoxide
NEUROTEC PHARMA, S.L
2011 - EUCTR2010-023048-34-DE Germany;Spain
Dibase
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy
Diclofenac sodium topical GEL
Brown, Theodore R., M.D., MPH
2011 Phase 4 NCT01454791 United States
Dimethyl fumarate
Alkermes, Inc.
2019 Phase 3 EUCTR2017-001294-16-DE Germany;Poland;United States
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States
Anders Svenningsson
2016 Phase 3 NCT02746744 Sweden
BIOGEN IDEC LTD
2008 - EUCTR2006-003696-12-IT Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
BIOGEN IDEC RESEARCH LIMITED
2015 Phase 3 EUCTR2014-005624-98-IT Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
Biogen
2024 - NCT05767736 United States
2023 - NCT05658497 Germany;Ireland;Spain;Switzerland;United States
2023 Phase 4 NCT05658484 China
2021 - NCT04756687 France
2019 - NCT04221191 France
2019 Phase 3 NCT03870763 Colombia;Estonia;Hungary;Jordan;Korea, Republic of;Malaysia;Mexico;Saudi Arabia;Taiwan;Thailand;Tunisia;Turkey;United States
2017 Phase 3 NCT03093324 Germany;Poland;United States
2016 - NCT02969304 Germany
2016 Phase 3 NCT02555215 Belgium;Bulgaria;Czech Republic;Czechia;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 NCT02428218 -
2015 Phase 3 NCT02525874 Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;Turkey;United States
2015 - NCT02519413 United States
2015 Phase 4 NCT02472938 -
2015 Phase 4 NCT02471560 Norway
2015 Phase 3 NCT02430532 Austria;Belgium;Czech Republic;Netherlands;Poland;Slovakia;Sweden;United States
2015 Phase 3 NCT02428231 Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 Phase 4 NCT02410278 United States
2015 Phase 2 NCT02410200 Belgium;Bulgaria;Czech Republic;Czechia;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2015 Phase 4 NCT02343159 United States
2015 - NCT02323269 Canada
2015 Phase 2 NCT02097849 United States
2015 Phase 4 NCT02090348 -
2014 Phase 3 NCT02579681 Italy
2014 Phase 3 NCT02283853 Argentina;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 - NCT02159573 United States
2014 Phase 4 NCT02125604 Germany
2014 Phase 4 NCT02090413 Ireland;United Kingdom
2013 - NCT02047097 Argentina;Australia;Austria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Switzerland;United Kingdom;United States
2013 Phase 4 NCT01930708 Austria;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2013 - NCT01911767 Australia;Canada;France;Germany;Ireland;Italy;Poland;Spain;United Kingdom;United States
2013 - NCT01903291 United States
2013 Phase 3 NCT01838668 Czech Republic;Czechia;Japan;Korea, Republic of;Poland;Taiwan
2010 Phase 2 NCT01156311 United States
2009 Phase 3 NCT00835770 Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;North Macedonia;Poland;Puerto Rico;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
Biogen GmbH
2015 Phase 4 EUCTR2014-000395-26-DE Germany
Biogen Idec Inc.
2004 - EUCTR2004-000663-99-SE Hungary;Sweden
2004 - EUCTR2004-000663-99-HU Hungary;Sweden
2004 - EUCTR2004-000663-99-CZ Czech Republic;Hungary;Sweden
Biogen Idec Italia S.r.l.
2015 - EUCTR2015-000303-21-IT Italy
2013 Phase 3 EUCTR2013-001422-25-IT Italy
Biogen Idec Limited
2010 Phase 3 EUCTR2008-004753-14-BG Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-SK Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-LV Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-IE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-GB Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-EE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-CZ Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-BE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-AT Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
Biogen Idec LtD.
2007 Phase 3 EUCTR2006-003696-12-SK Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Slovakia;Sweden;United Kingdom
Biogen Idec Ltd.
2010 Phase 3 EUCTR2008-004753-14-NL Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2008-004753-14-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom
2009 Phase 3 EUCTR2008-004753-14-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom
2009 Phase 3 EUCTR2008-004753-14-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom
2009 Phase 3 EUCTR2008-004753-14-DE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 - EUCTR2006-003696-12-BG Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2008 - EUCTR2006-003697-10-BG Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2008 - EUCTR2006-003696-12-NL Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2008 - EUCTR2006-003696-12-DE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 - EUCTR2006-003697-10-LV Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-IE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-GR Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 Phase 3 EUCTR2006-003697-10-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-EE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-DE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-CZ Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 Phase 3 EUCTR2006-003697-10-BE Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003696-12-SE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 - EUCTR2006-003696-12-GR Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 Phase 3 EUCTR2006-003696-12-GB Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Slovakia;Sweden;United Kingdom
2007 - EUCTR2006-003696-12-CZ Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 - EUCTR2006-003696-12-BE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 - EUCTR2006-003696-12-AT Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
Biogen Idec Norway
2015 Phase 4 EUCTR2015-001197-18-NO Norway
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2017 Phase 3 EUCTR2013-002318-11-FR Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-003282-29-LV Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-003282-29-DE Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-003282-29-CZ Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-003282-29-BG Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-003282-29-BE Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-001973-42-PL Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States
2016 Phase 3 EUCTR2015-001973-42-LT Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States
2016 Phase 3 EUCTR2015-001973-42-HR Austria;Belgium;Bulgaria;Canada;Croatia;Kuwait;Lithuania;Poland;Slovakia;Sweden;Turkey;United States
2016 Phase 3 EUCTR2015-001973-42-BG Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States
2016 Phase 3 EUCTR2014-005624-98-AT Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
2016 - EUCTR2013-002318-11-ES Argentina;Belgium;Canada;Croatia;Czech Republic;Denmark;France;Hungary;Israel;Italy;Poland;Portugal;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom
2016 Phase 3 EUCTR2013-002318-11-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Türkiye;United Kingdom;United States
2015 Phase 3 EUCTR2015-001973-42-BE Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Kuwait;Lithuania;Poland;Turkey;United States
2015 - EUCTR2014-005624-98-HU Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
2015 Phase 2 EUCTR2014-005003-24-PL Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom
2015 Phase 2 EUCTR2014-005003-24-LV Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom
2015 Phase 2 EUCTR2014-005003-24-DE Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom
2015 Phase 2 EUCTR2014-005003-24-CZ Australia;Belgium;Bulgaria;Czech Republic;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United States
2015 Phase 2 EUCTR2014-005003-24-BG Australia;Belgium;Bulgaria;Czech Republic;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Poland;Turkey;United Kingdom;United States
2015 Phase 2 EUCTR2014-005003-24-BE Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom
2015 Phase 3 EUCTR2014-004562-22-IT Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 - EUCTR2014-004562-22-HU Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 Phase 3 EUCTR2014-004562-22-DE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 Phase 3 EUCTR2014-004562-22-CZ Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 Phase 3 EUCTR2014-004562-22-BE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 - EUCTR2014-003021-18-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 Phase 3 EUCTR2014-003021-18-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 Phase 3 EUCTR2013-002318-11-PL Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2015 - EUCTR2013-001025-53-ES Denmark;Finland;Netherlands;Norway;Spain;United Kingdom
2015 Phase 4 EUCTR2013-001025-53-DK Denmark;Finland;Netherlands;Norway;Spain;United Kingdom
2014 Phase 3 EUCTR2013-004533-32-PL Czech Republic;Japan;Korea, Republic of;Poland;Taiwan
2014 Phase 3 EUCTR2013-004533-32-CZ Czech Republic;Japan;Korea, Republic of;Poland;Taiwan
2014 Phase 3 EUCTR2013-002318-11-SE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-IT Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3 EUCTR2013-002318-11-HU Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom
2014 Phase 3 EUCTR2013-002318-11-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-DK Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-CZ Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom
2014 Phase 4 EUCTR2013-001656-35-SK Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-SI Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-PT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-IT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-HU Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-FR Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-ES Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-CZ Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-BE Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-AT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 - EUCTR2013-001486-17-DE Germany
- Phase 3 EUCTR2014-005624-98-EE Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
- Phase 3 EUCTR2013-002318-11-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
Brigham and Women's Hospital
2015 - NCT02419638 United States
Department of Clinical Sciences, Danderyd Hospital
2015 Phase 3 EUCTR2015-004116-38-SE Sweden
Fakultní nemocnice Ostrava
2021 Phase 4 EUCTR2021-003195-13-CZ Czech Republic
Finn Sellebjerg
2016 Phase 2 EUCTR2016-000283-41-DK Denmark
Fondation Ophtalmologique Adolphe de Rothschild
2017 Phase 4 NCT02901106 France
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
2017 Phase 4 NCT03345940 Italy
Genesis Pharma CNS & Specialty
2016 - NCT03101735 Greece
Hikma Pharmaceuticals LLC
2021 - NCT04468165 Algeria;Egypt;Jordan
Imcyse SA
2022 Phase 1/Phase 2 NCT05417269 Moldova, Republic of
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Merck KGaA
2017 Phase 2 EUCTR2016-001448-21-SK Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-PL Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-ES Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-CZ Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-BG Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
Multiple Sclerosis Center of Northeastern New York
2015 Phase 4 NCT03092544 United States
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Oregon Health and Science University
2016 - NCT02644083 United States
Rigshospitalet, Denmark
2016 Phase 2 NCT02959658 Denmark
University Hospital Muenster
2015 Phase 4 NCT02461069 Germany
University at Buffalo
2018 - NCT03526224 United States
2015 - NCT02686684 -
University of British Columbia
2003 - NCT06705608 -
Universitätsklinikum Münster
2015 Phase 4 EUCTR2014-003481-25-DE Germany
Virginia Simnad
2015 - NCT02736279 United States
Washington University School of Medicine
2016 Phase 4 NCT02675413 United States
Dimethyl fumarate 240 MG
Banner Life Sciences LLC
2017 Phase 1 NCT04570670 -
IRCCS Centro Neurolesi Bonino Pulejo
2021 - NCT05811949 Italy
Dimetil-fumarato
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2017 Phase 4 EUCTR2017-000559-26-IT Israel;Italy;Switzerland;United States
Dimetilfumarato
Biogen Idec Italia S.r.l.
2013 Phase 3 EUCTR2013-001422-25-IT Italy
Diphenhydramine
Providence Health & Services
2020 Phase 3 NCT04175834 United States
Diphenhydramine IV
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Australia;Brazil;Canada;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
Diphenydramine
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
Diphtheria toxoid
Biogen
2008 Phase 4 NCT00536120 United States
Diroximel fumarate
Alkermes, Inc.
2019 Phase 3 EUCTR2017-001294-16-DE Germany;Poland;United States
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States
Biogen
2024 - NCT05767736 United States
2023 - NCT05658497 Germany;Ireland;Spain;Switzerland;United States
2021 - NCT05688436 United States
2021 Phase 3 NCT05083923 China;Japan
Hanna Jerome Thomas
2021 Phase 3 JPRN-jRCT2051210115 China;Japan
Dirucotide
Eli Lilly and Company
2007 Phase 2/Phase 3 NCT00870155 Canada;Denmark;Estonia;Finland;Germany;Latvia;Netherlands;Spain;Sweden;United Kingdom
2006 Phase 2/Phase 3 NCT00869986 Bulgaria;Poland;Russian Federation;Serbia;Slovakia;Ukraine
2004 Phase 2/Phase 3 NCT00869726 Canada;Denmark;Estonia;Finland;Germany;Latvia;Netherlands;Spain;Sweden;United Kingdom
Dirucotide acetate
BioMS Technology Corp
2007 - EUCTR2004-002571-16-GB Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-FI Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-EE Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-DK Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2005 - EUCTR2004-002571-16-SE Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Disability evaluation tests
University Hospital, Strasbourg, France
2025 Phase 3 NCT06663189 France
Discontinuation OF disease modifying therapy
University of Colorado, Denver
2017 Phase 4 NCT03073603 United States
Disease modifying therapy
Novartis Pharmaceuticals
2012 Phase 4 NCT01623596 Puerto Rico;United States
Divozilimab
Biocad
2022 Phase 3 NCT06987851 Russian Federation
2022 Phase 3 NCT05730699 Russian Federation
DMT
Merck KGaA
2012 - NCT01601119 United Kingdom
Novartis Pharmaceuticals
2022 Phase 4 NCT05090371 Canada;United States
VU University Medical Center
2020 - NCT04260711 Netherlands
DMT category 1
Novartis Pharmaceuticals
2024 - NCT06551519 Germany
DMT continuation
Rennes University Hospital
2019 Phase 3 NCT03653273 France
DMT withdrawal
Rennes University Hospital
2019 Phase 3 NCT03653273 France
Domperidone
University of Calgary
2015 Phase 2 NCT02493049 Canada
2015 Phase 2 NCT02308137 Canada
Donepezil
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
1999 Phase 3 NCT00062972 United States
Neurognostics
2004 Phase 4 NCT00315367 United States
Neurology Unit
2005 - EUCTR2005-003410-15-SE Sweden
OSPEDALE S. RAFFAELE
2008 - EUCTR2008-001940-38-IT Italy
Dosing interruption OF natalizumab
Berkovich, Regina MD, PhD Inc.
2019 Phase 4 NCT04048577 United States
DPA
VU University Medical Center
2014 - EUCTR2014-002547-17-NL Netherlands
DPA-714 PET/MRI
University of Alabama at Birmingham
2019 Phase 1 NCT03759522 United States
DRF
Alkermes, Inc.
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States
Biogen
2023 Phase 2 NCT05798520 Bulgaria;Czechia;Germany;Italy;Poland;Puerto Rico;Romania;Spain;Switzerland;United States
Hanna Jerome Thomas
2021 Phase 3 JPRN-jRCT2051210115 China;Japan
Dronabinol
Bionorica Research GmbH
2007 Phase 3 NCT00959218 Germany
Bionorica SE
2018 Phase 3 EUCTR2018-000001-23-ES Czech Republic;Hungary;Spain
Bionorica research GmbH
2007 Phase 3 EUCTR2006-004255-38-DK Austria;Denmark;Germany
2007 - EUCTR2006-004255-38-DE Austria;Germany
2007 - EUCTR2006-004255-38-AT Austria;Germany
Echo Pharmaceuticals B.V.
2011 - EUCTR2010-022033-28-NL Netherlands
Plymouth Hospitals NHS Trust
2006 - EUCTR2005-002728-33-GB United Kingdom
Dronabinol 25 MG/ML, oral drops
Bionorica SE
2020 Phase 3 EUCTR2018-000001-23-CZ Czech Republic;Hungary;Spain
2018 Phase 3 EUCTR2018-000001-23-HU Czech Republic;Hungary;Spain
Dronabinol capsule 2,5 MG
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark
Drug - SHR1459
Reistone Biopharma Company Limited
2021 Phase 2 NCT04670770 China
Dual task performance
Ankara Yildirim Beyazit University
2019 - NCT04408742 Turkey
2019 - NCT04286828 Turkey
Duloxetine
Brown, Theodore R., M.D., MPH
2007 Phase 2/Phase 3 NCT00457730 United States
Eli Lilly and Company
2008 Phase 3 NCT00755807 Belgium;Canada;Poland;United States
2008 - EUCTR2008-002560-34-BE Belgium
DUOC-01
Joanne Kurtzberg, MD
2021 Phase 1 NCT04943289 United States
Dydrogesterone
Irina Elovaara
2015 - EUCTR2014-005129-10-FI Finland
Dynamic balance training
Gazi University
2018 - NCT03501342 Turkey
Dynamic balance walking training
Marquette University
2017 - NCT04719494 -
Dynamic contrast-enhanced magnetic resonance imaging
University of Southern California
2011 - NCT02967380 United States
Dysport
Aránzazu Vázquez Doce
2018 Phase 3 EUCTR2018-003231-30-ES Spain
Ipsen Innovation
2016 Phase 3 EUCTR2015-003471-30-RO Canada;Czech Republic;Czechia;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-PT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-PL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-NL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-IT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-CZ Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-000507-44-LT Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-FR Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-ES Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-DE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-BE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2012 - EUCTR2010-023210-31-LT Austria;Czech Republic;Germany;Italy;Lithuania
2012 - EUCTR2010-023210-31-DE Austria;Czech Republic;Germany;Italy;Lithuania
2012 - EUCTR2010-023210-31-CZ Austria;Czech Republic;Germany;Italy;Lithuania
2012 - EUCTR2010-023210-31-AT Austria;Czech Republic;Germany;Italy;Lithuania
Dysport*SC IM 2FL 500U
IPSEN INNOVATION
2012 - EUCTR2010-023210-31-IT Austria;Czech Republic;Germany;Italy;Lithuania
Early harvest extra virgin olive OIL
Aristotle University Of Thessaloniki
2018 - NCT04120675 Greece
Early highly effective therapies group
The Cleveland Clinic
2019 Phase 4 NCT03535298 United Kingdom;United States
Ebixa
AZ. OSPEDALIERA GARIBALDI, S.LUIGI CURRO , ASCOLI TOMASELLI
2007 - EUCTR2007-000503-15-IT Italy
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France
OSPEDALE S. RAFFAELE
2008 Phase 2 EUCTR2008-000490-37-IT Italy
ECP002A
Echo Pharmaceuticals B.V.
2011 - EUCTR2010-022033-28-NL Netherlands
Eculizumab
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Alexion Pharmaceuticals
2015 Phase 3 NCT02003144 Argentina;Australia;Austria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Russian Federation;Singapore;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
2014 Phase 3 NCT01892345 Argentina;Australia;Austria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Russian Federation;Singapore;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
Alexion Pharmaceuticals Inc.
2020 Phase 2;Phase 3 EUCTR2019-001829-26-DE Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2019 Phase 2;Phase 3 EUCTR2019-001829-26-ES Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Alexion Pharmaceuticals, Inc.
2025 Phase 3 NCT06724809 China
2020 Phase 2/Phase 3 NCT04155424 Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2015 Phase 3 EUCTR2013-001151-12-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001151-12-DK Argentina;Australia;Austria;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Martinique;Romania;Russian Federation;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001151-12-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hong Kong;Italy;Japan;Korea, Republic of;Netherlands;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
Mayo Clinic
2009 Phase 1/Phase 2 NCT00904826 United States
Eculizumab administration
Huashan Hospital
2023 - NCT06888622 China
Efalizumab
Merck Serono International S.A.
2009 - EUCTR2007-001377-28-PT Austria;France;Germany;Netherlands;Portugal
2008 - EUCTR2007-001377-28-NL Austria;France;Germany;Netherlands;Portugal
2008 Phase 4 EUCTR2007-001377-28-FR Austria;France;Germany;Netherlands;Portugal
2008 - EUCTR2007-001377-28-DE Austria;France;Germany;Netherlands;Portugal
2008 - EUCTR2007-001377-28-AT Austria;France;Germany;Netherlands;Portugal
Efgartigimod alfa injection
Tianjin Medical University General Hospital
2024 Phase 2 NCT06497374 -
Egcg
Charite University, Berlin, Germany
2011 - NCT01417312 Germany
EHP-101 25 MG BID
Emerald Health Pharmaceuticals
2021 Phase 2 NCT04909502 Australia;United States
EHP-101 25 MG OD
Emerald Health Pharmaceuticals
2021 Phase 2 NCT04909502 Australia;United States
EHP-101 50 MG BID
Emerald Health Pharmaceuticals
2021 Phase 2 NCT04909502 Australia;United States
EHP-101 50 MG OD
Emerald Health Pharmaceuticals
2021 Phase 2 NCT04909502 Australia;United States
EK-12
Bosnalijek D.D
2019 Phase 3 NCT03283397 Turkey
Elezanumab
AbbVie
2019 Phase 2 NCT03737812 Canada;United States
2018 Phase 2 NCT03737851 Canada;United States
ELND002
Elan Pharmaceuticals
2010 Phase 1 NCT01318421 -
2010 Phase 1 NCT01144351 Canada;United States
EMD 28162
Academic MS Center Limburg
- Phase 2 EUCTR2014-000728-97-NL Netherlands
Merck Serono
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-DE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
2011 - EUCTR2010-020328-23-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Emselex 15 MG retardtabletten
Bayer Vital GmbH
2006 - EUCTR2006-002361-39-DE Germany
Emselex 7,5 MG retardtabletten
Bayer Vital GmbH
2006 - EUCTR2006-002361-39-DE Germany
Emtricitabine
Massachusetts General Hospital
2023 Phase 2 NCT05957913 United States
ENA713
Novartis Pharma GmbH
- - EUCTR2008-007015-32-DE Germany
Enalapril
West China Hospital,Sichuan University
2024 Phase 4 ChiCTR2400087203 China
Encapsulated baclofen 20 MG
Impax Laboratories, LLC
2007 Phase 3 NCT00488839 Canada;Estonia;Latvia;Ukraine;United States
Encapsulated simvastatin tablets
Imperial College London
2007 Phase 2 EUCTR2006-006347-31-GB United Kingdom
Endoxan
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Endoxan - ciclofosfamide
Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
2006 - EUCTR2006-002562-19-IT Italy
Endoxan baxter
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy
Enspryng
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2021-001088-26-IT Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States
2021 Phase 3 EUCTR2020-003413-35-IT Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2021-001088-26-DE Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States
2022 Phase 3 EUCTR2019-004092-39-PL Argentina;France;Italy;Mexico;Poland;United Kingdom;United States
2022 Phase 3 EUCTR2019-004092-39-FR Argentina;France;Italy;Mexico;Poland;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-PL Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-HU Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-BG Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd.
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-GB France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-DE France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
Entire-body PET-CT scans
Brain Health Alliance
2024 Early Phase 1 NCT04390009 United States
Eparmefolin 30 CPR 0,1/0,5MG
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy
Epigallocatechin
Charite University, Berlin, Germany
2007 Phase 1/Phase 2 NCT00525668 Germany
EPO
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany
Sun Yat-sen University
2006 - NCT00818103 China
Epoetin alfa
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany
Epoetin beta
Walton Centre for Neurology and Neurosurgery
2008 - EUCTR2008-005125-11-GB United Kingdom
Eritrociti accoppiati A peptidi
Cellerys AG
2023 Phase 1;Phase 2 EUCTR2022-000801-28-IT Czech Republic;Czechia;Germany;Italy;Switzerland
Erypo/erypo FS
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany
Erythropoietin
Rigshospitalet, Denmark
2009 Phase 2 NCT01144117 Denmark
Escalation therapies group
The Cleveland Clinic
2019 Phase 4 NCT03535298 United Kingdom;United States
Escitalopram
University of South Carolina
2009 Phase 3 NCT00965497 United States
Escitalopram oxalate antidepressant
Weill Medical College of Cornell University
2004 Phase 4 NCT00151294 United States
Esomeprazole
Genzyme, a Sanofi Company
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain
Essential - hydroxytyrosol
University of Iowa
2010 Phase 1 NCT01381354 United States
Essential fatty acids
National Center for Complementary and Integrative Health (NCCIH)
1999 Phase 1/Phase 2 NCT00010842 United States
Estradiol
Hospices Civils de Lyon
2005 Phase 3 NCT00127075 France
OSPEDALI CIVILI DI LIONE
2007 - EUCTR2006-005460-30-IT Italy
Estradiol hemihydrate
Irina Elovaara
2015 - EUCTR2014-005129-10-FI Finland
Estriol
University of California, Los Angeles
2011 Phase 2 NCT01466114 United States
2007 Phase 2 NCT00451204 Canada;United States
Estroprogestins
S. Andrea Hospital
2002 Phase 2 NCT00151801 Italy
Eszopiclone
University of Vermont
2006 - NCT00594087 United States
Ethinylestradiol
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands
Etifoxine
Imperial College London
2018 - NCT03850301 United Kingdom
Etims
University Medical Center Hamburg-Eppendorf
2009 - EUCTR2008-004408-29-DE Germany
Universitätsklinikum Hamburg-Eppendorf
2010 Phase 1/Phase 2 NCT01414634 -
Etoposide
FONDAZIONE ITALIANA SCLEROSI MULTIPLA ONLUS
2023 Phase 2 EUCTR2022-002654-95-IT Italy
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States
EU-ocrevus
Celltrion
2024 Phase 3 NCT05906992 Poland
EU/1/08/454/001-002, EU/1/08/454/005-007
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
EU/1/95/003/005-010
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
EU/1/97/033/002
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
EU/1/98/063/001-003
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
EU/1/98/063/004-006
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
Evaluation OF lower extremity muscle strength, physical activity, exercise capacity, balance, quality OF life, and fatigue IN healthy controls
Istanbul University - Cerrahpasa (IUC)
2024 - NCT06648499 -
Evaluation OF lower extremity muscle strength, physical activity, exercise capacity, balance, quality OF life, and fatigue IN poms
Istanbul University - Cerrahpasa (IUC)
2024 - NCT06648499 -
Evobrutinib
EMD Serono Research & Development Institute, Inc.
2019 Phase 3 NCT04032171 Germany;United States
2019 Phase 3 NCT04032158 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2017 Phase 2 NCT02975349 Bulgaria;Czechia;Germany;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
Merck Healthcare KGaA
2022 Phase 3 EUCTR2019-004980-36-CZ Belarus;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-SI Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-RO Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-SK Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PL Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-NO Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LV Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-GR Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-ES Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-DE Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-BG Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2020 Phase 3 NCT04338061 Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Latvia;Lithuania;Malaysia;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United States
2020 Phase 3 NCT04338022 Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
Evobrutinib 10MG
Merck Healthcare KGaA
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
Evobrutinib 25MG
Merck Healthcare KGaA
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
Exelon transdermales pflaster
Novartis Pharma GmbH
- - EUCTR2008-007015-32-DE Germany
Exercise intervention
Hasselt University
2017 - NCT03418376 Belgium
Exergame
University of Arizona
2014 - NCT02777060 United States
Experimental glatiramer acetate
Teva Pharmaceutical Industries
2009 Phase 3 NCT00947752 United States
Exposure TO methylprednisolone during pregnancy
Jena University Hospital
2020 - NCT04832269 Germany
Exposure TO ONE or more disease-modifying drug(S)(dmds) used TO treat MS
University of British Columbia
1996 - NCT04472975 -
Extavia
Bayer
2024 - NCT06053749 Finland;Sweden
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Charite Universitaetsmedizin Berlin
2012 Phase 3 EUCTR2011-004787-30-DE Germany
Charite University, Berlin, Germany
2013 Phase 2/Phase 3 NCT01647880 Germany
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Medizinische Universität Innsbruck
2014 - EUCTR2012-005450-30-SE Austria;Sweden
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy
2010 - EUCTR2010-023023-19-IT Germany;Italy
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy
Novartis Pharma Services AG
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
Extavia (interferon BETA-1B), novartis pharma AG
Bayer
2016 - NCT02749396 Finland
Extavia 250 microgram/ML
Octapharma AG
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Extavia 250 micrograms/ML
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Extavia*SC 15FL 250MCG/ML+15SI
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy
Extended release fampridine
Clinique Neuro-Outaouais
2013 Phase 4 NCT02146534 Canada
Extended-release oxycodone
University of Rochester
2007 Phase 4 NCT00414453 United States
Extended-release quetiapine fumarate
University of Calgary
2014 Phase 1/Phase 2 NCT02087631 Canada
Extracellular vesicles derived from human-induced neural stem cells FOR intrathecal injection
Tongji Hospital
2025 Phase 1 NCT06620809 China
Extracorporeal photopheresis
University of Utah
2014 - NCT02296346 United States
F-18 3f4AP
Massachusetts General Hospital
2021 Phase 1 NCT04699747 United States
Famciclovir
Queen Mary University London
2019 Phase 2 EUCTR2019-000169-19-GB United Kingdom
Queen Mary University of London
2020 Phase 2 NCT05283551 United Kingdom
Fampridina
IRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO
2016 Phase 4 EUCTR2014-004650-34-IT Italy
Fampridine
Amsterdam University Medical Center
2022 Phase 3 EUCTR2021-003677-66-NL Netherlands
BIOGEN IDEC RESEARCH LTD
2012 - EUCTR2012-000368-90-IT Belgium;Canada;Italy;Netherlands;Switzerland;United Kingdom
2012 - EUCTR2011-003507-38-IT Australia;Denmark;Italy;Netherlands;Portugal;United Kingdom
Biogen
2015 - NCT01532154 France;Germany;United Kingdom;United States
2014 Phase 3 NCT02219932 Argentina;Bulgaria;Czech Republic;Finland;Germany;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2013 Phase 3 NCT01917019 Japan
2012 Phase 2 NCT01597297 Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 Phase 4 NCT01480076 Australia;Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;United Kingdom;United States
2012 - NCT01480063 Argentina;Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Lebanon;Netherlands;Norway;Portugal;Spain;United Arab Emirates
Biogen Idec Research Limited
2015 Phase 3 EUCTR2013-003600-40-NL Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 - EUCTR2013-003600-40-LT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 - EUCTR2013-003600-40-IT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-GB Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States
2014 - EUCTR2013-003600-40-FI Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-CZ Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-BG Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2012 - EUCTR2012-000368-90-NL Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 - EUCTR2012-000368-90-GB Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 Phase 2 EUCTR2012-000368-90-BE Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-PT Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-NL Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 Phase 4 EUCTR2011-003507-38-GB Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-DK Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 Phase 4 EUCTR2011-003507-38-BE Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
CHDR
2015 Phase 2 EUCTR2015-000182-31-NL Netherlands
Centre Hospitalier Universitaire de Besancon
2014 Phase 4 NCT02849782 France
Cliniques Universitaires Saint-Luc, Neurologie
2013 Phase 3 EUCTR2012-005076-34-BE Belgium
FONDAZIONE SANTA LUCIA
2012 - EUCTR2012-000287-17-IT Italy
Genesis Pharma CNS & Specialty
2017 - NCT03164018 Greece
Medical University of Vienna
2015 - EUCTR2014-003498-41-AT Austria
Odense University Hospital
2013 Phase 4 EUCTR2013-001409-10-DK Denmark
St. Vincent's University Hospital
2012 Phase 4 EUCTR2011-002561-38-IE Ireland
Sønderjylland Hospital, department of neurology
2013 Phase 4 EUCTR2011-002959-34-DK Denmark
2012 - EUCTR2011-006151-10-DK Denmark
University College Dublin
2014 Phase 4 NCT02208050 Ireland
University of Southern Denmark
2018 - NCT03847545 Denmark
dipartimento di neurologia e psichiatria
2013 Phase 4 EUCTR2013-002558-64-IT Italy
Fampridine SR
London Health Sciences Centre
2012 Phase 2/Phase 3 NCT01667497 Canada
Fampridine-SR
Acorda Therapeutics
2007 Phase 3 NCT00649792 Canada;United States
2007 Phase 3 NCT00483652 Canada;United States
2006 Phase 3 NCT00648908 Canada;United States
2005 Phase 3 NCT00127530 Canada;United States
2003 Phase 3 NCT00654927 Canada;United States
2003 Phase 2 NCT00053417 Canada;United States
Biogen Idec
2010 Phase 3 NCT01235221 Canada
University of Southern Denmark
2012 Phase 4 NCT01656148 Denmark
Fampyra
BIOGEN IDEC RESEARCH LTD
2012 - EUCTR2012-000368-90-IT Belgium;Canada;Italy;Netherlands;Switzerland;United Kingdom
2012 - EUCTR2011-003507-38-IT Australia;Denmark;Italy;Netherlands;Portugal;United Kingdom
Biogen Idec Research Limited
2015 Phase 3 EUCTR2013-003600-40-NL Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 - EUCTR2013-003600-40-LT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 - EUCTR2013-003600-40-IT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-GB Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States
2014 - EUCTR2013-003600-40-FI Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-CZ Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-BG Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2012 - EUCTR2012-000368-90-NL Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 - EUCTR2012-000368-90-GB Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 Phase 2 EUCTR2012-000368-90-BE Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-PT Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-NL Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 Phase 4 EUCTR2011-003507-38-GB Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-DK Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 Phase 4 EUCTR2011-003507-38-BE Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
Cliniques Universitaires Saint-Luc, Neurologie
2013 Phase 3 EUCTR2012-005076-34-BE Belgium
FONDAZIONE SANTA LUCIA
2012 - EUCTR2012-000287-17-IT Italy
IRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO
2016 Phase 4 EUCTR2014-004650-34-IT Italy
Medical University of Vienna
2015 - EUCTR2014-003498-41-AT Austria
Odense University Hospital
2013 Phase 4 EUCTR2013-001409-10-DK Denmark
St. Vincent's University Hospital
2012 Phase 4 EUCTR2011-002561-38-IE Ireland
Sønderjylland Hospital, department of neurology
2013 Phase 4 EUCTR2011-002959-34-DK Denmark
2012 - EUCTR2011-006151-10-DK Denmark
Vestre Viken Hospital Trust
2012 - NCT01720849 Norway
dipartimento di neurologia e psichiatria
2013 Phase 4 EUCTR2013-002558-64-IT Italy
Fampyra 10 MG prolonged-release tablets
Amsterdam University Medical Center
2022 Phase 3 EUCTR2021-003677-66-NL Netherlands
CHDR
2015 Phase 2 EUCTR2015-000182-31-NL Netherlands
Fampyra 10MG prolonged release tablets
Walton Centre Foundation Trust
2013 Phase 4 EUCTR2013-000529-30-GB United Kingdom
Fatigue
Ankara Yildirim Beyazit University
2019 - NCT04408742 Turkey
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France
Fear OF falling
Ankara Yildirim Beyazit University
2019 - NCT03945006 Turkey
Febuxostat
Tsukuba International Clinical Pharmacology Clinic
2016 - JPRN-UMIN000024312 Japan
Fecal microbial transplants
Lawson Health Research Institute
2023 Phase 2 NCT04150549 -
Fecal microbiota
Lawson Health Research Institute
2017 Phase 2 NCT03183869 Canada
Fecal microbiota transplantation
Affiliated Hospital of Guangdong Medical University
2019 - ChiCTR1800018057 China
Chinese University of Hong Kong
2019 - NCT04014413 Hong Kong
Drum Tower Hospital, Medical School of Nanjing University
2021 Phase 0 ChiCTR2100048094 China
Rush University Medical Center
2018 - NCT03975413 United States
Fecal microbiota transplantation (FMT) OF FMP30 donor stool
Jeffrey Gelfand
2018 Phase 1 NCT03594487 United States
Femoston 1/10
Irina Elovaara
2015 - EUCTR2014-005129-10-FI Finland
Femoston 2/10
Irina Elovaara
2015 - EUCTR2014-005129-10-FI Finland
Fenebrutinib
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2019-003919-53-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-IT Austria;Bulgaria;Denmark;Finland;France;Greece;Italy;Netherlands;United States
2021 Phase 3 EUCTR2019-004857-10-IT Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
F. Hoffmann-La Roche Ltd
2022 Phase 2 EUCTR2021-003772-14-HR Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
2021 Phase 2 EUCTR2021-003772-14-SK Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
2021 Phase 2 EUCTR2021-003772-14-CZ Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
2021 Phase 3 EUCTR2020-001168-28-GR Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-DK Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-BG Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2019-004857-10-PT Algeria;Argentina;China;Dominican Republic;Egypt;Finland;France;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
2021 Phase 3 EUCTR2019-004857-10-NL Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2021 Phase 3 EUCTR2019-004857-10-HU Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2021 Phase 3 EUCTR2019-004857-10-DE Algeria;Argentina;China;Dominican Republic;Egypt;Finland;France;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
2021 Phase 3 EUCTR2019-003919-53-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-001168-28-FR Austria;Bulgaria;Denmark;Finland;France;Greece;Italy;Netherlands;United States
2020 Phase 3 EUCTR2019-004857-10-FI Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2020 Phase 3 EUCTR2019-003919-53-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-003919-53-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Hoffmann-La Roche
2022 Phase 2 NCT05119569 Bosnia and Herzegovina;Croatia;Czechia;Serbia;Slovakia;United States
2021 Phase 3 NCT04586023 Austria;Brazil;Bulgaria;Canada;Denmark;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Poland;Puerto Rico;Russian Federation;Turkey;United Kingdom;United States
2021 Phase 3 NCT04586010 Algeria;Argentina;China;Dominican Republic;Finland;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
2020 Phase 3 NCT04544449 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czechia;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;New Zealand;North Macedonia;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Feraheme
Stanford University
2014 - NCT01973517 United States
Ferumoxytol
National Institute of Neurological Disorders and Stroke (NINDS)
2015 Phase 1 NCT02511028 United States
Ferumoxytol infusion
University of Utah
2022 Early Phase 1 NCT05357833 United States
Fexofenadine
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark
Filgrastim
FONDAZIONE ITALIANA SCLEROSI MULTIPLA ONLUS
2023 Phase 2 EUCTR2022-002654-95-IT Italy
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States
Northwestern Memorial Hospital
2001 Phase 1 NCT00017628 United States
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom
Fingolimob
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
University Hospital, Clermont-Ferrand
2019 Phase 4 NCT02769689 France
Fingolimod
Biogen
2021 - NCT05688436 United States
2014 Phase 4 NCT02342704 Australia;Czech Republic;Czechia;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
Celgene
2025 Phase 3 NCT06408259 Australia;Italy;Mexico;Poland;Portugal;Romania;Spain;Taiwan;Turkey;United States
Charite Universitaetsmedizin Berlin
2012 Phase 3 EUCTR2011-004787-30-DE Germany
Charité - Universitätsmedizin Berlin
2013 Phase 4 EUCTR2012-000411-91-DE Germany
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2023 Phase 3 EUCTR2020-004128-41-RO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2023 Phase 3 EUCTR2020-004128-41-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-004128-41-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd.
2022 Phase 3 EUCTR2020-004128-41-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2017 Phase 4 EUCTR2017-000559-26-IT Israel;Italy;Switzerland;United States
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE
2016 Phase 4 EUCTR2016-000708-26-IT Italy
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
2017 Phase 4 NCT03345940 Italy
Heinrich-Heine University, Duesseldorf
2013 Phase 4 NCT01755871 Germany
Hikma Pharmaceuticals LLC
2022 - NCT05423769 Egypt
Hoffmann-La Roche
2022 Phase 3 NCT05123703 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Isfahan University of Medical Sciences
2015 Phase 2/Phase 3 NCT02939079 -
JANSSEN CILAG INTERNATIONAL NV
2023 Phase 3 EUCTR2020-004431-24-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
Janssen-Cilag International NV
2023 Phase 3 EUCTR2020-004431-24-PT Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2023 Phase 3 EUCTR2020-004431-24-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-004431-24-SE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
- Phase 3 EUCTR2020-004431-24-Outside-EU/EEA Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
- Phase 3 EUCTR2020-004431-24-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02193217 United Kingdom
NOVARTIS FARMA
2011 - EUCTR2011-001442-15-IT Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;United Kingdom
2011 - EUCTR2011-000770-60-IT Italy
2011 - EUCTR2010-024017-31-IT Italy
2010 - EUCTR2010-023023-19-IT Germany;Italy
2010 Phase 3 EUCTR2010-020515-37-IT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-IT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-002627-32-IT Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2006-000704-17-IT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States
Novartis
2011 - NCT01281657 Canada;United States
2010 Phase 3 NCT01199861 Austria;Belgium;Canada;Finland;France;Guatemala;Poland;Spain;Switzerland;United Kingdom
2008 Phase 2 NCT00670449 Japan
2006 Phase 3 NCT00355134 Australia;Austria;Canada;Lithuania;Poland;Romania;Turkey;United Kingdom;United States
Novartis Farmaceutica S.A.
2013 - EUCTR2012-000835-18-ES Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Farmacéutica S.A
2008 - EUCTR2007-002627-32-ES Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Novartis Farmacéutica S.A.
2011 Phase 3 EUCTR2011-003484-30-ES Australia;Spain
Novartis Farmacéutica, S.A.
2010 Phase 3 EUCTR2010-020515-37-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
Novartis Pharma AG
2013 - EUCTR2012-000835-18-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-000835-18-FR Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 - EUCTR2007-002627-32-HU Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
2010 - EUCTR2007-002627-32-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2009 - EUCTR2007-004122-24-IE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-EE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-002627-32-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 - EUCTR2007-002627-32-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 Phase 3 EUCTR2007-002627-32-FR Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
2008 - EUCTR2007-002627-32-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 - EUCTR2007-002627-32-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2007 - EUCTR2005-000365-19-HU Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
2006 - EUCTR2005-000365-19-CZ Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
Novartis Pharma GmbH
2011 Phase 3 EUCTR2010-022066-28-DE Germany
Novartis Pharma K.K.
2019 - JPRN-jRCT1080224761 Japan
Novartis Pharma Services AG
2014 Phase 3 EUCTR2012-000835-18-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-HU Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-GB Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-000835-18-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-000835-18-SE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-000835-18-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2010-020515-37-NO Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2011 Phase 3 EUCTR2010-020515-37-IE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2011 - EUCTR2010-020515-37-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
2011 Phase 3 EUCTR2010-020515-37-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;Venezuela, Bolivarian Republic of
2010 Phase 3 EUCTR2010-020515-37-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 - EUCTR2010-019028-30-GB Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-FR Belgium;Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-FI Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-BE Belgium;Finland;France;Spain;United Kingdom
2009 - EUCTR2008-002096-27-AT Austria;Lithuania;Poland;United Kingdom
2009 - EUCTR2007-002627-32-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom
2008 - EUCTR2008-002096-27-PL Austria;Lithuania;Poland;United Kingdom
2008 - EUCTR2008-002096-27-LT Austria;Lithuania;Poland;United Kingdom
2008 - EUCTR2008-002096-27-GB Austria;Lithuania;Poland;United Kingdom
2008 Phase 3 EUCTR2005-000365-19-GB Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom
2007 - EUCTR2006-000704-17-HU Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2007 - EUCTR2006-000704-17-BE Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 - EUCTR2006-000704-17-PT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 Phase 3 EUCTR2006-000704-17-GR Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 - EUCTR2006-000704-17-GB Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 - EUCTR2006-000704-17-DE Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 - EUCTR2006-000704-17-AT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 Phase 3 EUCTR2005-000365-19-SK Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom
- - EUCTR2007-002627-32-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharmaceuticals
2021 Phase 3 NCT04926818 Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
2020 - NCT05141669 United States
2020 Phase 4 NCT04480853 Taiwan
2017 Phase 4 NCT03257358 United States
2016 Phase 4 NCT02720107 Germany
2014 Phase 4 NCT02232061 Belgium;Germany;Italy
2014 Phase 3 NCT01941004 -
2013 Phase 3 NCT01892722 Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 4 NCT01621269 Germany
2012 Phase 4 NCT01705236 Germany;Switzerland
2012 Phase 3 NCT01633112 Argentina;Brazil;Canada;Chile;Mexico;Puerto Rico;United States
2012 Phase 4 NCT01623596 Puerto Rico;United States
2012 Phase 4 NCT01578330 Turkey
2012 Phase 4 NCT01534182 Russian Federation
2012 Phase 3 NCT01497262 Argentina;Brazil;Colombia;Costa Rica;Jordan;Malaysia;Mexico;Panama;Peru
2011 Phase 3 NCT01499667 Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Switzerland
2011 Phase 4 NCT01498887 Australia;Spain
2011 - NCT01442194 Argentina;Australia;Canada;Chile;Mexico;Puerto Rico;United States
2011 Phase 4 NCT01436643 Germany
2011 Phase 4 NCT01420055 France
2011 Phase 4 NCT01333501 Germany;Italy
2011 Phase 4 NCT01317004 Italy
2011 Phase 4 NCT01310166 Germany
2011 - NCT01285479 Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Cyprus;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Sweden;Switzerland;United Arab Emirates;United Kingdom;United States
2010 Phase 4 NCT01216072 Canada;Puerto Rico;United States
2010 Phase 3 NCT01201356 Argentina;Australia;Austria;Belgium;Brazil;Canada;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Services Pharma AG
2008 - EUCTR2007-002627-32-SE Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Sakari Simula
2012 Phase 4 EUCTR2012-002694-66-FI Finland
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University Hospital Muenster
2014 Phase 4 NCT02325440 Germany
University of British Columbia
2003 - NCT06705608 -
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands
Fingolimod 0.5 MG
Novartis
2008 Phase 3 NCT00662649 Australia;Belgium;Canada;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 NCT00340834 Argentina;Australia;Austria;Belgium;Brazil;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Portugal;Puerto Rico;Spain;Switzerland;United Kingdom;United States
2006 Phase 3 NCT00289978 Australia;Belgium;Canada;Czech Republic;Finland;France;Germany;Greece;Israel;Italy;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Sweden;Switzerland;Turkey;United Kingdom
Novartis Pharmaceuticals
2015 Phase 4 NCT02373098 Turkey
Fingolimod 0.5MG
Novartis Pharmaceuticals
2021 Phase 4 NCT04667949 China
Fingolimod 1.25 MG
Novartis
2008 Phase 3 NCT00662649 Australia;Belgium;Canada;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 NCT00340834 Argentina;Australia;Austria;Belgium;Brazil;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Portugal;Puerto Rico;Spain;Switzerland;United Kingdom;United States
2006 Phase 3 NCT00289978 Australia;Belgium;Canada;Czech Republic;Finland;France;Germany;Greece;Israel;Italy;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Sweden;Switzerland;Turkey;United Kingdom
Fingolimod hydrochloride
Biogen Idec Research Limited
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
Fakultní nemocnice Ostrava
2023 Phase 4 EUCTR2022-004331-23-CZ Czech Republic
2021 Phase 4 EUCTR2021-003195-13-CZ Czech Republic
NOVARTIS FARMA
2013 - EUCTR2012-000835-18-IT Australia;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
NOVARTIS FARMA S.p.A
2013 - EUCTR2012-005507-40-IT Italy
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Novartis Farma
2013 Phase 3 EUCTR2011-005677-23-IT Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy
Novartis Farma SpA
2014 - EUCTR2013-002660-17-IT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
Novartis Farmaceutica S.A.
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of
Novartis Pharma AG
2009 - EUCTR2007-004122-24-HU Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-GR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-FI Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-SE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-NL Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-GB Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-FR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-CZ Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-BE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
Novartis Pharma GmbH
2012 - EUCTR2012-002637-11-DE Germany
2012 Phase 4 EUCTR2012-000674-31-DE Germany;Switzerland
2012 Phase 4 EUCTR2012-000653-32-DE Germany
2011 - EUCTR2011-002969-38-DE Germany
- - EUCTR2011-001692-39-DE Germany
Novartis Pharma S.A.S
2011 Phase 4 EUCTR2011-001280-49-FR France
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-FR Austria;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
2013 Phase 3 EUCTR2011-005677-23-DE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Pharma Services AG
2015 - EUCTR2013-002660-17-PT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
2015 - EUCTR2013-002660-17-DK Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
2014 - EUCTR2012-000835-18-PL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2012 - EUCTR2011-001442-15-SE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
2011 - EUCTR2011-001442-15-HU Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-GR Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-GB Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-FI Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-DE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-CZ Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-AT Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2010-019029-32-SK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-SE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-PT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-NL Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-IE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-HU Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 2 EUCTR2010-019029-32-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-GB Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-FI Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-DK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-DE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-CZ Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 2 EUCTR2010-019029-32-BE Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-SK Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-DE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany
Fingolimodi
Turku University Hospital
2014 Phase 4 EUCTR2014-000296-12-FI Finland
2013 Phase 4 EUCTR2013-004626-28-FI Finland
Fingolmod
Novartis Farma SpA
2014 - EUCTR2013-002660-17-IT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
Novartis Pharma Services AG
2015 - EUCTR2013-002660-17-PT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
2015 - EUCTR2013-002660-17-DK Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
Firategrast
GlaxoSmithKline
2007 Phase 2 NCT00469378 Belgium;Czech Republic;Denmark;Norway;Sweden
GlaxoSmithKline Research & Development Ltd
2007 - EUCTR2006-007057-42-SE Czech Republic;Denmark;Sweden
2007 - EUCTR2006-007057-42-DK Czech Republic;Denmark;Sweden
2007 Phase 2 EUCTR2006-007057-42-CZ Belgium;Czech Republic;Denmark;Sweden
2007 - EUCTR2006-007057-42-BE Belgium;Czech Republic;Denmark;Sweden
2007 - EUCTR2006-002633-20-LT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2007 - EUCTR2006-002633-20-IT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2007 Phase 2 EUCTR2006-002633-20-GB Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2007 Phase 2 EUCTR2006-002633-20-FR Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2006 - EUCTR2006-002633-20-NL Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2006 - EUCTR2006-002633-20-FI Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2006 - EUCTR2006-002633-20-DE Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2006 - EUCTR2006-002633-20-AT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
GlaxoSmithKline S.A
2006 Phase 2 EUCTR2006-002633-20-ES Australia;Austria;Canada;Finland;France;Germany;Italy;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Spain;United Kingdom
Firategrast 150 MG
GlaxoSmithKline
2006 Phase 2 NCT00395317 Australia;Austria;Canada;Finland;France;Germany;Italy;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Spain;United Kingdom
Firategrast 300 MG
GlaxoSmithKline
2006 Phase 2 NCT00395317 Australia;Austria;Canada;Finland;France;Germany;Italy;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Spain;United Kingdom
Firategrast gastro-retentive solution
GlaxoSmithKline
2011 Phase 1 NCT01416363 Australia
Firategrast immediate release tablet
GlaxoSmithKline
2011 Phase 1 NCT01416363 Australia
Firategrast modified release tablet
GlaxoSmithKline
2011 Phase 1 NCT01416363 Australia
First line DMT
Novartis Pharmaceuticals
2021 Phase 3 NCT04788615 France;Germany;Italy;Spain;United Kingdom
Fish OIL
Coordinación de Investigación en Salud, Mexico
2010 Phase 4 NCT01842191 Mexico
Isfahan University of Medical Sciences
2015 Phase 2/Phase 3 NCT02939079 -
Fish OIL concentrate
Oregon Health and Science University
2005 Phase 1/Phase 2 NCT00122954 United States
Fish OIL, rich IN omega-3-acids
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece
Fish OIL,rich IN omega 3 acids
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece
Fludara
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
Fludarabine
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
Bruce Cree
2024 Phase 1 NCT06451159 United States
Hadassah Medical Organization
2015 - NCT02529839 -
Indapta Therapeutics, INC.
2026 Phase 1 NCT06677710 United States
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
2024 Phase 1 NCT06220201 Belgium;France;Germany;Italy;Spain;United Kingdom;United States
Seah Lim M.D.
2012 Phase 2 NCT01679041 United States
Fludarabine phosphate FOR injection
St. Petersburg State Pavlov Medical University
2020 Phase 1 NCT05832515 Russian Federation
Flumazenil
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
2013 - JPRN-UMIN000011111 Japan
VU University medical center Amsterdam
2017 Phase 4 EUCTR2017-002636-16-NL Netherlands
Fluoxetin hexal
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany
Fluoxetine
2012 Phase 4 EUCTR2011-003775-11-BE Belgium
2010 Phase 4 EUCTR2010-023996-25-BE Belgium
Novartis Pharmaceuticals
2011 Phase 4 NCT01436643 Germany
University College, London
2014 Phase 2 NCT01910259 United Kingdom
Fluoxetine hydrochloride
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany
UCL
2014 Phase 2 EUCTR2012-005394-31-GB United Kingdom
Flupirtin
Charité-Universitätsmedizin Berlin
2007 Phase 2 EUCTR2006-005262-39-DE Germany
Flupirtine
Charite University, Berlin, Germany
2007 Phase 2 NCT00623415 Germany
Flupirtinmaleat
Charité-Universitätsmedizin Berlin
2007 Phase 2 EUCTR2006-005262-39-DE Germany
Flurbiprofen
Fraunhofer Gesellschaft for its Institute Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)
2015 Phase 2 EUCTR2014-004483-38-DE Germany
Foralumab
Tiziana Life Sciences LTD
2023 Phase 2 NCT06292923 United States
Foralumab TZLS-401 100 µG
Tiziana Life Sciences LTD
2025 Phase 2 NCT06890923 United States
Foralumab TZLS-401 50 µG
Tiziana Life Sciences LTD
2025 - NCT06802328 United States
Formistin - 10 MG compresse rivestite CON film 20 compresse
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
Formistin 10 MG
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
Formulation A
GlaxoSmithKline
2007 Phase 1 NCT00548769 Czech Republic;Czechia;Germany;Poland
Formulation B
GlaxoSmithKline
2007 Phase 1 NCT00548769 Czech Republic;Czechia;Germany;Poland
Formulation C
GlaxoSmithKline
2007 Phase 1 NCT00548769 Czech Republic;Czechia;Germany;Poland
Formulation D
GlaxoSmithKline
2007 Phase 1 NCT00548769 Czech Republic;Czechia;Germany;Poland
Four square step test
Gazi University
2018 - NCT03584672 -
Frexalimab
Sanofi
2023 Phase 3 NCT06141486 Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;France;Germany;Greece;Hungary;India;Italy;Japan;Korea, Republic of;Netherlands;Poland;Portugal;Puerto Rico;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2023 Phase 3 NCT06141473 Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
FTY720
NOVARTIS FARMA
2011 - EUCTR2011-001442-15-IT Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-IT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
NOVARTIS FARMA S.p.A
2013 - EUCTR2012-005507-40-IT Italy
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Novartis
2010 Phase 3 NCT01127750 Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
2007 Phase 2 NCT00537082 Japan
2003 Phase 2 NCT00333138 Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
Novartis Farma
2013 Phase 3 EUCTR2011-005677-23-IT Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy
Novartis Farmaceutica S.A.
2013 - EUCTR2012-000835-18-ES Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of
Novartis Farmacéutica S.A
2008 - EUCTR2007-002627-32-ES Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Novartis Farmacéutica, S.A.
2011 Phase 4 EUCTR2011-001442-15-ES Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
Novartis Pharma AG
2013 - EUCTR2012-000835-18-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-000835-18-FR Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 - EUCTR2007-002627-32-HU Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
2010 - EUCTR2007-002627-32-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2009 - EUCTR2007-004122-24-IE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-HU Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-GR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-FI Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-EE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-002627-32-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 - EUCTR2007-004122-24-SE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-NL Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-GB Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-FR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-CZ Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-BE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-002627-32-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 Phase 3 EUCTR2007-002627-32-FR Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
2008 - EUCTR2007-002627-32-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 - EUCTR2007-002627-32-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2007 - EUCTR2005-000365-19-HU Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
2006 - EUCTR2005-000365-19-CZ Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
Novartis Pharma GmbH
2012 - EUCTR2012-002637-11-DE Germany
2012 Phase 4 EUCTR2012-000674-31-DE Germany;Switzerland
2012 Phase 4 EUCTR2012-000653-32-DE Germany
2011 - EUCTR2011-002969-38-DE Germany
2011 Phase 3 EUCTR2010-022066-28-DE Germany
Novartis Pharma S.A.S
2011 Phase 4 EUCTR2011-001280-49-FR France
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-FR Austria;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
2013 Phase 3 EUCTR2011-005677-23-DE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Pharma Services AG
2014 - EUCTR2012-000835-18-PL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2012-000835-18-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2012-000835-18-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-HU Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-GB Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-000835-18-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2012 - EUCTR2012-000835-18-SE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-000835-18-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2011-001442-15-SE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2012 Phase 3 EUCTR2010-020515-37-NO Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2011 - EUCTR2011-001442-15-HU Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-GR Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-GB Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-FI Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-DE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-CZ Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-AT Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 Phase 3 EUCTR2010-020515-37-IE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2011 - EUCTR2010-020515-37-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
2011 Phase 3 EUCTR2010-020515-37-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2011 - EUCTR2010-019029-32-SK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;Venezuela, Bolivarian Republic of
2010 Phase 3 EUCTR2010-020515-37-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 - EUCTR2010-019029-32-SE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-PT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-NL Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-IE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-HU Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 2 EUCTR2010-019029-32-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-GB Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-FI Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-DK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-DE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-CZ Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 2 EUCTR2010-019029-32-BE Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019028-30-GB Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-FR Belgium;Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-FI Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-BE Belgium;Finland;France;Spain;United Kingdom
2009 - EUCTR2008-002096-27-AT Austria;Lithuania;Poland;United Kingdom
2009 - EUCTR2007-002627-32-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom
2008 - EUCTR2008-002096-27-PL Austria;Lithuania;Poland;United Kingdom
2008 - EUCTR2008-002096-27-LT Austria;Lithuania;Poland;United Kingdom
2008 - EUCTR2008-002096-27-GB Austria;Lithuania;Poland;United Kingdom
2008 - EUCTR2007-004122-24-SK Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-DE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 Phase 3 EUCTR2005-000365-19-GB Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom
2007 - EUCTR2006-000704-17-HU Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2007 - EUCTR2006-000704-17-BE Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2007 - EUCTR2005-000365-19-IE Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
2007 - EUCTR2005-000365-19-GR Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
2007 - EUCTR2005-000365-19-EE Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
2006 - EUCTR2006-000704-17-PT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 Phase 3 EUCTR2006-000704-17-GR Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 - EUCTR2006-000704-17-GB Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 - EUCTR2006-000704-17-DE Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 - EUCTR2006-000704-17-AT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 Phase 3 EUCTR2005-000365-19-SK Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom
2006 - EUCTR2005-000365-19-FI Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
2006 - EUCTR2005-000365-19-DE Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
2005 - EUCTR2005-000365-19-SE Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
- - EUCTR2007-002627-32-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharmaceuticals
2013 Phase 3 NCT01779934 Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 4 NCT01585298 Germany
2011 Phase 4 NCT01498887 Australia;Spain
2008 Phase 3 NCT00731692 Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Services Pharma AG
2008 - EUCTR2007-002627-32-SE Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
NovartisPharma Services AG
2007 - EUCTR2005-000365-19-LT Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany
FTY720D
NOVARTIS FARMA
2013 - EUCTR2012-000835-18-IT Australia;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2011 - EUCTR2011-000770-60-IT Italy
2011 - EUCTR2010-024017-31-IT Italy
2010 - EUCTR2010-023023-19-IT Germany;Italy
2010 Phase 3 EUCTR2010-020515-37-IT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-IT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-002627-32-IT Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2006-000704-17-IT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
Novartis Farma SpA
2014 - EUCTR2013-002660-17-IT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
Novartis Farmaceutica S.A.
2013 - EUCTR2012-000835-18-ES Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Farmacéutica S.A
2008 - EUCTR2007-002627-32-ES Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Novartis Farmacéutica, S.A.
2010 Phase 3 EUCTR2010-020515-37-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
Novartis Pharma AG
2013 - EUCTR2012-000835-18-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-000835-18-FR Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 - EUCTR2007-002627-32-HU Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
2010 - EUCTR2007-002627-32-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2009 - EUCTR2007-004122-24-HU Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-GR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-FI Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-002627-32-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 - EUCTR2007-004122-24-NL Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-FR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-CZ Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-BE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-002627-32-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 Phase 3 EUCTR2007-002627-32-FR Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
2008 - EUCTR2007-002627-32-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 - EUCTR2007-002627-32-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2007 - EUCTR2005-000365-19-HU Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
2006 - EUCTR2005-000365-19-CZ Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
Novartis Pharma Services AG
2015 - EUCTR2013-002660-17-PT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
2015 - EUCTR2013-002660-17-DK Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
2014 - EUCTR2012-000835-18-PL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2012-000835-18-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-HU Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-GB Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-000835-18-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-000835-18-SE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-000835-18-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2010-020515-37-NO Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2011 Phase 3 EUCTR2010-020515-37-IE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2011 - EUCTR2010-020515-37-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
2011 Phase 3 EUCTR2010-020515-37-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2011 - EUCTR2010-019029-32-SK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;Venezuela, Bolivarian Republic of
2010 Phase 3 EUCTR2010-020515-37-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 - EUCTR2010-019029-32-SE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-PT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-NL Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-IE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-HU Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 2 EUCTR2010-019029-32-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-GB Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-FI Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-DK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-DE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-CZ Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 2 EUCTR2010-019029-32-BE Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019028-30-GB Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-FR Belgium;Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-FI Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-BE Belgium;Finland;France;Spain;United Kingdom
2009 - EUCTR2008-002096-27-AT Austria;Lithuania;Poland;United Kingdom
2009 - EUCTR2007-002627-32-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom
2008 - EUCTR2008-002096-27-PL Austria;Lithuania;Poland;United Kingdom
2008 - EUCTR2008-002096-27-LT Austria;Lithuania;Poland;United Kingdom
2008 - EUCTR2008-002096-27-GB Austria;Lithuania;Poland;United Kingdom
2008 Phase 3 EUCTR2005-000365-19-GB Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom
- - EUCTR2007-002627-32-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Services Pharma AG
2008 - EUCTR2007-002627-32-SE Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Full spectrum vitamin
University of Iowa
2010 Phase 1 NCT01381354 United States
Fully humanized ANTI-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody
Chugai Pharmaceutical Co. Ltd
2016 Phase 3 EUCTR2015-005431-41-RO Bulgaria;Canada;Croatia;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Turkey;Ukraine;United States
2015 Phase 3 EUCTR2013-003752-21-HU France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
2015 - EUCTR2013-003752-21-ES France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-IT France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom
Functional balance intervention
University of Illinois at Chicago
2025 - NCT06341023 United States
Functional mobility
Ankara Yildirim Beyazit University
2016 - NCT03566251 Turkey
Functional reach test
Gazi University
2018 - NCT03584672 -
G-CSF
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States
2017 Phase 3 NCT03342638 United States
GA 20 MG/ML
Teva Pharmaceutical Industries
2013 Phase 3 NCT01874145 United States
GA 40 MG/ML
Teva Pharmaceutical Industries
2013 Phase 3 NCT01874145 United States
GA depot
Mapi Pharma Ltd.
2019 Phase 3 NCT04121221 Belarus;Bosnia and Herzegovina;Bulgaria;Estonia;Georgia;Israel;Moldova, Republic of;Russian Federation;Ukraine;United States
2019 Phase 3 EUCTR2018-000284-93-EE Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Israel;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2019 Phase 3 EUCTR2018-000284-93-BG Belarus;Bosnia and Herzegovina;Bulgaria;Estonia;Georgia;Israel;Moldova, Republic of;Montenegro;Russian Federation;Ukraine;United States
GA depot 25MG once monthly
Mapi Pharma Ltd.
2017 Phase 2 NCT03362294 Israel;Moldova, Republic of
GA depot 40 MG
Mapi Pharma Ltd.
2014 Phase 1/Phase 2 NCT02212886 Israel
GA depot 40MG once monthly
Mapi Pharma Ltd.
2017 Phase 2 NCT03362294 Israel;Moldova, Republic of
GA depot 80 MG
Mapi Pharma Ltd.
2014 Phase 1/Phase 2 NCT02212886 Israel
Gabapentin
Charité University Medicine Berlin
2010 Phase 4 EUCTR2008-005167-33-DE Germany
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France
Hospices Civils de Lyon
2012 Phase 2 NCT01744444 France
Gabapentine
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France
Gabapentine 300MG
Charité University Medicine Berlin
2010 Phase 4 EUCTR2008-005167-33-DE Germany
Gadobenate dimeglumine
University of Southern California
2011 - NCT02967380 United States
Gadobutrol
Institut Diagnostic per la Imatge
2010 - EUCTR2009-016140-39-ES Spain
University of Southern California
2011 - NCT02967380 United States
Universitätsklinikum Erlangen
2010 Phase 4 EUCTR2009-014857-34-DE Germany
Gadolinium-based contrast
Stanford University
2014 - NCT01973517 United States
Gadopentetate dimeglumine
University of Southern California
2011 - NCT02967380 United States
Gadoteric acid
Universitätsklinikum Erlangen
2010 Phase 4 EUCTR2009-014857-34-DE Germany
Gadoteridol
University of Maryland, Baltimore
2018 - NCT03396822 United States
University of Nottingham
2017 - NCT02481882 United Kingdom
University of Utah
2022 Early Phase 1 NCT05357833 United States
Gadovist 1 mmol/ML solucióN inyectable EN jeringa precargada/ cartucho precargado
Institut Diagnostic per la Imatge
2010 - EUCTR2009-016140-39-ES Spain
Gadovist 1.0 mmol/ML injektionslösung
Universitätsklinikum Erlangen
2010 Phase 4 EUCTR2009-014857-34-DE Germany
Gamma-tocopherol
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece
GBP
Charité University Medicine Berlin
2010 Phase 4 EUCTR2008-005167-33-DE Germany
GDC-0853
F. Hoffmann-La Roche Ltd
2022 Phase 2 EUCTR2021-003772-14-HR Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
2021 Phase 2 EUCTR2021-003772-14-SK Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
2021 Phase 2 EUCTR2021-003772-14-CZ Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
GDC-0853 RO7010939
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2019-003919-53-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2019-003919-53-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-003919-53-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-003919-53-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Gemfibrozil
Sanofi
2020 Phase 1 NCT06064539 United States
Genotropin
University of Leipzig
- Phase 2 EUCTR2006-006465-16-DE Germany
Gilenya
Biogen Idec Research Limited
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Charite Universitaetsmedizin Berlin
2012 Phase 3 EUCTR2011-004787-30-DE Germany
Charite University, Berlin, Germany
2013 Phase 2/Phase 3 NCT01647880 Germany
Charité - Universitätsmedizin Berlin
2013 Phase 4 EUCTR2012-000411-91-DE Germany
F. Hoffmann-La Roche Ltd
2023 Phase 3 EUCTR2020-004128-41-RO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2023 Phase 3 EUCTR2020-004128-41-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-004128-41-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd.
2022 Phase 3 EUCTR2020-004128-41-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Janssen-Cilag International NV
2023 Phase 3 EUCTR2020-004431-24-BE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
Jochen Vehoff
2013 Phase 4 NCT02048072 Switzerland
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
McGill University
2012 - NCT02137707 Canada
NOVARTIS FARMA
2011 - EUCTR2011-001442-15-IT Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;United Kingdom
NOVARTIS FARMA S.p.A
2013 - EUCTR2012-005507-40-IT Italy
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States
Novartis Farma
2013 Phase 3 EUCTR2011-005677-23-IT Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy
Novartis Farma SpA
2014 - EUCTR2013-002660-17-IT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
Novartis Farmaceutica S.A.
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of
Novartis Farmacéutica S.A.
2011 Phase 3 EUCTR2011-003484-30-ES Australia;Spain
Novartis Pharma AG
2012 Phase 3 EUCTR2012-000835-18-FR Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 - EUCTR2007-002627-32-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 - EUCTR2007-002627-32-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharma GmbH
2012 - EUCTR2012-002637-11-DE Germany
2012 Phase 4 EUCTR2012-000674-31-DE Germany;Switzerland
2012 Phase 4 EUCTR2012-000653-32-DE Germany
2011 - EUCTR2011-002969-38-DE Germany
2011 Phase 3 EUCTR2010-022066-28-DE Germany
- - EUCTR2011-001692-39-DE Germany
Novartis Pharma K.K.
2019 - JPRN-jRCT1080224761 Japan
Novartis Pharma S.A.S
2011 Phase 4 EUCTR2011-001280-49-FR France
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-FR Austria;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
2013 Phase 3 EUCTR2011-005677-23-DE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Pharma Services AG
2015 - EUCTR2013-002660-17-PT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
2015 - EUCTR2013-002660-17-DK Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
2014 - EUCTR2012-000835-18-PL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2012-000835-18-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2012-000835-18-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-HU Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-000835-18-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2012 - EUCTR2012-000835-18-SE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2011-001442-15-SE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
2011 - EUCTR2011-001442-15-GR Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-GB Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-DE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-AT Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 Phase 3 EUCTR2010-020515-37-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2009 - EUCTR2007-002627-32-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom
Novartis Services Pharma AG
2008 - EUCTR2007-002627-32-SE Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Sakari Simula
2012 Phase 4 EUCTR2012-002694-66-FI Finland
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom
Turku University Hospital
2014 Phase 4 EUCTR2014-000296-12-FI Finland
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University of Southern California
2013 - NCT02225977 United States
Universitätsklinikum Hamburg-Eppendorf
2013 - NCT03216915 Germany
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands
Gilenya - 0.25 MG - capsule rigide - USO orale
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Gilenya - 0.5 MG - capsule rigide - USO orale
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Gilenya - 0.5 MG - capsule rigide - USO orale - blister divisibile PER dose unitaria(PVC/pvdc/ALU) scatola DA 7x1 capsule
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2017 Phase 4 EUCTR2017-000559-26-IT Israel;Italy;Switzerland;United States
Gilenya - 0.5 MG - capsule rigide - USO orale - blister(PVC/pvdc/ALU) scatola DA 28 capsule
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE
2016 Phase 4 EUCTR2016-000708-26-IT Italy
Gilenya 0,5 MG hartkapseln
Novartis Pharma Services AG
2010 Phase 3 EUCTR2010-020515-37-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
- - EUCTR2007-002627-32-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Gilenya 0,5MG CPS DUR
Fakultní nemocnice Ostrava
2023 Phase 4 EUCTR2022-004331-23-CZ Czech Republic
2021 Phase 4 EUCTR2021-003195-13-CZ Czech Republic
Gilenya hard capsules
JANSSEN CILAG INTERNATIONAL NV
2023 Phase 3 EUCTR2020-004431-24-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
Janssen-Cilag International NV
2023 Phase 3 EUCTR2020-004431-24-PT Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2023 Phase 3 EUCTR2020-004431-24-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-004431-24-SE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
- Phase 3 EUCTR2020-004431-24-Outside-EU/EEA Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
- Phase 3 EUCTR2020-004431-24-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
Gileyna
Stony Brook University
2013 - NCT02141022 United States
Ginkgo biloba
National Center for Complementary and Integrative Health (NCCIH)
1999 Phase 1/Phase 2 NCT00010842 United States
VA Office of Research and Development
2009 Phase 2 NCT00841321 United States
Ginseng
Isfahan University of Medical Sciences
2010 Phase 2 NCT01712373 Iran, Islamic Republic of
Glatiramer acetate
AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA` DEGLI STUDI DI NAPOLI
2009 - EUCTR2009-010661-23-IT Italy
Amphia Hospital
2009 Phase 4 NCT00910598 Netherlands
Amphia Ziekenhuis
2009 - EUCTR2009-013129-41-NL Netherlands
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Biogen
2021 - NCT05688436 United States
2021 Phase 2 NCT04079088 -
2010 Phase 2 NCT01071083 Germany;Spain;United States
2010 Phase 3 NCT01058005 Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States
2007 Phase 3 NCT00451451 Australia;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Costa Rica;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Ireland;Israel;Italy;Kazakhstan;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;New Zealand;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States
Biogen Idec
2010 - EUCTR2009-017490-38-DE Germany;Spain
Biogen Idec Limited
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Biogen Idec Ltd.
2008 - EUCTR2006-003697-10-BG Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-LV Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-IE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-GR Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 Phase 3 EUCTR2006-003697-10-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-EE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-DE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-CZ Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 Phase 3 EUCTR2006-003697-10-BE Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
Cinnagen
2015 - NCT04928313 -
FONDAZIONE DON CARLO GNOCCHI ONLUS
2011 - EUCTR2011-000150-31-IT Italy
Fred Lublin
2005 Phase 3 NCT00211887 Canada;United States
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
Glostrup Hospital, Dep. of Neurology
2009 - EUCTR2006-001827-21-DK Denmark
ISTITUTO C. MONDINO
2007 - EUCTR2008-007162-32-IT Italy
Isfahan University of Medical Sciences
2017 Phase 2/Phase 3 NCT03315923 Iran, Islamic Republic of
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Mapi Pharma Ltd.
2019 Phase 3 EUCTR2018-000284-93-EE Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Israel;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2019 Phase 3 EUCTR2018-000284-93-BG Belarus;Bosnia and Herzegovina;Bulgaria;Estonia;Georgia;Israel;Moldova, Republic of;Montenegro;Russian Federation;Ukraine;United States
Merck KGaA
2014 - EUCTR2013-002283-25-PL Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-GR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 Phase 2 EUCTR2013-002283-25-GB Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-ES Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-BG Bulgaria;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2013-002283-25-IT Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-HU Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-FI Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-CZ Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
Merck Serono S.A. - Geneva
2010 - EUCTR2009-016087-37-GB France;Ireland;Italy;Spain;United Kingdom
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy
National Institute of Allergy and Infectious Diseases (NIAID)
2001 - NCT00039988 United States
Neurognostics
2006 - NCT00398528 United States
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;Italy
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;United Kingdom
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Novartis Pharma Services AG
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
Novartis Pharmaceuticals
2022 - NCT05344469 Germany
2012 Phase 3 NCT01633112 Argentina;Brazil;Canada;Chile;Mexico;Puerto Rico;United States
2012 Phase 4 NCT01534182 Russian Federation
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Peptimmune Inc.
2010 Phase 2 EUCTR2009-012716-40-SK Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 Phase 2 EUCTR2009-012716-40-PL Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 - EUCTR2009-012716-40-FR Bulgaria;Czech Republic;Estonia;France;Germany;Poland
2010 Phase 2 EUCTR2009-012716-40-DE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 Phase 2 EUCTR2009-012716-40-CZ Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 - EUCTR2009-012716-40-BG Bulgaria;Czech Republic;Estonia;France;Germany;Poland
2009 - EUCTR2009-012716-40-EE Bulgaria;Czech Republic;Estonia;France;Germany;Poland
Philipps-Universität Marburg
2010 Phase 4 EUCTR2009-011088-35-DE Germany
SYNTHON BV
2011 - EUCTR2011-000888-27-IT Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Romania;Russian Federation;Ukraine;United Kingdom;United States
Sanofi
2007 Phase 2 NCT00811395 Austria;Canada;Germany;Italy;Spain;United Kingdom;United States
2007 Phase 2 NCT00475865 Austria;Canada;Germany;Italy;United Kingdom;United States
2003 Phase 4 NCT00267319 Czech Republic
Sheba Medical Center
2006 - NCT00331747 Israel
Synthon BV
2012 - EUCTR2011-000888-27-GR Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 - EUCTR2011-000888-27-DE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 NCT01489254 Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Italy;Kazakhstan;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;South Africa;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2011-000888-27-RO Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-GB Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-EE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-CZ Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-BG Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
TAKEDA PHARMACEUTICAL COMPANY LTD.
2015 - JPRN-jRCT1080223004 Japan
TEVA
2004 - EUCTR2004-000759-40-IT Italy
2004 - EUCTR2004-000463-94-IT Hungary;Italy
2004 - EUCTR2004-000462-13-IT Hungary;Italy
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
2015 Phase 4 EUCTR2015-000922-12-IT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
TEVA ITALIA srl
2004 Phase 2 EUCTR2004-000762-13-IT Italy
Teva Branded Pharmaceutical Products R&D, Inc.
2010 Phase 3 NCT01067521 Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Turkey;Ukraine;United Kingdom;United States
1994 Phase 4 NCT00203021 United States
Teva Pharmaceutical Industries
2012 Phase 3 NCT01578785 Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Greece;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 Phase 2 NCT01404117 -
2005 Phase 4 NCT00203047 Canada;United States
2004 Phase 3 NCT00666224 Argentina;Australia;Austria;Denmark;Finland;France;Germany;Hungary;Israel;Italy;New Zealand;Norway;Romania;Spain;Sweden;United Kingdom;United States
2004 Phase 4 NCT00202995 Canada;United States
Teva Pharmaceutical Industries, Ltd
2016 Phase 4 EUCTR2015-000922-12-PL Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-FR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-ES Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-DE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-BE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-IE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-HR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-FI Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-AT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
Teva Pharmaceuticals Industries Ltd.
2006 - EUCTR2006-002037-20-IT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Teva Takeda Pharma Ltd.
2015 - NCT03209479 Japan
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University of California, San Francisco
2008 - NCT00819195 United States
University of Colorado, Denver
2012 Phase 2 NCT01569451 United States
Università degli Studi Aldo Moro
2019 Phase 3 EUCTR2017-005129-18-IT Italy
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands
Glatiramer acetate (GA) 40 MG
Teva Pharmaceutical Industries
2006 Phase 3 NCT00337779 Argentina;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;Spain;United Kingdom;United States
Glatiramer acetate 150MG enteric coated tablets
TEVA Pharmaceutical Industries Ltd.
2007 - EUCTR2004-000463-94-HU Hungary;Italy
Glatiramer acetate 150MG enteric-coated (gastro-resistant) tablets
TEVA Pharmaceutical Industries Ltd.
2004 - EUCTR2004-000462-13-HU Hungary;Italy
Glatiramer acetate 20 MG
Teva Pharmaceutical Industries
2006 Phase 3 NCT00337779 Argentina;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;Spain;United Kingdom;United States
2003 Phase 2 NCT00202982 United States
Glatiramer acetate 20 MG, with mitoxantrone
Teva Pharmaceutical Industries
2003 Phase 2 NCT00203073 Canada;United States
Glatiramer acetate 20 MG/0.5 ML
Teva Neuroscience, Inc.
2010 Phase 3 NCT01167426 United States
Glatiramer acetate 40 MG
Teva Pharmaceutical Industries
2003 Phase 2 NCT00202982 United States
Glatiramer acetate injection with oral cetirizine hydrochloride
Teva Pharmaceutical Industries
2004 Phase 4 NCT00240032 United States
Glatiramer acetate with minocycline
Teva Pharmaceutical Industries
2004 Phase 2 NCT00203112 Canada
Glatiramer acetate, IFN-beta 1A (IM), IFN-beta 1A (subcutaneous), and IFN-beta 1B
Teva Neuroscience, Inc.
2008 - NCT00819000 United States
Glatiramer acetate, interferons (intramuscular, subcutaneous, pegylated) teriflunomide, fumarates (dimethyl, diroximel, monomethyl) fingolimod, siponimod, ozanimod, ponesimod
Johns Hopkins University
2018 - NCT03500328 United States
Glatiramer acetate, N-acetylcysteine
Teva Pharmaceutical Industries
2004 Phase 2 NCT00203099 Canada
Glatiramer acetato
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
2015 Phase 4 EUCTR2015-000922-12-IT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
Teva Pharmaceutical Industries, Ltd.
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Glatiramero acetato
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Teva Pharmaceutical Industries, Ltd.
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Glicerol-1,3-didecanoato-2-octadeca-(6Z,9Z,12Z)-trienoato
BTG International Ltd
2009 - EUCTR2009-011585-28-ES Belgium;France;Germany;Spain
Glucose
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
1999 Phase 3 NCT00062972 United States
Glutamate and aspartate
University Hospital, Caen
2007 - NCT02523703 -
Glycerol-1,3-didecanoate-2-octadeca-(6Z,9Z,12Z)-trienoate
BTG International Ltd
2009 - EUCTR2009-011585-28-FR Belgium;France;Germany;Spain
2009 - EUCTR2009-011585-28-DE Belgium;European Union;France;Germany;Russian Federation;Spain
2009 Phase 2 EUCTR2009-011585-28-BE Belgium;European Union;France;Germany;Russian Federation;Spain
Gnbac1
GENEURO SA
2017 Phase 2 EUCTR2016-004935-18-IT Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
GeNeuro Australia PTY Ltd
2018 Phase 1 NCT03574428 Australia
GeNeuro Innovation SAS
2021 Phase 2 EUCTR2021-001973-21-SE Sweden
2020 Phase 2 EUCTR2019-004822-15-SE Sweden
2012 Phase 2 NCT01639300 Switzerland
2011 Phase 1 NCT01699555 -
GeNeuro SA
2017 Phase 2 EUCTR2016-004935-18-PL Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2017 Phase 2 EUCTR2016-004935-18-HU Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2017 Phase 2 EUCTR2016-004935-18-HR Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2017 Phase 2 EUCTR2016-004935-18-ES Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2017 Phase 2 EUCTR2016-004935-18-DE Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2017 Phase 2 EUCTR2016-004935-18-CZ Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2017 Phase 2 EUCTR2016-004935-18-BG Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 NCT02782858 Bulgaria;Croatia;Czechia;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 EUCTR2015-004059-29-PL Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 EUCTR2015-004059-29-HU Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 EUCTR2015-004059-29-HR Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 EUCTR2015-004059-29-ES Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 EUCTR2015-004059-29-EE Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 EUCTR2015-004059-29-DE Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 EUCTR2015-004059-29-CZ Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 EUCTR2015-004059-29-BG Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
Gnbac1 monoclonal antibody
GeNeuro SA
2017 Phase 2 NCT03239860 Bulgaria;Croatia;Czechia;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
Gold nanocrystals
Clene Nanomedicine
2019 Phase 2 NCT03993171 United States
Granulocyte-colony stimulating factor (G-CSF) and prednisone
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States
Group balance training
Örebro County Council
2014 - NCT02209467 Sweden
2012 - NCT01582126 Sweden
GSK1223249
GlaxoSmithKline
2011 Phase 1 NCT01435993 Germany;Italy;Norway
2010 Phase 1 NCT01424423 Australia
GSK1841157
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD.
2012 - EUCTR2011-002333-19-IT Canada;Czech Republic;Germany;Italy;Netherlands;Russian Federation;Spain;United States
GlaxoSmithKline Research and Development Limited
2012 - EUCTR2011-002333-19-CZ Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
2011 - EUCTR2011-002333-19-NL Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
2011 Phase 2 EUCTR2011-002333-19-DK Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
2011 - EUCTR2011-002333-19-DE Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
GlaxoSmithKline SA
2011 Phase 2 EUCTR2011-002333-19-ES Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
GSK2018682
GlaxoSmithKline
2010 Phase 1 NCT01431937 Australia
2010 Phase 1 NCT01387217 Australia
GSK2018682 CD2 capsule
GlaxoSmithKline
2010 Phase 1 NCT01466322 Australia
GSK2018682 CD3 micronised tablet
GlaxoSmithKline
2010 Phase 1 NCT01466322 Australia
GSK2018682 CD3 NON-micronised tablet IN FED state
GlaxoSmithKline
2010 Phase 1 NCT01466322 Australia
GSK239512
GlaxoSmithKline
2013 Phase 1 NCT01802931 Australia
2013 Phase 2 NCT01772199 Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
GlaxoSmithKline Research & Development Ltd
2013 - EUCTR2012-003627-38-SE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-003627-38-GB Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 - EUCTR2012-003627-38-DE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 - EUCTR2012-003627-38-CZ Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-003627-38-BG Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
GlaxoSmithKline, S.A.
2012 - EUCTR2012-003627-38-ES Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
GSK2395612
GlaxoSmithKline Research & Development Ltd
2013 - EUCTR2012-003627-38-SE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 - EUCTR2012-003627-38-DE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 - EUCTR2012-003627-38-CZ Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-003627-38-BG Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
GlaxoSmithKline, S.A.
2012 - EUCTR2012-003627-38-ES Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
GSK3888130B
GlaxoSmithKline
2021 Phase 1 NCT05131971 United Kingdom
GTR
Synthon BV
2011 Phase 3 NCT01489254 Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Italy;Kazakhstan;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;South Africa;Ukraine;United Kingdom;United States
GTR.ACE
SYNTHON BV
2011 - EUCTR2011-000888-27-IT Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Romania;Russian Federation;Ukraine;United Kingdom;United States
Synthon BV
2012 - EUCTR2011-000888-27-GR Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 - EUCTR2011-000888-27-DE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2011-000888-27-RO Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-GB Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-EE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-CZ Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-BG Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
Guanabenz
National Institute of Neurological Disorders and Stroke (NINDS)
2015 Phase 1 NCT02423083 United States
GW-1000-02
GW PHARMA LTD
2008 - EUCTR2006-005910-11-IT Germany;Italy;Spain;United Kingdom
GW Pharma Ltd
2007 Phase 3 EUCTR2006-005910-11-CZ Czech Republic;Germany;Italy;Spain;United Kingdom
2006 Phase 3 EUCTR2005-005265-11-GB Czech Republic;France;United Kingdom
2006 Phase 3 EUCTR2005-005265-11-FR Czech Republic;France;United Kingdom
2006 - EUCTR2005-005265-11-CZ Czech Republic;France;United Kingdom
2005 Phase 3 EUCTR2004-002509-63-GB Czech Republic;United Kingdom
2005 - EUCTR2004-002509-63-CZ Czech Republic;United Kingdom
GW Pharma Ltd.
2008 Phase 3 EUCTR2006-005910-11-GB Czech Republic;Germany;Italy;Spain;United Kingdom
2008 - EUCTR2006-005910-11-DE Germany;Italy;Spain;United Kingdom
2007 - EUCTR2007-002138-13-GB United Kingdom
GW Pharmaceuticals Ltd.
2002 Phase 3 NCT01606176 United Kingdom
2002 Phase 3 NCT01606137 United Kingdom
2001 Phase 3 NCT01610713 United Kingdom
2001 Phase 3 NCT01610700 United Kingdom
2001 Phase 3 NCT01610687 United Kingdom
Gylenia
NOVARTIS FARMA
2011 - EUCTR2011-001442-15-IT Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;United Kingdom
Gylenia 0,5 MG
Novartis Farmaceutica S.A.
2013 - EUCTR2012-000835-18-ES Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
GZ402668
Genzyme, a Sanofi Company
2014 Phase 1 NCT02282826 Germany
Sanofi
2016 Phase 1 NCT02977533 Germany
GZ402673
GENZYME CORPORATION
2017 Phase 3 EUCTR2016-003100-30-IT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
Genzyme Corporation
2017 Phase 3 EUCTR2016-003100-30-PT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-NO Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-NL Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-GR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-GB Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-ES Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-DE Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-BE Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-AT Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 3;Phase 4 EUCTR2013-003884-71-NL Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3;Phase 4 EUCTR2013-003884-71-DK Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3;Phase 4 EUCTR2013-003884-71-BE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 4 EUCTR2014-000092-62-NL Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-FR Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-ES Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-BE Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 3;Phase 4 EUCTR2013-003884-71-IT Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3;Phase 4 EUCTR2013-003884-71-HR Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2014 Phase 3;Phase 4 EUCTR2013-003884-71-ES Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3;Phase 4 EUCTR2013-003884-71-DE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2014 Phase 3;Phase 4 EUCTR2013-003884-71-CZ Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2016-003100-30-PL Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-Outside-EU/EEA Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-FR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-BG Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
Genzyme GmbH
2016 Phase 3 EUCTR2016-000464-42-DE Germany
Genzyme, a Sanofi Company
2015 - NCT03774914 Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
H5g1.1-MAB
Alexion Pharmaceuticals Inc.
2020 Phase 2;Phase 3 EUCTR2019-001829-26-DE Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2019 Phase 2;Phase 3 EUCTR2019-001829-26-ES Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Alexion Pharmaceuticals, Inc.
2015 Phase 3 EUCTR2013-001151-12-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001151-12-DK Argentina;Australia;Austria;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Martinique;Romania;Russian Federation;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001151-12-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hong Kong;Italy;Japan;Korea, Republic of;Netherlands;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
HB-admscs
Hope Biosciences Stem Cell Research Foundation
2021 Phase 2 NCT05116540 United States
HBM9161 injection
Harbour BioMed (Guangzhou) Co. Ltd.
2020 Phase 1 NCT04227470 China
Helminth OVA
University of Wisconsin, Madison
2008 Phase 1 NCT00645749 United States
Hematopoetic stem cell infusion
Talaris Therapeutics Inc.
2007 Phase 1/Phase 2 NCT00497952 United States
Hematopoietic stem cell therapy
Northwestern University
2005 Phase 2 NCT00273364 United States
Hematopoietic stem cell transplantation
Northwestern University
2003 Phase 1/Phase 2 NCT00278655 United States
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom
Heterologous booster
Griffin Hospital
2021 Early Phase 1 NCT05081271 United States
Hiberix
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Hidrocloruro DE fingolimod
Novartis Farmacéutica, S.A.
2011 Phase 4 EUCTR2011-001442-15-ES Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom
High dose myobloc
Supernus Pharmaceuticals, Inc.
2021 Phase 2/Phase 3 NCT04815967 Czechia;United States
High phenolic extra virgin olive OIL
University of Cyprus
2022 - NCT04787497 Greece
HIGH-dose intravenous methylprednisolone
Tianjin Medical University General Hospital
2024 Phase 2 NCT06497374 -
High/LOW sodium diet
Yale University
2014 - NCT02282878 United States
Histamine
University of Nottingham
2008 Phase 2 NCT00630383 United Kingdom
HMR 1726D
Sanofi-Aventis recherche & développement
2008 - EUCTR2007-003997-24-GB Austria;Italy;Spain;United Kingdom
2007 - EUCTR2007-003997-24-ES Austria;Italy;Spain;United Kingdom
2007 - EUCTR2007-003997-24-AT Austria;Italy;Spain;United Kingdom
Sanofi-aventis recherche & développement
2010 - EUCTR2007-004452-36-SK Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-SE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-GR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-GB Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-004452-36-FR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-ES Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-EE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-DE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
sanofi-aventis recherche & développement
2009 - EUCTR2007-004452-36-AT Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-004452-36-NL Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-004452-36-CZ Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-004452-36-BE Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
HMR1726
Aventis Pharmaceuticals Inc.
2006 - EUCTR2004-000555-42-PT Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
GENZYME CORPORATION
2022 Phase 3 EUCTR2020-000644-55-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2017 Phase 3 EUCTR2011-005249-12-IT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States
Genzyme Corporation
2022 Phase 3 EUCTR2020-000644-55-EE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NO Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HR Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-BE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-RO Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2017 Phase 3 EUCTR2011-005249-12-SI Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Egypt;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2011-005249-12-PT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Egypt;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2011-005249-12-NL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2011-005249-12-LT Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2014 Phase 4 EUCTR2013-001439-34-IT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States
2014 Phase 4 EUCTR2013-001439-34-GR Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 Phase 4 EUCTR2013-001439-34-GB Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-DE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-BE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-AT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2011-005249-12-GB Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005249-12-ES Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2011-005249-12-EE Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2011-005249-12-BE Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-SE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-FI Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-ES Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States
2013 - EUCTR2012-005324-16-NL Belgium;Germany;Netherlands
2013 - EUCTR2012-005324-16-DE Belgium;Germany;Netherlands
2013 - EUCTR2012-005324-16-BE Belgium;Germany;Netherlands
- Phase 3 EUCTR2011-005249-12-Outside-EU/EEA Australia;Bosnia and Herzegovina;Canada;China;Israel;Lebanon;Morocco;Russian Federation;Tunisia;Turkey;United States
- Phase 3 EUCTR2011-005249-12-FR Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States
- Phase 3 EUCTR2011-005249-12-BG Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
Sanofi
2013 - NCT03198351 Canada;United States
2006 Phase 3 NCT00803049 Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2002 Phase 2 NCT00228163 Canada;France
Sanofi-Aventis US, Inc.
2004 - EUCTR2004-000555-42-AT Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
Sanofi-aventis US, Inc
2008 Phase 3 EUCTR2004-000555-42-GB Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
2005 - EUCTR2004-000555-42-DK Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
2004 - EUCTR2004-000555-42-SE Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
2004 - EUCTR2004-000555-42-NO Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
sanofi-aventis Recherche & De`veloppement
2004 - EUCTR2004-000555-42-IT Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
sanofi-aventis Recherche & Dévelopment
2009 - EUCTR2008-006226-34-FR Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis U.S Inc
2007 - EUCTR2004-000555-42-CZ Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
sanofi-aventis group
2011 - EUCTR2010-023172-12-GR Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
sanofi-aventis recherche et development
2012 - EUCTR2010-023172-12-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 Phase 3 EUCTR2010-023172-12-SK Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-PT Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-NO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-IT Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 Phase 3 EUCTR2010-023172-12-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-GB Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-ES Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 Phase 3 EUCTR2010-023172-12-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2009 - EUCTR2008-006226-34-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 Phase 3 EUCTR2008-006226-34-GR Belgium;Czech Republic;France;Germany;Greece;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis recherche et developpement
2010 - EUCTR2008-006226-34-GB Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-HU Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-CZ Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
HMR1726D
Sanofi-Aventis recherche & de'veloppement
2008 - EUCTR2007-003997-24-IT Austria;Italy;Spain;United Kingdom
Sanofi-Aventis recherche & développement
2008 - EUCTR2007-003997-24-GB Austria;Italy;Spain;United Kingdom
2007 - EUCTR2007-003997-24-ES Austria;Italy;Spain;United Kingdom
2007 - EUCTR2007-003997-24-AT Austria;Italy;Spain;United Kingdom
Sanofi-aventis U.S. Inc
2007 - EUCTR2006-003134-14-IT Germany;Italy;Spain
2007 - EUCTR2004-000555-42-EE Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
Sanofi-aventis U.S. Inc.
2007 - EUCTR2006-004893-29-IT Austria;Germany;Italy;United Kingdom
2007 Phase 2 EUCTR2006-004893-29-GB Austria;Germany;Italy;United Kingdom
2007 - EUCTR2006-004893-29-AT Austria;Germany;Italy;United Kingdom
2007 Phase 2 EUCTR2006-003134-14-ES Germany;Italy;Spain
2007 - EUCTR2006-003134-14-DE Germany;Italy;Spain
- - EUCTR2006-004893-29-DE Austria;Germany;Italy;United Kingdom
Sanofi-aventis recherche & développement
2010 - EUCTR2007-004452-36-SK Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-SE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-GR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-GB Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-004452-36-FR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-ES Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-EE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-DE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2006-001152-12-SK Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2008 Phase 3 EUCTR2006-001152-12-FR Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
sanofi-aventis Recherche & Dévelopment
2009 - EUCTR2008-006226-34-FR Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis recherche de veloppement
2007 - EUCTR2006-003361-14-IT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
sanofi-aventis recherche & developpement
2011 - EUCTR2011-001160-21-DE Austria;Canada;Germany;Russian Federation;Ukraine
2011 - EUCTR2011-001160-21-AT Austria;Canada;Germany;Russian Federation;Ukraine
sanofi-aventis recherche & développement
2009 - EUCTR2007-004452-36-AT Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2006-003361-14-EE Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2009 - EUCTR2006-003361-14-CZ Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2006-001152-12-LT Australia;Austria;Belarus;Bulgaria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2006-001152-12-DE Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2008 - EUCTR2007-004452-36-NL Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-004452-36-CZ Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-004452-36-BE Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2006-003361-14-PT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2008 - EUCTR2006-003361-14-NL Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2006-003361-14-DK Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2008 - EUCTR2006-001152-12-HU Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2006-001152-12-EE Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2006-001152-12-BG Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2007 Phase 3 EUCTR2006-003361-14-SE Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2007 Phase 3 EUCTR2006-003361-14-GB Austria;Canada;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2006-003361-14-DE Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Poland;Portugal;Russian Federation;Sweden;Switzerland;Ukraine;United Kingdom;United States
2007 Phase 3 EUCTR2006-001152-12-GB Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2007 Phase 3 EUCTR2006-001152-12-FI Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2007 - EUCTR2006-001152-12-DK Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2007 Phase 3 EUCTR2006-001152-12-CZ Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2006-001152-12-AT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2006 Phase 3 EUCTR2006-003361-14-FI Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2006 - EUCTR2006-003361-14-AT Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 Phase 3 EUCTR2008-006226-34-GR Belgium;Czech Republic;France;Germany;Greece;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis recherche et developpement
2010 - EUCTR2008-006226-34-GB Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-HU Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-CZ Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
Home based balance training
University of Arizona
2014 - NCT02777060 United States
HOME-based balance training
University of Vermont
2024 - NCT06412003 -
Homologous booster
Griffin Hospital
2021 Early Phase 1 NCT05081271 United States
Hookworm larvae
University of Nottingham
2011 Phase 2 NCT01470521 United Kingdom
HP184
Sanofi
2008 Phase 2 NCT00811902 Canada;Finland;France;Germany;Norway;Spain;United States
2008 Phase 2 NCT00772525 United States
sanofi-aventis Recherche & Développement
2009 Phase 2 EUCTR2008-001999-67-FR Finland;France;Germany;Spain
2009 - EUCTR2008-001999-67-FI Finland;France;Germany;Spain
2009 Phase 2 EUCTR2008-001999-67-ES Finland;France;Germany;Spain
2009 - EUCTR2008-001999-67-DE Finland;France;Germany;Spain
Human ANTI-IL-12 IGG1 MAB
Centocor B.V.
2005 Phase 2 EUCTR2004-000145-38-GB Czech Republic;Hungary;United Kingdom
2004 - EUCTR2004-000145-38-HU Czech Republic;Hungary;United Kingdom
2004 Phase 2 EUCTR2004-000145-38-CZ Czech Republic;Hungary;United Kingdom
Human ANTI-IL-12 MAB
Centocor B.V.
2005 Phase 2 EUCTR2004-000145-38-GB Czech Republic;Hungary;United Kingdom
2004 - EUCTR2004-000145-38-HU Czech Republic;Hungary;United Kingdom
2004 Phase 2 EUCTR2004-000145-38-CZ Czech Republic;Hungary;United Kingdom
Human ANTI-lingo-1 monoclonal antibody
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-IT Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-HU Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-GB Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-CZ Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
Human autologous mesenchymal stem cells
SALK - Gemeinnützige Salzburger Landeskliniken Betriebsges. m.b.H., Christian-Doppler-Klinik, UK für Neurologie der PMU
- - EUCTR2015-000137-78-AT Austria
Human interferon beta
Aaron Boster
2006 Phase 0 NCT00618527 United States
Human interferon BETA-1A and glatiramer acetate
EMD Serono
2004 Phase 4 NCT00078338 Argentina;Austria;Brazil;France;Germany;Italy;Netherlands;Russian Federation;Spain;Switzerland;United Kingdom;United States
Human leucocyte interferon-alpha
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark
Human monoclonal antibody (cnto 1275) TO interleukin-12p40
Centocor B.V.
2005 Phase 2 EUCTR2004-000145-38-GB Czech Republic;Hungary;United Kingdom
2004 - EUCTR2004-000145-38-HU Czech Republic;Hungary;United Kingdom
2004 Phase 2 EUCTR2004-000145-38-CZ Czech Republic;Hungary;United Kingdom
Human neural stem cells
Casa Sollievo della Sofferenza IRCCS
2017 Phase 1 NCT03282760 Italy;Switzerland
Human normal immunoglobulin
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Human recombinant growth hormone
University of Leipzig
- Phase 2 EUCTR2006-006465-16-DE Germany
Human umbilical cord mesenchymal stem cells
Shenzhen Beike Bio-Technology Co., Ltd.
2010 Phase 1/Phase 2 NCT01364246 China
Humax-CD20
Genmab A/S
2008 Phase 2 EUCTR2007-004223-38-DE Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom
2008 - EUCTR2007-004223-38-BE Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom
GlaxoSmithKline
2008 - EUCTR2007-004223-38-DK Czech Republic;Denmark;Germany;Sweden;United Kingdom
GlaxoSmithKline AB
2008 - EUCTR2007-004223-38-SE Czech Republic;Denmark;Germany;Sweden;United Kingdom
GlaxoSmithKline UK
2009 Phase 2 EUCTR2007-004223-38-GB Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom
GlaxoSmithKline s.r.o.
2008 - EUCTR2007-004223-38-CZ Czech Republic;Denmark;Germany;Sweden;United Kingdom
Hydrochlorothiazide
Universitätsklinik für Neurologie, Medizinische Universität Wien
2013 - EUCTR2012-005113-39-AT Austria
Hydrogen peroxide
Tehran University of Medical Sciences
2012 - NCT02463318 Iran, Islamic Republic of
Hydroxychloroquine
University of Calgary
2016 Phase 2 NCT02913157 Canada
Hydroxychloroquine pill
University of Calgary
2021 Phase 2 NCT05013463 Canada
Hydroxychloroquine sulfate
Varsinais-Suomen sairaanhoitopiirin kuntayhtymä
2022 Phase 2 EUCTR2022-003170-23-FI Finland
Hydroxyurea
S. Andrea Hospital
2011 Phase 2/Phase 3 NCT01103583 Italy
Hyperimmune caprine serum against HIV lysate
Daval International Limited
2009 Phase 2 NCT01228396 United Kingdom
Ibudilast
MediciNova
2013 Phase 2 NCT01982942 United States
Ibuprofen
Genzyme, a Sanofi Company
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain
Ibuprofen sandoz 400 MG filmtabletten
Merck Serono International SA
2007 - EUCTR2006-005972-42-DE France;Germany
ICP-022
InnoCare Pharma, Inc.
2021 Phase 2 EUCTR2020-005117-41-PL China;Poland;Ukraine;United States
Idebenone
National Institute of Allergy and Infectious Diseases (NIAID)
2013 Phase 1/Phase 2 NCT01854359 United States
2009 Phase 1/Phase 2 NCT00950248 United States
Idmt
Novartis Pharmaceuticals
2021 Phase 4 NCT04667117 United States
IDP-023
Indapta Therapeutics, INC.
2026 Phase 1 NCT06677710 United States
IFA incomplete freund'S adjuvant
Immune Response BioPharma, Inc.
2020 Phase 1 NCT02200718 United States
2020 Phase 2 NCT02149706 United States
Ifenprodil
Assistance Publique - Hôpitaux de Paris
2024 Phase 2 NCT06330077 France
IFN beta 1A 44 MCG TIW
Merck KGaA, Darmstadt, Germany
2012 Phase 2 NCT01514370 Italy
IFN BETA-1A
Merck KGaA, Darmstadt, Germany
2018 Phase 2 NCT03387046 Germany;Italy
IFN ß-1A
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Brigham and Women's Hospital
2015 - NCT02419638 United States
Celgene
2013 Phase 3 NCT02047734 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
IL2
Assistance Publique - Hôpitaux de Paris
2016 Phase 2 NCT02424396 France
IM90838
Immunic AG
2023 Phase 3 EUCTR2021-000028-36-GR Albania;Belarus;Bulgaria;Colombia;Georgia;Germany;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2023 Phase 3 EUCTR2021-000028-36-ES Albania;Bulgaria;Colombia;Georgia;Germany;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Russian Federation;Spain;Ukraine;United States
2023 Phase 3 EUCTR2021-000028-36-DE Albania;Algeria;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2022 Phase 2 EUCTR2021-000048-23-NL Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2022 Phase 2 EUCTR2021-000048-23-DE Bulgaria;Canada;Czechia;Georgia;Germany;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Serbia;Ukraine;United States
2022 Phase 3 EUCTR2021-000029-28-RO Armenia;Bosnia and Herzegovina;Estonia;Germany;India;Peru;Poland;Romania;Serbia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000029-28-PL Bosnia and Herzegovina;Estonia;India;Peru;Poland;Romania;Russian Federation;Serbia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000028-36-LT Albania;Algeria;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-000028-36-BG Albania;Algeria;Belarus;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2021 Phase 2 EUCTR2021-000048-23-RO Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine
2021 Phase 2 EUCTR2021-000048-23-PL Bulgaria;Canada;Czechia;Georgia;Germany;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Serbia;Ukraine;United States
2021 Phase 2 EUCTR2021-000048-23-BG Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine
Imatinib mesilate
Department of Clinical Neuroscience, Karolinska Institutet
2020 Phase 2 EUCTR2018-000620-34-DE Germany;Sweden
2018 Phase 2 EUCTR2018-000620-34-SE Sweden
2018 Phase 2 EUCTR2018-000620-34-NO Germany;Norway;Sweden
Imatinib mesylate
Tomas Olsson
2018 Phase 2 NCT03674099 Denmark;Germany;Norway;Sweden
IMC-002
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
2024 Phase 1/Phase 2 NCT06557174 -
IMCY-0141
Imcyse SA
2022 Phase 1/Phase 2 NCT05417269 Moldova, Republic of
Immune globulin
National Institute of Neurological Disorders and Stroke (NINDS)
1993 Phase 3 NCT00004744 -
Immune globulin IV [human], 10% caprylate/chromatography purified
Grifols Therapeutics Inc.
2002 Phase 2 NCT00220779 Austria;Canada;Czech Republic;Germany;Greece;Hungary;Israel;Poland;Slovakia;Sweden;United Kingdom;United States
Immunoadsorption
University Hospital Muenster
2018 - NCT04450030 Germany
Immunoglobulin
Octapharma AG
2008 - EUCTR2008-004579-22-AT Austria
Immunoglobulin G
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Immunosuppressive agents
Actelion Pharmaceuticals Ltd
2010 Phase 2 EUCTR2009-011470-15-IT Austria;Bulgaria;Czech Republic;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
IMS001
ImStem Biotechnology
2021 Phase 1 NCT04956744 United States
IMU-838
Immunic AG
2023 Phase 3 EUCTR2021-000028-36-GR Albania;Belarus;Bulgaria;Colombia;Georgia;Germany;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2023 Phase 3 EUCTR2021-000028-36-ES Albania;Bulgaria;Colombia;Georgia;Germany;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Russian Federation;Spain;Ukraine;United States
2023 Phase 3 EUCTR2021-000028-36-DE Albania;Algeria;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2022 Phase 2 EUCTR2021-000048-23-NL Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2022 Phase 2 EUCTR2021-000048-23-DE Bulgaria;Canada;Czechia;Georgia;Germany;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Serbia;Ukraine;United States
2022 Phase 3 EUCTR2021-000029-28-RO Armenia;Bosnia and Herzegovina;Estonia;Germany;India;Peru;Poland;Romania;Serbia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000029-28-PL Bosnia and Herzegovina;Estonia;India;Peru;Poland;Romania;Russian Federation;Serbia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000028-36-LT Albania;Algeria;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-000028-36-BG Albania;Algeria;Belarus;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2021 Phase 2 NCT05054140 Bulgaria;Canada;Czechia;Germany;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Serbia;Ukraine;United States
2021 Phase 2 EUCTR2021-000048-23-RO Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine
2021 Phase 2 EUCTR2021-000048-23-PL Bulgaria;Canada;Czechia;Georgia;Germany;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Serbia;Ukraine;United States
2021 Phase 2 EUCTR2021-000048-23-BG Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine
2019 Phase 2 NCT03846219 Bulgaria;Poland;Romania;Ukraine
2019 Phase 2 EUCTR2018-001896-19-RO Bulgaria;Germany;Poland;Romania;Ukraine
IMU-838 tablets
Immunic AG
2022 Phase 3 NCT05201638 Armenia;Bosnia and Herzegovina;Estonia;India;Peru;Poland;Romania;Serbia;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 NCT05134441 Albania;Bulgaria;Colombia;Georgia;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Spain;Ukraine;United States
IMU-838-RC
Immunic AG
2022 Phase 2 EUCTR2018-001896-19-DE Bulgaria;Germany;Poland;Romania;Ukraine
2018 Phase 2 EUCTR2018-001896-19-BG Bulgaria;Germany;Poland;Romania;Ukraine
Imurel
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Incabotulinumtoxina
Multiple Sclerosis Center of Northeastern New York
2013 Phase 4 NCT01968902 United States
Incobotulinum toxin A
Pôle Saint Hélier
2014 - NCT04265092 -
Incontinence severity
Ankara Yildirim Beyazit University
2019 - NCT03945006 Turkey
Indapamide pill
University of Calgary
2021 Phase 2 NCT05013463 Canada
Inebilizumab
Amgen
2024 Phase 4 NCT06180278 China;Czechia;Hong Kong;Hungary;Korea, Republic of;Poland;Thailand;United States
2023 Phase 2 NCT05549258 Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
Feng Jinzhou
2023 - NCT06068829 -
Hansoh BioMedical R&D Company
2024 Phase 4 NCT06212245 China
Horizon Therapeutics Ireland DAC
2022 Phase 2 EUCTR2021-003528-33-SE Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
2022 Phase 2 EUCTR2021-003528-33-PL Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
2022 Phase 2 EUCTR2021-003528-33-FR Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
- Phase 2 EUCTR2021-003528-33-NL Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
MedImmune LLC
2018 Phase 2;Phase 3 EUCTR2014-000253-36-NL Australia;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;India;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2017 Phase 2;Phase 3 EUCTR2014-000253-36-HU Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2015 Phase 2/Phase 3 NCT02200770 Australia;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;Germany;Greece;Hong Kong;Hungary;India;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2015 Phase 2;Phase 3 EUCTR2014-000253-36-DE Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2015 Phase 2;Phase 3 EUCTR2014-000253-36-BG Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2014 Phase 2;Phase 3 EUCTR2014-000253-36-PL Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2014 Phase 2;Phase 3 EUCTR2014-000253-36-EE Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2014 Phase 2;Phase 3 EUCTR2014-000253-36-CZ Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
Sato Toshiyuki
2020 Phase 3 JPRN-jRCT2051210017 -
West China Hospital,Sichuan University
2024 Phase 4 ChiCTR2400087203 China
Xuanwu Hospital, Beijing
2024 - NCT05891379 China
INF BETA-1A
Bosnalijek D.D
2019 Phase 3 NCT03283397 Turkey
Influenza vaccine
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States
Sanofi
2011 Phase 2 NCT01403376 Austria;Canada;Germany;Russian Federation;Ukraine
Inhaled cannabis
University of California, Davis
2004 Phase 1/Phase 2 NCT00682929 United States
Injectable MS DMT
Biogen
2015 Phase 4 NCT02471560 Norway
Injection OF autologous bone marrow derived mesenchymal stem cells
Hadassah Medical Organization
2006 Phase 1/Phase 2 NCT00781872 -
Injection OF cell free media
Royan Institute
2011 Phase 1/Phase 2 NCT01377870 Iran, Islamic Republic of
INN colecalciferol
Merja Soilu Häninen
2007 - EUCTR2007-001958-99-FI Finland
Inosine
National Center for Complementary and Integrative Health (NCCIH)
2002 Phase 2 NCT00067327 United States
Tsukuba International Clinical Pharmacology Clinic
2016 - JPRN-UMIN000024312 Japan
Inspiratory muscle training
Marmara University
2023 - NCT06075472 Turkey
Insulin
Johns Hopkins University
2017 Phase 1/Phase 2 NCT02988401 United States
INT131
InteKrin Therapeutics, Inc.
2015 Phase 2 NCT02638038 -
Inteferone BETA-1A
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Interferon beta
Biogen
2021 - NCT05688436 United States
Biogen Idec
2014 Phase 4 NCT02234869 -
Biogen Idec Ltd
2012 Phase 3 EUCTR2009-012500-11-SI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Biogen Idec Research Limited
2014 Phase 3 EUCTR2013-002318-11-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
Heidelberg University
2006 Phase 3 NCT00344253 Germany
Interferon beta - 1A
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Novartis Pharmaceuticals
2012 Phase 4 NCT01534182 Russian Federation
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Interferon beta -1B
EMD Serono
2006 Phase 3 NCT00428584 United States
Interferon beta 1
Bayer
2011 - NCT01071694 Korea, Republic of
University of Turin, Italy
1999 Phase 3 NCT00473213 -
Interferon beta 1-A
Biogen
2010 Phase 2 NCT01071083 Germany;Spain;United States
2008 Phase 3 NCT00784836 United States
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland
Fred Lublin
2005 Phase 3 NCT00211887 Canada;United States
Merck Healthcare KGaA
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Interferon beta 1A
Aaron Boster
2006 Phase 0 NCT00618527 United States
Biocad
2014 Phase 2/Phase 3 NCT02727907 Russian Federation
Biogen Idec Limited
2012 Phase 3 EUCTR2010-024477-39-GR Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2010-024477-39-GB Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2012 - EUCTR2010-024477-39-CZ Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-LV Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-EE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-024477-39-DE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-024477-39-BG Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-BE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2010 - EUCTR2008-006333-27-CZ Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-NL Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-006333-27-GB Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-EE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-BG Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-BE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
- - EUCTR2008-006333-27-DE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
Biogen Idec Ltd
2009 Phase 3 EUCTR2008-003098-42-CZ Czech Republic
Merck KGaA
2005 - NCT01142518 -
2005 - NCT01142453 -
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
2002 Phase 4 NCT00037115 United States
2001 Phase 4 NCT00037102 United States
Rennes University Hospital
2010 Phase 3 NCT02937285 France
Revalesio Corporation
2013 Phase 2 NCT01714089 United States
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom
Trio Medicines Ltd.
2001 Phase 1 NCT01863069 United Kingdom
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom
University of California, San Francisco
2006 Phase 2 NCT00501943 United States
Interferon beta 1A 30 UG IM once weekly
Beth Israel Deaconess Medical Center
2001 Phase 4 NCT00179478 Canada;United States
Interferon beta 1A pegilado
Biogen Idec Limited
2011 - EUCTR2010-024477-39-ES Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Interferon beta 1A, oral doxycycline
Louisiana State University Health Sciences Center Shreveport
2003 Phase 4 NCT00246324 United States
Interferon beta 1B
Bayer
2003 Phase 2 NCT00235989 United States
Charite Universitaetsmedizin Berlin
2012 Phase 3 EUCTR2011-004787-30-DE Germany
Novartis Pharmaceuticals
2011 Phase 4 NCT01333501 Germany;Italy
Schering AG
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom
University Hospital Inselspital, Berne
2005 Phase 2 NCT00942591 Switzerland
Interferon beta therapy
Biogen
2021 - NCT04655222 Germany
Interferon beta treatment TO ADD-ON atorvastatin treatment
Charite University, Berlin, Germany
2003 Phase 2 NCT00616187 -
Interferon beta type 1A
Biogen
2019 Phase 3 NCT03958877 Argentina;Australia;Belgium;Bulgaria;Croatia;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Interferon BETA-1 A
Serono GmbH
2005 - EUCTR2005-001026-89-DE Germany
Interferon BETA-1A
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-012500-11-IT Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
BIOGEN-DOMPE` SRL
2010 - EUCTR2009-017003-28-IT Italy
Biogen
2017 Phase 4 NCT03177083 Portugal
2013 - NCT02076841 Czech Republic;Switzerland
2012 - NCT01272128 Belgium;United States
2010 Phase 3 NCT01064401 Argentina;Australia;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Egypt;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 NCT01058005 Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States
2009 Phase 3 NCT00828204 United States
Biogen Idec
2012 Phase 1 NCT01500408 United States
2010 - EUCTR2009-017490-38-DE Germany;Spain
2007 Phase 4 NCT00574041 Australia
2005 Phase 3 NCT00915577 -
2004 - NCT00168714 United States
2003 Phase 2 NCT00912860 -
2002 Phase 4 NCT00913666 -
2002 - NCT00599274 Australia;Austria;Canada;United States
1999 Phase 4 NCT00915460 -
1999 Phase 4 NCT00534261 Belgium;Luxembourg;United Kingdom
Biogen Idec GmbH
2005 - EUCTR2004-004130-14-AT Austria
Biogen Idec Limited
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Biogen Idec Ltd
2010 - EUCTR2009-012500-11-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-GR Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012500-11-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012500-11-FR Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012500-11-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Biogen Idec Research Limited
2017 Phase 3 EUCTR2013-002318-11-FR Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom
2016 - EUCTR2013-002318-11-ES Argentina;Belgium;Canada;Croatia;Czech Republic;Denmark;France;Hungary;Israel;Italy;Poland;Portugal;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom
2016 Phase 3 EUCTR2013-002318-11-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Türkiye;United Kingdom;United States
2015 Phase 3 EUCTR2013-002318-11-PL Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-SE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-IT Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3 EUCTR2013-002318-11-HU Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom
2014 Phase 3 EUCTR2013-002318-11-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-DK Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-CZ Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-IT Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-HU Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-GB Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-ES Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-CZ Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
- Phase 3 EUCTR2013-002318-11-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Celgene
2014 Phase 3 NCT02294058 Argentina;Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Centre Hospitalier Universitaire Vaudois
2005 Phase 1 NCT02515695 -
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020337-99-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020337-99-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-FR Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020315-36-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 - EUCTR2010-020337-99-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-FI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
F.Hoffmann-La Roche Ltd.
2008 - EUCTR2007-006338-32-IT Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Russian Federation;Spain;Switzerland;Ukraine;United Kingdom;United States
Genzyme Corporation
2008 - EUCTR2007-001162-32-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-NL Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-IT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-001162-32-CZ Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-AT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001161-14-SE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 - EUCTR2007-001161-14-PL Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 Phase 3 EUCTR2007-001161-14-FR Czech Republic;France;Germany;Poland;Sweden;United Kingdom
2008 - EUCTR2007-001161-14-DE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 - EUCTR2007-001161-14-CZ Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2007 Phase 3 EUCTR2007-001162-32-GB Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2007 - EUCTR2007-001161-14-GB Czech Republic;France;Germany;Poland;Sweden;United Kingdom
Genzyme, a Sanofi Company
2007 Phase 3 NCT00548405 Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2007 Phase 3 NCT00530348 Argentina;Australia;Brazil;Canada;Croatia;Czech Republic;Former Serbia and Montenegro;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;United States
2002 Phase 2 NCT00050778 Croatia;Poland;Russian Federation;United Kingdom;United States
German University in Cairo
2022 Phase 2 NCT05298670 Egypt
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-SK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
Hoffmann-La Roche
2011 Phase 3 NCT01412333 Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;France;Germany;Ireland;Italy;Mexico;Morocco;Norway;Poland;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 NCT01247324 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Czechia;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
ISTITUTO C. MONDINO
2007 - EUCTR2008-007162-32-IT Italy
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
MERCK ROMANIA SRL
2014 Phase 4 EUCTR2014-001290-14-RO Romania
MERCK SERONO SA
2010 - EUCTR2009-016087-37-IT France;Ireland;Italy;Spain;United Kingdom
2009 - EUCTR2008-004954-34-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain
2009 - EUCTR2008-003706-33-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2008-000499-25-IT Germany;Italy;Spain;Sweden
MERCK SERONO SPA
2009 - EUCTR2009-013333-24-IT Italy
MedImmune LLC
2012 - EUCTR2011-005475-16-GB Austria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden
Merck Healthcare KGaA
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
Merck KGaA
2014 - EUCTR2013-003126-83-HU Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-GR Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-ES Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-DE Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2010 - NCT01101776 Australia
2009 - NCT01075880 Czech Republic
2005 Phase 4 NCT01201343 -
2005 - NCT01142492 -
2005 Phase 4 NCT01142466 -
2004 - NCT01142557 Germany
Merck KGaA, Darmstadt, Germany
2016 - NCT02921035 Algeria;Argentina;Bahrain;Bulgaria;Egypt;Germany;Hungary;Iran, Islamic Republic of;Korea, Republic of;Kuwait;Lebanon;Morocco;Poland;Saudi Arabia;Tunisia;United Arab Emirates
Merck Serono International S.A.
2008 - EUCTR2008-000499-25-SE Germany;Italy;Spain;Sweden
2008 - EUCTR2008-000499-25-ES Germany;Italy;Spain;Sweden
- - EUCTR2008-000499-25-DE Germany;Italy;Spain;Sweden
Merck Serono International SA
2007 - EUCTR2006-005972-42-DE France;Germany
Merck Serono S.A. - Geneva
2010 - EUCTR2009-016087-37-GB France;Ireland;Italy;Spain;United Kingdom
Merck Serono SA – Geneva
2010 - EUCTR2009-015502-19-GB Belgium;Finland;Germany;Sweden;United Kingdom
Merck, S.L.
2006 Phase 4 EUCTR2006-000606-23-ES Spain
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy
2006 - EUCTR2006-000704-17-IT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
Novartis Farma
2013 Phase 3 EUCTR2011-005677-23-IT Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Farmaceutica S.A.
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;Italy
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;United Kingdom
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-FR Austria;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Pharma Services AG
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
2006 - EUCTR2006-000704-17-PT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 Phase 3 EUCTR2006-000704-17-GR Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 - EUCTR2006-000704-17-GB Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
Novartis Pharmaceuticals
2013 Phase 3 NCT01892722 Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
OSPEDALE S. RAFFAELE
2004 - EUCTR2004-001601-10-IT France;Italy
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
ROCHE
2011 Phase 3 EUCTR2010-020337-99-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IT Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Receptos, Inc.
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-IT Belgium;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Israel;Italy;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-GR Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-ES Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
Sahlgrenska University Hospital
2005 Phase 4 EUCTR2005-001008-37-SE Sweden
Serono International SA
2004 Phase 4 EUCTR2004-000337-12-HU Hungary
TEVA ITALIA srl
2008 - EUCTR2007-005450-23-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
Teva Pharmaceutical Industries Ltd
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-DE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
Teva Pharmaceutical Industries, Ltd.
2014 - EUCTR2013-002082-19-NL Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2014 - EUCTR2013-002082-19-ES Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-SE Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 EUCTR2013-002082-19-GB Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-FI Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-DK Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 EUCTR2013-002082-19-BE Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
The Multiple Sclerosis Research Group, Department of Clinical Neuroscience
2009 - EUCTR2008-008554-23-SE Sweden
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
Universita di Firenze
2006 Phase 3 EUCTR2006-004937-13-IT Italy
Università degli Studi Aldo Moro
2019 Phase 3 EUCTR2017-005129-18-IT Italy
Universitätsklinikum Heidelberg
2006 Phase 3 EUCTR2004-004403-37-DE Germany
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands
2011 - EUCTR2011-003570-89-NL Netherlands
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis recherche et developpement
2010 - EUCTR2008-006226-34-GB Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-HU Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-CZ Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
Interferon BETA-1A (rebif®) alone
Merck KGaA
2011 Phase 2 NCT01285401 Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
Interferon BETA-1A FBS-free/HSA free, RNF
Serono International, S.A.
2007 - EUCTR2006-003366-33-ES Italy;Spain
Interferon BETA-1A FBS-free/HSA-free
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
Merck Serono S.A. - Geneva
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
Interferon BETA-1A FBS-free/HSA-free, RNF
MERCK SERONO INTERNATIONAL SA
2007 - EUCTR2006-003037-32-IT Estonia;Germany;Italy;Lithuania;Spain
Merck Serono International SA
2007 - EUCTR2006-003037-32-LT Estonia;Germany;Italy;Lithuania;Spain
2007 Phase 3 EUCTR2006-003037-32-ES Estonia;Germany;Italy;Lithuania;Spain
2007 - EUCTR2006-003037-32-EE Estonia;Germany;Italy;Lithuania;Spain
Merck Serono SA
2007 - EUCTR2006-003037-32-DE Estonia;Germany;Italy;Lithuania;Spain
Serono International SA
2006 - EUCTR2006-002982-38-IT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
Interferon BETA-1A HSA+ biosimilar
Centre Hospitalier Universitaire Vaudois
2006 Phase 1 NCT02517788 -
Interferon BETA-1A HSA-free biosimilar
Centre Hospitalier Universitaire Vaudois
2006 Phase 1 NCT02517788 -
Interferon BETA-1A original
Centre Hospitalier Universitaire Vaudois
2006 Phase 1 NCT02517788 -
Interferon BETA-1A prefilled syringe
Cinnagen
2017 Phase 3 NCT05242133 Iran, Islamic Republic of
Interferon BETA-1B
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy
Bayer
2017 - NCT03134573 Germany
2016 - NCT02652091 United States
2015 - NCT02486640 Germany
2014 - NCT02247310 Austria;Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Czechia;France;Greece;Hungary;Italy;Netherlands;Spain;Switzerland
2014 - NCT02121444 Germany
2012 - NCT01766063 Germany
2012 - NCT01706055 Poland
2012 - NCT01491100 Albania;Algeria;Argentina;Belgium;Bosnia and Herzegovina;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Jordan;Kazakhstan;Lebanon;Mexico;Netherlands;Poland;Portugal;Saudi Arabia;Syrian Arab Republic;Tunisia;Turkey
2012 - NCT01436838 China
2010 - NCT01354665 Poland
2010 - NCT01076595 France
2010 - NCT01031459 Canada;United States
2009 - NCT03408093 -
2009 - NCT00963833 Austria;Belgium;Finland;Germany;Israel;Italy;Portugal;United Kingdom
2009 - NCT00902135 Germany
2008 - NCT03577977 Russian Federation
2008 - NCT01414816 Korea, Republic of
2008 - NCT01184833 Poland
2008 - NCT00787657 Argentina;Bahrain;Belgium;Bosnia and Herzegovina;Canada;China;Colombia;Czech Republic;Egypt;Estonia;France;Germany;Iran, Islamic Republic of;Israel;Italy;Jordan;Korea, Republic of;Kuwait;Lebanon;Libyan Arab Jamahiriya;Mexico;Netherlands;New Zealand;Norway;Pakistan;Portugal;Saudi Arabia;Singapore;Slovakia;Slovenia;Sweden;Syrian Arab Republic;Taiwan;United Arab Emirates;United Kingdom;Venezuela
2007 - NCT01235455 Portugal
2007 - NCT00928967 France
2007 - NCT00544037 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2007 Phase 3 NCT00459667 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States
2006 - NCT00882453 Australia;Austria;Bahrain;Belgium;Canada;Colombia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Indonesia;Israel;Italy;Jordan;Kazakhstan;Korea, Republic of;Kuwait;Lebanon;Mexico;Netherlands;Norway;Oman;Portugal;Slovenia;Spain;Sweden;Switzerland;Taiwan;Thailand;United Arab Emirates;United Kingdom
2006 Phase 3 NCT00370071 China
2005 Phase 3 NCT00313976 Denmark;Sweden
2005 - NCT00206635 Canada;United Kingdom;United States
2004 - NCT01233245 Czech Republic;France;Germany;Iran, Islamic Republic of;Israel;Italy;Jordan;Korea, Republic of;Lebanon;Netherlands;Portugal;Saudi Arabia;Spain;Taiwan;Turkey
2003 Phase 3 NCT00099502 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States
2002 Phase 2 NCT00893217 United States
2002 Phase 3 NCT00185211 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer HealthCare AG
- - EUCTR2014-004613-93-Outside-EU/EEA China
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Biogen
2017 Phase 4 NCT03177083 Portugal
Charite Universitaetsmedizin Berlin
2012 Phase 3 EUCTR2011-004787-30-DE Germany
Claudio Gobbi
2012 Phase 4 NCT01701856 Switzerland
2010 Phase 4 NCT01144052 Switzerland
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Medical University Innsbruck
2009 - EUCTR2009-013284-19-AT Austria
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy
2010 - EUCTR2010-023023-19-IT Germany;Italy
NURON BIOTECH INC.
2012 - EUCTR2011-002683-24-IT Belarus;Bulgaria;Hungary;Italy;Russian Federation;Spain
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;Italy
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;United Kingdom
Novartis Pharma Services AG
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
Nuron Biotech, Inc.
2012 - EUCTR2011-002683-24-HU Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine
2012 - EUCTR2011-002683-24-ES Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Poland;Russian Federation;Spain;Ukraine
2012 - EUCTR2011-002683-24-BG Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Ospedale Regionale di Lugano
2013 - EUCTR2012-004040-30-AT Austria;Switzerland
Pfenex, Inc
2015 Phase 1 NCT02474134 Australia
SCHERING
2007 - EUCTR2006-005270-47-IT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Schering AG
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Universita di Firenze
2006 Phase 3 EUCTR2006-004937-13-IT Italy
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands
Interferon BETA-1B and tacrolimus
Clinique de sclérose en plaques et neuromusculaire de l'Outaouais
2003 Phase 2 NCT00298662 Canada
Interferon BETA-1B group
University Hospital Inselspital, Berne
2007 Phase 2 NCT01111656 Switzerland
Interferon BETA-1B, FRP about 6 weeks after randomization
Bayer
2008 Phase 4 NCT00780455 France
Interferon BETA-1B, FRP within 15 days after randomization
Bayer
2008 Phase 4 NCT00780455 France
Interferon BETA-1B/atorvastatin group
University Hospital Inselspital, Berne
2007 Phase 2 NCT01111656 Switzerland
Interferon BETA1A
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Biogen Idec Ltd
2010 Phase 3 EUCTR2009-012500-11-ES Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
2009 Phase 3 EUCTR2008-004954-34-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 - EUCTR2006-002982-38-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
Interferon or glatiramer acetate
Novartis Pharmaceuticals
2021 Phase 4 NCT04878211 United States
Interferon ß-1A
Biogen
2014 Phase 3 NCT02283853 Argentina;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
Celgene
2013 Phase 3 NCT02047734 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;Italy
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;United Kingdom
Sanofi
2009 Phase 3 NCT00883337 Belgium;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Spain;Switzerland;Tunisia;United Kingdom
Interferon ß-1A 30 µG
Novartis
2006 Phase 3 NCT00340834 Argentina;Australia;Austria;Belgium;Brazil;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Portugal;Puerto Rico;Spain;Switzerland;United Kingdom;United States
Interferon ß-1B
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;Italy
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;United Kingdom
S. Andrea Hospital
2005 Phase 2/Phase 3 NCT00270816 Italy
Interferon ß1
Novartis Pharmaceuticals
2022 - NCT05344469 Germany
Interferon-beta
Central Hospital, Nancy, France
2012 - NCT04289675 -
EMD Serono Research & Development Institute, Inc.
2006 Phase 2 NCT00436826 Italy;Russian Federation;Spain;United States
Fundació Institut Germans Trias i Pujol
2017 Phase 1 NCT02903537 Spain
Sanofi
2011 Phase 3 NCT01252355 Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
Teva Pharmaceutical Industries
2012 Phase 2 NCT01404117 -
Interferon-beta 1A
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden
Merck Serono International SA
2007 - EUCTR2006-003037-32-LT Estonia;Germany;Italy;Lithuania;Spain
2007 Phase 3 EUCTR2006-003037-32-ES Estonia;Germany;Italy;Lithuania;Spain
2007 - EUCTR2006-003037-32-EE Estonia;Germany;Italy;Lithuania;Spain
Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
2009 - EUCTR2008-004954-34-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2010 - EUCTR2008-004954-34-AT Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 Phase 3 EUCTR2008-004954-34-SK Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 Phase 3 EUCTR2008-004954-34-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain
2009 - EUCTR2008-004954-34-PL Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 - EUCTR2008-004954-34-LV Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain
2009 - EUCTR2008-004954-34-FI Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 - EUCTR2008-004954-34-EE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 - EUCTR2008-004954-34-DE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 - EUCTR2008-004954-34-BG Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 Phase 3 EUCTR2008-004954-34-BE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2008 - EUCTR2008-004954-34-CZ Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
Merck Serono S.A.- Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2009 Phase 3 EUCTR2008-004954-34-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain
Merck Serono SA
2007 - EUCTR2006-003037-32-DE Estonia;Germany;Italy;Lithuania;Spain
Nancy Hammond, MD
2007 - NCT00490906 United States
S. Andrea Hospital
2002 Phase 2 NCT00151801 Italy
Interferon-beta 1A FBS-free/HSA free, RNF
Merck Serono International S.A.
2007 - EUCTR2006-002982-38-LT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2007 - EUCTR2006-002982-38-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-AT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA
2007 Phase 3 EUCTR2006-002982-38-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain
2007 - EUCTR2006-002982-38-EE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2007 - EUCTR2006-002982-38-PT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2007 - EUCTR2006-002982-38-DE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-FI Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-CZ Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
Merck Serono S.A.-Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 Phase 3 EUCTR2006-002982-38-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain
Serono International SA
2007 Phase 3 EUCTR2006-002982-38-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain
Interferon-beta 1A FBS-free/HSA-free, RNF
Merck Serono International SA
2007 Phase 3 EUCTR2006-005972-42-FR France;Germany
2007 - EUCTR2006-005972-42-DE France;Germany
Interferon-beta 1B
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden
Nancy Hammond, MD
2007 - NCT00490906 United States
Rutgers, The State University of New Jersey
2007 - NCT00468182 United States
Interferon-beta and human leukocyte interferon-A
Melinda Magyari
2010 Phase 2 NCT01171209 Denmark
Interferon-BETA-1A
Biogen Idec
2006 Phase 4 NCT00492765 Denmark
2003 Phase 4 NCT00493116 Australia;New Zealand
2003 Phase 4 NCT00492466 Finland
Merck, S.L.
2006 Phase 4 EUCTR2006-000606-23-ES Spain
Interferon-BETA-1A (avonex) plus methylprednisolone
Biogen Idec
2003 Phase 4 NCT00168766 Belgium;Denmark;Finland;Netherlands;Norway;Sweden;Switzerland;United Kingdom
Interferon-BETA-1A FBS-free/HSA free, RNF
Serono International SA
2005 - EUCTR2004-003799-13-SE Ireland;Lithuania;Spain;Sweden;United Kingdom
2005 - EUCTR2004-003799-13-LT Ireland;Lithuania;Spain;Sweden;United Kingdom
2005 Phase 3 EUCTR2004-003799-13-GB Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
2005 Phase 3 EUCTR2004-003799-13-ES Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
2005 Phase 3 EUCTR2004-003799-13-DK Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
- Phase 3 EUCTR2004-003799-13-IE Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
Interferon-BETA-1A FBS-free/HSA-free
EMD Serono
2005 Phase 3 NCT00110396 United States
Interferon-BETA-1B
Bayer
2020 - NCT04356339 United States
Interferon-BETA1
Biogen
2021 Phase 2 NCT04079088 -
Interferon-ß-1
Sanofi
2011 Phase 2 NCT01403376 Austria;Canada;Germany;Russian Federation;Ukraine
Interferon-ß-1A
Merck KGaA
2014 Phase 3 EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - NCT01074346 Korea, Republic of
Interferon-ß-1B
S. Andrea Hospital
2005 Phase 2/Phase 3 NCT00270816 Italy
Interferone
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
Interferone beta 1A
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
Interferone beta 1B
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Interferone BETA-1A
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
Interferone BETA-1B
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
IMPULS Endowment Fund
2019 - NCT05762003 Czechia
InterferóN beta 1A pegilado
Biogen Idec Limited
2011 - EUCTR2010-024477-39-ES Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
InterferóN BETA-1A pegilado
Biogen Idec Limited
2009 Phase 3 EUCTR2008-006333-27-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom
Interleukin-2
Indapta Therapeutics, INC.
2026 Phase 1 NCT06677710 United States
Intradetrusor injection OF botulinum toxin-A
Rose Khavari, M.D.
2014 - NCT03033355 United States
Intranasal foralumab solution
Tiziana Life Sciences, PLC
2021 Phase 1 NCT05029609 -
Intratect
Guy's and St Thomas NHS Foundation Trust
2014 Phase 3 EUCTR2014-002335-34-GB United Kingdom
Intrathecal administration OF autologous MSC-NP
Tisch Multiple Sclerosis Research Center of New York
2014 Phase 1 NCT01933802 United States
Intrathecal methotrexate
Tel-Aviv Sourasky Medical Center
2016 Phase 0 NCT02644044 -
Intrathecal MSC-NP injection
Tisch Multiple Sclerosis Research Center of New York
2019 - NCT03822858 United States
2018 Phase 2 NCT03355365 United States
Intrathecal saline injection
Tisch Multiple Sclerosis Research Center of New York
2018 Phase 2 NCT03355365 United States
Intravenous (IV) infusions
Polpharma Biologics S.A.
2019 Phase 3 NCT04115488 Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine
Intravenous glucocorticoids
Guangzhou JOYO Pharma Co., Ltd
2023 Phase 2 NCT06697535 China
Intravenous immunoglobulin
Guy's and St Thomas' NHS Foundation Trust
2015 Phase 3 NCT02398994 United Kingdom
Intravenous injection OF mesenchymal stem cells
Royan Institute
2011 Phase 1/Phase 2 NCT01377870 Iran, Islamic Republic of
Intravenous methylprednisolone
Guy's and St Thomas' NHS Foundation Trust
2015 Phase 3 NCT02398994 United Kingdom
The Third Affiliated Hospital Sun Yat-sen University
2025 - ChiCTR2500100495 China
Third Affiliated Hospital, Sun Yat-Sen University
2025 - NCT06763848 China
Intravenous methylprednisolone (ivmp) and efgartigimod
Feng Jinzhou
2023 - NCT06118398 -
Intravenous steroid
Beijing Tiantan Hospital
2021 - NCT05154370 China
2019 - NCT04106830 China
IPX056
Impax Laboratories, LLC
2009 Phase 2 NCT00914290 United States
IPX056 10 MG
Impax Laboratories, LLC
2007 Phase 3 NCT00488839 Canada;Estonia;Latvia;Ukraine;United States
IPX056 20 MG
Impax Laboratories, LLC
2007 Phase 3 NCT00488839 Canada;Estonia;Latvia;Ukraine;United States
IPX056 30 MG
Impax Laboratories, LLC
2007 Phase 3 NCT00488839 Canada;Estonia;Latvia;Ukraine;United States
IPX056 35 MG
Impax Laboratories, LLC
2007 Phase 3 NCT00488839 Canada;Estonia;Latvia;Ukraine;United States
IPX056 40 MG
Impax Laboratories, LLC
2007 Phase 3 NCT00488839 Canada;Estonia;Latvia;Ukraine;United States
IPX056-10 MG
IMPAX Laboratories, Inc.
2007 - EUCTR2007-000236-16-LV Estonia;Latvia
2007 - EUCTR2007-000236-16-EE Estonia;Latvia
IPX056-20 MG
IMPAX Laboratories, Inc.
2007 - EUCTR2007-000236-16-LV Estonia;Latvia
2007 - EUCTR2007-000236-16-EE Estonia;Latvia
IPX056-25 MG
IMPAX Laboratories, Inc.
2007 - EUCTR2007-000236-16-LV Estonia;Latvia
IPX056-30 MG
IMPAX Laboratories, Inc.
2007 - EUCTR2007-000236-16-LV Estonia;Latvia
2007 - EUCTR2007-000236-16-EE Estonia;Latvia
IPX056-35 MG
IMPAX Laboratories, Inc.
2007 - EUCTR2007-000236-16-LV Estonia;Latvia
2007 - EUCTR2007-000236-16-EE Estonia;Latvia
IPX056-40 MG
IMPAX Laboratories, Inc.
2007 - EUCTR2007-000236-16-LV Estonia;Latvia
2007 - EUCTR2007-000236-16-EE Estonia;Latvia
IR902
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia
Irradiation
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States
Isentress
Queen Mary University of London
2013 - EUCTR2012-004847-61-GB United Kingdom
Isoxsuprine hydrochloride
University of New Mexico
2019 Phase 1/Phase 2 NCT03752307 United States
IV methylprednisolone
Biogen Idec
2003 Phase 4 NCT00112034 United States
Fred Lublin
2003 Phase 3 NCT00418145 United States
University of Colorado, Denver
2013 Phase 4 NCT01838174 United States
IV methylprednisolone administration
Universidad Nacional Autonoma de Mexico
2023 Phase 2 NCT06223074 Mexico
Ivig
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States
2017 Phase 3 NCT03342638 United States
Ivmp
The Third Affiliated Hospital Sun Yat-sen University
2025 - ChiCTR2500100495 China
Tianjin Medical University General Hospital
2024 Phase 2 NCT06673394 -
Ixazomib (ninlaro®) capsules
Queen Mary University of London
2020 Phase 1 NCT03783416 United Kingdom
JM-4
Cook, Stuart, MD
2019 Early Phase 1 NCT03887065 -
JNJ-67896153/ACT-128800
JANSSEN CILAG INTERNATIONAL NV
2023 Phase 3 EUCTR2020-004431-24-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
Janssen-Cilag International NV
2023 Phase 3 EUCTR2020-004431-24-PT Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2023 Phase 3 EUCTR2020-004431-24-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
2023 Phase 3 EUCTR2020-004431-24-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
2023 Phase 3 EUCTR2020-004431-24-DE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2023 Phase 3 EUCTR2020-004431-24-BG Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2022 Phase 3 EUCTR2020-004431-24-SE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
- Phase 3 EUCTR2020-004431-24-Outside-EU/EEA Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
- Phase 3 EUCTR2020-004431-24-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
JYP0061
Guangzhou JOYO Pharma Co., Ltd
2023 Phase 2 NCT06697535 China
Kemstro
UCB Pharma
2005 Phase 3 NCT00139789 United States
Kepivance
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom
Keppra
AZIENDA SANITARIA N. 3 GENOVESE
2007 - EUCTR2007-005414-40-IT Italy
Søren H. Sindrup, Department of Neurology, Odense University Hospital
2006 - EUCTR2006-000397-71-DK Denmark
Keppra 250MG
Newcastle-upon-Tyne Hospitals NHS Trust
2006 Phase 4 EUCTR2005-003903-35-GB United Kingdom
Keppra 500MG
Newcastle-upon-Tyne Hospitals NHS Trust
2006 Phase 4 EUCTR2005-003903-35-GB United Kingdom
Kesimpta
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;Italy
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;United Kingdom
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-SI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-NO Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-NO Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-RO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
Kesimpta 20 MG injektionslösung IM fertigpen
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany
Kesimpta 20 MG solution FOR injection IN PRE-filled PEN
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Ketamine
Alta Bates Summit Medical Center
2023 Early Phase 1 NCT06064162 United States
Johns Hopkins University
2023 Phase 2 NCT05378100 United States
2018 Phase 1/Phase 2 NCT03500289 United States
Ketoconazole
GlaxoSmithKline
2013 Phase 1 NCT01802931 Australia
Ketogenic diet
IRCCS National Neurological Institute C. Mondino Foundation
2024 - NCT06715436 Italy
Ketoprofen
National Institute of Mental Health (NIMH)
2022 Phase 2 NCT05062083 United States
Keyhole limpet hemocyanin
Biogen
2008 Phase 4 NCT00536120 United States
Keyhole limpet hemocyanin (KLH) NEO-antigen
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
Kirunal fish OIL
Terry L. Wahls
2022 - NCT05007483 United States
KLH
Biogen
2008 Phase 4 NCT00536120 United States
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States
KYV-101
Kyverna Therapeutics
2024 Phase 2 NCT06384976 United States
KYV-101 (biological) - 0.33 ×10^8 cells
Bruce Cree
2024 Phase 1 NCT06451159 United States
KYV-101 (biological) - 1 ×10^8 cells
Bruce Cree
2024 Phase 1 NCT06451159 United States
KYV-101 ANTI-CD19 CAR-T cell therapy
Stanford University
2024 Phase 1 NCT06138132 United States
L acetyl carnitine
University of Iowa
2010 Phase 1 NCT01381354 United States
L-000124467
Merck & Co., Inc./Suomen MSD Oy
2004 Phase 2 EUCTR2004-000073-64-FI Finland
L-carnitine
CHU de Bordeaux
2010 Phase 3 EUCTR2009-015934-30-FR France
University Hospital, Bordeaux
2010 Phase 3 NCT01149525 France
L-histidine
University of Miami
2022 Phase 2 NCT04764383 United States
2018 Phase 1 NCT03266965 United States
L01bb04
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
L03 AB
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
L03 AB 08
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Schering AG
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
L03 AB07
Merck Serono SA – Geneva
2010 - EUCTR2009-015502-19-GB Belgium;Finland;Germany;Sweden;United Kingdom
L03ab13
BIOGEN IDEC ITALIA S.R.L.
2015 Phase 4 EUCTR2015-002201-11-IT Italy
L04aa04 - immunoglobulina antitimocitaria (DI coniglio) immunoglobulina DI coniglio antitimociti umani thymoglobuline
Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
2006 - EUCTR2006-002562-19-IT Italy
L04aa31
NOVARTIS PHARMA AG
2022 Phase 3 EUCTR2020-005929-89-IT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Japan;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-IT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Guatemala;Hong Kong;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
Turku University Hospital
2017 Phase 4 EUCTR2016-003622-16-FI Finland
Laboratory biomarker analysis
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
Lactose monohydrate
Queen Mary University of London
2013 - EUCTR2012-004847-61-GB United Kingdom
Lactulose
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2021 - JPRN-UMIN000043910 Japan
Lamotrigine
Cantonal Hospital of St. Gallen
2009 Phase 2 NCT00917839 Switzerland
University College London Hospitals
2005 Phase 2 NCT00257855 United Kingdom
Lamotrigine extended release tablets
University College London
2005 Phase 2 EUCTR2005-001949-42-GB United Kingdom
Laquinimod
TEVA
2005 - EUCTR2004-003943-28-IT Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
TEVA ITALIA srl
2008 - EUCTR2007-005450-23-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2007 - EUCTR2007-003226-19-IT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.
2015 Phase 2 NCT02284568 Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
2014 Phase 3 NCT01975298 Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 NCT01707992 Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2010 Phase 3 NCT01047319 Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, The Former Yugoslav Republic of;North Macedonia;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2009 Phase 3 NCT00988052 Austria;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 NCT00605215 Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Israel;Italy;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Montenegro;North Macedonia;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
Teva Pharmaceutical Industries
2007 Phase 3 NCT00509145 Austria;Bulgaria;Canada;Czech Republic;Estonia;Former Serbia and Montenegro;France;Georgia;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Teva Pharmaceutical Industries Ldt
2005 Phase 2 EUCTR2005-004334-41-IT Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
Teva Pharmaceutical Industries Ltd
2010 Phase 3 EUCTR2009-015815-42-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain
2009 Phase 3 EUCTR2009-012989-30-IT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Teva Pharmaceutical Industries Ltd.
2015 Phase 2 EUCTR2014-001579-30-NL Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
2015 Phase 2 EUCTR2014-001579-30-DE Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
2014 Phase 2 EUCTR2014-001579-30-IT Canada;Germany;Italy;Netherlands;Russian Federation;Spain;Ukraine;United Kingdom;United States
2014 Phase 2 EUCTR2014-001579-30-GB Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
2014 Phase 2 EUCTR2014-001579-30-ES Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
Teva Pharmaceutical Industries, Ltd.
2005 Phase 2 NCT00745615 Czech Republic;Czechia;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom
Laquinimod 0.3
Teva Pharmaceutical Industries
2005 Phase 2 NCT00349193 Italy
Laquinimod 0.6
Teva Pharmaceutical Industries
2012 Phase 2 NCT01404117 -
2005 Phase 2 NCT00349193 Italy
Laquinimod 1.2
Teva Pharmaceutical Industries
2012 Phase 2 NCT01404117 -
Laquinimod capsulas 0.6 MG
Teva Pharmaceutical Industries Ltd
2009 Phase 3 EUCTR2009-012989-30-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Laquinimod capsules 0.3 MG
Teva Pharmaceutical Industries Ltd
2009 - EUCTR2009-011234-99-DE Germany
Laquinimod capsules 0.6 MG
TEVA PHARMACEUTICALS INDUSTRIES LTD
2013 Phase 3 EUCTR2012-003647-30-IT Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Puerto Rico;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
Teva Pharmaceutical Industries Ltd
2013 Phase 3 EUCTR2012-003647-30-PL Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-HU Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-ES Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-EE Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-CZ Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-BE Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-AT Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2012-003647-30-SK Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2012-003647-30-LV Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2012-003647-30-GR Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2012-003647-30-GB Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-015815-42-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain
2010 Phase 3 EUCTR2009-015815-42-PL Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-LT Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-EE Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-CZ Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-BG Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-012989-30-SE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012989-30-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012989-30-BG Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012989-30-AT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-NL Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-LT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-HU Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-GB Austria;Bulgaria;Canada;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-EE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 - EUCTR2009-011234-99-DE Germany
2008 Phase 3 EUCTR2007-005450-23-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Slovakia;Spain
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-DE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-CZ Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-BG Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-003226-19-PT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2007-003226-19-LT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2007-003226-19-BG Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-SE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-NL Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-LV Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-HU Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-GB Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 Phase 3 EUCTR2007-003226-19-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 Phase 3 EUCTR2007-003226-19-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-EE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-DE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-AT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-GB Czech Republic;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-DE Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-CZ Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
2005 Phase 2 EUCTR2005-004334-41-HU Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
Teva Pharmaceutical Industries, Ltd.
2014 - EUCTR2013-002082-19-NL Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2014 - EUCTR2013-002082-19-ES Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-SE Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 EUCTR2013-002082-19-GB Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-FI Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-DK Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 EUCTR2013-002082-19-BE Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
Laquinimod tablets 0.3 MG
Teva Pharmaceutical Industries Ltd
2006 Phase 2 EUCTR2005-004334-41-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 - EUCTR2004-003943-28-HU Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 Phase 2 EUCTR2004-003943-28-GB Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 Phase 2 EUCTR2004-003943-28-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 - EUCTR2004-003943-28-DE Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 - EUCTR2004-003943-28-CZ Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
Lavender OIL
Ataturk University
2023 - NCT05929638 Turkey
LCAR-AIO T cells
Wuhan Union Hospital, China
2025 Phase 1 NCT06869278 China
Learning
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
2021 - ChiCTR2100052936 China
University of Iowa
2010 Phase 1 NCT01381354 United States
Lemtrada
GENZYME CORPORATION
2017 Phase 3 EUCTR2016-003100-30-IT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
Genzyme Corporation
2017 Phase 3 EUCTR2016-003100-30-PT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-NO Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-NL Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-GR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-GB Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-ES Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-DE Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-BE Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-AT Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 3;Phase 4 EUCTR2013-003884-71-NL Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3;Phase 4 EUCTR2013-003884-71-DK Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3;Phase 4 EUCTR2013-003884-71-BE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 4 EUCTR2014-000092-62-NL Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-FR Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-ES Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-BE Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 3;Phase 4 EUCTR2013-003884-71-IT Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3;Phase 4 EUCTR2013-003884-71-HR Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2014 Phase 3;Phase 4 EUCTR2013-003884-71-ES Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3;Phase 4 EUCTR2013-003884-71-DE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2014 Phase 3;Phase 4 EUCTR2013-003884-71-CZ Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2016-003100-30-PL Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-Outside-EU/EEA Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-FR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-BG Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
Genzyme GmbH
2016 Phase 3 EUCTR2016-000464-42-DE Germany
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-SE Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University Hospital Muenster
2017 - NCT04082260 Germany
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany
Lemtrada 12 MG konzentrat ZUR herstellung einer infusionslösung
Universitätsklinikum Münster
2014 Phase 4 EUCTR2014-000709-10-DE Germany
Lenograstim
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom
Levetiracetam
AZIENDA SANITARIA N. 3 GENOVESE
2007 - EUCTR2007-005414-40-IT Italy
Newcastle-upon-Tyne Hospitals NHS Trust
2006 Phase 4 EUCTR2005-003903-35-GB United Kingdom
Odense University Hospital
2007 Phase 4 NCT00423527 Denmark
Organisation name was not entered
2005 - EUCTR2005-001776-13-DE Germany
Søren H. Sindrup, Department of Neurology, Odense University Hospital
2006 - EUCTR2006-000397-71-DK Denmark
Levitra
Unidad de Neuroinmunología
2005 Phase 4 EUCTR2004-003761-33-ES Spain
Levocarnil
CHU de Bordeaux
2010 Phase 3 EUCTR2009-015934-30-FR France
Levofolene 4 MG 30 CPR
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy
Levonorgestrel
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands
LFB-R603
TG Therapeutics
2017 Phase 3 EUCTR2017-000639-15-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000639-15-GB Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000639-15-ES Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-GB Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-ES Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
TG Therapeutics, Inc.
2017 Phase 3 EUCTR2017-000639-15-PL Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-PL Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
LFB-R603, TGTX1101
TG Therapeutics, Inc.
2020 Phase 3 EUCTR2019-003625-16-PL Belarus;Croatia;Georgia;Poland;Russian Federation;Serbia;Ukraine;United States
2020 Phase 3 EUCTR2019-003625-16-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
Liberation therapy
Genesis Limited
2015 Phase 1/Phase 2 NCT02418351 India;Trinidad and Tobago
2015 Phase 1/Phase 2 NCT02418325 Trinidad and Tobago
Novo Cellular Medicine Institute LLP
2015 Phase 1/Phase 2 NCT02587806 India;Trinidad and Tobago
2015 Phase 1/Phase 2 NCT02587715 Trinidad and Tobago
Lidocaine
University of Rochester
2007 Phase 4 NCT00414453 United States
Linoleic acid
Universität Münster
2023 - NCT05920018 Germany
Linoleic acid/oleic acid
University of Rochester
2008 Phase 1 NCT00638196 United States
Liofen XL
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States
Liothyronine
Johns Hopkins University
2015 Phase 1 NCT02506751 United States
Liothyronine sodium
Oregon Health and Science University
2016 Phase 1 NCT02760056 United States
Lipoic acid
Portland VA Medical Center
2010 Phase 1 NCT00997438 United States
VA Office of Research and Development
2018 Phase 2 NCT03161028 Canada;United States
2010 Phase 2/Phase 3 NCT01188811 United States
Lipoic acid (LA) with fish OIL and LA without fish OIL
Oregon Health and Science University
2005 Phase 1 NCT00676156 United States
Lipoic acid and omega-3 fatty acids
Oregon Health and Science University
2014 Phase 1/Phase 2 NCT02133664 United States
Liraglutide
University of Chicago
2024 Early Phase 1 NCT06171152 United States
Lisdexamfetamine sulfate
State University of New York at Buffalo
2009 Phase 2 NCT01615887 United States
Listed FOR each disorder below, UP TO three drugs PER disorder (TOO many characters TO list IN this field
NorthShore University HealthSystem
2016 Phase 4 NCT02670161 United States
Lithium carbonate
VA Office of Research and Development
2011 Phase 1/Phase 2 NCT01259388 United States
Live hookworm larvae
University of Nottingham
2008 Phase 2 NCT00630383 United Kingdom
Live necator americanus larvae
University of Nottingham
2011 Phase 2 EUCTR2008-005008-24-GB United Kingdom
Lodosyn
University of Miami
2022 Phase 2 NCT04764383 United States
Lokomat training
IRCCS Centro Neurolesi Bonino-Pulejo
2016 - NCT03186664 Italy
Loperamide
Rocky Mountain MS Research Group, LLC
2014 Phase 4 NCT02217982 United States
Loratadine
Genzyme, a Sanofi Company
2015 Phase 1 NCT02583594 Spain
LOU064
Iwasaki Ryohei
2023 Phase 3 JPRN-jRCT2071220034 France;Italy;Japan;Poland;Portugal;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;US
Novartis Farmacéutica S.A.
2022 Phase 3 EUCTR2020-005929-89-ES Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-ES Slovakia;Spain
Novartis Pharma AG
2023 Phase 3 EUCTR2020-005899-36-LT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2023 Phase 3 EUCTR2020-005899-36-DK Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2023 Phase 3 EUCTR2020-005899-36-AT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;Finland;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SK Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SI Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-RO Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Türkiye;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-PT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-PL Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Türkiye;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-HR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-GR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-FR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-EE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-BG Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-SK Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-NL Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-LV Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-HR Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-BG Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-BE Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
LOU064c1
NOVARTIS PHARMA AG
2022 Phase 3 EUCTR2020-005929-89-IT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Japan;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-IT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Guatemala;Hong Kong;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
LOW dose ARM receiving neutral OIL and 400 IU/G OF vitamin D every second DAY
Charite University, Berlin, Germany
2011 Phase 2 NCT01440062 Germany
LOW dose cannabis
University of California, Davis
2009 Phase 1/Phase 2 NCT01037088 United States
LOW dose myobloc
Supernus Pharmaceuticals, Inc.
2021 Phase 2/Phase 3 NCT04815967 Czechia;United States
LOW immunogenic interferon-BETA-1A
Biogen Idec
2004 Phase 4 NCT00493077 Sweden
LP-168 tablet
Guangzhou Lupeng Pharmaceutical Company LTD.
2022 Phase 1 NCT05432713 China
LPX-TI641
LAPIX Therapeutics Inc.
2023 Phase 1 NCT05853835 Jordan;United States
LU AG06466
H. Lundbeck A/S
2021 Phase 1 NCT04990219 Germany;United States
Lubiprostone
University of Rochester
2010 Phase 4 NCT01236534 United States
Lumbar puncture
Centre Hospitalier Universitaire de Nimes
2013 Phase 3 NCT01817166 France;Martinique
Genentech, Inc.
2016 Phase 3 NCT02688985 Canada;Germany;Sweden;United States
Lutein
University of Illinois at Urbana-Champaign
2021 - NCT04843813 United States
Lutenyl
OSPEDALI CIVILI DI LIONE
2007 - EUCTR2006-005460-30-IT Italy
LY2127399
Eli Lilly and Company
2010 - EUCTR2008-007459-28-BG Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 Phase 2 NCT00882999 Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Switzerland;Ukraine;United States
2009 - EUCTR2008-007459-28-HU Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 Phase 2 EUCTR2008-007459-28-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-DK Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-DE Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-CZ Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-BE Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
LY248686
Eli Lilly and Company
2008 - EUCTR2008-002560-34-BE Belgium
LY3541860
Eli Lilly and Company
2024 Phase 2 NCT06220669 France;Germany;Israel;Italy;Latvia;Lithuania;Poland;Slovakia;United Kingdom;United States
M2951
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
Merck Healthcare KGaA
2022 Phase 3 EUCTR2019-004980-36-CZ Belarus;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-SI Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-RO Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-SK Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PL Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-NO Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LV Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-GR Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-ES Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-DE Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-BG Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
Merck KGaA
2017 Phase 2 EUCTR2016-001448-21-SK Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-PL Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-ES Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-CZ Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-BG Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
MAB therapy
Tongji Hospital
2025 - NCT06885957 China
Mabcampath
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom
Genzyme Corporation
2011 Phase 3 EUCTR2009-010788-18-IT Austria;Belgium;Czech Republic;Denmark;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-010788-18-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-010788-18-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-010788-18-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-010788-18-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-010788-18-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-NL Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-IT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-001162-32-CZ Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-AT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001161-14-SE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 - EUCTR2007-001161-14-PL Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 Phase 3 EUCTR2007-001161-14-FR Czech Republic;France;Germany;Poland;Sweden;United Kingdom
2008 - EUCTR2007-001161-14-DE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 - EUCTR2007-001161-14-CZ Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2007 Phase 3 EUCTR2007-001162-32-GB Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2007 - EUCTR2007-001161-14-GB Czech Republic;France;Germany;Poland;Sweden;United Kingdom
R&D Addenbrookes Hospital
2008 Phase 2 EUCTR2005-002305-23-GB United Kingdom
Mabcampath 10 MG/ML concentrado para solucióN para perfusióN
Genzyme Corporation
2010 Phase 3 EUCTR2009-010788-18-ES Austria;Belgium;Czech Republic;Denmark;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
Mabcampath-1H
University of British Columbia
2011 Phase 3 NCT01307332 Canada
Mabthera
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
Centre Hospitalier de Pau
2015 Phase 2 EUCTR2014-005493-11-FR France
Department of Clinical Sciences, Danderyd Hospital
2015 Phase 3 EUCTR2015-004116-38-SE Sweden
Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital
2018 Phase 2 EUCTR2018-000721-31-SE Sweden
Dept of Neurology
2009 Phase 2 EUCTR2008-002626-11-SE Sweden
Dept of Neurology, Umeå University Hospital, Umeå, Sweden
2012 Phase 2 EUCTR2012-000721-53-SE Sweden
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Odense University Hospital
2013 Phase 2 EUCTR2012-004436-36-DK Denmark
Västerbottens Läns Landsting
2014 Phase 2 EUCTR2013-002378-26-SE Sweden
Västerbottens läns landsting
2011 - EUCTR2010-023021-38-SE Sweden
Mabthera or biosimilar rituximab product
Medical University of Vienna - Department of Neurology
2018 Phase 2 EUCTR2017-000426-35-AT Austria
Magnesium
University of Iowa
2010 Phase 1 NCT01381354 United States
Magnetic resonance imaging
Sanofi
2019 Phase 2 NCT03889639 Canada;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
University of Nottingham
2017 - NCT02481882 United Kingdom
Maltodextrin
Medical University of Vienna
2012 Phase 2 NCT01879202 Austria
Maltodextrin fiber supplement
University of Iowa
2010 Phase 1 NCT01381354 United States
Mangafodipir
National Institute of Neurological Disorders and Stroke (NINDS)
2013 Phase 1 NCT01326715 United States
Mannitol
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2021 - JPRN-UMIN000043910 Japan
Mantadan*20CPR 100MG
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
2011 - EUCTR2010-023678-38-IT Italy
Masitinb mesylate
AB Science
2015 Phase 3 EUCTR2012-003735-32-GR Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom
2013 - EUCTR2010-021219-17-PL Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain
2013 Phase 3 EUCTR2010-021219-17-GR Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey
2011 Phase 3 EUCTR2010-021219-17-DE Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
Masitinib
AB Science
2022 Phase 3 NCT05441488 France;Greece;Italy;Poland;Russian Federation;Spain;Sweden;Ukraine
2011 Phase 3 NCT01433497 Bulgaria;France;Germany;Greece;Poland;Romania;Spain;United States
2005 Phase 2 NCT01450488 -
Masitinib 100 MG
AB SCIENCE
2022 Phase 3 EUCTR2021-000639-30-IT Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Masitinib 200 MG
AB SCIENCE
2022 Phase 3 EUCTR2021-000639-30-IT Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Masitinib mesilate
AB Science
2022 Phase 3 EUCTR2021-000639-30-NO Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000639-30-GR Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000639-30-ES Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000639-30-DE Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000639-30-BG Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-000639-30-FR Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Masitinib mesilato
AB SCIENCE
2022 Phase 3 EUCTR2021-000639-30-IT Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Masitinib mesylate
AB Science
2015 Phase 3 EUCTR2012-003735-32-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Colombia;Germany;Greece;Italy;Mexico;Slovakia;Spain;Switzerland;United Kingdom
2015 Phase 3 EUCTR2012-003735-32-GR Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom
2015 Phase 3 EUCTR2010-021219-17-BG Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
2013 - EUCTR2010-021219-17-PL Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain
2013 Phase 3 EUCTR2010-021219-17-GR Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey
2012 Phase 3 EUCTR2010-021219-17-SK Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-021219-17-ES Bulgaria;Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;United States
2011 Phase 3 EUCTR2010-021219-17-DE Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
Mastinib
AB Science
2015 Phase 3 EUCTR2012-003735-32-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Colombia;Germany;Greece;Italy;Mexico;Slovakia;Spain;Switzerland;United Kingdom
2015 Phase 3 EUCTR2012-003735-32-GR Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom
2013 - EUCTR2010-021219-17-PL Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain
2013 Phase 3 EUCTR2010-021219-17-GR Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey
2012 Phase 3 EUCTR2010-021219-17-SK Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-021219-17-DE Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
Mavenclad
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-SE Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
MERCK KGAA
2019 Phase 4 EUCTR2019-000069-19-IT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2018 Phase 4 EUCTR2017-002632-17-IT Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Ireland;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-IT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
Merck Healthcare KGaA
2021 Phase 4 EUCTR2020-003995-42-PL Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-HU Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-CZ Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-AT Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003874-30-SK Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-HU Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-FR Austria;Czech Republic;Denmark;France;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-DK Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-CZ Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2020 Phase 4 EUCTR2020-003995-42-FI Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2020 Phase 4 EUCTR2020-003995-42-DE Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2020 Phase 4 EUCTR2020-003874-30-AT Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2023 - NCT05797740 Belgium;Czechia;Greece;Netherlands;Poland;Portugal
2021 Phase 4 NCT04783935 Australia;Austria;Canada;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom
2021 Phase 4 NCT04776213 Austria;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain
Merck KGaA
2020 Phase 4 EUCTR2019-000069-19-RO Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-SE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-PT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-PL Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-LT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-HR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-ES Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-EE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-CZ Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-BG Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-BE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2018 Phase 4 EUCTR2017-002632-17-SK Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-SE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-PT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-NO Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-NL Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-LT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-HU Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Ireland;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-GR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-GB Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-FR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-FI Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-ES Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-DK Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-CZ Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-BE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-AT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-FR Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-CZ Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-AT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
Merck KGaA, Darmstadt, Germany
2018 Phase 4 NCT03369665 Austria;Belgium;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
Merck, S.L.
2019 Phase 4 EUCTR2019-000069-19-AT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
Queen Mary University of London
2021 Phase 2/Phase 3 NCT04695080 United Kingdom
2020 Phase 2 EUCTR2018-005038-39-GB United Kingdom
Turku PET centre
2019 Phase 4 EUCTR2019-001960-31-FI Finland
Mavenclad - 10 MG - compressa - USO orale - blister (AL/AL) - 6 compresse
MERCK KGAA
2021 Phase 4 EUCTR2020-003995-42-IT Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003874-30-IT Austria;Czech Republic;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain
Mavenclad 10 MG tablets
Westfälische Wilhelms-Universität Münster c/o Universitätsklinikum Münster, Geschäftsbereich Recht u. Drittmittel
2019 Phase 4 EUCTR2018-004557-24-DE Germany
Mavenclad 10MG TBL NOB
Fakultní nemocnice Ostrava
2021 Phase 4 EUCTR2021-003195-13-CZ Czech Republic
Mavenclad 6CPR 10 MG
Azienda Ospedaliera Universitaria Integrata Verona
2019 Phase 4 EUCTR2018-004947-21-IT Italy
Mavenclad 6CPR 10MG
Azienda Ospedaliera Universitaria Integrata Verona
2019 Phase 4 EUCTR2018-004947-21-IT Italy
Mavenclad tabletter 10 MG
Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital
2019 Phase 3 EUCTR2019-001505-24-NO Norway
Mayzent
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-RO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
Novartis Pharmaceuticals
2020 - NCT04593927 Japan
State University of New York at Buffalo
2021 Phase 2/Phase 3 NCT04925557 United States
Mayzent 0,25 MG compresse rivestite CON film
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2023 Phase 4 EUCTR2023-000142-42-IT Italy
Mayzent 0,25 MG filmtabletten
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Mayzent 0.25 MG FI
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Mayzent 2 MG compresse rivestite CON film
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2023 Phase 4 EUCTR2023-000142-42-IT Italy
Mayzent 2 MG FILM-coated tablets
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Mayzent 2 MG filmtabletten
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
MBP peptide
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland
MBP8298
BioMS Technology Corp.
2007 Phase 3 NCT00468611 United States
MBP8298 synthetic peptide
BioMS Technology Corp
2007 - EUCTR2004-002571-16-GB Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-NL Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-LV Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-LT Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-FI Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 Phase 2;Phase 3 EUCTR2004-002571-16-ES Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-EE Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-DK Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2005 - EUCTR2004-002571-16-SE Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
BioMS Technology Corp.
2006 Phase 2 EUCTR2006-001947-70-SK Slovakia
MD1003
MEDDAY PHARMACEUTICALS
2017 Phase 3 EUCTR2016-000700-29-IT Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
MEDDAY PHARMACEUTICALS SA
2018 Phase 3 EUCTR2016-000700-29-PL Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2016-000700-29-HU Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2016-000700-29-BE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-000700-29-SE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-000700-29-ES Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Poland;Spain;Sweden;United Kingdom;United States
2017 Phase 3 EUCTR2016-000700-29-DE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-000700-29-CZ Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
MEDDAY Pharmaceuticals SA
2014 Phase 3 EUCTR2013-002112-27-GB France;United Kingdom
MEDDAY SAS
- Phase 3 EUCTR2013-002113-35-FR France
- Phase 3 EUCTR2013-002112-27-FR France;United Kingdom
MD1003 100MG capsule
MedDay Pharmaceuticals SA
2016 Phase 3 NCT02936037 Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2013 Phase 3 NCT02220933 France
2013 Phase 3 NCT02220244 France;United Kingdom
MEDI-551
Horizon Therapeutics Ireland DAC
2022 Phase 2 EUCTR2021-003528-33-SE Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
2022 Phase 2 EUCTR2021-003528-33-PL Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
2022 Phase 2 EUCTR2021-003528-33-FR Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
- Phase 2 EUCTR2021-003528-33-NL Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
MedImmune LLC
2018 Phase 2;Phase 3 EUCTR2014-000253-36-NL Australia;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;India;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2017 Phase 2;Phase 3 EUCTR2014-000253-36-HU Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2017 Phase 2;Phase 3 EUCTR2014-000253-36-GR Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2015 Phase 2;Phase 3 EUCTR2014-000253-36-ES Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2015 Phase 2;Phase 3 EUCTR2014-000253-36-DE Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2015 Phase 2;Phase 3 EUCTR2014-000253-36-BG Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2014 Phase 2;Phase 3 EUCTR2014-000253-36-PL Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2014 Phase 2;Phase 3 EUCTR2014-000253-36-EE Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2014 Phase 2;Phase 3 EUCTR2014-000253-36-CZ Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2012 - EUCTR2011-005475-16-GB Austria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
Sato Toshiyuki
2020 Phase 3 JPRN-jRCT2051210017 -
MEDI-551 100 MG-IV
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States
MEDI-551 30 MG-IV
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States
MEDI-551 300 MG-SC
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States
MEDI-551 60 MG-SC
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States
MEDI-551 600 MG-IV
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States
Medical marijuana
Colorado State University
2017 Phase 2/Phase 3 NCT03172741 -
2016 - NCT02898974 United States
Medication diary
University of Chicago
2024 Early Phase 1 NCT06171152 United States
Meditation
University of Iowa
2010 Phase 1 NCT01381354 United States
Mediterranean diet
IRCCS National Neurological Institute C. Mondino Foundation
2024 - NCT06715436 Italy
Medrol
Scleroseklinikken, Rigshospitalet
2011 - EUCTR2010-024561-43-DK Denmark
Megadose oral methylprednisolone
Fred Lublin
2003 Phase 3 NCT00418145 United States
Melatonin
Isfahan University of Medical Sciences
2012 Phase 2 NCT01718678 Iran, Islamic Republic of
North Bristol NHS Trust
2013 Phase 2 EUCTR2012-004183-21-GB United Kingdom
Tehran University of Medical Sciences
2012 - NCT02463318 Iran, Islamic Republic of
2010 Phase 2 NCT01279876 Iran, Islamic Republic of
University of California, San Francisco
2019 - NCT04035889 United States
Melphalan
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States
Memantine
AZ. OSPEDALIERA GARIBALDI, S.LUIGI CURRO , ASCOLI TOMASELLI
2007 - EUCTR2007-000503-15-IT Italy
Clinica Universidad de Navarra, Universidad de Navarra
2007 Phase 2 NCT00638833 Spain
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France
Hospices Civils de Lyon
2012 Phase 2 NCT01744444 France
OSPEDALE S. RAFFAELE
2008 Phase 2 EUCTR2008-000490-37-IT Italy
Oregon Health and Science University
2004 Phase 2/Phase 3 NCT00300716 United States
University Hospital, Caen
2005 Phase 3 NCT01074619 France
University of Rochester
2006 Phase 4 NCT00638027 United States
Menitorix
R & D, Cambridge University Hospitals
2009 - EUCTR2009-011523-31-GB United Kingdom
Menveo
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Mesenchymal stem cells
Dimitrios Karussis
2015 Phase 2 NCT02166021 Israel
Hadassah Medical Organization
2013 Phase 1/Phase 2 NCT04823000 -
Haukeland University Hospital
2021 Phase 2 EUCTR2020-002373-95-NO Norway
Imperial College London
2013 Phase 1/Phase 2 NCT01606215 United Kingdom
Ottawa Hospital Research Institute
2015 Phase 2 NCT02239393 Canada
Prof. Per Soelberg Sørensen
2012 Phase 2 EUCTR2012-000518-13-DK Denmark
University Hospital, Toulouse
2015 Phase 1/Phase 2 NCT02403947 France
Mesenchymal stem/stromal cells
Prof. Per Soelberg Sørensen
2012 Phase 2 EUCTR2012-000518-13-DK Denmark
Mesna
Baylor College of Medicine
1999 Phase 2 NCT00040482 United States
Indapta Therapeutics, INC.
2026 Phase 1 NCT06677710 United States
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States
2017 Phase 3 NCT03342638 United States
Metabolic fatigue
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France
Metex
Universitätsklinikum Heidelberg
2006 Phase 3 EUCTR2004-004403-37-DE Germany
Metformin
German University in Cairo
2022 Phase 2 NCT06812585 Egypt
State University of New York at Buffalo
2025 Phase 2 NCT06463743 -
The Hospital for Sick Children
2020 Phase 1/Phase 2 NCT04121468 Canada
Metformin 1000 MG oral tablet
German University in Cairo
2022 Phase 2 NCT05298670 Egypt
Metformin 500 MG oral tablet, UP TO 4 tablets A DAY
University of California, Los Angeles
2022 Early Phase 1 NCT05349474 United States
Metformin and clemastine IN combination
Cambridge University Hospitals NHS Foundation Trust
2022 Phase 2 NCT05131828 United Kingdom
Metformin hydrochloride 850 MG oral tablet
University Hospital, Antwerp
2023 Phase 2 NCT05893225 Belgium
Methelphenidate
Kessler Foundation
2014 Phase 2 NCT02286557 United States
Methotrexat
Universitätsklinikum Heidelberg
2006 Phase 3 EUCTR2004-004403-37-DE Germany
Methotrexate
Biogen Idec
2003 Phase 4 NCT00112034 United States
Heidelberg University
2006 Phase 3 NCT00344253 Germany
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
2002 Phase 4 NCT00037115 United States
2001 Phase 4 NCT00037102 United States
Methyl B12
University of Iowa
2010 Phase 1 NCT01381354 United States
Methyl folate
University of Iowa
2010 Phase 1 NCT01381354 United States
Methyl prednisolonate
University Hospital Muenster
2018 - NCT04450030 Germany
Methyloprednisolone
Genentech, Inc.
2016 Phase 3 NCT02688985 Canada;Germany;Sweden;United States
Methylphenidate
Johns Hopkins University
2017 Phase 3 NCT03185065 United States
Oregon Health and Science University
2013 Phase 2/Phase 3 NCT01896700 United States
Methylphenidate hydrochloride
Medizinische Universität Wien
2012 Phase 2 EUCTR2012-003418-15-AT Austria
Methylphenidate modified release
Medical University of Vienna
2012 Phase 2 NCT01879202 Austria
Methylphenidate modified release 20 MG
Medizinische Universität Wien
2012 Phase 2 EUCTR2012-003418-15-AT Austria
Methylphenidate modified release 30 MG
Medizinische Universität Wien
2012 Phase 2 EUCTR2012-003418-15-AT Austria
Methylphenidate modified release 40 MG
Medizinische Universität Wien
2012 Phase 2 EUCTR2012-003418-15-AT Austria
Methylprednisolon-21-hydrogensuccinat, natriumsalz
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany
Methylprednisolone
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
2008 - EUCTR2007-002179-15-FR France
Beijing Tongren Hospital
2020 - NCT04601142 China
Biogen
2010 Phase 2 NCT01071083 Germany;Spain;United States
Biogen Idec
2010 - EUCTR2009-017490-38-DE Germany;Spain
2003 Phase 4 NCT00493116 Australia;New Zealand
2003 Phase 4 NCT00492466 Finland
CHU Rennes
2007 - EUCTR2007-000590-37-FR France
Galapagos NV
2009 Phase 2 NCT01039103 Belgium;Germany;Poland
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 1 NCT02583594 Spain
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain
Germans Trias i Pujol Hospital
2008 Phase 4 NCT00753792 Spain
Hoffmann-La Roche
2020 Phase 3 NCT04548999 Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 NCT04544436 Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany
Merck KGaA, Darmstadt, Germany
2018 Phase 2 NCT03387046 Germany;Italy
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
2002 Phase 4 NCT00037115 United States
National Eye Institute (NEI)
1988 - NCT00000147 United States
1988 Phase 3 NCT00000146 United States
National Institute of Neurological Disorders and Stroke (NINDS)
2016 Phase 2 NCT02784210 United States
Neurologique Foundation, Inc.
2009 Phase 2/Phase 3 NCT00947895 United States
Northwestern Memorial Hospital
2001 Phase 1 NCT00017628 United States
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States
2017 Phase 3 NCT03342638 United States
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark
2011 Phase 2 NCT01305837 Denmark
Scleroseklinikken, Rigshospitalet
2011 - EUCTR2010-024561-43-DK Denmark
Servicio de Neurología
2008 - EUCTR2007-000888-15-ES Spain
Stanford University
2014 Phase 1 NCT02087813 United States
Sykehuset Innlandet HF
2009 - NCT00764413 Norway
Tomas Olsson
2018 Phase 2 NCT03674099 Denmark;Germany;Norway;Sweden
University Hospital, Bordeaux
2005 Phase 3 NCT00241254 France
University Hospital, Clermont-Ferrand
2019 Phase 4 NCT02769689 France
University Medical Center Hamburg Eppendorf
2013 Phase 2 EUCTR2012-004807-10-DE Germany
University of Southern California
2009 Phase 1 NCT01049451 United States
University of Texas Southwestern Medical Center
2013 Phase 2 NCT01710228 United States
Universität Leipzig
2018 Phase 3 EUCTR2017-000635-13-DE Germany
Methylprednisolone 1250 MG/24H X3 days
Germans Trias i Pujol Hospital
2013 Phase 4 NCT01986998 Spain
Methylprednisolone hemisuccinate
BBB-Therapeutics B.V.
2013 Phase 1 NCT02048358 Netherlands
Methylprednisolone IV
Centre Hospitalier de PAU
2015 Phase 2 NCT02545959 France
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Australia;Brazil;Canada;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
Rennes University Hospital
2008 Phase 3 NCT00984984 France
Methylprednisolone PO
Rennes University Hospital
2008 Phase 3 NCT00984984 France
Methylprednisolone sodium hemisuccinate
Servicio de Neurología, HU. Germans Trias i Pujol
2012 Phase 4 EUCTR2012-001965-34-ES Spain
Methylprednisolone sodium succinate
Danish Multiple Sclerosis Research Centre
2009 Phase 2 EUCTR2009-011516-37-DK Denmark
Department of Clinical Neuroscience, Karolinska Institutet
2020 Phase 2 EUCTR2018-000620-34-DE Germany;Sweden
2018 Phase 2 EUCTR2018-000620-34-SE Sweden
2018 Phase 2 EUCTR2018-000620-34-NO Germany;Norway;Sweden
Enceladus Pharmaceuticals BV
2010 - EUCTR2009-013884-21-PL Belgium;Germany;Poland
2009 - EUCTR2009-013884-21-DE Belgium;Germany;Poland
2009 Phase 2 EUCTR2009-013884-21-BE Belgium;Germany;Poland
Methylprednisolone succinate
Mazandaran University of Medical Sciences
2021 Phase 2 NCT04979650 Iran, Islamic Republic of
Metilprednisolone sodio succinato
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
Microgynon
Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2019 Phase 1 NCT04086225 Germany;Poland
Merck KGaA, Darmstadt, Germany
2019 Phase 1 NCT03745144 Germany;Poland
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands
Micropirin
Biogen Idec Research Limited
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom
Midazolam
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States
Johns Hopkins University
2023 Phase 2 NCT05378100 United States
2018 Phase 1/Phase 2 NCT03500289 United States
MIL62
Beijing Mabworks Biotech Co., Ltd.
2022 Phase 3 NCT05314010 China
Mild dose cannabis
University of California, Davis
2009 Phase 1/Phase 2 NCT01037088 United States
Minocycline
Dr. Luanne Metz
2009 Phase 3 NCT00666887 Canada
Merck KGaA
2006 Phase 2 NCT01134627 Denmark
University of Calgary
2010 Phase 2 NCT01073813 Canada
Minocycline 100 MG FILM-coated tablets
E. Merck AB
2005 - EUCTR2005-004289-18-DK Denmark;Finland;Sweden
Merck AB
2006 - EUCTR2005-004289-18-SE Finland;Sweden
2006 - EUCTR2005-004289-18-FI Finland;Sweden
Minocycline 100MG
University of Calgary
2020 Phase 3 NCT04291456 Canada
Minocycline hydrochloride
E. Merck AB
2005 - EUCTR2005-004289-18-DK Denmark;Finland;Sweden
Merck AB
2006 - EUCTR2005-004289-18-SE Finland;Sweden
2006 - EUCTR2005-004289-18-FI Finland;Sweden
Mirabegron
Theodore R. Brown, MD MPH
2014 Phase 4 NCT02086188 United States
Mirna
University of Gaziantep
2015 - NCT04772495 -
MIS416
Innate Immunotherapeutics
2014 Phase 2 NCT02228213 Australia;New Zealand
2010 Phase 1/Phase 2 NCT01191996 New Zealand
Mitoquinone
Oregon Health and Science University
2018 Phase 1/Phase 2 NCT03166800 United States
Mitoxantrone
AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA` DEGLI STUDI DI NAPOLI
2009 - EUCTR2009-010661-23-IT Italy
Fundación Española de Esclerosis Múltiple (FEDEM)
2006 - EUCTR2004-001286-17-PT Portugal
OSPEDALE S. RAFFAELE
2004 - EUCTR2004-001601-10-IT France;Italy
PD Dr. Andrew Chan
2012 Phase 2 NCT01627938 Germany
Queen Mary, University of London
2009 - EUCTR2008-000256-26-GB United Kingdom
Rennes University Hospital
2010 Phase 3 NCT02937285 France
1999 Phase 2 NCT00219908 France;Italy
State University of New York at Buffalo
2001 Phase 4 NCT00304291 United States
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom
University Medical Center Hamburg Eppendorf
2007 - EUCTR2007-001962-34-DE Germany
Wyeth is now a wholly owned subsidiary of Pfizer
2005 Phase 3 NCT00146159 Germany
Xuanwu Hospital, Beijing
2009 Phase 4 NCT02021825 China
Mitoxantrone - immunomodulator
Rennes University Hospital
2010 - NCT01065727 France
Mitoxantrone hydrochloride liposome injection
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
2022 Phase 2 NCT05551598 China
2022 Phase 2 NCT05496894 China
MK0812
Merck Sharp & Dohme Corp.
2004 Phase 2 NCT00239655 Canada;Finland;Germany;United Kingdom;United States
MLN1202
Millennium Pharmaceuticals, Inc.
2006 Phase 2 EUCTR2004-002567-24-GB Czech Republic;Hungary;United Kingdom
2005 Phase 2 NCT01199640 -
2005 - EUCTR2004-002567-24-HU Czech Republic;Hungary;United Kingdom
2005 - EUCTR2004-002567-24-CZ Czech Republic;Hungary;United Kingdom
MMF
Hoffmann-La Roche
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States
Modafinil
Institute for Clinical Research
2003 - NCT00210301 United States
Johns Hopkins University
2017 Phase 3 NCT03185065 United States
Kessler Foundation
2003 - NCT00142402 United States
University of Michigan
2018 Phase 4 NCT03621761 United States
Modafinil generis 100 MG
Clinical Academic Center (2CA-Braga)
2024 Phase 2 NCT06592352 Portugal
Moderna MRNA-1273, bivalent
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States
Modified paleolithic diet
University of Iowa
2010 Phase 1 NCT01381354 United States
Modified paleolithic elimination diet
Terry L. Wahls
2022 - NCT05007483 United States
MOG peptide
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland
Monoclonal antibody M-T412
National Center for Research Resources (NCRR)
1995 Phase 1 NCT00004816 -
Monomethyl fumarate
Banner Life Sciences LLC
2023 - NCT05978531 Puerto Rico;United States
2021 - NCT04925778 -
Monomethyl fumarate 190 MG
Banner Life Sciences LLC
2017 Phase 1 NCT04570670 -
Monovalent [B.1.351] COV2 pres DTM-AS03
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States
Montelukast
Biogen
2015 Phase 4 NCT02410278 United States
MOR103
MorphoSys AG
2012 Phase 1/Phase 2 NCT01517282 Germany;Poland;United Kingdom
Most recent vaccine TO seasonal influenza
Heinrich-Heine University, Duesseldorf
2020 - NCT05019248 Germany
Motivational interviewing
Oakland University
2015 - NCT02335450 United States
Motor imagery AS compared TO physical practice FOR balance tasks
Dominican University of New York
2023 - NCT05615207 United States
MPA
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States
MRI brain and cervical spine
University of Utah
2022 Early Phase 1 NCT05357833 United States
MRI contrast-enhancing agents
Sanofi
2023 Phase 3 NCT06141486 Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;France;Germany;Greece;Hungary;India;Italy;Japan;Korea, Republic of;Netherlands;Poland;Portugal;Puerto Rico;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2023 Phase 3 NCT06141473 Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
MRI contrast-enhancing preparations
Sanofi
2021 Phase 2 NCT04879628 Bulgaria;Canada;Czechia;France;Germany;Russian Federation;Spain;Turkey;Ukraine;United States
Mrna covid-19 vaccine
Novartis Pharmaceuticals
2021 Phase 4 NCT04878211 United States
MRNA-1195
ModernaTX, Inc.
2025 Phase 2 NCT06735248 -
MRNA-1273
Novartis Pharmaceuticals
2021 Phase 4 NCT04792567 Germany
MSC2015
SALK - Gemeinnützige Salzburger Landeskliniken Betriebsges. m.b.H., Christian-Doppler-Klinik, UK für Neurologie der PMU
- - EUCTR2015-000137-78-AT Austria
MSC2304479A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation
MSC2304480A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation
MSC2304481A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation
MSC2304482A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation
MSC2358825A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation
MSC2364447C
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
Merck Healthcare KGaA
2022 Phase 3 EUCTR2019-004980-36-CZ Belarus;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-SI Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-RO Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-SK Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PL Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-NO Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LV Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-GR Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-ES Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-DE Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-BG Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
MSC2491529A
Merck KGaA
2014 - EUCTR2013-002283-25-PL Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-GR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 Phase 2 EUCTR2013-002283-25-GB Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-ES Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-BG Bulgaria;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2013-002283-25-IT Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-HU Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-HR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-FI Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-CZ Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
Mscs
Haukeland University Hospital
2021 Phase 1/Phase 2 NCT04749667 Norway
Prof. Per Soelberg Sørensen
2012 Phase 2 EUCTR2012-000518-13-DK Denmark
MT-1303
MITSUBISHI PHARMA CORPORATION
2013 - EUCTR2012-002470-31-IT Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Hungary;Italy;Lithuania;Poland;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom
MITSUBISHI TANABE PHARMA CORPORATION
2013 Phase 2 EUCTR2012-002639-27-IT Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02293967 United Kingdom
Mitsubishi Tanabe Pharma Corporation (MTPC)
2013 Phase 2 EUCTR2012-002639-27-PL Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-002639-27-LT Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-002639-27-HU Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-002639-27-GB Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-002639-27-FI Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-002639-27-ES Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-002639-27-CZ Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-002639-27-BG Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-002639-27-BE Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 - EUCTR2012-002470-31-LT Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 - EUCTR2012-002470-31-FI Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 - EUCTR2012-002470-31-ES Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 - EUCTR2012-002470-31-BG Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 - EUCTR2012-002470-31-BE Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2012 - EUCTR2012-002470-31-PL Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2012 - EUCTR2012-002470-31-HU Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2012 - EUCTR2012-002470-31-GB Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2012 - EUCTR2012-002470-31-CZ Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
MT-1303-forma
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02310048 United Kingdom
MT-1303-formb
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02310048 United Kingdom
MT-1303-high
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02193217 United Kingdom
2013 Phase 2 NCT01890655 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom
2013 Phase 2 NCT01742052 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom
MT-1303-LOW
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02193217 United Kingdom
2013 Phase 2 NCT01890655 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom
2013 Phase 2 NCT01742052 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom
MT-1303-middle
Mitsubishi Tanabe Pharma Corporation
2013 Phase 2 NCT01890655 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom
2013 Phase 2 NCT01742052 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom
MTR-601
Motric Bio
2023 Phase 1 NCT06117020 United States
MTX
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States
Multiferon
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark
Mutagrip
sanofi-aventis recherche & developpement
2011 - EUCTR2011-001160-21-DE Austria;Canada;Germany;Russian Federation;Ukraine
2011 - EUCTR2011-001160-21-AT Austria;Canada;Germany;Russian Federation;Ukraine
Mybetaapp
Bayer
2019 - NCT03808142 Germany
2017 - NCT03134573 Germany
Mycophenolate mofetil
Aaron Boster
2006 Phase 0 NCT00618527 United States
Hoffmann-La Roche
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Kobe University Hospital
2018 - JPRN-UMIN000031135 Japan
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
2023 Phase 1 ChiCTR2300076302 China
Sekiguchi Kenji
2018 Phase 2 JPRN-jRCTs051180080 -
Shandong University Qilu Hospital
2021 Phase 4 ChiCTR2100043013 China
The Ophthalmology Department of the Chinese Peoples Liberation Army Hospital
2019 Phase 4 ChiCTR1900025744 China
2014 - ChiCTR-ICR-15007177 China
The third affiliated hospital,Sun Yat-sen university
2016 - ChiCTR-OPB-16007730 China
Third Affiliated Hospital, Sun Yat-Sen University
2016 Phase 4 NCT02809079 -
University of Texas Southwestern Medical Center
2006 Phase 2 NCT00324506 United States
2004 Phase 2/Phase 3 NCT00223301 United States
Mycophenolate mofetil, MMF
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
2024 Phase 1/Phase 2 NCT06557174 -
Myelin
Fundació Institut Germans Trias i Pujol
2017 Phase 1 NCT02903537 Spain
Hadassah Medical Organization
2002 Phase 1/Phase 2 NCT01448252 Israel
University Medical Center Hamburg-Eppendorf
2009 - EUCTR2008-004408-29-DE Germany
Myeloablative regimen
Stanford University
2025 Phase 1 NCT06900192 -
Méthylprednisolone mylan
Centre Hospitalier de Pau
2015 Phase 2 EUCTR2014-005493-11-FR France
N acetylcysteine
University of Iowa
2010 Phase 1 NCT01381354 United States
N-acetyl cysteine
Emmanuelle Waubant, MD PhD
2022 Phase 2 NCT05122559 United States
Thomas Jefferson University
2017 - NCT03032601 United States
University of California, San Francisco
2016 Phase 2 NCT02804594 United States
N-acetylcysteine
ISTITUTO C. MONDINO
2007 - EUCTR2008-000955-90-IT Italy
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
2012 Phase 4 EUCTR2011-003775-11-BE Belgium
N. meningitidis group W135 oligosaccharide conjugated CRM197
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
N02bg10
JOSE MANUEL GARCIA DOMINGUEZ
2013 - EUCTR2011-000985-36-ES Spain
N03ax12
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France
N06dx01
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France
NA18F
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2016 Phase 2 EUCTR2015-001202-34-IT Italy
Nabilone
NEMA Research, Inc.
2006 Phase 4 NCT00381264 United States
University of Manitoba
2007 Phase 4 NCT00480181 Canada
Nabiximols
Jazz Pharmaceuticals
2021 Phase 3 NCT04984278 Czechia;Poland;Spain;United Kingdom;United States
2020 Phase 3 NCT04657666 Czechia;Poland
2020 Phase 3 NCT04203498 Czechia;Poland;Romania;United Kingdom;United States
Michael, Levy M.D.,Ph.D.
2025 Phase 2 NCT05974293 United States
Nabiximols - sativex
GW Pharma Limited
2022 Phase 3 EUCTR2020-004306-58-LT Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom
2021 Phase 3 EUCTR2020-003271-18-CZ Czech Republic;Czechia;Poland;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom
Naltrexone
OSPEDALE S. RAFFAELE
2006 - EUCTR2005-005679-13-IT Italy
Namisol
Echo Pharmaceuticals B.V.
2011 - EUCTR2010-022033-28-NL Netherlands
Nanocort
Enceladus Pharmaceuticals BV
2010 - EUCTR2009-013884-21-PL Belgium;Germany;Poland
2009 - EUCTR2009-013884-21-DE Belgium;Germany;Poland
2009 Phase 2 EUCTR2009-013884-21-BE Belgium;Germany;Poland
Nanocurcumin
Tabriz University of Medical Sciences
2016 Phase 2 NCT03150966 Iran, Islamic Republic of
Naproxen
Biogen
2013 Phase 3 NCT01939002 United States
Natalizumab
Amir Hadi Maghzi
2022 Phase 3 JPRN-jRCT2051210146 -
Amsterdam University Medical Center
2019 Phase 4 EUCTR2019-002566-13-NL Netherlands
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2007 - EUCTR2005-004061-41-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2007 - EUCTR2005-004061-41-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom
2006 - EUCTR2005-004061-41-IT Australia;Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-IE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Spain;Sweden;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-002145-11-IT Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
Biogen
2023 - NCT05925049 United States
2023 - NCT05701423 Germany
2023 Phase 4 NCT05532163 Germany
2022 Phase 3 NCT05265728 Japan
2021 - NCT05688436 United States
2021 - NCT05304520 Germany
2019 - NCT05236777 Czechia
2018 Phase 3 NCT03689972 Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;United Kingdom;United States
2015 - NCT02677077 Belgium;Czech Republic;Czechia
2015 - NCT02386566 Switzerland
2014 Phase 4 NCT02342704 Australia;Czech Republic;Czechia;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 NCT02241785 Germany;United States
2014 - NCT02159573 United States
2014 Phase 2 NCT02142192 Belgium;Denmark;Germany;Italy
2014 - NCT02137109 -
2013 - NCT04832399 Portugal
2013 Phase 1 NCT01884935 Italy
2012 - NCT01485003 United States
2011 - NCT01943526 Ireland
2011 Phase 3 NCT01416181 Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2010 Phase 2/Phase 3 NCT01440101 China;Japan
2010 Phase 2 NCT01416155 China;Japan
2010 Phase 2 NCT01071083 Germany;Spain;United States
2010 - NCT01070836 Puerto Rico;United States
2010 - NCT01070823 United States
2010 Phase 3 NCT01058005 Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States
2009 - NCT00884481 Austria;Denmark;Norway;Sweden;United States
2009 Phase 4 NCT00871780 Belgium;Mexico;Poland;Romania;Saudi Arabia;Ukraine;Venezuela
2008 Phase 4 NCT00536120 United States
2006 Phase 2 NCT00516893 United States
2006 Phase 3 NCT00306592 Canada;United States
2006 Phase 3 NCT00297232 Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2001 Phase 3 NCT00027300 Belgium;Canada;Czech Republic;France;Germany;Netherlands;United Kingdom;United States
Biogen Idec
2014 Phase 4 EUCTR2014-003669-97-BE Belgium
2010 - EUCTR2009-017490-38-DE Germany;Spain
2009 - NCT00818038 United States
2008 Phase 4 NCT00744679 United States
2007 Phase 1 NCT00559702 United States
2003 Phase 3 NCT00276172 United States
2003 Phase 2 NCT00097760 -
2002 Phase 3 NCT00030966 Austria;Belgium;France;Germany;Israel;Italy;United States
Biogen Idec GmbH
2005 - EUCTR2004-004130-14-AT Austria
Biogen Idec International GmbH
2010 Phase 4 EUCTR2009-009503-19-BE Belgium
Biogen Idec Limited
2012 Phase 3 EUCTR2010-021978-11-IE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2012 - EUCTR2010-021978-11-BE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-SE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-PL Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-GB Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-FI Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-ES Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-DK Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-DE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Iraq;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-CZ Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Biogen Idec Ltd.
2004 - EUCTR2004-000047-18-SE Sweden
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-002145-11-NL Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-GB Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-FR Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-ES Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-DE Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2015 - EUCTR2013-005586-39-DE Germany;Italy;United States
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2013 - EUCTR2012-005082-13-IT Italy
Claudio Gobbi
2010 Phase 4 NCT01144052 Switzerland
Cornerstone Health Care, PA
2012 Phase 4 NCT01591551 United States
Dansk Multipel Sclerose Center
2010 Phase 2 EUCTR2009-016703-35-DK Denmark
Hôpitaux Universitaires de Strasbourg
2014 - EUCTR2014-003209-14-FR France
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Multiple Sclerosis Center of Northeastern New York
2021 - NCT04964700 United States
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States
Novartis Pharma Services AG
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
Novartis Pharmaceuticals
2023 - NCT05627271 Switzerland
Polpharma Biologics S.A.
2019 Phase 3 EUCTR2018-004751-20-PL Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine
2019 Phase 3 EUCTR2018-004751-20-HR Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine
Rennes University Hospital
2010 - NCT01065727 France
Rigshospitalet, Denmark
2010 Phase 2 NCT01077466 Denmark
State University of New York at Buffalo
2015 Phase 4 NCT03046251 United States
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University Hospital Muenster
2014 Phase 4 NCT02325440 Germany
University Hospital, Caen
2020 - NCT04580381 France
University Hospital, Clermont-Ferrand
2019 Phase 4 NCT02769689 France
University Hospital, Toulouse
2009 Phase 4 NCT00942214 France
University of British Columbia
2003 - NCT06705608 -
University of South Florida
2011 - NCT01455220 United States
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany
Uppsala l?ns landsting
2011 Phase 2 EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States
VU University Medical Center
2016 Phase 4 NCT03516526 Netherlands
VU medical center
2016 Phase 4 EUCTR2016-000345-31-NL Netherlands
Natalizumab 300 MG IN 15 ML injection
Vanderbilt University Medical Center
2022 Phase 4 NCT05177718 United States
Natalizumab discontinuation
University at Buffalo
2012 Phase 4 NCT02775110 United States
Natalizumab FOR IV infusion
Biogen Idec Limited
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain
Natalizumab FOR subcutaneous injection
Biogen Idec Limited
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain
Biogen Idec Research Limited
2014 - EUCTR2014-000917-30-IT Belgium;Denmark;Italy
2014 - EUCTR2014-000917-30-DK Belgium;Denmark;Italy
2014 Phase 2 EUCTR2014-000917-30-DE Belgium;Denmark;Germany;Italy
2014 - EUCTR2014-000917-30-BE Belgium;Denmark;Italy
Natalizumab IV
Biogen
2011 Phase 2 NCT01405820 Belgium;France;Germany;Italy;Spain
Natalizumab SC
Biogen
2011 Phase 2 NCT01405820 Belgium;France;Germany;Italy;Spain
Natalizumab treatment
Biogen Idec
2007 Phase 0 NCT00424788 United States
Natalizumab/natalizumab-sztn, alemtuzumab, ocrelizumab, rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, cladribine, ofatumumab, ublituximab-xiiy, ocrelizumab and hyaluronidase-ocsq
Johns Hopkins University
2018 - NCT03500328 United States
NBI-5788
Neurocrine Biosciences
2003 Phase 2 NCT00079495 -
Nebido
Hôpitaux Universitaires de Strasbourg
2019 Phase 2 EUCTR2018-002648-10-FR France
Nebido® testosterone undecanoate 1000 MG/4 ML solution FOR injection
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France
Neorecormon
Danish Multiple Sclerosis Research Centre
2009 Phase 2 EUCTR2009-011516-37-DK Denmark
Walton Centre for Neurology and Neurosurgery
2008 - EUCTR2008-005125-11-GB United Kingdom
Neramexane mesylate
Merz Pharmaceuticals GmbH
2009 Phase 2 NCT00799942 United Kingdom
Nerispirdine
Sanofi
2008 Phase 2 NCT00811902 Canada;Finland;France;Germany;Norway;Spain;United States
2008 Phase 2 NCT00772525 United States
Nerispirdine hydrochloride
sanofi-aventis Recherche & Développement
2009 Phase 2 EUCTR2008-001999-67-FR Finland;France;Germany;Spain
2009 - EUCTR2008-001999-67-FI Finland;France;Germany;Spain
2009 Phase 2 EUCTR2008-001999-67-ES Finland;France;Germany;Spain
2009 - EUCTR2008-001999-67-DE Finland;France;Germany;Spain
Neupogen
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy
Uppsala l?ns landsting
2011 Phase 2 EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States
Neuromuscular electrical stimulation delivered using THE electrical therapy device empi 300 PV
University of Iowa
2010 Phase 1 NCT01381354 United States
Neuromuscular evaluation
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France
Neurontin
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France
Neurontin 300 MG hard capsule
Charité University Medicine Berlin
2010 Phase 4 EUCTR2008-005167-33-DE Germany
Neurovax
Immune Response BioPharma, Inc.
2020 Phase 1 NCT02200718 United States
2020 Phase 2 NCT02149706 United States
2020 Phase 2/Phase 3 NCT02057159 United States
Neurovax 300UG/ML dose FOR IM injection
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia
NEW formulation OF rebif - human interferon BETA-1A
EMD Serono
2006 Phase 3 NCT00428584 United States
NG01 - autologous bone marrow derived human stromal cells
NeuroGenesis Ltd.
2025 Phase 2 NCT06961383 Israel;United States
Niacinamide
University of Iowa
2010 Phase 1 NCT01381354 United States
Nicotinamid riboside
Haukeland University Hospital
2023 Phase 2 NCT05740722 Norway
Nicotine and cotinine serum levels
University of Jordan
2021 - NCT05046535 Jordan
Nicotine dependence
University of Jordan
2021 - NCT05046535 Jordan
Nintendo WII FIT balance board
University Hospital of Ferrara
2014 - NCT02287948 Italy
Nintendo WII FIT balance exercises
Biruni University
2016 - NCT03436927 -
Nirs after bosentan administration
Universitair Ziekenhuis Brussel
2014 - NCT02389426 Belgium
Nirs baseline
Universitair Ziekenhuis Brussel
2014 - NCT02389426 Belgium
Nitrofurantoin
University College London
2010 Phase 4 EUCTR2009-017939-18-GB United Kingdom
Nivolumab
Alliance Foundation Trials, LLC.
2019 Phase 1 NCT03656627 United States
National Cancer Institute (NCI)
2019 Phase 1 NCT03816345 Canada;United States
NO treatment ARM
New York University School of Medicine
2015 Phase 4 NCT02665221 United States
Nomegestrol
OSPEDALI CIVILI DI LIONE
2007 - EUCTR2006-005460-30-IT Italy
Nomegestrol acetate
Hospices Civils de Lyon
2005 Phase 3 NCT00127075 France
NON disponibile
FONDAZIONE ITALIANA SCLEROSI MULTIPLA ONLUS
2023 Phase 2 EUCTR2022-002654-95-IT Italy
NON-pegylated interferon
Biogen
2015 Phase 2 NCT02097849 United States
Norethindrone
University of California, Los Angeles
2011 Phase 2 NCT01466114 United States
Normal saline
Allergan
2012 Phase 3 NCT01600716 Belgium;Canada;Czech Republic;Czechia;France;Poland;Portugal;Russian Federation;United States
Mazandaran University of Medical Sciences
2021 Phase 2 NCT04979650 Iran, Islamic Republic of
National Institute of Neurological Disorders and Stroke (NINDS)
2010 Phase 1/Phase 2 NCT01212094 United States
Normal saline FOR injection
University of Manitoba
2013 Phase 2 NCT01911377 Canada
NOT applicable
Biogen Idec GmbH
2005 - EUCTR2004-004130-14-AT Austria
Cellerys AG
2023 Phase 1;Phase 2 EUCTR2022-000801-28-CZ Czech Republic;Czechia;Germany;Italy;Switzerland
MERCK KGAA
2021 Phase 4 EUCTR2020-003995-42-IT Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003874-30-IT Austria;Czech Republic;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain
2019 Phase 4 EUCTR2019-000069-19-IT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
Merck Healthcare KGaA
2021 Phase 4 EUCTR2020-003995-42-PL Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-HU Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-CZ Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-AT Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003874-30-SK Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-HU Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-FR Austria;Czech Republic;Denmark;France;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-DK Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-CZ Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2020 Phase 4 EUCTR2020-003995-42-FI Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2020 Phase 4 EUCTR2020-003995-42-DE Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2020 Phase 4 EUCTR2020-003874-30-AT Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
Merck KGaA
2020 Phase 4 EUCTR2019-000069-19-RO Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-SE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-PT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-PL Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-LT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-HR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-ES Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-EE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-CZ Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-BG Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-BE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
Merck Serono International S.A.
2008 - EUCTR2007-000381-20-NL Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2008 - EUCTR2007-000381-20-GR Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2007 Phase 3 EUCTR2007-000381-20-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lithuania;Netherlands;Portugal;United Kingdom
2007 - EUCTR2006-002982-38-LT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2007 - EUCTR2006-002982-38-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-AT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2004-005148-28-LT Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-FI Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-EE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-DK Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-CZ Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Merck Serono International SA
2007 - EUCTR2006-003037-32-LT Estonia;Germany;Italy;Lithuania;Spain
2007 Phase 3 EUCTR2006-003037-32-ES Estonia;Germany;Italy;Lithuania;Spain
2007 - EUCTR2006-003037-32-EE Estonia;Germany;Italy;Lithuania;Spain
Merck Serono International, a branch of Laboratoires Serono S.A.
2005 Phase 3 EUCTR2004-005148-28-GB Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom
Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA
2007 Phase 3 EUCTR2006-002982-38-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain
2007 - EUCTR2006-002982-38-EE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
Merck Serono International, a branch of Laboratories Serono S.A.
2005 - EUCTR2004-005148-28-DE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Merck Serono S.A. - Geneva
2012 Phase 3 EUCTR2009-017978-21-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2012 Phase 3 EUCTR2009-017978-21-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2012 Phase 3 EUCTR2009-017978-21-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-SE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-LV Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 - EUCTR2009-017978-21-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-DK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 - EUCTR2009-017978-21-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2010 Phase 3 EUCTR2009-017978-21-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - EUCTR2007-000381-20-PT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2008 - EUCTR2007-000381-20-LV Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-000381-20-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-EE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-DK Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-000381-20-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2007-000381-20-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2007-000381-20-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2007 - EUCTR2006-002982-38-PT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2007 - EUCTR2006-002982-38-DE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-FI Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-CZ Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
Merck Serono S.A.-Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 Phase 3 EUCTR2006-002982-38-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain
Merck Serono SA
2007 - EUCTR2006-003037-32-DE Estonia;Germany;Italy;Lithuania;Spain
Merck, S.L.
2019 Phase 4 EUCTR2019-000069-19-AT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
Sahlgrenska University Hospital
2005 Phase 4 EUCTR2005-001008-37-SE Sweden
Sanofi-Aventis Recherche et Développement
2021 Phase 2 EUCTR2020-004785-19-FR Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States
2021 Phase 2 EUCTR2020-004785-19-DE Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States
2021 Phase 2 EUCTR2020-004785-19-CZ Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States
2021 Phase 2 EUCTR2020-004785-19-BG Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Türkiye;Ukraine;United States
Serono International S.A.
2006 Phase 3 EUCTR2004-005148-28-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom
2006 - EUCTR2004-005148-28-LV Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-AT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Serono International SA
2007 Phase 3 EUCTR2006-002982-38-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain
2005 - EUCTR2004-003799-13-SE Ireland;Lithuania;Spain;Sweden;United Kingdom
2005 - EUCTR2004-003799-13-LT Ireland;Lithuania;Spain;Sweden;United Kingdom
2005 Phase 3 EUCTR2004-003799-13-GB Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
2005 Phase 3 EUCTR2004-003799-13-ES Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
2005 Phase 3 EUCTR2004-003799-13-DK Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
2004 Phase 4 EUCTR2004-000337-12-HU Hungary
- Phase 3 EUCTR2004-003799-13-IE Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
Serono International, S.A.
2007 - EUCTR2006-003366-33-ES Italy;Spain
Teva Pharmaceutical Industries, Ltd
2016 Phase 4 EUCTR2015-000922-12-PL Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-FR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-DE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-BE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-IE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-HR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-FI Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-AT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
University College London
2020 Phase 2 EUCTR2017-003008-30-GB United Kingdom
Novantrone*INF 2MG/ML 5ML
OSPEDALE S. RAFFAELE
2004 - EUCTR2004-001601-10-IT France;Italy
Novartis pharmaceuticals corporation
Universitätsklinikum Hamburg-Eppendorf
2013 - NCT03216915 Germany
Novatrex
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
NPB-01
Nihon Pharmaceutical Co., Ltd
2013 Phase 2 NCT01845584 Japan
NT-KO-003
Neurotec Pharma
2011 Phase 2 NCT01428726 Germany;Spain
NU100
NURON BIOTECH INC.
2012 - EUCTR2011-002683-24-IT Belarus;Bulgaria;Hungary;Italy;Russian Federation;Spain
Nuron Biotech Inc.
2011 Phase 3 NCT01464905 Belarus;Bulgaria;Croatia;Georgia;Hungary;India;Italy;Lebanon;Poland;Russian Federation;Serbia;Spain;Ukraine
Nuron Biotech, Inc.
2012 - EUCTR2011-002683-24-HU Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine
2012 - EUCTR2011-002683-24-ES Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Poland;Russian Federation;Spain;Ukraine
2012 - EUCTR2011-002683-24-BG Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine
NVF233
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy
Obexelimab
Zenas BioPharma (USA), LLC
2024 Phase 2 NCT06564311 Austria;Belgium;China;Croatia;Czechia;Denmark;Greece;Italy;Poland;Spain;United Kingdom;United States
Observation OF ocrelizumab AS treatment IN rrms patients
Wayne State University
2021 - NCT04458688 United States
Observational control
Jeffrey Gelfand
2018 Phase 1 NCT03594487 United States
OCH-NCNP1
National Center of Neurology and Psychiatry, Japan
2019 Phase 2 NCT04211740 Japan
Oclelizumab
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
OCR
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States
Ocrelizumab
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
2018 Phase 3 EUCTR2017-004158-40-FR France
Amgen
2025 Phase 3 NCT06700343 Georgia;Serbia;Switzerland;United States
Amsterdam UMC, location VUmc
2022 Phase 4 NCT05296161 Netherlands
Assistance Publique - Hôpitaux de Paris
2018 Phase 3 NCT03691077 France
Biogen
2021 - NCT05688436 United States
Biogen Idec Research Limited
2020 Phase 2 EUCTR2019-001967-58-PL Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States
2020 Phase 2 EUCTR2019-001967-58-FR Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States
Brigham and Women's Hospital
2021 - NCT05131984 United States
Centre Hospitalier Universitaire de Nice
2022 Phase 3 NCT05210621 France
Cinnagen
2019 Phase 3 NCT04966338 Iran, Islamic Republic of
Claudio Gobbi
2020 - NCT04640818 Switzerland
Danish Multiple Sclerosis Center, Rigshospitalet
2020 Phase 3 EUCTR2020-002981-15-DK Denmark
Dr Recai Turkoglu
2021 - NCT04874597 Turkey
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2019-003919-53-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-005448-48-IT Brazil;Czech Republic;Czechia;France;Italy;Poland;Spain
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-IT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-IT Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 2 EUCTR2016-002667-34-IT Italy;Poland;United States
2018 Phase 3;Phase 4 EUCTR2017-004886-29-IT Belgium;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-002937-31-IT Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005597-38-IT Belgium;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
F. Hoffmann - La Roche
2010 Phase 3 EUCTR2010-020338-25-IT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Poland;Portugal;Spain;United Kingdom
F. Hoffmann-La Roche Ltd
2023 Phase 3 EUCTR2020-004128-41-RO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2023 Phase 3 EUCTR2020-004128-41-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-005448-48-FR Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2022 Phase 3 EUCTR2020-005448-48-CZ Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2022 Phase 3 EUCTR2020-004128-41-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 4 EUCTR2021-000063-79-ES Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000063-79-DE Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000062-14-ES Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000062-14-DE Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 3 EUCTR2020-005448-48-PL Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2020-004128-41-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-GR Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-DK Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-BG Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-BE Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000893-69-GR Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000893-69-DK Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2017-004886-29-SK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-SI Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-PT Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-PL Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-HU Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-HR Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-BG Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-BE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2020 Phase 3 EUCTR2020-000894-26-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-GB Argentina;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-FR Argentina;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-PT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-PL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-NL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-HU Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-GB Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-FR Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-DE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-BE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-003919-53-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-003919-53-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-RO Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-IE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-FR Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-DE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2017-001313-93-DE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2020 Phase 2 EUCTR2016-002667-34-PL Italy;Mexico;Poland;United States
2019 Phase 3 EUCTR2018-001511-73-PL Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-HU Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-HR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-GB Bulgaria;Croatia;Germany;Hungary;Ireland;Poland;Portugal;Spain;United Kingdom
2019 Phase 3 EUCTR2018-001511-73-ES Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2017-004886-29-IE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-SE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-NL Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-GB Czech Republic;Denmark;Estonia;Finland;France;Ireland;Netherlands;Spain;Sweden;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-FR Belgium;Bulgaria;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-FI Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-EE Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-DK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-001313-93-PL Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-IE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-HU Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Kuwait;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-FR Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Kuwait;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-DK Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-CZ Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2017 Phase 3 EUCTR2016-002937-31-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-SI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-SE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-NO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-FR Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005597-38-SE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-NL Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-IE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-GB Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-FR Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-FI Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-EE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-DK Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-DE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-CZ Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-BE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2020-004128-41-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd.
2022 Phase 4 EUCTR2021-003296-33-GR Greece;Russian Federation
2022 Phase 3 EUCTR2020-004128-41-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020337-99-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020338-25-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Portugal;Spain;United Kingdom
2011 Phase 3 EUCTR2010-020338-25-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020337-99-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-FR Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020315-36-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2010 - EUCTR2010-020338-25-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2010-020338-25-ES Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Greece;Hungary;Italy;Lithuania;Portugal;Spain;United Kingdom
2010 - EUCTR2010-020337-99-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-FI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States
F.Hoffmann-La Roche Ltd.
2008 - EUCTR2007-006338-32-IT Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Russian Federation;Spain;Switzerland;Ukraine;United Kingdom;United States
FONDAZIONE ITALIANA SCLEROSI MULTIPLA ONLUS
2023 Phase 2 EUCTR2022-002654-95-IT Italy
Fondation Ophtalmologique Adolphe de Rothschild
2023 Phase 3 NCT05999604 France
Genentech, Inc.
2020 Phase 4 NCT04377555 Kenya;Puerto Rico;United States
2016 - NCT02807285 United States
2016 Phase 3 NCT02688985 Canada;Germany;Sweden;United States
2016 Phase 3 NCT02637856 Canada;United States
2008 Phase 2 NCT00676715 Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
Georgia State University
2021 Phase 4 NCT04387734 United States
Haukeland University Hospital
2020 Phase 3 NCT04578639 Norway;Sweden
2018 Phase 3 NCT03477500 Denmark;Netherlands;Norway;Sweden
Helse Bergen HF, Haukeland University Hospital
2022 Phase 3 EUCTR2020-001205-23-SE Norway;Sweden
2020 Phase 3 EUCTR2020-001205-23-NO Norway;Sweden
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-SE Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
Hoffman La Roche Ltd
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
Hoffmann-La Roche
2024 - NCT06780150 Germany
2024 Phase 3 NCT06675955 France;Germany;Ukraine
2023 Phase 4 NCT05208840 Russian Federation
2022 Phase 3 NCT05269004 Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 NCT05123703 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 4 NCT04998812 Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 NCT04998851 Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2020 Phase 3 NCT04548999 Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 NCT04544449 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czechia;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;New Zealand;North Macedonia;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 NCT04544436 Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 2 NCT04075266 Italy;Mexico;Poland;United States
2019 Phase 3 NCT04035005 Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 1 NCT03972306 Canada;United States
2018 Phase 3 NCT03599245 Argentina;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Kuwait;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 - NCT03593590 Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Dominican Republic;Egypt;Israel;Italy;Kuwait;Montenegro;Netherlands;Panama;Paraguay;Poland;Portugal;Qatar;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Turkey;United Arab Emirates;United Kingdom
2018 Phase 3 NCT03523858 Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates;United States
2017 Phase 3 NCT03085810 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2016 Phase 3 NCT02861014 Australia;Belgium;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Hong Kong;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2011 Phase 3 NCT01412333 Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;France;Germany;Ireland;Italy;Mexico;Morocco;Norway;Poland;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 NCT01247324 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Czechia;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 NCT01194570 Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;Uruguay
Hospital Italiano de Buenos Aires
2019 - NCT03784547 Argentina
Indapta Therapeutics, INC.
2026 Phase 1 NCT06677710 United States
Johns Hopkins University
2020 Phase 4 NCT04261790 United States
2019 - NCT03873389 United States
2019 Phase 4 NCT03853746 United States
NYU Langone Health
2020 - NCT04855617 United States
National Institute of Allergy and Infectious Diseases (NIAID)
2023 Phase 4 NCT05285891 United States
Novartis Pharmaceuticals
2025 Phase 3 NCT06846281 -
2023 - NCT06121349 United States
2023 - NCT05627271 Switzerland
2022 - NCT05266469 Oman;United Arab Emirates
2021 - NCT04676555 Australia;United Kingdom;United States
Peking Union Medical College Hospital
2025 Phase 4 ChiCTR2500102783 China
ROCHE
2018 Phase 4 EUCTR2018-000780-91-FR France
2011 Phase 3 EUCTR2010-020337-99-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IT Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark
Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-005448-48-ES Brazil;Czechia;France;Italy;Spain
Roche Farma S.A(Soc. Unipersonal) que realiza el ensayo en España y actúa como representante de F. Hoffmann-La Roche LTD
2018 Phase 3 EUCTR2017-001313-93-ES Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;France;Guatemala;Hungary;Ireland;Italy;Kuwait;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates
Roche Farma S.A. (Soc.unipersonal)que realiza el ensayo en España y que actúa como representante de F.Hoffmann-La Roche
2017 Phase 3 EUCTR2016-002937-31-ES Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Roche Farma S.A. que representa en España a F. Hoffmann-La Roche Ltd
2016 Phase 3 EUCTR2015-005597-38-ES Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
Roche Farma SA (Soc unipersonal) que realiza el ensayo en España y que actúa como representante F.Hoffmann-La Roche Ltd
2018 Phase 3 EUCTR2017-004886-29-ES Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom
State University of New York at Buffalo
2023 - NCT05974852 United States
2023 - NCT05974839 United States
University Nice Hospital
2022 Phase 3 EUCTR2021-006107-15-FR France
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany
University at Buffalo
2017 - NCT03025269 United States
University of California, San Francisco
2025 Phase 4 NCT06495593 United States
2020 Phase 4 NCT04466150 United States
2020 - NCT04387110 United States
University of Chicago
2017 - NCT03344094 United States
University of Colorado, Denver
2017 Phase 3 NCT02980042 United States
University of Michigan
2020 - NCT04459988 United States
University of South Florida
2018 - NCT03562975 United States
Universitätsklinikum Hamburg-Eppendorf
2021 Phase 2 NCT04971005 Germany
VU medical center
2022 Phase 4 EUCTR2021-004791-34-NL Netherlands
Yale University
2022 Phase 4 NCT04877457 United States
Ocrelizumab 300 MG
Hoffmann-La Roche
2018 Phase 4 NCT03589105 France
Ocrelizumab 300MG
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-SK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
Ocrelizumab 300MG/10 ML
F.Hoffmann-La Roche
2011 Phase 3 EUCTR2010-020338-25-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
Ocrelizumab 300MG/10ML
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2021-005746-15-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2021-005746-15-SK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-SE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-RO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-NO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-LT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-FI Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-CZ Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-AT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
F.Hoffmann-La Roche
2013 Phase 3 EUCTR2010-020338-25-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-GR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
GENENTECH Inc.
2016 Phase 3 EUCTR2015-004616-37-SE Germany;Sweden;Switzerland;United States
2016 Phase 3 EUCTR2015-004616-37-DE Germany;Sweden;Switzerland;United States
Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2021-005746-15-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
Ocrelizumab 600 MG
Hoffmann-La Roche
2018 Phase 4 NCT03589105 France
Ocrelizumab AT home
University of Colorado, Denver
2021 Phase 4 NCT04650321 United States
Ocrelizumab dose 1
Genentech, Inc.
2018 Phase 3 NCT03606460 United States
Ocrelizumab dose 2 and dose 3
Genentech, Inc.
2018 Phase 3 NCT03606460 United States
Ocrelizumab IV
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Australia;Brazil;Canada;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
Ocrelizumab SC
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Australia;Brazil;Canada;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
Ocrevus
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
2018 Phase 3 EUCTR2017-004158-40-FR France
Biogen Idec Research Limited
2020 Phase 2 EUCTR2019-001967-58-PL Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States
2020 Phase 2 EUCTR2019-001967-58-FR Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States
Danish Multiple Sclerosis Center, Rigshospitalet
2020 Phase 3 EUCTR2020-002981-15-DK Denmark
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2021-005746-15-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2019-003919-53-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-005448-48-IT Brazil;Czech Republic;Czechia;France;Italy;Poland;Spain
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-IT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-IT Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 2 EUCTR2016-002667-34-IT Italy;Poland;United States
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2023 Phase 3 EUCTR2020-004128-41-RO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2023 Phase 3 EUCTR2020-004128-41-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-SK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-SE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-RO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-NO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-LT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-FI Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-CZ Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-AT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-005448-48-FR Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2022 Phase 3 EUCTR2020-005448-48-CZ Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2022 Phase 3 EUCTR2020-004128-41-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 4 EUCTR2021-000063-79-ES Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000063-79-DE Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000062-14-ES Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000062-14-DE Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 3 EUCTR2020-005448-48-PL Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2020-004128-41-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-GR Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-DK Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-BG Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-BE Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000893-69-GR Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000893-69-DK Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2017-004886-29-SK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-SI Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-PT Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-PL Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-HU Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-HR Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-BG Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-BE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2020 Phase 3 EUCTR2020-000894-26-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-GB Argentina;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-FR Argentina;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-PT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-PL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-NL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-HU Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-GB Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-FR Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-DE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-BE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-003919-53-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-003919-53-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-RO Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-IE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-FR Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-DE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2017-001313-93-DE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2020 Phase 2 EUCTR2016-002667-34-PL Italy;Mexico;Poland;United States
2019 Phase 3 EUCTR2018-001511-73-PL Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-HU Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-HR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-GB Bulgaria;Croatia;Germany;Hungary;Ireland;Poland;Portugal;Spain;United Kingdom
2019 Phase 3 EUCTR2018-001511-73-ES Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2017-004886-29-IE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-SE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-NL Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-GB Czech Republic;Denmark;Estonia;Finland;France;Ireland;Netherlands;Spain;Sweden;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-FI Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-EE Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-DK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-001313-93-PL Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-IE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-DK Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-CZ Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2017 Phase 3 EUCTR2016-002937-31-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-SI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-SE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-NO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
- Phase 3 EUCTR2020-004128-41-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd.
2022 Phase 4 EUCTR2021-003296-33-GR Greece;Russian Federation
2022 Phase 3 EUCTR2020-004128-41-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F.Hoffmann-La Roche
2013 Phase 3 EUCTR2010-020338-25-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-GR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
FONDAZIONE ITALIANA SCLEROSI MULTIPLA ONLUS
2023 Phase 2 EUCTR2022-002654-95-IT Italy
Fondation Ophtalmologique Adolphe de Rothschild
2023 Phase 3 NCT05999604 France
GENENTECH Inc.
2016 Phase 3 EUCTR2015-004616-37-SE Germany;Sweden;Switzerland;United States
2016 Phase 3 EUCTR2015-004616-37-DE Germany;Sweden;Switzerland;United States
Helse Bergen HF, Haukeland University Hospital
2022 Phase 3 EUCTR2020-001205-23-SE Norway;Sweden
2020 Phase 3 EUCTR2020-001205-23-NO Norway;Sweden
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-SE Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-SK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
Kessler Foundation
2021 - NCT04448977 United States
Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2021-005746-15-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-005448-48-ES Brazil;Czechia;France;Italy;Spain
State University of New York at Buffalo
2021 Phase 2/Phase 3 NCT04925557 United States
University Nice Hospital
2022 Phase 3 EUCTR2021-006107-15-FR France
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany
VU medical center
2022 Phase 4 EUCTR2021-004791-34-NL Netherlands
Ocrevus 300 MG, solution à diluer pour perfusion
ROCHE
2018 Phase 4 EUCTR2018-000780-91-FR France
Ocrevus-EU
Sandoz
2025 Phase 3 NCT06847724 -
Ocrevus-US
Sandoz
2025 Phase 3 NCT06847724 -
Ocrrelizumab 300 MG
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
Octagam
Octapharma AG
2009 - EUCTR2008-004579-22-DE Austria;Germany
2008 - EUCTR2008-004579-22-AT Austria
Octagam 50 MG/ML
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Ocufolin
University of Miami
2007 - NCT03135327 United States
Ofatumumab
Biogen
2021 - NCT05688436 United States
Brigham and Women's Hospital
2020 Phase 3 NCT04510220 United States
Chinese PLA General Hospital & Chinese PLA Medical School
2022 Phase 4 ChiCTR2400086835 China
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD.
2012 - EUCTR2011-002333-19-IT Canada;Czech Republic;Germany;Italy;Netherlands;Russian Federation;Spain;United States
Genmab A/S
2008 Phase 2 EUCTR2007-004223-38-DE Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom
2008 - EUCTR2007-004223-38-BE Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom
GlaxoSmithKline
2008 - EUCTR2007-004223-38-DK Czech Republic;Denmark;Germany;Sweden;United Kingdom
GlaxoSmithKline AB
2008 - EUCTR2007-004223-38-SE Czech Republic;Denmark;Germany;Sweden;United Kingdom
GlaxoSmithKline Research and Development Limited
2012 - EUCTR2011-002333-19-CZ Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
2011 - EUCTR2011-002333-19-NL Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
2011 Phase 2 EUCTR2011-002333-19-DK Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
2011 - EUCTR2011-002333-19-DE Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
GlaxoSmithKline SA
2011 Phase 2 EUCTR2011-002333-19-ES Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
GlaxoSmithKline UK
2009 Phase 2 EUCTR2007-004223-38-GB Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom
GlaxoSmithKline s.r.o.
2008 - EUCTR2007-004223-38-CZ Czech Republic;Denmark;Germany;Sweden;United Kingdom
Johns Hopkins University
2023 - NCT06167642 United States
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States
Novartis Farmacéutica, S.A
2019 Phase 3 EUCTR2017-004703-51-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
Novartis Farmacéutica, S.A.
2018 Phase 2 EUCTR2017-004702-17-ES Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2016 Phase 3 EUCTR2015-005419-33-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-ES Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2016 Phase 3 EUCTR2015-005419-33-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;Italy
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;United Kingdom
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-SI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-NO Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-NO Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 2 EUCTR2017-004702-17-PL Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 3 EUCTR2017-004703-51-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 2 EUCTR2017-004702-17-LV Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-LT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-EE Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-CZ Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-BG Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-AT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2017 Phase 3 EUCTR2015-005418-31-FR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HU Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BE Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-RO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
Novartis Pharma K.K.
2018 Phase 2 JPRN-jRCT2080223655 Japan;Russia
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-NL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-CZ Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-PL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GB Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-EE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BG Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany
Novartis Pharma. K.K.
2019 Phase 3 JPRN-jRCT2080224590 Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russia;Slovakia(Slovak Republic);South Africa;Spain;United Kingdom;United States
Novartis Pharmaceuticals
2024 - NCT06551519 Germany
2024 - NCT06486779 Greece
2024 - NCT06345157 Italy
2024 - NCT06251986 Spain
2023 - NCT06157086 France
2023 - NCT06121349 United States
2023 - NCT05809986 Portugal
2023 - NCT05776888 Austria
2023 - NCT05627271 Switzerland
2022 - NCT05566756 Germany
2022 - NCT05344469 Germany
2022 - NCT05285904 Switzerland
2022 - NCT05266469 Oman;United Arab Emirates
2022 Phase 4 NCT05199571 China
2022 Phase 4 NCT05090371 Canada;United States
2022 - NCT05090033 Australia
2022 Phase 4 NCT05084638 Puerto Rico;United States
2021 Phase 3 NCT04926818 Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
2021 Phase 4 NCT04878211 United States
2021 Phase 4 NCT04869358 Germany
2021 - NCT04847596 Puerto Rico;United States
2021 Phase 3 NCT04788615 France;Germany;Italy;Spain;United Kingdom
2021 - NCT04676555 Australia;United Kingdom;United States
2021 Phase 4 NCT04667117 United States
2020 Phase 3 NCT04486716 Puerto Rico;United States
2020 Phase 3 NCT04353492 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 2 NCT03249714 Japan;Russian Federation
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
2023 Phase 1 ChiCTR2300076302 China
Tianjin Medical University General Hospital
2022 - NCT05414487 China
University of Southern California
2022 - NCT05171972 United States
Ofatumumab 100
GlaxoSmithKline
2008 Phase 2 NCT00640328 Belgium;Czech Republic;Denmark;Former Serbia and Montenegro;Germany;Poland;Serbia;Sweden;United Kingdom
Ofatumumab 300
GlaxoSmithKline
2008 Phase 2 NCT00640328 Belgium;Czech Republic;Denmark;Former Serbia and Montenegro;Germany;Poland;Serbia;Sweden;United Kingdom
Ofatumumab 30MG
GlaxoSmithKline
2011 Phase 2 NCT01457924 Bulgaria;Canada;Czech Republic;Czechia;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
Ofatumumab 3MG
GlaxoSmithKline
2011 Phase 2 NCT01457924 Bulgaria;Canada;Czech Republic;Czechia;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
Ofatumumab 60MG
GlaxoSmithKline
2011 Phase 2 NCT01457924 Bulgaria;Canada;Czech Republic;Czechia;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
Ofatumumab 700
GlaxoSmithKline
2008 Phase 2 NCT00640328 Belgium;Czech Republic;Denmark;Former Serbia and Montenegro;Germany;Poland;Serbia;Sweden;United Kingdom
Ofatumumab approved dose
Novartis Pharmaceuticals
2025 Phase 3 NCT06869785 United States
Ofatumumab NEW dose
Novartis Pharmaceuticals
2025 Phase 3 NCT06869785 United States
Ofatumumab subcutaneous injection
Novartis Pharmaceuticals
2016 Phase 3 NCT02792231 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Finland;France;Germany;Hungary;India;Italy;Latvia;Lithuania;Mexico;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 NCT02792218 Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Ofatumumab with AI
Novartis Pharmaceuticals
2018 Phase 2 NCT03560739 Austria;Bulgaria;Czechia;Estonia;Latvia;Lithuania;Russian Federation;Spain;United States
Ofatumumab with PRF
Novartis Pharmaceuticals
2018 Phase 2 NCT03560739 Austria;Bulgaria;Czechia;Estonia;Latvia;Lithuania;Russian Federation;Spain;United States
Ofatunumab
Novartis Pharmaceuticals
2024 Phase 4 NCT06444113 Germany;Puerto Rico;United Kingdom;United States
Oleovit D3 14.400 IU/ML oral drops, solution
University medical centre Maribor
2017 Phase 4 EUCTR2017-004846-31-SI Slovenia
Olesoxime
Hoffmann-La Roche
2013 Phase 1 NCT01808885 France
OMB157
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States
Novartis Farmacéutica, S.A
2019 Phase 3 EUCTR2017-004703-51-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
Novartis Farmacéutica, S.A.
2018 Phase 2 EUCTR2017-004702-17-ES Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2016 Phase 3 EUCTR2015-005419-33-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-ES Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2016 Phase 3 EUCTR2015-005419-33-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;Italy
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;United Kingdom
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-SI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-NO Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-NO Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 2 EUCTR2017-004702-17-PL Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 3 EUCTR2017-004703-51-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 2 EUCTR2017-004702-17-LV Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-LT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-EE Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-CZ Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-BG Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-AT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2017 Phase 3 EUCTR2015-005418-31-FR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HU Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BE Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-RO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-NL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-CZ Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-PL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GB Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-EE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BG Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
OMB157G
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany
Omega 3 fatty acids
University of Iowa
2010 Phase 1 NCT01381354 United States
Omega-3 fatty acids
Haukeland University Hospital
2004 Phase 2/Phase 3 NCT00360906 Norway
Omeprazole
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States
Onabotulinumtoxina
Allergan
2012 Phase 3 NCT01600716 Belgium;Canada;Czech Republic;Czechia;France;Poland;Portugal;Russian Federation;United States
ONE-LEG stance test
Gazi University
2018 - NCT03584672 -
ONO-4641
EMD Serono
2010 Phase 2 NCT01226745 Belgium;Canada;Czech Republic;Germany;Greece;Japan;Poland;Russian Federation;Spain;Ukraine;United States
Merck KGaA
2014 - EUCTR2013-003126-83-HU Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-GR Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-ES Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-DE Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
ONO Pharmaceutical Co., Ltd.
2011 - EUCTR2010-018705-11-GR Belgium;Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States
2010 - EUCTR2010-018705-11-ES Belgium;Czech Republic;Germany;Greece;Spain
2010 - EUCTR2009-014339-19-GR Czech Republic;Germany;Greece;Spain
2010 Phase 2 EUCTR2009-014339-19-ES Czech Republic;Germany;Greece;Spain
2010 - EUCTR2009-014339-19-DE Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States
2010 - EUCTR2009-014339-19-CZ Czech Republic;Germany;Greece;Spain
Ono Pharma USA Inc
2010 Phase 2 NCT01081782 Belgium;Canada;Czech Republic;Germany;Greece;Japan;Poland;Russian Federation;Spain;Ukraine;United States
ONO-4641/ MSC2430913A
Merck KGaA
- - EUCTR2010-018705-11-DE Belgium;Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States
ONO-4641/MSC2430913A
Merck KGaA
2010 - EUCTR2010-018705-11-CZ Belgium;Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States
Merck Serono S.A. - Geneva
2010 - EUCTR2010-018705-11-BE Belgium;Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States
Opicinumab
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 2 EUCTR2017-001224-22-IT Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Biogen
2017 Phase 2 NCT03222973 Australia;Belgium;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
2016 Phase 1 NCT02833142 United States
Biogen Idec Research Limited
2018 Phase 2 EUCTR2017-001224-22-PL Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 2 EUCTR2017-001224-22-NL Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 2 EUCTR2017-001224-22-DE Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 2 EUCTR2017-001224-22-BE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2017 Phase 2 EUCTR2017-001224-22-HU Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2017 Phase 2 EUCTR2017-001224-22-GB Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2017 Phase 2 EUCTR2017-001224-22-ES Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2017 Phase 2 EUCTR2017-001224-22-CZ Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Oral corticosteroids
Hoffmann-La Roche
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Oral glucocorticoids
Guangzhou JOYO Pharma Co., Ltd
2023 Phase 2 NCT06697535 China
Oral glucose tolerance test
Slovak Academy of Sciences
2017 - NCT03052595 Slovakia
Oral immunosuppressant
Xuanwu Hospital, Beijing
2024 - NCT05891379 China
Oral methylprednisolone 625 MG/24H X3 days
Germans Trias i Pujol Hospital
2013 Phase 4 NCT01986998 Spain
Oral THC
University of California, Davis
2004 Phase 1/Phase 2 NCT00682929 United States
ORCA-Q
Stanford University
2025 Phase 1 NCT06900192 -
Orelabrutinib
Beijing InnoCare Pharma Tech Co., Ltd.
2021 Phase 2 NCT04711148 China;Poland;Ukraine;United States
InnoCare Pharma, Inc.
2021 Phase 2 EUCTR2020-005117-41-PL China;Poland;Ukraine;United States
Peking Union Medical College Hospital
2022 - NCT05284175 China
2022 Phase 1 ChiCTR2200057880 China
ORY2001
Oryzon Genomics S. A
2017 Phase 2 EUCTR2017-002838-23-ES Spain
OS440
Osmotica Pharmaceutical US LLC
2018 Phase 3 EUCTR2017-004101-40-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004101-40-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004101-40-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
Other analgesics and antipyretics
GW PHARMA LTD
2008 - EUCTR2006-005910-11-IT Germany;Italy;Spain;United Kingdom
Other disease modifying therapies
University of Maryland, Baltimore
2025 - NCT06864936 United States
Other disease-modifying therapy
Novartis Pharmaceuticals
2011 - NCT01442194 Argentina;Australia;Canada;Chile;Mexico;Puerto Rico;United States
Other H1 antagonist
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
Other nervous system drugs
NOVARTIS FARMA
2011 - EUCTR2011-000770-60-IT Italy
Ovastat 1000
medac Gesellschaft für klinische Spezialpräparate mbH
2007 - EUCTR2006-002856-14-DE Germany
Ovastat 5000
medac Gesellschaft für klinische Spezialpräparate mbH
2007 - EUCTR2006-002856-14-DE Germany
Oxcarbazepine
Queen Mary University London
2014 Phase 2 EUCTR2013-002419-87-GB United Kingdom
Queen Mary University of London
2014 Phase 2 NCT02104661 United Kingdom
Oxiklorin
Varsinais-Suomen sairaanhoitopiirin kuntayhtymä
2022 Phase 2 EUCTR2022-003170-23-FI Finland
Oxine
University of Alabama at Birmingham
2021 Phase 1 NCT03807973 United States
Oxybutynin hydrochloride
Astellas Pharma Inc
2008 Phase 4 NCT00629642 Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Portugal;Russian Federation;Spain;United Kingdom
Ozanimod
Biogen
2021 - NCT05688436 United States
Brigham and Women's Hospital
2022 - NCT05319093 -
Bristol-Myers Squibb
2021 - NCT05335031 Germany
Celgene
2025 Phase 3 NCT06408259 Australia;Italy;Mexico;Poland;Portugal;Romania;Spain;Taiwan;Turkey;United States
2014 Phase 3 NCT02294058 Argentina;Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2015-002500-91-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
I.R.C.C.S. FONDAZIONE S.LUCIA
2022 Phase 4 EUCTR2021-005860-24-IT Italy
Receptos, Inc.
2015 Phase 3 EUCTR2015-002500-91-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
The University of Texas at Dallas
2024 Phase 4 NCT06334094 United States
University of Colorado, Denver
2024 Phase 4 NCT06529406 United States
Ozanimod 0.5 MG
Celgene
2013 Phase 3 NCT02047734 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
Ozanimod 1 MG
Celgene
2013 Phase 3 NCT02047734 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
Ozanimod cloridrato
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2023 Phase 4 EUCTR2023-000018-16-IT Italy
OSPEDALE SAN RAFFAELE
2022 Phase 4 EUCTR2021-003577-63-IT Italy
Ozanimod HCI
Celgene International II Sàrl (CIS II)
2016 Phase 3 EUCTR2015-002500-91-PT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-GR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Ozanimod HCL
CELGENE INTERNATIONAL II SàRL
2016 Phase 3 EUCTR2015-002500-91-IT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Celgene International II Sàrl (CIS II)
2017 Phase 3 EUCTR2015-002500-91-SE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-PL Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-LV Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-LT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-EE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Ozanimod hydrochloride
Celgene International II Sàrl
2016 Phase 1 EUCTR2016-003073-18-GB United Kingdom
Ozanimod oral capsule
I.R.C.C.S. Fondazione Santa Lucia
2023 Phase 4 NCT05777902 Italy
Pain
Ankara Yildirim Beyazit University
2019 - NCT04408742 Turkey
Palifermin
Cambridge University Hospitals NHS Foundation Trust
2012 Phase 1/Phase 2 NCT01712945 United Kingdom
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom
Pantoprazole
Merck KGaA
2008 Phase 1 NCT00938366 -
Paracetamol
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 1 NCT02583594 Spain
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark
Paracetamolo 500 MG
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
Paroxetine
University of Manitoba
2006 Phase 3 NCT00291148 Canada
Part A: 100 MG/ML GSK2618960
GlaxoSmithKline
2013 Phase 1 NCT01808482 United Kingdom
Part B: dose OF GSK2618960 decided from part A
GlaxoSmithKline
2013 Phase 1 NCT01808482 United Kingdom
Part C: dose OF GSK2618960 decided from part A and B
GlaxoSmithKline
2013 Phase 1 NCT01808482 United Kingdom
PB006
Polpharma Biologics S.A.
2019 Phase 3 EUCTR2018-004751-20-PL Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine
2019 Phase 3 EUCTR2018-004751-20-HR Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine
PCV
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
Peak
Bayer
2019 - NCT03808142 Germany
Peanut butter
Rocky Mountain MS Research Group, LLC
2014 Phase 4 NCT02217982 United States
PEG
Bayer
2024 - NCT06053749 Finland;Sweden
PEG-liposomal prednisolone sodium phosphate
Enceladus Pharmaceuticals BV
2010 - EUCTR2009-013884-21-PL Belgium;Germany;Poland
2009 - EUCTR2009-013884-21-DE Belgium;Germany;Poland
2009 Phase 2 EUCTR2009-013884-21-BE Belgium;Germany;Poland
Galapagos NV
2009 Phase 2 NCT01039103 Belgium;Germany;Poland
Peginterferon BETA-1A
Biogen
2021 - NCT05688436 United States
2019 Phase 3 NCT03958877 Argentina;Australia;Belgium;Bulgaria;Croatia;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 NCT03870763 Colombia;Estonia;Hungary;Jordan;Korea, Republic of;Malaysia;Mexico;Saudi Arabia;Taiwan;Thailand;Tunisia;Turkey;United States
2017 Phase 4 NCT03177083 Portugal
2016 Phase 4 NCT02587065 Italy
2016 Phase 4 NCT02568111 -
2014 - NCT02230969 Australia;Austria;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;Switzerland;United Kingdom;United States
2013 - NCT01911767 Australia;Canada;France;Germany;Ireland;Italy;Poland;Spain;United Kingdom;United States
2011 Phase 3 NCT01332019 Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2009 Phase 3 NCT00906399 Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Biogen Idec
2014 Phase 1 NCT02269930 United States
2014 Phase 4 NCT02234869 -
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Peginterferone beta 1A
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
Peginterferone BETA-1A
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Peginterferone lambda-1A
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Pegylated intereron BETA-1A
Biogen Idec Limited
2012 Phase 3 EUCTR2010-024477-39-GR Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2010-024477-39-GB Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2012 - EUCTR2010-024477-39-CZ Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-LV Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-EE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-024477-39-DE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-024477-39-BG Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-BE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Pegylated interferon BETA-1A
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Biogen Idec LTD
2009 - EUCTR2008-006333-27-LV Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom
Biogen Idec Limited
2012 Phase 3 EUCTR2010-024477-39-GR Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2010-024477-39-GB Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2012 - EUCTR2010-024477-39-CZ Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-LV Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-EE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-024477-39-DE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-024477-39-BG Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-BE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2010 - EUCTR2008-006333-27-GR Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom
2010 - EUCTR2008-006333-27-CZ Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-NL Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-006333-27-GB Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-EE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-BG Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-BE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
- - EUCTR2008-006333-27-DE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
Cinnagen
2017 Phase 3 NCT05242133 Iran, Islamic Republic of
Pending
JOSE MANUEL GARCIA DOMINGUEZ
2013 - EUCTR2011-000985-36-ES Spain
Peptid coupled RED blood cells
Cellerys AG
2023 Phase 1;Phase 2 EUCTR2022-000801-28-CZ Czech Republic;Czechia;Germany;Italy;Switzerland
Peptide coupled RED blood cells
Cellerys AG
2023 Phase 1;Phase 2 EUCTR2022-000801-28-IT Czech Republic;Czechia;Germany;Italy;Switzerland
Perfusion OF treatment ocrelizumab
Rennes University Hospital
2023 Phase 3 NCT05758831 France
Perfusion OF treatment rituximab
Rennes University Hospital
2023 Phase 3 NCT05758831 France
Periodized exercise training
Hasselt University
2019 - NCT03803800 Belgium
Peripheral blood stem cell transplantation
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States
Peripheral blood withdrawal
Neuromed IRCCS
2023 - NCT05779449 Italy
Personalized extended interval dosing OF natalizumab
Amsterdam UMC, location VUmc
2020 Phase 4 NCT04225312 Netherlands
PET with 11C-flumazenil
Assistance Publique - Hôpitaux de Paris
2013 - NCT01651520 France
PET with [11C]flumazenil
Institut National de la Santé Et de la Recherche Médicale, France
2019 - NCT03825601 France
PET/CT scan
Mayo Clinic
2023 Phase 2 NCT05805839 United States
PF-06342674 0.25 MG/KG
Pfizer
2014 Phase 1 NCT02045732 United States
PF-06342674 1.5 MG/KG
Pfizer
2014 Phase 1 NCT02045732 United States
PF-06342674 6.0 MG/KG
Pfizer
2014 Phase 1 NCT02045732 United States
Phase 2
Supernus Pharmaceuticals, Inc.
2021 Phase 2/Phase 3 NCT04815967 Czechia;United States
Phase 3
Supernus Pharmaceuticals, Inc.
2021 Phase 2/Phase 3 NCT04815967 Czechia;United States
Phenylcyclopropylamine derivatives and dual LSD1/MAO-B (lysine-specific demethylase 1 and monoamine oxidase-B) inhibitor
Oryzon Genomics S. A
2017 Phase 2 EUCTR2017-002838-23-ES Spain
Phenytoin
University College, London
2011 Phase 2 NCT01451593 United Kingdom
Phosphate
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
PI-2301
PEPTIMMUNE Inc
2008 - EUCTR2007-007759-15-HU Hungary
Peptimmune Inc.
2010 Phase 2 EUCTR2009-012716-40-SK Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 Phase 2 EUCTR2009-012716-40-PL Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 - EUCTR2009-012716-40-FR Bulgaria;Czech Republic;Estonia;France;Germany;Poland
2010 Phase 2 EUCTR2009-012716-40-DE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 Phase 2 EUCTR2009-012716-40-CZ Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 - EUCTR2009-012716-40-BG Bulgaria;Czech Republic;Estonia;France;Germany;Poland
2009 - EUCTR2009-012716-40-EE Bulgaria;Czech Republic;Estonia;France;Germany;Poland
Pioglitazone
National Institute of Allergy and Infectious Diseases (NIAID)
2017 Phase 1/Phase 2 NCT03109288 United States
University of Illinois at Chicago
2003 Phase 1 NCT00242177 United States
PIPE-307
Pipeline Therapeutics, Inc.
2021 Phase 1 NCT04941781 United Kingdom
2021 Phase 1 NCT04725175 Australia
PIPE-307 dose A
Contineum Therapeutics
2023 Phase 2 NCT06083753 United States
PIPE-307 dose B
Contineum Therapeutics
2023 Phase 2 NCT06083753 United States
PIPE-791
Contineum Therapeutics
2024 Phase 1 NCT06683612 United Kingdom
2023 Phase 1 NCT05983939 United States
Pirfenidone
National Institute of Allergy and Infectious Diseases (NIAID)
2017 Phase 1/Phase 2 NCT03109288 United States
Pirtobrutinib
Loxo Oncology, Inc.
2024 Phase 2 NCT06104683 Puerto Rico;United States
Pixantrone
Fondation Charcot Stichting
2009 Phase 1;Phase 2 EUCTR2007-003086-40-BE Belgium;France
2008 - EUCTR2007-003086-40-FR France
PL 04515/0127
Queen Mary, University of London
2009 - EUCTR2008-000256-26-GB United Kingdom
PL 12762/0049
University College London
2010 Phase 4 EUCTR2009-017939-18-GB United Kingdom
Plasma exchange
Biogen Idec
2007 Phase 0 NCT00424788 United States
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
2023 Phase 1 ChiCTR2300076302 China
2020 Phase 0 ChiCTR2000036285 China
Plasticity-based computerized cognitive remediation program
Stony Brook University
2013 - NCT02141022 United States
Platelet transfusion
Region Skane
2016 - NCT02601131 Sweden
Platform
Georgia State University
2021 Phase 4 NCT04387734 United States
Pledigry
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Plegridy
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Bayer
2024 - NCT06053749 Finland;Sweden
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
Holy Name Medical Center, Inc.
2017 Phase 4 NCT03424733 United States
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
Plegridy (peginterferon BETA-1A), biogen idec LTD
Bayer
2016 - NCT02749396 Finland
Plegridy - 125 MCG - soluzione iniettabile - USO sottocutaneo - penna preriempita - 0,5 ML - 6 penne preriempite
BIOGEN IDEC ITALIA S.R.L.
2015 Phase 4 EUCTR2015-002201-11-IT Italy
Plegridy 125 micrograms
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Plegridy 63 micrograms
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Pleneva TM BGC20-0134
Boston Scientific Corporation
2009 Phase 2 NCT01037907 Belgium;France;Germany;Italy;Poland;Russian Federation;Spain
Plovamer acetate
Merck KGaA
2014 - EUCTR2013-002283-25-PL Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-GR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 Phase 2 EUCTR2013-002283-25-GB Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-ES Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-BG Bulgaria;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2013-002283-25-IT Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-HU Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-HR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-FI Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-CZ Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
Plovamer acetate 10 MG
EMD Serono
2013 Phase 2 NCT01963611 Bulgaria;Croatia;Czech Republic;Finland;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
Plovamer acetate 20 MG
EMD Serono
2013 Phase 2 NCT01963611 Bulgaria;Croatia;Czech Republic;Finland;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
Plovamer acetate 3 MG
EMD Serono
2013 Phase 2 NCT01963611 Bulgaria;Croatia;Czech Republic;Finland;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
PLP peptide
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland
Pneumococcal polysaccharide vaccine
Celgene
2021 Phase 3 NCT05028634 Germany;United States
Pneumovax II
R & D, Cambridge University Hospitals
2009 - EUCTR2009-011523-31-GB United Kingdom
PNF
Somogy Megyei Kaposi Mór Teaching Hospital
2018 - NCT04550650 Hungary
PNU-215062 sodium salt
Teva Pharmaceutical Industries Ltd
2006 Phase 2 EUCTR2005-004334-41-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 - EUCTR2004-003943-28-HU Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 Phase 2 EUCTR2004-003943-28-GB Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 Phase 2 EUCTR2004-003943-28-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 - EUCTR2004-003943-28-DE Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 - EUCTR2004-003943-28-CZ Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
Polyphenon E
Louisiana State University Health Sciences Center in New Orleans
2011 Phase 2 NCT01451723 United States
2009 Phase 1 NCT00836719 United States
Ponesimod
ACTELION Pharmaceuticals Ltd
2010 Phase 2 EUCTR2009-011470-15-PL Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-NL Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-HU Australia;Austria;Bulgaria;Canada;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-GB Austria;Bulgaria;Canada;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-FI Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-DE Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-CZ Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-BG Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-AT Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
ACTELION Pharmaceuticals Ltd.
2010 Phase 2 EUCTR2009-011470-15-SE Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Actelion
2017 Phase 3 NCT03232073 Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 NCT02907177 Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Mexico;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;United Kingdom;United States
2015 Phase 3 NCT02425644 Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Actelion Pharmaceuticals Ltd
2015 Phase 3 EUCTR2012-000540-10-SE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-PT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-PL Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LV Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-HU Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-HR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-GR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FI Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-ES Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-DE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-CZ Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Actelion Pharmaceuticals Ltd.
2019 Phase 3 EUCTR2012-000541-12-HR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Mexico;Poland;Portugal;Russian Federation;Spain;Switzerland;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-RO Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-PT Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-LV Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-HU Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-HR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-GR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-GB Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-FI Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-CZ Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-BG Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2012-000541-12-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2017 Phase 3 EUCTR2016-004719-10-SE Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2016-004719-10-PL Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2016-004719-10-LT Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2016-004719-10-ES Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2012-000541-12-PL Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2017 Phase 3 EUCTR2012-000541-12-FR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2017 Phase 3 EUCTR2012-000541-12-FI Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2017 Phase 3 EUCTR2012-000541-12-BG Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-PT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-HU Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-GR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-ES Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-DK Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-DE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-CZ Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-AT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
Biogen
2021 - NCT05688436 United States
JANSSEN CILAG INTERNATIONAL NV
2023 Phase 3 EUCTR2020-004431-24-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
Janssen-Cilag International NV
2023 Phase 3 EUCTR2020-004431-24-PT Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2023 Phase 3 EUCTR2020-004431-24-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
2023 Phase 3 EUCTR2020-004431-24-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
2023 Phase 3 EUCTR2020-004431-24-DE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2023 Phase 3 EUCTR2020-004431-24-BG Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2022 Phase 3 EUCTR2020-004431-24-SE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
- Phase 3 EUCTR2020-004431-24-Outside-EU/EEA Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
- Phase 3 EUCTR2020-004431-24-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
Ponesimod 10 MG
Actelion
2010 Phase 2 NCT01093326 Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Ponesimod 20 MG
Actelion
2010 Phase 2 NCT01093326 Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Ponesimod 40 MG
Actelion
2010 Phase 2 NCT01093326 Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Ponvory
Janssen-Cilag International NV
2023 Phase 3 EUCTR2020-004431-24-DE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2023 Phase 3 EUCTR2020-004431-24-BG Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
Position sense
Ankara Yildirim Beyazit University
2019 - NCT04408742 Turkey
2019 - NCT04286828 Turkey
Pravastatin
Nantes University Hospital
2004 Phase 3 NCT00200655 France
PRD806998
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
Prebiotics and probiotics supplementation
Neuromed IRCCS
2023 - NCT05779449 Italy
Prednisolone
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
Tohoku University Hospital
2013 Phase 1,2 JPRN-UMIN000010094 Japan
Prednisone
Claudio Gobbi
2011 Phase 4 NCT01411514 Switzerland
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States
Holy Name Medical Center, Inc.
2017 Phase 4 NCT03424733 United States
National Eye Institute (NEI)
1988 - NCT00000147 United States
1988 Phase 3 NCT00000146 United States
National Institute of Neurological Disorders and Stroke (NINDS)
2016 Phase 2 NCT02784210 United States
Teva Pharmaceutical Industries
2005 Phase 4 NCT00203047 Canada;United States
The Affiliated Hospital of Guangdong Medical University
2024 Phase 3 ChiCTR2400087660 China
Third Affiliated Hospital, Sun Yat-Sen University
2016 Phase 4 NCT02809079 -
West China Hospital,Sichuan University
2024 Phase 4 ChiCTR2400087203 China
Pregabalin
Pfizer Japan Inc.
2010 Phase 3 JPRN-jRCT2080221298 -
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
2010 Phase 3 NCT01202227 Japan
University of Manitoba
2006 Phase 3 NCT00291148 Canada
Prepulsid
Department of Neurology UMCG
2006 - EUCTR2006-004318-42-NL Netherlands
Prevenar 13
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
PRN2246
GENZYME CORPORATION
2022 Phase 3 EUCTR2020-000644-55-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
Genzyme Corporation
2022 Phase 3 EUCTR2020-000644-55-EE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000647-30-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000647-30-FR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000647-30-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000647-30-RO Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-NO Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-FI Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-RO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-NO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-FR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-DK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-CZ Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-BG Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NO Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HR Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-BE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-RO Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-SK Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-NL Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-FR Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-ES Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-EE Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-CZ Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-SK Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-SE Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-NL Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-ES Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-EE Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
Procedure/surgery: implant procedure
SetPoint Medical Corporation
2025 - NCT06796504 -
Progressive exercise
University of Iowa
2010 Phase 1 NCT01381354 United States
Prolonged-release fampridine
University of Zurich
2012 Phase 2 NCT01576354 Switzerland
Propensity score
University Hospital, Clermont-Ferrand
2018 - NCT03552211 France
Propionic acid 1000 MG capsule
Salzburger Landeskliniken
2024 Phase 2/Phase 3 NCT06402487 Austria
Protein A immunoadsorption
The Third Affiliated Hospital Sun Yat-sen University
2025 - ChiCTR2500100495 China
Third Affiliated Hospital, Sun Yat-Sen University
2025 - NCT06763848 China
Provigil
Institute for Clinical Research
2003 - NCT00210301 United States
Sheba Medical Center
2005 - NCT00220506 Israel
Prucalopride
2010 Phase 4 EUCTR2010-023996-25-BE Belgium
Psilocybin therapy
University Medical Center Groningen
2025 Phase 2 NCT06782724 -
PSP
Biogen
2019 - NCT04221191 France
PTL201
PhytoTech Therapeutics, Ltd.
2018 Phase 2 NCT03005119 Israel
Qalcimum questionnaire
Centre Hospitalier Universitaire de Nimes
2016 - NCT02636829 France
Quadrivalent influenza vaccine
Novartis Pharmaceuticals
2021 Phase 4 NCT04667117 United States
Quality OF life
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France
Quality OF life questionnaires
University Hospital, Strasbourg, France
2025 Phase 3 NCT06663189 France
Questionnaires
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France
Quinidina sulfato
Avanir Pharmaceuticals, Inc.
2011 Phase 2 EUCTR2011-002178-22-ES Argentina;Bulgaria;Czech Republic;Poland;Spain;United Kingdom;United States
Quinidine sulfate
Avanir Pharmaceuticals, Inc.
2012 - EUCTR2011-002178-22-PL Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2012 Phase 2 EUCTR2011-002178-22-GB Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2012 - EUCTR2011-002178-22-CZ Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
R lipoic acid
Oregon Health and Science University
2005 Phase 1 NCT00676156 United States
RA15804589, C19061501-F, DNL788, DN2489, DN0002489
Sanofi-aventis recherche & développement
2022 Phase 2 EUCTR2022-000049-34-ES Belgium;Canada;China;Czechia;France;Germany;Italy;Poland;Spain;United States
Rabbit
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
Rabbit ANTI-human thymocyte immunoglobulin
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom
Rabbit human T lymphocyte immunoglobulin
Uppsala l?ns landsting
2011 Phase 2 EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States
Radiation therapy
Baylor College of Medicine
1999 Phase 2 NCT00040482 United States
Radiotracer [11C]-CS1p1
Washington University School of Medicine
2024 - NCT06591429 United States
Radiotracer [11C]-DPA-713
Washington University School of Medicine
2024 - NCT06591429 United States
Radiotracer [12F]-FDG
Washington University School of Medicine
2024 - NCT06591429 United States
Ralenova
University Medical Center Hamburg Eppendorf
2007 - EUCTR2007-001962-34-DE Germany
Raltegravir
Queen Mary University of London
2013 Phase 2 NCT01767701 United Kingdom
2013 - EUCTR2012-004847-61-GB United Kingdom
Ramatroban
Iou hospital
2008 - JPRN-UMIN000002725 Japan
Ranitidine
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain
Raptiva 100 MG/ML powder and solvent FOR solution FOR injection
Merck Serono International S.A.
2009 - EUCTR2007-001377-28-PT Austria;France;Germany;Netherlands;Portugal
2008 - EUCTR2007-001377-28-NL Austria;France;Germany;Netherlands;Portugal
2008 Phase 4 EUCTR2007-001377-28-FR Austria;France;Germany;Netherlands;Portugal
2008 - EUCTR2007-001377-28-DE Austria;France;Germany;Netherlands;Portugal
2008 - EUCTR2007-001377-28-AT Austria;France;Germany;Netherlands;Portugal
Ratg
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States
2017 Phase 3 NCT03342638 United States
Ravulizumab
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 3 EUCTR2019-003352-37-IT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
Alexion Pharma GK
2020 Phase 3 JPRN-jRCT2080225205 Asia except Japan;Europe;Japan;North America
Alexion Pharmaceuticals, Inc.
2022 Phase 2/Phase 3 NCT05346354 Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2022 Phase 2;Phase 3 EUCTR2021-006075-42-FR Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2022 Phase 2;Phase 3 EUCTR2021-006075-42-ES Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2020 Phase 3 EUCTR2019-003352-37-PL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-NL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-ES Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-DK Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-DE Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-AT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2019 Phase 3 NCT04201262 Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Poland;Spain;United Kingdom;United States
- Phase 2;Phase 3 EUCTR2021-006075-42-DE Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
University of Texas Southwestern Medical Center
2024 - NCT06398158 United States
Wuebbenhorst Hiroaki
2021 Phase 2-3 JPRN-jRCT2031220259 Japan;Spain;US
RC18 160 MG
RemeGen Co., Ltd.
2018 Phase 3 NCT03330418 China
RC18 160MG
RemeGen Co., Ltd.
2021 Phase 2 NCT04625153 China
RC18 240MG
RemeGen Co., Ltd.
2021 Phase 2 NCT04625153 China
RD06-05 cart cell injection
Nanjing Bioheng Biotech Co., Ltd.
2025 Early Phase 1 NCT06775912 China
Rebif
Aaron Boster
2006 Phase 0 NCT00618527 United States
Bayer
2024 - NCT06053749 Finland;Sweden
2006 Phase 4 NCT00317941 France
Biocad
2014 Phase 2/Phase 3 NCT02727907 Russian Federation
Biogen Idec
2014 Phase 1 NCT02269930 United States
Brigham and Women's Hospital
2015 - NCT02419638 United States
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark
EMD Serono
2014 Phase 4 NCT02117050 United States
2010 - NCT01207648 Argentina;Canada;France;Italy;Russian Federation;Tunisia;United States;Venezuela
2010 Phase 4 NCT01085318 United States
2004 Phase 4 NCT00101959 United States
1999 Phase 3 NCT00292266 -
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020337-99-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020337-99-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-FR Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020315-36-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 - EUCTR2010-020337-99-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-FI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
Genzyme Corporation
2008 - EUCTR2007-001162-32-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-NL Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-IT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-001162-32-CZ Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-AT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001161-14-SE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 - EUCTR2007-001161-14-PL Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 Phase 3 EUCTR2007-001161-14-FR Czech Republic;France;Germany;Poland;Sweden;United Kingdom
2008 - EUCTR2007-001161-14-DE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 - EUCTR2007-001161-14-CZ Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2007 Phase 3 EUCTR2007-001162-32-GB Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2007 - EUCTR2007-001161-14-GB Czech Republic;France;Germany;Poland;Sweden;United Kingdom
IMS HEALTH GmbH & Co. OHG
2016 - NCT02823951 Canada;United States
Karolinska Institutet
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
MERCK ROMANIA SRL
2014 Phase 4 EUCTR2014-001290-14-RO Romania
MERCK SERONO SA
2010 - EUCTR2009-016087-37-IT France;Ireland;Italy;Spain;United Kingdom
MERCK SERONO SPA
2009 - EUCTR2009-013333-24-IT Italy
Medizinische Universität Innsbruck
2014 - EUCTR2012-005450-30-SE Austria;Sweden
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden
Merck KGaA
2013 Phase 4 NCT01791244 Germany;Sweden
2012 - NCT01601119 United Kingdom
2010 - NCT01101776 Australia
2009 Phase 2 NCT01198132 France
2009 - NCT01075880 Czech Republic
2005 Phase 4 NCT01142466 -
2004 - NCT01142557 Germany
2004 Phase 4 NCT00367484 -
Merck KGaA, Darmstadt, Germany
2017 - NCT02949908 Germany
2016 - NCT02921035 Algeria;Argentina;Bahrain;Bulgaria;Egypt;Germany;Hungary;Iran, Islamic Republic of;Korea, Republic of;Kuwait;Lebanon;Morocco;Poland;Saudi Arabia;Tunisia;United Arab Emirates
2014 Phase 4 NCT02254304 Germany
2014 Phase 4 NCT02064816 Germany
Merck Serono International SA
2007 - EUCTR2006-003037-32-LT Estonia;Germany;Italy;Lithuania;Spain
2007 Phase 3 EUCTR2006-003037-32-ES Estonia;Germany;Italy;Lithuania;Spain
2007 - EUCTR2006-003037-32-EE Estonia;Germany;Italy;Lithuania;Spain
Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA
2007 Phase 3 EUCTR2006-002982-38-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain
2007 - EUCTR2006-002982-38-EE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
2009 - EUCTR2008-004954-34-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain
Merck Serono S.A. - Geneva
2010 - EUCTR2009-016087-37-GB France;Ireland;Italy;Spain;United Kingdom
2009 - EUCTR2009-016087-37-ES France;Ireland;Italy;Spain;United Kingdom
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2007 - EUCTR2006-002982-38-PT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2007 - EUCTR2006-002982-38-DE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-FI Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-CZ Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2010 - EUCTR2008-004954-34-AT Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 Phase 3 EUCTR2008-004954-34-SK Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 Phase 3 EUCTR2008-004954-34-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain
2009 - EUCTR2008-004954-34-PL Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 - EUCTR2008-004954-34-LV Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain
2009 - EUCTR2008-004954-34-FI Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 - EUCTR2008-004954-34-EE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 - EUCTR2008-004954-34-DE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 - EUCTR2008-004954-34-BG Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 Phase 3 EUCTR2008-004954-34-BE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2008 - EUCTR2008-004954-34-CZ Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
Merck Serono S.A.- Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2009 Phase 3 EUCTR2008-004954-34-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain
Merck Serono S.A.-Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 Phase 3 EUCTR2006-002982-38-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain
Merck Serono SA
2007 - EUCTR2006-003037-32-DE Estonia;Germany;Italy;Lithuania;Spain
Merck Serono SA – Geneva
2010 - EUCTR2009-015502-19-GB Belgium;Finland;Germany;Sweden;United Kingdom
2010 - EUCTR2009-015502-19-DE Belgium;Finland;Germany;Sweden;United Kingdom
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
PD Dr. Marcus Müller
2015 Phase 1 NCT02364986 Germany
Queen Mary, University of London
2009 - EUCTR2008-000256-26-GB United Kingdom
ROCHE
2011 Phase 3 EUCTR2010-020337-99-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IT Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Sahlgrenska University Hospital
2005 Phase 4 EUCTR2005-001008-37-SE Sweden
Serono International SA
2005 Phase 3 EUCTR2004-003799-13-ES Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
2004 Phase 4 EUCTR2004-000337-12-HU Hungary
Teva Pharmaceutical Industries
2004 Phase 4 NCT00202995 Canada;United States
The Multiple Sclerosis Research Group, Department of Clinical Neuroscience
2009 - EUCTR2008-008554-23-SE Sweden
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University of North Carolina, Chapel Hill
2004 - NCT00137176 United States
Universitätsklinikum Heidelberg
2006 Phase 3 EUCTR2004-004403-37-DE Germany
VU University Medical Center
2011 - EUCTR2011-003570-89-NL Netherlands
Waukesha Memorial Hospital
2008 - NCT00391352 United States
sanofi-aventis Recherche & Dévelopment
2009 - EUCTR2008-006226-34-FR Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 Phase 3 EUCTR2008-006226-34-GR Belgium;Czech Republic;France;Germany;Greece;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis recherche et developpement
2010 - EUCTR2008-006226-34-GB Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-HU Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-CZ Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
Rebif (interferon BETA-1A), merck serono europe LTD
Bayer
2016 - NCT02749396 Finland
Rebif 22
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
Rebif 22 micrograms
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Rebif 22 Y 44 MCG
Merck, S.L.
2006 Phase 4 EUCTR2006-000606-23-ES Spain
Rebif 44
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
Rebif 44 microgrammi/0.5ML soluzione iniettabile IN cartuccia
Merck Serono S.p.A.
2014 Phase 4 EUCTR2013-004450-21-IT Italy
Rebif 44 microgramos solucióN inyectable
Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
2009 Phase 3 EUCTR2008-004954-34-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 - EUCTR2006-002982-38-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
Rebif 44 microgramos solucióN inyectable EN jeringa precargada
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Rebif 44 micrograms
Biogen Idec GmbH
2005 - EUCTR2004-004130-14-AT Austria
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Rebif 44 micrograms solution FOR injection
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
Merck Serono S.A. - Geneva
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
Rebif 44 micrograms solution FOR injection IN PRE-filled syringe
Biogen Idec Limited
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Rebif 44 µG
Serono GmbH
2005 - EUCTR2005-001026-89-DE Germany
Rebif 8,8 µG, rebif 22µG
Serono GmbH
2005 - EUCTR2005-001026-89-DE Germany
Rebif 8.8 micrograms and 22 micrograms solution FOR injection IN PRE-filled syringe initiation pack
Biogen Idec Limited
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Rebif NEW formulation + ibuprofen PRN
Merck KGaA
2007 Phase 3 NCT00619307 France;Germany
Rebif NEW formulation + prophylactic ibuprofen
Merck KGaA
2007 Phase 3 NCT00619307 France;Germany
Rebif NEW formulation 44MCG multidose cartridge
Merck Serono International S.A.
2008 - EUCTR2008-000499-25-SE Germany;Italy;Spain;Sweden
2008 - EUCTR2008-000499-25-ES Germany;Italy;Spain;Sweden
- - EUCTR2008-000499-25-DE Germany;Italy;Spain;Sweden
Rebif NEW formulation NON titrated
EMD Serono
2007 Phase 3 NCT00472797 United States
Rebif NEW formulation titrated
EMD Serono
2007 Phase 3 NCT00472797 United States
Rebif SC 12SIR 12000000ui44MCG
Universita di Firenze
2006 Phase 3 EUCTR2006-004937-13-IT Italy
Rebif SC 12SIR 6000000UI 22MCG
Universita di Firenze
2006 Phase 3 EUCTR2006-004937-13-IT Italy
Rebif*SC 12SIR 12000000ui44MCG
MERCK SERONO INTERNATIONAL SA
2008 - EUCTR2006-003366-33-IT Italy;Spain
MERCK SERONO SA
2009 - EUCTR2008-004954-34-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain
2009 - EUCTR2008-003706-33-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
OSPEDALE S. RAFFAELE
2004 - EUCTR2004-001601-10-IT France;Italy
Rebif*SC 12SIR 6000000UI 22MCG
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Rebif® NEW formulation
EMD Serono
2008 Phase 3 NCT00725985 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;India;Italy;Korea, Republic of;Lebanon;Macedonia, The Former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Merck KGaA
2008 - NCT01080027 Greece
2006 Phase 3 NCT00441103 Canada;Germany;Italy;Russian Federation;Spain;Switzerland
Rebif® NEW formulation (RNF) using rebismarttm
EMD Serono
2008 Phase 3 NCT00735007 Canada;Germany;Italy;Spain;Sweden;United States
Recombinant human alpha B-crystallin
Delta Crystallon B.V.
2012 - EUCTR2011-004475-36-BG Bulgaria
Delta Crystallon BV
2012 Phase 2 NCT02442570 Bulgaria
2009 Phase 1 NCT02442557 Netherlands
Recombinant human erythropoietin
Walton Centre for Neurology and Neurosurgery
2008 - EUCTR2008-005125-11-GB United Kingdom
Recombinant human IFN beta
Merck Serono International SA
2007 - EUCTR2006-005972-42-DE France;Germany
Recombinant human interferon beta
Serono International SA
2004 Phase 4 EUCTR2004-000337-12-HU Hungary
Recombinant humanized ANTI-alpha 4 integrin antibody
BIOGEN IDEC LTD
2007 - EUCTR2005-004061-41-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2007 - EUCTR2005-004061-41-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom
2006 - EUCTR2005-004061-41-IE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Spain;Sweden;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
Recombinant humanized ANTI-CD20 monoclonal antibody
F. Hoffmann-La Roche Ltd.
2022 Phase 4 EUCTR2021-003296-33-GR Greece;Russian Federation
Recombinant interferon BE
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Recombinant interferon BETA-1B
Bayer AG
2017 Phase 4 EUCTR2017-001176-31-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
Bayer HealthCare AG
2013 - EUCTR2012-005262-35-SI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-IT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Recombinant neisseria meningitidis group B nhba fusion protein
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Recombinant zoster vaccine
Prof Patrice Lalive
2022 Phase 4 NCT05596526 Switzerland
Remibrutinib
Iwasaki Ryohei
2023 Phase 3 JPRN-jRCT2071220034 France;Italy;Japan;Poland;Portugal;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;US
NOVARTIS PHARMA AG
2022 Phase 3 EUCTR2020-005929-89-IT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Japan;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-IT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Guatemala;Hong Kong;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
Novartis Farmacéutica S.A.
2022 Phase 3 EUCTR2020-005929-89-ES Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-ES Slovakia;Spain
Novartis Pharma AG
2023 Phase 3 EUCTR2020-005899-36-LT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2023 Phase 3 EUCTR2020-005899-36-DK Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2023 Phase 3 EUCTR2020-005899-36-AT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;Finland;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SK Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SI Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-RO Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Türkiye;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-PT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-PL Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Türkiye;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-HR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-GR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-FR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-EE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-BG Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-SK Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-NL Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-LV Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-HR Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-BG Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-BE Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
Novartis Pharmaceuticals
2021 Phase 3 NCT05156281 Argentina;Brazil;Bulgaria;Canada;China;Croatia;Estonia;France;Greece;India;Italy;Japan;Mexico;Poland;Portugal;Puerto Rico;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2021 Phase 3 NCT05147220 Argentina;Austria;Belgium;Brazil;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Georgia;Guatemala;Hong Kong;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Saudi Arabia;Slovakia;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
Remibrutinib oral treatment
Novartis Pharmaceuticals
2025 Phase 3 NCT06846281 -
Repository corticotropin injection
Mallinckrodt
2017 Phase 4 NCT03126760 United States
The University of Texas Health Science Center, Houston
2013 Phase 4 NCT01888354 United States
University at Buffalo
2009 Phase 2 NCT00986960 United States
Revaxis
R & D, Cambridge University Hospitals
2009 - EUCTR2009-011523-31-GB United Kingdom
University of Nottingham
2010 Phase 2 EUCTR2007-001496-11-GB United Kingdom
REX robotic assisted balance exercises
East Kent Hospitals University NHS Foundation Trust
2018 Phase 1 NCT06429085 United Kingdom
RHB-104
RedHill Biopharma Limited
2013 Phase 2 NCT01717664 Israel
Rhepo
Walton Centre for Neurology and Neurosurgery
2008 - EUCTR2008-005125-11-GB United Kingdom
Rhifn BETA-1B
Nuron Biotech Inc.
2011 Phase 3 NCT01464905 Belarus;Bulgaria;Croatia;Georgia;Hungary;India;Italy;Lebanon;Poland;Russian Federation;Serbia;Spain;Ukraine
Rhigm22
Acorda Therapeutics
2015 Phase 1 NCT02398461 United States
2013 Phase 1 NCT01803867 United States
Rhumab 2h7
Hoffman La Roche Ltd
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
Rhumab TO IL-17A IGG1-K-class
Novartis Pharma Services AG
2012 - EUCTR2011-001629-25-CZ Czech Republic;Russian Federation;Ukraine
Rhuph20
Hoffmann-La Roche
2019 Phase 1 NCT03972306 Canada;United States
Riboflavin
University of Iowa
2010 Phase 1 NCT01381354 United States
Rifampicin
Sanofi
2020 Phase 1 NCT06064539 United States
Rifampin
National Center for Research Resources (NCRR)
2001 Phase 2 NCT00043264 United States
Rilutek
UCL
2014 Phase 2 EUCTR2012-005394-31-GB United Kingdom
Riluzole
S. Andrea Hospital
2005 Phase 2 NCT00202397 Italy
UCL
2014 Phase 2 EUCTR2012-005394-31-GB United Kingdom
University College, London
2014 Phase 2 NCT01910259 United Kingdom
University of California, San Francisco
2006 Phase 2 NCT00501943 United States
RIPK1 inhibitor
Sanofi
2021 Phase 1 NCT04982991 United Kingdom
Ritalin
Sheba Medical Center
2003 Phase 1 NCT00220493 Israel
Ritalin LA 20MG capsules
Medizinische Universität Wien
2012 Phase 2 EUCTR2012-003418-15-AT Austria
Ritalin LA 30MG capsules
Medizinische Universität Wien
2012 Phase 2 EUCTR2012-003418-15-AT Austria
Ritalin LA 40MG capsules
Medizinische Universität Wien
2012 Phase 2 EUCTR2012-003418-15-AT Austria
Rituximab
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
Amsterdam UMC, location VUmc
2023 Phase 3 NCT05834855 Netherlands
Anders Svenningsson
2016 Phase 3 NCT02746744 Sweden
2009 Phase 2 NCT01719159 Sweden
Cairo University
2024 Phase 2 NCT06599307 Egypt
Centre Hospitalier de Pau
2015 Phase 2 EUCTR2014-005493-11-FR France
Claudio Gobbi
2020 - NCT04640818 Switzerland
Clinical Research Center, NHO Utano National Hospital
2014 Phase 2,3 JPRN-UMIN000013453 Japan
Clinical Research Center, Utano National Hospital, National Hospital Organization
2015 Phase 2,3 JPRN-UMIN000017217 Japan
Danish Multiple Sclerosis Center, Rigshospitalet
2020 Phase 3 EUCTR2020-002981-15-DK Denmark
Department of Clinical Sciences, Danderyd Hospital
2015 Phase 3 EUCTR2015-004116-38-SE Sweden
Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital
2018 Phase 2 EUCTR2018-000721-31-SE Sweden
Department of Pediatrics, Kobe Universtiy Graduate School of Medicine
2012 - JPRN-UMIN000009421 Japan
Dept of Neurology
2009 Phase 2 EUCTR2008-002626-11-SE Sweden
Dept of Neurology, Umeå University Hospital, Umeå, Sweden
2012 Phase 2 EUCTR2012-000721-53-SE Sweden
Feng Jinzhou
2023 - NCT06068829 -
Genentech, Inc.
2004 Phase 2 NCT00097188 United States
2004 Phase 2/Phase 3 NCT00087529 Canada;United States
Haukeland University Hospital
2020 Phase 3 NCT04578639 Norway;Sweden
Helse Bergen HF, Haukeland University Hospital
2022 Phase 3 EUCTR2020-001205-23-SE Norway;Sweden
2020 Phase 3 EUCTR2020-001205-23-NO Norway;Sweden
Isfahan University of Medical Sciences
2017 Phase 2/Phase 3 NCT03315923 Iran, Islamic Republic of
2015 Phase 2/Phase 3 NCT03002038 Iran, Islamic Republic of
Johns Hopkins University
2014 Phase 1 NCT02253264 United States
Karolinska Institutet
2018 Phase 3 NCT03979456 Sweden
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
National Institute of Neurological Disorders and Stroke (NINDS)
2010 Phase 1/Phase 2 NCT01212094 United States
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States
Odense University Hospital
2013 Phase 2 EUCTR2012-004436-36-DK Denmark
Oslo University Hospital
2019 Phase 3 NCT04121403 Norway
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark
Shandong University Qilu Hospital
2021 Phase 4 ChiCTR2100043013 China
Tang-Du Hospital
2014 Phase 4 NCT04256252 -
The Ophthalmology Department of the Chinese Peoples Liberation Army Hospital
2019 Phase 4 ChiCTR1900025744 China
2014 - ChiCTR-ICR-15007177 China
University of California, San Francisco
2004 Phase 1 NCT00501748 United States
University of Colorado, Denver
2017 Phase 3 NCT02980042 United States
2012 Phase 2 NCT01569451 United States
Västerbottens Läns Landsting
2014 Phase 2 EUCTR2013-002378-26-SE Sweden
Västerbottens läns landsting
2011 - EUCTR2010-023021-38-SE Sweden
Rituximab infusion
Wake Forest University Health Sciences
2013 Phase 4 NCT02040116 United States
Rituximab IT
Centre Hospitalier de PAU
2015 Phase 2 NCT02545959 France
Rituximab IV
Centre Hospitalier de PAU
2015 Phase 2 NCT02545959 France
Rituximab konsentrat TIL infusjonsvaeske oppløsning 10 MG/ML
Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital
2019 Phase 3 EUCTR2019-001505-24-NO Norway
Rivastigmin
Novartis Pharma GmbH
- - EUCTR2008-007015-32-DE Germany
Rivastigmine transdermal patch
Novartis Pharmaceuticals
2009 Phase 4 NCT00881205 Germany
Rixathon
Danish Multiple Sclerosis Center, Rigshospitalet
2020 Phase 3 EUCTR2020-002981-15-DK Denmark
RNF
EMD Serono
2008 Phase 3 NCT00725985 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;India;Italy;Korea, Republic of;Lebanon;Macedonia, The Former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Merck KGaA
2008 Phase 3 NCT00813709 Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Turkey
2006 Phase 3 NCT00441103 Canada;Germany;Italy;Russian Federation;Spain;Switzerland
2006 Phase 3 NCT00404352 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Turkey
RNS60
University Hospital Zürich
2014 Phase 2 EUCTR2014-000221-20-AT Austria;Switzerland
RNS60 125 ML
Revalesio Corporation
2013 Phase 2 NCT01714089 United States
RNS60 250 ML
Revalesio Corporation
2013 Phase 2 NCT01714089 United States
RO 496-4913/F03
F.Hoffmann-La Roche
2011 Phase 3 EUCTR2010-020338-25-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2010-020338-25-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
RO 496-4913/F07
F.Hoffmann-La Roche
2013 Phase 3 EUCTR2010-020338-25-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-GR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
RO 533-3787/F01- 06
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2019-004092-39-IT Argentina;France;Italy;Mexico;Poland;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2019-004092-39-PL Argentina;France;Italy;Mexico;Poland;United Kingdom;United States
2022 Phase 3 EUCTR2019-004092-39-FR Argentina;France;Italy;Mexico;Poland;Ukraine;United Kingdom;United States
RO0506997
F. Hoffmann-La Roche Ltd
2007 Phase 2 EUCTR2004-004519-43-SK Czech Republic;Germany;Slovakia;Spain;United Kingdom
2007 - EUCTR2004-004519-43-GB Czech Republic;Germany;Spain;United Kingdom
2007 - EUCTR2004-004519-43-DE Czech Republic;Germany;Spain;United Kingdom
2005 Phase 2 EUCTR2004-004519-43-CZ Czech Republic;Germany;Slovakia;Spain;United Kingdom
RO4964913
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2019-003919-53-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-005448-48-IT Brazil;Czech Republic;Czechia;France;Italy;Poland;Spain
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3;Phase 4 EUCTR2017-004886-29-IT Belgium;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
F. Hoffmann - La Roche
2010 Phase 3 EUCTR2010-020338-25-IT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Poland;Portugal;Spain;United Kingdom
F. Hoffmann-La Roche Ltd
2023 Phase 3 EUCTR2020-004128-41-RO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2023 Phase 3 EUCTR2020-004128-41-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-005448-48-FR Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2022 Phase 3 EUCTR2020-005448-48-CZ Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2022 Phase 3 EUCTR2020-004128-41-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 4 EUCTR2021-000063-79-ES Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000063-79-DE Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000062-14-ES Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000062-14-DE Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 3 EUCTR2020-005448-48-PL Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2020-004128-41-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2017-004886-29-SK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-SI Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-PT Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-PL Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-HU Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-HR Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-BG Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-BE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2020 Phase 3 EUCTR2019-003919-53-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-003919-53-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2017-001313-93-DE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2019 Phase 3 EUCTR2017-004886-29-IE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-SE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-NL Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-GB Czech Republic;Denmark;Estonia;Finland;France;Ireland;Netherlands;Spain;Sweden;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-FR Belgium;Bulgaria;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-FI Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-EE Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-DK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-001313-93-PL Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-IE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-HU Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Kuwait;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-FR Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Kuwait;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-DK Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-CZ Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
- Phase 3 EUCTR2020-004128-41-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd.
2022 Phase 4 EUCTR2021-003296-33-GR Greece;Russian Federation
2022 Phase 3 EUCTR2020-004128-41-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F.Hoffmann-La Roche
2013 Phase 3 EUCTR2010-020338-25-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-GR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020338-25-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Portugal;Spain;United Kingdom
2011 Phase 3 EUCTR2010-020338-25-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020337-99-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-FR Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020315-36-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2010-020338-25-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2010-020338-25-ES Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Greece;Hungary;Italy;Lithuania;Portugal;Spain;United Kingdom
2010 - EUCTR2010-020337-99-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-FI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States
F.Hoffmann-La Roche Ltd.
2008 - EUCTR2007-006338-32-IT Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Russian Federation;Spain;Switzerland;Ukraine;United Kingdom;United States
Hoffman La Roche Ltd
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
ROCHE
2018 Phase 4 EUCTR2018-000780-91-FR France
2011 Phase 3 EUCTR2010-020337-99-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IT Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-005448-48-ES Brazil;Czechia;France;Italy;Spain
Roche Farma S.A(Soc. Unipersonal) que realiza el ensayo en España y actúa como representante de F. Hoffmann-La Roche LTD
2018 Phase 3 EUCTR2017-001313-93-ES Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;France;Guatemala;Hungary;Ireland;Italy;Kuwait;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates
Roche Farma SA (Soc unipersonal) que realiza el ensayo en España y que actúa como representante F.Hoffmann-La Roche Ltd
2018 Phase 3 EUCTR2017-004886-29-ES Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom
University Nice Hospital
2022 Phase 3 EUCTR2021-006107-15-FR France
RO4964913 F07
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020337-99-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
RO4964913/F03
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
RO4964913/F07
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2021-005746-15-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-005597-38-IT Belgium;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2021-005746-15-SK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-SE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-RO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-NO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-LT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-FI Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-CZ Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-AT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-005597-38-SE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-NL Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-IE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-GB Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-FR Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-FI Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-EE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-DK Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-DE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-CZ Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-BE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
GENENTECH Inc.
2016 Phase 3 EUCTR2015-004616-37-SE Germany;Sweden;Switzerland;United States
2016 Phase 3 EUCTR2015-004616-37-DE Germany;Sweden;Switzerland;United States
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-SK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2021-005746-15-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
Roche Farma S.A. que representa en España a F. Hoffmann-La Roche Ltd
2016 Phase 3 EUCTR2015-005597-38-ES Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
RO4964913/F07-01
F. HOFFMANN - LA ROCHE LTD.
2020 Phase 3 EUCTR2020-000894-26-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-IT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-IT Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 2 EUCTR2016-002667-34-IT Italy;Poland;United States
2017 Phase 3 EUCTR2016-002937-31-IT Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-000894-26-GR Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-DK Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-BG Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-BE Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000893-69-GR Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000893-69-DK Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-GB Argentina;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-FR Argentina;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-PT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-PL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-NL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-HU Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-GB Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-FR Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-DE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-BE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-RO Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-IE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-FR Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-DE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 2 EUCTR2016-002667-34-PL Italy;Mexico;Poland;United States
2019 Phase 3 EUCTR2018-001511-73-PL Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-HU Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-HR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-GB Bulgaria;Croatia;Germany;Hungary;Ireland;Poland;Portugal;Spain;United Kingdom
2019 Phase 3 EUCTR2018-001511-73-ES Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-SI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-SE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-NO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-FR Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Roche Farma S.A. (Soc.unipersonal)que realiza el ensayo en España y que actúa como representante de F.Hoffmann-La Roche
2017 Phase 3 EUCTR2016-002937-31-ES Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
RO5333787
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2019-004092-39-IT Argentina;France;Italy;Mexico;Poland;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-001088-26-IT Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States
2021 Phase 3 EUCTR2020-003413-35-IT Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2021-001088-26-DE Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States
2022 Phase 3 EUCTR2019-004092-39-PL Argentina;France;Italy;Mexico;Poland;United Kingdom;United States
2022 Phase 3 EUCTR2019-004092-39-FR Argentina;France;Italy;Mexico;Poland;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-PL Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-HU Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-HR Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-DE Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-BG Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd.
2017 Phase 3 EUCTR2015-005431-41-PL Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Russian Federation;Taiwan;Turkey;Ukraine;United States
2016 Phase 3 EUCTR2015-005431-41-HR Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Taiwan;Turkey;Ukraine;United States
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-GB France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-DE France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
RO7010939
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-001168-28-IT Austria;Bulgaria;Denmark;Finland;France;Greece;Italy;Netherlands;United States
2021 Phase 3 EUCTR2019-004857-10-IT Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
F. Hoffmann-La Roche Ltd
2022 Phase 2 EUCTR2021-003772-14-HR Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
2021 Phase 2 EUCTR2021-003772-14-SK Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
2021 Phase 2 EUCTR2021-003772-14-CZ Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
2021 Phase 3 EUCTR2020-001168-28-GR Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-DK Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-BG Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2019-004857-10-PT Algeria;Argentina;China;Dominican Republic;Egypt;Finland;France;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
2021 Phase 3 EUCTR2019-004857-10-NL Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2021 Phase 3 EUCTR2019-004857-10-HU Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2021 Phase 3 EUCTR2019-004857-10-DE Algeria;Argentina;China;Dominican Republic;Egypt;Finland;France;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
2020 Phase 3 EUCTR2020-001168-28-FR Austria;Bulgaria;Denmark;Finland;France;Greece;Italy;Netherlands;United States
2020 Phase 3 EUCTR2019-004857-10-FI Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
RO7121932 - MAD
Hoffmann-La Roche
2021 Phase 1 NCT05704361 Belgium;Canada;Germany;Israel;Italy;Moldova, Republic of;Poland;Portugal;Romania;Serbia;Spain;United States
RO7121932 IV - SAD
Hoffmann-La Roche
2021 Phase 1 NCT05704361 Belgium;Canada;Germany;Israel;Italy;Moldova, Republic of;Poland;Portugal;Romania;Serbia;Spain;United States
RO7121932 SC - SAD
Hoffmann-La Roche
2021 Phase 1 NCT05704361 Belgium;Canada;Germany;Israel;Italy;Moldova, Republic of;Poland;Portugal;Romania;Serbia;Spain;United States
Rolipram
National Institute of Neurological Disorders and Stroke (NINDS)
2001 Phase 2 NCT00011375 United States
RPC-1063
Celgene
2020 Phase 3 NCT04140305 Canada;Puerto Rico;United States
RPC1063
Celgene
2016 Phase 1 NCT02797015 United States
2015 Phase 3 NCT02576717 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2012 Phase 2/Phase 3 NCT01628393 Belgium;Bulgaria;Georgia;Greece;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
Celgene International II Sàrl
2016 Phase 1 EUCTR2016-003073-18-GB United Kingdom
RTL1000
Artielle ImmunoTherapeutics
2006 Phase 1 NCT00411723 United States
RTX
Feng Jinzhou
2023 - NCT06068829 -
Ruxience
Danish Multiple Sclerosis Center, Rigshospitalet
2020 Phase 3 EUCTR2020-002981-15-DK Denmark
Ruxolitinib
Tianjin Medical University General Hospital
2024 Phase 1/Phase 2 NCT05909943 China
RVP-001
Reveal Pharmaceuticals Inc.
2024 Phase 2 NCT06322342 United States
RYAH-medtech inhaler
OMNI Medical Services, LLC
2018 Phase 2 NCT03944447 United States
S-warfarin
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States
SA237
Chugai Pharmaceutical Co. Ltd
2016 Phase 3 EUCTR2015-005431-41-RO Bulgaria;Canada;Croatia;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Turkey;Ukraine;United States
2015 Phase 3 EUCTR2013-003752-21-HU France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
2015 - EUCTR2013-003752-21-ES France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-IT France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom
Chugai Pharmaceutical Co., Ltd.
2019 - JPRN-jRCT2080225027 Japan
2014 Phase 3 JPRN-jRCT2080222347 Asia except Japan;Europe;Japan;North America
F. Hoffmann-La Roche Ltd.
2017 Phase 3 EUCTR2015-005431-41-PL Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Russian Federation;Taiwan;Turkey;Ukraine;United States
2016 Phase 3 EUCTR2015-005431-41-HR Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Taiwan;Turkey;Ukraine;United States
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-GB France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-DE France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
Saline
Cairo University
2024 Phase 2 NCT06599307 Egypt
GlaxoSmithKline
2011 Phase 1 NCT01435993 Germany;Italy;Norway
Haukeland University Hospital
2021 Phase 1/Phase 2 NCT04749667 Norway
Innate Immunotherapeutics
2014 Phase 2 NCT02228213 Australia;New Zealand
University at Buffalo
2009 Phase 2 NCT00986960 United States
Sapelizumab
Chugai Pharmaceutical Co. Ltd
2016 Phase 3 EUCTR2015-005431-41-RO Bulgaria;Canada;Croatia;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Turkey;Ukraine;United States
SAR339658
Genzyme Corporation
2015 Phase 2 EUCTR2014-003265-19-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-SE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-DE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
SAR441344
Sanofi-Aventis Recherche et Développement
2021 Phase 2 EUCTR2020-004785-19-FR Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States
2021 Phase 2 EUCTR2020-004785-19-DE Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States
2021 Phase 2 EUCTR2020-004785-19-CZ Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States
2021 Phase 2 EUCTR2020-004785-19-BG Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Türkiye;Ukraine;United States
SAR441344 IV
Sanofi
2021 Phase 2 NCT04879628 Bulgaria;Canada;Czechia;France;Germany;Russian Federation;Spain;Turkey;Ukraine;United States
SAR441344 SC
Sanofi
2021 Phase 2 NCT04879628 Bulgaria;Canada;Czechia;France;Germany;Russian Federation;Spain;Turkey;Ukraine;United States
SAR442168
GENZYME CORPORATION
2022 Phase 3 EUCTR2020-000644-55-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
Genzyme Corporation
2022 Phase 3 EUCTR2020-000644-55-EE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000647-30-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000647-30-FR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000647-30-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000647-30-RO Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-NO Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-FI Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-RO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-NO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-FR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-DK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-CZ Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-BG Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NO Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HR Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-BE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-RO Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-SK Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-NL Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-FR Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-ES Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-EE Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-CZ Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-SK Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-SE Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-NL Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-ES Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-EE Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
Peking University Third Hospital
2020 - NCT04964791 China
Sanofi
2019 Phase 1 NCT04171310 United Kingdom
2019 Phase 2 NCT03889639 Canada;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
Tanaka Tomoyuki
2024 Phase 3 JPRN-jRCT2031240058 China;Japan;Republic of Korea;Turkey;Ukraine;United States
2021 Phase 3 JPRN-jRCT2021200035 Austria;Belarus;Bulgaria;Canada;China;Czechia;Denmark;Estonia;Finland;Germany;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
SAR443820
Sanofi
2022 Phase 2 NCT05630547 Belgium;Bulgaria;Canada;Chile;China;France;Germany;Italy;Poland;Spain
Sanofi-aventis recherche & développement
2023 Phase 2 EUCTR2022-000049-34-DE Belgium;Bulgaria;Canada;Chile;China;France;Germany;Greece;Italy;Poland;Spain
2023 Phase 2 EUCTR2022-000049-34-BG Belgium;Bulgaria;Canada;Chile;China;France;Germany;Greece;Italy;Poland;Spain
2022 Phase 2 EUCTR2022-000049-34-PL Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Greece;Italy;Poland;Spain;United States
2022 Phase 2 EUCTR2022-000049-34-FR Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Greece;Italy;Poland;Spain;United States
2022 Phase 2 EUCTR2022-000049-34-ES Belgium;Canada;China;Czechia;France;Germany;Italy;Poland;Spain;United States
2022 Phase 2 EUCTR2022-000049-34-BE Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Greece;Italy;Poland;Spain;United States
SARS-COV-2 mrna vaccine
NYU Langone Health
2021 - NCT04843774 United States
Sativex
ALMIRALL PRODESFARMA
2011 - EUCTR2011-002258-30-IT Italy
AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
2004 - EUCTR2005-000393-47-IT Italy
Almirall Hermal GmbH
2016 Phase 4 EUCTR2015-004451-40-CZ Austria;Czech Republic
2016 Phase 4 EUCTR2015-004451-40-AT Austria;Czech Republic
Almirall, S.A.
2012 Phase 3 NCT01538225 Italy
GW PHARMA LTD
2008 - EUCTR2006-005910-11-IT Germany;Italy;Spain;United Kingdom
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-PL Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
2007 Phase 3 EUCTR2006-005910-11-CZ Czech Republic;Germany;Italy;Spain;United Kingdom
2006 Phase 3 EUCTR2005-005265-11-GB Czech Republic;France;United Kingdom
2006 Phase 3 EUCTR2005-005265-11-FR Czech Republic;France;United Kingdom
2006 - EUCTR2005-005265-11-CZ Czech Republic;France;United Kingdom
2005 Phase 3 EUCTR2004-002509-63-GB Czech Republic;United Kingdom
2005 - EUCTR2004-002509-63-CZ Czech Republic;United Kingdom
GW Pharma Ltd.
2008 Phase 3 EUCTR2006-005910-11-GB Czech Republic;Germany;Italy;Spain;United Kingdom
2008 - EUCTR2006-005910-11-DE Germany;Italy;Spain;United Kingdom
2007 - EUCTR2007-002138-13-GB United Kingdom
GW Pharmaceuticals Ltd.
2012 Phase 4 NCT01964547 Czech Republic
2008 Phase 3 NCT00681538 United Kingdom
2007 Phase 3 NCT00702468 United Kingdom
2006 Phase 3 NCT00391079 Canada
2005 Phase 3 NCT01599234 United Kingdom
2002 Phase 3 NCT01604265 United Kingdom
2002 Phase 3 NCT00711646 United Kingdom
2002 Phase 3 NCT00678795 United Kingdom
GW Research Ltd
2013 Phase 3 NCT01868048 -
IRCCS Centro Neurolesi Bonino-Pulejo
2016 - NCT03186664 Italy
JOSE MANUEL GARCIA DOMINGUEZ
2013 - EUCTR2011-000985-36-ES Spain
Jazz Pharmaceuticals
2011 - NCT02073474 -
S. Andrea Hospital
2005 Phase 2 NCT00202423 Italy
Sativex - spray PER mucosa orale 3 flaconi nebulizzatori CON pompa dosatrice DA 10 ML - 90 erogazioni
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2016 Phase 4 EUCTR2016-000840-32-IT Italy
Sativex 2,7MG/2,5 MG solucion para pulverizacion bucal
GW Pharma Limited
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom
Sativex oromucosal spray
GW Pharma Limited
2021 Phase 3 EUCTR2020-003271-18-CZ Czech Republic;Czechia;Poland;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-GB Poland;United Kingdom
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-CZ Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
GW Pharma Ltd.
2011 - EUCTR2011-000926-31-CZ Czech Republic
Satralizumab
Chugai Pharmaceutical Co., Ltd.
2019 - JPRN-jRCT2080225027 Japan
2014 Phase 3 JPRN-jRCT2080222347 Asia except Japan;Europe;Japan;North America
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2019-004092-39-IT Argentina;France;Italy;Mexico;Poland;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-001088-26-IT Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States
2021 Phase 3 EUCTR2020-003413-35-IT Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2021-001088-26-DE Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States
2022 Phase 3 EUCTR2019-004092-39-PL Argentina;France;Italy;Mexico;Poland;United Kingdom;United States
2022 Phase 3 EUCTR2019-004092-39-FR Argentina;France;Italy;Mexico;Poland;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-PL Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-HU Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-HR Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-DE Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-BG Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd.
2017 Phase 3 EUCTR2015-005431-41-PL Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Russian Federation;Taiwan;Turkey;Ukraine;United States
2016 Phase 3 EUCTR2015-005431-41-HR Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Taiwan;Turkey;Ukraine;United States
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-GB France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-DE France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
Hans-Christian von Buedingen
2021 Phase 4 JPRN-jRCT2031200333 Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Hoffmann-La Roche
2025 Phase 3 NCT05199688 Argentina;France;Italy;Mexico;Poland;Ukraine;United Kingdom;United States
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 NCT02073279 Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Philippines;Poland;Puerto Rico;Romania;Singapore;Taiwan;Turkey;Ukraine;United States
2014 Phase 3 NCT02028884 France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States
Huashan Hospital
2025 - NCT06829524 China
Huashan Hospital, Fudan University
2025 - ChiCTR2500099340 China
Okuno Tatsusada
2024 Phase 1 JPRN-jRCT2051230006 -
Regine Buffels
2022 Phase 4 JPRN-jRCT2021220014 Canada;France;Germany;India;Italy;Japan;Korea;Turkey;United States
Satralizumab 120 MG
Hoffmann-La Roche
2022 Phase 4 NCT05269667 Canada;France;Germany;India;Italy;Japan;Korea, Republic of;Turkey;United States
SB-683699
GlaxoSmithKline Research & Development Ltd
2007 - EUCTR2006-007057-42-SE Czech Republic;Denmark;Sweden
2007 - EUCTR2006-007057-42-DK Czech Republic;Denmark;Sweden
2007 Phase 2 EUCTR2006-007057-42-CZ Belgium;Czech Republic;Denmark;Sweden
2007 - EUCTR2006-007057-42-BE Belgium;Czech Republic;Denmark;Sweden
SB683699
GLAXO SMITHKLINE
2004 - EUCTR2004-000374-31-IT Italy
GlaxoSmithKline
2004 Phase 2 NCT00097331 Belgium;Canada;France;Germany;Italy;Poland;Romania;Russian Federation;Spain;United States
GlaxoSmithKline Research & Development Ltd
2007 - EUCTR2006-002633-20-LT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2007 - EUCTR2006-002633-20-IT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2007 Phase 2 EUCTR2006-002633-20-GB Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2007 Phase 2 EUCTR2006-002633-20-FR Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2006 - EUCTR2006-002633-20-NL Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2006 - EUCTR2006-002633-20-FI Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2006 - EUCTR2006-002633-20-DE Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2006 - EUCTR2006-002633-20-AT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
GlaxoSmithKline S.A
2006 Phase 2 EUCTR2006-002633-20-ES Australia;Austria;Canada;Finland;France;Germany;Italy;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Spain;United Kingdom
SC interferon BETA-1A
Biogen
2017 - NCT03347370 Germany
SC interferon BETA-1B
Biogen
2017 - NCT03347370 Germany
SC peginterferon BETA-1A
Biogen
2017 - NCT03347370 Germany
Sclerolym
ImCyse S.A
2014 Phase 1;Phase 2 EUCTR2014-001081-99-BE Belgium
SCM-010
Stem Cell Medicine Ltd.
2024 Phase 1/Phase 2 NCT03696485 Israel
Seasonal influenza vaccine
Celgene
2021 Phase 3 NCT05028634 Germany;United States
Novartis
2010 Phase 3 NCT01199861 Austria;Belgium;Canada;Finland;France;Guatemala;Poland;Spain;Switzerland;United Kingdom
Seasonal quadrivalent influenza vaccine
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
Second-generation fumaric acid
Biogen Idec Inc.
2004 - EUCTR2004-000663-99-SE Hungary;Sweden
2004 - EUCTR2004-000663-99-HU Hungary;Sweden
2004 - EUCTR2004-000663-99-CZ Czech Republic;Hungary;Sweden
Secukinumab
NOVARTIS FARMA
2013 - EUCTR2012-004019-29-IT Argentina;Canada;Colombia;Finland;Germany;Italy;Japan;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
Novartis Farmacéutica, S.A.
2013 - EUCTR2012-004019-29-ES Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
Novartis Pharma AG
2013 - EUCTR2012-004019-29-SE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 - EUCTR2012-004019-29-PT Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 - EUCTR2012-004019-29-PL Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 - EUCTR2012-004019-29-FI Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 - EUCTR2012-004019-29-DE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 Phase 2 EUCTR2012-004019-29-CZ Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 Phase 2 EUCTR2012-004019-29-BE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
Novartis Pharma K.K.
2013 Phase 2 JPRN-jRCT2080222132 -
Novartis Pharma Services AG
2012 - EUCTR2011-001629-25-CZ Czech Republic;Russian Federation;Ukraine
Select dmts other than ozanimod
Bristol-Myers Squibb
2021 - NCT06133049 United States
Selenium
National Center for Complementary and Integrative Health (NCCIH)
1999 Phase 1/Phase 2 NCT00010842 United States
Self massage
University of Iowa
2010 Phase 1 NCT01381354 United States
Sendoxan
Uppsala l?ns landsting
2011 Phase 2 EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States
Sendoxane
Helse Bergen HF, Haukeland University Hospital
2018 Phase 3 EUCTR2017-001362-25-SE Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
Serum containing avonex
Biogen Idec
2003 Phase 1 NCT00913250 -
Serum free avonex
Biogen Idec
2003 Phase 1 NCT00913250 -
SF-12 questionnaire
University Hospital, Lille
2020 - NCT04334031 France
SH U 555 C
C.H.U. de RENNES
2008 - EUCTR2007-005363-10-FR France
2008 - EUCTR2007-005362-12-FR France
Max-Planck-Institute of Psychiatry
2007 - EUCTR2006-001337-17-DE Germany
Short-course ocrelizumab
Johns Hopkins University
2021 Phase 2 NCT04767698 United States
Silodyx
Erasmus MC Dept. Urology
2016 Phase 3 EUCTR2015-002820-20-NL Netherlands
Simethicone
Rocky Mountain MS Research Group, LLC
2014 Phase 4 NCT02217982 United States
Simvahexal® 40 MG filmtabletten
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom
Simvastatin
Alabama Neurology Associates, PC
2005 Phase 3 NCT00242268 United States
Anna Tsakiri
2008 Phase 3 NCT00429442 Denmark
Biogen Idec
2006 Phase 4 NCT00492765 Denmark
Glostrup Hospital, Dep. of Neurology
2009 - EUCTR2006-001827-21-DK Denmark
Glostrup University Hospital, Copenhagen
2006 Phase 3 NCT00261326 Denmark
Imperial College London
2008 Phase 2 NCT00647348 United Kingdom
Tehran University of Medical Sciences
2005 Phase 3 NCT00668343 Iran, Islamic Republic of
University College, London
2019 Phase 2 NCT03896217 United Kingdom
2018 Phase 3 NCT03387670 Ireland;United Kingdom
VUmc Neurology Department
2020 Phase 2 EUCTR2019-003127-38-NL Netherlands
Simvastatin 40 MG FILM-coated tablets
University College London
2020 Phase 2 EUCTR2017-003008-30-GB United Kingdom
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom
Simvastatin alternova
Biogen Idec A/S
2006 - EUCTR2005-003930-16-SE Finland;Sweden
2006 - EUCTR2005-003930-16-FI Finland;Sweden
2005 - EUCTR2005-003930-16-DK Denmark;Finland;Sweden
Simvastatin IN relapsing remitting multiple sclerosis
Assiut University
2020 Phase 1 NCT04178980 -
Simvastatina sandoz 40 MG comprimidos recubiertos CON PELícula EFG
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom
Simvastatine
VUmc Neurology Department
2020 Phase 2 EUCTR2019-003127-38-NL Netherlands
Simvastatine sandoz 40 MG filmomhulde tabletten
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom
Simvastatine sandoz 40MG deelbare filmomhulde tabletten
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom
Single-USE autoinjector
Biogen Idec
2005 Phase 3 NCT00915577 -
Single-USE autoinjector with A prefilled liquid avonex syringe
Biogen
2009 Phase 3 NCT00828204 United States
Sinvastatina sandoz 40 MG comprimidos revestidos POR PELícula
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom
Siponimob
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Siponimod
Biogen
2021 - NCT05688436 United States
NOVARTIS FARMA
2012 Phase 3 EUCTR2012-003056-36-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Novartis Pharma K.K.
2014 Phase 3 JPRN-jRCT2080222397 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;United Kingdom;United States
Novartis Pharma Services AG
2010 Phase 2 EUCTR2009-014392-51-PL Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States
2010 Phase 2 EUCTR2009-014392-51-HU Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States
2010 Phase 2 EUCTR2009-014392-51-FI Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States
2010 - EUCTR2009-014392-51-DE Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States
Novartis Pharmaceuticals
2022 - NCT05376579 Italy
2021 - NCT04933552 United States
2021 Phase 3 NCT04926818 Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
2021 - NCT04895202 Switzerland
2021 - NCT04540861 -
2019 Phase 3 NCT03623243 Puerto Rico;United States
Siponimod 0,25 MG
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2021 Phase 4 EUCTR2020-005947-22-IT Italy
Siponimod 0.25 MG tablet
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Siponimod 0.5 MG tablet
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Siponimod 1 MG
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2021 Phase 4 EUCTR2020-005947-22-IT Italy
Siponimod 1 MG tablet
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Siponimod 2 MG
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2023 Phase 4 EUCTR2023-000142-42-IT Italy
2021 Phase 4 EUCTR2020-005947-22-IT Italy
Siponimod 2 MG tablet
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Siponimod fumarato
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2023 Phase 4 EUCTR2023-000142-42-IT Italy
Siponimod fumaric acid
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-RO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
Sirolimus
National Institute of Allergy and Infectious Diseases (NIAID)
2003 Phase 1/Phase 2 NCT00095329 United States
Sivatin 40 MG FILM-coated tablets
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom
Sivelestat
Tohoku University Hospital
2013 Phase 1,2 JPRN-UMIN000010094 Japan
Sleep assessment
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France
Sleep quality and physical activity
University of Jordan
2021 - NCT05046535 Jordan
Smderpept
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland
Smoked cannabis
Center for Medicinal Cannabis Research
2003 Phase 1/Phase 2 NCT00260741 United States
2001 Phase 1/Phase 2 NCT00248378 United States
Smoking
University of Jordan
2021 - NCT05046535 Jordan
Sodium chlorid
Sykehuset Innlandet HF
2009 - NCT00764413 Norway
Sodium chloride
NeuroGenesis Ltd.
2025 Phase 2 NCT06961383 Israel;United States
Sodium chloride solution
Anders Svenningsson
2016 Phase 3 NCT02746744 Sweden
Solifenacin succinate
Astellas Pharma Inc
2008 Phase 4 NCT00629642 Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Portugal;Russian Federation;Spain;United Kingdom
Soliris
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Alexion Pharmaceuticals Inc.
2020 Phase 2;Phase 3 EUCTR2019-001829-26-DE Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2019 Phase 2;Phase 3 EUCTR2019-001829-26-ES Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Alexion Pharmaceuticals, Inc.
2015 Phase 3 EUCTR2013-001151-12-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001151-12-DK Argentina;Australia;Austria;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Martinique;Romania;Russian Federation;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001151-12-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hong Kong;Italy;Japan;Korea, Republic of;Netherlands;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
Solriamfetol
Johns Hopkins University
2024 Phase 2 NCT06170970 United States
Solu medrol - 125 MG/2 ML polvere E solvente PER soluzione iniettabile 1 flacone A doppia camera DA 125 MG/2 ML
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
SOLU-medrol
Danish Multiple Sclerosis Research Centre
2009 Phase 2 EUCTR2009-011516-37-DK Denmark
Department of Clinical Neuroscience, Karolinska Institutet
2018 Phase 2 EUCTR2018-000620-34-SE Sweden
2018 Phase 2 EUCTR2018-000620-34-NO Germany;Norway;Sweden
Enceladus Pharmaceuticals BV
2010 - EUCTR2009-013884-21-PL Belgium;Germany;Poland
2009 - EUCTR2009-013884-21-DE Belgium;Germany;Poland
2009 Phase 2 EUCTR2009-013884-21-BE Belgium;Germany;Poland
Uppsala l?ns landsting
2011 Phase 2 EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States
SOLU-moderin 1 G
Servicio de Neurología
2008 - EUCTR2007-000888-15-ES Spain
Solumedrol
University of Utah
2014 - NCT02296346 United States
Solumedrol IM 125MG/2ML
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
Somatorelin
UNIVERSITA' DEGLI STUDI DI NAPOLI FEDERICO II
2009 - EUCTR2008-007447-14-IT Italy
Sparc0921
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States
Specifically design 6 month resistance training program
University of Nebraska
2013 - NCT01816100 United States
Spikevax
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany
Spinning GRP
Somogy Megyei Kaposi Mór Teaching Hospital
2018 - NCT04550650 Hungary
Spiropent
Department of Neurology UMCG
2006 - EUCTR2006-004318-42-NL Netherlands
SR-fampridine
University of Southern Denmark
2014 Phase 4 NCT02143167 Denmark
Standard gadolinium contrast
National Center for Research Resources (NCRR)
1999 - NCT00006060 United States
Standard interval dosing
Amsterdam UMC, location VUmc
2020 Phase 4 NCT04225312 Netherlands
Standard lymphodepletion regimen
Kyverna Therapeutics
2024 Phase 2 NCT06384976 United States
Stanford University
2024 Phase 1 NCT06138132 United States
Standard MS DMT
Novartis Pharmaceuticals
2011 Phase 4 NCT01317004 Italy
Standard MS dmts
Novartis Pharmaceuticals
2010 Phase 4 NCT01216072 Canada;Puerto Rico;United States
Standard treatment with A conventional drug
Northwestern University
2005 Phase 2 NCT00273364 United States
Standard-OF-care
University Hospital, Antwerp
2025 Phase 2 NCT06715605 Belgium
Standardized cannabis extract
Institut fur Klinische Forschung, Germany
2006 Phase 3 NCT00552604 United Kingdom
Static balance test
Gazi University
2018 - NCT03584672 -
Statin
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy
Stem cell transplantation
Stem Cells Arabia
2016 Phase 1 NCT03069170 Jordan
Step tracking
Ohio State University
2017 - NCT03244696 United States
Strength training
University of Aarhus
2016 - NCT02870023 Denmark
Stretching
University of Illinois at Chicago
2025 - NCT06341023 United States
Stroop test
Slovak Academy of Sciences
2017 - NCT03052595 Slovakia
Study drug
Biogen
2014 Phase 1 NCT02201849 United States
SUB0750MIG
St. Vincent's University Hospital
2012 Phase 4 EUCTR2011-002561-38-IE Ireland
SUB175614
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
SUB22282
Biogen Idec Limited
2012 Phase 3 EUCTR2010-021978-11-IE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2012 - EUCTR2010-021978-11-BE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-SE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-PL Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-GB Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-FI Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-ES Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-DK Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-DE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Iraq;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-CZ Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
Sublingual tizanidine 12 MG
Teva GTC
2008 Phase 1/Phase 2 NCT00464958 Israel
Sunphenon
Charite University, Berlin, Germany
2007 Phase 1/Phase 2 NCT00525668 Germany
Sunphenon egcg
Charite Universitätsmedizin Berlin
- Phase 2;Phase 3 EUCTR2008-005213-22-DE Germany
Friedemann Paul
2009 Phase 2/Phase 3 NCT00799890 Germany
Sunphenon egcg TM
Charité-Universitätsmedizin Berlin
2007 - EUCTR2006-006323-39-DE Germany
Supervised physical therapy
University of Jordan
2017 Phase 1/Phase 2 NCT03326505 Jordan
Suspension media
University Hospital, Toulouse
2015 Phase 1/Phase 2 NCT02403947 France
Sustained-release oral dalfampridine
Sheba Medical Center
2014 Phase 4 NCT02259361 Israel
Suvorexant
Theodore R. Brown, MD MPH
2017 Phase 4 NCT03110315 United States
Syngeneic bone marrow transplantation
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
T cell vaccination
Hadassah Medical Organization
2002 Phase 1/Phase 2 NCT01448252 Israel
Sheba Medical Center
2002 Phase 3 NCT00228228 Israel
T-cell vaccination
Sheba Medical Center
1998 Phase 1/Phase 2 NCT00220428 Israel
Tachipirina - 500 MG compresse20 compresse
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
TACI-FC5
Merck Serono Geneva- an affiliate of Merck KGaA, Darmstadt Germany
2008 - EUCTR2007-003936-50-SE Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Merck Serono International
2009 - EUCTR2008-005021-11-SE Belgium;Czech Republic;France;Sweden
2009 Phase 2 EUCTR2008-005021-11-FR Belgium;Czech Republic;France;Sweden
2009 Phase 2 EUCTR2008-005021-11-CZ Belgium;Czech Republic;France;Sweden
Merck Serono International S.A.
2008 - EUCTR2007-003936-50-NL Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2008 Phase 2 EUCTR2007-003936-50-FR Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2008 Phase 2 EUCTR2007-003936-50-ES Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Merck Serono S.A. - Geneva
2008 - EUCTR2007-003936-50-GB Australia;Austria;Canada;Czech Republic;France;Lebanon;Lithuania;Netherlands;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-003936-50-AT Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Merck Serono SA - Geneva, An affiliate of Merck KGaA, Darmstadt, Germany
2009 - EUCTR2008-005021-11-BE Belgium;Czech Republic;France;Sweden
Merck Serono SA - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2008 - EUCTR2007-003936-50-CZ Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2008 - EUCTR2007-003936-50-BE Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Merck Serono SA-Geneva
2008 - EUCTR2007-003936-50-LT Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Tamsulosin
Centre Hospitalier Universitaire de Nimes
2022 - NCT05439902 France
Tanakan
Ipsen
2003 Phase 3 NCT00276341 France
Tarenflurbil
Fraunhofer Gesellschaft for its Institute Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)
2015 Phase 2 EUCTR2014-004483-38-DE Germany
Targretin
Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge
2015 Phase 2 EUCTR2014-003145-99-GB United Kingdom
Taurine
University of Iowa
2010 Phase 1 NCT01381354 United States
TCD after bosentan administration
Universitair Ziekenhuis Brussel
2014 - NCT02389426 Belgium
TCD baseline
Universitair Ziekenhuis Brussel
2014 - NCT02389426 Belgium
Tcelna
Opexa Therapeutics, Inc.
2012 Phase 2 NCT01684761 Canada;United States
Tecfidera
Banner Life Sciences LLC
2019 Phase 1 NCT04022473 United States
Biogen GmbH
2015 Phase 4 EUCTR2014-000395-26-DE Germany
Biogen Idec Italia S.r.l.
2015 - EUCTR2015-000303-21-IT Italy
Biogen Idec Ltd.
2009 Phase 3 EUCTR2008-004753-14-DE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
Biogen Idec Norway
2015 Phase 4 EUCTR2015-001197-18-NO Norway
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2015 Phase 3 EUCTR2014-004562-22-DE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 - EUCTR2013-001025-53-ES Denmark;Finland;Netherlands;Norway;Spain;United Kingdom
2015 Phase 4 EUCTR2013-001025-53-DK Denmark;Finland;Netherlands;Norway;Spain;United Kingdom
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom
2014 Phase 4 EUCTR2013-001656-35-SK Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-SI Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-PT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-IT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-HU Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-FR Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-ES Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-CZ Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-BE Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-AT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 - EUCTR2013-001486-17-DE Germany
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Department of Clinical Sciences, Danderyd Hospital
2015 Phase 3 EUCTR2015-004116-38-SE Sweden
EMD Serono Research & Development Institute, Inc.
2017 Phase 2 NCT02975349 Bulgaria;Czechia;Germany;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States
Finn Sellebjerg
2016 Phase 2 EUCTR2016-000283-41-DK Denmark
IMS HEALTH GmbH & Co. OHG
2016 - NCT02823951 Canada;United States
IRCCS Centro Neurolesi Bonino Pulejo
2021 - NCT05811949 Italy
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Merck KGaA
2017 Phase 2 EUCTR2016-001448-21-SK Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-PL Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-ES Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-CZ Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-BG Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
Multiple Sclerosis Center of Northeastern New York
2015 Phase 4 NCT02683863 United States
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom
University of Texas Southwestern Medical Center
2016 Phase 4 NCT02739542 United States
Yale University
2014 - NCT02218879 United States
Tecfidera - 240 MG - capsula rigida gastroresistente - USO orale - blister (PVC/PE/PVDC-PVC alluminio) - 56 capsule
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2017 Phase 4 EUCTR2017-000559-26-IT Israel;Italy;Switzerland;United States
Tecfidera 240MG CPS ETD
Fakultní nemocnice Ostrava
2021 Phase 4 EUCTR2021-003195-13-CZ Czech Republic
Tecfidera® 120 MG
Alkermes, Inc.
2019 Phase 3 EUCTR2017-001294-16-DE Germany;Poland;United States
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States
Tecfidera® 120MG magensaftresistente hartkapseln
Universitätsklinikum Münster
2015 Phase 4 EUCTR2014-003481-25-DE Germany
Tecfidera® 240 MG
Alkermes, Inc.
2019 Phase 3 EUCTR2017-001294-16-DE Germany;Poland;United States
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States
Tecfidera® 240MG magensaftresistente hartkapseln
Universitätsklinikum Münster
2015 Phase 4 EUCTR2014-003481-25-DE Germany
Telephone-based cognitive behavioral therapy
University of Michigan
2018 Phase 4 NCT03621761 United States
Telitacicept
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
2020 Phase 0 ChiCTR2000036285 China
Temelimab
GeNeuro Innovation SAS
2021 Phase 2 EUCTR2021-001973-21-SE Sweden
2020 Phase 2 EUCTR2019-004822-15-SE Sweden
Temsirolimus tablets
Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
2005 - EUCTR2005-000171-18-FI Finland
Tenofovir
Massachusetts General Hospital
2023 Phase 2 NCT05957913 United States
Tenofovir alafenamide
Massachusetts General Hospital
2022 Phase 2 NCT04880577 United States
Teriflunomide
Actelion
2015 Phase 3 NCT02425644 Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Actelion Pharmaceuticals Ltd
2015 Phase 3 EUCTR2012-000540-10-SE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-PT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-PL Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LV Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-HU Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-HR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-GR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FI Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-ES Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-DE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-CZ Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Aventis Pharmaceuticals Inc.
2006 - EUCTR2004-000555-42-PT Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
Biocad
2021 Phase 3 NCT05385744 Russian Federation
2019 Phase 2 NCT04056897 Russian Federation
Centre Hospitalier Universitaire de Nice
2015 Phase 3 NCT02587195 France
Centre hospitalier de l'Université de Montréal (CHUM)
2015 - NCT02490982 Canada
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-001168-28-IT Austria;Bulgaria;Denmark;Finland;France;Greece;Italy;Netherlands;United States
2021 Phase 3 EUCTR2019-004857-10-IT Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-001168-28-GR Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-DK Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-BG Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2019-004857-10-PT Algeria;Argentina;China;Dominican Republic;Egypt;Finland;France;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
2021 Phase 3 EUCTR2019-004857-10-NL Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2021 Phase 3 EUCTR2019-004857-10-HU Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2021 Phase 3 EUCTR2019-004857-10-DE Algeria;Argentina;China;Dominican Republic;Egypt;Finland;France;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
2020 Phase 3 EUCTR2020-001168-28-FR Austria;Bulgaria;Denmark;Finland;France;Greece;Italy;Netherlands;United States
2020 Phase 3 EUCTR2019-004857-10-FI Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
Fakultní nemocnice Ostrava
2023 Phase 4 EUCTR2022-004331-23-CZ Czech Republic
2021 Phase 4 EUCTR2021-003195-13-CZ Czech Republic
GENZYME CORPORATION
2022 Phase 3 EUCTR2020-000644-55-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2017 Phase 3 EUCTR2011-005249-12-IT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States
Genzyme Corporation
2022 Phase 3 EUCTR2020-000644-55-EE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NO Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HR Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-BE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-RO Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2017 Phase 3 EUCTR2011-005249-12-SI Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Egypt;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2011-005249-12-PT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Egypt;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2011-005249-12-NL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2011-005249-12-LT Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2014 Phase 4 EUCTR2013-001439-34-IT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States
2014 Phase 4 EUCTR2013-001439-34-GR Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 Phase 4 EUCTR2013-001439-34-GB Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-DE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-BE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-AT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2011-005249-12-GB Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005249-12-ES Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2011-005249-12-EE Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2011-005249-12-BE Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-SE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-FI Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-ES Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States
2013 - EUCTR2012-005324-16-NL Belgium;Germany;Netherlands
2013 - EUCTR2012-005324-16-DE Belgium;Germany;Netherlands
2013 - EUCTR2012-005324-16-BE Belgium;Germany;Netherlands
- Phase 3 EUCTR2011-005249-12-Outside-EU/EEA Australia;Bosnia and Herzegovina;Canada;China;Israel;Lebanon;Morocco;Russian Federation;Tunisia;Turkey;United States
- Phase 3 EUCTR2011-005249-12-FR Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States
- Phase 3 EUCTR2011-005249-12-BG Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
Genzyme, a Sanofi Company
2014 Phase 3 NCT02201108 Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Israel;Lebanon;Lithuania;Macedonia, The Former Yugoslav Republic of;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
Hoffmann-La Roche
2021 Phase 3 NCT04586023 Austria;Brazil;Bulgaria;Canada;Denmark;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Poland;Puerto Rico;Russian Federation;Turkey;United Kingdom;United States
2021 Phase 3 NCT04586010 Algeria;Argentina;China;Dominican Republic;Finland;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
MS Centrum, Department of Neurology, Sshlgrenska University Hospital
2018 Phase 4 EUCTR2016-004414-10-SE Sweden
McGill University
2016 - NCT03561402 Canada
Merck Healthcare KGaA
2022 Phase 3 EUCTR2019-004980-36-CZ Belarus;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-SI Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-RO Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-SK Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PL Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-NO Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LV Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-GR Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-ES Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-DE Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-BG Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2020 Phase 3 NCT04338061 Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Latvia;Lithuania;Malaysia;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United States
2020 Phase 3 NCT04338022 Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
NOVARTIS PHARMA AG
2022 Phase 3 EUCTR2020-005929-89-IT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Japan;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-IT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Guatemala;Hong Kong;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Farmacéutica S.A.
2022 Phase 3 EUCTR2020-005929-89-ES Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-ES Slovakia;Spain
Novartis Farmacéutica, S.A.
2016 Phase 3 EUCTR2015-005419-33-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-ES Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2016 Phase 3 EUCTR2015-005419-33-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
Novartis Pharma AG
2023 Phase 3 EUCTR2020-005899-36-LT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2023 Phase 3 EUCTR2020-005899-36-DK Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2023 Phase 3 EUCTR2020-005899-36-AT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;Finland;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SK Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SI Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-RO Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Türkiye;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-PT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-PL Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Türkiye;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-HR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-GR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-FR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-EE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-BG Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-SK Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-NL Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-LV Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-HR Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-BG Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-BE Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-FR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HU Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BE Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-NL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-CZ Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-PL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GB Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-EE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BG Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharmaceuticals
2021 Phase 3 NCT05156281 Argentina;Brazil;Bulgaria;Canada;China;Croatia;Estonia;France;Greece;India;Italy;Japan;Mexico;Poland;Portugal;Puerto Rico;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2021 Phase 3 NCT05147220 Argentina;Austria;Belgium;Brazil;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Georgia;Guatemala;Hong Kong;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Saudi Arabia;Slovakia;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
Providence Health & Services
2013 Phase 4 NCT01970410 United States
Sanofi
2024 Phase 3 NCT06372145 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
2023 Phase 3 NCT06141473 Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
2020 Phase 4 NCT04410965 China
2013 - NCT03198351 Canada;United States
2013 Phase 4 NCT01895335 Austria;Belgium;Canada;Chile;Finland;France;Germany;Greece;Italy;Norway;Spain;Sweden;United Kingdom;United States
2011 Phase 2 NCT01403376 Austria;Canada;Germany;Russian Federation;Ukraine
2011 Phase 3 NCT01252355 Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2009 Phase 3 NCT00883337 Belgium;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Spain;Switzerland;Tunisia;United Kingdom
2008 Phase 3 NCT00751881 Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;South Africa;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 NCT00622700 Australia;Austria;Brazil;Bulgaria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Italy;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2007 Phase 2 NCT00811395 Austria;Canada;Germany;Italy;Spain;United Kingdom;United States
2007 Phase 2 NCT00489489 Canada;Germany;Italy;Poland;Spain;United States
2007 Phase 2 NCT00475865 Austria;Canada;Germany;Italy;United Kingdom;United States
2006 Phase 3 NCT00803049 Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2004 Phase 3 NCT00134563 Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2002 Phase 2 NCT00228163 Canada;France
2001 Phase 2 NCT01487096 Canada;France
Sanofi-Aventis US, Inc.
2004 - EUCTR2004-000555-42-AT Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
Sanofi-Aventis recherche & de'veloppement
2008 - EUCTR2007-003997-24-IT Austria;Italy;Spain;United Kingdom
Sanofi-Aventis recherche & développement
2008 - EUCTR2007-003997-24-GB Austria;Italy;Spain;United Kingdom
2007 - EUCTR2007-003997-24-ES Austria;Italy;Spain;United Kingdom
2007 - EUCTR2007-003997-24-AT Austria;Italy;Spain;United Kingdom
Sanofi-aventis U.S. Inc
2007 - EUCTR2006-003134-14-IT Germany;Italy;Spain
2007 - EUCTR2004-000555-42-EE Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
Sanofi-aventis U.S. Inc.
2007 - EUCTR2006-004893-29-IT Austria;Germany;Italy;United Kingdom
2007 Phase 2 EUCTR2006-004893-29-GB Austria;Germany;Italy;United Kingdom
2007 - EUCTR2006-004893-29-AT Austria;Germany;Italy;United Kingdom
2007 Phase 2 EUCTR2006-003134-14-ES Germany;Italy;Spain
2007 - EUCTR2006-003134-14-DE Germany;Italy;Spain
- - EUCTR2006-004893-29-DE Austria;Germany;Italy;United Kingdom
Sanofi-aventis US, Inc
2008 Phase 3 EUCTR2004-000555-42-GB Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
2005 - EUCTR2004-000555-42-DK Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
2004 - EUCTR2004-000555-42-SE Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
2004 - EUCTR2004-000555-42-NO Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
Sanofi-aventis recherche & développement
2010 - EUCTR2007-004452-36-SK Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-SE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-GR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-GB Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-004452-36-FR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-ES Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-EE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-DE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2006-001152-12-SK Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2008 Phase 3 EUCTR2006-001152-12-FR Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
TG Therapeutics
2017 Phase 3 EUCTR2017-000639-15-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000639-15-GB Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000639-15-ES Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-GB Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-ES Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
TG Therapeutics, Inc.
2017 Phase 3 NCT03277261 United States
2017 Phase 3 NCT03277248 United States
2017 Phase 3 EUCTR2017-000639-15-PL Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-PL Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Turku University Hospital
2017 Phase 4 EUCTR2016-003622-16-FI Finland
UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
2016 Phase 4 EUCTR2016-001515-20-IT Italy
University at Buffalo
2018 - NCT03526224 United States
University of British Columbia
2003 - NCT06705608 -
University of Michigan
2018 - NCT03464448 United States
sanofi-aventis Recherche & De`veloppement
2004 - EUCTR2004-000555-42-IT Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
sanofi-aventis Recherche & Dévelopment
2009 - EUCTR2008-006226-34-FR Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis U.S Inc
2007 - EUCTR2004-000555-42-CZ Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
sanofi-aventis group
2011 - EUCTR2010-023172-12-GR Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
sanofi-aventis recherche de veloppement
2007 - EUCTR2006-003361-14-IT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
sanofi-aventis recherche & developpement
2011 - EUCTR2011-001160-21-DE Austria;Canada;Germany;Russian Federation;Ukraine
2011 - EUCTR2011-001160-21-AT Austria;Canada;Germany;Russian Federation;Ukraine
sanofi-aventis recherche & développement
2009 - EUCTR2007-004452-36-AT Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2006-003361-14-EE Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2009 - EUCTR2006-003361-14-CZ Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2006-001152-12-LT Australia;Austria;Belarus;Bulgaria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2006-001152-12-DE Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2008 - EUCTR2007-004452-36-NL Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-004452-36-CZ Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-004452-36-BE Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2006-003361-14-PT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2008 - EUCTR2006-003361-14-NL Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2006-003361-14-DK Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2008 - EUCTR2006-001152-12-HU Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2006-001152-12-EE Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2006-001152-12-BG Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2007 Phase 3 EUCTR2006-003361-14-SE Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2007 Phase 3 EUCTR2006-003361-14-GB Austria;Canada;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2006-003361-14-DE Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Poland;Portugal;Russian Federation;Sweden;Switzerland;Ukraine;United Kingdom;United States
2007 Phase 3 EUCTR2006-001152-12-GB Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2007 Phase 3 EUCTR2006-001152-12-FI Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2007 - EUCTR2006-001152-12-DK Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2007 Phase 3 EUCTR2006-001152-12-CZ Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2006-001152-12-AT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2006 Phase 3 EUCTR2006-003361-14-FI Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2006 - EUCTR2006-003361-14-AT Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
sanofi-aventis recherche et development
2012 - EUCTR2010-023172-12-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 Phase 3 EUCTR2010-023172-12-SK Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-PT Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-NO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-IT Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 Phase 3 EUCTR2010-023172-12-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-GB Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-ES Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 Phase 3 EUCTR2010-023172-12-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2009 - EUCTR2008-006226-34-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 Phase 3 EUCTR2008-006226-34-GR Belgium;Czech Republic;France;Germany;Greece;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis recherche et developpement
2010 - EUCTR2008-006226-34-GB Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-HU Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-CZ Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
Teriflunomide 14 MG
Centre Hospitalier Universitaire de Nice
2017 Phase 3 NCT03122652 France;Germany;Martinique;Sweden;Switzerland;Turkey;United Kingdom
Jan Lycke
2019 Phase 4 NCT04129736 Sweden
Tanaka Tomoyuki
2024 Phase 3 JPRN-jRCT2031240058 China;Japan;Republic of Korea;Turkey;Ukraine;United States
Teriflunomide capsule
Iwasaki Ryohei
2023 Phase 3 JPRN-jRCT2071220034 France;Italy;Japan;Poland;Portugal;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;US
Novartis Pharmaceuticals
2016 Phase 3 NCT02792231 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Finland;France;Germany;Hungary;India;Italy;Latvia;Lithuania;Mexico;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 NCT02792218 Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Teriflunomide HMR1726
Sanofi
2020 Phase 3 NCT04410991 Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 NCT04410978 Austria;Belarus;Bulgaria;Canada;China;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2019 Phase 4 NCT03856619 India
2014 Phase 1 NCT02046629 China
2013 Phase 3 NCT01863888 Belgium;Germany;Netherlands
Tanaka Tomoyuki
2021 Phase 3 JPRN-jRCT2021200035 Austria;Belarus;Bulgaria;Canada;China;Czechia;Denmark;Estonia;Finland;Germany;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
Testing OF autonomous nervous system function
Slovak Academy of Sciences
2017 - NCT03052595 Slovakia
Testosterone
University of California, Los Angeles
2014 Phase 2 NCT02317263 -
Testosterone undecanoate
Health Sciences Centre, Winnipeg, Manitoba
2012 Phase 2 NCT01516554 Canada
Hôpitaux Universitaires de Strasbourg
2019 Phase 2 EUCTR2018-002648-10-FR France
Tetanus diphtheria toxoids vaccine
Biogen
2015 Phase 2 NCT02097849 United States
Tetanus toxoid
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
Tetanus toxoid vaccine
Novartis
2010 Phase 3 NCT01199861 Austria;Belgium;Canada;Finland;France;Guatemala;Poland;Spain;Switzerland;United Kingdom
Tetanus, diphtheria, and acellular pertussis vaccine
Celgene
2021 Phase 3 NCT05028634 Germany;United States
Tetracycline
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy
Tetracycline - statin - antimycotic
Università Popolare Homo & Natura
2015 Phase 0 NCT02606929 Italy
Tetrahydrocannabinol
Tiffany J. Braley, MD, MS
2022 Phase 2 NCT05269628 United States
TG-1101
TG Therapeutics
2017 Phase 3 EUCTR2017-000639-15-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000639-15-GB Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000639-15-ES Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-GB Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-ES Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
TG Therapeutics, Inc.
2020 Phase 3 EUCTR2019-003625-16-PL Belarus;Croatia;Georgia;Poland;Russian Federation;Serbia;Ukraine;United States
2020 Phase 3 EUCTR2019-003625-16-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2017 Phase 3 EUCTR2017-000639-15-PL Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-PL Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
THC
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark
Almirall Hermal GmbH
2016 Phase 4 EUCTR2015-004451-40-AT Austria;Czech Republic
GW Pharma Limited
2022 Phase 3 EUCTR2020-004306-58-LT Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom
2021 Phase 3 EUCTR2020-003271-18-CZ Czech Republic;Czechia;Poland;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-GB Poland;United Kingdom
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-PL Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
2020 Phase 3 EUCTR2019-002623-14-GB Czech Republic;Poland;Romania;United Kingdom;United States
2020 Phase 3 EUCTR2019-002623-14-CZ Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
Tiffany J. Braley, MD, MS
2022 Phase 2 NCT05269628 United States
University of Calgary
2024 Phase 2 NCT06261489 -
Thiamine
University of Iowa
2010 Phase 1 NCT01381354 United States
Thioplex
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy
Thiotepa
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy
Thymoglobuline
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-SE Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom
Uppsala l?ns landsting
2011 Phase 2 EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States
Thymol
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2021 - JPRN-UMIN000043910 Japan
Time restricted olive OIL based (troo) ketogenic diet
Terry L. Wahls
2022 - NCT05007483 United States
Timed UP AN GO test
Gazi University
2018 - NCT03584672 -
Tissue selective estrogen complex
University of California, San Francisco
2016 Phase 2 NCT02710214 United States
Tizanidine
Teva GTC
2006 Phase 1/Phase 2 NCT00358293 Israel
Tizanidine hydrochloride capsule
Elan Pharmaceuticals
2002 Phase 3 NCT00047580 United States
TMP001
Dr. Frank Behrens
2015 Phase 2 NCT02686788 Germany
Fraunhofer Gesellschaft for its Institute Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)
2015 Phase 2 EUCTR2014-004483-38-DE Germany
Tocilizumab
Department of Immunology, National Institute of Neuroscience, NCNP
2014 - JPRN-UMIN000012705 Japan
2012 - JPRN-UMIN000007866 Japan
2011 - JPRN-UMIN000005889 Japan
Department of Neurology, Shimane University Hospital
2016 - JPRN-UMIN000022201 Japan
Fu-Dong Shi
2017 Phase 1/Phase 2 NCT03062579 China
Yamamura Takashi
2013 - JPRN-jRCTs031180346 -
2012 - JPRN-jRCTs031180152 -
Tocilizumab injection
Tianjin Medical University General Hospital
2017 Phase 2/Phase 3 NCT03350633 China
Toldc - intradermal
Antwerp University Hospital
2023 Phase 2 EUCTR2022-003465-38-BE Belgium;Spain
Toldc - intranodal
Antwerp University Hospital
2023 Phase 2 EUCTR2022-003465-38-BE Belgium;Spain
Tolebrutinib
Sanofi
2024 Phase 3 NCT06372145 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
2020 Phase 1 NCT06106074 United States
2020 Phase 1 NCT06064539 United States
2020 Phase 3 NCT04458051 Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Estonia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 NCT04411641 Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 NCT04410991 Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 NCT04410978 Austria;Belarus;Bulgaria;Canada;China;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2019 Phase 2 NCT03996291 Canada;Czechia;Estonia;France;Netherlands;Russian Federation;Spain;Ukraine;United States
Tanaka Tomoyuki
2024 Phase 3 JPRN-jRCT2031240058 China;Japan;Republic of Korea;Turkey;Ukraine;United States
2021 Phase 3 JPRN-jRCT2021200035 Austria;Belarus;Bulgaria;Canada;China;Czechia;Denmark;Estonia;Finland;Germany;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
Tolebrutinib 120MG
National Institute of Neurological Disorders and Stroke (NINDS)
2021 Phase 2 NCT04742400 United States
Tolebrutinib 60MG
National Institute of Neurological Disorders and Stroke (NINDS)
2021 Phase 2 NCT04742400 United States
Tolerogenic dendritic cells loaded with myelin peptides
Sara Varea
2015 Phase 1 NCT02283671 Spain
Tolerogenic fibroblasts
FibroBiologics
2020 Early Phase 1 NCT05080270 Mexico
Tolperisone HC1
Avigen Inc
2007 - EUCTR2007-001031-63-DE Germany
2007 Phase 2 EUCTR2007-001031-63-CZ Czech Republic;Germany
Tolperisone HCL
Avigen
2007 Phase 2 NCT00532532 Czech Republic;Former Serbia and Montenegro;Germany;Russian Federation;Serbia;Ukraine
Tolpersan
Avigen Inc
2007 - EUCTR2007-001031-63-DE Germany
2007 Phase 2 EUCTR2007-001031-63-CZ Czech Republic;Germany
Tolposan
Avigen Inc
2007 - EUCTR2007-001031-63-DE Germany
2007 Phase 2 EUCTR2007-001031-63-CZ Czech Republic;Germany
Topical preparation H ARM
New York University School of Medicine
2015 Phase 4 NCT02665221 United States
Torvast*10CPR 10MG
DR DIMENSIONE RICERCA
2005 - EUCTR2005-001009-25-IT Italy
Tovaxin
Opexa Therapeutics, Inc.
2007 Phase 2 NCT00595920 United States
Tovaxin autologous T cell vaccine
Opexa Therapeutics, Inc.
2006 Phase 2 NCT00245622 United States
2002 Phase 1/Phase 2 NCT00587691 United States
Tracleer
UZ Brussel
2017 Phase 2 EUCTR2017-001253-13-BE Belgium
Traditional balance exercises
Halic University
2024 - NCT06387043 Turkey
Training groupe
Somogy Megyei Kaposi Mór Teaching Hospital
2018 - NCT04550650 Hungary
Trancopal dolo
Charité-Universitätsmedizin Berlin
2007 Phase 2 EUCTR2006-005262-39-DE Germany
Transcranial magnetic stimulation
Hospital San Carlos, Madrid
2022 Phase 3 NCT05809414 Spain
Maimónides Biomedical Research Institute of Córdoba
2019 Phase 1/Phase 2 NCT04062331 -
Neuromed IRCCS
2023 - NCT05779449 Italy
Trap myelin test
Nantes University Hospital
2012 - NCT01723631 France
Treatment withdrawal
University Hospital, Strasbourg, France
2025 Phase 3 NCT06663189 France
Treosulfan
medac Gesellschaft für klinische Spezialpräparate mbH
2007 - EUCTR2006-002856-14-DE Germany
Trichuris suis eggs
Danish Multiple Sclerosis Research Center
2009 Phase 2 EUCTR2008-007549-29-DK Denmark
Trichuris suis OVA
Charite University, Berlin, Germany
2012 Phase 2 NCT01413243 Germany
Danish Multiple Sclerosis Research Center
2009 Phase 2 EUCTR2008-007549-29-DK Denmark
Rigshospitalet, Denmark
2010 Phase 2 NCT01006941 Denmark
Trichuris suis OVA (eggs), embryonated, viable
Charite Universitätsmedizin Berlin
2011 Phase 2 EUCTR2009-015319-41-DE Germany
Trileptal
Queen Mary University London
2014 Phase 2 EUCTR2013-002419-87-GB United Kingdom
Trivalent seasonal influenza vaccine
Biogen
2010 Phase 2 NCT01051349 Czech Republic;Czechia;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
Trulicity 0,75 MG injekcný roztok naplnený V injekcnom pere
Lekárska fakulta UK Bratislava
2019 Phase 2 EUCTR2019-003001-94-SK Slovakia
Trunk impairment
Ankara Yildirim Beyazit University
2019 - NCT03945006 Turkey
Trunk position sense
Ankara Yildirim Beyazit University
2016 - NCT03566251 Turkey
TSO
Charite Universitätsmedizin Berlin
2011 Phase 2 EUCTR2009-015319-41-DE Germany
Danish Multiple Sclerosis Research Center
2009 Phase 2 EUCTR2008-007549-29-DK Denmark
TT vaccine
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States
TV-5010
TEVA
2004 - EUCTR2004-000759-40-IT Italy
TEVA ITALIA srl
2004 Phase 2 EUCTR2004-000762-13-IT Italy
TV-5600
TEVA ITALIA srl
2008 - EUCTR2007-005450-23-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2007 - EUCTR2007-003226-19-IT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
TEVA PHARMACEUTICALS INDUSTRIES LTD
2013 Phase 3 EUCTR2012-003647-30-IT Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Puerto Rico;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
Teva Pharmaceutical Industries Ltd
2013 Phase 3 EUCTR2012-003647-30-PL Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-HU Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-ES Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-EE Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-CZ Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-BE Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-AT Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2012-003647-30-SK Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2012-003647-30-LV Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2012-003647-30-GR Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2012-003647-30-GB Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-015815-42-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain
2010 Phase 3 EUCTR2009-015815-42-PL Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-LT Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain
2010 Phase 3 EUCTR2009-015815-42-EE Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-CZ Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-BG Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-012989-30-SE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012989-30-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012989-30-BG Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012989-30-AT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-NL Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-LT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-IT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2009-012989-30-HU Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-GB Austria;Bulgaria;Canada;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2009-012989-30-EE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 - EUCTR2009-011234-99-DE Germany
2008 Phase 3 EUCTR2007-005450-23-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Slovakia;Spain
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-ES Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-DE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-CZ Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-BG Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-003226-19-PT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2007-003226-19-LT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2007-003226-19-BG Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-SE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-NL Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-LV Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-HU Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-GB Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 Phase 3 EUCTR2007-003226-19-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 Phase 3 EUCTR2007-003226-19-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-EE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-DE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-AT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-GB Czech Republic;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-DE Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-CZ Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
2005 Phase 2 EUCTR2005-004334-41-HU Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
Teva Pharmaceutical Industries Ltd.
2015 Phase 2 EUCTR2014-001579-30-NL Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
2015 Phase 2 EUCTR2014-001579-30-DE Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
2014 Phase 2 EUCTR2014-001579-30-IT Canada;Germany;Italy;Netherlands;Russian Federation;Spain;Ukraine;United Kingdom;United States
2014 Phase 2 EUCTR2014-001579-30-GB Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
2014 Phase 2 EUCTR2014-001579-30-ES Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
Teva Pharmaceutical Industries, Ltd.
2014 - EUCTR2013-002082-19-NL Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2014 - EUCTR2013-002082-19-ES Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-SE Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 EUCTR2013-002082-19-GB Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-FI Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-DK Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 EUCTR2013-002082-19-BE Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
Tylenol pill
Holy Name Medical Center, Inc.
2017 Phase 4 NCT03424733 United States
Tysabri
Amsterdam University Medical Center
2019 Phase 4 EUCTR2019-002566-13-NL Netherlands
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2007 - EUCTR2005-004061-41-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-IT Australia;Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-IE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Spain;Sweden;United Kingdom
2006 - EUCTR2005-004061-41-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-002145-11-IT Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
Biogen
2023 - NCT05658497 Germany;Ireland;Spain;Switzerland;United States
2017 - NCT03399981 United States
2010 - NCT01070823 United States
2007 - NCT00493298 Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Italy;Mexico;Netherlands;Norway;Portugal;Slovakia;Spain;Switzerland;United Kingdom
Biogen Idec
2014 Phase 4 EUCTR2014-003669-97-BE Belgium
2010 - EUCTR2009-017490-38-DE Germany;Spain
Biogen Idec International GmbH
2010 Phase 4 EUCTR2009-009503-19-BE Belgium
Biogen Idec Limited
2012 Phase 3 EUCTR2010-021978-11-IE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2012 - EUCTR2010-021978-11-BE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain
2011 - EUCTR2010-021978-11-SE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-PL Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-GB Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-FI Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-ES Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-DK Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-DE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Iraq;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-CZ Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-002145-11-NL Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-GB Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-FR Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-ES Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-DE Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2015 - EUCTR2013-005586-39-DE Germany;Italy;United States
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2013 - EUCTR2012-005082-13-IT Italy
BiogenIdec A/S
2009 - EUCTR2008-008065-35-SE Sweden
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
CHU de Toulouse
2009 - EUCTR2008-005906-38-FR France
Cornerstone Health Care, PA
2012 Phase 4 NCT01591551 United States
Dansk Multipel Sclerose Center
2010 Phase 2 EUCTR2009-016703-35-DK Denmark
Imperial College London
2008 Phase 4 EUCTR2007-007394-22-GB United Kingdom
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Kessler Foundation
2021 - NCT04565431 United States
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States
Novartis Pharma Services AG
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
Polpharma Biologics S.A.
2019 Phase 3 EUCTR2018-004751-20-PL Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine
2019 Phase 3 EUCTR2018-004751-20-HR Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University Hospital, Caen
2020 - NCT04580381 France
University at Buffalo
2007 - NCT00937677 United States
University of Chicago
2010 - NCT01071512 United States
University of South Florida
2011 - NCT01455220 United States
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany
Uppsala l?ns landsting
2011 Phase 2 EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States
VU medical center
2016 Phase 4 EUCTR2016-000345-31-NL Netherlands
Tysabri 300 MG concentrado para solucióN para perfusióN
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Tysabri 300 MG concentrate FOR solution FOR infusion
BIOGEN IDEC LTD
2006 Phase 3 EUCTR2005-004061-41-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
Tysabri 300 MG solution à diluer pour perfusion
Hôpitaux Universitaires de Strasbourg
2014 - EUCTR2014-003209-14-FR France
Tysabri and avonex
Biogen
2008 Phase 4 NCT00771043 United States
Tysabri injectable product
Queen Mary University of London
2022 Phase 2 NCT05418010 United Kingdom
Tysabri*IV 1FL 300MG 15ML
BIOGEN IDEC LTD
2011 - EUCTR2010-024000-10-IT Belgium;Germany;Italy;Spain
2011 - EUCTR2010-021978-11-IT Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Ireland;Italy;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
Ublituximab
Georgia State University
2024 Early Phase 1 NCT06629428 United States
Johns Hopkins University
2016 Phase 1 NCT02276963 United States
Neurology Center of New England P.C.
2024 - NCT06681623 United States
TG Therapeutics
2017 Phase 3 EUCTR2017-000639-15-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000639-15-GB Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000639-15-ES Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-GB Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-ES Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
TG Therapeutics, Inc.
2023 Phase 3 NCT05877963 United States
2020 Phase 3 EUCTR2019-003625-16-PL Belarus;Croatia;Georgia;Poland;Russian Federation;Serbia;Ukraine;United States
2020 Phase 3 EUCTR2019-003625-16-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2019 Phase 3 NCT04130997 Belarus;Croatia;Georgia;Poland;Russian Federation;Serbia;Ukraine;United States
2017 Phase 2 NCT03381170 United States
2017 Phase 3 NCT03277261 United States
2017 Phase 3 NCT03277248 United States
2017 Phase 3 EUCTR2017-000639-15-PL Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-PL Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2016 Phase 2 NCT02738775 United States
University of Maryland, Baltimore
2025 - NCT06864936 United States
Ubltuximab
TG Therapeutics
2017 Phase 3 EUCTR2017-000639-15-GB Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
Ucar T-cell
Tianjin Huanhu Hospital
2025 Early Phase 1 NCT06939166 China
UCB L059
Søren H. Sindrup, Department of Neurology, Odense University Hospital
2006 - EUCTR2006-000397-71-DK Denmark
UK: sativex oromucosal spray
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-GB Czech Republic;Poland;Romania;United Kingdom;United States
Ultomiris
Alexion Pharmaceuticals, Inc.
2024 - NCT06312644 United States
2022 Phase 2;Phase 3 EUCTR2021-006075-42-FR Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2022 Phase 2;Phase 3 EUCTR2021-006075-42-ES Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2020 Phase 3 EUCTR2019-003352-37-PL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-NL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-ES Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-DK Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-DE Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-AT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
- Phase 2;Phase 3 EUCTR2021-006075-42-DE Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Ultrasmall particles OF iron oxide
Max-Planck-Institute of Psychiatry
2007 - EUCTR2006-001337-17-DE Germany
Ultromiris
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 3 EUCTR2019-003352-37-IT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
Umbilical cord derived mesenchymal stem cells
University of Jordan
2017 Phase 1/Phase 2 NCT03326505 Jordan
Umbilical cord mesenchymal stem cells
Translational Biosciences
2014 Phase 1/Phase 2 NCT02034188 Panama
Uncoupled rbcs
Cellerys AG
2024 Phase 1/Phase 2 NCT06430671 Czech Republic;Czechia;Germany;Italy;Switzerland
Undifferentiated autologous mesenchymal stem cells
SALK - Gemeinnützige Salzburger Landeskliniken Betriebsges. m.b.H., Christian-Doppler-Klinik, UK für Neurologie der PMU
- - EUCTR2015-000137-78-AT Austria
Universal bcma CAR-T
Xuanwu Hospital, Beijing
2025 Early Phase 1 NCT06485232 China
Universal BCMA-CD19 cart
Bioray Laboratories
2024 Phase 1 NCT06633042 -
Universal CD19 CAR-T
Xuanwu Hospital, Beijing
2025 Early Phase 1 NCT06485232 China
Untreated TO atorvastatin treatment
Charite University, Berlin, Germany
2003 Phase 2 NCT00616187 -
Uplizna
Amgen
2025 - NCT05909761 United States
Urbason 40 MG
Servicio de Neurología, HU. Germans Trias i Pujol
2012 Phase 4 EUCTR2012-001965-34-ES Spain
Urbason 40 MG comprimidos
Servicio de Neurología
2008 - EUCTR2007-000888-15-ES Spain
Urbason forte
Biogen Idec
2010 - EUCTR2009-017490-38-DE Germany;Spain
Urbason solubile forte 1000MG
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany
Urbason® solubile forte 1000 MG
University Medical Center Hamburg Eppendorf
2013 Phase 2 EUCTR2012-004807-10-DE Germany
Urine samples
Centre Hospitalier Universitaire de Nimes
2013 Phase 3 NCT01817166 France;Martinique
US-ocrevus
Celltrion
2024 Phase 3 NCT05906992 Poland
Uspio MRI - gadolinium MRI
Rennes University Hospital
2009 - NCT01567553 France
Usual diet with dietary guidelines FOR americans diet information
Terry L. Wahls
2022 - NCT05007483 United States
Usual DMT continuation
University Hospital, Strasbourg, France
2025 Phase 3 NCT06663189 France
Uvedose
CHU de Nîmes
2022 Phase 4 EUCTR2022-002157-25-FR France
2013 Phase 4 EUCTR2013-000910-40-FR France
Uvedose 100 000 UI, solution buvable EN ampoule
MERCK SERONO s.a.s
2009 - EUCTR2009-013695-46-FR France
V08ca02
Universitätsklinikum Erlangen
2010 Phase 4 EUCTR2009-014857-34-DE Germany
V08ca09
Universitätsklinikum Erlangen
2010 Phase 4 EUCTR2009-014857-34-DE Germany
Vaginal estriol
Texas Tech University Health Sciences Center
2019 Phase 2/Phase 3 NCT03774407 United States
Vancomycin
Icahn School of Medicine at Mount Sinai
2023 Phase 1 NCT05539729 United States
Vardenafil
Unidad de Neuroinmunología
2005 Phase 4 EUCTR2004-003761-33-ES Spain
Vardenafilo hidrocloruro
Unidad de Neuroinmunología
2005 Phase 4 EUCTR2004-003761-33-ES Spain
Vatelizumab
Genzyme Corporation
2015 Phase 2 EUCTR2014-003265-19-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-SE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-DE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
Genzyme, a Sanofi Company
2015 Phase 2 NCT02306811 Canada;Poland;Russian Federation;United States
2014 Phase 2 NCT02222948 Canada;Poland;Russian Federation;Sweden;United States
VAY736
Novartis Pharma Services AG
2014 Phase 2 EUCTR2013-002324-16-PL Czech Republic;Poland;Russian Federation;Ukraine;United States
2014 Phase 2 EUCTR2013-002324-16-CZ Czech Republic;Poland;Russian Federation;Ukraine;United States
Novartis Pharmaceuticals
2013 Phase 2 NCT02038049 Czech Republic;Czechia;Germany;Poland;Russian Federation;Ukraine;United States
VB13s1
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia
VB5s2
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia
VB6s5
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia
Vehicle GEL
Biogen
2016 Phase 4 NCT02568111 -
Venlafaxin hexal
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany
Venlafaxine
Novartis Pharmaceuticals
2011 Phase 4 NCT01436643 Germany
Venlafaxine hydrochloride
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany
Verum ARM receiving vitamin D OIL
Charite University, Berlin, Germany
2011 Phase 2 NCT01440062 Germany
Vesicare 10MG tablet
Brigitte Schürch
2021 Phase 4 NCT04819360 Switzerland
Vestibular habituation exercises
October 6 University
2017 - NCT03670459 Egypt
Vestibular rehabilitation: balance and EYE movement exercises
University of Colorado, Denver
2012 - NCT01698086 United States
VIB0551
Horizon Therapeutics Ireland DAC
2022 Phase 2 EUCTR2021-003528-33-SE Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
2022 Phase 2 EUCTR2021-003528-33-PL Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
2022 Phase 2 EUCTR2021-003528-33-FR Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
- Phase 2 EUCTR2021-003528-33-NL Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
Video game therapy
University Hospital of Ferrara
2017 - NCT03353974 Italy
Vidofludimus calcium
Immunic AG
2023 Phase 3 EUCTR2021-000028-36-GR Albania;Belarus;Bulgaria;Colombia;Georgia;Germany;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2023 Phase 3 EUCTR2021-000028-36-ES Albania;Bulgaria;Colombia;Georgia;Germany;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Russian Federation;Spain;Ukraine;United States
2023 Phase 3 EUCTR2021-000028-36-DE Albania;Algeria;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2022 Phase 2 EUCTR2021-000048-23-NL Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2022 Phase 2 EUCTR2021-000048-23-DE Bulgaria;Canada;Czechia;Georgia;Germany;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Serbia;Ukraine;United States
2022 Phase 3 EUCTR2021-000029-28-RO Armenia;Bosnia and Herzegovina;Estonia;Germany;India;Peru;Poland;Romania;Serbia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000029-28-PL Bosnia and Herzegovina;Estonia;India;Peru;Poland;Romania;Russian Federation;Serbia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000028-36-LT Albania;Algeria;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-000028-36-BG Albania;Algeria;Belarus;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2022 Phase 2 EUCTR2018-001896-19-DE Bulgaria;Germany;Poland;Romania;Ukraine
2021 Phase 2 EUCTR2021-000048-23-RO Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine
2021 Phase 2 EUCTR2021-000048-23-PL Bulgaria;Canada;Czechia;Georgia;Germany;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Serbia;Ukraine;United States
2021 Phase 2 EUCTR2021-000048-23-BG Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine
2019 Phase 2 EUCTR2018-001896-19-RO Bulgaria;Germany;Poland;Romania;Ukraine
2018 Phase 2 EUCTR2018-001896-19-BG Bulgaria;Germany;Poland;Romania;Ukraine
Vigantol
University College Dublin
2012 Phase 2 EUCTR2012-000635-68-IE Ireland
Vigantol OEL
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-DE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
2011 - EUCTR2010-020328-23-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Vigantol OIL
MERCK SERONO SA
2011 - EUCTR2010-020328-23-IT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Merck KGaA
2011 Phase 2 NCT01285401 Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-LT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-DE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
2011 - EUCTR2010-020328-23-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Vigantol® OIL
Academic MS Center Limburg
- Phase 2 EUCTR2014-000728-97-NL Netherlands
Vigantol® ÖL 20.000 I.E./ML
Charité - Universitätsmedizin Berlin
2011 Phase 2 EUCTR2011-002785-20-DE Germany
Virtual reality group
Gazi University
2018 - NCT03501342 Turkey
Vitamin A
Tehran University of Medical Sciences
2011 Phase 4 NCT01407211 Iran, Islamic Republic of
2010 Phase 4 NCT01705457 Iran, Islamic Republic of
2010 Phase 4 NCT01417273 Iran, Islamic Republic of
2009 Phase 4 NCT01225289 Iran, Islamic Republic of
Vitamin D
Centre Hospitalier Universitaire de Nimes
2013 Phase 3 NCT01817166 France;Martinique
Mazandaran University of Medical Sciences
2013 Phase 3 NCT01768039 Iran, Islamic Republic of
University Medical Centre Maribor
2017 Phase 4 NCT03385356 Slovenia
Vitamin D3
AlJohara M AlQuaiz, M.D.
2013 Phase 2 NCT01753375 Saudi Arabia
American University of Beirut Medical Center
2018 - NCT03610139 Lebanon
Carmel Medical Center
2010 Phase 4 NCT01005095 Israel
Isfahan University of Medical Sciences
2015 - NCT02696590 Iran, Islamic Republic of
Johns Hopkins University
2012 Phase 3 NCT01490502 United States
2010 - NCT01667796 United States
Maastricht University Medical Center
2009 - NCT00940719 Netherlands
Merck KGaA
2009 Phase 2 NCT01198132 France
Tehran University of Medical Sciences
2022 Phase 4 NCT05340985 -
University of Toronto
2006 Phase 1/Phase 2 NCT00644904 Canada
Vitamin K
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States
Vitamin K cream
Biogen
2017 Phase 4 NCT03091569 Italy
Vitamina D3 kern pharma soluciÓN oleosa
Javier Olascoaga Urtaza
2013 Phase 2 EUCTR2012-004602-97-ES Spain
VSN16R
Canbex Therapeutics Ltd
2015 Phase 2 NCT02542787 United Kingdom
VSN16R 100MG
Canbex Therapeutics Ltd
2015 Phase 2 EUCTR2014-004412-11-GB United Kingdom
VX15/2503
Vaccinex Inc.
2012 Phase 1 NCT01764737 United States
Warm compress prior TO injection OF glatiramer acetate
Teva Neuroscience, Inc.
2005 Phase 4 NCT00239993 United States
Water
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2021 - JPRN-UMIN000043910 Japan
Kharazmi university
2024 - JPRN-UMIN000053947 Asia(except Japan)
Water tracking
Ohio State University
2017 - NCT03244696 United States
WAY-130799
Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
2005 - EUCTR2005-000171-18-FI Finland
Withdrawal OF dalfampridine-ER 10MG
Acorda Therapeutics
2012 - NCT01535664 United States
Wristband physical activity monitor
Oakland University
2015 - NCT02335450 United States
XBD173
Imperial College London
2018 - NCT03850301 United Kingdom
XCEL-MC-alpha
Banc de Sang i Teixits
2015 Phase 1/Phase 2 NCT02495766 Spain
2014 - EUCTR2012-000734-19-ES Spain
Xeomin
OSPEDALE S. RAFFAELE
2008 - EUCTR2007-006268-32-IT Italy
Xyosted 75 milligram (MG) IN 0.5 ML AUTO-injector
Tulane University
2025 Phase 4 NCT04601233 United States
Zanubrutinib
Xuanwu Hospital, Beijing
2022 Phase 2 NCT05356858 China
Zenapax
National Institute of Neurological Disorders and Stroke (NINDS)
1999 Phase 2 NCT00001934 United States
Zeposia
I.R.C.C.S. FONDAZIONE S.LUCIA
2022 Phase 4 EUCTR2021-005860-24-IT Italy
Kessler Foundation
2022 - NCT04885894 United States
Zeposia 0,92 MG capsule rigide
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2023 Phase 4 EUCTR2023-000018-16-IT Italy
Zeposia® indicated FOR THE treatment OF: relapsing forms OF multiple sclerosis, and active ulcerative colitis IN adults
Corium Innovations, Inc.
2025 - NCT06528665 Malaysia
Zinbryta
BIOGEN IDEC RESEARCH LIMITED
2017 Phase 3 EUCTR2016-002820-10-IT Canada;Denmark;France;Germany;Italy;United Kingdom;United States
Biogen Idec Research Limited
2017 Phase 3 EUCTR2016-002820-10-GB Canada;Denmark;France;Germany;Italy;United Kingdom;United States
2017 Phase 3 EUCTR2016-002820-10-DE Canada;Germany;Italy;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
ZK 157046
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
SCHERING
2007 - EUCTR2006-005270-47-IT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Schering AG
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-IE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
ZOL446H
North Bristol Trust
2009 - EUCTR2008-005304-93-GB United Kingdom
Novartis Pharma GmbH
2010 - EUCTR2009-011888-37-DE Germany
Zoledronic acid
Novartis
2010 Phase 3 NCT01166178 Germany
Zoledronic acid monohydrate
Novartis Pharma GmbH
2010 - EUCTR2009-011888-37-DE Germany
Novartis Pharmaceuticals
2016 Phase 4 NCT02575365 Turkey
0.25 MG RPC1063
Celgene International II Sàrl (CIS II)
2014 Phase 2;Phase 3 EUCTR2012-002714-40-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Receptos, Inc.
2014 Phase 2;Phase 3 EUCTR2012-002714-40-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-IT Belgium;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Israel;Italy;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-GR Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-ES Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
0.25MG RPC1063
CELGENE INTERNATIONAL II SàRL
2016 Phase 3 EUCTR2015-002500-91-IT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Celgene International II Sàrl (CIS II)
2017 Phase 3 EUCTR2015-002500-91-SE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-PT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-PL Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-LV Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-LT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-EE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-GR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Receptos, Inc.
2015 Phase 3 EUCTR2015-002500-91-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
0.5 MG RPC1063
Celgene International II Sàrl (CIS II)
2014 Phase 2;Phase 3 EUCTR2012-002714-40-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Receptos, Inc.
2014 Phase 2;Phase 3 EUCTR2012-002714-40-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-IT Belgium;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Israel;Italy;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-GR Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-ES Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
0.5MG RPC1063
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Receptos, Inc.
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
0.9% chloride injection sodium
Institute of Psychiatry and Neurology, Warsaw
2022 Phase 2/Phase 3 NCT05961644 Poland
1 - andrographis paniculata P/ST extract
Universidad Austral de Chile
2012 Phase 1/Phase 2 NCT02280876 Chile
1 MG RPC1063
Celgene International II Sàrl (CIS II)
2014 Phase 2;Phase 3 EUCTR2012-002714-40-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Receptos, Inc.
2014 Phase 2;Phase 3 EUCTR2012-002714-40-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-IT Belgium;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Israel;Italy;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-GR Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-ES Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
1% steroid cream
University of Nebraska
2010 Phase 4 NCT00988988 United States
1-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-YL)OXY]-3-pyridinyl}-2-pyrrolidinone
GlaxoSmithKline Research & Development Ltd
2013 - EUCTR2012-003627-38-SE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-003627-38-GB Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 - EUCTR2012-003627-38-DE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 - EUCTR2012-003627-38-CZ Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-003627-38-BG Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
1.0MG RPC1063
CELGENE INTERNATIONAL II SàRL
2016 Phase 3 EUCTR2015-002500-91-IT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Celgene International II Sàrl (CIS II)
2017 Phase 3 EUCTR2015-002500-91-SE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-PT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-PL Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-LV Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-LT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-EE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-GR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Receptos, Inc.
2015 Phase 3 EUCTR2015-002500-91-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
10000IU vitamin D
University College Dublin
2012 Phase 1/Phase 2 NCT01728922 Ireland
11C-acetate
department of neurology, Osaka university school of medicine
2015 - JPRN-UMIN000018154 Japan
11C-BMS-986196
Bristol-Myers Squibb
2021 Phase 1 NCT05064436 United Kingdom;United States
11C-MC1
National Institute of Mental Health (NIMH)
2022 Phase 2 NCT05062083 United States
11C-PBR28
Massachusetts General Hospital
2020 Phase 4 NCT04230174 -
11C-PIB
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
2009 - EUCTR2008-004174-40-FR France
11C-PS13
National Institute of Mental Health (NIMH)
2022 Phase 2 NCT05062083 United States
13-PCV booster
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States
18F-DPA-714 and 18F-FDG
Assistance Publique - Hôpitaux de Paris
2012 - NCT02305264 France
18F-OP-801
Ashvattha Therapeutics, Inc.
2023 Phase 1/Phase 2 NCT05395624 United States
18F-PM-PBB3
Chang Gung Memorial Hospital
2020 Phase 1/Phase 2 NCT04242056 -
19 NOR vitamin D
University of Wisconsin, Madison
1998 Phase 1 NCT01257958 United States
2 - excipients
Universidad Austral de Chile
2012 Phase 1/Phase 2 NCT02280876 Chile
2 MA transcranial direct current stimulation
University of Iowa
2022 - NCT04391023 United States
2-(2-(2-amino-9H-purin-9-YL)ethyl)-1,3-propanediol diacetate ester
Queen Mary University London
2019 Phase 2 EUCTR2019-000169-19-GB United Kingdom
2-CDA
MERCK KGAA
2018 Phase 4 EUCTR2017-002631-42-IT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
Merck KGaA
2018 Phase 4 EUCTR2017-002632-17-SK Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-SE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-PT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-NO Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-NL Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-LT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-HU Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Ireland;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-GR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-GB Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-FR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-FI Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-ES Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-DK Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-CZ Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-BE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-AT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-FR Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-CZ Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-AT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
Merck Serono International S.A.
2008 - EUCTR2007-000381-20-NL Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2008 - EUCTR2007-000381-20-GR Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2007 Phase 3 EUCTR2007-000381-20-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lithuania;Netherlands;Portugal;United Kingdom
Merck Serono S.A. - Geneva
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - EUCTR2007-000381-20-PT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2008 - EUCTR2007-000381-20-LV Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-000381-20-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-EE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-DK Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-000381-20-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2007-000381-20-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2007-000381-20-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2-CDA, 2-chloro-2'-deoxy-ß-D-adenosine
MERCK SERONO SA
2011 Phase 3 EUCTR2009-017978-21-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Finland;Georgia;Germany;Greece;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Portugal;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States Minor Outlying Islands
2-CDA, 2-chloro-2?-deoxy-ß-D-adenosine
Merck Serono S.A. - Geneva
2011 Phase 3 EUCTR2009-017978-21-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2-CDA, 2-chloro-2’-deoxy-ß-D-adenosine
Merck Serono S.A. - Geneva
2012 Phase 3 EUCTR2009-017978-21-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2012 Phase 3 EUCTR2009-017978-21-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2012 Phase 3 EUCTR2009-017978-21-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-SE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-LV Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 - EUCTR2009-017978-21-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-DK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 - EUCTR2009-017978-21-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2010 Phase 3 EUCTR2009-017978-21-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2-chloro-2'-deoxyadenosine, 2CDA
Merck Serono International S.A.
2006 - EUCTR2004-005148-28-LT Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-FI Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-EE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-DK Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-CZ Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Merck Serono International, a branch of Laboratoires Serono S.A.
2005 Phase 3 EUCTR2004-005148-28-GB Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom
Merck Serono International, a branch of Laboratories Serono S.A.
2005 - EUCTR2004-005148-28-DE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Serono International S.A.
2006 Phase 3 EUCTR2004-005148-28-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom
2006 - EUCTR2004-005148-28-LV Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-AT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2-chloro-2?-deoxy-ß-D-adenosine
Merck Serono International
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2-chloro-2’-deoxy-ß-D-adenosine
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
Merck Serono S.A. - Geneva
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
20 MG GA
Teva Pharmaceutical Industries, Ltd.
2007 - EUCTR2006-002037-20-EE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-LV Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-LT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-HU Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-GB Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 Phase 3 EUCTR2006-002037-20-FI Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-DE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-BE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
20 MG mitoq
VA Office of Research and Development
2020 Phase 1/Phase 2 NCT04267926 United States
200106 or EMD 28162
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-LT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
20MG/0.5ML GA
Teva Pharmaceutical Industries Ltd.
2012 - EUCTR2011-005550-57-PL Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 - EUCTR2011-005550-57-LV Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 - EUCTR2011-005550-57-GR Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Greece;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 - EUCTR2011-005550-57-EE Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 - EUCTR2011-005550-57-BG Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
20MG/0.5ML glatiramer acetate
Teva Pharmaceutical Industries Ltd.
2012 - EUCTR2011-005550-57-PL Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 - EUCTR2011-005550-57-LV Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 - EUCTR2011-005550-57-GR Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Greece;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 - EUCTR2011-005550-57-EE Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 - EUCTR2011-005550-57-BG Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
23-PPV
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
23-valent pneumococcal polysaccharide vaccine
Biogen
2015 Phase 2 NCT02097849 United States
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
25(OH)D3
Tehran University of Medical Sciences
2022 Phase 4 NCT05340985 -
25OH-vitamin D
Charité - Universitätsmedizin Berlin
2011 Phase 2 EUCTR2011-002785-20-DE Germany
2b3-201
BBB-Therapeutics B.V.
2013 Phase 1 NCT02048358 Netherlands
3 MG melatonin
Providence Health & Services
2018 Early Phase 1 NCT03498131 United States
3,4-diaminopyridine
Assistance Publique - Hôpitaux de Paris
2005 Phase 3 NCT00190268 France
University of Aarhus
2006 Phase 2 NCT00342381 Denmark
4 MA transcranial direct current stimulation
University of Iowa
2022 - NCT04391023 United States
4-aminopyridine
Acorda Therapeutics
2003 Phase 2 NCT00053417 Canada;United States
Coordinación de Investigación en Salud, Mexico
2014 Phase 2 NCT02280096 Mexico
IRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO
2016 Phase 4 EUCTR2014-004650-34-IT Italy
4-AP
Acorda Therapeutics
2003 Phase 2 NCT00053417 Canada;United States
IRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO
2016 Phase 4 EUCTR2014-004650-34-IT Italy
4.5 MG naltrexone
University of California, San Francisco
2007 Phase 3 NCT00501696 United States
40 MG GA
Teva Pharmaceutical Industries Ltd.
2010 Phase 3 EUCTR2009-018084-27-IT Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Lithuania;United Kingdom
Teva Pharmaceutical Industries, Ltd.
2010 Phase 3 EUCTR2009-018084-27-LT Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-HU Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-GB Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-EE Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-DE Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-CZ Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-BG Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2007 - EUCTR2006-002037-20-EE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-LV Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-LT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-HU Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-GB Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 Phase 3 EUCTR2006-002037-20-FI Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-DE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-BE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Teva Pharmaceuticals Industries Ltd.
2006 - EUCTR2006-002037-20-IT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
40 MG glatiramer acetate
Teva Pharmaceutical Industries Ltd.
2010 Phase 3 EUCTR2009-018084-27-IT Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Lithuania;United Kingdom
Teva Pharmaceutical Industries, Ltd.
2010 Phase 3 EUCTR2009-018084-27-LT Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-HU Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-GB Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-EE Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-DE Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-CZ Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-018084-27-BG Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States
2007 - EUCTR2006-002037-20-EE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-LV Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-LT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-HU Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-GB Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 Phase 3 EUCTR2006-002037-20-FI Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-DE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-BE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
40 MG glatiramer acetato
Teva Pharmaceuticals Industries Ltd.
2006 - EUCTR2006-002037-20-IT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
40MG OF mitoq
VA Office of Research and Development
2020 Phase 1/Phase 2 NCT04267926 United States
5 MG melatonin
Providence Health & Services
2018 Early Phase 1 NCT03498131 United States
5000IU vitamin D
University College Dublin
2012 Phase 1/Phase 2 NCT01728922 Ireland
52069.00.01
Philipps-Universität Marburg
2010 Phase 4 EUCTR2009-011088-35-DE Germany
6 months weight resistance and balance program
University of Nebraska
2013 - NCT01816100 United States
89 ZR-DF-crefmirlimab
National Institute of Neurological Disorders and Stroke (NINDS)
2023 Phase 1 NCT05849467 United States
9060X
Allergan
2008 - EUCTR2006-006299-39-NL France;Netherlands
2008 Phase 3 EUCTR2006-006299-39-FR France;Netherlands
Allergan Ltd.
2013 - EUCTR2012-000957-30-PT Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2013 - EUCTR2012-000957-30-GB Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2012 - EUCTR2012-000957-30-CZ Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2012 - EUCTR2012-000957-30-BE Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
95% pure ecgc capsules 200MG
Louisiana State University Health Sciences Center in New Orleans
2015 Phase 2 NCT02011451 United States
A4I antagonist
Hoffmann-La Roche
2007 Phase 2 NCT00104143 Bulgaria;Canada;Czech Republic;Finland;Germany;Poland;Russian Federation;Slovakia;Spain;United Kingdom;United States
AB1010
AB SCIENCE
2022 Phase 3 EUCTR2021-000639-30-IT Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
AB Science
2022 Phase 3 EUCTR2021-000639-30-NO Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000639-30-GR Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000639-30-ES Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000639-30-DE Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000639-30-BG Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-000639-30-FR Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-003735-32-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Colombia;Germany;Greece;Italy;Mexico;Slovakia;Spain;Switzerland;United Kingdom
2015 Phase 3 EUCTR2012-003735-32-GR Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom
2015 Phase 3 EUCTR2010-021219-17-BG Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
2013 - EUCTR2010-021219-17-PL Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain
2013 Phase 3 EUCTR2010-021219-17-GR Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey
2012 Phase 3 EUCTR2010-021219-17-SK Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-021219-17-ES Bulgaria;Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;United States
2011 Phase 3 EUCTR2010-021219-17-DE Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
ABA-101
Abata Therapeutics
2024 Phase 1 NCT06566261 United States
Abatacept
Bristol-Myers Squibb
2001 Phase 2 NCT00035529 United States
National Institute of Allergy and Infectious Diseases (NIAID)
2010 Phase 2 NCT01116427 Canada;United States
Abobotulinumtoxin A
Neurology Center of New England P.C.
2018 Phase 3 NCT03585569 United States
ABP 692
Amgen
2025 Phase 3 NCT06700343 Georgia;Serbia;Switzerland;United States
ABR-215062
TEVA
2005 - EUCTR2004-003943-28-IT Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
Teva Pharmaceutical Industries Ldt
2005 Phase 2 EUCTR2005-004334-41-IT Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
ABR-215062 sodium salt
Teva Pharmaceutical Industries Ltd
2010 Phase 3 EUCTR2009-015815-42-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain
2010 Phase 3 EUCTR2009-015815-42-PL Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-LT Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-EE Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-CZ Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-BG Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-012989-30-SE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012989-30-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012989-30-BG Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012989-30-AT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-NL Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-LT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-HU Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-GB Austria;Bulgaria;Canada;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2009-012989-30-EE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 - EUCTR2009-011234-99-DE Germany
2008 - EUCTR2007-003226-19-PT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2007-003226-19-LT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2007-003226-19-BG Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-SE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-NL Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-LV Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-HU Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-GB Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 Phase 3 EUCTR2007-003226-19-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 Phase 3 EUCTR2007-003226-19-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-EE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-DE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-AT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-GB Czech Republic;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-DE Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-CZ Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
2005 Phase 2 EUCTR2005-004334-41-HU Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
2005 - EUCTR2004-003943-28-HU Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 Phase 2 EUCTR2004-003943-28-GB Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 Phase 2 EUCTR2004-003943-28-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 - EUCTR2004-003943-28-DE Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 - EUCTR2004-003943-28-CZ Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
ABT-555
AbbVie
2016 Phase 1 NCT02601885 United States
2015 Phase 1 NCT02606630 United Kingdom
ABT-874/human monoclonal antibody against IL-12
AbbVie (prior sponsor, Abbott)
2004 Phase 2 NCT00086671 Canada;Germany;Netherlands;United Kingdom;United States
ABX-1431 HCL
Abide Therapeutics
2017 Phase 1 NCT03138421 United Kingdom
Acetaminophen tablet 650MG
Columbia University
2019 Phase 3 NCT03824938 United States
Acetazolamide
The University of Texas Health Science Center, Houston
2016 Phase 2 NCT02466074 United States
Acetylsalicylic acid
Biogen
2014 Phase 4 NCT02090413 Ireland;United Kingdom
Biogen Idec Research Limited
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom
Columbia University
2017 Early Phase 1 NCT03051646 United States
Aciclovir
Genzyme, a Sanofi Company
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain
Aclasta 5 MG infusionslösung
Novartis Pharma GmbH
2010 - EUCTR2009-011888-37-DE Germany
Aclasta 5MG solution FOR infusion
North Bristol Trust
2009 - EUCTR2008-005304-93-GB United Kingdom
ACT
Janssen-Cilag International NV
2023 Phase 3 EUCTR2020-004431-24-BE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
ACT-1
Actelion Pharmaceuticals Ltd
2015 Phase 3 EUCTR2012-000540-10-LV Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-GR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FI Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-CZ Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
ACT-128800
ACTELION Pharmaceuticals Ltd
2010 Phase 2 EUCTR2009-011470-15-PL Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-NL Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-HU Australia;Austria;Bulgaria;Canada;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-GB Austria;Bulgaria;Canada;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-FI Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-011470-15-ES Austria;Bulgaria;Czech Republic;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2010 Phase 2 EUCTR2009-011470-15-DE Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-CZ Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-BG Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-AT Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
ACTELION Pharmaceuticals Ltd.
2010 Phase 2 EUCTR2009-011470-15-SE Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Actelion Pharmaceuticals Ltd
2015 Phase 3 EUCTR2012-000540-10-SE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-PT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-PL Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LV Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-HU Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-HR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-GR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FI Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-ES Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-DE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-CZ Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-IT Austria;Bulgaria;Czech Republic;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2010 Phase 2 EUCTR2008-006786-92-FR Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 - EUCTR2008-006786-92-SE Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 - EUCTR2008-006786-92-PL Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 - EUCTR2008-006786-92-NL Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 - EUCTR2008-006786-92-HU Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 - EUCTR2008-006786-92-GB Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 - EUCTR2008-006786-92-FI Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 Phase 2 EUCTR2008-006786-92-ES Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 Phase 2 EUCTR2008-006786-92-CZ Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 - EUCTR2008-006786-92-BG Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 Phase 2 EUCTR2008-006786-92-BE Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2009 - EUCTR2008-006786-92-AT Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
Actelion Pharmaceuticals Ltd.
2019 Phase 3 EUCTR2012-000541-12-HR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Mexico;Poland;Portugal;Russian Federation;Spain;Switzerland;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-RO Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-PT Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-LV Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-HU Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-HR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-GR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-GB Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-FI Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-CZ Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-BG Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2012-000541-12-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2017 Phase 3 EUCTR2016-004719-10-SE Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2016-004719-10-PL Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2016-004719-10-LT Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2016-004719-10-ES Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2012-000541-12-PL Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2017 Phase 3 EUCTR2012-000541-12-FR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2017 Phase 3 EUCTR2012-000541-12-FI Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2017 Phase 3 EUCTR2012-000541-12-BG Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-PT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-HU Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-GR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-ES Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-DK Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-DE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-CZ Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-AT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2009 - EUCTR2008-006786-92-IT Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
ACT-128800 dose 1
Actelion
2009 Phase 2 NCT01006265 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
ACT-128800 dose 2
Actelion
2009 Phase 2 NCT01006265 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
ACT-128800 dose 3
Actelion
2009 Phase 2 NCT01006265 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Acth
Neurologique Foundation, Inc.
2009 Phase 2/Phase 3 NCT00947895 United States
Providence Health & Services
2015 Phase 3 NCT02315872 United States
University of Colorado, Denver
2013 Phase 4 NCT01838174 United States
University of Minnesota
2014 Phase 2 NCT01950234 United States
University of Southern California
2009 Phase 1 NCT01049451 United States
Weill Medical College of Cornell University
2016 Phase 4 NCT02446886 United States
Acthar
Elliot Frohman
2009 Phase 4 NCT00854750 United States
OhioHealth
2014 - NCT02258217 United States
University of Chicago
2016 Phase 4 NCT03021317 -
Weill Medical College of Cornell University
2016 Phase 4 NCT02446886 United States
Acthar GEL
Aaron Miller
2013 - NCT01900093 United States
Tanner Foundation for Multiple Sclerosis
2013 - NCT01906684 United States
The University of Texas Health Science Center, Houston
2013 Phase 4 NCT01888354 United States
University of Colorado, Denver
2013 Phase 4 NCT01838174 United States
Activated charcoal
Sanofi
2023 Phase 3 NCT06141473 Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
Active control
Biogen
2014 Phase 1 NCT02201849 United States
Acyclovir
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 1 NCT02583594 Spain
2014 Phase 1 NCT02282826 Germany
Sanofi
2016 Phase 1 NCT02977533 Germany
AD26.COV2.S
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States
Adderall XR
Sarah Morrow
2016 Phase 2/Phase 3 NCT02676739 Canada
Adderall XR 10 MG
London Health Sciences Centre
2012 Phase 2/Phase 3 NCT01667484 Canada
Adderall XR 5MG
London Health Sciences Centre
2012 Phase 2/Phase 3 NCT01667484 Canada
Adenosine
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Adezunap
Apurano Pharmaceuticals GmbH
2023 Phase 3 NCT06072001 Germany
2023 Phase 3 NCT06071949 Germany
Adherence counseling
Biogen
2015 Phase 4 NCT02343159 United States
Adipose tissue-derived mesenchymal stromal cells
Rennes University Hospital
2025 Phase 1 NCT06592703 France
Adrenocorticotropic hormone
State University of New York at Buffalo
2013 Phase 3 NCT02290444 United States
Weill Medical College of Cornell University
2016 Phase 4 NCT02446886 United States
ADS-5102
Adamas Pharmaceuticals, Inc.
2015 Phase 2 NCT02471222 United States
ADS-5102, 137 MG
Adamas Pharmaceuticals, Inc.
2018 Phase 3 NCT03436199 Canada;United States
ADS-5102, 274 MG
Adamas Pharmaceuticals, Inc.
2018 Phase 3 NCT03567057 Canada;United States
2018 Phase 3 NCT03436199 Canada;United States
Aerobic training
Istituto Auxologico Italiano
2016 - NCT06051019 -
Aert, (R)-baclofen
Osmotica Pharmaceutical US LLC
2018 Phase 3 EUCTR2017-004101-40-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004101-40-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004101-40-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
Agee cream
University of Nebraska
2010 Phase 4 NCT00988988 United States
Ahsc
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany
Aimspro
Daval International Limited
2008 Phase 2 EUCTR2006-006872-39-GB United Kingdom
AIN
NOVARTIS FARMA
2013 - EUCTR2012-004019-29-IT Argentina;Canada;Colombia;Finland;Germany;Italy;Japan;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
AIN457
NOVARTIS FARMA
2013 - EUCTR2012-004019-29-IT Argentina;Canada;Colombia;Finland;Germany;Italy;Japan;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
Novartis Farmacéutica, S.A.
2013 - EUCTR2012-004019-29-ES Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
Novartis Pharma AG
2013 - EUCTR2012-004019-29-SE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 - EUCTR2012-004019-29-PT Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 - EUCTR2012-004019-29-PL Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 - EUCTR2012-004019-29-FI Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 - EUCTR2012-004019-29-DE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 Phase 2 EUCTR2012-004019-29-CZ Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 Phase 2 EUCTR2012-004019-29-BE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
Novartis Pharma K.K.
2013 Phase 2 JPRN-jRCT2080222132 -
Novartis Pharma Services AG
2012 - EUCTR2011-001629-25-CZ Czech Republic;Russian Federation;Ukraine
2009 Phase 2 EUCTR2009-011626-34-SE Czech Republic;Sweden
2009 - EUCTR2009-011626-34-CZ Czech Republic;Russian Federation;Serbia;Sweden;Ukraine
Novartis Pharmaceuticals
2013 Phase 2 NCT01874340 Belgium;Canada;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2012 Phase 2 NCT01433250 Czech Republic;Russian Federation;Ukraine
2009 Phase 2 NCT01051817 Czech Republic;Russian Federation;Serbia;Sweden;Ukraine
Albuterol
National Institute of Allergy and Infectious Diseases (NIAID)
2001 - NCT00039988 United States
Alcohol wipes VS. NO alcohol wipes
Teva Neuroscience, Inc.
2004 Phase 4 NCT00220922 United States
Alemtuzumab
Biogen
2021 - NCT05688436 United States
Cambridge University Hospitals NHS Foundation Trust
2012 Phase 1/Phase 2 NCT01712945 United Kingdom
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom
Central Texas Neurology Consultants
2011 Phase 3 NCT01333358 -
GENZYME CORPORATION
2017 Phase 3 EUCTR2016-003100-30-IT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
Genzyme Corporation
2017 Phase 3 EUCTR2016-003100-30-PT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-NO Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-NL Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-GR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-GB Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-ES Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-DE Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-BE Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-AT Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 3;Phase 4 EUCTR2013-003884-71-NL Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3;Phase 4 EUCTR2013-003884-71-DK Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3;Phase 4 EUCTR2013-003884-71-BE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2015 Phase 3 EUCTR2009-010788-18-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2014 Phase 4 EUCTR2014-000092-62-NL Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-FR Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-ES Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-BE Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 3;Phase 4 EUCTR2013-003884-71-IT Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3;Phase 4 EUCTR2013-003884-71-HR Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2014 Phase 3;Phase 4 EUCTR2013-003884-71-ES Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3;Phase 4 EUCTR2013-003884-71-DE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2014 Phase 3;Phase 4 EUCTR2013-003884-71-CZ Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2009-010788-18-IT Austria;Belgium;Czech Republic;Denmark;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-010788-18-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-010788-18-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-010788-18-ES Austria;Belgium;Czech Republic;Denmark;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-010788-18-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-010788-18-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-010788-18-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-010788-18-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 - EUCTR2009-010788-18-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-010788-18-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-NL Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-IT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-001162-32-CZ Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-AT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001161-14-SE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 - EUCTR2007-001161-14-PL Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 Phase 3 EUCTR2007-001161-14-FR Czech Republic;France;Germany;Poland;Sweden;United Kingdom
2008 - EUCTR2007-001161-14-DE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 - EUCTR2007-001161-14-CZ Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2007 Phase 3 EUCTR2007-001162-32-GB Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2007 - EUCTR2007-001161-14-GB Czech Republic;France;Germany;Poland;Sweden;United Kingdom
- Phase 3 EUCTR2016-003100-30-PL Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-Outside-EU/EEA Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-FR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-BG Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
Genzyme GmbH
2016 Phase 3 EUCTR2016-000464-42-DE Germany
Genzyme, a Sanofi Company
2015 - NCT03774914 Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
2009 Phase 3 NCT00930553 Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2007 Phase 3 NCT00530348 Argentina;Australia;Brazil;Canada;Croatia;Czech Republic;Former Serbia and Montenegro;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;United States
Glostrup University Hospital, Copenhagen
2017 - NCT03193086 Denmark
Hadassah Medical Organization
2015 - NCT02529839 -
Haukeland University Hospital
2018 Phase 3 NCT03477500 Denmark;Netherlands;Norway;Sweden
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
Queen Mary University of London
2022 - NCT06310343 United Kingdom
2017 - NCT03250169 United Kingdom
R&D Addenbrookes Hospital
2008 Phase 2 EUCTR2005-002305-23-GB United Kingdom
Seah Lim M.D.
2012 Phase 2 NCT01679041 United States
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University Hospital Muenster
2015 Phase 4 NCT02419378 Germany
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany
University of Aarhus
2017 - NCT03806387 Denmark
University of British Columbia
2003 - NCT06705608 -
University of Chicago
2011 Phase 4 NCT01395316 -
University of Texas Southwestern Medical Center
2018 Phase 4 NCT03135249 United States
Universitätsklinikum Hamburg-Eppendorf
2021 Phase 2 NCT04971005 Germany
Universitätsklinikum Münster
2014 Phase 4 EUCTR2014-000709-10-DE Germany
Alemtuzumab 12 MG
Genzyme, a Sanofi Company
2007 Phase 3 NCT00548405 Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2002 Phase 2 NCT00050778 Croatia;Poland;Russian Federation;United Kingdom;United States
Alemtuzumab 24 MG
Genzyme, a Sanofi Company
2007 Phase 3 NCT00548405 Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2002 Phase 2 NCT00050778 Croatia;Poland;Russian Federation;United Kingdom;United States
Alemtuzumab GZ402673
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 1 NCT02583594 Spain
2015 Phase 4 NCT02255656 Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain
Alemtuzumab immunotherapy
Samuel Forrester Hunter, MD, PhD
2012 Phase 1 NCT01624714 United States
Alemtuzumab injection
Maritime Neurology
2016 - NCT04633967 Canada
University Hospital Muenster
2017 - NCT04082260 Germany
Alfuzosin
Capital District Health Authority, Canada
2007 Phase 2/Phase 3 NCT00688948 Canada
Alks 8700
Alkermes, Inc.
2019 Phase 3 EUCTR2017-001294-16-DE Germany;Poland;United States
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States
Biogen
2017 Phase 3 NCT03093324 Germany;Poland;United States
Alks 8700 delayed release (DR) capsule
Alkermes, Inc.
2016 Phase 3 EUCTR2015-005160-41-ES Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2016 Phase 3 EUCTR2015-005160-41-BG Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2016 Phase 3 EUCTR2015-005160-41-BE Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
Biogen Idec Research Limited
2016 Phase 3 EUCTR2015-005160-41-PL Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2016 Phase 3 EUCTR2015-005160-41-DE Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
ALL patients IN THE study will BE treated with ocrelizumab
Providence Health & Services
2020 - NCT05081700 United States
Allogeneic fecal microbiota
St. Petersburg State Pavlov Medical University
2019 Phase 1 NCT04203017 Russian Federation
Allogeneic human umbilical cord tissue-derived mesenchymal stem cells
Genesis Limited
2015 Phase 1/Phase 2 NCT02418325 Trinidad and Tobago
Novo Cellular Medicine Institute LLP
2015 Phase 1/Phase 2 NCT02587715 Trinidad and Tobago
Allogeneic umbilical cord mesenchymal stem cells
Ever Supreme Bio Technology Co., Ltd.
2023 Phase 1/Phase 2 NCT05532943 Taiwan
Allogenic placenta derived mesenchymal stem cells
Tehran University of Medical Sciences
2019 Phase 1 NCT06360861 Iran, Islamic Republic of
Allorx
The Foundation for Orthopaedics and Regenerative Medicine
2021 Phase 1 NCT05003388 Antigua and Barbuda;Argentina;Greece;Mexico
Alpha lipoic acid
Rebecca Spain
2018 Phase 1 NCT03493841 United States
University of Iowa
2010 Phase 1 NCT01381354 United States
Alpha-lipoic acid
National Center for Complementary and Integrative Health (NCCIH)
1999 Phase 1/Phase 2 NCT00010842 United States
Alpha1-antitrypsin
Stanford University
2014 Phase 1 NCT02087813 United States
Altri farmaci DEL sistema nervoso
GLAXO SMITHKLINE
2004 - EUCTR2004-000374-31-IT Italy
ALXN1210
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 3 EUCTR2019-003352-37-IT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
Alexion Pharmaceuticals, Inc.
2022 Phase 2;Phase 3 EUCTR2021-006075-42-FR Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2022 Phase 2;Phase 3 EUCTR2021-006075-42-ES Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2020 Phase 3 EUCTR2019-003352-37-PL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-NL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-ES Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-DK Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-DE Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-AT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
- Phase 2;Phase 3 EUCTR2021-006075-42-DE Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Amantadine
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
2011 - EUCTR2010-023678-38-IT Italy
Johns Hopkins University
2017 Phase 3 NCT03185065 United States
Amantadine hydrochloride
Fundación para la Inv. Biomédica Hospital Clínico San Carlos
2022 Phase 4 EUCTR2021-004868-95-ES Spain
Amantadine hydrochloride 100 MG (milligrams) oral capsule
Hospital San Carlos, Madrid
2022 Phase 3 NCT05809414 Spain
Amantadine level
Fundación para la Inv. Biomédica Hospital Clínico San Carlos
2022 Phase 4 EUCTR2021-004868-95-ES Spain
American ginseng extract HT-1001
Oregon Health and Science University
2005 Phase 2 NCT00754832 United States
Amiloride
UCL
2014 Phase 2 EUCTR2012-005394-31-GB United Kingdom
University College, London
2014 Phase 2 NCT01910259 United Kingdom
University of Oxford
2013 Phase 2 NCT01802489 United Kingdom
Amiloride hydrochloride
Oxford Racliffe NHS Trust
2008 - EUCTR2007-004051-11-GB United Kingdom
Amiloride hydrochloride, 2 H2O
Universitätsklinik für Neurologie, Medizinische Universität Wien
2013 - EUCTR2012-005113-39-AT Austria
Amilostad HCT tablets
Universitätsklinik für Neurologie, Medizinische Universität Wien
2013 - EUCTR2012-005113-39-AT Austria
Amniotic fluid or placental CD117 stem cells
Wake Forest University Health Sciences
2026 Phase 1/Phase 2 NCT06841068 United States
Ampyra
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
2011 - EUCTR2010-023678-38-IT Italy
MGH Institute of Health Professions
2024 Phase 4 NCT06136728 United States
Amyvid radiopharmaceutical
Brain Health Alliance
2024 Early Phase 1 NCT04390009 United States
AN100226
BIOGEN IDEC LTD
2011 - EUCTR2010-024000-10-IT Belgium;Germany;Italy;Spain
Biogen Idec Limited
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain
Biogen Idec Ltd.
2004 - EUCTR2004-000047-18-SE Sweden
AN100226, BG00002
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-002145-11-IT Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
Biogen Idec Limited
2012 Phase 3 EUCTR2010-021978-11-IE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2012 - EUCTR2010-021978-11-BE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-SE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-PL Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-GB Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-FI Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-ES Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-DK Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-DE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Iraq;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-CZ Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-002145-11-NL Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-FR Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-ES Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-DE Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2015 - EUCTR2013-005586-39-DE Germany;Italy;United States
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2013 - EUCTR2012-005082-13-IT Italy
Anakinra
National Institute of Neurological Disorders and Stroke (NINDS)
2019 Phase 1/Phase 2 NCT04025554 United States
Androgel 1 % topical GEL
University of California, Los Angeles
2018 Phase 2 NCT03000127 United States
Androgel 10 grams OF GEL containing 100 MG OF testosterone
University of California, Los Angeles
2002 Phase 1/Phase 2 NCT00405353 United States
Andrographolides
Innobioscience SpA
2014 Phase 1/Phase 2 NCT02273635 Chile
Anesthetic topical adhesive synera
Brown, Theodore R., M.D., MPH
2013 Phase 4 NCT01834586 United States
ANK-700
Anokion SA
2020 Phase 1 NCT04602390 United States
Anti LP40 antibody, subclass IGG4 LA294
Eli Lilly and Company
2010 - EUCTR2008-007459-28-BG Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-HU Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 Phase 2 EUCTR2008-007459-28-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-DK Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-DE Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-CZ Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-BE Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
ANTI-aquaporin-4 antibody
Pontificia Universidade Católica do Rio Grande do Sul
2017 - NCT03087136 Brazil
ANTI-baffr cart
Tianjin Medical University General Hospital
2024 Phase 1/Phase 2 NCT06561009 -
ANTI-CD20 antibody
Heinrich-Heine University, Duesseldorf
2021 - NCT06586177 Germany
ANTI-CD20 MAB
Kyverna Therapeutics
2024 Phase 2 NCT06384976 United States
ANTI-CD20 monoclonal antibody
Region Stockholm
2025 - NCT06711354 -
ANTI-CD20 MS treatment
Washington University School of Medicine
2024 - NCT06591429 United States
ANTI-CD25 humanized monoclonal antibody
PDL BioPharma, Inc.
2005 Phase 2 NCT00109161 Canada;United States
Protein Design Labs, Inc.
2006 - EUCTR2005-001567-55-DE Germany;Spain;United Kingdom
2005 Phase 2 EUCTR2005-001567-55-GB Austria;Germany;Spain;United Kingdom
2005 Phase 2 EUCTR2005-001567-55-ES Austria;Germany;Spain;United Kingdom
2005 - EUCTR2005-001567-55-AT Austria;Germany;Spain;United Kingdom
ANTI-CD52 monoclonal antibody
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom
ANTI-mullerian hormone (AMH) level
University Hospital, Bordeaux
2023 - NCT05754593 France
ANTI-myelin oligodendrocyte glycoprotein
Pontificia Universidade Católica do Rio Grande do Sul
2017 - NCT03087136 Brazil
ANTI-thymocyte globulin
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States
Anticholinergic medication
Wellspect HealthCare
2009 - NCT00913510 Belgium;France;Germany;Netherlands;United Kingdom
Anticuerpo monoclonal ANTI-lingo-1 humano
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-ES Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
Antihistamine
Genentech, Inc.
2016 Phase 3 NCT02688985 Canada;Germany;Sweden;United States
Hoffmann-La Roche
2020 Phase 3 NCT04548999 Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 NCT04544436 Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Antimycotic
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy
Antithymocyte
Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
2006 - EUCTR2006-002562-19-IT Italy
Antithymocyte immunoglobulin
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
Anxiety
Ankara Yildirim Beyazit University
2019 - NCT04408742 Turkey
Anxiety/depression and work and activities
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France
Apitox - pure honeybee toxin
Apimeds, Inc.
2019 Phase 3 NCT03710655 -
Arbaclofen
RVL Pharmaceuticals, Inc.
2026 Phase 3 NCT05179577 -
2013 Phase 3 NCT01844232 Russian Federation;Ukraine;United States
2012 Phase 3 NCT01743651 Russian Federation;Ukraine;United States
Arbaclofen ER tablets
RVL Pharmaceuticals, Inc.
2016 Phase 3 NCT02869425 United States
Arbaclofen extended release tablets
Osmotica Pharmaceutical US LLC
2018 Phase 3 EUCTR2017-004101-40-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004101-40-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004101-40-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
Arbaclofen placarbil
XenoPort, Inc.
2011 Phase 3 NCT01360489 United States
Arbaclofen placarbil 15 MG BID
XenoPort, Inc.
2011 Phase 3 NCT01359566 United States
Arbaclofen placarbil 30 MG BID
XenoPort, Inc.
2011 Phase 3 NCT01359566 United States
Arbaclofen placarbil 45 MG BID
XenoPort, Inc.
2011 Phase 3 NCT01359566 United States
Aricept
OSPEDALE S. RAFFAELE
2008 - EUCTR2008-001940-38-IT Italy
Aricept 10 MG filmdragerade tabletter
Neurology Unit
2005 - EUCTR2005-003410-15-SE Sweden
Aricept 5 MG filmdragerade tabletter
Neurology Unit
2005 - EUCTR2005-003410-15-SE Sweden
ARM 1 - GEH120714 (18F) injection
GE Healthcare
2013 Phase 1 NCT01738347 Canada;United States
Armodafinil
University of Missouri, Kansas City
2009 Phase 2/Phase 3 NCT00981084 United States
ARN-6039
Arrien Pharmaceuticals
2016 Phase 1 NCT03237832 -
Arzerra
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD.
2012 - EUCTR2011-002333-19-IT Canada;Czech Republic;Germany;Italy;Netherlands;Russian Federation;Spain;United States
GlaxoSmithKline Research and Development Limited
2012 - EUCTR2011-002333-19-CZ Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
2011 - EUCTR2011-002333-19-NL Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
2011 Phase 2 EUCTR2011-002333-19-DK Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
GlaxoSmithKline SA
2011 Phase 2 EUCTR2011-002333-19-ES Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
Novartis Farmacéutica S.A.
2020 Phase 3 EUCTR2019-001341-40-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States
Novartis Farmacéutica, S.A
2019 Phase 3 EUCTR2017-004703-51-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
Novartis Farmacéutica, S.A.
2018 Phase 2 EUCTR2017-004702-17-ES Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2016 Phase 3 EUCTR2015-005419-33-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-ES Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2016 Phase 3 EUCTR2015-005419-33-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
Novartis Pharma AG
2020 Phase 3 EUCTR2019-001341-40-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-NO Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 2 EUCTR2017-004702-17-PL Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 3 EUCTR2017-004703-51-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 2 EUCTR2017-004702-17-LV Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-LT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-EE Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-CZ Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-BG Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-AT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2017 Phase 3 EUCTR2015-005418-31-FR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HU Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BE Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-NL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-CZ Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-PL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GB Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-EE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BG Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Arzerra - 100 MG - concentrato PER soluzione PER infusione - USO endovenoso - flacone(vetro) - 5 ML(20MG/ML) 3 flaconi
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
Arzerra - 1000 MG - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino (vetro) - 50 ML (20 MG/ML) 1 flaconcino + 2 KIT DI prolunga
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
ASA
Biogen
2014 Phase 4 NCT02090413 Ireland;United Kingdom
Biogen Idec Research Limited
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom
ASB-683699
GLAXO SMITHKLINE
2004 - EUCTR2004-000374-31-IT Italy
Aspirin
Mayo Clinic
2007 Phase 3 NCT00467584 United States
Aspirin 650MG oral capsule
Columbia University
2019 Phase 3 NCT03824938 United States
Assessment OF disability
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France
Assessment OF impact OF MS ON cognition
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France
AT-home natalizumab treated MS patient
Nantes University Hospital
2021 - NCT04777539 France
ATA188
Atara Biotherapeutics
2017 Phase 1/Phase 2 NCT03283826 Australia;Canada;United States
Atacicept
EMD Serono
2008 Phase 2 NCT00642902 Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Lebanon;Lithuania;Netherlands;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Merck Serono Geneva- an affiliate of Merck KGaA, Darmstadt Germany
2008 - EUCTR2007-003936-50-SE Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Merck Serono International
2009 - EUCTR2008-005021-11-SE Belgium;Czech Republic;France;Sweden
2009 Phase 2 EUCTR2008-005021-11-FR Belgium;Czech Republic;France;Sweden
2009 Phase 2 EUCTR2008-005021-11-CZ Belgium;Czech Republic;France;Sweden
Merck Serono International S.A.
2008 - EUCTR2007-003936-50-NL Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2008 Phase 2 EUCTR2007-003936-50-FR Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2008 Phase 2 EUCTR2007-003936-50-ES Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Merck Serono S.A. - Geneva
2008 - EUCTR2007-003936-50-GB Australia;Austria;Canada;Czech Republic;France;Lebanon;Lithuania;Netherlands;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-003936-50-AT Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Merck Serono SA - Geneva, An affiliate of Merck KGaA, Darmstadt, Germany
2009 - EUCTR2008-005021-11-BE Belgium;Czech Republic;France;Sweden
Merck Serono SA - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2008 - EUCTR2007-003936-50-CZ Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2008 - EUCTR2007-003936-50-BE Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Merck Serono SA-Geneva
2008 - EUCTR2007-003936-50-LT Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Atacicept 150 MG
EMD Serono
2009 Phase 2 NCT00853762 Australia;Belgium;Canada;Czech Republic;France;Germany;Lebanon;Lithuania;Netherlands;New Caledonia;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Atacicept 25 MG
EMD Serono
2009 Phase 2 NCT00853762 Australia;Belgium;Canada;Czech Republic;France;Germany;Lebanon;Lithuania;Netherlands;New Caledonia;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Atacicept 75 MG
EMD Serono
2009 Phase 2 NCT00853762 Australia;Belgium;Canada;Czech Republic;France;Germany;Lebanon;Lithuania;Netherlands;New Caledonia;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
ATG
Baylor College of Medicine
1999 Phase 2 NCT00040482 United States
ATL1102
Antisense Therapeutics Ltd.
2007 Phase 2 EUCTR2006-004736-79-SK Czech Republic;Slovakia
2007 - EUCTR2006-004736-79-CZ Czech Republic
Atomoxetine
Icahn School of Medicine at Mount Sinai
2017 Phase 2 NCT03091400 United States
Atorvastatin
DR DIMENSIONE RICERCA
2005 - EUCTR2005-001009-25-IT Italy
National Institute of Allergy and Infectious Diseases (NIAID)
2005 Phase 2 NCT00094172 Canada;United States
Sun Yat-sen University
2006 - NCT00818103 China
University Hospital Inselspital, Berne
2005 Phase 2 NCT00942591 Switzerland
ATX-MS-1467
Apitope Technology (Bristol) Ltd.
2010 Phase 1 NCT01097668 Russian Federation;United Kingdom
Merck KGaA
2014 Phase 2 NCT01973491 Germany
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation
Aubagio
Actelion Pharmaceuticals Ltd
2015 Phase 3 EUCTR2012-000540-10-SE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-PT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-PL Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LV Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-HU Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-HR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-GR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FI Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-ES Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-DE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-CZ Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Centre Hospitalier Universitaire de Nice
2017 Phase 3 NCT03122652 France;Germany;Martinique;Sweden;Switzerland;Turkey;United Kingdom
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-001168-28-IT Austria;Bulgaria;Denmark;Finland;France;Greece;Italy;Netherlands;United States
2021 Phase 3 EUCTR2019-004857-10-IT Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-001168-28-GR Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-DK Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-BG Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2019-004857-10-NL Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2021 Phase 3 EUCTR2019-004857-10-HU Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2021 Phase 3 EUCTR2019-004857-10-DE Algeria;Argentina;China;Dominican Republic;Egypt;Finland;France;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
2020 Phase 3 EUCTR2020-001168-28-FR Austria;Bulgaria;Denmark;Finland;France;Greece;Italy;Netherlands;United States
2020 Phase 3 EUCTR2019-004857-10-FI Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
GENZYME CORPORATION
2022 Phase 3 EUCTR2020-000644-55-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
Genzyme Corporation
2022 Phase 3 EUCTR2020-000644-55-EE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NO Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HR Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-BE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-RO Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2014 Phase 4 EUCTR2013-001439-34-IT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States
2014 Phase 4 EUCTR2013-001439-34-GR Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 Phase 4 EUCTR2013-001439-34-GB Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-DE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-BE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-AT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-SE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-FI Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-ES Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
MS Centrum, Department of Neurology, Sshlgrenska University Hospital
2018 Phase 4 EUCTR2016-004414-10-SE Sweden
Merck Healthcare KGaA
2022 Phase 3 EUCTR2019-004980-36-CZ Belarus;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-SI Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-RO Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-SK Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PL Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-NO Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LV Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-GR Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-ES Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-DE Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-BG Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
NOVARTIS PHARMA AG
2022 Phase 3 EUCTR2020-005929-89-IT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Japan;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-IT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Guatemala;Hong Kong;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
Novartis Farmacéutica S.A.
2022 Phase 3 EUCTR2020-005929-89-ES Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-ES Slovakia;Spain
Novartis Farmacéutica, S.A.
2016 Phase 3 EUCTR2015-005419-33-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-ES Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2016 Phase 3 EUCTR2015-005419-33-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
Novartis Pharma AG
2023 Phase 3 EUCTR2020-005899-36-LT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2023 Phase 3 EUCTR2020-005899-36-DK Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2023 Phase 3 EUCTR2020-005899-36-AT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;Finland;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SK Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SI Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-RO Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Türkiye;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-PT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-PL Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Türkiye;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-HR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-GR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-FR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-EE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-BG Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-SK Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-NL Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-LV Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-HR Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-BG Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-BE Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-FR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HU Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BE Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-NL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-CZ Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-PL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GB Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-EE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BG Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Turku University Hospital
2017 Phase 4 EUCTR2016-003622-16-FI Finland
Aubagio - 14 MG - compressa rivestita CON film - USO orale - bister (ALU/ALU) perforato monodose - 10 X 1 compressa
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Aubagio - 14 MG - compressa rivestita CON film - USO orale - blister (ALU/ALU) - 28 compresse
UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
2016 Phase 4 EUCTR2016-001515-20-IT Italy
Aubagio 14 MG FILM-coated tablets
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2019-004857-10-PT Algeria;Argentina;China;Dominican Republic;Egypt;Finland;France;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
Aubagio 14MG TBL FLM
Fakultní nemocnice Ostrava
2023 Phase 4 EUCTR2022-004331-23-CZ Czech Republic
2021 Phase 4 EUCTR2021-003195-13-CZ Czech Republic
Autologous adipose derived mesenchymal cells
American CryoStem Corporation
2014 Phase 1 NCT02326935 Cayman Islands
Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved
Banc de Sang i Teixits
2014 - EUCTR2012-000734-19-ES Spain
Autologous bone marrow transplantation
Hadassah Medical Organization
2015 - NCT02529839 -
Autologous bone marrow-derived mononuclear stem cells
Genesis Limited
2015 Phase 1/Phase 2 NCT02418351 India;Trinidad and Tobago
Novo Cellular Medicine Institute LLP
2015 Phase 1/Phase 2 NCT02587806 India;Trinidad and Tobago
Autologous CD4+T cells stimulated and expanded EX vivo BY A MOG peptide modified BY THE introduction OF A thioreductase motif into THE flanking residues OF THE T cell epitope
Imcyse SA
2015 Phase 1/Phase 2 NCT02427776 Belgium
Autologous HB-admscs
Hope Biosciences
2025 Phase 2 NCT06800404 United States
Autologous hematopoietic stem cell
Makati Medical Center
2015 Phase 1 NCT03113162 Philippines
Autologous hematopoietic stem cell transplant
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States
Autologous hematopoietic stem cell transplantation
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
National Institute of Allergy and Infectious Diseases (NIAID)
2019 Phase 3 NCT04047628 United Kingdom;United States
Scripps Health
2023 - NCT05482542 United States
Universitätsklinikum Hamburg-Eppendorf
2021 Phase 2 NCT04971005 Germany
Autologous hematopoietic stem cells
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany
Autologous mesenchymal cell product
Imperial College London
2012 Phase 2 EUCTR2012-002357-35-GB United Kingdom
Autologous mesenchymal stem cell transplantation
The Cleveland Clinic
2011 Phase 1 NCT00813969 United States
Autologous mesenchymal stem cells
Albert Saiz
2010 Phase 2 NCT01228266 Spain
Antonio Uccelli
2012 Phase 1/Phase 2 NCT01854957 Italy
Karolinska Institutet
2013 Phase 1/Phase 2 NCT01730547 Sweden
2012 Phase 1 NCT03778333 Sweden
Tianjin Medical University General Hospital
2013 Phase 2 NCT02249676 China
University of Jordan
2012 Phase 1/Phase 2 NCT01895439 Jordan
Autologous myelin-derived peptide-pulsed tolerogenic dendritic cells
Antwerp University Hospital
2023 Phase 2 EUCTR2022-003465-38-BE Belgium;Spain
Autologous stem cell transplantation
Northwestern Memorial Hospital
2001 Phase 1 NCT00017628 United States
Autologous stem cells
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States
2017 Phase 3 NCT03342638 United States
Autologous T-lymphocytes
ImCyse S.A
2014 Phase 1;Phase 2 EUCTR2014-001081-99-BE Belgium
AV605
Avigen Inc
2007 - EUCTR2007-001031-63-DE Germany
2007 Phase 2 EUCTR2007-001031-63-CZ Czech Republic;Germany
Avonex
BIOGEN IDEC LTD
2010 - EUCTR2009-012500-11-IT Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
BIOGEN-DOMPE` SRL
2010 - EUCTR2009-017003-28-IT Italy
Bayer
2024 - NCT06053749 Finland;Sweden
Biocad
2017 Phase 2/Phase 3 NCT02744222 Russian Federation
Biogen
2023 - NCT05658497 Germany;Ireland;Spain;Switzerland;United States
2013 Phase 2 NCT01864148 Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
Biogen Idec
2010 Phase 3 NCT01181115 China
2010 - EUCTR2009-017490-38-DE Germany;Spain
2002 Phase 4 NCT00913666 -
1999 Phase 4 NCT00915460 -
Biogen Idec Ltd
2010 - EUCTR2009-012500-11-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-GR Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012500-11-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012500-11-FR Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012500-11-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-003098-42-CZ Czech Republic
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2017 Phase 3 EUCTR2013-002318-11-FR Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom
2016 - EUCTR2013-002318-11-ES Argentina;Belgium;Canada;Croatia;Czech Republic;Denmark;France;Hungary;Israel;Italy;Poland;Portugal;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom
2016 Phase 3 EUCTR2013-002318-11-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Türkiye;United Kingdom;United States
2015 Phase 3 EUCTR2013-002318-11-PL Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-SE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-IT Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3 EUCTR2013-002318-11-HU Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom
2014 Phase 3 EUCTR2013-002318-11-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-DK Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-CZ Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-IT Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-HU Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-GB Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-ES Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-CZ Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
- Phase 3 EUCTR2013-002318-11-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland
EMD Serono
1999 Phase 3 NCT00292266 -
EMD Serono Research & Development Institute, Inc.
2019 Phase 3 NCT04032171 Germany;United States
2019 Phase 3 NCT04032158 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
F.Hoffmann-La Roche Ltd.
2008 - EUCTR2007-006338-32-IT Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Russian Federation;Spain;Switzerland;Ukraine;United Kingdom;United States
Genentech, Inc.
2008 Phase 2 NCT00676715 Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-SK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
ISTITUTO C. MONDINO
2007 - EUCTR2008-007162-32-IT Italy
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
MedImmune LLC
2012 - EUCTR2011-005475-16-GB Austria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
Medizinische Universität Innsbruck
2014 - EUCTR2012-005450-30-SE Austria;Sweden
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden
Merck Healthcare KGaA
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
Merck KGaA
2014 - EUCTR2013-003126-83-HU Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-GR Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-ES Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-DE Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
Neurognostics
2006 - NCT00398528 United States
Novartis Farma
2013 Phase 3 EUCTR2011-005677-23-IT Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Farmaceutica S.A.
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-FR Austria;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Pharma Services AG
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
2006 - EUCTR2006-000704-17-PT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
PD Dr. Marcus Müller
2015 Phase 1 NCT02364986 Germany
Receptos, Inc.
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-IT Belgium;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Israel;Italy;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-GR Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-ES Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
Saint Francis Care
2012 - NCT01641120 United States
State University of New York at Buffalo
2005 - NCT00463710 United States
Teva Branded Pharmaceutical Products R&D, Inc.
2014 Phase 3 NCT01975298 Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2008 Phase 3 NCT00605215 Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Israel;Italy;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Montenegro;North Macedonia;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
Teva Pharmaceutical Industries, Ltd.
2014 - EUCTR2013-002082-19-NL Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2014 - EUCTR2013-002082-19-ES Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-SE Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 EUCTR2013-002082-19-GB Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-FI Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-DK Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 EUCTR2013-002082-19-BE Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
Trio Medicines Ltd.
2001 Phase 1 NCT01863069 United Kingdom
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
University of California, San Francisco
2006 Phase 2 NCT00501943 United States
Avonex (interferon BETA-1A), biogen idec LTD
Bayer
2016 - NCT02749396 Finland
Avonex - 30 MCG (6 milioni UI) polvere E solvente PER soluzione iniettabile 4 flaconi CON dispositivo bioset + 4 siringhe preriempite USO intramuscolare
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Avonex 30 microgram/0.5 ML solution FOR injection
Teva Pharmaceutical Industries Ltd
2008 Phase 3 EUCTR2007-005450-23-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Slovakia;Spain
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-DE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-CZ Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-BG Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
Avonex 30 microgramos/0,5 ML (interferóN beta - 1A) solucióN inyectable
Biogen Idec Ltd
2010 Phase 3 EUCTR2009-012500-11-ES Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
Avonex 30 microgramos/0.5 ML solucióN para inyeccióN
Teva Pharmaceutical Industries Ltd
2008 - EUCTR2007-005450-23-ES Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
Avonex 30 µG/0,5 ML solution FOR injection
Università degli Studi Aldo Moro
2019 Phase 3 EUCTR2017-005129-18-IT Italy
Avonex and topamax
Multiple Sclerosis Institute
2004 Phase 2 NCT00217295 United States
Avonex IM 4SIR 30MCG/0,5ML 4AG
Universita di Firenze
2006 Phase 3 EUCTR2006-004937-13-IT Italy
Avonex prefilled syringe VIA manual IM injection
Biogen
2009 Phase 3 NCT00828204 United States
Avonex*IM 4SIR 30MCG/0,5ML+4AG
TEVA ITALIA srl
2008 - EUCTR2007-005450-23-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
Avonex/betaseron/copaxone/rebif
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom
Avonex/zocor
University of North Carolina
2004 Phase 4 NCT00146068 United States
AVP-923
Avanir Pharmaceuticals
2011 Phase 2 NCT01324232 Argentina;Czech Republic;Czechia;Germany;Poland;Spain;United Kingdom;United States
2002 Phase 3 NCT00050232 United States
Avanir Pharmaceuticals, Inc.
2012 - EUCTR2011-002178-22-PL Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2012 Phase 2 EUCTR2011-002178-22-GB Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2012 - EUCTR2011-002178-22-CZ Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2011 Phase 2 EUCTR2011-002178-22-ES Argentina;Bulgaria;Czech Republic;Poland;Spain;United Kingdom;United States
Azathioprine
First Affiliated Hospital of Guangxi Medical University
2020 Phase 4 NCT05896605 China
Hoffmann-La Roche
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Isfahan University of Medical Sciences
2015 Phase 2/Phase 3 NCT03002038 Iran, Islamic Republic of
The Ophthalmology Department of the Chinese Peoples Liberation Army Hospital
2019 Phase 4 ChiCTR1900025744 China
2014 - ChiCTR-ICR-15007177 China
Tianjin Medical University General Hospital
2017 Phase 2/Phase 3 NCT03350633 China
Universita di Firenze
2006 Phase 3 EUCTR2006-004937-13-IT Italy
Azatioprina HEX. 50CPR 50MG BL
Universita di Firenze
2006 Phase 3 EUCTR2006-004937-13-IT Italy
Azithromycin
National Center for Research Resources (NCRR)
2001 Phase 2 NCT00043264 United States
B001
Shanghai Jiaolian Drug Research and Development Co., Ltd
2024 Phase 2/Phase 3 NCT06413654 China
B001 injection
Shanghai Pharmaceuticals Holding Co., Ltd
2022 Early Phase 1 NCT05145361 China
Bacille calmette-guerin vaccine
S. Andrea Hospital
2019 Phase 2 NCT03888924 Italy
Bacille OF calmette-guerin
S. Andrea Hospital
2001 Phase 2/Phase 3 NCT00202410 Italy
Baclofen
DAIICHI SANKYO COMPANY, LIMITED
2005 Phase 4 JPRN-jRCT1080220031 -
RVL Pharmaceuticals, Inc.
2012 Phase 3 NCT01743651 Russian Federation;Ukraine;United States
Baclofen 20 MG
IMPAX Laboratories, Inc.
2007 - EUCTR2007-000236-16-LV Estonia;Latvia
2007 - EUCTR2007-000236-16-EE Estonia;Latvia
Baclofen ER capsules (GRS) 10 MG
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States
Baclofen ER capsules (GRS) 20 MG
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States
Baclofen ER capsules (GRS) 30MG
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States
Baclofen ER capsules (GRS) 40MG
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States
Baclofen ER capsules (GRS) 50 MG
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States
Baclofen IR
Impax Laboratories, LLC
2009 Phase 2 NCT00914290 United States
Baclofen tablets USP 10 MG
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States
BAF312
NOVARTIS FARMA
2010 - EUCTR2009-014392-51-IT Finland;Germany;Hungary;Italy;Poland;Spain
2009 - EUCTR2008-008719-25-IT Finland;Germany;Hungary;Italy;Spain
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Novartis Farmacéutica, S.A
2009 - EUCTR2008-008719-25-ES Finland;Germany;Hungary;Italy;Spain
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-RO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Novartis Pharma K.K.
2014 Phase 3 JPRN-jRCT2080222397 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;United Kingdom;United States
Novartis Pharma Services AG
2010 Phase 2 EUCTR2009-014392-51-PL Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States
2010 Phase 2 EUCTR2009-014392-51-HU Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States
2010 Phase 2 EUCTR2009-014392-51-FI Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States
2010 - EUCTR2009-014392-51-DE Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States
2009 - EUCTR2008-008719-25-HU Finland;Germany;Hungary;Italy;Spain
2009 - EUCTR2008-008719-25-FI Finland;Germany;Hungary;Italy;Spain
- - EUCTR2008-008719-25-DE Finland;Germany;Hungary;Italy;Spain
Novartis Pharmaceuticals
2021 Phase 4 NCT04792567 Germany
2012 Phase 3 NCT01665144 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 2 NCT01185821 Canada;Finland;Germany;Hungary;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;Turkey;United States
2009 Phase 2 NCT00879658 Canada;Finland;Germany;Hungary;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;Turkey;United States
BAF312 0,25 MG tablet
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands
BAF312 1 MG tablet
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands
BAF312 4 MG tablet
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands
BAF312 hemifumarate
NOVARTIS FARMA
2012 Phase 3 EUCTR2012-003056-36-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2011-006043-30-NL Netherlands
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
BAF312A
NOVARTIS FARMA
2012 Phase 3 EUCTR2012-003056-36-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Bafiertam
Banner Life Sciences LLC
2019 Phase 1 NCT04022473 United States
BAL
McMaster University
2024 - NCT06461741 Canada
Balance exercise program using exoskeleton device
East Kent Hospitals University NHS Foundation Trust
2017 Phase 1 NCT05102682 United Kingdom
Balance exercises
Marmara University
2023 - NCT06075472 Turkey
October 6 University
2017 - NCT03670459 Egypt
Balance exercises with stroboscopic glasses
Halic University
2024 - NCT06387043 Turkey
Balance exercises with virtual reality glasses
Halic University
2024 - NCT06387043 Turkey
Balance exercises with visual-based metaphor training
Halic University
2024 - NCT06387043 Turkey
Balance platform therapy
University Hospital of Ferrara
2017 - NCT03353974 Italy
Balance targeted exercises
University of Miami
2023 - NCT06159361 United States
Balance trainer balance exercises
Biruni University
2016 - NCT03436927 -
Balance training
Istituto Auxologico Italiano
2016 - NCT06051019 -
Riphah International University
2024 - NCT06845722 Pakistan
University of Aarhus
2016 - NCT02870023 Denmark
University of Iowa
2022 - NCT04391023 United States
Wayne State University
2020 - NCT03404388 United States
Baminercept
Biogen Idec
2010 Phase 1/Phase 2 NCT01181089 Canada;United Kingdom
Baricitinib
Tianjin Medical University General Hospital
2023 Phase 1/Phase 2 NCT05792462 China
Baseline treatment
Hoffmann-La Roche
2014 Phase 3 NCT02028884 France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States
BAT4406F
Bio-Thera Solutions
2020 Phase 1 NCT04146285 China
BAT4406F injection
Bio-Thera Solutions
2023 Phase 2 NCT06044350 China
BAY 79-4998
Bayer Vital GmbH
2006 - EUCTR2006-002361-39-DE Germany
BAY86-5046
Bayer
2024 - NCT06053749 Finland;Sweden
2016 - NCT02652091 United States
2012 - NCT01706055 Poland
2012 - NCT01491100 Albania;Algeria;Argentina;Belgium;Bosnia and Herzegovina;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Jordan;Kazakhstan;Lebanon;Mexico;Netherlands;Poland;Portugal;Saudi Arabia;Syrian Arab Republic;Tunisia;Turkey
2012 - NCT01436838 China
2011 - NCT01071694 Korea, Republic of
2010 - NCT01076595 France
2010 - NCT01031459 Canada;United States
2009 - NCT03408093 -
2009 - NCT00963833 Austria;Belgium;Finland;Germany;Israel;Italy;Portugal;United Kingdom
2009 - NCT00902135 Germany
2008 - NCT01414816 Korea, Republic of
2008 - NCT01184833 Poland
2008 - NCT00787657 Argentina;Bahrain;Belgium;Bosnia and Herzegovina;Canada;China;Colombia;Czech Republic;Egypt;Estonia;France;Germany;Iran, Islamic Republic of;Israel;Italy;Jordan;Korea, Republic of;Kuwait;Lebanon;Libyan Arab Jamahiriya;Mexico;Netherlands;New Zealand;Norway;Pakistan;Portugal;Saudi Arabia;Singapore;Slovakia;Slovenia;Sweden;Syrian Arab Republic;Taiwan;United Arab Emirates;United Kingdom;Venezuela
2007 - NCT01235455 Portugal
2007 - NCT00928967 France
2007 - NCT00873340 Colombia
2007 - NCT00544037 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2007 - NCT00461396 United States
2007 Phase 3 NCT00459667 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States
2006 - NCT00882453 Australia;Austria;Bahrain;Belgium;Canada;Colombia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Indonesia;Israel;Italy;Jordan;Kazakhstan;Korea, Republic of;Kuwait;Lebanon;Mexico;Netherlands;Norway;Oman;Portugal;Slovenia;Spain;Sweden;Switzerland;Taiwan;Thailand;United Arab Emirates;United Kingdom
2006 Phase 3 NCT00370071 China
2005 Phase 3 NCT00313976 Denmark;Sweden
2005 - NCT00206635 Canada;United Kingdom;United States
2004 - NCT01233245 Czech Republic;France;Germany;Iran, Islamic Republic of;Israel;Italy;Jordan;Korea, Republic of;Lebanon;Netherlands;Portugal;Saudi Arabia;Spain;Taiwan;Turkey
2003 Phase 2 NCT00235989 United States
2003 Phase 3 NCT00099502 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States
2002 Phase 2 NCT00893217 United States
2002 Phase 3 NCT00185211 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
Bayer AG
2017 Phase 4 EUCTR2017-001176-31-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
Bayer HealthCare AG
2013 - EUCTR2012-005262-35-SI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-IT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
- - EUCTR2014-004613-93-Outside-EU/EEA China
BAY86-5046_interferon-BETA-1B
Bayer
2007 - NCT01158183 United States
Bazedoxifene acetate
Riley Bove, MD
2019 Phase 2 NCT04002934 United States
BBR 2778
Fondation Charcot Stichting
2009 Phase 1;Phase 2 EUCTR2007-003086-40-BE Belgium;France
2008 - EUCTR2007-003086-40-FR France
BCD-054 180 MCG
Biocad
2017 Phase 2/Phase 3 NCT02744222 Russian Federation
BCD-054 240 MCG
Biocad
2017 Phase 2/Phase 3 NCT02744222 Russian Federation
BCD-063
Biocad
2013 Phase 3 NCT02753088 -
BCD-132
Biocad
2021 Phase 3 NCT05385744 Russian Federation
2018 Phase 1 NCT03551275 Russian Federation
BCD-132, 125 MG
Biocad
2019 Phase 2 NCT04056897 Russian Federation
BCD-132, 500 MG
Biocad
2019 Phase 2 NCT04056897 Russian Federation
BCG20-0134
BTG International Ltd
2009 - EUCTR2009-011585-28-FR Belgium;France;Germany;Spain
2009 - EUCTR2009-011585-28-DE Belgium;European Union;France;Germany;Russian Federation;Spain
2009 Phase 2 EUCTR2009-011585-28-BE Belgium;European Union;France;Germany;Russian Federation;Spain
Beam regimen
Makati Medical Center
2015 Phase 1 NCT03113162 Philippines
Beetainterferoni -1A
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
Belimumab
Johns Hopkins University
2021 Phase 2 NCT04767698 United States
Tianjin Medical University General Hospital
2021 Phase 1/Phase 2 NCT05154734 China
Berg balance scale
Gazi University
2018 - NCT03584672 -
BETA-1B interferoni
Schering Oy
2006 - EUCTR2005-005211-21-FI Finland
BETA-alanine
Hasselt University
2019 - NCT03803800 Belgium
BETA-alanine supplementation
Hasselt University
2017 - NCT03418376 Belgium
BETA-carotene
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece
BETA-interferon
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
Betacarotene
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece
Betaconnect
Bayer
2019 - NCT03808142 Germany
2014 - NCT02247310 Austria;Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Czechia;France;Greece;Hungary;Italy;Netherlands;Spain;Switzerland
Betaconnect AUTO-injector
Bayer
2017 - NCT03134573 Germany
2014 - NCT02121444 Germany
Betaconnect autoinjector
Bayer
2015 - NCT02486640 Germany
Betaconnect device
Bayer
2016 - NCT02652091 United States
Betaferon
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy
Bayer
2014 - NCT02247310 Austria;Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Czechia;France;Greece;Hungary;Italy;Netherlands;Spain;Switzerland
2014 - NCT02121444 Germany
2012 - NCT01766063 Germany
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Medical University Innsbruck
2009 - EUCTR2009-013284-19-AT Austria
Medizinische Universität Innsbruck
2014 - EUCTR2012-005450-30-SE Austria;Sweden
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden
NURON BIOTECH INC.
2012 - EUCTR2011-002683-24-IT Belarus;Bulgaria;Hungary;Italy;Russian Federation;Spain
Nuron Biotech, Inc.
2012 - EUCTR2011-002683-24-HU Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine
2012 - EUCTR2011-002683-24-ES Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Poland;Russian Federation;Spain;Ukraine
2012 - EUCTR2011-002683-24-BG Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine
Ospedale Regionale di Lugano
2013 - EUCTR2012-004040-30-AT Austria;Switzerland
Pfenex, Inc
2015 Phase 1 NCT02474134 Australia
Schering Nordiska AB
2006 - EUCTR2005-001540-23-SE Denmark;Sweden
2005 Phase 3 EUCTR2005-001540-23-DK Denmark;Sweden
Schering Oy
2006 - EUCTR2005-005211-21-FI Finland
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
Betaferon - 15 flaconcini 0.25 MG + 15 flaconcini 2 ML
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Betaferon 250 MCG
SCHERING
2007 - EUCTR2006-005270-47-IT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Betaferon 250 microgram/ML
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Betaferon 250 microgram/ML, powder and solvent FOR solution FOR injection
Bayer AG
2017 Phase 4 EUCTR2017-001176-31-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
Bayer HealthCare AG
2013 - EUCTR2012-005262-35-SI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-IT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
Betaferon 250 microgramos
Schering AG
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Betaferon 250MCG
Schering AG
2007 - EUCTR2006-005270-47-IE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Betaferon 250µG
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Schering AG
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Betaferon 500 MCG
SCHERING
2007 - EUCTR2006-005270-47-IT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Betaferon 500 µG
Schering AG
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Betaferon 500MCG
Schering AG
2007 - EUCTR2006-005270-47-IE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom
Betaferon 500µG
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Schering AG
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Betaferon SC 15F 0,25MG 15SIR
Universita di Firenze
2006 Phase 3 EUCTR2006-004937-13-IT Italy
Betaferon, BAY86-5046
Bayer
2019 - NCT03808142 Germany
2017 - NCT03134573 Germany
2015 - NCT02486640 Germany
2010 - NCT01354665 Poland
2008 - NCT03577977 Russian Federation
Betaferon/betaseron
Bayer
2011 - NCT01071694 Korea, Republic of
2006 Phase 4 NCT00317941 France
2005 Phase 3 NCT00313976 Denmark;Sweden
2003 Phase 4 NCT00206648 Canada;United States
2003 Phase 3 NCT00099502 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States
Betaseron
Bayer
2024 - NCT06053749 Finland;Sweden
2020 - NCT04356339 United States
2016 - NCT02652091 United States
2012 - NCT01706055 Poland
2012 - NCT01491100 Albania;Algeria;Argentina;Belgium;Bosnia and Herzegovina;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Jordan;Kazakhstan;Lebanon;Mexico;Netherlands;Poland;Portugal;Saudi Arabia;Syrian Arab Republic;Tunisia;Turkey
2012 - NCT01436838 China
2010 - NCT01076595 France
2010 - NCT01031459 Canada;United States
2009 - NCT03408093 -
2009 - NCT00963833 Austria;Belgium;Finland;Germany;Israel;Italy;Portugal;United Kingdom
2009 - NCT00902135 Germany
2008 - NCT03577977 Russian Federation
2008 - NCT01414816 Korea, Republic of
2008 - NCT01184833 Poland
2008 - NCT00787657 Argentina;Bahrain;Belgium;Bosnia and Herzegovina;Canada;China;Colombia;Czech Republic;Egypt;Estonia;France;Germany;Iran, Islamic Republic of;Israel;Italy;Jordan;Korea, Republic of;Kuwait;Lebanon;Libyan Arab Jamahiriya;Mexico;Netherlands;New Zealand;Norway;Pakistan;Portugal;Saudi Arabia;Singapore;Slovakia;Slovenia;Sweden;Syrian Arab Republic;Taiwan;United Arab Emirates;United Kingdom;Venezuela
2007 - NCT01235455 Portugal
2007 - NCT00928967 France
2007 - NCT00873340 Colombia
2007 - NCT00544037 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2007 - NCT00461396 United States
2007 Phase 3 NCT00459667 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States
2006 - NCT00882453 Australia;Austria;Bahrain;Belgium;Canada;Colombia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Indonesia;Israel;Italy;Jordan;Kazakhstan;Korea, Republic of;Kuwait;Lebanon;Mexico;Netherlands;Norway;Oman;Portugal;Slovenia;Spain;Sweden;Switzerland;Taiwan;Thailand;United Arab Emirates;United Kingdom
2006 Phase 3 NCT00370071 China
2005 - NCT00206635 Canada;United Kingdom;United States
2004 - NCT01233245 Czech Republic;France;Germany;Iran, Islamic Republic of;Israel;Italy;Jordan;Korea, Republic of;Lebanon;Netherlands;Portugal;Saudi Arabia;Spain;Taiwan;Turkey
2003 Phase 2 NCT00235989 United States
2002 Phase 2 NCT00893217 United States
2002 Phase 3 NCT00185211 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
Bayer HealthCare AG
- - EUCTR2014-004613-93-Outside-EU/EEA China
Rutgers, The State University of New Jersey
2007 - NCT00468182 United States
Stuart D Cook MD
2003 Phase 4 NCT00176592 United States
Teva Pharmaceutical Industries
2004 Phase 4 NCT00202995 Canada;United States
Betaseron (interferon BETA-1B, BAY86-5046), bayer healthcare AG
Bayer
2016 - NCT02749396 Finland
Bevacizumab
Johns Hopkins University
2013 Phase 1 NCT01777412 United States
Bexarotene
Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge
2015 Phase 2 EUCTR2014-003145-99-GB United Kingdom
Bexsero
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
BG-12 120
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States
BG00002
BIOGEN IDEC LTD
2011 - EUCTR2010-024000-10-IT Belgium;Germany;Italy;Spain
2007 - EUCTR2005-004061-41-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2007 - EUCTR2005-004061-41-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom
2006 - EUCTR2005-004061-41-IT Australia;Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-IE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Spain;Sweden;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
Biogen
2010 Phase 2/Phase 3 NCT01440101 China;Japan
2010 Phase 3 NCT01058005 Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States
2009 Phase 4 NCT00871780 Belgium;Mexico;Poland;Romania;Saudi Arabia;Ukraine;Venezuela
2008 Phase 4 NCT00536120 United States
2006 Phase 2 NCT00516893 United States
2006 Phase 3 NCT00306592 Canada;United States
Biogen Idec
2012 Phase 4 NCT02142205 Russian Federation
Biogen Idec International GmbH
2010 Phase 4 EUCTR2009-009503-19-BE Belgium
Biogen Idec Limited
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-002145-11-GB Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany
BG00012
BIOGEN IDEC LTD
2010 Phase 3 EUCTR2008-004753-14-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom
2008 - EUCTR2006-003696-12-IT Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
BIOGEN IDEC RESEARCH LIMITED
2015 Phase 3 EUCTR2014-005624-98-IT Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
Biogen
2013 Phase 4 NCT01873417 United States
2009 Phase 1 NCT00837785 Germany;United Kingdom
2007 Phase 3 NCT00451451 Australia;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Costa Rica;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Ireland;Israel;Italy;Kazakhstan;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;New Zealand;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States
2007 Phase 3 NCT00420212 Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Guatemala;India;Israel;Italy;Kazakhstan;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Virgin Islands (U.S.)
2004 Phase 2 NCT00168701 Czech Republic;Czechia;Germany;Hungary;Netherlands;Poland;Russian Federation;Sweden;Switzerland;Turkey;United Kingdom
Biogen Idec Inc.
2004 - EUCTR2004-000663-99-SE Hungary;Sweden
2004 - EUCTR2004-000663-99-HU Hungary;Sweden
2004 - EUCTR2004-000663-99-CZ Czech Republic;Hungary;Sweden
Biogen Idec Italia S.r.l.
2015 - EUCTR2015-000303-21-IT Italy
2013 Phase 3 EUCTR2013-001422-25-IT Italy
Biogen Idec Limited
2010 Phase 3 EUCTR2008-004753-14-BG Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-SK Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-LV Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-IE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-GB Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-EE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-CZ Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-BE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-AT Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
Biogen Idec LtD.
2007 Phase 3 EUCTR2006-003696-12-SK Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Slovakia;Sweden;United Kingdom
Biogen Idec Ltd.
2010 Phase 3 EUCTR2008-004753-14-NL Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2008-004753-14-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom
2009 Phase 3 EUCTR2008-004753-14-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom
2009 Phase 3 EUCTR2008-004753-14-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom
2009 Phase 3 EUCTR2008-004753-14-DE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 - EUCTR2006-003696-12-BG Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2008 - EUCTR2006-003697-10-BG Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2008 - EUCTR2006-003696-12-NL Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2008 - EUCTR2006-003696-12-DE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 - EUCTR2006-003697-10-LV Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-IE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-GR Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 Phase 3 EUCTR2006-003697-10-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-EE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-DE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-CZ Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 Phase 3 EUCTR2006-003697-10-BE Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003696-12-SE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 - EUCTR2006-003696-12-GR Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 Phase 3 EUCTR2006-003696-12-GB Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Slovakia;Sweden;United Kingdom
2007 - EUCTR2006-003696-12-CZ Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 - EUCTR2006-003696-12-BE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 - EUCTR2006-003696-12-AT Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2017 Phase 3 EUCTR2013-002318-11-FR Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-003282-29-LV Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-003282-29-DE Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-003282-29-CZ Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-003282-29-BG Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-003282-29-BE Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-001973-42-PL Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States
2016 Phase 3 EUCTR2015-001973-42-LT Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States
2016 Phase 3 EUCTR2015-001973-42-HR Austria;Belgium;Bulgaria;Canada;Croatia;Kuwait;Lithuania;Poland;Slovakia;Sweden;Turkey;United States
2016 Phase 3 EUCTR2015-001973-42-BG Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States
2016 Phase 3 EUCTR2014-005624-98-AT Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
2016 - EUCTR2013-002318-11-ES Argentina;Belgium;Canada;Croatia;Czech Republic;Denmark;France;Hungary;Israel;Italy;Poland;Portugal;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom
2016 Phase 3 EUCTR2013-002318-11-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Türkiye;United Kingdom;United States
2015 Phase 3 EUCTR2015-001973-42-BE Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Kuwait;Lithuania;Poland;Turkey;United States
2015 - EUCTR2014-005624-98-HU Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
2015 Phase 2 EUCTR2014-005003-24-PL Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom
2015 Phase 2 EUCTR2014-005003-24-LV Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom
2015 Phase 2 EUCTR2014-005003-24-DE Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom
2015 Phase 2 EUCTR2014-005003-24-CZ Australia;Belgium;Bulgaria;Czech Republic;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United States
2015 Phase 2 EUCTR2014-005003-24-BG Australia;Belgium;Bulgaria;Czech Republic;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Poland;Turkey;United Kingdom;United States
2015 Phase 2 EUCTR2014-005003-24-BE Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom
2015 Phase 3 EUCTR2014-004562-22-IT Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 - EUCTR2014-004562-22-HU Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 Phase 3 EUCTR2014-004562-22-DE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 Phase 3 EUCTR2014-004562-22-CZ Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 Phase 3 EUCTR2014-004562-22-BE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 - EUCTR2014-003021-18-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 Phase 3 EUCTR2014-003021-18-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 Phase 3 EUCTR2013-002318-11-PL Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2015 - EUCTR2013-001025-53-ES Denmark;Finland;Netherlands;Norway;Spain;United Kingdom
2015 Phase 4 EUCTR2013-001025-53-DK Denmark;Finland;Netherlands;Norway;Spain;United Kingdom
2014 Phase 3 EUCTR2013-004533-32-PL Czech Republic;Japan;Korea, Republic of;Poland;Taiwan
2014 Phase 3 EUCTR2013-004533-32-CZ Czech Republic;Japan;Korea, Republic of;Poland;Taiwan
2014 Phase 3 EUCTR2013-002318-11-SE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-IT Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3 EUCTR2013-002318-11-HU Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom
2014 Phase 3 EUCTR2013-002318-11-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-DK Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-CZ Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom
2014 Phase 4 EUCTR2013-001656-35-SK Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-SI Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-PT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-IT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-HU Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-FR Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-ES Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-CZ Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-BE Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-AT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 - EUCTR2013-001486-17-DE Germany
- Phase 3 EUCTR2013-002318-11-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
- Phase 3 EUCTR2014-005624-98-EE Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
Multiple Sclerosis Center of Northeastern New York
2015 Phase 4 NCT02683863 United States
BG9418
Biogen
2009 Phase 3 NCT00828204 United States
2008 Phase 3 NCT00784836 United States
Biogen Idec
2004 - NCT00168714 United States
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
BGC20-0134
BTG International Ltd
2009 - EUCTR2009-011585-28-FR Belgium;France;Germany;Spain
2009 - EUCTR2009-011585-28-ES Belgium;France;Germany;Spain
2009 - EUCTR2009-011585-28-DE Belgium;European Union;France;Germany;Russian Federation;Spain
2009 Phase 2 EUCTR2009-011585-28-BE Belgium;European Union;France;Germany;Russian Federation;Spain
BGG492
Novartis Pharmaceuticals
2016 Phase 2 NCT01649050 Germany;Russian Federation
BHT-3009
Bayhill Therapeutics
2006 - EUCTR2005-001340-22-CZ Czech Republic;Finland;United Kingdom
2005 Phase 2 EUCTR2005-001340-22-SK Czech Republic;Finland;Slovakia;United Kingdom
2005 - EUCTR2005-001340-22-GB Czech Republic;Finland;United Kingdom
2005 - EUCTR2005-001340-22-FI Czech Republic;Finland;United Kingdom
BHT-3009 0.5 MG
Bayhill Therapeutics
2006 Phase 2 NCT00382629 -
BHT-3009 1.5 MG
Bayhill Therapeutics
2006 Phase 2 NCT00382629 -
BHT-3009-01
Bayhill Therapeutics
2004 Phase 1 NCT00103974 Canada;United States
BIIB017
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Biogen
2019 Phase 3 NCT03958877 Argentina;Australia;Belgium;Bulgaria;Croatia;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2013 Phase 3 NCT01939002 United States
2009 Phase 3 NCT00906399 Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Biogen Idec
2014 Phase 4 NCT02234869 -
Biogen Idec LTD
2009 - EUCTR2008-006333-27-LV Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom
Biogen Idec Limited
2012 Phase 3 EUCTR2010-024477-39-GR Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2010-024477-39-GB Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2012 - EUCTR2010-024477-39-CZ Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-LV Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-ES Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-EE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-024477-39-DE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-024477-39-BG Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-BE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2010 - EUCTR2008-006333-27-GR Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom
2010 - EUCTR2008-006333-27-CZ Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-NL Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-006333-27-GB Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-006333-27-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom
2009 - EUCTR2008-006333-27-EE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-BG Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-BE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
- - EUCTR2008-006333-27-DE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
Johns Hopkins University
2010 Phase 3 NCT01337427 United States
BIIB017 (peginterferon BETA-1A) autoinjector
Biogen Idec
2012 Phase 1 NCT01610310 United States
BIIB019
BIOGEN IDEC RESEARCH LIMITED
2017 Phase 3 EUCTR2016-002820-10-IT Canada;Denmark;France;Germany;Italy;United Kingdom;United States
BIOGEN IDEC RESEARCH LTD
2013 Phase 3 EUCTR2012-003176-39-IT Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Biogen
2013 Phase 3 NCT01797965 Argentina;Australia;Brazil;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States
2010 Phase 3 NCT01064401 Argentina;Australia;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Egypt;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 NCT01051349 Czech Republic;Czechia;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2010 Phase 2 EUCTR2009-015318-23-GB Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2009 Phase 2 NCT00870740 Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2008 Phase 2 NCT00390221 Australia;Czech Republic;Former Serbia and Montenegro;Germany;Hungary;India;Poland;Russian Federation;Sweden;Turkey;Ukraine;United Kingdom
Biogen Idec Limited
2011 - EUCTR2010-023856-97-PL Czech Republic;Hungary;Poland;Russian Federation;United States
2011 - EUCTR2010-023856-97-HU Czech Republic;Hungary;Poland;Russian Federation;United States
2011 - EUCTR2010-023856-97-CZ Czech Republic;Hungary;Poland;United States
Biogen Idec Ltd
2010 - EUCTR2009-012500-11-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012500-11-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012500-11-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Biogen Idec Ltd.
2011 Phase 2 EUCTR2009-015318-23-DE Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2010 Phase 2 EUCTR2009-015318-23-HU Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2010 Phase 2 EUCTR2009-015318-23-CZ Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2009 - EUCTR2008-005559-46-HU Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 Phase 2 EUCTR2008-005559-46-GB Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 - EUCTR2008-005559-46-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 - EUCTR2008-005559-46-CZ Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2008 - EUCTR2006-001161-42-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Sweden;Ukraine;United Kingdom
Biogen Idec Research Limited
2017 Phase 3 EUCTR2016-002820-10-GB Canada;Denmark;France;Germany;Italy;United Kingdom;United States
2017 Phase 3 EUCTR2016-002820-10-DE Canada;Germany;Italy;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-PL Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-GR Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-FR Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 - EUCTR2012-003176-39-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-ES Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
BIIB033
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 2 EUCTR2017-001224-22-IT Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Biogen
2017 Phase 2 NCT03222973 Australia;Belgium;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
2016 Phase 1 NCT02833142 United States
2016 Phase 1 NCT02641041 United Kingdom
2013 Phase 2 NCT01864148 Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2010 Phase 1 NCT01244139 United States
Biogen Idec Research Limited
2018 Phase 2 EUCTR2017-001224-22-PL Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 2 EUCTR2017-001224-22-NL Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 2 EUCTR2017-001224-22-DE Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 2 EUCTR2017-001224-22-BE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2017 Phase 2 EUCTR2017-001224-22-HU Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2017 Phase 2 EUCTR2017-001224-22-ES Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2017 Phase 2 EUCTR2017-001224-22-CZ Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-IT Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-HU Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-GB Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-ES Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-CZ Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
BIIB033 (ANTI-lingo) - EV substance code SUB118957
Biogen Idec Research Limited
2017 Phase 2 EUCTR2017-001224-22-GB Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
BIIB041
BIOGEN IDEC RESEARCH LTD
2012 - EUCTR2012-000368-90-IT Belgium;Canada;Italy;Netherlands;Switzerland;United Kingdom
2012 - EUCTR2011-003507-38-IT Australia;Denmark;Italy;Netherlands;Portugal;United Kingdom
Biogen
2013 Phase 3 NCT01917019 Japan
2012 Phase 2 NCT01597297 Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
Biogen Idec
2010 Phase 3 NCT01235221 Canada
Biogen Idec Research Limited
2015 Phase 3 EUCTR2013-003600-40-NL Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 - EUCTR2013-003600-40-LT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 - EUCTR2013-003600-40-IT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-GB Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States
2014 - EUCTR2013-003600-40-FI Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-CZ Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-BG Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2012 - EUCTR2012-000368-90-NL Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 - EUCTR2012-000368-90-GB Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 Phase 2 EUCTR2012-000368-90-BE Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-PT Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-NL Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 Phase 4 EUCTR2011-003507-38-GB Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-DK Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 Phase 4 EUCTR2011-003507-38-BE Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
Cliniques Universitaires Saint-Luc, Neurologie
2013 Phase 3 EUCTR2012-005076-34-BE Belgium
BIIB061
Biogen
2021 Phase 2 NCT04079088 -
2015 Phase 1 NCT02521545 United States
BIIB091
Biogen
2023 Phase 2 NCT05798520 Bulgaria;Czechia;Germany;Italy;Poland;Puerto Rico;Romania;Spain;Switzerland;United States
BIIB133
Biogen Idec Research Limited
2020 Phase 2 EUCTR2019-001967-58-PL Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States
2020 Phase 2 EUCTR2019-001967-58-FR Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States
Biobanking with genetic analysis
University Hospital, Lille
2020 - NCT04334031 France
Biological samples
Centre Hospitalier Régional d'Orléans
2021 Phase 4 NCT04952766 France
Biospecimen collection
National Cancer Institute (NCI)
2019 Phase 1 NCT03816345 Canada;United States
Biotin
MEDDAY Pharmaceuticals SA
2014 Phase 3 EUCTR2013-002112-27-GB France;United Kingdom
MEDDAY SAS
- Phase 3 EUCTR2013-002113-35-FR France
- Phase 3 EUCTR2013-002112-27-FR France;United Kingdom
University Hospital, Clermont-Ferrand
2018 - NCT03552211 France
Birt 2584 XX
BOEHRINGER ING.
2006 - EUCTR2005-005985-35-IT Czech Republic;Italy;Netherlands
Boehringer Ingelheim
2006 Phase 2 EUCTR2005-005985-35-NL Czech Republic;Netherlands
Boehringer Ingelheim Ltd
2006 - EUCTR2005-005985-35-CZ Czech Republic;Italy;Netherlands
Birt 2584XX
BOEHRINGER ING.
2006 - EUCTR2005-005985-35-IT Czech Republic;Italy;Netherlands
Bisacodyl
David Levinthal
2016 Phase 2 NCT02609607 United States
Blood sample
Biogen Idec
2011 Phase 4 NCT01556685 Colombia;Mexico
Centre Hospitalier Régional d'Orléans
2023 - NCT05746845 France
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France
University Hospital, Bordeaux
2021 - NCT04798651 France
Blood samples
University Hospital, Bordeaux
2014 - NCT02142764 France
Blood sampling
Centre Hospitalier Universitaire de Nimes
2013 Phase 3 NCT01817166 France;Martinique
Rennes University Hospital
2021 - NCT04697407 France
Sohag University
2021 - NCT05196425 Egypt
Blood tests
Amgen
2024 Phase 4 NCT06180278 China;Czechia;Hong Kong;Hungary;Korea, Republic of;Poland;Thailand;United States
Bmmnc
Chaitanya Hospital, Pune
2014 Phase 1/Phase 2 NCT01883661 India
BMS-986368
Celgene
2025 Phase 2 NCT06782490 Australia;Canada;Czechia;Germany;Poland;Puerto Rico;United States
BMS-986374
Bristol-Myers Squibb
2024 Phase 4 NCT06396039 China
BNT162
Novartis Pharmaceuticals
2021 Phase 4 NCT04792567 Germany
BNT162b2, bivalent
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States
Bodybio balance OIL
Terry L. Wahls
2022 - NCT05007483 United States
Bodybio PC
Terry L. Wahls
2022 - NCT05007483 United States
Bone marrow autologous mesenchymal stem cells transplantation
Germans Trias i Pujol Hospital
2013 Phase 1/Phase 2 NCT02035514 Spain
Borage OIL 20% GLA
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece
Bortezomib
Tianjin Medical University General Hospital
2015 Phase 2 NCT02893111 China
Boswelan
University Medical Center Eppendorf
- Phase 2 EUCTR2009-014724-32-DE Germany
Universitätsklinikum Hamburg-Eppendorf
2011 Phase 2 NCT01450124 Germany
Boswellia serrata extract PS0201BO capsules
University Medical Center Eppendorf
- Phase 2 EUCTR2009-014724-32-DE Germany
Botox
ALLERGAN
2008 - EUCTR2007-000192-42-IT France;Germany;Italy;Netherlands;Portugal;Spain;United Kingdom
Allergan
2008 - EUCTR2006-006299-39-NL France;Netherlands
2008 Phase 3 EUCTR2006-006299-39-FR France;Netherlands
Allergan Ltd.
2013 - EUCTR2012-000957-30-PT Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2013 - EUCTR2012-000957-30-GB Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2012 - EUCTR2012-000957-30-CZ Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2012 - EUCTR2012-000957-30-BE Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
Centre Hospitalier Universitaire de Lille
2022 Phase 3 EUCTR2022-000259-35-FR France
Krajská nemocnice Liberec, a.s.
2010 Phase 3 EUCTR2009-012431-15-CZ Czech Republic
Botox 100 UNT injection
Brigitte Schürch
2021 Phase 4 NCT04819360 Switzerland
Botulinum toxin
ALLERGAN
2008 - EUCTR2007-000192-42-IT France;Germany;Italy;Netherlands;Portugal;Spain;United Kingdom
Botulinum toxin A
Centre Hospitalier Universitaire de Lille
2022 Phase 3 EUCTR2022-000259-35-FR France
Sunnybrook Health Sciences Centre
2006 Phase 3 NCT01091727 Canada
Botulinum toxin A - haemagglutinin complex
Ipsen Innovation
2016 Phase 3 EUCTR2015-003471-30-RO Canada;Czech Republic;Czechia;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-PT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-PL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-NL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-IT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-CZ Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-000507-44-LT Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-FR Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-ES Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-DE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-BE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
Botulinum toxin type A
Allergan
2008 - EUCTR2006-006299-39-NL France;Netherlands
2008 Phase 3 EUCTR2006-006299-39-FR France;Netherlands
Allergan Ltd.
2013 - EUCTR2012-000957-30-PT Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2013 - EUCTR2012-000957-30-GB Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2012 - EUCTR2012-000957-30-CZ Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
2012 - EUCTR2012-000957-30-BE Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States
Aránzazu Vázquez Doce
2018 Phase 3 EUCTR2018-003231-30-ES Spain
IPSEN INNOVATION
2012 - EUCTR2010-023210-31-IT Austria;Czech Republic;Germany;Italy;Lithuania
Ipsen
2016 Phase 3 NCT02660359 Argentina;Australia;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 NCT02660138 Canada;Czech Republic;Czechia;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Turkey;United States
2011 Phase 2 NCT01357980 Austria;Czech Republic;Czechia;France;Germany;Italy;Poland
Krajská nemocnice Liberec, a.s.
2010 Phase 3 EUCTR2009-012431-15-CZ Czech Republic
Melbourne Health
2008 Phase 3 NCT01018485 Australia
University of Manitoba
2013 Phase 2 NCT01911377 Canada
Botulinum toxin type A 200U
Allergan
2009 Phase 3 NCT00876447 Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Czechia;France;Germany;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Singapore;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Botulinum toxin type A 300U
Allergan
2009 Phase 3 NCT00876447 Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Czechia;France;Germany;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Singapore;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Bouchard belgian dark chocolate probiotic napolitains, containing bifidobacterium longum
Columbia University
2024 - NCT06475183 United States
Brimonidine tartrate
Biogen
2016 Phase 4 NCT02568111 -
Bryostatin 1
Robert Fox
2024 Phase 1 NCT06190912 United States
BX-1
Bionorica SE
2020 Phase 3 EUCTR2018-000001-23-CZ Czech Republic;Hungary;Spain
2019 Phase 3 NCT03756974 Czechia;Germany;Hungary;Poland;Spain
2018 Phase 3 EUCTR2018-000001-23-HU Czech Republic;Hungary;Spain
2018 Phase 3 EUCTR2018-000001-23-ES Czech Republic;Hungary;Spain
C-11 ER176 radiotracer
Mayo Clinic
2023 Phase 2 NCT05805839 United States
C105
Cognition Pharmaceuticals, LLC
2006 Phase 2 NCT00529581 United States
C11 pittsburgh compound B
Mayo Clinic
2023 Phase 2 NCT05805839 United States
Caffeine
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States
Calcio
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy
Calcium and vitamin D combination
Novartis
2010 Phase 3 NCT01166178 Germany
Calcium carbonate
University Hospital of North Norway
2008 Phase 4 NCT00785473 Norway
Calcium levofolinate
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy
Calculus bovis
Tongji Hospital
2024 - NCT06474520 China
Cannabidiol
ALMIRALL PRODESFARMA
2011 - EUCTR2011-002258-30-IT Italy
Almirall Hermal GmbH
2016 Phase 4 EUCTR2015-004451-40-AT Austria;Czech Republic
GW Pharma Limited
2022 Phase 3 EUCTR2020-004306-58-LT Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom
2021 Phase 3 EUCTR2020-003271-18-CZ Czech Republic;Czechia;Poland;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-GB Poland;United Kingdom
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-PL Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
2020 Phase 3 EUCTR2019-002623-14-GB Czech Republic;Poland;Romania;United Kingdom;United States
2020 Phase 3 EUCTR2019-002623-14-CZ Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
2007 Phase 3 EUCTR2006-005910-11-CZ Czech Republic;Germany;Italy;Spain;United Kingdom
2006 Phase 3 EUCTR2005-005265-11-GB Czech Republic;France;United Kingdom
2006 Phase 3 EUCTR2005-005265-11-FR Czech Republic;France;United Kingdom
2006 - EUCTR2005-005265-11-CZ Czech Republic;France;United Kingdom
2005 Phase 3 EUCTR2004-002509-63-GB Czech Republic;United Kingdom
2005 - EUCTR2004-002509-63-CZ Czech Republic;United Kingdom
GW Pharma Ltd.
2011 - EUCTR2011-000926-31-CZ Czech Republic
2008 Phase 3 EUCTR2006-005910-11-GB Czech Republic;Germany;Italy;Spain;United Kingdom
2008 - EUCTR2006-005910-11-DE Germany;Italy;Spain;United Kingdom
2007 - EUCTR2007-002138-13-GB United Kingdom
JOSE MANUEL GARCIA DOMINGUEZ
2013 - EUCTR2011-000985-36-ES Spain
Tiffany J. Braley, MD, MS
2022 Phase 2 NCT05269628 United States
Cannabidiol / dronabinol capsule 5 MG+2,5 MG
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark
Cannabidiol capsule 5 MG
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark
Cannabis
AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
2004 - EUCTR2005-000393-47-IT Italy
Centre hospitalier de l'Université de Montréal (CHUM)
2022 Phase 2 NCT05092191 Canada
Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research)
2006 Phase 3 EUCTR2005-005263-29-GB United Kingdom
Cannabis, medical
OMNI Medical Services, LLC
2018 Phase 2 NCT03944447 United States
Cannador
Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research)
2006 Phase 3 EUCTR2005-005263-29-GB United Kingdom
Capacity OF muscular oxygen extraction
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France
Caprylic triglyceride
University of Miami
2013 - NCT01848327 United States
Carbamazepine
Stine Maarbjerg, MD PhD
2012 - NCT04371575 -
Carbidopa
University of Miami
2018 Phase 1 NCT03266965 United States
Carbone vegetale polvere
NOVARTIS PHARMA AG
2022 Phase 3 EUCTR2020-005929-89-IT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Japan;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-IT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Guatemala;Hong Kong;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
Cardiopulmonary evaluation
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France
Carmustina
FONDAZIONE ITALIANA SCLEROSI MULTIPLA ONLUS
2023 Phase 2 EUCTR2022-002654-95-IT Italy
Carmustine
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States
Carnosine, capsulle, 2 G/DAY, 8 weeks
University of Novi Sad, Faculty of Sport and Physical Education
2019 - NCT03995810 Serbia
Cawthorne cooksey exercises
October 6 University
2017 - NCT03670459 Egypt
CBD
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark
Almirall Hermal GmbH
2016 Phase 4 EUCTR2015-004451-40-AT Austria;Czech Republic
GW Pharma Limited
2022 Phase 3 EUCTR2020-004306-58-LT Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom
2021 Phase 3 EUCTR2020-003271-18-CZ Czech Republic;Czechia;Poland;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-GB Poland;United Kingdom
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-PL Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
2020 Phase 3 EUCTR2019-002623-14-GB Czech Republic;Poland;Romania;United Kingdom;United States
2020 Phase 3 EUCTR2019-002623-14-CZ Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
Tiffany J. Braley, MD, MS
2022 Phase 2 NCT05269628 United States
University of Calgary
2024 Phase 2 NCT06261489 -
CC-97540
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
2024 Phase 1 NCT06220201 Belgium;France;Germany;Italy;Spain;United Kingdom;United States
CCI-779
Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
2005 - EUCTR2005-000171-18-FI Finland
Wyeth is now a wholly owned subsidiary of Pfizer
2003 Phase 2 NCT00228397 -
CD20/BCMA-directed CAR-T cells
RenJi Hospital
2024 Phase 1 NCT06249438 China
CDP323
UCB Pharma
2008 Phase 1/Phase 2 NCT00726648 United Kingdom
2007 Phase 2 NCT00484536 Belgium;Canada;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;United States
2007 - EUCTR2006-002204-33-FI Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
2007 Phase 2 EUCTR2006-002204-33-ES Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
UCB Pharma S.A.
2007 - EUCTR2006-002204-33-SE Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
2007 - EUCTR2006-002204-33-NL Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
2007 - EUCTR2006-002204-33-HU Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
2007 Phase 2 EUCTR2006-002204-33-GB Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
2007 Phase 2 EUCTR2006-002204-33-FR Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
2007 - EUCTR2006-002204-33-DE Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
2007 - EUCTR2006-002204-33-BE Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom
Celecoxib
National Institute of Mental Health (NIMH)
2022 Phase 2 NCT05062083 United States
Cell suspension containing dendritic cells
Antwerp University Hospital
2023 Phase 2 EUCTR2022-003465-38-BE Belgium;Spain
Cellcept
Aaron Boster
2006 Phase 0 NCT00618527 United States
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
University of Texas Southwestern Medical Center
2006 Phase 2 NCT00324506 United States
2004 Phase 2/Phase 3 NCT00223301 United States
Cellular therapy with EBV specific autologous CTL infusion
Nantes University Hospital
2021 Phase 1 NCT02912897 France
Ceralifimod
Merck KGaA
2014 - EUCTR2013-003126-83-HU Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-GR Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-ES Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-DE Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Ceralifmod
Merck KGaA
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Cerebro-spinal fluid
University Hospital, Bordeaux
2021 - NCT04798651 France
Ceterizine
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 1 NCT02583594 Spain
Cetirizina mylan generics
Biogen Idec Italia S.r.l.
2015 - EUCTR2013-001055-12-IT Italy
Cetirizine
Genzyme, a Sanofi Company
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain
Icahn School of Medicine at Mount Sinai
2014 Phase 1/Phase 2 NCT02865018 United States
Cetirizine hydrochloride
Biogen Idec Italia S.r.l.
2015 - EUCTR2013-001055-12-IT Italy
Cetrizine
Providence Health & Services
2020 Phase 3 NCT04175834 United States
CGP 77116
National Institute of Neurological Disorders and Stroke (NINDS)
1998 Phase 2 NCT00001781 United States
Charcoal
Sanofi
2013 Phase 3 NCT01863888 Belgium;Germany;Netherlands
Cholecalciferol
Academic MS Center Limburg
2014 Phase 2 NCT02096133 Netherlands
Johns Hopkins University
2010 Phase 1 NCT01024777 United States
Merck KGaA
2009 Phase 2 NCT01198132 France
University Hospital of North Norway
2008 Phase 4 NCT00785473 Norway
Cholecalciferol, vitamin D3
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-LT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-DE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
2011 - EUCTR2010-020328-23-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Cholestyramine
Sanofi
2023 Phase 3 NCT06141473 Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
2014 Phase 1 NCT02046629 China
2013 Phase 3 NCT01863888 Belgium;Germany;Netherlands
CHR-1103 / GBR500
Genzyme Corporation
2015 Phase 2 EUCTR2014-003265-19-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-SE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-DE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
Cianocobalamina
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy
CIC using lofric primo
Wellspect HealthCare
2009 - NCT00913510 Belgium;France;Germany;Netherlands;United Kingdom
Circadin
North Bristol NHS Trust
2013 Phase 2 EUCTR2012-004183-21-GB United Kingdom
Cisapride
2010 Phase 4 EUCTR2010-023996-25-BE Belgium
Citalopram
Novartis Pharmaceuticals
2011 Phase 4 NCT01436643 Germany
Citarabina
FONDAZIONE ITALIANA SCLEROSI MULTIPLA ONLUS
2023 Phase 2 EUCTR2022-002654-95-IT Italy
Citochine ED immunomodulatori
TEVA
2005 - EUCTR2004-003943-28-IT Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
CLA
Universität Münster
2023 - NCT05920018 Germany
Cladribina
MERCK KGAA
2021 Phase 4 EUCTR2020-003995-42-IT Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003874-30-IT Austria;Czech Republic;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain
2019 Phase 4 EUCTR2019-000069-19-IT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2018 Phase 4 EUCTR2017-002632-17-IT Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Ireland;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-IT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
MERCK SERONO SA
2008 - EUCTR2007-000381-20-IT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
Cladribina oral
Serono International, S.A.
2007 - EUCTR2006-003366-33-ES Italy;Spain
Cladribine
Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital
2019 Phase 3 EUCTR2019-001505-24-NO Norway
EMD Serono
2008 Phase 3 NCT00725985 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;India;Italy;Korea, Republic of;Lebanon;Macedonia, The Former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
EMD Serono Research & Development Institute, Inc.
2019 - NCT03933215 United States
2008 Phase 3 NCT00641537 Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;Former Serbia and Montenegro;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2006 Phase 2 NCT00436826 Italy;Russian Federation;Spain;United States
Fakultní nemocnice Ostrava
2021 Phase 4 EUCTR2021-003195-13-CZ Czech Republic
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-SE Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
MERCK SERONO INTERNATIONAL SA
2008 - EUCTR2006-003366-33-IT Italy;Spain
MERCK SERONO SA
2009 - EUCTR2008-003706-33-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2007-000381-20-IT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2005 - EUCTR2004-005148-28-IT Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2019 Phase 1 NCT04086225 Germany;Poland
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2019 - NCT04934800 Austria;Greece;Italy;Norway;Poland;Portugal;Switzerland
Merck KGaA
2018 Phase 4 EUCTR2017-002632-17-SK Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-SE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-PT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-NO Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-NL Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-LT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-HU Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Ireland;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-GR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-GB Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-FR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-FI Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-ES Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-DK Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-CZ Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-BE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-AT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-FR Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-CZ Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-AT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2008 Phase 1 NCT00938366 -
Merck KGaA, Darmstadt, Germany
2019 Phase 1 NCT03745144 Germany;Poland
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
Merck Serono International S.A.
2008 - EUCTR2007-000381-20-NL Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2008 - EUCTR2007-000381-20-GR Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2007 Phase 3 EUCTR2007-000381-20-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lithuania;Netherlands;Portugal;United Kingdom
2006 - EUCTR2004-005148-28-LT Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-FI Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-EE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-DK Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-CZ Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Merck Serono International, a branch of Laboratoires Serono S.A.
2005 Phase 3 EUCTR2004-005148-28-GB Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom
Merck Serono International, a branch of Laboratories Serono S.A.
2005 - EUCTR2004-005148-28-DE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Merck Serono S.A. - Geneva
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - EUCTR2007-000381-20-PT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2008 - EUCTR2007-000381-20-LV Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-000381-20-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-EE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-DK Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-000381-20-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2007-000381-20-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2007-000381-20-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
Oslo University Hospital
2019 Phase 3 NCT04121403 Norway
Queen Mary University of London
2021 Phase 2/Phase 3 NCT04695080 United Kingdom
2020 Phase 2 EUCTR2018-005038-39-GB United Kingdom
Serono International S.A.
2006 Phase 3 EUCTR2004-005148-28-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom
2006 - EUCTR2004-005148-28-LV Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-AT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Serono International, S.A.
2007 - EUCTR2006-003366-33-ES Italy;Spain
University Hospital, Strasbourg, France
2025 - NCT06887426 France
University of Texas Southwestern Medical Center
2020 Phase 4 NCT04178005 United States
Washington University School of Medicine
2019 Phase 4 NCT03963375 United States
Westfälische Wilhelms-Universität Münster c/o Universitätsklinikum Münster, Geschäftsbereich Recht u. Drittmittel
2019 Phase 4 EUCTR2018-004557-24-DE Germany
Cladribine 10 MG oral tablet
Pontificia Universidade Católica do Rio Grande do Sul
2021 Phase 4 NCT05902429 Brazil
Cladribine 3.5 MG/KG
EMD Serono
2005 Phase 3 NCT00213135 Canada;Switzerland
Cladribine 5.25 MG/KG
EMD Serono
2005 Phase 3 NCT00213135 Canada;Switzerland
Cladribine oral tablet
Claudio Gobbi
2020 - NCT04640818 Switzerland
Cladribine pill
Haukeland University Hospital
2018 Phase 3 NCT03477500 Denmark;Netherlands;Norway;Sweden
Cladribine subcutaneous injection
Institute of Psychiatry and Neurology, Warsaw
2022 Phase 2/Phase 3 NCT05961644 Poland
Cladribine tablet
MERCK SERONO SA
2011 Phase 3 EUCTR2009-017978-21-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Finland;Georgia;Germany;Greece;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Portugal;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States Minor Outlying Islands
Cladribine tablets
EMD Serono Research & Development Institute, Inc.
2019 - NCT03933202 United States
Keith Edwards, M.D.
2020 Phase 4 NCT04550455 United States
MERCK KGAA
2021 Phase 4 EUCTR2020-003995-42-IT Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003874-30-IT Austria;Czech Republic;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain
Merck Healthcare KGaA
2021 Phase 4 EUCTR2020-003995-42-PL Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-HU Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-CZ Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-AT Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003874-30-SK Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-HU Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-FR Austria;Czech Republic;Denmark;France;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-DK Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-CZ Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2020 Phase 4 EUCTR2020-003995-42-FI Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2020 Phase 4 EUCTR2020-003995-42-DE Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2020 Phase 4 EUCTR2020-003874-30-AT Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
Merck KGaA
2020 Phase 4 EUCTR2019-000069-19-RO Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-SE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-PT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-PL Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-LT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-HR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-ES Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-EE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-CZ Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-BG Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-BE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
Merck Serono S.A. - Geneva
2012 Phase 3 EUCTR2009-017978-21-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2012 Phase 3 EUCTR2009-017978-21-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2012 Phase 3 EUCTR2009-017978-21-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-SE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-LV Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 - EUCTR2009-017978-21-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-DK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 - EUCTR2009-017978-21-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2010 Phase 3 EUCTR2009-017978-21-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Merck, S.L.
2019 Phase 4 EUCTR2019-000069-19-AT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
Classic, progressive endurance training
Hasselt University
2019 - NCT03803800 Belgium
Clemastine
University of California, San Francisco
2014 Phase 2 NCT02040298 United States
Clemastine fumarate
Amsterdam UMC, location VUmc
2022 Phase 3 NCT05338450 Netherlands
Amsterdam University Medical Center
2022 Phase 3 EUCTR2021-003677-66-NL Netherlands
National Institute of Allergy and Infectious Diseases (NIAID)
2017 Phase 1/Phase 2 NCT03109288 United States
University of California, San Francisco
2024 Phase 1/Phase 2 NCT06065670 United States
2023 Phase 1/Phase 2 NCT05359653 United States
Clemastine milstein 1 MG, tabletten
Amsterdam University Medical Center
2022 Phase 3 EUCTR2021-003677-66-NL Netherlands
Clinical and neurological evaluation
Biogen Idec
2011 Phase 4 NCT01556685 Colombia;Mexico
Clinical assessment
University Hospital, Bordeaux
2023 - NCT05754593 France
Clinican CBD 10% OIL
Wageningen Research Stichting
2024 Phase 2 EUCTR2022-002372-36-NL Netherlands
Clostridium botulinum toxin type A
Ipsen Innovation
2016 Phase 3 EUCTR2015-003471-30-RO Canada;Czech Republic;Czechia;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-PT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-PL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-NL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-IT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-CZ Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-000507-44-LT Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-FR Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-ES Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-DE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-BE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2012 - EUCTR2010-023210-31-LT Austria;Czech Republic;Germany;Italy;Lithuania
2012 - EUCTR2010-023210-31-DE Austria;Czech Republic;Germany;Italy;Lithuania
2012 - EUCTR2010-023210-31-CZ Austria;Czech Republic;Germany;Italy;Lithuania
2012 - EUCTR2010-023210-31-AT Austria;Czech Republic;Germany;Italy;Lithuania
CLS12311
Cellerys AG
2023 Phase 1;Phase 2 EUCTR2022-000801-28-IT Czech Republic;Czechia;Germany;Italy;Switzerland
2023 Phase 1;Phase 2 EUCTR2022-000801-28-CZ Czech Republic;Czechia;Germany;Italy;Switzerland
CLS12311 high
Cellerys AG
2024 Phase 1/Phase 2 NCT06430671 Czech Republic;Czechia;Germany;Italy;Switzerland
CLS12311 LOW
Cellerys AG
2024 Phase 1/Phase 2 NCT06430671 Czech Republic;Czechia;Germany;Italy;Switzerland
CLS12311 medium
Cellerys AG
2024 Phase 1/Phase 2 NCT06430671 Czech Republic;Czechia;Germany;Italy;Switzerland
CNM-AU8
Clene Nanomedicine
2020 Phase 2/Phase 3 NCT04626921 Australia;Canada;United States
2019 - NCT04081714 United States
2018 Phase 2 NCT03536559 Australia;Canada;United States
CNP-MS-0601
Bionorica research GmbH
2007 Phase 3 EUCTR2006-004255-38-DK Austria;Denmark;Germany
2007 - EUCTR2006-004255-38-DE Austria;Germany
2007 - EUCTR2006-004255-38-AT Austria;Germany
Cnto 1275
Centocor, Inc.
2004 Phase 2 NCT00207727 Australia;Canada;Czech Republic;Hungary;Poland;United Kingdom;United States
CO-14
PEPTIMMUNE Inc
2008 - EUCTR2007-007759-15-HU Hungary
Coconut OIL
University of Iowa
2010 Phase 1 NCT01381354 United States
Coconut OIL and epigallocatechin gallate
Fundación Universidad Católica de Valencia San Vicente Mártir
2018 Phase 2 NCT03740295 Spain
Coduse balance training and step square exercises
Lama Saad El-Din Mahmoud
2020 - NCT04528121 Egypt
Coenzyme Q
University of Iowa
2010 Phase 1 NCT01381354 United States
Colecalciferol
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy
Charité - Universitätsmedizin Berlin
2011 Phase 2 EUCTR2011-002785-20-DE Germany
Javier Olascoaga Urtaza
2013 Phase 2 EUCTR2012-004602-97-ES Spain
MERCK SERONO SA
2011 - EUCTR2010-020328-23-IT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
MERCK SERONO s.a.s
2009 - EUCTR2009-013695-46-FR France
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
University of Turku
2008 Phase 2/Phase 3 NCT01432704 -
2008 Phase 4 NCT01339676 Finland
Colestiramina
NOVARTIS PHARMA AG
2022 Phase 3 EUCTR2020-005929-89-IT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Japan;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-IT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Guatemala;Hong Kong;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
Comirnaty konzentrat ZUR herstellung einer injektionsdispersion
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany
Complement protein C5 inhibitor
Tianjin Medical University General Hospital
2024 Phase 2 NCT06673394 -
Continued ocrelizumab
Johns Hopkins University
2021 Phase 2 NCT04767698 United States
Conventional balance training
Lama Saad El-Din Mahmoud
2020 - NCT04528121 Egypt
COP-1/copolymer-1
TEVA Pharmaceutical Industries Ltd.
2007 - EUCTR2004-000463-94-HU Hungary;Italy
2004 - EUCTR2004-000462-13-HU Hungary;Italy
Copaxone
Amphia Ziekenhuis
2009 - EUCTR2009-013129-41-NL Netherlands
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Bayer
2003 Phase 3 NCT00099502 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States
Biogen Idec
2010 - EUCTR2009-017490-38-DE Germany;Spain
Biogen Idec Limited
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Biogen Idec Ltd.
2008 - EUCTR2006-003697-10-BG Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-LV Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-IE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-GR Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 Phase 3 EUCTR2006-003697-10-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-EE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-DE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-CZ Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 Phase 3 EUCTR2006-003697-10-BE Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
FONDAZIONE DON CARLO GNOCCHI ONLUS
2011 - EUCTR2011-000150-31-IT Italy
Glostrup Hospital, Dep. of Neurology
2009 - EUCTR2006-001827-21-DK Denmark
ISTITUTO C. MONDINO
2007 - EUCTR2008-007162-32-IT Italy
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Merck KGaA
2014 - EUCTR2013-002283-25-PL Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-GR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 Phase 2 EUCTR2013-002283-25-GB Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-ES Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-BG Bulgaria;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2013-002283-25-IT Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-HU Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-FI Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-CZ Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
Merck Serono S.A. - Geneva
2010 - EUCTR2009-016087-37-GB France;Ireland;Italy;Spain;United Kingdom
2009 - EUCTR2009-016087-37-ES France;Ireland;Italy;Spain;United Kingdom
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy
Nancy Hammond, MD
2007 - NCT00490906 United States
Neurognostics
2006 - NCT00398528 United States
Novartis Pharma Services AG
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
Peptimmune Inc.
2010 Phase 2 EUCTR2009-012716-40-SK Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 Phase 2 EUCTR2009-012716-40-PL Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 - EUCTR2009-012716-40-FR Bulgaria;Czech Republic;Estonia;France;Germany;Poland
2010 Phase 2 EUCTR2009-012716-40-DE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 Phase 2 EUCTR2009-012716-40-CZ Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 - EUCTR2009-012716-40-BG Bulgaria;Czech Republic;Estonia;France;Germany;Poland
2009 - EUCTR2009-012716-40-EE Bulgaria;Czech Republic;Estonia;France;Germany;Poland
Philipps-Universität Marburg
2010 Phase 4 EUCTR2009-011088-35-DE Germany
SYNTHON BV
2011 - EUCTR2011-000888-27-IT Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Romania;Russian Federation;Ukraine;United Kingdom;United States
Stuart D Cook MD
2003 Phase 4 NCT00176592 United States
Synthon BV
2012 - EUCTR2011-000888-27-GR Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 - EUCTR2011-000888-27-DE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 NCT01489254 Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Italy;Kazakhstan;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;South Africa;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2011-000888-27-RO Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-GB Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-EE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-CZ Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-BG Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
TAKEDA PHARMACEUTICAL COMPANY LTD.
2015 - JPRN-jRCT1080223004 Japan
Teva Branded Pharmaceutical Products R&D, Inc.
2015 Phase 4 NCT02499900 Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Puerto Rico;Russian Federation;Spain;Turkey;United States
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University at Buffalo
2007 - NCT00937157 United States
University of California, Los Angeles
2007 Phase 2 NCT00451204 Canada;United States
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands
Copaxone - 20 MG/ML soluzione iniettabile 28 siringhe preriempite
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
Copaxone - 20 MG/ML soluzione iniettabile IN siringhe preriempite 30 siringhe
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
2015 Phase 4 EUCTR2015-000922-12-IT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
Copaxone - 40 MG/ML soluzione iniettabile IN
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
Copaxone - 40 MG/ML soluzione iniettabile IN siringa preriempita 12 siringhe preriempite DA 1 ML CON AGO
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
2015 Phase 4 EUCTR2015-000922-12-IT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
Copaxone 20 MG
EMD Serono
2013 Phase 2 NCT01963611 Bulgaria;Croatia;Czech Republic;Finland;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
Copaxone 20 MG/ML
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Teva Pharmaceutical Industries, Ltd
2016 Phase 4 EUCTR2015-000922-12-PL Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-FR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-ES Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-DE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-BE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-IE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-HR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-FI Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-AT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
Copaxone 20 MG/ML solucióN inyectable EN jeringa precargada
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Copaxone 20 MG/ML solucióN para inyeccióN EN jeringa precargada
Teva Pharmaceutical Industries, Ltd.
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Copaxone 20 MG/ML solution FOR injection, PRE-filled syringe
Teva Pharmaceutical Industries, Ltd.
2007 - EUCTR2006-002037-20-EE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-LV Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-LT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-HU Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-GB Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 Phase 3 EUCTR2006-002037-20-FI Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-DE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
2006 - EUCTR2006-002037-20-BE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Copaxone 20 MG/ML, solution FOR injection, PRE-filled syringes
Teva Pharmaceutical Industries, Ltd.
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Copaxone 20MG/ML solution FOR injection, PRE-filled syringe
Teva Pharmaceutical Industries, Ltd.
2006 - EUCTR2006-002037-20-LT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Copaxone 40 MG/ML
Teva Pharmaceutical Industries, Ltd
2016 Phase 4 EUCTR2015-000922-12-PL Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-FR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-ES Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-DE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-BE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-IE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-HR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-FI Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-AT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
Copaxone 40 MG/ML solution FOR injection, PRE-filled syringe
Università degli Studi Aldo Moro
2019 Phase 3 EUCTR2017-005129-18-IT Italy
Copaxone*SC 28SIR 20MG/ML
Teva Pharmaceuticals Industries Ltd.
2006 - EUCTR2006-002037-20-IT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Copaxone-teva
Biocad
2013 Phase 3 NCT02753088 -
Copolymer 1
National Center for Research Resources (NCRR)
1991 Phase 3 NCT00004814 -
Core stability
Ankara Yildirim Beyazit University
2016 - NCT03566251 Turkey
Corticosteroid
The Affiliated Hospital of Guangdong Medical University
2024 Phase 3 ChiCTR2400087660 China
University of New Mexico
2019 Phase 1/Phase 2 NCT03752307 United States
Corticosteroids & tancart19/20
Chinese PLA General Hospital
2018 Phase 1 NCT03605238 China
Covid-19 vaccination
Sheba Medical Center
2021 - NCT05075499 Israel
Covid-19 vaccine
Novartis Pharmaceuticals
2021 - NCT04847596 Puerto Rico;United States
Covid19 vaccine
Yale University
2021 - NCT05286242 United States
Cranberry
Rennes University Hospital
2006 Phase 3 NCT00280592 France
Creatine
University of Iowa
2010 Phase 1 NCT01381354 United States
Cryopreserved myelin-derived peptide-loaded tolerogenic dendritic cells
Antwerp University Hospital
2023 Phase 2 EUCTR2022-003465-38-BE Belgium;Spain
CS-0777 tablets
Daiichi Sankyo Inc.
2008 Phase 1 NCT00616733 United States
CSF sampling
Rennes University Hospital
2021 - NCT04697407 France
CT-P53
Celltrion
2024 Phase 3 NCT05906992 Poland
CT103A cells
Tongji Hospital
2020 Early Phase 1 NCT04561557 China
Curcumin
Merck KGaA, Darmstadt, Germany
2012 Phase 2 NCT01514370 Italy
CYB704
Sandoz
2025 Phase 3 NCT06847724 -
Cyclophosfamide
Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
2006 - EUCTR2006-002562-19-IT Italy
Cyclophosphamide
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
Baylor College of Medicine
1999 Phase 2 NCT00040482 United States
Bruce Cree
2024 Phase 1 NCT06451159 United States
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States
Hadassah Medical Organization
2015 - NCT02529839 -
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-SE Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
Indapta Therapeutics, INC.
2026 Phase 1 NCT06677710 United States
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
2024 Phase 1 NCT06220201 Belgium;France;Germany;Italy;Spain;United Kingdom;United States
Northwestern Memorial Hospital
2001 Phase 1 NCT00017628 United States
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States
2017 Phase 3 NCT03342638 United States
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy
Seah Lim M.D.
2012 Phase 2 NCT01679041 United States
Stony Brook University
2003 Phase 2 NCT00296205 United States
University Hospital, Bordeaux
2005 Phase 3 NCT00241254 France
Cyclophosphamide and ATG
Haukeland University Hospital
2018 Phase 3 NCT03477500 Denmark;Netherlands;Norway;Sweden
Cyclophosphamide and fludarabine
Tongji Hospital
2020 Early Phase 1 NCT04561557 China
Cyclophosphamide monohydrate
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom
Uppsala l?ns landsting
2011 Phase 2 EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States
Cyclophosphamide/ATG
Scripps Health
2023 - NCT05482542 United States
Cyclophosphamide/glatiramer acetate
Johns Hopkins University
2010 Phase 2 NCT00939549 United States
Cyclophosphamide/rituximab
Scripps Health
2023 - NCT05482542 United States
Cymbalta
Eli Lilly and Company
2008 - EUCTR2008-002560-34-BE Belgium
Cytarabine
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States
Cytolytic CD4+ T cells
ImCyse S.A
2014 Phase 1;Phase 2 EUCTR2014-001081-99-BE Belgium
Cápsulas DE laquinimod 0.6 MG
Teva Pharmaceutical Industries Ltd
2008 - EUCTR2007-005450-23-ES Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
Células madre mesenquimales
Fundació Clínic per a la Recerca Biomèdica
- - EUCTR2009-016442-74-ES Spain
D mannose
University College, London
2015 Phase 1 NCT02490046 United Kingdom
D-aspartate
Merck KGaA, Darmstadt, Germany
2018 Phase 2 NCT03387046 Germany;Italy
D-biotin
MEDDAY PHARMACEUTICALS
2017 Phase 3 EUCTR2016-000700-29-IT Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
MEDDAY PHARMACEUTICALS SA
2018 Phase 3 EUCTR2016-000700-29-PL Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2016-000700-29-HU Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2016-000700-29-BE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-000700-29-SE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-000700-29-ES Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Poland;Spain;Sweden;United Kingdom;United States
2017 Phase 3 EUCTR2016-000700-29-DE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-000700-29-CZ Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
D-biotina
MEDDAY PHARMACEUTICALS
2017 Phase 3 EUCTR2016-000700-29-IT Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
DAC HYP
BIOGEN IDEC RESEARCH LIMITED
2017 Phase 3 EUCTR2016-002820-10-IT Canada;Denmark;France;Germany;Italy;United Kingdom;United States
Biogen Idec Research Limited
2017 Phase 3 EUCTR2016-002820-10-GB Canada;Denmark;France;Germany;Italy;United Kingdom;United States
2017 Phase 3 EUCTR2016-002820-10-DE Canada;Germany;Italy;United Kingdom;United States
DAC-HYP
National Institute of Neurological Disorders and Stroke (NINDS)
2010 Phase 1 NCT01143441 United States
Daclizumab
BIOGEN IDEC RESEARCH LIMITED
2017 Phase 3 EUCTR2016-002820-10-IT Canada;Denmark;France;Germany;Italy;United Kingdom;United States
Biogen
2017 Phase 3 NCT02881567 Canada;France;Germany;Italy;Puerto Rico;United Kingdom;United States
2013 Phase 3 NCT01797965 Argentina;Australia;Brazil;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States
2010 Phase 2 NCT01051349 Czech Republic;Czechia;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
Biogen Idec Research Limited
2017 Phase 3 EUCTR2016-002820-10-GB Canada;Denmark;France;Germany;Italy;United Kingdom;United States
2017 Phase 3 EUCTR2016-002820-10-DE Canada;Germany;Italy;United Kingdom;United States
National Institute of Neurological Disorders and Stroke (NINDS)
2003 Phase 2 NCT00071838 United States
PDL BioPharma, Inc.
2005 Phase 2 NCT00109161 Canada;United States
Protein Design Labs, Inc.
2006 - EUCTR2005-001567-55-DE Germany;Spain;United Kingdom
2005 Phase 2 EUCTR2005-001567-55-GB Austria;Germany;Spain;United Kingdom
2005 Phase 2 EUCTR2005-001567-55-ES Austria;Germany;Spain;United Kingdom
2005 - EUCTR2005-001567-55-AT Austria;Germany;Spain;United Kingdom
Daclizumab high yield process
Biogen
2010 Phase 3 NCT01064401 Argentina;Australia;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Egypt;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 2 NCT00870740 Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2008 Phase 2 NCT00390221 Australia;Czech Republic;Former Serbia and Montenegro;Germany;Hungary;India;Poland;Russian Federation;Sweden;Turkey;Ukraine;United Kingdom
Biogen Idec Ltd.
2011 Phase 2 EUCTR2009-015318-23-DE Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2010 Phase 2 EUCTR2009-015318-23-HU Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2010 Phase 2 EUCTR2009-015318-23-CZ Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
Daclizumab HYP
BIOGEN IDEC LTD
2010 - EUCTR2009-012500-11-IT Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
Daclizumab HYP (DAC HYP
BIOGEN IDEC RESEARCH LTD
2013 Phase 3 EUCTR2012-003176-39-IT Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Biogen
2013 Phase 3 EUCTR2012-003176-39-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-015318-23-GB Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
Biogen Idec Limited
2011 - EUCTR2010-023856-97-PL Czech Republic;Hungary;Poland;Russian Federation;United States
2011 - EUCTR2010-023856-97-HU Czech Republic;Hungary;Poland;Russian Federation;United States
2011 - EUCTR2010-023856-97-CZ Czech Republic;Hungary;Poland;United States
Biogen Idec Ltd
2010 - EUCTR2009-012500-11-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-GR Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012500-11-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012500-11-FR Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012500-11-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012500-11-ES Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-012500-11-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2006 Phase 2 EUCTR2006-001161-42-GB Czech Republic;Germany;Hungary;Sweden;United Kingdom
Biogen Idec Ltd.
2011 Phase 2 EUCTR2009-015318-23-DE Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2010 Phase 2 EUCTR2009-015318-23-HU Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2010 Phase 2 EUCTR2009-015318-23-CZ Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom
2009 - EUCTR2008-005559-46-HU Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 Phase 2 EUCTR2008-005559-46-GB Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 - EUCTR2008-005559-46-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 - EUCTR2008-005559-46-CZ Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2008 - EUCTR2006-001161-42-HU Germany;Hungary;Sweden;United Kingdom
2008 - EUCTR2006-001161-42-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Sweden;Ukraine;United Kingdom
2006 - EUCTR2006-001161-42-SE Germany;Hungary;Sweden;United Kingdom
2006 - EUCTR2006-001161-42-CZ Czech Republic;Germany;Hungary;Sweden;United Kingdom
Biogen Idec Research Limited
2013 Phase 3 EUCTR2012-003176-39-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-PL Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-GR Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-FR Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 - EUCTR2012-003176-39-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-ES Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Daclizumab HYP (DAC HYP)
Biogen Idec Ltd
2012 Phase 3 EUCTR2009-012500-11-SI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Daclizumab with greek suufix
Biogen Idec Ltd.
2009 - EUCTR2008-005559-46-HU Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 Phase 2 EUCTR2008-005559-46-GB Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 - EUCTR2008-005559-46-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
2009 - EUCTR2008-005559-46-CZ Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
Dalfampridine
Johns Hopkins University
2014 Phase 2 NCT02166346 United States
Oregon Health and Science University
2011 Phase 2 NCT01444300 United States
State University of New York at Buffalo
2011 Phase 2/Phase 3 NCT02006160 United States
VA Office of Research and Development
2015 Phase 2 NCT02391961 United States
Washington University School of Medicine
2011 Phase 2/Phase 3 NCT01337986 United States
Dalfampridine ER
Brown, Theodore R., M.D., MPH
2010 Phase 4 NCT01356940 United States
Dalfampridine ER, 10 MG oral tablet, extended release
Ain Shams University
2021 - NCT05730738 Egypt
Dalfampridine plus physical therapy
MGH Institute of Health Professions
2024 Phase 4 NCT06136728 United States
Dalfampridine-ER 10MG
Acorda Therapeutics
2011 Phase 3 NCT01328379 United States
Dalfampridine-ER 5MG
Acorda Therapeutics
2011 Phase 3 NCT01328379 United States
Dantrolene
National Institute of Allergy and Infectious Diseases (NIAID)
2017 Phase 1/Phase 2 NCT03109288 United States
Dapirolizumab pegol
Biogen Idec Research Limited
2020 Phase 2 EUCTR2019-001967-58-PL Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States
2020 Phase 2 EUCTR2019-001967-58-FR Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States
Daratumumab
Tianjin Medical University General Hospital
2022 Phase 2/Phase 3 NCT05403138 China
Darifenacin
Bayer
2007 Phase 2 NCT00845338 Germany
Bayer Vital GmbH
2006 - EUCTR2006-002361-39-DE Germany
DC-TAB
Delta Crystallon B.V.
2012 - EUCTR2011-004475-36-BG Bulgaria
Dekristol 20000 IE
Merja Soilu Häninen
2007 - EUCTR2007-001958-99-FI Finland
Dekristol® 400-tabletten
Charité - Universitätsmedizin Berlin
2011 Phase 2 EUCTR2011-002785-20-DE Germany
Delta-9-tetrahydrocannabinol
ALMIRALL PRODESFARMA
2011 - EUCTR2011-002258-30-IT Italy
Almirall Hermal GmbH
2016 Phase 4 EUCTR2015-004451-40-AT Austria;Czech Republic
Bionorica research GmbH
2007 Phase 3 EUCTR2006-004255-38-DK Austria;Denmark;Germany
2007 - EUCTR2006-004255-38-DE Austria;Germany
2007 - EUCTR2006-004255-38-AT Austria;Germany
GW Pharma Limited
2022 Phase 3 EUCTR2020-004306-58-LT Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom
2021 Phase 3 EUCTR2020-003271-18-CZ Czech Republic;Czechia;Poland;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-GB Poland;United Kingdom
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-PL Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
2020 Phase 3 EUCTR2019-002623-14-GB Czech Republic;Poland;Romania;United Kingdom;United States
2020 Phase 3 EUCTR2019-002623-14-CZ Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
2007 Phase 3 EUCTR2006-005910-11-CZ Czech Republic;Germany;Italy;Spain;United Kingdom
2006 Phase 3 EUCTR2005-005265-11-GB Czech Republic;France;United Kingdom
2006 Phase 3 EUCTR2005-005265-11-FR Czech Republic;France;United Kingdom
2006 - EUCTR2005-005265-11-CZ Czech Republic;France;United Kingdom
2005 Phase 3 EUCTR2004-002509-63-GB Czech Republic;United Kingdom
2005 - EUCTR2004-002509-63-CZ Czech Republic;United Kingdom
GW Pharma Ltd.
2011 - EUCTR2011-000926-31-CZ Czech Republic
2008 Phase 3 EUCTR2006-005910-11-GB Czech Republic;Germany;Italy;Spain;United Kingdom
2008 - EUCTR2006-005910-11-DE Germany;Italy;Spain;United Kingdom
2007 - EUCTR2007-002138-13-GB United Kingdom
Demestril septem
OSPEDALI CIVILI DI LIONE
2007 - EUCTR2006-005460-30-IT Italy
Desloratadine given orally
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Australia;Brazil;Canada;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
Determination OF calcium intake BY A dietician interview
Centre Hospitalier Universitaire de Nimes
2016 - NCT02636829 France
Dexamethason
Department of Neurology UMCG
2006 - EUCTR2006-003113-40-NL Netherlands
Dexamethasone
Department of Neurology UMCG
2006 - EUCTR2006-003113-40-NL Netherlands
Dexamethasone given orally
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Australia;Brazil;Canada;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
Dexamethasone soduim phosphate
Hadassah Medical Organization
2008 Phase 1 NCT00674141 Israel
Dexchlorpheniramine
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 1 NCT02583594 Spain
Dexrazoxane
PD Dr. Andrew Chan
2012 Phase 2 NCT01627938 Germany
Dextromethorphan
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States
Dextromethorphan hydrobromide
Avanir Pharmaceuticals, Inc.
2012 - EUCTR2011-002178-22-PL Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2012 Phase 2 EUCTR2011-002178-22-GB Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2012 - EUCTR2011-002178-22-CZ Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
Dextromethorphan hydrobromide 20 MG and quinidine sulfate 10 MG
Avanir Pharmaceuticals
2007 Phase 3 NCT00573443 Argentina;Brazil;United States
Dextromethorphan hydrobromide 30 MG and quinidine sulfate 10 MG
Avanir Pharmaceuticals
2007 Phase 3 NCT00573443 Argentina;Brazil;United States
Dextromethorphan/quinidine
Avanir Pharmaceuticals, Inc.
2012 - EUCTR2011-002178-22-PL Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2012 Phase 2 EUCTR2011-002178-22-GB Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2012 - EUCTR2011-002178-22-CZ Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
Dextrometorfano hidrobromuro
Avanir Pharmaceuticals, Inc.
2011 Phase 2 EUCTR2011-002178-22-ES Argentina;Bulgaria;Czech Republic;Poland;Spain;United Kingdom;United States
Dextrometorfano/quinidina
Avanir Pharmaceuticals, Inc.
2011 Phase 2 EUCTR2011-002178-22-ES Argentina;Bulgaria;Czech Republic;Poland;Spain;United Kingdom;United States
Diazoxide
NEUROTEC PHARMA, S.L
2011 - EUCTR2010-023048-34-DE Germany;Spain
Dibase
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy
Diclofenac sodium topical GEL
Brown, Theodore R., M.D., MPH
2011 Phase 4 NCT01454791 United States
Dimethyl fumarate
Alkermes, Inc.
2019 Phase 3 EUCTR2017-001294-16-DE Germany;Poland;United States
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States
Anders Svenningsson
2016 Phase 3 NCT02746744 Sweden
BIOGEN IDEC LTD
2008 - EUCTR2006-003696-12-IT Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
BIOGEN IDEC RESEARCH LIMITED
2015 Phase 3 EUCTR2014-005624-98-IT Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
Biogen
2024 - NCT05767736 United States
2023 - NCT05658497 Germany;Ireland;Spain;Switzerland;United States
2023 Phase 4 NCT05658484 China
2021 - NCT04756687 France
2019 - NCT04221191 France
2019 Phase 3 NCT03870763 Colombia;Estonia;Hungary;Jordan;Korea, Republic of;Malaysia;Mexico;Saudi Arabia;Taiwan;Thailand;Tunisia;Turkey;United States
2017 Phase 3 NCT03093324 Germany;Poland;United States
2016 - NCT02969304 Germany
2016 Phase 3 NCT02555215 Belgium;Bulgaria;Czech Republic;Czechia;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 NCT02428218 -
2015 Phase 3 NCT02525874 Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;Turkey;United States
2015 - NCT02519413 United States
2015 Phase 4 NCT02472938 -
2015 Phase 4 NCT02471560 Norway
2015 Phase 3 NCT02430532 Austria;Belgium;Czech Republic;Netherlands;Poland;Slovakia;Sweden;United States
2015 Phase 3 NCT02428231 Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 Phase 4 NCT02410278 United States
2015 Phase 2 NCT02410200 Belgium;Bulgaria;Czech Republic;Czechia;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2015 Phase 4 NCT02343159 United States
2015 - NCT02323269 Canada
2015 Phase 2 NCT02097849 United States
2015 Phase 4 NCT02090348 -
2014 Phase 3 NCT02579681 Italy
2014 Phase 3 NCT02283853 Argentina;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 - NCT02159573 United States
2014 Phase 4 NCT02125604 Germany
2014 Phase 4 NCT02090413 Ireland;United Kingdom
2013 - NCT02047097 Argentina;Australia;Austria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Switzerland;United Kingdom;United States
2013 Phase 4 NCT01930708 Austria;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2013 - NCT01911767 Australia;Canada;France;Germany;Ireland;Italy;Poland;Spain;United Kingdom;United States
2013 - NCT01903291 United States
2013 Phase 3 NCT01838668 Czech Republic;Czechia;Japan;Korea, Republic of;Poland;Taiwan
2010 Phase 2 NCT01156311 United States
2009 Phase 3 NCT00835770 Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;North Macedonia;Poland;Puerto Rico;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
Biogen GmbH
2015 Phase 4 EUCTR2014-000395-26-DE Germany
Biogen Idec Inc.
2004 - EUCTR2004-000663-99-SE Hungary;Sweden
2004 - EUCTR2004-000663-99-HU Hungary;Sweden
2004 - EUCTR2004-000663-99-CZ Czech Republic;Hungary;Sweden
Biogen Idec Italia S.r.l.
2015 - EUCTR2015-000303-21-IT Italy
2013 Phase 3 EUCTR2013-001422-25-IT Italy
Biogen Idec Limited
2010 Phase 3 EUCTR2008-004753-14-BG Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-SK Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-LV Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-IE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-GB Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-EE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-CZ Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-BE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-004753-14-AT Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
Biogen Idec LtD.
2007 Phase 3 EUCTR2006-003696-12-SK Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Slovakia;Sweden;United Kingdom
Biogen Idec Ltd.
2010 Phase 3 EUCTR2008-004753-14-NL Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2008-004753-14-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom
2009 Phase 3 EUCTR2008-004753-14-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom
2009 Phase 3 EUCTR2008-004753-14-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom
2009 Phase 3 EUCTR2008-004753-14-DE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
2009 - EUCTR2006-003696-12-BG Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2008 - EUCTR2006-003697-10-BG Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2008 - EUCTR2006-003696-12-NL Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2008 - EUCTR2006-003696-12-DE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 - EUCTR2006-003697-10-LV Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-IE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-GR Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 Phase 3 EUCTR2006-003697-10-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-EE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-DE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-CZ Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 Phase 3 EUCTR2006-003697-10-BE Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003696-12-SE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 - EUCTR2006-003696-12-GR Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 Phase 3 EUCTR2006-003696-12-GB Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Slovakia;Sweden;United Kingdom
2007 - EUCTR2006-003696-12-CZ Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 - EUCTR2006-003696-12-BE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
2007 - EUCTR2006-003696-12-AT Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom
Biogen Idec Norway
2015 Phase 4 EUCTR2015-001197-18-NO Norway
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2017 Phase 3 EUCTR2013-002318-11-FR Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-003282-29-LV Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-003282-29-DE Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-003282-29-CZ Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-003282-29-BG Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-003282-29-BE Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States
2016 Phase 3 EUCTR2015-001973-42-PL Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States
2016 Phase 3 EUCTR2015-001973-42-LT Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States
2016 Phase 3 EUCTR2015-001973-42-HR Austria;Belgium;Bulgaria;Canada;Croatia;Kuwait;Lithuania;Poland;Slovakia;Sweden;Turkey;United States
2016 Phase 3 EUCTR2015-001973-42-BG Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States
2016 Phase 3 EUCTR2014-005624-98-AT Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
2016 - EUCTR2013-002318-11-ES Argentina;Belgium;Canada;Croatia;Czech Republic;Denmark;France;Hungary;Israel;Italy;Poland;Portugal;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom
2016 Phase 3 EUCTR2013-002318-11-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Türkiye;United Kingdom;United States
2015 Phase 3 EUCTR2015-001973-42-BE Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Kuwait;Lithuania;Poland;Turkey;United States
2015 - EUCTR2014-005624-98-HU Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
2015 Phase 2 EUCTR2014-005003-24-PL Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom
2015 Phase 2 EUCTR2014-005003-24-LV Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom
2015 Phase 2 EUCTR2014-005003-24-DE Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom
2015 Phase 2 EUCTR2014-005003-24-CZ Australia;Belgium;Bulgaria;Czech Republic;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United States
2015 Phase 2 EUCTR2014-005003-24-BG Australia;Belgium;Bulgaria;Czech Republic;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Poland;Turkey;United Kingdom;United States
2015 Phase 2 EUCTR2014-005003-24-BE Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom
2015 Phase 3 EUCTR2014-004562-22-IT Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 - EUCTR2014-004562-22-HU Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 Phase 3 EUCTR2014-004562-22-DE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 Phase 3 EUCTR2014-004562-22-CZ Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 Phase 3 EUCTR2014-004562-22-BE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 - EUCTR2014-003021-18-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 Phase 3 EUCTR2014-003021-18-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 - EUCTR2014-003021-18-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
2015 Phase 3 EUCTR2013-002318-11-PL Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2015 - EUCTR2013-001025-53-ES Denmark;Finland;Netherlands;Norway;Spain;United Kingdom
2015 Phase 4 EUCTR2013-001025-53-DK Denmark;Finland;Netherlands;Norway;Spain;United Kingdom
2014 Phase 3 EUCTR2013-004533-32-PL Czech Republic;Japan;Korea, Republic of;Poland;Taiwan
2014 Phase 3 EUCTR2013-004533-32-CZ Czech Republic;Japan;Korea, Republic of;Poland;Taiwan
2014 Phase 3 EUCTR2013-002318-11-SE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-IT Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3 EUCTR2013-002318-11-HU Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom
2014 Phase 3 EUCTR2013-002318-11-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-DK Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-CZ Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom
2014 Phase 4 EUCTR2013-001656-35-SK Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-SI Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-PT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-IT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-HU Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-FR Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-ES Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-CZ Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-BE Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-AT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 - EUCTR2013-001486-17-DE Germany
- Phase 3 EUCTR2014-005624-98-EE Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
- Phase 3 EUCTR2013-002318-11-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
Brigham and Women's Hospital
2015 - NCT02419638 United States
Department of Clinical Sciences, Danderyd Hospital
2015 Phase 3 EUCTR2015-004116-38-SE Sweden
Fakultní nemocnice Ostrava
2021 Phase 4 EUCTR2021-003195-13-CZ Czech Republic
Finn Sellebjerg
2016 Phase 2 EUCTR2016-000283-41-DK Denmark
Fondation Ophtalmologique Adolphe de Rothschild
2017 Phase 4 NCT02901106 France
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
2017 Phase 4 NCT03345940 Italy
Genesis Pharma CNS & Specialty
2016 - NCT03101735 Greece
Hikma Pharmaceuticals LLC
2021 - NCT04468165 Algeria;Egypt;Jordan
Imcyse SA
2022 Phase 1/Phase 2 NCT05417269 Moldova, Republic of
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Merck KGaA
2017 Phase 2 EUCTR2016-001448-21-SK Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-PL Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-ES Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-CZ Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-BG Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
Multiple Sclerosis Center of Northeastern New York
2015 Phase 4 NCT03092544 United States
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Oregon Health and Science University
2016 - NCT02644083 United States
Rigshospitalet, Denmark
2016 Phase 2 NCT02959658 Denmark
University Hospital Muenster
2015 Phase 4 NCT02461069 Germany
University at Buffalo
2018 - NCT03526224 United States
2015 - NCT02686684 -
University of British Columbia
2003 - NCT06705608 -
Universitätsklinikum Münster
2015 Phase 4 EUCTR2014-003481-25-DE Germany
Virginia Simnad
2015 - NCT02736279 United States
Washington University School of Medicine
2016 Phase 4 NCT02675413 United States
Dimethyl fumarate 240 MG
Banner Life Sciences LLC
2017 Phase 1 NCT04570670 -
IRCCS Centro Neurolesi Bonino Pulejo
2021 - NCT05811949 Italy
Dimetil-fumarato
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2017 Phase 4 EUCTR2017-000559-26-IT Israel;Italy;Switzerland;United States
Dimetilfumarato
Biogen Idec Italia S.r.l.
2013 Phase 3 EUCTR2013-001422-25-IT Italy
Diphenhydramine
Providence Health & Services
2020 Phase 3 NCT04175834 United States
Diphenhydramine IV
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Australia;Brazil;Canada;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
Diphenydramine
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
Diphtheria toxoid
Biogen
2008 Phase 4 NCT00536120 United States
Diroximel fumarate
Alkermes, Inc.
2019 Phase 3 EUCTR2017-001294-16-DE Germany;Poland;United States
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States
Biogen
2024 - NCT05767736 United States
2023 - NCT05658497 Germany;Ireland;Spain;Switzerland;United States
2021 - NCT05688436 United States
2021 Phase 3 NCT05083923 China;Japan
Hanna Jerome Thomas
2021 Phase 3 JPRN-jRCT2051210115 China;Japan
Dirucotide
Eli Lilly and Company
2007 Phase 2/Phase 3 NCT00870155 Canada;Denmark;Estonia;Finland;Germany;Latvia;Netherlands;Spain;Sweden;United Kingdom
2006 Phase 2/Phase 3 NCT00869986 Bulgaria;Poland;Russian Federation;Serbia;Slovakia;Ukraine
2004 Phase 2/Phase 3 NCT00869726 Canada;Denmark;Estonia;Finland;Germany;Latvia;Netherlands;Spain;Sweden;United Kingdom
Dirucotide acetate
BioMS Technology Corp
2007 - EUCTR2004-002571-16-GB Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-FI Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-EE Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-DK Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2005 - EUCTR2004-002571-16-SE Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Disability evaluation tests
University Hospital, Strasbourg, France
2025 Phase 3 NCT06663189 France
Discontinuation OF disease modifying therapy
University of Colorado, Denver
2017 Phase 4 NCT03073603 United States
Disease modifying therapy
Novartis Pharmaceuticals
2012 Phase 4 NCT01623596 Puerto Rico;United States
Divozilimab
Biocad
2022 Phase 3 NCT06987851 Russian Federation
2022 Phase 3 NCT05730699 Russian Federation
DMT
Merck KGaA
2012 - NCT01601119 United Kingdom
Novartis Pharmaceuticals
2022 Phase 4 NCT05090371 Canada;United States
VU University Medical Center
2020 - NCT04260711 Netherlands
DMT category 1
Novartis Pharmaceuticals
2024 - NCT06551519 Germany
DMT continuation
Rennes University Hospital
2019 Phase 3 NCT03653273 France
DMT withdrawal
Rennes University Hospital
2019 Phase 3 NCT03653273 France
Domperidone
University of Calgary
2015 Phase 2 NCT02493049 Canada
2015 Phase 2 NCT02308137 Canada
Donepezil
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
1999 Phase 3 NCT00062972 United States
Neurognostics
2004 Phase 4 NCT00315367 United States
Neurology Unit
2005 - EUCTR2005-003410-15-SE Sweden
OSPEDALE S. RAFFAELE
2008 - EUCTR2008-001940-38-IT Italy
Dosing interruption OF natalizumab
Berkovich, Regina MD, PhD Inc.
2019 Phase 4 NCT04048577 United States
DPA
VU University Medical Center
2014 - EUCTR2014-002547-17-NL Netherlands
DPA-714 PET/MRI
University of Alabama at Birmingham
2019 Phase 1 NCT03759522 United States
DRF
Alkermes, Inc.
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States
Biogen
2023 Phase 2 NCT05798520 Bulgaria;Czechia;Germany;Italy;Poland;Puerto Rico;Romania;Spain;Switzerland;United States
Hanna Jerome Thomas
2021 Phase 3 JPRN-jRCT2051210115 China;Japan
Dronabinol
Bionorica Research GmbH
2007 Phase 3 NCT00959218 Germany
Bionorica SE
2018 Phase 3 EUCTR2018-000001-23-ES Czech Republic;Hungary;Spain
Bionorica research GmbH
2007 Phase 3 EUCTR2006-004255-38-DK Austria;Denmark;Germany
2007 - EUCTR2006-004255-38-DE Austria;Germany
2007 - EUCTR2006-004255-38-AT Austria;Germany
Echo Pharmaceuticals B.V.
2011 - EUCTR2010-022033-28-NL Netherlands
Plymouth Hospitals NHS Trust
2006 - EUCTR2005-002728-33-GB United Kingdom
Dronabinol 25 MG/ML, oral drops
Bionorica SE
2020 Phase 3 EUCTR2018-000001-23-CZ Czech Republic;Hungary;Spain
2018 Phase 3 EUCTR2018-000001-23-HU Czech Republic;Hungary;Spain
Dronabinol capsule 2,5 MG
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark
Drug - SHR1459
Reistone Biopharma Company Limited
2021 Phase 2 NCT04670770 China
Dual task performance
Ankara Yildirim Beyazit University
2019 - NCT04408742 Turkey
2019 - NCT04286828 Turkey
Duloxetine
Brown, Theodore R., M.D., MPH
2007 Phase 2/Phase 3 NCT00457730 United States
Eli Lilly and Company
2008 Phase 3 NCT00755807 Belgium;Canada;Poland;United States
2008 - EUCTR2008-002560-34-BE Belgium
DUOC-01
Joanne Kurtzberg, MD
2021 Phase 1 NCT04943289 United States
Dydrogesterone
Irina Elovaara
2015 - EUCTR2014-005129-10-FI Finland
Dynamic balance training
Gazi University
2018 - NCT03501342 Turkey
Dynamic balance walking training
Marquette University
2017 - NCT04719494 -
Dynamic contrast-enhanced magnetic resonance imaging
University of Southern California
2011 - NCT02967380 United States
Dysport
Aránzazu Vázquez Doce
2018 Phase 3 EUCTR2018-003231-30-ES Spain
Ipsen Innovation
2016 Phase 3 EUCTR2015-003471-30-RO Canada;Czech Republic;Czechia;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-PT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-PL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-NL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-IT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-003471-30-CZ Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States
2016 Phase 3 EUCTR2015-000507-44-LT Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-FR Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-ES Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-DE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2016 Phase 3 EUCTR2015-000507-44-BE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom
2012 - EUCTR2010-023210-31-LT Austria;Czech Republic;Germany;Italy;Lithuania
2012 - EUCTR2010-023210-31-DE Austria;Czech Republic;Germany;Italy;Lithuania
2012 - EUCTR2010-023210-31-CZ Austria;Czech Republic;Germany;Italy;Lithuania
2012 - EUCTR2010-023210-31-AT Austria;Czech Republic;Germany;Italy;Lithuania
Dysport*SC IM 2FL 500U
IPSEN INNOVATION
2012 - EUCTR2010-023210-31-IT Austria;Czech Republic;Germany;Italy;Lithuania
Early harvest extra virgin olive OIL
Aristotle University Of Thessaloniki
2018 - NCT04120675 Greece
Early highly effective therapies group
The Cleveland Clinic
2019 Phase 4 NCT03535298 United Kingdom;United States
Ebixa
AZ. OSPEDALIERA GARIBALDI, S.LUIGI CURRO , ASCOLI TOMASELLI
2007 - EUCTR2007-000503-15-IT Italy
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France
OSPEDALE S. RAFFAELE
2008 Phase 2 EUCTR2008-000490-37-IT Italy
ECP002A
Echo Pharmaceuticals B.V.
2011 - EUCTR2010-022033-28-NL Netherlands
Eculizumab
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Alexion Pharmaceuticals
2015 Phase 3 NCT02003144 Argentina;Australia;Austria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Russian Federation;Singapore;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
2014 Phase 3 NCT01892345 Argentina;Australia;Austria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Russian Federation;Singapore;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
Alexion Pharmaceuticals Inc.
2020 Phase 2;Phase 3 EUCTR2019-001829-26-DE Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2019 Phase 2;Phase 3 EUCTR2019-001829-26-ES Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Alexion Pharmaceuticals, Inc.
2025 Phase 3 NCT06724809 China
2020 Phase 2/Phase 3 NCT04155424 Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2015 Phase 3 EUCTR2013-001151-12-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001151-12-DK Argentina;Australia;Austria;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Martinique;Romania;Russian Federation;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001151-12-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hong Kong;Italy;Japan;Korea, Republic of;Netherlands;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
Mayo Clinic
2009 Phase 1/Phase 2 NCT00904826 United States
Eculizumab administration
Huashan Hospital
2023 - NCT06888622 China
Efalizumab
Merck Serono International S.A.
2009 - EUCTR2007-001377-28-PT Austria;France;Germany;Netherlands;Portugal
2008 - EUCTR2007-001377-28-NL Austria;France;Germany;Netherlands;Portugal
2008 Phase 4 EUCTR2007-001377-28-FR Austria;France;Germany;Netherlands;Portugal
2008 - EUCTR2007-001377-28-DE Austria;France;Germany;Netherlands;Portugal
2008 - EUCTR2007-001377-28-AT Austria;France;Germany;Netherlands;Portugal
Efgartigimod alfa injection
Tianjin Medical University General Hospital
2024 Phase 2 NCT06497374 -
Egcg
Charite University, Berlin, Germany
2011 - NCT01417312 Germany
EHP-101 25 MG BID
Emerald Health Pharmaceuticals
2021 Phase 2 NCT04909502 Australia;United States
EHP-101 25 MG OD
Emerald Health Pharmaceuticals
2021 Phase 2 NCT04909502 Australia;United States
EHP-101 50 MG BID
Emerald Health Pharmaceuticals
2021 Phase 2 NCT04909502 Australia;United States
EHP-101 50 MG OD
Emerald Health Pharmaceuticals
2021 Phase 2 NCT04909502 Australia;United States
EK-12
Bosnalijek D.D
2019 Phase 3 NCT03283397 Turkey
Elezanumab
AbbVie
2019 Phase 2 NCT03737812 Canada;United States
2018 Phase 2 NCT03737851 Canada;United States
ELND002
Elan Pharmaceuticals
2010 Phase 1 NCT01318421 -
2010 Phase 1 NCT01144351 Canada;United States
EMD 28162
Academic MS Center Limburg
- Phase 2 EUCTR2014-000728-97-NL Netherlands
Merck Serono
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-DE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
2011 - EUCTR2010-020328-23-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Emselex 15 MG retardtabletten
Bayer Vital GmbH
2006 - EUCTR2006-002361-39-DE Germany
Emselex 7,5 MG retardtabletten
Bayer Vital GmbH
2006 - EUCTR2006-002361-39-DE Germany
Emtricitabine
Massachusetts General Hospital
2023 Phase 2 NCT05957913 United States
ENA713
Novartis Pharma GmbH
- - EUCTR2008-007015-32-DE Germany
Enalapril
West China Hospital,Sichuan University
2024 Phase 4 ChiCTR2400087203 China
Encapsulated baclofen 20 MG
Impax Laboratories, LLC
2007 Phase 3 NCT00488839 Canada;Estonia;Latvia;Ukraine;United States
Encapsulated simvastatin tablets
Imperial College London
2007 Phase 2 EUCTR2006-006347-31-GB United Kingdom
Endoxan
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Endoxan - ciclofosfamide
Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
2006 - EUCTR2006-002562-19-IT Italy
Endoxan baxter
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy
Enspryng
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2021-001088-26-IT Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States
2021 Phase 3 EUCTR2020-003413-35-IT Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2021-001088-26-DE Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States
2022 Phase 3 EUCTR2019-004092-39-PL Argentina;France;Italy;Mexico;Poland;United Kingdom;United States
2022 Phase 3 EUCTR2019-004092-39-FR Argentina;France;Italy;Mexico;Poland;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-PL Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-HU Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-BG Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd.
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-GB France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-DE France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
Entire-body PET-CT scans
Brain Health Alliance
2024 Early Phase 1 NCT04390009 United States
Eparmefolin 30 CPR 0,1/0,5MG
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy
Epigallocatechin
Charite University, Berlin, Germany
2007 Phase 1/Phase 2 NCT00525668 Germany
EPO
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany
Sun Yat-sen University
2006 - NCT00818103 China
Epoetin alfa
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany
Epoetin beta
Walton Centre for Neurology and Neurosurgery
2008 - EUCTR2008-005125-11-GB United Kingdom
Eritrociti accoppiati A peptidi
Cellerys AG
2023 Phase 1;Phase 2 EUCTR2022-000801-28-IT Czech Republic;Czechia;Germany;Italy;Switzerland
Erypo/erypo FS
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany
Erythropoietin
Rigshospitalet, Denmark
2009 Phase 2 NCT01144117 Denmark
Escalation therapies group
The Cleveland Clinic
2019 Phase 4 NCT03535298 United Kingdom;United States
Escitalopram
University of South Carolina
2009 Phase 3 NCT00965497 United States
Escitalopram oxalate antidepressant
Weill Medical College of Cornell University
2004 Phase 4 NCT00151294 United States
Esomeprazole
Genzyme, a Sanofi Company
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain
Essential - hydroxytyrosol
University of Iowa
2010 Phase 1 NCT01381354 United States
Essential fatty acids
National Center for Complementary and Integrative Health (NCCIH)
1999 Phase 1/Phase 2 NCT00010842 United States
Estradiol
Hospices Civils de Lyon
2005 Phase 3 NCT00127075 France
OSPEDALI CIVILI DI LIONE
2007 - EUCTR2006-005460-30-IT Italy
Estradiol hemihydrate
Irina Elovaara
2015 - EUCTR2014-005129-10-FI Finland
Estriol
University of California, Los Angeles
2011 Phase 2 NCT01466114 United States
2007 Phase 2 NCT00451204 Canada;United States
Estroprogestins
S. Andrea Hospital
2002 Phase 2 NCT00151801 Italy
Eszopiclone
University of Vermont
2006 - NCT00594087 United States
Ethinylestradiol
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands
Etifoxine
Imperial College London
2018 - NCT03850301 United Kingdom
Etims
University Medical Center Hamburg-Eppendorf
2009 - EUCTR2008-004408-29-DE Germany
Universitätsklinikum Hamburg-Eppendorf
2010 Phase 1/Phase 2 NCT01414634 -
Etoposide
FONDAZIONE ITALIANA SCLEROSI MULTIPLA ONLUS
2023 Phase 2 EUCTR2022-002654-95-IT Italy
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States
EU-ocrevus
Celltrion
2024 Phase 3 NCT05906992 Poland
EU/1/08/454/001-002, EU/1/08/454/005-007
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
EU/1/95/003/005-010
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
EU/1/97/033/002
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
EU/1/98/063/001-003
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
EU/1/98/063/004-006
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
Evaluation OF lower extremity muscle strength, physical activity, exercise capacity, balance, quality OF life, and fatigue IN healthy controls
Istanbul University - Cerrahpasa (IUC)
2024 - NCT06648499 -
Evaluation OF lower extremity muscle strength, physical activity, exercise capacity, balance, quality OF life, and fatigue IN poms
Istanbul University - Cerrahpasa (IUC)
2024 - NCT06648499 -
Evobrutinib
EMD Serono Research & Development Institute, Inc.
2019 Phase 3 NCT04032171 Germany;United States
2019 Phase 3 NCT04032158 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2017 Phase 2 NCT02975349 Bulgaria;Czechia;Germany;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
Merck Healthcare KGaA
2022 Phase 3 EUCTR2019-004980-36-CZ Belarus;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-SI Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-RO Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-SK Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PL Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-NO Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LV Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-GR Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-ES Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-DE Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-BG Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2020 Phase 3 NCT04338061 Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Latvia;Lithuania;Malaysia;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United States
2020 Phase 3 NCT04338022 Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
Evobrutinib 10MG
Merck Healthcare KGaA
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
Evobrutinib 25MG
Merck Healthcare KGaA
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
Exelon transdermales pflaster
Novartis Pharma GmbH
- - EUCTR2008-007015-32-DE Germany
Exercise intervention
Hasselt University
2017 - NCT03418376 Belgium
Exergame
University of Arizona
2014 - NCT02777060 United States
Experimental glatiramer acetate
Teva Pharmaceutical Industries
2009 Phase 3 NCT00947752 United States
Exposure TO methylprednisolone during pregnancy
Jena University Hospital
2020 - NCT04832269 Germany
Exposure TO ONE or more disease-modifying drug(S)(dmds) used TO treat MS
University of British Columbia
1996 - NCT04472975 -
Extavia
Bayer
2024 - NCT06053749 Finland;Sweden
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Charite Universitaetsmedizin Berlin
2012 Phase 3 EUCTR2011-004787-30-DE Germany
Charite University, Berlin, Germany
2013 Phase 2/Phase 3 NCT01647880 Germany
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Medizinische Universität Innsbruck
2014 - EUCTR2012-005450-30-SE Austria;Sweden
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy
2010 - EUCTR2010-023023-19-IT Germany;Italy
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy
Novartis Pharma Services AG
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
Extavia (interferon BETA-1B), novartis pharma AG
Bayer
2016 - NCT02749396 Finland
Extavia 250 microgram/ML
Octapharma AG
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Extavia 250 micrograms/ML
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Extavia*SC 15FL 250MCG/ML+15SI
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy
Extended release fampridine
Clinique Neuro-Outaouais
2013 Phase 4 NCT02146534 Canada
Extended-release oxycodone
University of Rochester
2007 Phase 4 NCT00414453 United States
Extended-release quetiapine fumarate
University of Calgary
2014 Phase 1/Phase 2 NCT02087631 Canada
Extracellular vesicles derived from human-induced neural stem cells FOR intrathecal injection
Tongji Hospital
2025 Phase 1 NCT06620809 China
Extracorporeal photopheresis
University of Utah
2014 - NCT02296346 United States
F-18 3f4AP
Massachusetts General Hospital
2021 Phase 1 NCT04699747 United States
Famciclovir
Queen Mary University London
2019 Phase 2 EUCTR2019-000169-19-GB United Kingdom
Queen Mary University of London
2020 Phase 2 NCT05283551 United Kingdom
Fampridina
IRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO
2016 Phase 4 EUCTR2014-004650-34-IT Italy
Fampridine
Amsterdam University Medical Center
2022 Phase 3 EUCTR2021-003677-66-NL Netherlands
BIOGEN IDEC RESEARCH LTD
2012 - EUCTR2012-000368-90-IT Belgium;Canada;Italy;Netherlands;Switzerland;United Kingdom
2012 - EUCTR2011-003507-38-IT Australia;Denmark;Italy;Netherlands;Portugal;United Kingdom
Biogen
2015 - NCT01532154 France;Germany;United Kingdom;United States
2014 Phase 3 NCT02219932 Argentina;Bulgaria;Czech Republic;Finland;Germany;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2013 Phase 3 NCT01917019 Japan
2012 Phase 2 NCT01597297 Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 Phase 4 NCT01480076 Australia;Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;United Kingdom;United States
2012 - NCT01480063 Argentina;Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Lebanon;Netherlands;Norway;Portugal;Spain;United Arab Emirates
Biogen Idec Research Limited
2015 Phase 3 EUCTR2013-003600-40-NL Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 - EUCTR2013-003600-40-LT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 - EUCTR2013-003600-40-IT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-GB Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States
2014 - EUCTR2013-003600-40-FI Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-CZ Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-BG Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2012 - EUCTR2012-000368-90-NL Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 - EUCTR2012-000368-90-GB Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 Phase 2 EUCTR2012-000368-90-BE Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-PT Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-NL Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 Phase 4 EUCTR2011-003507-38-GB Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-DK Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 Phase 4 EUCTR2011-003507-38-BE Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
CHDR
2015 Phase 2 EUCTR2015-000182-31-NL Netherlands
Centre Hospitalier Universitaire de Besancon
2014 Phase 4 NCT02849782 France
Cliniques Universitaires Saint-Luc, Neurologie
2013 Phase 3 EUCTR2012-005076-34-BE Belgium
FONDAZIONE SANTA LUCIA
2012 - EUCTR2012-000287-17-IT Italy
Genesis Pharma CNS & Specialty
2017 - NCT03164018 Greece
Medical University of Vienna
2015 - EUCTR2014-003498-41-AT Austria
Odense University Hospital
2013 Phase 4 EUCTR2013-001409-10-DK Denmark
St. Vincent's University Hospital
2012 Phase 4 EUCTR2011-002561-38-IE Ireland
Sønderjylland Hospital, department of neurology
2013 Phase 4 EUCTR2011-002959-34-DK Denmark
2012 - EUCTR2011-006151-10-DK Denmark
University College Dublin
2014 Phase 4 NCT02208050 Ireland
University of Southern Denmark
2018 - NCT03847545 Denmark
dipartimento di neurologia e psichiatria
2013 Phase 4 EUCTR2013-002558-64-IT Italy
Fampridine SR
London Health Sciences Centre
2012 Phase 2/Phase 3 NCT01667497 Canada
Fampridine-SR
Acorda Therapeutics
2007 Phase 3 NCT00649792 Canada;United States
2007 Phase 3 NCT00483652 Canada;United States
2006 Phase 3 NCT00648908 Canada;United States
2005 Phase 3 NCT00127530 Canada;United States
2003 Phase 3 NCT00654927 Canada;United States
2003 Phase 2 NCT00053417 Canada;United States
Biogen Idec
2010 Phase 3 NCT01235221 Canada
University of Southern Denmark
2012 Phase 4 NCT01656148 Denmark
Fampyra
BIOGEN IDEC RESEARCH LTD
2012 - EUCTR2012-000368-90-IT Belgium;Canada;Italy;Netherlands;Switzerland;United Kingdom
2012 - EUCTR2011-003507-38-IT Australia;Denmark;Italy;Netherlands;Portugal;United Kingdom
Biogen Idec Research Limited
2015 Phase 3 EUCTR2013-003600-40-NL Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 - EUCTR2013-003600-40-LT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 - EUCTR2013-003600-40-IT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-GB Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States
2014 - EUCTR2013-003600-40-FI Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-CZ Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2013-003600-40-BG Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States
2012 - EUCTR2012-000368-90-NL Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 - EUCTR2012-000368-90-GB Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 Phase 2 EUCTR2012-000368-90-BE Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-PT Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-NL Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 Phase 4 EUCTR2011-003507-38-GB Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 - EUCTR2011-003507-38-DK Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
2012 Phase 4 EUCTR2011-003507-38-BE Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
Cliniques Universitaires Saint-Luc, Neurologie
2013 Phase 3 EUCTR2012-005076-34-BE Belgium
FONDAZIONE SANTA LUCIA
2012 - EUCTR2012-000287-17-IT Italy
IRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO
2016 Phase 4 EUCTR2014-004650-34-IT Italy
Medical University of Vienna
2015 - EUCTR2014-003498-41-AT Austria
Odense University Hospital
2013 Phase 4 EUCTR2013-001409-10-DK Denmark
St. Vincent's University Hospital
2012 Phase 4 EUCTR2011-002561-38-IE Ireland
Sønderjylland Hospital, department of neurology
2013 Phase 4 EUCTR2011-002959-34-DK Denmark
2012 - EUCTR2011-006151-10-DK Denmark
Vestre Viken Hospital Trust
2012 - NCT01720849 Norway
dipartimento di neurologia e psichiatria
2013 Phase 4 EUCTR2013-002558-64-IT Italy
Fampyra 10 MG prolonged-release tablets
Amsterdam University Medical Center
2022 Phase 3 EUCTR2021-003677-66-NL Netherlands
CHDR
2015 Phase 2 EUCTR2015-000182-31-NL Netherlands
Fampyra 10MG prolonged release tablets
Walton Centre Foundation Trust
2013 Phase 4 EUCTR2013-000529-30-GB United Kingdom
Fatigue
Ankara Yildirim Beyazit University
2019 - NCT04408742 Turkey
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France
Fear OF falling
Ankara Yildirim Beyazit University
2019 - NCT03945006 Turkey
Febuxostat
Tsukuba International Clinical Pharmacology Clinic
2016 - JPRN-UMIN000024312 Japan
Fecal microbial transplants
Lawson Health Research Institute
2023 Phase 2 NCT04150549 -
Fecal microbiota
Lawson Health Research Institute
2017 Phase 2 NCT03183869 Canada
Fecal microbiota transplantation
Affiliated Hospital of Guangdong Medical University
2019 - ChiCTR1800018057 China
Chinese University of Hong Kong
2019 - NCT04014413 Hong Kong
Drum Tower Hospital, Medical School of Nanjing University
2021 Phase 0 ChiCTR2100048094 China
Rush University Medical Center
2018 - NCT03975413 United States
Fecal microbiota transplantation (FMT) OF FMP30 donor stool
Jeffrey Gelfand
2018 Phase 1 NCT03594487 United States
Femoston 1/10
Irina Elovaara
2015 - EUCTR2014-005129-10-FI Finland
Femoston 2/10
Irina Elovaara
2015 - EUCTR2014-005129-10-FI Finland
Fenebrutinib
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2019-003919-53-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-IT Austria;Bulgaria;Denmark;Finland;France;Greece;Italy;Netherlands;United States
2021 Phase 3 EUCTR2019-004857-10-IT Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
F. Hoffmann-La Roche Ltd
2022 Phase 2 EUCTR2021-003772-14-HR Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
2021 Phase 2 EUCTR2021-003772-14-SK Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
2021 Phase 2 EUCTR2021-003772-14-CZ Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
2021 Phase 3 EUCTR2020-001168-28-GR Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-DK Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-BG Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2019-004857-10-PT Algeria;Argentina;China;Dominican Republic;Egypt;Finland;France;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
2021 Phase 3 EUCTR2019-004857-10-NL Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2021 Phase 3 EUCTR2019-004857-10-HU Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2021 Phase 3 EUCTR2019-004857-10-DE Algeria;Argentina;China;Dominican Republic;Egypt;Finland;France;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
2021 Phase 3 EUCTR2019-003919-53-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-001168-28-FR Austria;Bulgaria;Denmark;Finland;France;Greece;Italy;Netherlands;United States
2020 Phase 3 EUCTR2019-004857-10-FI Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2020 Phase 3 EUCTR2019-003919-53-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-003919-53-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Hoffmann-La Roche
2022 Phase 2 NCT05119569 Bosnia and Herzegovina;Croatia;Czechia;Serbia;Slovakia;United States
2021 Phase 3 NCT04586023 Austria;Brazil;Bulgaria;Canada;Denmark;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Poland;Puerto Rico;Russian Federation;Turkey;United Kingdom;United States
2021 Phase 3 NCT04586010 Algeria;Argentina;China;Dominican Republic;Finland;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
2020 Phase 3 NCT04544449 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czechia;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;New Zealand;North Macedonia;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Feraheme
Stanford University
2014 - NCT01973517 United States
Ferumoxytol
National Institute of Neurological Disorders and Stroke (NINDS)
2015 Phase 1 NCT02511028 United States
Ferumoxytol infusion
University of Utah
2022 Early Phase 1 NCT05357833 United States
Fexofenadine
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark
Filgrastim
FONDAZIONE ITALIANA SCLEROSI MULTIPLA ONLUS
2023 Phase 2 EUCTR2022-002654-95-IT Italy
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States
Northwestern Memorial Hospital
2001 Phase 1 NCT00017628 United States
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom
Fingolimob
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
University Hospital, Clermont-Ferrand
2019 Phase 4 NCT02769689 France
Fingolimod
Biogen
2021 - NCT05688436 United States
2014 Phase 4 NCT02342704 Australia;Czech Republic;Czechia;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
Celgene
2025 Phase 3 NCT06408259 Australia;Italy;Mexico;Poland;Portugal;Romania;Spain;Taiwan;Turkey;United States
Charite Universitaetsmedizin Berlin
2012 Phase 3 EUCTR2011-004787-30-DE Germany
Charité - Universitätsmedizin Berlin
2013 Phase 4 EUCTR2012-000411-91-DE Germany
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2023 Phase 3 EUCTR2020-004128-41-RO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2023 Phase 3 EUCTR2020-004128-41-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-004128-41-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd.
2022 Phase 3 EUCTR2020-004128-41-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2017 Phase 4 EUCTR2017-000559-26-IT Israel;Italy;Switzerland;United States
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE
2016 Phase 4 EUCTR2016-000708-26-IT Italy
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
2017 Phase 4 NCT03345940 Italy
Heinrich-Heine University, Duesseldorf
2013 Phase 4 NCT01755871 Germany
Hikma Pharmaceuticals LLC
2022 - NCT05423769 Egypt
Hoffmann-La Roche
2022 Phase 3 NCT05123703 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Isfahan University of Medical Sciences
2015 Phase 2/Phase 3 NCT02939079 -
JANSSEN CILAG INTERNATIONAL NV
2023 Phase 3 EUCTR2020-004431-24-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
Janssen-Cilag International NV
2023 Phase 3 EUCTR2020-004431-24-PT Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2023 Phase 3 EUCTR2020-004431-24-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-004431-24-SE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
- Phase 3 EUCTR2020-004431-24-Outside-EU/EEA Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
- Phase 3 EUCTR2020-004431-24-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02193217 United Kingdom
NOVARTIS FARMA
2011 - EUCTR2011-001442-15-IT Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;United Kingdom
2011 - EUCTR2011-000770-60-IT Italy
2011 - EUCTR2010-024017-31-IT Italy
2010 - EUCTR2010-023023-19-IT Germany;Italy
2010 Phase 3 EUCTR2010-020515-37-IT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-IT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-002627-32-IT Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2006-000704-17-IT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States
Novartis
2011 - NCT01281657 Canada;United States
2010 Phase 3 NCT01199861 Austria;Belgium;Canada;Finland;France;Guatemala;Poland;Spain;Switzerland;United Kingdom
2008 Phase 2 NCT00670449 Japan
2006 Phase 3 NCT00355134 Australia;Austria;Canada;Lithuania;Poland;Romania;Turkey;United Kingdom;United States
Novartis Farmaceutica S.A.
2013 - EUCTR2012-000835-18-ES Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Farmacéutica S.A
2008 - EUCTR2007-002627-32-ES Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Novartis Farmacéutica S.A.
2011 Phase 3 EUCTR2011-003484-30-ES Australia;Spain
Novartis Farmacéutica, S.A.
2010 Phase 3 EUCTR2010-020515-37-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
Novartis Pharma AG
2013 - EUCTR2012-000835-18-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-000835-18-FR Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 - EUCTR2007-002627-32-HU Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
2010 - EUCTR2007-002627-32-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2009 - EUCTR2007-004122-24-IE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-EE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-002627-32-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 - EUCTR2007-002627-32-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 Phase 3 EUCTR2007-002627-32-FR Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
2008 - EUCTR2007-002627-32-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 - EUCTR2007-002627-32-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2007 - EUCTR2005-000365-19-HU Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
2006 - EUCTR2005-000365-19-CZ Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
Novartis Pharma GmbH
2011 Phase 3 EUCTR2010-022066-28-DE Germany
Novartis Pharma K.K.
2019 - JPRN-jRCT1080224761 Japan
Novartis Pharma Services AG
2014 Phase 3 EUCTR2012-000835-18-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-HU Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-GB Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-000835-18-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-000835-18-SE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-000835-18-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2010-020515-37-NO Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2011 Phase 3 EUCTR2010-020515-37-IE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2011 - EUCTR2010-020515-37-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
2011 Phase 3 EUCTR2010-020515-37-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;Venezuela, Bolivarian Republic of
2010 Phase 3 EUCTR2010-020515-37-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 - EUCTR2010-019028-30-GB Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-FR Belgium;Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-FI Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-BE Belgium;Finland;France;Spain;United Kingdom
2009 - EUCTR2008-002096-27-AT Austria;Lithuania;Poland;United Kingdom
2009 - EUCTR2007-002627-32-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom
2008 - EUCTR2008-002096-27-PL Austria;Lithuania;Poland;United Kingdom
2008 - EUCTR2008-002096-27-LT Austria;Lithuania;Poland;United Kingdom
2008 - EUCTR2008-002096-27-GB Austria;Lithuania;Poland;United Kingdom
2008 Phase 3 EUCTR2005-000365-19-GB Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom
2007 - EUCTR2006-000704-17-HU Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2007 - EUCTR2006-000704-17-BE Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 - EUCTR2006-000704-17-PT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 Phase 3 EUCTR2006-000704-17-GR Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 - EUCTR2006-000704-17-GB Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 - EUCTR2006-000704-17-DE Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 - EUCTR2006-000704-17-AT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 Phase 3 EUCTR2005-000365-19-SK Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom
- - EUCTR2007-002627-32-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharmaceuticals
2021 Phase 3 NCT04926818 Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
2020 - NCT05141669 United States
2020 Phase 4 NCT04480853 Taiwan
2017 Phase 4 NCT03257358 United States
2016 Phase 4 NCT02720107 Germany
2014 Phase 4 NCT02232061 Belgium;Germany;Italy
2014 Phase 3 NCT01941004 -
2013 Phase 3 NCT01892722 Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 4 NCT01621269 Germany
2012 Phase 4 NCT01705236 Germany;Switzerland
2012 Phase 3 NCT01633112 Argentina;Brazil;Canada;Chile;Mexico;Puerto Rico;United States
2012 Phase 4 NCT01623596 Puerto Rico;United States
2012 Phase 4 NCT01578330 Turkey
2012 Phase 4 NCT01534182 Russian Federation
2012 Phase 3 NCT01497262 Argentina;Brazil;Colombia;Costa Rica;Jordan;Malaysia;Mexico;Panama;Peru
2011 Phase 3 NCT01499667 Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Switzerland
2011 Phase 4 NCT01498887 Australia;Spain
2011 - NCT01442194 Argentina;Australia;Canada;Chile;Mexico;Puerto Rico;United States
2011 Phase 4 NCT01436643 Germany
2011 Phase 4 NCT01420055 France
2011 Phase 4 NCT01333501 Germany;Italy
2011 Phase 4 NCT01317004 Italy
2011 Phase 4 NCT01310166 Germany
2011 - NCT01285479 Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Cyprus;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Sweden;Switzerland;United Arab Emirates;United Kingdom;United States
2010 Phase 4 NCT01216072 Canada;Puerto Rico;United States
2010 Phase 3 NCT01201356 Argentina;Australia;Austria;Belgium;Brazil;Canada;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Services Pharma AG
2008 - EUCTR2007-002627-32-SE Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Sakari Simula
2012 Phase 4 EUCTR2012-002694-66-FI Finland
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University Hospital Muenster
2014 Phase 4 NCT02325440 Germany
University of British Columbia
2003 - NCT06705608 -
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands
Fingolimod 0.5 MG
Novartis
2008 Phase 3 NCT00662649 Australia;Belgium;Canada;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 NCT00340834 Argentina;Australia;Austria;Belgium;Brazil;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Portugal;Puerto Rico;Spain;Switzerland;United Kingdom;United States
2006 Phase 3 NCT00289978 Australia;Belgium;Canada;Czech Republic;Finland;France;Germany;Greece;Israel;Italy;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Sweden;Switzerland;Turkey;United Kingdom
Novartis Pharmaceuticals
2015 Phase 4 NCT02373098 Turkey
Fingolimod 0.5MG
Novartis Pharmaceuticals
2021 Phase 4 NCT04667949 China
Fingolimod 1.25 MG
Novartis
2008 Phase 3 NCT00662649 Australia;Belgium;Canada;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 NCT00340834 Argentina;Australia;Austria;Belgium;Brazil;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Portugal;Puerto Rico;Spain;Switzerland;United Kingdom;United States
2006 Phase 3 NCT00289978 Australia;Belgium;Canada;Czech Republic;Finland;France;Germany;Greece;Israel;Italy;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Sweden;Switzerland;Turkey;United Kingdom
Fingolimod hydrochloride
Biogen Idec Research Limited
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
Fakultní nemocnice Ostrava
2023 Phase 4 EUCTR2022-004331-23-CZ Czech Republic
2021 Phase 4 EUCTR2021-003195-13-CZ Czech Republic
NOVARTIS FARMA
2013 - EUCTR2012-000835-18-IT Australia;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
NOVARTIS FARMA S.p.A
2013 - EUCTR2012-005507-40-IT Italy
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Novartis Farma
2013 Phase 3 EUCTR2011-005677-23-IT Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy
Novartis Farma SpA
2014 - EUCTR2013-002660-17-IT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
Novartis Farmaceutica S.A.
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of
Novartis Pharma AG
2009 - EUCTR2007-004122-24-HU Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-GR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-FI Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-SE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-NL Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-GB Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-FR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-CZ Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-BE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
Novartis Pharma GmbH
2012 - EUCTR2012-002637-11-DE Germany
2012 Phase 4 EUCTR2012-000674-31-DE Germany;Switzerland
2012 Phase 4 EUCTR2012-000653-32-DE Germany
2011 - EUCTR2011-002969-38-DE Germany
- - EUCTR2011-001692-39-DE Germany
Novartis Pharma S.A.S
2011 Phase 4 EUCTR2011-001280-49-FR France
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-FR Austria;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
2013 Phase 3 EUCTR2011-005677-23-DE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Pharma Services AG
2015 - EUCTR2013-002660-17-PT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
2015 - EUCTR2013-002660-17-DK Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
2014 - EUCTR2012-000835-18-PL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2012 - EUCTR2011-001442-15-SE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
2011 - EUCTR2011-001442-15-HU Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-GR Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-GB Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-FI Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-DE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-CZ Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-AT Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2010-019029-32-SK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-SE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-PT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-NL Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-IE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-HU Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 2 EUCTR2010-019029-32-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-GB Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-FI Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-DK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-DE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-CZ Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 2 EUCTR2010-019029-32-BE Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-SK Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-DE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany
Fingolimodi
Turku University Hospital
2014 Phase 4 EUCTR2014-000296-12-FI Finland
2013 Phase 4 EUCTR2013-004626-28-FI Finland
Fingolmod
Novartis Farma SpA
2014 - EUCTR2013-002660-17-IT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
Novartis Pharma Services AG
2015 - EUCTR2013-002660-17-PT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
2015 - EUCTR2013-002660-17-DK Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
Firategrast
GlaxoSmithKline
2007 Phase 2 NCT00469378 Belgium;Czech Republic;Denmark;Norway;Sweden
GlaxoSmithKline Research & Development Ltd
2007 - EUCTR2006-007057-42-SE Czech Republic;Denmark;Sweden
2007 - EUCTR2006-007057-42-DK Czech Republic;Denmark;Sweden
2007 Phase 2 EUCTR2006-007057-42-CZ Belgium;Czech Republic;Denmark;Sweden
2007 - EUCTR2006-007057-42-BE Belgium;Czech Republic;Denmark;Sweden
2007 - EUCTR2006-002633-20-LT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2007 - EUCTR2006-002633-20-IT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2007 Phase 2 EUCTR2006-002633-20-GB Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2007 Phase 2 EUCTR2006-002633-20-FR Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2006 - EUCTR2006-002633-20-NL Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2006 - EUCTR2006-002633-20-FI Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2006 - EUCTR2006-002633-20-DE Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2006 - EUCTR2006-002633-20-AT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
GlaxoSmithKline S.A
2006 Phase 2 EUCTR2006-002633-20-ES Australia;Austria;Canada;Finland;France;Germany;Italy;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Spain;United Kingdom
Firategrast 150 MG
GlaxoSmithKline
2006 Phase 2 NCT00395317 Australia;Austria;Canada;Finland;France;Germany;Italy;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Spain;United Kingdom
Firategrast 300 MG
GlaxoSmithKline
2006 Phase 2 NCT00395317 Australia;Austria;Canada;Finland;France;Germany;Italy;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Spain;United Kingdom
Firategrast gastro-retentive solution
GlaxoSmithKline
2011 Phase 1 NCT01416363 Australia
Firategrast immediate release tablet
GlaxoSmithKline
2011 Phase 1 NCT01416363 Australia
Firategrast modified release tablet
GlaxoSmithKline
2011 Phase 1 NCT01416363 Australia
First line DMT
Novartis Pharmaceuticals
2021 Phase 3 NCT04788615 France;Germany;Italy;Spain;United Kingdom
Fish OIL
Coordinación de Investigación en Salud, Mexico
2010 Phase 4 NCT01842191 Mexico
Isfahan University of Medical Sciences
2015 Phase 2/Phase 3 NCT02939079 -
Fish OIL concentrate
Oregon Health and Science University
2005 Phase 1/Phase 2 NCT00122954 United States
Fish OIL, rich IN omega-3-acids
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece
Fish OIL,rich IN omega 3 acids
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece
Fludara
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
Fludarabine
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
Bruce Cree
2024 Phase 1 NCT06451159 United States
Hadassah Medical Organization
2015 - NCT02529839 -
Indapta Therapeutics, INC.
2026 Phase 1 NCT06677710 United States
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
2024 Phase 1 NCT06220201 Belgium;France;Germany;Italy;Spain;United Kingdom;United States
Seah Lim M.D.
2012 Phase 2 NCT01679041 United States
Fludarabine phosphate FOR injection
St. Petersburg State Pavlov Medical University
2020 Phase 1 NCT05832515 Russian Federation
Flumazenil
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
2013 - JPRN-UMIN000011111 Japan
VU University medical center Amsterdam
2017 Phase 4 EUCTR2017-002636-16-NL Netherlands
Fluoxetin hexal
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany
Fluoxetine
2012 Phase 4 EUCTR2011-003775-11-BE Belgium
2010 Phase 4 EUCTR2010-023996-25-BE Belgium
Novartis Pharmaceuticals
2011 Phase 4 NCT01436643 Germany
University College, London
2014 Phase 2 NCT01910259 United Kingdom
Fluoxetine hydrochloride
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany
UCL
2014 Phase 2 EUCTR2012-005394-31-GB United Kingdom
Flupirtin
Charité-Universitätsmedizin Berlin
2007 Phase 2 EUCTR2006-005262-39-DE Germany
Flupirtine
Charite University, Berlin, Germany
2007 Phase 2 NCT00623415 Germany
Flupirtinmaleat
Charité-Universitätsmedizin Berlin
2007 Phase 2 EUCTR2006-005262-39-DE Germany
Flurbiprofen
Fraunhofer Gesellschaft for its Institute Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)
2015 Phase 2 EUCTR2014-004483-38-DE Germany
Foralumab
Tiziana Life Sciences LTD
2023 Phase 2 NCT06292923 United States
Foralumab TZLS-401 100 µG
Tiziana Life Sciences LTD
2025 Phase 2 NCT06890923 United States
Foralumab TZLS-401 50 µG
Tiziana Life Sciences LTD
2025 - NCT06802328 United States
Formistin - 10 MG compresse rivestite CON film 20 compresse
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
Formistin 10 MG
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
Formulation A
GlaxoSmithKline
2007 Phase 1 NCT00548769 Czech Republic;Czechia;Germany;Poland
Formulation B
GlaxoSmithKline
2007 Phase 1 NCT00548769 Czech Republic;Czechia;Germany;Poland
Formulation C
GlaxoSmithKline
2007 Phase 1 NCT00548769 Czech Republic;Czechia;Germany;Poland
Formulation D
GlaxoSmithKline
2007 Phase 1 NCT00548769 Czech Republic;Czechia;Germany;Poland
Four square step test
Gazi University
2018 - NCT03584672 -
Frexalimab
Sanofi
2023 Phase 3 NCT06141486 Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;France;Germany;Greece;Hungary;India;Italy;Japan;Korea, Republic of;Netherlands;Poland;Portugal;Puerto Rico;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2023 Phase 3 NCT06141473 Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
FTY720
NOVARTIS FARMA
2011 - EUCTR2011-001442-15-IT Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-IT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
NOVARTIS FARMA S.p.A
2013 - EUCTR2012-005507-40-IT Italy
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Novartis
2010 Phase 3 NCT01127750 Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
2007 Phase 2 NCT00537082 Japan
2003 Phase 2 NCT00333138 Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
Novartis Farma
2013 Phase 3 EUCTR2011-005677-23-IT Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy
Novartis Farmaceutica S.A.
2013 - EUCTR2012-000835-18-ES Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of
Novartis Farmacéutica S.A
2008 - EUCTR2007-002627-32-ES Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Novartis Farmacéutica, S.A.
2011 Phase 4 EUCTR2011-001442-15-ES Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
Novartis Pharma AG
2013 - EUCTR2012-000835-18-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-000835-18-FR Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 - EUCTR2007-002627-32-HU Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
2010 - EUCTR2007-002627-32-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2009 - EUCTR2007-004122-24-IE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-HU Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-GR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-FI Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-EE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-002627-32-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 - EUCTR2007-004122-24-SE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-NL Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-GB Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-FR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-CZ Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-BE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-002627-32-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 Phase 3 EUCTR2007-002627-32-FR Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
2008 - EUCTR2007-002627-32-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 - EUCTR2007-002627-32-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2007 - EUCTR2005-000365-19-HU Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
2006 - EUCTR2005-000365-19-CZ Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
Novartis Pharma GmbH
2012 - EUCTR2012-002637-11-DE Germany
2012 Phase 4 EUCTR2012-000674-31-DE Germany;Switzerland
2012 Phase 4 EUCTR2012-000653-32-DE Germany
2011 - EUCTR2011-002969-38-DE Germany
2011 Phase 3 EUCTR2010-022066-28-DE Germany
Novartis Pharma S.A.S
2011 Phase 4 EUCTR2011-001280-49-FR France
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-FR Austria;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
2013 Phase 3 EUCTR2011-005677-23-DE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Pharma Services AG
2014 - EUCTR2012-000835-18-PL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2012-000835-18-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2012-000835-18-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-HU Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-GB Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-000835-18-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2012 - EUCTR2012-000835-18-SE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-000835-18-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2011-001442-15-SE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2012 Phase 3 EUCTR2010-020515-37-NO Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2011 - EUCTR2011-001442-15-HU Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-GR Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-GB Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-FI Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-DE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-CZ Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-AT Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 Phase 3 EUCTR2010-020515-37-IE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2011 - EUCTR2010-020515-37-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
2011 Phase 3 EUCTR2010-020515-37-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2011 - EUCTR2010-019029-32-SK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;Venezuela, Bolivarian Republic of
2010 Phase 3 EUCTR2010-020515-37-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 - EUCTR2010-019029-32-SE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-PT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-NL Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-IE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-HU Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 2 EUCTR2010-019029-32-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-GB Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-FI Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-DK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-DE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-CZ Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 2 EUCTR2010-019029-32-BE Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019028-30-GB Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-FR Belgium;Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-FI Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-BE Belgium;Finland;France;Spain;United Kingdom
2009 - EUCTR2008-002096-27-AT Austria;Lithuania;Poland;United Kingdom
2009 - EUCTR2007-002627-32-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom
2008 - EUCTR2008-002096-27-PL Austria;Lithuania;Poland;United Kingdom
2008 - EUCTR2008-002096-27-LT Austria;Lithuania;Poland;United Kingdom
2008 - EUCTR2008-002096-27-GB Austria;Lithuania;Poland;United Kingdom
2008 - EUCTR2007-004122-24-SK Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-DE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 Phase 3 EUCTR2005-000365-19-GB Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom
2007 - EUCTR2006-000704-17-HU Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2007 - EUCTR2006-000704-17-BE Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2007 - EUCTR2005-000365-19-IE Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
2007 - EUCTR2005-000365-19-GR Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
2007 - EUCTR2005-000365-19-EE Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
2006 - EUCTR2006-000704-17-PT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 Phase 3 EUCTR2006-000704-17-GR Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 - EUCTR2006-000704-17-GB Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 - EUCTR2006-000704-17-DE Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 - EUCTR2006-000704-17-AT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 Phase 3 EUCTR2005-000365-19-SK Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom
2006 - EUCTR2005-000365-19-FI Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
2006 - EUCTR2005-000365-19-DE Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
2005 - EUCTR2005-000365-19-SE Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
- - EUCTR2007-002627-32-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharmaceuticals
2013 Phase 3 NCT01779934 Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 4 NCT01585298 Germany
2011 Phase 4 NCT01498887 Australia;Spain
2008 Phase 3 NCT00731692 Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Services Pharma AG
2008 - EUCTR2007-002627-32-SE Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
NovartisPharma Services AG
2007 - EUCTR2005-000365-19-LT Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany
FTY720D
NOVARTIS FARMA
2013 - EUCTR2012-000835-18-IT Australia;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2011 - EUCTR2011-000770-60-IT Italy
2011 - EUCTR2010-024017-31-IT Italy
2010 - EUCTR2010-023023-19-IT Germany;Italy
2010 Phase 3 EUCTR2010-020515-37-IT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-IT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-002627-32-IT Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2006-000704-17-IT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
Novartis Farma SpA
2014 - EUCTR2013-002660-17-IT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
Novartis Farmaceutica S.A.
2013 - EUCTR2012-000835-18-ES Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Farmacéutica S.A
2008 - EUCTR2007-002627-32-ES Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Novartis Farmacéutica, S.A.
2010 Phase 3 EUCTR2010-020515-37-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
Novartis Pharma AG
2013 - EUCTR2012-000835-18-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-000835-18-FR Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 - EUCTR2007-002627-32-HU Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
2010 - EUCTR2007-002627-32-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2009 - EUCTR2007-004122-24-HU Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-GR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 - EUCTR2007-004122-24-FI Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-002627-32-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 - EUCTR2007-004122-24-NL Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-FR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-CZ Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-004122-24-BE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom
2008 - EUCTR2007-002627-32-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 Phase 3 EUCTR2007-002627-32-FR Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
2008 - EUCTR2007-002627-32-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 - EUCTR2007-002627-32-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2007 - EUCTR2005-000365-19-HU Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
2006 - EUCTR2005-000365-19-CZ Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom
Novartis Pharma Services AG
2015 - EUCTR2013-002660-17-PT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
2015 - EUCTR2013-002660-17-DK Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
2014 - EUCTR2012-000835-18-PL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2012-000835-18-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-HU Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-GB Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-000835-18-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-000835-18-SE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-000835-18-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2010-020515-37-NO Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2011 Phase 3 EUCTR2010-020515-37-IE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2011 - EUCTR2010-020515-37-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
2011 Phase 3 EUCTR2010-020515-37-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2011 - EUCTR2010-019029-32-SK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;Venezuela, Bolivarian Republic of
2010 Phase 3 EUCTR2010-020515-37-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 - EUCTR2010-019029-32-SE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-PT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-NL Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-IE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-HU Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 2 EUCTR2010-019029-32-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-GB Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-FI Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-DK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-DE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-CZ Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 Phase 2 EUCTR2010-019029-32-BE Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019029-32-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
2010 - EUCTR2010-019028-30-GB Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-FR Belgium;Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-FI Finland;France;Spain;United Kingdom
2010 - EUCTR2010-019028-30-BE Belgium;Finland;France;Spain;United Kingdom
2009 - EUCTR2008-002096-27-AT Austria;Lithuania;Poland;United Kingdom
2009 - EUCTR2007-002627-32-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom
2008 - EUCTR2008-002096-27-PL Austria;Lithuania;Poland;United Kingdom
2008 - EUCTR2008-002096-27-LT Austria;Lithuania;Poland;United Kingdom
2008 - EUCTR2008-002096-27-GB Austria;Lithuania;Poland;United Kingdom
2008 Phase 3 EUCTR2005-000365-19-GB Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom
- - EUCTR2007-002627-32-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Services Pharma AG
2008 - EUCTR2007-002627-32-SE Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Full spectrum vitamin
University of Iowa
2010 Phase 1 NCT01381354 United States
Fully humanized ANTI-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody
Chugai Pharmaceutical Co. Ltd
2016 Phase 3 EUCTR2015-005431-41-RO Bulgaria;Canada;Croatia;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Turkey;Ukraine;United States
2015 Phase 3 EUCTR2013-003752-21-HU France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
2015 - EUCTR2013-003752-21-ES France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-IT France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom
Functional balance intervention
University of Illinois at Chicago
2025 - NCT06341023 United States
Functional mobility
Ankara Yildirim Beyazit University
2016 - NCT03566251 Turkey
Functional reach test
Gazi University
2018 - NCT03584672 -
G-CSF
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States
2017 Phase 3 NCT03342638 United States
GA 20 MG/ML
Teva Pharmaceutical Industries
2013 Phase 3 NCT01874145 United States
GA 40 MG/ML
Teva Pharmaceutical Industries
2013 Phase 3 NCT01874145 United States
GA depot
Mapi Pharma Ltd.
2019 Phase 3 NCT04121221 Belarus;Bosnia and Herzegovina;Bulgaria;Estonia;Georgia;Israel;Moldova, Republic of;Russian Federation;Ukraine;United States
2019 Phase 3 EUCTR2018-000284-93-EE Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Israel;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2019 Phase 3 EUCTR2018-000284-93-BG Belarus;Bosnia and Herzegovina;Bulgaria;Estonia;Georgia;Israel;Moldova, Republic of;Montenegro;Russian Federation;Ukraine;United States
GA depot 25MG once monthly
Mapi Pharma Ltd.
2017 Phase 2 NCT03362294 Israel;Moldova, Republic of
GA depot 40 MG
Mapi Pharma Ltd.
2014 Phase 1/Phase 2 NCT02212886 Israel
GA depot 40MG once monthly
Mapi Pharma Ltd.
2017 Phase 2 NCT03362294 Israel;Moldova, Republic of
GA depot 80 MG
Mapi Pharma Ltd.
2014 Phase 1/Phase 2 NCT02212886 Israel
Gabapentin
Charité University Medicine Berlin
2010 Phase 4 EUCTR2008-005167-33-DE Germany
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France
Hospices Civils de Lyon
2012 Phase 2 NCT01744444 France
Gabapentine
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France
Gabapentine 300MG
Charité University Medicine Berlin
2010 Phase 4 EUCTR2008-005167-33-DE Germany
Gadobenate dimeglumine
University of Southern California
2011 - NCT02967380 United States
Gadobutrol
Institut Diagnostic per la Imatge
2010 - EUCTR2009-016140-39-ES Spain
University of Southern California
2011 - NCT02967380 United States
Universitätsklinikum Erlangen
2010 Phase 4 EUCTR2009-014857-34-DE Germany
Gadolinium-based contrast
Stanford University
2014 - NCT01973517 United States
Gadopentetate dimeglumine
University of Southern California
2011 - NCT02967380 United States
Gadoteric acid
Universitätsklinikum Erlangen
2010 Phase 4 EUCTR2009-014857-34-DE Germany
Gadoteridol
University of Maryland, Baltimore
2018 - NCT03396822 United States
University of Nottingham
2017 - NCT02481882 United Kingdom
University of Utah
2022 Early Phase 1 NCT05357833 United States
Gadovist 1 mmol/ML solucióN inyectable EN jeringa precargada/ cartucho precargado
Institut Diagnostic per la Imatge
2010 - EUCTR2009-016140-39-ES Spain
Gadovist 1.0 mmol/ML injektionslösung
Universitätsklinikum Erlangen
2010 Phase 4 EUCTR2009-014857-34-DE Germany
Gamma-tocopherol
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece
GBP
Charité University Medicine Berlin
2010 Phase 4 EUCTR2008-005167-33-DE Germany
GDC-0853
F. Hoffmann-La Roche Ltd
2022 Phase 2 EUCTR2021-003772-14-HR Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
2021 Phase 2 EUCTR2021-003772-14-SK Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
2021 Phase 2 EUCTR2021-003772-14-CZ Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
GDC-0853 RO7010939
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2019-003919-53-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2019-003919-53-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-003919-53-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-003919-53-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Gemfibrozil
Sanofi
2020 Phase 1 NCT06064539 United States
Genotropin
University of Leipzig
- Phase 2 EUCTR2006-006465-16-DE Germany
Gilenya
Biogen Idec Research Limited
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Charite Universitaetsmedizin Berlin
2012 Phase 3 EUCTR2011-004787-30-DE Germany
Charite University, Berlin, Germany
2013 Phase 2/Phase 3 NCT01647880 Germany
Charité - Universitätsmedizin Berlin
2013 Phase 4 EUCTR2012-000411-91-DE Germany
F. Hoffmann-La Roche Ltd
2023 Phase 3 EUCTR2020-004128-41-RO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2023 Phase 3 EUCTR2020-004128-41-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-004128-41-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd.
2022 Phase 3 EUCTR2020-004128-41-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Janssen-Cilag International NV
2023 Phase 3 EUCTR2020-004431-24-BE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
Jochen Vehoff
2013 Phase 4 NCT02048072 Switzerland
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
McGill University
2012 - NCT02137707 Canada
NOVARTIS FARMA
2011 - EUCTR2011-001442-15-IT Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;United Kingdom
NOVARTIS FARMA S.p.A
2013 - EUCTR2012-005507-40-IT Italy
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States
Novartis Farma
2013 Phase 3 EUCTR2011-005677-23-IT Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy
Novartis Farma SpA
2014 - EUCTR2013-002660-17-IT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
Novartis Farmaceutica S.A.
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of
Novartis Farmacéutica S.A.
2011 Phase 3 EUCTR2011-003484-30-ES Australia;Spain
Novartis Pharma AG
2012 Phase 3 EUCTR2012-000835-18-FR Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 - EUCTR2007-002627-32-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2008 - EUCTR2007-002627-32-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharma GmbH
2012 - EUCTR2012-002637-11-DE Germany
2012 Phase 4 EUCTR2012-000674-31-DE Germany;Switzerland
2012 Phase 4 EUCTR2012-000653-32-DE Germany
2011 - EUCTR2011-002969-38-DE Germany
2011 Phase 3 EUCTR2010-022066-28-DE Germany
- - EUCTR2011-001692-39-DE Germany
Novartis Pharma K.K.
2019 - JPRN-jRCT1080224761 Japan
Novartis Pharma S.A.S
2011 Phase 4 EUCTR2011-001280-49-FR France
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-FR Austria;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
2013 Phase 3 EUCTR2011-005677-23-DE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Pharma Services AG
2015 - EUCTR2013-002660-17-PT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
2015 - EUCTR2013-002660-17-DK Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom
2014 - EUCTR2012-000835-18-PL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2012-000835-18-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2012-000835-18-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 - EUCTR2012-000835-18-HU Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-000835-18-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2012 - EUCTR2012-000835-18-SE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2011-001442-15-SE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
2011 - EUCTR2011-001442-15-GR Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-GB Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-DE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 - EUCTR2011-001442-15-AT Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2011 Phase 3 EUCTR2010-020515-37-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom
2010 Phase 3 EUCTR2010-020515-37-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2010 Phase 3 EUCTR2010-020515-37-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2009 - EUCTR2007-002627-32-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom
Novartis Services Pharma AG
2008 - EUCTR2007-002627-32-SE Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Sakari Simula
2012 Phase 4 EUCTR2012-002694-66-FI Finland
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom
Turku University Hospital
2014 Phase 4 EUCTR2014-000296-12-FI Finland
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University of Southern California
2013 - NCT02225977 United States
Universitätsklinikum Hamburg-Eppendorf
2013 - NCT03216915 Germany
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands
Gilenya - 0.25 MG - capsule rigide - USO orale
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Gilenya - 0.5 MG - capsule rigide - USO orale
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Gilenya - 0.5 MG - capsule rigide - USO orale - blister divisibile PER dose unitaria(PVC/pvdc/ALU) scatola DA 7x1 capsule
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2017 Phase 4 EUCTR2017-000559-26-IT Israel;Italy;Switzerland;United States
Gilenya - 0.5 MG - capsule rigide - USO orale - blister(PVC/pvdc/ALU) scatola DA 28 capsule
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE
2016 Phase 4 EUCTR2016-000708-26-IT Italy
Gilenya 0,5 MG hartkapseln
Novartis Pharma Services AG
2010 Phase 3 EUCTR2010-020515-37-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
- - EUCTR2007-002627-32-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Gilenya 0,5MG CPS DUR
Fakultní nemocnice Ostrava
2023 Phase 4 EUCTR2022-004331-23-CZ Czech Republic
2021 Phase 4 EUCTR2021-003195-13-CZ Czech Republic
Gilenya hard capsules
JANSSEN CILAG INTERNATIONAL NV
2023 Phase 3 EUCTR2020-004431-24-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
Janssen-Cilag International NV
2023 Phase 3 EUCTR2020-004431-24-PT Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2023 Phase 3 EUCTR2020-004431-24-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-004431-24-SE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
- Phase 3 EUCTR2020-004431-24-Outside-EU/EEA Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
- Phase 3 EUCTR2020-004431-24-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
Gileyna
Stony Brook University
2013 - NCT02141022 United States
Ginkgo biloba
National Center for Complementary and Integrative Health (NCCIH)
1999 Phase 1/Phase 2 NCT00010842 United States
VA Office of Research and Development
2009 Phase 2 NCT00841321 United States
Ginseng
Isfahan University of Medical Sciences
2010 Phase 2 NCT01712373 Iran, Islamic Republic of
Glatiramer acetate
AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA` DEGLI STUDI DI NAPOLI
2009 - EUCTR2009-010661-23-IT Italy
Amphia Hospital
2009 Phase 4 NCT00910598 Netherlands
Amphia Ziekenhuis
2009 - EUCTR2009-013129-41-NL Netherlands
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Biogen
2021 - NCT05688436 United States
2021 Phase 2 NCT04079088 -
2010 Phase 2 NCT01071083 Germany;Spain;United States
2010 Phase 3 NCT01058005 Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States
2007 Phase 3 NCT00451451 Australia;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Costa Rica;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Ireland;Israel;Italy;Kazakhstan;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;New Zealand;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States
Biogen Idec
2010 - EUCTR2009-017490-38-DE Germany;Spain
Biogen Idec Limited
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Biogen Idec Ltd.
2008 - EUCTR2006-003697-10-BG Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-LV Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-IE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-GR Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 Phase 3 EUCTR2006-003697-10-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-EE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-DE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 - EUCTR2006-003697-10-CZ Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
2007 Phase 3 EUCTR2006-003697-10-BE Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain
Cinnagen
2015 - NCT04928313 -
FONDAZIONE DON CARLO GNOCCHI ONLUS
2011 - EUCTR2011-000150-31-IT Italy
Fred Lublin
2005 Phase 3 NCT00211887 Canada;United States
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
Glostrup Hospital, Dep. of Neurology
2009 - EUCTR2006-001827-21-DK Denmark
ISTITUTO C. MONDINO
2007 - EUCTR2008-007162-32-IT Italy
Isfahan University of Medical Sciences
2017 Phase 2/Phase 3 NCT03315923 Iran, Islamic Republic of
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Mapi Pharma Ltd.
2019 Phase 3 EUCTR2018-000284-93-EE Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Israel;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2019 Phase 3 EUCTR2018-000284-93-BG Belarus;Bosnia and Herzegovina;Bulgaria;Estonia;Georgia;Israel;Moldova, Republic of;Montenegro;Russian Federation;Ukraine;United States
Merck KGaA
2014 - EUCTR2013-002283-25-PL Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-GR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 Phase 2 EUCTR2013-002283-25-GB Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-ES Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-BG Bulgaria;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2013-002283-25-IT Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-HU Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-FI Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-CZ Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
Merck Serono S.A. - Geneva
2010 - EUCTR2009-016087-37-GB France;Ireland;Italy;Spain;United Kingdom
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy
National Institute of Allergy and Infectious Diseases (NIAID)
2001 - NCT00039988 United States
Neurognostics
2006 - NCT00398528 United States
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;Italy
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;United Kingdom
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Novartis Pharma Services AG
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
Novartis Pharmaceuticals
2022 - NCT05344469 Germany
2012 Phase 3 NCT01633112 Argentina;Brazil;Canada;Chile;Mexico;Puerto Rico;United States
2012 Phase 4 NCT01534182 Russian Federation
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Peptimmune Inc.
2010 Phase 2 EUCTR2009-012716-40-SK Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 Phase 2 EUCTR2009-012716-40-PL Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 - EUCTR2009-012716-40-FR Bulgaria;Czech Republic;Estonia;France;Germany;Poland
2010 Phase 2 EUCTR2009-012716-40-DE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 Phase 2 EUCTR2009-012716-40-CZ Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 - EUCTR2009-012716-40-BG Bulgaria;Czech Republic;Estonia;France;Germany;Poland
2009 - EUCTR2009-012716-40-EE Bulgaria;Czech Republic;Estonia;France;Germany;Poland
Philipps-Universität Marburg
2010 Phase 4 EUCTR2009-011088-35-DE Germany
SYNTHON BV
2011 - EUCTR2011-000888-27-IT Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Romania;Russian Federation;Ukraine;United Kingdom;United States
Sanofi
2007 Phase 2 NCT00811395 Austria;Canada;Germany;Italy;Spain;United Kingdom;United States
2007 Phase 2 NCT00475865 Austria;Canada;Germany;Italy;United Kingdom;United States
2003 Phase 4 NCT00267319 Czech Republic
Sheba Medical Center
2006 - NCT00331747 Israel
Synthon BV
2012 - EUCTR2011-000888-27-GR Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 - EUCTR2011-000888-27-DE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 NCT01489254 Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Italy;Kazakhstan;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;South Africa;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2011-000888-27-RO Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-GB Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-EE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-CZ Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-BG Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
TAKEDA PHARMACEUTICAL COMPANY LTD.
2015 - JPRN-jRCT1080223004 Japan
TEVA
2004 - EUCTR2004-000759-40-IT Italy
2004 - EUCTR2004-000463-94-IT Hungary;Italy
2004 - EUCTR2004-000462-13-IT Hungary;Italy
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
2015 Phase 4 EUCTR2015-000922-12-IT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
TEVA ITALIA srl
2004 Phase 2 EUCTR2004-000762-13-IT Italy
Teva Branded Pharmaceutical Products R&D, Inc.
2010 Phase 3 NCT01067521 Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Turkey;Ukraine;United Kingdom;United States
1994 Phase 4 NCT00203021 United States
Teva Pharmaceutical Industries
2012 Phase 3 NCT01578785 Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Greece;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2012 Phase 2 NCT01404117 -
2005 Phase 4 NCT00203047 Canada;United States
2004 Phase 3 NCT00666224 Argentina;Australia;Austria;Denmark;Finland;France;Germany;Hungary;Israel;Italy;New Zealand;Norway;Romania;Spain;Sweden;United Kingdom;United States
2004 Phase 4 NCT00202995 Canada;United States
Teva Pharmaceutical Industries, Ltd
2016 Phase 4 EUCTR2015-000922-12-PL Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-FR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-ES Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-DE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-BE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-IE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-HR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-FI Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-AT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
Teva Pharmaceuticals Industries Ltd.
2006 - EUCTR2006-002037-20-IT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Teva Takeda Pharma Ltd.
2015 - NCT03209479 Japan
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University of California, San Francisco
2008 - NCT00819195 United States
University of Colorado, Denver
2012 Phase 2 NCT01569451 United States
Università degli Studi Aldo Moro
2019 Phase 3 EUCTR2017-005129-18-IT Italy
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands
Glatiramer acetate (GA) 40 MG
Teva Pharmaceutical Industries
2006 Phase 3 NCT00337779 Argentina;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;Spain;United Kingdom;United States
Glatiramer acetate 150MG enteric coated tablets
TEVA Pharmaceutical Industries Ltd.
2007 - EUCTR2004-000463-94-HU Hungary;Italy
Glatiramer acetate 150MG enteric-coated (gastro-resistant) tablets
TEVA Pharmaceutical Industries Ltd.
2004 - EUCTR2004-000462-13-HU Hungary;Italy
Glatiramer acetate 20 MG
Teva Pharmaceutical Industries
2006 Phase 3 NCT00337779 Argentina;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;Spain;United Kingdom;United States
2003 Phase 2 NCT00202982 United States
Glatiramer acetate 20 MG, with mitoxantrone
Teva Pharmaceutical Industries
2003 Phase 2 NCT00203073 Canada;United States
Glatiramer acetate 20 MG/0.5 ML
Teva Neuroscience, Inc.
2010 Phase 3 NCT01167426 United States
Glatiramer acetate 40 MG
Teva Pharmaceutical Industries
2003 Phase 2 NCT00202982 United States
Glatiramer acetate injection with oral cetirizine hydrochloride
Teva Pharmaceutical Industries
2004 Phase 4 NCT00240032 United States
Glatiramer acetate with minocycline
Teva Pharmaceutical Industries
2004 Phase 2 NCT00203112 Canada
Glatiramer acetate, IFN-beta 1A (IM), IFN-beta 1A (subcutaneous), and IFN-beta 1B
Teva Neuroscience, Inc.
2008 - NCT00819000 United States
Glatiramer acetate, interferons (intramuscular, subcutaneous, pegylated) teriflunomide, fumarates (dimethyl, diroximel, monomethyl) fingolimod, siponimod, ozanimod, ponesimod
Johns Hopkins University
2018 - NCT03500328 United States
Glatiramer acetate, N-acetylcysteine
Teva Pharmaceutical Industries
2004 Phase 2 NCT00203099 Canada
Glatiramer acetato
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
2015 Phase 4 EUCTR2015-000922-12-IT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
Teva Pharmaceutical Industries, Ltd.
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Glatiramero acetato
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Teva Pharmaceutical Industries, Ltd.
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom
Glicerol-1,3-didecanoato-2-octadeca-(6Z,9Z,12Z)-trienoato
BTG International Ltd
2009 - EUCTR2009-011585-28-ES Belgium;France;Germany;Spain
Glucose
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
1999 Phase 3 NCT00062972 United States
Glutamate and aspartate
University Hospital, Caen
2007 - NCT02523703 -
Glycerol-1,3-didecanoate-2-octadeca-(6Z,9Z,12Z)-trienoate
BTG International Ltd
2009 - EUCTR2009-011585-28-FR Belgium;France;Germany;Spain
2009 - EUCTR2009-011585-28-DE Belgium;European Union;France;Germany;Russian Federation;Spain
2009 Phase 2 EUCTR2009-011585-28-BE Belgium;European Union;France;Germany;Russian Federation;Spain
Gnbac1
GENEURO SA
2017 Phase 2 EUCTR2016-004935-18-IT Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
GeNeuro Australia PTY Ltd
2018 Phase 1 NCT03574428 Australia
GeNeuro Innovation SAS
2021 Phase 2 EUCTR2021-001973-21-SE Sweden
2020 Phase 2 EUCTR2019-004822-15-SE Sweden
2012 Phase 2 NCT01639300 Switzerland
2011 Phase 1 NCT01699555 -
GeNeuro SA
2017 Phase 2 EUCTR2016-004935-18-PL Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2017 Phase 2 EUCTR2016-004935-18-HU Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2017 Phase 2 EUCTR2016-004935-18-HR Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2017 Phase 2 EUCTR2016-004935-18-ES Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2017 Phase 2 EUCTR2016-004935-18-DE Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2017 Phase 2 EUCTR2016-004935-18-CZ Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2017 Phase 2 EUCTR2016-004935-18-BG Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 NCT02782858 Bulgaria;Croatia;Czechia;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 EUCTR2015-004059-29-PL Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 EUCTR2015-004059-29-HU Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 EUCTR2015-004059-29-HR Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 EUCTR2015-004059-29-ES Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 EUCTR2015-004059-29-EE Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 EUCTR2015-004059-29-DE Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 EUCTR2015-004059-29-CZ Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
2016 Phase 2 EUCTR2015-004059-29-BG Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
Gnbac1 monoclonal antibody
GeNeuro SA
2017 Phase 2 NCT03239860 Bulgaria;Croatia;Czechia;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine
Gold nanocrystals
Clene Nanomedicine
2019 Phase 2 NCT03993171 United States
Granulocyte-colony stimulating factor (G-CSF) and prednisone
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States
Group balance training
Örebro County Council
2014 - NCT02209467 Sweden
2012 - NCT01582126 Sweden
GSK1223249
GlaxoSmithKline
2011 Phase 1 NCT01435993 Germany;Italy;Norway
2010 Phase 1 NCT01424423 Australia
GSK1841157
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD.
2012 - EUCTR2011-002333-19-IT Canada;Czech Republic;Germany;Italy;Netherlands;Russian Federation;Spain;United States
GlaxoSmithKline Research and Development Limited
2012 - EUCTR2011-002333-19-CZ Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
2011 - EUCTR2011-002333-19-NL Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
2011 Phase 2 EUCTR2011-002333-19-DK Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
2011 - EUCTR2011-002333-19-DE Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
GlaxoSmithKline SA
2011 Phase 2 EUCTR2011-002333-19-ES Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
GSK2018682
GlaxoSmithKline
2010 Phase 1 NCT01431937 Australia
2010 Phase 1 NCT01387217 Australia
GSK2018682 CD2 capsule
GlaxoSmithKline
2010 Phase 1 NCT01466322 Australia
GSK2018682 CD3 micronised tablet
GlaxoSmithKline
2010 Phase 1 NCT01466322 Australia
GSK2018682 CD3 NON-micronised tablet IN FED state
GlaxoSmithKline
2010 Phase 1 NCT01466322 Australia
GSK239512
GlaxoSmithKline
2013 Phase 1 NCT01802931 Australia
2013 Phase 2 NCT01772199 Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
GlaxoSmithKline Research & Development Ltd
2013 - EUCTR2012-003627-38-SE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-003627-38-GB Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 - EUCTR2012-003627-38-DE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 - EUCTR2012-003627-38-CZ Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-003627-38-BG Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
GlaxoSmithKline, S.A.
2012 - EUCTR2012-003627-38-ES Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
GSK2395612
GlaxoSmithKline Research & Development Ltd
2013 - EUCTR2012-003627-38-SE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 - EUCTR2012-003627-38-DE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 - EUCTR2012-003627-38-CZ Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-003627-38-BG Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
GlaxoSmithKline, S.A.
2012 - EUCTR2012-003627-38-ES Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom
GSK3888130B
GlaxoSmithKline
2021 Phase 1 NCT05131971 United Kingdom
GTR
Synthon BV
2011 Phase 3 NCT01489254 Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Italy;Kazakhstan;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;South Africa;Ukraine;United Kingdom;United States
GTR.ACE
SYNTHON BV
2011 - EUCTR2011-000888-27-IT Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Romania;Russian Federation;Ukraine;United Kingdom;United States
Synthon BV
2012 - EUCTR2011-000888-27-GR Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 - EUCTR2011-000888-27-DE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2011-000888-27-RO Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-GB Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-EE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-CZ Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2011-000888-27-BG Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
Guanabenz
National Institute of Neurological Disorders and Stroke (NINDS)
2015 Phase 1 NCT02423083 United States
GW-1000-02
GW PHARMA LTD
2008 - EUCTR2006-005910-11-IT Germany;Italy;Spain;United Kingdom
GW Pharma Ltd
2007 Phase 3 EUCTR2006-005910-11-CZ Czech Republic;Germany;Italy;Spain;United Kingdom
2006 Phase 3 EUCTR2005-005265-11-GB Czech Republic;France;United Kingdom
2006 Phase 3 EUCTR2005-005265-11-FR Czech Republic;France;United Kingdom
2006 - EUCTR2005-005265-11-CZ Czech Republic;France;United Kingdom
2005 Phase 3 EUCTR2004-002509-63-GB Czech Republic;United Kingdom
2005 - EUCTR2004-002509-63-CZ Czech Republic;United Kingdom
GW Pharma Ltd.
2008 Phase 3 EUCTR2006-005910-11-GB Czech Republic;Germany;Italy;Spain;United Kingdom
2008 - EUCTR2006-005910-11-DE Germany;Italy;Spain;United Kingdom
2007 - EUCTR2007-002138-13-GB United Kingdom
GW Pharmaceuticals Ltd.
2002 Phase 3 NCT01606176 United Kingdom
2002 Phase 3 NCT01606137 United Kingdom
2001 Phase 3 NCT01610713 United Kingdom
2001 Phase 3 NCT01610700 United Kingdom
2001 Phase 3 NCT01610687 United Kingdom
Gylenia
NOVARTIS FARMA
2011 - EUCTR2011-001442-15-IT Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;United Kingdom
Gylenia 0,5 MG
Novartis Farmaceutica S.A.
2013 - EUCTR2012-000835-18-ES Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
GZ402668
Genzyme, a Sanofi Company
2014 Phase 1 NCT02282826 Germany
Sanofi
2016 Phase 1 NCT02977533 Germany
GZ402673
GENZYME CORPORATION
2017 Phase 3 EUCTR2016-003100-30-IT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
Genzyme Corporation
2017 Phase 3 EUCTR2016-003100-30-PT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-NO Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-NL Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-GR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-GB Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-ES Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-DE Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-BE Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-AT Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 3;Phase 4 EUCTR2013-003884-71-NL Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3;Phase 4 EUCTR2013-003884-71-DK Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3;Phase 4 EUCTR2013-003884-71-BE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 4 EUCTR2014-000092-62-NL Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-FR Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-ES Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-BE Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 3;Phase 4 EUCTR2013-003884-71-IT Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3;Phase 4 EUCTR2013-003884-71-HR Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2014 Phase 3;Phase 4 EUCTR2013-003884-71-ES Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3;Phase 4 EUCTR2013-003884-71-DE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2014 Phase 3;Phase 4 EUCTR2013-003884-71-CZ Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2016-003100-30-PL Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-Outside-EU/EEA Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-FR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-BG Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
Genzyme GmbH
2016 Phase 3 EUCTR2016-000464-42-DE Germany
Genzyme, a Sanofi Company
2015 - NCT03774914 Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
H5g1.1-MAB
Alexion Pharmaceuticals Inc.
2020 Phase 2;Phase 3 EUCTR2019-001829-26-DE Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2019 Phase 2;Phase 3 EUCTR2019-001829-26-ES Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Alexion Pharmaceuticals, Inc.
2015 Phase 3 EUCTR2013-001151-12-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001151-12-DK Argentina;Australia;Austria;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Martinique;Romania;Russian Federation;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001151-12-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hong Kong;Italy;Japan;Korea, Republic of;Netherlands;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
HB-admscs
Hope Biosciences Stem Cell Research Foundation
2021 Phase 2 NCT05116540 United States
HBM9161 injection
Harbour BioMed (Guangzhou) Co. Ltd.
2020 Phase 1 NCT04227470 China
Helminth OVA
University of Wisconsin, Madison
2008 Phase 1 NCT00645749 United States
Hematopoetic stem cell infusion
Talaris Therapeutics Inc.
2007 Phase 1/Phase 2 NCT00497952 United States
Hematopoietic stem cell therapy
Northwestern University
2005 Phase 2 NCT00273364 United States
Hematopoietic stem cell transplantation
Northwestern University
2003 Phase 1/Phase 2 NCT00278655 United States
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom
Heterologous booster
Griffin Hospital
2021 Early Phase 1 NCT05081271 United States
Hiberix
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Hidrocloruro DE fingolimod
Novartis Farmacéutica, S.A.
2011 Phase 4 EUCTR2011-001442-15-ES Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom
High dose myobloc
Supernus Pharmaceuticals, Inc.
2021 Phase 2/Phase 3 NCT04815967 Czechia;United States
High phenolic extra virgin olive OIL
University of Cyprus
2022 - NCT04787497 Greece
HIGH-dose intravenous methylprednisolone
Tianjin Medical University General Hospital
2024 Phase 2 NCT06497374 -
High/LOW sodium diet
Yale University
2014 - NCT02282878 United States
Histamine
University of Nottingham
2008 Phase 2 NCT00630383 United Kingdom
HMR 1726D
Sanofi-Aventis recherche & développement
2008 - EUCTR2007-003997-24-GB Austria;Italy;Spain;United Kingdom
2007 - EUCTR2007-003997-24-ES Austria;Italy;Spain;United Kingdom
2007 - EUCTR2007-003997-24-AT Austria;Italy;Spain;United Kingdom
Sanofi-aventis recherche & développement
2010 - EUCTR2007-004452-36-SK Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-SE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-GR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-GB Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-004452-36-FR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-ES Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-EE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-DE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
sanofi-aventis recherche & développement
2009 - EUCTR2007-004452-36-AT Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-004452-36-NL Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-004452-36-CZ Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-004452-36-BE Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
HMR1726
Aventis Pharmaceuticals Inc.
2006 - EUCTR2004-000555-42-PT Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
GENZYME CORPORATION
2022 Phase 3 EUCTR2020-000644-55-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2017 Phase 3 EUCTR2011-005249-12-IT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States
Genzyme Corporation
2022 Phase 3 EUCTR2020-000644-55-EE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NO Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HR Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-BE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-RO Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2017 Phase 3 EUCTR2011-005249-12-SI Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Egypt;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2011-005249-12-PT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Egypt;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2011-005249-12-NL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2011-005249-12-LT Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2014 Phase 4 EUCTR2013-001439-34-IT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States
2014 Phase 4 EUCTR2013-001439-34-GR Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 Phase 4 EUCTR2013-001439-34-GB Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-DE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-BE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-AT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2011-005249-12-GB Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005249-12-ES Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2011-005249-12-EE Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2011-005249-12-BE Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-SE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-FI Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-ES Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States
2013 - EUCTR2012-005324-16-NL Belgium;Germany;Netherlands
2013 - EUCTR2012-005324-16-DE Belgium;Germany;Netherlands
2013 - EUCTR2012-005324-16-BE Belgium;Germany;Netherlands
- Phase 3 EUCTR2011-005249-12-Outside-EU/EEA Australia;Bosnia and Herzegovina;Canada;China;Israel;Lebanon;Morocco;Russian Federation;Tunisia;Turkey;United States
- Phase 3 EUCTR2011-005249-12-FR Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States
- Phase 3 EUCTR2011-005249-12-BG Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
Sanofi
2013 - NCT03198351 Canada;United States
2006 Phase 3 NCT00803049 Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2002 Phase 2 NCT00228163 Canada;France
Sanofi-Aventis US, Inc.
2004 - EUCTR2004-000555-42-AT Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
Sanofi-aventis US, Inc
2008 Phase 3 EUCTR2004-000555-42-GB Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
2005 - EUCTR2004-000555-42-DK Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
2004 - EUCTR2004-000555-42-SE Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
2004 - EUCTR2004-000555-42-NO Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
sanofi-aventis Recherche & De`veloppement
2004 - EUCTR2004-000555-42-IT Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
sanofi-aventis Recherche & Dévelopment
2009 - EUCTR2008-006226-34-FR Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis U.S Inc
2007 - EUCTR2004-000555-42-CZ Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
sanofi-aventis group
2011 - EUCTR2010-023172-12-GR Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
sanofi-aventis recherche et development
2012 - EUCTR2010-023172-12-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 Phase 3 EUCTR2010-023172-12-SK Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-PT Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-NO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-IT Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 Phase 3 EUCTR2010-023172-12-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-GB Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-ES Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 Phase 3 EUCTR2010-023172-12-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2009 - EUCTR2008-006226-34-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 Phase 3 EUCTR2008-006226-34-GR Belgium;Czech Republic;France;Germany;Greece;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis recherche et developpement
2010 - EUCTR2008-006226-34-GB Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-HU Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-CZ Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
HMR1726D
Sanofi-Aventis recherche & de'veloppement
2008 - EUCTR2007-003997-24-IT Austria;Italy;Spain;United Kingdom
Sanofi-Aventis recherche & développement
2008 - EUCTR2007-003997-24-GB Austria;Italy;Spain;United Kingdom
2007 - EUCTR2007-003997-24-ES Austria;Italy;Spain;United Kingdom
2007 - EUCTR2007-003997-24-AT Austria;Italy;Spain;United Kingdom
Sanofi-aventis U.S. Inc
2007 - EUCTR2006-003134-14-IT Germany;Italy;Spain
2007 - EUCTR2004-000555-42-EE Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
Sanofi-aventis U.S. Inc.
2007 - EUCTR2006-004893-29-IT Austria;Germany;Italy;United Kingdom
2007 Phase 2 EUCTR2006-004893-29-GB Austria;Germany;Italy;United Kingdom
2007 - EUCTR2006-004893-29-AT Austria;Germany;Italy;United Kingdom
2007 Phase 2 EUCTR2006-003134-14-ES Germany;Italy;Spain
2007 - EUCTR2006-003134-14-DE Germany;Italy;Spain
- - EUCTR2006-004893-29-DE Austria;Germany;Italy;United Kingdom
Sanofi-aventis recherche & développement
2010 - EUCTR2007-004452-36-SK Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-SE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-GR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-GB Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-004452-36-FR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-ES Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-EE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-DE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2006-001152-12-SK Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2008 Phase 3 EUCTR2006-001152-12-FR Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
sanofi-aventis Recherche & Dévelopment
2009 - EUCTR2008-006226-34-FR Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis recherche de veloppement
2007 - EUCTR2006-003361-14-IT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
sanofi-aventis recherche & developpement
2011 - EUCTR2011-001160-21-DE Austria;Canada;Germany;Russian Federation;Ukraine
2011 - EUCTR2011-001160-21-AT Austria;Canada;Germany;Russian Federation;Ukraine
sanofi-aventis recherche & développement
2009 - EUCTR2007-004452-36-AT Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2006-003361-14-EE Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2009 - EUCTR2006-003361-14-CZ Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2006-001152-12-LT Australia;Austria;Belarus;Bulgaria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2006-001152-12-DE Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2008 - EUCTR2007-004452-36-NL Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-004452-36-CZ Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-004452-36-BE Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2006-003361-14-PT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2008 - EUCTR2006-003361-14-NL Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2006-003361-14-DK Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2008 - EUCTR2006-001152-12-HU Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2006-001152-12-EE Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2006-001152-12-BG Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2007 Phase 3 EUCTR2006-003361-14-SE Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2007 Phase 3 EUCTR2006-003361-14-GB Austria;Canada;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2006-003361-14-DE Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Poland;Portugal;Russian Federation;Sweden;Switzerland;Ukraine;United Kingdom;United States
2007 Phase 3 EUCTR2006-001152-12-GB Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2007 Phase 3 EUCTR2006-001152-12-FI Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2007 - EUCTR2006-001152-12-DK Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2007 Phase 3 EUCTR2006-001152-12-CZ Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2006-001152-12-AT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2006 Phase 3 EUCTR2006-003361-14-FI Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2006 - EUCTR2006-003361-14-AT Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 Phase 3 EUCTR2008-006226-34-GR Belgium;Czech Republic;France;Germany;Greece;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis recherche et developpement
2010 - EUCTR2008-006226-34-GB Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-HU Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-CZ Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
Home based balance training
University of Arizona
2014 - NCT02777060 United States
HOME-based balance training
University of Vermont
2024 - NCT06412003 -
Homologous booster
Griffin Hospital
2021 Early Phase 1 NCT05081271 United States
Hookworm larvae
University of Nottingham
2011 Phase 2 NCT01470521 United Kingdom
HP184
Sanofi
2008 Phase 2 NCT00811902 Canada;Finland;France;Germany;Norway;Spain;United States
2008 Phase 2 NCT00772525 United States
sanofi-aventis Recherche & Développement
2009 Phase 2 EUCTR2008-001999-67-FR Finland;France;Germany;Spain
2009 - EUCTR2008-001999-67-FI Finland;France;Germany;Spain
2009 Phase 2 EUCTR2008-001999-67-ES Finland;France;Germany;Spain
2009 - EUCTR2008-001999-67-DE Finland;France;Germany;Spain
Human ANTI-IL-12 IGG1 MAB
Centocor B.V.
2005 Phase 2 EUCTR2004-000145-38-GB Czech Republic;Hungary;United Kingdom
2004 - EUCTR2004-000145-38-HU Czech Republic;Hungary;United Kingdom
2004 Phase 2 EUCTR2004-000145-38-CZ Czech Republic;Hungary;United Kingdom
Human ANTI-IL-12 MAB
Centocor B.V.
2005 Phase 2 EUCTR2004-000145-38-GB Czech Republic;Hungary;United Kingdom
2004 - EUCTR2004-000145-38-HU Czech Republic;Hungary;United Kingdom
2004 Phase 2 EUCTR2004-000145-38-CZ Czech Republic;Hungary;United Kingdom
Human ANTI-lingo-1 monoclonal antibody
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-IT Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-HU Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-GB Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-CZ Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
Human autologous mesenchymal stem cells
SALK - Gemeinnützige Salzburger Landeskliniken Betriebsges. m.b.H., Christian-Doppler-Klinik, UK für Neurologie der PMU
- - EUCTR2015-000137-78-AT Austria
Human interferon beta
Aaron Boster
2006 Phase 0 NCT00618527 United States
Human interferon BETA-1A and glatiramer acetate
EMD Serono
2004 Phase 4 NCT00078338 Argentina;Austria;Brazil;France;Germany;Italy;Netherlands;Russian Federation;Spain;Switzerland;United Kingdom;United States
Human leucocyte interferon-alpha
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark
Human monoclonal antibody (cnto 1275) TO interleukin-12p40
Centocor B.V.
2005 Phase 2 EUCTR2004-000145-38-GB Czech Republic;Hungary;United Kingdom
2004 - EUCTR2004-000145-38-HU Czech Republic;Hungary;United Kingdom
2004 Phase 2 EUCTR2004-000145-38-CZ Czech Republic;Hungary;United Kingdom
Human neural stem cells
Casa Sollievo della Sofferenza IRCCS
2017 Phase 1 NCT03282760 Italy;Switzerland
Human normal immunoglobulin
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Human recombinant growth hormone
University of Leipzig
- Phase 2 EUCTR2006-006465-16-DE Germany
Human umbilical cord mesenchymal stem cells
Shenzhen Beike Bio-Technology Co., Ltd.
2010 Phase 1/Phase 2 NCT01364246 China
Humax-CD20
Genmab A/S
2008 Phase 2 EUCTR2007-004223-38-DE Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom
2008 - EUCTR2007-004223-38-BE Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom
GlaxoSmithKline
2008 - EUCTR2007-004223-38-DK Czech Republic;Denmark;Germany;Sweden;United Kingdom
GlaxoSmithKline AB
2008 - EUCTR2007-004223-38-SE Czech Republic;Denmark;Germany;Sweden;United Kingdom
GlaxoSmithKline UK
2009 Phase 2 EUCTR2007-004223-38-GB Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom
GlaxoSmithKline s.r.o.
2008 - EUCTR2007-004223-38-CZ Czech Republic;Denmark;Germany;Sweden;United Kingdom
Hydrochlorothiazide
Universitätsklinik für Neurologie, Medizinische Universität Wien
2013 - EUCTR2012-005113-39-AT Austria
Hydrogen peroxide
Tehran University of Medical Sciences
2012 - NCT02463318 Iran, Islamic Republic of
Hydroxychloroquine
University of Calgary
2016 Phase 2 NCT02913157 Canada
Hydroxychloroquine pill
University of Calgary
2021 Phase 2 NCT05013463 Canada
Hydroxychloroquine sulfate
Varsinais-Suomen sairaanhoitopiirin kuntayhtymä
2022 Phase 2 EUCTR2022-003170-23-FI Finland
Hydroxyurea
S. Andrea Hospital
2011 Phase 2/Phase 3 NCT01103583 Italy
Hyperimmune caprine serum against HIV lysate
Daval International Limited
2009 Phase 2 NCT01228396 United Kingdom
Ibudilast
MediciNova
2013 Phase 2 NCT01982942 United States
Ibuprofen
Genzyme, a Sanofi Company
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain
Ibuprofen sandoz 400 MG filmtabletten
Merck Serono International SA
2007 - EUCTR2006-005972-42-DE France;Germany
ICP-022
InnoCare Pharma, Inc.
2021 Phase 2 EUCTR2020-005117-41-PL China;Poland;Ukraine;United States
Idebenone
National Institute of Allergy and Infectious Diseases (NIAID)
2013 Phase 1/Phase 2 NCT01854359 United States
2009 Phase 1/Phase 2 NCT00950248 United States
Idmt
Novartis Pharmaceuticals
2021 Phase 4 NCT04667117 United States
IDP-023
Indapta Therapeutics, INC.
2026 Phase 1 NCT06677710 United States
IFA incomplete freund'S adjuvant
Immune Response BioPharma, Inc.
2020 Phase 1 NCT02200718 United States
2020 Phase 2 NCT02149706 United States
Ifenprodil
Assistance Publique - Hôpitaux de Paris
2024 Phase 2 NCT06330077 France
IFN beta 1A 44 MCG TIW
Merck KGaA, Darmstadt, Germany
2012 Phase 2 NCT01514370 Italy
IFN BETA-1A
Merck KGaA, Darmstadt, Germany
2018 Phase 2 NCT03387046 Germany;Italy
IFN ß-1A
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Brigham and Women's Hospital
2015 - NCT02419638 United States
Celgene
2013 Phase 3 NCT02047734 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
IL2
Assistance Publique - Hôpitaux de Paris
2016 Phase 2 NCT02424396 France
IM90838
Immunic AG
2023 Phase 3 EUCTR2021-000028-36-GR Albania;Belarus;Bulgaria;Colombia;Georgia;Germany;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2023 Phase 3 EUCTR2021-000028-36-ES Albania;Bulgaria;Colombia;Georgia;Germany;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Russian Federation;Spain;Ukraine;United States
2023 Phase 3 EUCTR2021-000028-36-DE Albania;Algeria;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2022 Phase 2 EUCTR2021-000048-23-NL Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2022 Phase 2 EUCTR2021-000048-23-DE Bulgaria;Canada;Czechia;Georgia;Germany;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Serbia;Ukraine;United States
2022 Phase 3 EUCTR2021-000029-28-RO Armenia;Bosnia and Herzegovina;Estonia;Germany;India;Peru;Poland;Romania;Serbia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000029-28-PL Bosnia and Herzegovina;Estonia;India;Peru;Poland;Romania;Russian Federation;Serbia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000028-36-LT Albania;Algeria;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-000028-36-BG Albania;Algeria;Belarus;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2021 Phase 2 EUCTR2021-000048-23-RO Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine
2021 Phase 2 EUCTR2021-000048-23-PL Bulgaria;Canada;Czechia;Georgia;Germany;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Serbia;Ukraine;United States
2021 Phase 2 EUCTR2021-000048-23-BG Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine
Imatinib mesilate
Department of Clinical Neuroscience, Karolinska Institutet
2020 Phase 2 EUCTR2018-000620-34-DE Germany;Sweden
2018 Phase 2 EUCTR2018-000620-34-SE Sweden
2018 Phase 2 EUCTR2018-000620-34-NO Germany;Norway;Sweden
Imatinib mesylate
Tomas Olsson
2018 Phase 2 NCT03674099 Denmark;Germany;Norway;Sweden
IMC-002
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
2024 Phase 1/Phase 2 NCT06557174 -
IMCY-0141
Imcyse SA
2022 Phase 1/Phase 2 NCT05417269 Moldova, Republic of
Immune globulin
National Institute of Neurological Disorders and Stroke (NINDS)
1993 Phase 3 NCT00004744 -
Immune globulin IV [human], 10% caprylate/chromatography purified
Grifols Therapeutics Inc.
2002 Phase 2 NCT00220779 Austria;Canada;Czech Republic;Germany;Greece;Hungary;Israel;Poland;Slovakia;Sweden;United Kingdom;United States
Immunoadsorption
University Hospital Muenster
2018 - NCT04450030 Germany
Immunoglobulin
Octapharma AG
2008 - EUCTR2008-004579-22-AT Austria
Immunoglobulin G
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Immunosuppressive agents
Actelion Pharmaceuticals Ltd
2010 Phase 2 EUCTR2009-011470-15-IT Austria;Bulgaria;Czech Republic;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
IMS001
ImStem Biotechnology
2021 Phase 1 NCT04956744 United States
IMU-838
Immunic AG
2023 Phase 3 EUCTR2021-000028-36-GR Albania;Belarus;Bulgaria;Colombia;Georgia;Germany;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2023 Phase 3 EUCTR2021-000028-36-ES Albania;Bulgaria;Colombia;Georgia;Germany;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Russian Federation;Spain;Ukraine;United States
2023 Phase 3 EUCTR2021-000028-36-DE Albania;Algeria;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2022 Phase 2 EUCTR2021-000048-23-NL Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2022 Phase 2 EUCTR2021-000048-23-DE Bulgaria;Canada;Czechia;Georgia;Germany;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Serbia;Ukraine;United States
2022 Phase 3 EUCTR2021-000029-28-RO Armenia;Bosnia and Herzegovina;Estonia;Germany;India;Peru;Poland;Romania;Serbia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000029-28-PL Bosnia and Herzegovina;Estonia;India;Peru;Poland;Romania;Russian Federation;Serbia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000028-36-LT Albania;Algeria;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-000028-36-BG Albania;Algeria;Belarus;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2021 Phase 2 NCT05054140 Bulgaria;Canada;Czechia;Germany;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Serbia;Ukraine;United States
2021 Phase 2 EUCTR2021-000048-23-RO Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine
2021 Phase 2 EUCTR2021-000048-23-PL Bulgaria;Canada;Czechia;Georgia;Germany;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Serbia;Ukraine;United States
2021 Phase 2 EUCTR2021-000048-23-BG Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine
2019 Phase 2 NCT03846219 Bulgaria;Poland;Romania;Ukraine
2019 Phase 2 EUCTR2018-001896-19-RO Bulgaria;Germany;Poland;Romania;Ukraine
IMU-838 tablets
Immunic AG
2022 Phase 3 NCT05201638 Armenia;Bosnia and Herzegovina;Estonia;India;Peru;Poland;Romania;Serbia;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 NCT05134441 Albania;Bulgaria;Colombia;Georgia;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Spain;Ukraine;United States
IMU-838-RC
Immunic AG
2022 Phase 2 EUCTR2018-001896-19-DE Bulgaria;Germany;Poland;Romania;Ukraine
2018 Phase 2 EUCTR2018-001896-19-BG Bulgaria;Germany;Poland;Romania;Ukraine
Imurel
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Incabotulinumtoxina
Multiple Sclerosis Center of Northeastern New York
2013 Phase 4 NCT01968902 United States
Incobotulinum toxin A
Pôle Saint Hélier
2014 - NCT04265092 -
Incontinence severity
Ankara Yildirim Beyazit University
2019 - NCT03945006 Turkey
Indapamide pill
University of Calgary
2021 Phase 2 NCT05013463 Canada
Inebilizumab
Amgen
2024 Phase 4 NCT06180278 China;Czechia;Hong Kong;Hungary;Korea, Republic of;Poland;Thailand;United States
2023 Phase 2 NCT05549258 Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
Feng Jinzhou
2023 - NCT06068829 -
Hansoh BioMedical R&D Company
2024 Phase 4 NCT06212245 China
Horizon Therapeutics Ireland DAC
2022 Phase 2 EUCTR2021-003528-33-SE Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
2022 Phase 2 EUCTR2021-003528-33-PL Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
2022 Phase 2 EUCTR2021-003528-33-FR Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
- Phase 2 EUCTR2021-003528-33-NL Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
MedImmune LLC
2018 Phase 2;Phase 3 EUCTR2014-000253-36-NL Australia;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;India;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2017 Phase 2;Phase 3 EUCTR2014-000253-36-HU Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2015 Phase 2/Phase 3 NCT02200770 Australia;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;Germany;Greece;Hong Kong;Hungary;India;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2015 Phase 2;Phase 3 EUCTR2014-000253-36-DE Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2015 Phase 2;Phase 3 EUCTR2014-000253-36-BG Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2014 Phase 2;Phase 3 EUCTR2014-000253-36-PL Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2014 Phase 2;Phase 3 EUCTR2014-000253-36-EE Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2014 Phase 2;Phase 3 EUCTR2014-000253-36-CZ Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
Sato Toshiyuki
2020 Phase 3 JPRN-jRCT2051210017 -
West China Hospital,Sichuan University
2024 Phase 4 ChiCTR2400087203 China
Xuanwu Hospital, Beijing
2024 - NCT05891379 China
INF BETA-1A
Bosnalijek D.D
2019 Phase 3 NCT03283397 Turkey
Influenza vaccine
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States
Sanofi
2011 Phase 2 NCT01403376 Austria;Canada;Germany;Russian Federation;Ukraine
Inhaled cannabis
University of California, Davis
2004 Phase 1/Phase 2 NCT00682929 United States
Injectable MS DMT
Biogen
2015 Phase 4 NCT02471560 Norway
Injection OF autologous bone marrow derived mesenchymal stem cells
Hadassah Medical Organization
2006 Phase 1/Phase 2 NCT00781872 -
Injection OF cell free media
Royan Institute
2011 Phase 1/Phase 2 NCT01377870 Iran, Islamic Republic of
INN colecalciferol
Merja Soilu Häninen
2007 - EUCTR2007-001958-99-FI Finland
Inosine
National Center for Complementary and Integrative Health (NCCIH)
2002 Phase 2 NCT00067327 United States
Tsukuba International Clinical Pharmacology Clinic
2016 - JPRN-UMIN000024312 Japan
Inspiratory muscle training
Marmara University
2023 - NCT06075472 Turkey
Insulin
Johns Hopkins University
2017 Phase 1/Phase 2 NCT02988401 United States
INT131
InteKrin Therapeutics, Inc.
2015 Phase 2 NCT02638038 -
Inteferone BETA-1A
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Interferon beta
Biogen
2021 - NCT05688436 United States
Biogen Idec
2014 Phase 4 NCT02234869 -
Biogen Idec Ltd
2012 Phase 3 EUCTR2009-012500-11-SI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Biogen Idec Research Limited
2014 Phase 3 EUCTR2013-002318-11-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
Heidelberg University
2006 Phase 3 NCT00344253 Germany
Interferon beta - 1A
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Novartis Pharmaceuticals
2012 Phase 4 NCT01534182 Russian Federation
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Interferon beta -1B
EMD Serono
2006 Phase 3 NCT00428584 United States
Interferon beta 1
Bayer
2011 - NCT01071694 Korea, Republic of
University of Turin, Italy
1999 Phase 3 NCT00473213 -
Interferon beta 1-A
Biogen
2010 Phase 2 NCT01071083 Germany;Spain;United States
2008 Phase 3 NCT00784836 United States
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland
Fred Lublin
2005 Phase 3 NCT00211887 Canada;United States
Merck Healthcare KGaA
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Interferon beta 1A
Aaron Boster
2006 Phase 0 NCT00618527 United States
Biocad
2014 Phase 2/Phase 3 NCT02727907 Russian Federation
Biogen Idec Limited
2012 Phase 3 EUCTR2010-024477-39-GR Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2010-024477-39-GB Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2012 - EUCTR2010-024477-39-CZ Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-LV Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-EE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-024477-39-DE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-024477-39-BG Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-BE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2010 - EUCTR2008-006333-27-CZ Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-NL Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-006333-27-GB Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-EE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-BG Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-BE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
- - EUCTR2008-006333-27-DE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
Biogen Idec Ltd
2009 Phase 3 EUCTR2008-003098-42-CZ Czech Republic
Merck KGaA
2005 - NCT01142518 -
2005 - NCT01142453 -
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
2002 Phase 4 NCT00037115 United States
2001 Phase 4 NCT00037102 United States
Rennes University Hospital
2010 Phase 3 NCT02937285 France
Revalesio Corporation
2013 Phase 2 NCT01714089 United States
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom
Trio Medicines Ltd.
2001 Phase 1 NCT01863069 United Kingdom
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom
University of California, San Francisco
2006 Phase 2 NCT00501943 United States
Interferon beta 1A 30 UG IM once weekly
Beth Israel Deaconess Medical Center
2001 Phase 4 NCT00179478 Canada;United States
Interferon beta 1A pegilado
Biogen Idec Limited
2011 - EUCTR2010-024477-39-ES Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Interferon beta 1A, oral doxycycline
Louisiana State University Health Sciences Center Shreveport
2003 Phase 4 NCT00246324 United States
Interferon beta 1B
Bayer
2003 Phase 2 NCT00235989 United States
Charite Universitaetsmedizin Berlin
2012 Phase 3 EUCTR2011-004787-30-DE Germany
Novartis Pharmaceuticals
2011 Phase 4 NCT01333501 Germany;Italy
Schering AG
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom
University Hospital Inselspital, Berne
2005 Phase 2 NCT00942591 Switzerland
Interferon beta therapy
Biogen
2021 - NCT04655222 Germany
Interferon beta treatment TO ADD-ON atorvastatin treatment
Charite University, Berlin, Germany
2003 Phase 2 NCT00616187 -
Interferon beta type 1A
Biogen
2019 Phase 3 NCT03958877 Argentina;Australia;Belgium;Bulgaria;Croatia;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Interferon BETA-1 A
Serono GmbH
2005 - EUCTR2005-001026-89-DE Germany
Interferon BETA-1A
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-012500-11-IT Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
BIOGEN-DOMPE` SRL
2010 - EUCTR2009-017003-28-IT Italy
Biogen
2017 Phase 4 NCT03177083 Portugal
2013 - NCT02076841 Czech Republic;Switzerland
2012 - NCT01272128 Belgium;United States
2010 Phase 3 NCT01064401 Argentina;Australia;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Egypt;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 NCT01058005 Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States
2009 Phase 3 NCT00828204 United States
Biogen Idec
2012 Phase 1 NCT01500408 United States
2010 - EUCTR2009-017490-38-DE Germany;Spain
2007 Phase 4 NCT00574041 Australia
2005 Phase 3 NCT00915577 -
2004 - NCT00168714 United States
2003 Phase 2 NCT00912860 -
2002 Phase 4 NCT00913666 -
2002 - NCT00599274 Australia;Austria;Canada;United States
1999 Phase 4 NCT00915460 -
1999 Phase 4 NCT00534261 Belgium;Luxembourg;United Kingdom
Biogen Idec GmbH
2005 - EUCTR2004-004130-14-AT Austria
Biogen Idec Limited
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Biogen Idec Ltd
2010 - EUCTR2009-012500-11-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-GR Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012500-11-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012500-11-FR Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012500-11-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2009-012500-11-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Biogen Idec Research Limited
2017 Phase 3 EUCTR2013-002318-11-FR Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom
2016 - EUCTR2013-002318-11-ES Argentina;Belgium;Canada;Croatia;Czech Republic;Denmark;France;Hungary;Israel;Italy;Poland;Portugal;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom
2016 Phase 3 EUCTR2013-002318-11-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Türkiye;United Kingdom;United States
2015 Phase 3 EUCTR2013-002318-11-PL Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-SE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-IT Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3 EUCTR2013-002318-11-HU Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom
2014 Phase 3 EUCTR2013-002318-11-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-DK Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-002318-11-CZ Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-IT Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-HU Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-GB Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-ES Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
2013 Phase 2 EUCTR2011-006262-40-CZ Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
- Phase 3 EUCTR2013-002318-11-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Celgene
2014 Phase 3 NCT02294058 Argentina;Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Centre Hospitalier Universitaire Vaudois
2005 Phase 1 NCT02515695 -
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020337-99-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020337-99-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-FR Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020315-36-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 - EUCTR2010-020337-99-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-FI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
F.Hoffmann-La Roche Ltd.
2008 - EUCTR2007-006338-32-IT Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Russian Federation;Spain;Switzerland;Ukraine;United Kingdom;United States
Genzyme Corporation
2008 - EUCTR2007-001162-32-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-NL Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-IT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-001162-32-CZ Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-AT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001161-14-SE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 - EUCTR2007-001161-14-PL Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 Phase 3 EUCTR2007-001161-14-FR Czech Republic;France;Germany;Poland;Sweden;United Kingdom
2008 - EUCTR2007-001161-14-DE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 - EUCTR2007-001161-14-CZ Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2007 Phase 3 EUCTR2007-001162-32-GB Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2007 - EUCTR2007-001161-14-GB Czech Republic;France;Germany;Poland;Sweden;United Kingdom
Genzyme, a Sanofi Company
2007 Phase 3 NCT00548405 Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2007 Phase 3 NCT00530348 Argentina;Australia;Brazil;Canada;Croatia;Czech Republic;Former Serbia and Montenegro;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;United States
2002 Phase 2 NCT00050778 Croatia;Poland;Russian Federation;United Kingdom;United States
German University in Cairo
2022 Phase 2 NCT05298670 Egypt
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-SK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
Hoffmann-La Roche
2011 Phase 3 NCT01412333 Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;France;Germany;Ireland;Italy;Mexico;Morocco;Norway;Poland;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 NCT01247324 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Czechia;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
ISTITUTO C. MONDINO
2007 - EUCTR2008-007162-32-IT Italy
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
MERCK ROMANIA SRL
2014 Phase 4 EUCTR2014-001290-14-RO Romania
MERCK SERONO SA
2010 - EUCTR2009-016087-37-IT France;Ireland;Italy;Spain;United Kingdom
2009 - EUCTR2008-004954-34-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain
2009 - EUCTR2008-003706-33-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2008-000499-25-IT Germany;Italy;Spain;Sweden
MERCK SERONO SPA
2009 - EUCTR2009-013333-24-IT Italy
MedImmune LLC
2012 - EUCTR2011-005475-16-GB Austria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden
Merck Healthcare KGaA
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
Merck KGaA
2014 - EUCTR2013-003126-83-HU Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-GR Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-ES Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-DE Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2010 - NCT01101776 Australia
2009 - NCT01075880 Czech Republic
2005 Phase 4 NCT01201343 -
2005 - NCT01142492 -
2005 Phase 4 NCT01142466 -
2004 - NCT01142557 Germany
Merck KGaA, Darmstadt, Germany
2016 - NCT02921035 Algeria;Argentina;Bahrain;Bulgaria;Egypt;Germany;Hungary;Iran, Islamic Republic of;Korea, Republic of;Kuwait;Lebanon;Morocco;Poland;Saudi Arabia;Tunisia;United Arab Emirates
Merck Serono International S.A.
2008 - EUCTR2008-000499-25-SE Germany;Italy;Spain;Sweden
2008 - EUCTR2008-000499-25-ES Germany;Italy;Spain;Sweden
- - EUCTR2008-000499-25-DE Germany;Italy;Spain;Sweden
Merck Serono International SA
2007 - EUCTR2006-005972-42-DE France;Germany
Merck Serono S.A. - Geneva
2010 - EUCTR2009-016087-37-GB France;Ireland;Italy;Spain;United Kingdom
Merck Serono SA – Geneva
2010 - EUCTR2009-015502-19-GB Belgium;Finland;Germany;Sweden;United Kingdom
Merck, S.L.
2006 Phase 4 EUCTR2006-000606-23-ES Spain
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy
2006 - EUCTR2006-000704-17-IT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
Novartis Farma
2013 Phase 3 EUCTR2011-005677-23-IT Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Farmaceutica S.A.
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;Italy
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;United Kingdom
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-FR Austria;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;Venezuela, Bolivarian Republic of
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
Novartis Pharma Services AG
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
2006 - EUCTR2006-000704-17-PT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 Phase 3 EUCTR2006-000704-17-GR Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
2006 - EUCTR2006-000704-17-GB Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
Novartis Pharmaceuticals
2013 Phase 3 NCT01892722 Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
OSPEDALE S. RAFFAELE
2004 - EUCTR2004-001601-10-IT France;Italy
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
ROCHE
2011 Phase 3 EUCTR2010-020337-99-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IT Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Receptos, Inc.
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2012-002714-40-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-IT Belgium;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Israel;Italy;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-GR Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-ES Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
Sahlgrenska University Hospital
2005 Phase 4 EUCTR2005-001008-37-SE Sweden
Serono International SA
2004 Phase 4 EUCTR2004-000337-12-HU Hungary
TEVA ITALIA srl
2008 - EUCTR2007-005450-23-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
Teva Pharmaceutical Industries Ltd
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-DE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
Teva Pharmaceutical Industries, Ltd.
2014 - EUCTR2013-002082-19-NL Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2014 - EUCTR2013-002082-19-ES Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-SE Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 EUCTR2013-002082-19-GB Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-FI Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-DK Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 EUCTR2013-002082-19-BE Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
The Multiple Sclerosis Research Group, Department of Clinical Neuroscience
2009 - EUCTR2008-008554-23-SE Sweden
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
Universita di Firenze
2006 Phase 3 EUCTR2006-004937-13-IT Italy
Università degli Studi Aldo Moro
2019 Phase 3 EUCTR2017-005129-18-IT Italy
Universitätsklinikum Heidelberg
2006 Phase 3 EUCTR2004-004403-37-DE Germany
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands
2011 - EUCTR2011-003570-89-NL Netherlands
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis recherche et developpement
2010 - EUCTR2008-006226-34-GB Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-HU Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-CZ Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
Interferon BETA-1A (rebif®) alone
Merck KGaA
2011 Phase 2 NCT01285401 Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
Interferon BETA-1A FBS-free/HSA free, RNF
Serono International, S.A.
2007 - EUCTR2006-003366-33-ES Italy;Spain
Interferon BETA-1A FBS-free/HSA-free
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
Merck Serono S.A. - Geneva
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
Interferon BETA-1A FBS-free/HSA-free, RNF
MERCK SERONO INTERNATIONAL SA
2007 - EUCTR2006-003037-32-IT Estonia;Germany;Italy;Lithuania;Spain
Merck Serono International SA
2007 - EUCTR2006-003037-32-LT Estonia;Germany;Italy;Lithuania;Spain
2007 Phase 3 EUCTR2006-003037-32-ES Estonia;Germany;Italy;Lithuania;Spain
2007 - EUCTR2006-003037-32-EE Estonia;Germany;Italy;Lithuania;Spain
Merck Serono SA
2007 - EUCTR2006-003037-32-DE Estonia;Germany;Italy;Lithuania;Spain
Serono International SA
2006 - EUCTR2006-002982-38-IT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
Interferon BETA-1A HSA+ biosimilar
Centre Hospitalier Universitaire Vaudois
2006 Phase 1 NCT02517788 -
Interferon BETA-1A HSA-free biosimilar
Centre Hospitalier Universitaire Vaudois
2006 Phase 1 NCT02517788 -
Interferon BETA-1A original
Centre Hospitalier Universitaire Vaudois
2006 Phase 1 NCT02517788 -
Interferon BETA-1A prefilled syringe
Cinnagen
2017 Phase 3 NCT05242133 Iran, Islamic Republic of
Interferon BETA-1B
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy
Bayer
2017 - NCT03134573 Germany
2016 - NCT02652091 United States
2015 - NCT02486640 Germany
2014 - NCT02247310 Austria;Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Czechia;France;Greece;Hungary;Italy;Netherlands;Spain;Switzerland
2014 - NCT02121444 Germany
2012 - NCT01766063 Germany
2012 - NCT01706055 Poland
2012 - NCT01491100 Albania;Algeria;Argentina;Belgium;Bosnia and Herzegovina;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Jordan;Kazakhstan;Lebanon;Mexico;Netherlands;Poland;Portugal;Saudi Arabia;Syrian Arab Republic;Tunisia;Turkey
2012 - NCT01436838 China
2010 - NCT01354665 Poland
2010 - NCT01076595 France
2010 - NCT01031459 Canada;United States
2009 - NCT03408093 -
2009 - NCT00963833 Austria;Belgium;Finland;Germany;Israel;Italy;Portugal;United Kingdom
2009 - NCT00902135 Germany
2008 - NCT03577977 Russian Federation
2008 - NCT01414816 Korea, Republic of
2008 - NCT01184833 Poland
2008 - NCT00787657 Argentina;Bahrain;Belgium;Bosnia and Herzegovina;Canada;China;Colombia;Czech Republic;Egypt;Estonia;France;Germany;Iran, Islamic Republic of;Israel;Italy;Jordan;Korea, Republic of;Kuwait;Lebanon;Libyan Arab Jamahiriya;Mexico;Netherlands;New Zealand;Norway;Pakistan;Portugal;Saudi Arabia;Singapore;Slovakia;Slovenia;Sweden;Syrian Arab Republic;Taiwan;United Arab Emirates;United Kingdom;Venezuela
2007 - NCT01235455 Portugal
2007 - NCT00928967 France
2007 - NCT00544037 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2007 Phase 3 NCT00459667 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States
2006 - NCT00882453 Australia;Austria;Bahrain;Belgium;Canada;Colombia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Indonesia;Israel;Italy;Jordan;Kazakhstan;Korea, Republic of;Kuwait;Lebanon;Mexico;Netherlands;Norway;Oman;Portugal;Slovenia;Spain;Sweden;Switzerland;Taiwan;Thailand;United Arab Emirates;United Kingdom
2006 Phase 3 NCT00370071 China
2005 Phase 3 NCT00313976 Denmark;Sweden
2005 - NCT00206635 Canada;United Kingdom;United States
2004 - NCT01233245 Czech Republic;France;Germany;Iran, Islamic Republic of;Israel;Italy;Jordan;Korea, Republic of;Lebanon;Netherlands;Portugal;Saudi Arabia;Spain;Taiwan;Turkey
2003 Phase 3 NCT00099502 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States
2002 Phase 2 NCT00893217 United States
2002 Phase 3 NCT00185211 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer HealthCare AG
- - EUCTR2014-004613-93-Outside-EU/EEA China
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Biogen
2017 Phase 4 NCT03177083 Portugal
Charite Universitaetsmedizin Berlin
2012 Phase 3 EUCTR2011-004787-30-DE Germany
Claudio Gobbi
2012 Phase 4 NCT01701856 Switzerland
2010 Phase 4 NCT01144052 Switzerland
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Medical University Innsbruck
2009 - EUCTR2009-013284-19-AT Austria
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy
2010 - EUCTR2010-023023-19-IT Germany;Italy
NURON BIOTECH INC.
2012 - EUCTR2011-002683-24-IT Belarus;Bulgaria;Hungary;Italy;Russian Federation;Spain
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;Italy
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;United Kingdom
Novartis Pharma Services AG
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
Nuron Biotech, Inc.
2012 - EUCTR2011-002683-24-HU Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine
2012 - EUCTR2011-002683-24-ES Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Poland;Russian Federation;Spain;Ukraine
2012 - EUCTR2011-002683-24-BG Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Ospedale Regionale di Lugano
2013 - EUCTR2012-004040-30-AT Austria;Switzerland
Pfenex, Inc
2015 Phase 1 NCT02474134 Australia
SCHERING
2007 - EUCTR2006-005270-47-IT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Schering AG
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Universita di Firenze
2006 Phase 3 EUCTR2006-004937-13-IT Italy
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands
Interferon BETA-1B and tacrolimus
Clinique de sclérose en plaques et neuromusculaire de l'Outaouais
2003 Phase 2 NCT00298662 Canada
Interferon BETA-1B group
University Hospital Inselspital, Berne
2007 Phase 2 NCT01111656 Switzerland
Interferon BETA-1B, FRP about 6 weeks after randomization
Bayer
2008 Phase 4 NCT00780455 France
Interferon BETA-1B, FRP within 15 days after randomization
Bayer
2008 Phase 4 NCT00780455 France
Interferon BETA-1B/atorvastatin group
University Hospital Inselspital, Berne
2007 Phase 2 NCT01111656 Switzerland
Interferon BETA1A
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Biogen Idec Ltd
2010 Phase 3 EUCTR2009-012500-11-ES Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom
Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
2009 Phase 3 EUCTR2008-004954-34-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 - EUCTR2006-002982-38-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
Interferon or glatiramer acetate
Novartis Pharmaceuticals
2021 Phase 4 NCT04878211 United States
Interferon ß-1A
Biogen
2014 Phase 3 NCT02283853 Argentina;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom;United States
Celgene
2013 Phase 3 NCT02047734 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;Italy
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;United Kingdom
Sanofi
2009 Phase 3 NCT00883337 Belgium;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Spain;Switzerland;Tunisia;United Kingdom
Interferon ß-1A 30 µG
Novartis
2006 Phase 3 NCT00340834 Argentina;Australia;Austria;Belgium;Brazil;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Portugal;Puerto Rico;Spain;Switzerland;United Kingdom;United States
Interferon ß-1B
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;Italy
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;United Kingdom
S. Andrea Hospital
2005 Phase 2/Phase 3 NCT00270816 Italy
Interferon ß1
Novartis Pharmaceuticals
2022 - NCT05344469 Germany
Interferon-beta
Central Hospital, Nancy, France
2012 - NCT04289675 -
EMD Serono Research & Development Institute, Inc.
2006 Phase 2 NCT00436826 Italy;Russian Federation;Spain;United States
Fundació Institut Germans Trias i Pujol
2017 Phase 1 NCT02903537 Spain
Sanofi
2011 Phase 3 NCT01252355 Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
Teva Pharmaceutical Industries
2012 Phase 2 NCT01404117 -
Interferon-beta 1A
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden
Merck Serono International SA
2007 - EUCTR2006-003037-32-LT Estonia;Germany;Italy;Lithuania;Spain
2007 Phase 3 EUCTR2006-003037-32-ES Estonia;Germany;Italy;Lithuania;Spain
2007 - EUCTR2006-003037-32-EE Estonia;Germany;Italy;Lithuania;Spain
Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
2009 - EUCTR2008-004954-34-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2010 - EUCTR2008-004954-34-AT Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 Phase 3 EUCTR2008-004954-34-SK Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 Phase 3 EUCTR2008-004954-34-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain
2009 - EUCTR2008-004954-34-PL Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 - EUCTR2008-004954-34-LV Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain
2009 - EUCTR2008-004954-34-FI Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 - EUCTR2008-004954-34-EE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 - EUCTR2008-004954-34-DE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 - EUCTR2008-004954-34-BG Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 Phase 3 EUCTR2008-004954-34-BE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2008 - EUCTR2008-004954-34-CZ Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
Merck Serono S.A.- Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2009 Phase 3 EUCTR2008-004954-34-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain
Merck Serono SA
2007 - EUCTR2006-003037-32-DE Estonia;Germany;Italy;Lithuania;Spain
Nancy Hammond, MD
2007 - NCT00490906 United States
S. Andrea Hospital
2002 Phase 2 NCT00151801 Italy
Interferon-beta 1A FBS-free/HSA free, RNF
Merck Serono International S.A.
2007 - EUCTR2006-002982-38-LT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2007 - EUCTR2006-002982-38-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-AT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA
2007 Phase 3 EUCTR2006-002982-38-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain
2007 - EUCTR2006-002982-38-EE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2007 - EUCTR2006-002982-38-PT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2007 - EUCTR2006-002982-38-DE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-FI Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-CZ Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
Merck Serono S.A.-Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 Phase 3 EUCTR2006-002982-38-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain
Serono International SA
2007 Phase 3 EUCTR2006-002982-38-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain
Interferon-beta 1A FBS-free/HSA-free, RNF
Merck Serono International SA
2007 Phase 3 EUCTR2006-005972-42-FR France;Germany
2007 - EUCTR2006-005972-42-DE France;Germany
Interferon-beta 1B
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden
Nancy Hammond, MD
2007 - NCT00490906 United States
Rutgers, The State University of New Jersey
2007 - NCT00468182 United States
Interferon-beta and human leukocyte interferon-A
Melinda Magyari
2010 Phase 2 NCT01171209 Denmark
Interferon-BETA-1A
Biogen Idec
2006 Phase 4 NCT00492765 Denmark
2003 Phase 4 NCT00493116 Australia;New Zealand
2003 Phase 4 NCT00492466 Finland
Merck, S.L.
2006 Phase 4 EUCTR2006-000606-23-ES Spain
Interferon-BETA-1A (avonex) plus methylprednisolone
Biogen Idec
2003 Phase 4 NCT00168766 Belgium;Denmark;Finland;Netherlands;Norway;Sweden;Switzerland;United Kingdom
Interferon-BETA-1A FBS-free/HSA free, RNF
Serono International SA
2005 - EUCTR2004-003799-13-SE Ireland;Lithuania;Spain;Sweden;United Kingdom
2005 - EUCTR2004-003799-13-LT Ireland;Lithuania;Spain;Sweden;United Kingdom
2005 Phase 3 EUCTR2004-003799-13-GB Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
2005 Phase 3 EUCTR2004-003799-13-ES Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
2005 Phase 3 EUCTR2004-003799-13-DK Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
- Phase 3 EUCTR2004-003799-13-IE Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
Interferon-BETA-1A FBS-free/HSA-free
EMD Serono
2005 Phase 3 NCT00110396 United States
Interferon-BETA-1B
Bayer
2020 - NCT04356339 United States
Interferon-BETA1
Biogen
2021 Phase 2 NCT04079088 -
Interferon-ß-1
Sanofi
2011 Phase 2 NCT01403376 Austria;Canada;Germany;Russian Federation;Ukraine
Interferon-ß-1A
Merck KGaA
2014 Phase 3 EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - NCT01074346 Korea, Republic of
Interferon-ß-1B
S. Andrea Hospital
2005 Phase 2/Phase 3 NCT00270816 Italy
Interferone
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
Interferone beta 1A
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
Interferone beta 1B
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Interferone BETA-1A
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
Interferone BETA-1B
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
IMPULS Endowment Fund
2019 - NCT05762003 Czechia
InterferóN beta 1A pegilado
Biogen Idec Limited
2011 - EUCTR2010-024477-39-ES Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
InterferóN BETA-1A pegilado
Biogen Idec Limited
2009 Phase 3 EUCTR2008-006333-27-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom
Interleukin-2
Indapta Therapeutics, INC.
2026 Phase 1 NCT06677710 United States
Intradetrusor injection OF botulinum toxin-A
Rose Khavari, M.D.
2014 - NCT03033355 United States
Intranasal foralumab solution
Tiziana Life Sciences, PLC
2021 Phase 1 NCT05029609 -
Intratect
Guy's and St Thomas NHS Foundation Trust
2014 Phase 3 EUCTR2014-002335-34-GB United Kingdom
Intrathecal administration OF autologous MSC-NP
Tisch Multiple Sclerosis Research Center of New York
2014 Phase 1 NCT01933802 United States
Intrathecal methotrexate
Tel-Aviv Sourasky Medical Center
2016 Phase 0 NCT02644044 -
Intrathecal MSC-NP injection
Tisch Multiple Sclerosis Research Center of New York
2019 - NCT03822858 United States
2018 Phase 2 NCT03355365 United States
Intrathecal saline injection
Tisch Multiple Sclerosis Research Center of New York
2018 Phase 2 NCT03355365 United States
Intravenous (IV) infusions
Polpharma Biologics S.A.
2019 Phase 3 NCT04115488 Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine
Intravenous glucocorticoids
Guangzhou JOYO Pharma Co., Ltd
2023 Phase 2 NCT06697535 China
Intravenous immunoglobulin
Guy's and St Thomas' NHS Foundation Trust
2015 Phase 3 NCT02398994 United Kingdom
Intravenous injection OF mesenchymal stem cells
Royan Institute
2011 Phase 1/Phase 2 NCT01377870 Iran, Islamic Republic of
Intravenous methylprednisolone
Guy's and St Thomas' NHS Foundation Trust
2015 Phase 3 NCT02398994 United Kingdom
The Third Affiliated Hospital Sun Yat-sen University
2025 - ChiCTR2500100495 China
Third Affiliated Hospital, Sun Yat-Sen University
2025 - NCT06763848 China
Intravenous methylprednisolone (ivmp) and efgartigimod
Feng Jinzhou
2023 - NCT06118398 -
Intravenous steroid
Beijing Tiantan Hospital
2021 - NCT05154370 China
2019 - NCT04106830 China
IPX056
Impax Laboratories, LLC
2009 Phase 2 NCT00914290 United States
IPX056 10 MG
Impax Laboratories, LLC
2007 Phase 3 NCT00488839 Canada;Estonia;Latvia;Ukraine;United States
IPX056 20 MG
Impax Laboratories, LLC
2007 Phase 3 NCT00488839 Canada;Estonia;Latvia;Ukraine;United States
IPX056 30 MG
Impax Laboratories, LLC
2007 Phase 3 NCT00488839 Canada;Estonia;Latvia;Ukraine;United States
IPX056 35 MG
Impax Laboratories, LLC
2007 Phase 3 NCT00488839 Canada;Estonia;Latvia;Ukraine;United States
IPX056 40 MG
Impax Laboratories, LLC
2007 Phase 3 NCT00488839 Canada;Estonia;Latvia;Ukraine;United States
IPX056-10 MG
IMPAX Laboratories, Inc.
2007 - EUCTR2007-000236-16-LV Estonia;Latvia
2007 - EUCTR2007-000236-16-EE Estonia;Latvia
IPX056-20 MG
IMPAX Laboratories, Inc.
2007 - EUCTR2007-000236-16-LV Estonia;Latvia
2007 - EUCTR2007-000236-16-EE Estonia;Latvia
IPX056-25 MG
IMPAX Laboratories, Inc.
2007 - EUCTR2007-000236-16-LV Estonia;Latvia
IPX056-30 MG
IMPAX Laboratories, Inc.
2007 - EUCTR2007-000236-16-LV Estonia;Latvia
2007 - EUCTR2007-000236-16-EE Estonia;Latvia
IPX056-35 MG
IMPAX Laboratories, Inc.
2007 - EUCTR2007-000236-16-LV Estonia;Latvia
2007 - EUCTR2007-000236-16-EE Estonia;Latvia
IPX056-40 MG
IMPAX Laboratories, Inc.
2007 - EUCTR2007-000236-16-LV Estonia;Latvia
2007 - EUCTR2007-000236-16-EE Estonia;Latvia
IR902
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia
Irradiation
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States
Isentress
Queen Mary University of London
2013 - EUCTR2012-004847-61-GB United Kingdom
Isoxsuprine hydrochloride
University of New Mexico
2019 Phase 1/Phase 2 NCT03752307 United States
IV methylprednisolone
Biogen Idec
2003 Phase 4 NCT00112034 United States
Fred Lublin
2003 Phase 3 NCT00418145 United States
University of Colorado, Denver
2013 Phase 4 NCT01838174 United States
IV methylprednisolone administration
Universidad Nacional Autonoma de Mexico
2023 Phase 2 NCT06223074 Mexico
Ivig
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States
2017 Phase 3 NCT03342638 United States
Ivmp
The Third Affiliated Hospital Sun Yat-sen University
2025 - ChiCTR2500100495 China
Tianjin Medical University General Hospital
2024 Phase 2 NCT06673394 -
Ixazomib (ninlaro®) capsules
Queen Mary University of London
2020 Phase 1 NCT03783416 United Kingdom
JM-4
Cook, Stuart, MD
2019 Early Phase 1 NCT03887065 -
JNJ-67896153/ACT-128800
JANSSEN CILAG INTERNATIONAL NV
2023 Phase 3 EUCTR2020-004431-24-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
Janssen-Cilag International NV
2023 Phase 3 EUCTR2020-004431-24-PT Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2023 Phase 3 EUCTR2020-004431-24-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
2023 Phase 3 EUCTR2020-004431-24-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
2023 Phase 3 EUCTR2020-004431-24-DE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2023 Phase 3 EUCTR2020-004431-24-BG Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2022 Phase 3 EUCTR2020-004431-24-SE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
- Phase 3 EUCTR2020-004431-24-Outside-EU/EEA Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
- Phase 3 EUCTR2020-004431-24-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
JYP0061
Guangzhou JOYO Pharma Co., Ltd
2023 Phase 2 NCT06697535 China
Kemstro
UCB Pharma
2005 Phase 3 NCT00139789 United States
Kepivance
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom
Keppra
AZIENDA SANITARIA N. 3 GENOVESE
2007 - EUCTR2007-005414-40-IT Italy
Søren H. Sindrup, Department of Neurology, Odense University Hospital
2006 - EUCTR2006-000397-71-DK Denmark
Keppra 250MG
Newcastle-upon-Tyne Hospitals NHS Trust
2006 Phase 4 EUCTR2005-003903-35-GB United Kingdom
Keppra 500MG
Newcastle-upon-Tyne Hospitals NHS Trust
2006 Phase 4 EUCTR2005-003903-35-GB United Kingdom
Kesimpta
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;Italy
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;United Kingdom
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-SI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-NO Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-NO Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-RO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
Kesimpta 20 MG injektionslösung IM fertigpen
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany
Kesimpta 20 MG solution FOR injection IN PRE-filled PEN
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Ketamine
Alta Bates Summit Medical Center
2023 Early Phase 1 NCT06064162 United States
Johns Hopkins University
2023 Phase 2 NCT05378100 United States
2018 Phase 1/Phase 2 NCT03500289 United States
Ketoconazole
GlaxoSmithKline
2013 Phase 1 NCT01802931 Australia
Ketogenic diet
IRCCS National Neurological Institute C. Mondino Foundation
2024 - NCT06715436 Italy
Ketoprofen
National Institute of Mental Health (NIMH)
2022 Phase 2 NCT05062083 United States
Keyhole limpet hemocyanin
Biogen
2008 Phase 4 NCT00536120 United States
Keyhole limpet hemocyanin (KLH) NEO-antigen
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
Kirunal fish OIL
Terry L. Wahls
2022 - NCT05007483 United States
KLH
Biogen
2008 Phase 4 NCT00536120 United States
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States
KYV-101
Kyverna Therapeutics
2024 Phase 2 NCT06384976 United States
KYV-101 (biological) - 0.33 ×10^8 cells
Bruce Cree
2024 Phase 1 NCT06451159 United States
KYV-101 (biological) - 1 ×10^8 cells
Bruce Cree
2024 Phase 1 NCT06451159 United States
KYV-101 ANTI-CD19 CAR-T cell therapy
Stanford University
2024 Phase 1 NCT06138132 United States
L acetyl carnitine
University of Iowa
2010 Phase 1 NCT01381354 United States
L-000124467
Merck & Co., Inc./Suomen MSD Oy
2004 Phase 2 EUCTR2004-000073-64-FI Finland
L-carnitine
CHU de Bordeaux
2010 Phase 3 EUCTR2009-015934-30-FR France
University Hospital, Bordeaux
2010 Phase 3 NCT01149525 France
L-histidine
University of Miami
2022 Phase 2 NCT04764383 United States
2018 Phase 1 NCT03266965 United States
L01bb04
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
L03 AB
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
L03 AB 08
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Schering AG
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
L03 AB07
Merck Serono SA – Geneva
2010 - EUCTR2009-015502-19-GB Belgium;Finland;Germany;Sweden;United Kingdom
L03ab13
BIOGEN IDEC ITALIA S.R.L.
2015 Phase 4 EUCTR2015-002201-11-IT Italy
L04aa04 - immunoglobulina antitimocitaria (DI coniglio) immunoglobulina DI coniglio antitimociti umani thymoglobuline
Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
2006 - EUCTR2006-002562-19-IT Italy
L04aa31
NOVARTIS PHARMA AG
2022 Phase 3 EUCTR2020-005929-89-IT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Japan;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-IT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Guatemala;Hong Kong;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
Turku University Hospital
2017 Phase 4 EUCTR2016-003622-16-FI Finland
Laboratory biomarker analysis
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
Lactose monohydrate
Queen Mary University of London
2013 - EUCTR2012-004847-61-GB United Kingdom
Lactulose
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2021 - JPRN-UMIN000043910 Japan
Lamotrigine
Cantonal Hospital of St. Gallen
2009 Phase 2 NCT00917839 Switzerland
University College London Hospitals
2005 Phase 2 NCT00257855 United Kingdom
Lamotrigine extended release tablets
University College London
2005 Phase 2 EUCTR2005-001949-42-GB United Kingdom
Laquinimod
TEVA
2005 - EUCTR2004-003943-28-IT Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
TEVA ITALIA srl
2008 - EUCTR2007-005450-23-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2007 - EUCTR2007-003226-19-IT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.
2015 Phase 2 NCT02284568 Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
2014 Phase 3 NCT01975298 Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 NCT01707992 Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2010 Phase 3 NCT01047319 Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, The Former Yugoslav Republic of;North Macedonia;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2009 Phase 3 NCT00988052 Austria;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 NCT00605215 Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Israel;Italy;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Montenegro;North Macedonia;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
Teva Pharmaceutical Industries
2007 Phase 3 NCT00509145 Austria;Bulgaria;Canada;Czech Republic;Estonia;Former Serbia and Montenegro;France;Georgia;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Teva Pharmaceutical Industries Ldt
2005 Phase 2 EUCTR2005-004334-41-IT Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
Teva Pharmaceutical Industries Ltd
2010 Phase 3 EUCTR2009-015815-42-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain
2009 Phase 3 EUCTR2009-012989-30-IT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Teva Pharmaceutical Industries Ltd.
2015 Phase 2 EUCTR2014-001579-30-NL Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
2015 Phase 2 EUCTR2014-001579-30-DE Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
2014 Phase 2 EUCTR2014-001579-30-IT Canada;Germany;Italy;Netherlands;Russian Federation;Spain;Ukraine;United Kingdom;United States
2014 Phase 2 EUCTR2014-001579-30-GB Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
2014 Phase 2 EUCTR2014-001579-30-ES Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
Teva Pharmaceutical Industries, Ltd.
2005 Phase 2 NCT00745615 Czech Republic;Czechia;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom
Laquinimod 0.3
Teva Pharmaceutical Industries
2005 Phase 2 NCT00349193 Italy
Laquinimod 0.6
Teva Pharmaceutical Industries
2012 Phase 2 NCT01404117 -
2005 Phase 2 NCT00349193 Italy
Laquinimod 1.2
Teva Pharmaceutical Industries
2012 Phase 2 NCT01404117 -
Laquinimod capsulas 0.6 MG
Teva Pharmaceutical Industries Ltd
2009 Phase 3 EUCTR2009-012989-30-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Laquinimod capsules 0.3 MG
Teva Pharmaceutical Industries Ltd
2009 - EUCTR2009-011234-99-DE Germany
Laquinimod capsules 0.6 MG
TEVA PHARMACEUTICALS INDUSTRIES LTD
2013 Phase 3 EUCTR2012-003647-30-IT Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Puerto Rico;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
Teva Pharmaceutical Industries Ltd
2013 Phase 3 EUCTR2012-003647-30-PL Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-HU Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-ES Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-EE Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-CZ Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-BE Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-AT Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2012-003647-30-SK Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2012-003647-30-LV Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2012-003647-30-GR Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2012-003647-30-GB Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-015815-42-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain
2010 Phase 3 EUCTR2009-015815-42-PL Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-LT Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-EE Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-CZ Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-BG Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-012989-30-SE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012989-30-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012989-30-BG Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012989-30-AT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-NL Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-LT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-HU Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-GB Austria;Bulgaria;Canada;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-EE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 - EUCTR2009-011234-99-DE Germany
2008 Phase 3 EUCTR2007-005450-23-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Slovakia;Spain
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-DE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-CZ Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-BG Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-003226-19-PT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2007-003226-19-LT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2007-003226-19-BG Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-SE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-NL Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-LV Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-HU Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-GB Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 Phase 3 EUCTR2007-003226-19-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 Phase 3 EUCTR2007-003226-19-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-EE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-DE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-AT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-GB Czech Republic;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-DE Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-CZ Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
2005 Phase 2 EUCTR2005-004334-41-HU Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
Teva Pharmaceutical Industries, Ltd.
2014 - EUCTR2013-002082-19-NL Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2014 - EUCTR2013-002082-19-ES Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-SE Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 EUCTR2013-002082-19-GB Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-FI Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-DK Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 EUCTR2013-002082-19-BE Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
Laquinimod tablets 0.3 MG
Teva Pharmaceutical Industries Ltd
2006 Phase 2 EUCTR2005-004334-41-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 - EUCTR2004-003943-28-HU Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 Phase 2 EUCTR2004-003943-28-GB Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 Phase 2 EUCTR2004-003943-28-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 - EUCTR2004-003943-28-DE Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 - EUCTR2004-003943-28-CZ Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
Lavender OIL
Ataturk University
2023 - NCT05929638 Turkey
LCAR-AIO T cells
Wuhan Union Hospital, China
2025 Phase 1 NCT06869278 China
Learning
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
2021 - ChiCTR2100052936 China
University of Iowa
2010 Phase 1 NCT01381354 United States
Lemtrada
GENZYME CORPORATION
2017 Phase 3 EUCTR2016-003100-30-IT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
Genzyme Corporation
2017 Phase 3 EUCTR2016-003100-30-PT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-NO Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-NL Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-GR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-GB Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-ES Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-DE Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-BE Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-003100-30-AT Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 3;Phase 4 EUCTR2013-003884-71-NL Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3;Phase 4 EUCTR2013-003884-71-DK Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3;Phase 4 EUCTR2013-003884-71-BE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 4 EUCTR2014-000092-62-NL Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-FR Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-ES Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 4 EUCTR2014-000092-62-BE Belgium;France;Netherlands;Spain;Switzerland
2014 Phase 3;Phase 4 EUCTR2013-003884-71-IT Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3;Phase 4 EUCTR2013-003884-71-HR Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2014 Phase 3;Phase 4 EUCTR2013-003884-71-ES Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom
2014 Phase 3;Phase 4 EUCTR2013-003884-71-DE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2014 Phase 3;Phase 4 EUCTR2013-003884-71-CZ Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2016-003100-30-PL Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-Outside-EU/EEA Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-FR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2016-003100-30-BG Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
Genzyme GmbH
2016 Phase 3 EUCTR2016-000464-42-DE Germany
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-SE Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University Hospital Muenster
2017 - NCT04082260 Germany
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany
Lemtrada 12 MG konzentrat ZUR herstellung einer infusionslösung
Universitätsklinikum Münster
2014 Phase 4 EUCTR2014-000709-10-DE Germany
Lenograstim
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom
Levetiracetam
AZIENDA SANITARIA N. 3 GENOVESE
2007 - EUCTR2007-005414-40-IT Italy
Newcastle-upon-Tyne Hospitals NHS Trust
2006 Phase 4 EUCTR2005-003903-35-GB United Kingdom
Odense University Hospital
2007 Phase 4 NCT00423527 Denmark
Organisation name was not entered
2005 - EUCTR2005-001776-13-DE Germany
Søren H. Sindrup, Department of Neurology, Odense University Hospital
2006 - EUCTR2006-000397-71-DK Denmark
Levitra
Unidad de Neuroinmunología
2005 Phase 4 EUCTR2004-003761-33-ES Spain
Levocarnil
CHU de Bordeaux
2010 Phase 3 EUCTR2009-015934-30-FR France
Levofolene 4 MG 30 CPR
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy
Levonorgestrel
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands
LFB-R603
TG Therapeutics
2017 Phase 3 EUCTR2017-000639-15-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000639-15-GB Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000639-15-ES Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-GB Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-ES Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
TG Therapeutics, Inc.
2017 Phase 3 EUCTR2017-000639-15-PL Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-PL Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
LFB-R603, TGTX1101
TG Therapeutics, Inc.
2020 Phase 3 EUCTR2019-003625-16-PL Belarus;Croatia;Georgia;Poland;Russian Federation;Serbia;Ukraine;United States
2020 Phase 3 EUCTR2019-003625-16-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
Liberation therapy
Genesis Limited
2015 Phase 1/Phase 2 NCT02418351 India;Trinidad and Tobago
2015 Phase 1/Phase 2 NCT02418325 Trinidad and Tobago
Novo Cellular Medicine Institute LLP
2015 Phase 1/Phase 2 NCT02587806 India;Trinidad and Tobago
2015 Phase 1/Phase 2 NCT02587715 Trinidad and Tobago
Lidocaine
University of Rochester
2007 Phase 4 NCT00414453 United States
Linoleic acid
Universität Münster
2023 - NCT05920018 Germany
Linoleic acid/oleic acid
University of Rochester
2008 Phase 1 NCT00638196 United States
Liofen XL
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States
Liothyronine
Johns Hopkins University
2015 Phase 1 NCT02506751 United States
Liothyronine sodium
Oregon Health and Science University
2016 Phase 1 NCT02760056 United States
Lipoic acid
Portland VA Medical Center
2010 Phase 1 NCT00997438 United States
VA Office of Research and Development
2018 Phase 2 NCT03161028 Canada;United States
2010 Phase 2/Phase 3 NCT01188811 United States
Lipoic acid (LA) with fish OIL and LA without fish OIL
Oregon Health and Science University
2005 Phase 1 NCT00676156 United States
Lipoic acid and omega-3 fatty acids
Oregon Health and Science University
2014 Phase 1/Phase 2 NCT02133664 United States
Liraglutide
University of Chicago
2024 Early Phase 1 NCT06171152 United States
Lisdexamfetamine sulfate
State University of New York at Buffalo
2009 Phase 2 NCT01615887 United States
Listed FOR each disorder below, UP TO three drugs PER disorder (TOO many characters TO list IN this field
NorthShore University HealthSystem
2016 Phase 4 NCT02670161 United States
Lithium carbonate
VA Office of Research and Development
2011 Phase 1/Phase 2 NCT01259388 United States
Live hookworm larvae
University of Nottingham
2008 Phase 2 NCT00630383 United Kingdom
Live necator americanus larvae
University of Nottingham
2011 Phase 2 EUCTR2008-005008-24-GB United Kingdom
Lodosyn
University of Miami
2022 Phase 2 NCT04764383 United States
Lokomat training
IRCCS Centro Neurolesi Bonino-Pulejo
2016 - NCT03186664 Italy
Loperamide
Rocky Mountain MS Research Group, LLC
2014 Phase 4 NCT02217982 United States
Loratadine
Genzyme, a Sanofi Company
2015 Phase 1 NCT02583594 Spain
LOU064
Iwasaki Ryohei
2023 Phase 3 JPRN-jRCT2071220034 France;Italy;Japan;Poland;Portugal;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;US
Novartis Farmacéutica S.A.
2022 Phase 3 EUCTR2020-005929-89-ES Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-ES Slovakia;Spain
Novartis Pharma AG
2023 Phase 3 EUCTR2020-005899-36-LT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2023 Phase 3 EUCTR2020-005899-36-DK Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2023 Phase 3 EUCTR2020-005899-36-AT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;Finland;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SK Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SI Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-RO Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Türkiye;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-PT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-PL Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Türkiye;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-HR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-GR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-FR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-EE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-BG Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-SK Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-NL Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-LV Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-HR Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-BG Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-BE Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
LOU064c1
NOVARTIS PHARMA AG
2022 Phase 3 EUCTR2020-005929-89-IT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Japan;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-IT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Guatemala;Hong Kong;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
LOW dose ARM receiving neutral OIL and 400 IU/G OF vitamin D every second DAY
Charite University, Berlin, Germany
2011 Phase 2 NCT01440062 Germany
LOW dose cannabis
University of California, Davis
2009 Phase 1/Phase 2 NCT01037088 United States
LOW dose myobloc
Supernus Pharmaceuticals, Inc.
2021 Phase 2/Phase 3 NCT04815967 Czechia;United States
LOW immunogenic interferon-BETA-1A
Biogen Idec
2004 Phase 4 NCT00493077 Sweden
LP-168 tablet
Guangzhou Lupeng Pharmaceutical Company LTD.
2022 Phase 1 NCT05432713 China
LPX-TI641
LAPIX Therapeutics Inc.
2023 Phase 1 NCT05853835 Jordan;United States
LU AG06466
H. Lundbeck A/S
2021 Phase 1 NCT04990219 Germany;United States
Lubiprostone
University of Rochester
2010 Phase 4 NCT01236534 United States
Lumbar puncture
Centre Hospitalier Universitaire de Nimes
2013 Phase 3 NCT01817166 France;Martinique
Genentech, Inc.
2016 Phase 3 NCT02688985 Canada;Germany;Sweden;United States
Lutein
University of Illinois at Urbana-Champaign
2021 - NCT04843813 United States
Lutenyl
OSPEDALI CIVILI DI LIONE
2007 - EUCTR2006-005460-30-IT Italy
LY2127399
Eli Lilly and Company
2010 - EUCTR2008-007459-28-BG Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 Phase 2 NCT00882999 Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Switzerland;Ukraine;United States
2009 - EUCTR2008-007459-28-HU Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 Phase 2 EUCTR2008-007459-28-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-DK Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-DE Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-CZ Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
2009 - EUCTR2008-007459-28-BE Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary
LY248686
Eli Lilly and Company
2008 - EUCTR2008-002560-34-BE Belgium
LY3541860
Eli Lilly and Company
2024 Phase 2 NCT06220669 France;Germany;Israel;Italy;Latvia;Lithuania;Poland;Slovakia;United Kingdom;United States
M2951
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
Merck Healthcare KGaA
2022 Phase 3 EUCTR2019-004980-36-CZ Belarus;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-SI Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-RO Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-SK Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PL Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-NO Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LV Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-GR Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-ES Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-DE Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-BG Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
Merck KGaA
2017 Phase 2 EUCTR2016-001448-21-SK Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-PL Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-ES Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-CZ Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-BG Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
MAB therapy
Tongji Hospital
2025 - NCT06885957 China
Mabcampath
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom
Genzyme Corporation
2011 Phase 3 EUCTR2009-010788-18-IT Austria;Belgium;Czech Republic;Denmark;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-010788-18-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-010788-18-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-010788-18-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-010788-18-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-010788-18-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-NL Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-IT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-001162-32-CZ Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-AT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001161-14-SE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 - EUCTR2007-001161-14-PL Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 Phase 3 EUCTR2007-001161-14-FR Czech Republic;France;Germany;Poland;Sweden;United Kingdom
2008 - EUCTR2007-001161-14-DE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 - EUCTR2007-001161-14-CZ Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2007 Phase 3 EUCTR2007-001162-32-GB Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2007 - EUCTR2007-001161-14-GB Czech Republic;France;Germany;Poland;Sweden;United Kingdom
R&D Addenbrookes Hospital
2008 Phase 2 EUCTR2005-002305-23-GB United Kingdom
Mabcampath 10 MG/ML concentrado para solucióN para perfusióN
Genzyme Corporation
2010 Phase 3 EUCTR2009-010788-18-ES Austria;Belgium;Czech Republic;Denmark;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
Mabcampath-1H
University of British Columbia
2011 Phase 3 NCT01307332 Canada
Mabthera
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
Centre Hospitalier de Pau
2015 Phase 2 EUCTR2014-005493-11-FR France
Department of Clinical Sciences, Danderyd Hospital
2015 Phase 3 EUCTR2015-004116-38-SE Sweden
Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital
2018 Phase 2 EUCTR2018-000721-31-SE Sweden
Dept of Neurology
2009 Phase 2 EUCTR2008-002626-11-SE Sweden
Dept of Neurology, Umeå University Hospital, Umeå, Sweden
2012 Phase 2 EUCTR2012-000721-53-SE Sweden
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Odense University Hospital
2013 Phase 2 EUCTR2012-004436-36-DK Denmark
Västerbottens Läns Landsting
2014 Phase 2 EUCTR2013-002378-26-SE Sweden
Västerbottens läns landsting
2011 - EUCTR2010-023021-38-SE Sweden
Mabthera or biosimilar rituximab product
Medical University of Vienna - Department of Neurology
2018 Phase 2 EUCTR2017-000426-35-AT Austria
Magnesium
University of Iowa
2010 Phase 1 NCT01381354 United States
Magnetic resonance imaging
Sanofi
2019 Phase 2 NCT03889639 Canada;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
University of Nottingham
2017 - NCT02481882 United Kingdom
Maltodextrin
Medical University of Vienna
2012 Phase 2 NCT01879202 Austria
Maltodextrin fiber supplement
University of Iowa
2010 Phase 1 NCT01381354 United States
Mangafodipir
National Institute of Neurological Disorders and Stroke (NINDS)
2013 Phase 1 NCT01326715 United States
Mannitol
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2021 - JPRN-UMIN000043910 Japan
Mantadan*20CPR 100MG
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
2011 - EUCTR2010-023678-38-IT Italy
Masitinb mesylate
AB Science
2015 Phase 3 EUCTR2012-003735-32-GR Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom
2013 - EUCTR2010-021219-17-PL Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain
2013 Phase 3 EUCTR2010-021219-17-GR Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey
2011 Phase 3 EUCTR2010-021219-17-DE Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
Masitinib
AB Science
2022 Phase 3 NCT05441488 France;Greece;Italy;Poland;Russian Federation;Spain;Sweden;Ukraine
2011 Phase 3 NCT01433497 Bulgaria;France;Germany;Greece;Poland;Romania;Spain;United States
2005 Phase 2 NCT01450488 -
Masitinib 100 MG
AB SCIENCE
2022 Phase 3 EUCTR2021-000639-30-IT Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Masitinib 200 MG
AB SCIENCE
2022 Phase 3 EUCTR2021-000639-30-IT Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Masitinib mesilate
AB Science
2022 Phase 3 EUCTR2021-000639-30-NO Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000639-30-GR Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000639-30-ES Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000639-30-DE Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000639-30-BG Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-000639-30-FR Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Masitinib mesilato
AB SCIENCE
2022 Phase 3 EUCTR2021-000639-30-IT Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Masitinib mesylate
AB Science
2015 Phase 3 EUCTR2012-003735-32-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Colombia;Germany;Greece;Italy;Mexico;Slovakia;Spain;Switzerland;United Kingdom
2015 Phase 3 EUCTR2012-003735-32-GR Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom
2015 Phase 3 EUCTR2010-021219-17-BG Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
2013 - EUCTR2010-021219-17-PL Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain
2013 Phase 3 EUCTR2010-021219-17-GR Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey
2012 Phase 3 EUCTR2010-021219-17-SK Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-021219-17-ES Bulgaria;Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;United States
2011 Phase 3 EUCTR2010-021219-17-DE Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
Mastinib
AB Science
2015 Phase 3 EUCTR2012-003735-32-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Colombia;Germany;Greece;Italy;Mexico;Slovakia;Spain;Switzerland;United Kingdom
2015 Phase 3 EUCTR2012-003735-32-GR Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom
2013 - EUCTR2010-021219-17-PL Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain
2013 Phase 3 EUCTR2010-021219-17-GR Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey
2012 Phase 3 EUCTR2010-021219-17-SK Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-021219-17-DE Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States
Mavenclad
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-SE Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
MERCK KGAA
2019 Phase 4 EUCTR2019-000069-19-IT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2018 Phase 4 EUCTR2017-002632-17-IT Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Ireland;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-IT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
Merck Healthcare KGaA
2021 Phase 4 EUCTR2020-003995-42-PL Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-HU Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-CZ Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-AT Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003874-30-SK Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-HU Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-FR Austria;Czech Republic;Denmark;France;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-DK Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-CZ Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2020 Phase 4 EUCTR2020-003995-42-FI Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2020 Phase 4 EUCTR2020-003995-42-DE Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2020 Phase 4 EUCTR2020-003874-30-AT Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2023 - NCT05797740 Belgium;Czechia;Greece;Netherlands;Poland;Portugal
2021 Phase 4 NCT04783935 Australia;Austria;Canada;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom
2021 Phase 4 NCT04776213 Austria;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain
Merck KGaA
2020 Phase 4 EUCTR2019-000069-19-RO Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-SE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-PT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-PL Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-LT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-HR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-ES Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-EE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-CZ Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-BG Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-BE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2018 Phase 4 EUCTR2017-002632-17-SK Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-SE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-PT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-NO Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-NL Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-LT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-HU Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Ireland;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-GR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-GB Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-FR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-FI Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-ES Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-DK Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-CZ Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-BE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002632-17-AT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-FR Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-CZ Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
2018 Phase 4 EUCTR2017-002631-42-AT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom
Merck KGaA, Darmstadt, Germany
2018 Phase 4 NCT03369665 Austria;Belgium;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
Merck, S.L.
2019 Phase 4 EUCTR2019-000069-19-AT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
Queen Mary University of London
2021 Phase 2/Phase 3 NCT04695080 United Kingdom
2020 Phase 2 EUCTR2018-005038-39-GB United Kingdom
Turku PET centre
2019 Phase 4 EUCTR2019-001960-31-FI Finland
Mavenclad - 10 MG - compressa - USO orale - blister (AL/AL) - 6 compresse
MERCK KGAA
2021 Phase 4 EUCTR2020-003995-42-IT Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003874-30-IT Austria;Czech Republic;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain
Mavenclad 10 MG tablets
Westfälische Wilhelms-Universität Münster c/o Universitätsklinikum Münster, Geschäftsbereich Recht u. Drittmittel
2019 Phase 4 EUCTR2018-004557-24-DE Germany
Mavenclad 10MG TBL NOB
Fakultní nemocnice Ostrava
2021 Phase 4 EUCTR2021-003195-13-CZ Czech Republic
Mavenclad 6CPR 10 MG
Azienda Ospedaliera Universitaria Integrata Verona
2019 Phase 4 EUCTR2018-004947-21-IT Italy
Mavenclad 6CPR 10MG
Azienda Ospedaliera Universitaria Integrata Verona
2019 Phase 4 EUCTR2018-004947-21-IT Italy
Mavenclad tabletter 10 MG
Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital
2019 Phase 3 EUCTR2019-001505-24-NO Norway
Mayzent
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-RO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
Novartis Pharmaceuticals
2020 - NCT04593927 Japan
State University of New York at Buffalo
2021 Phase 2/Phase 3 NCT04925557 United States
Mayzent 0,25 MG compresse rivestite CON film
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2023 Phase 4 EUCTR2023-000142-42-IT Italy
Mayzent 0,25 MG filmtabletten
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Mayzent 0.25 MG FI
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Mayzent 2 MG compresse rivestite CON film
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2023 Phase 4 EUCTR2023-000142-42-IT Italy
Mayzent 2 MG FILM-coated tablets
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Mayzent 2 MG filmtabletten
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
MBP peptide
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland
MBP8298
BioMS Technology Corp.
2007 Phase 3 NCT00468611 United States
MBP8298 synthetic peptide
BioMS Technology Corp
2007 - EUCTR2004-002571-16-GB Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-NL Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-LV Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-LT Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-FI Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 Phase 2;Phase 3 EUCTR2004-002571-16-ES Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-EE Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2006 - EUCTR2004-002571-16-DK Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2005 - EUCTR2004-002571-16-SE Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom
BioMS Technology Corp.
2006 Phase 2 EUCTR2006-001947-70-SK Slovakia
MD1003
MEDDAY PHARMACEUTICALS
2017 Phase 3 EUCTR2016-000700-29-IT Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
MEDDAY PHARMACEUTICALS SA
2018 Phase 3 EUCTR2016-000700-29-PL Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2016-000700-29-HU Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2016-000700-29-BE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-000700-29-SE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-000700-29-ES Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Poland;Spain;Sweden;United Kingdom;United States
2017 Phase 3 EUCTR2016-000700-29-DE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-000700-29-CZ Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
MEDDAY Pharmaceuticals SA
2014 Phase 3 EUCTR2013-002112-27-GB France;United Kingdom
MEDDAY SAS
- Phase 3 EUCTR2013-002113-35-FR France
- Phase 3 EUCTR2013-002112-27-FR France;United Kingdom
MD1003 100MG capsule
MedDay Pharmaceuticals SA
2016 Phase 3 NCT02936037 Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States
2013 Phase 3 NCT02220933 France
2013 Phase 3 NCT02220244 France;United Kingdom
MEDI-551
Horizon Therapeutics Ireland DAC
2022 Phase 2 EUCTR2021-003528-33-SE Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
2022 Phase 2 EUCTR2021-003528-33-PL Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
2022 Phase 2 EUCTR2021-003528-33-FR Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
- Phase 2 EUCTR2021-003528-33-NL Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
MedImmune LLC
2018 Phase 2;Phase 3 EUCTR2014-000253-36-NL Australia;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;India;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2017 Phase 2;Phase 3 EUCTR2014-000253-36-HU Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2017 Phase 2;Phase 3 EUCTR2014-000253-36-GR Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2015 Phase 2;Phase 3 EUCTR2014-000253-36-ES Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2015 Phase 2;Phase 3 EUCTR2014-000253-36-DE Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2015 Phase 2;Phase 3 EUCTR2014-000253-36-BG Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2014 Phase 2;Phase 3 EUCTR2014-000253-36-PL Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2014 Phase 2;Phase 3 EUCTR2014-000253-36-EE Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2014 Phase 2;Phase 3 EUCTR2014-000253-36-CZ Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
2012 - EUCTR2011-005475-16-GB Austria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
Sato Toshiyuki
2020 Phase 3 JPRN-jRCT2051210017 -
MEDI-551 100 MG-IV
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States
MEDI-551 30 MG-IV
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States
MEDI-551 300 MG-SC
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States
MEDI-551 60 MG-SC
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States
MEDI-551 600 MG-IV
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States
Medical marijuana
Colorado State University
2017 Phase 2/Phase 3 NCT03172741 -
2016 - NCT02898974 United States
Medication diary
University of Chicago
2024 Early Phase 1 NCT06171152 United States
Meditation
University of Iowa
2010 Phase 1 NCT01381354 United States
Mediterranean diet
IRCCS National Neurological Institute C. Mondino Foundation
2024 - NCT06715436 Italy
Medrol
Scleroseklinikken, Rigshospitalet
2011 - EUCTR2010-024561-43-DK Denmark
Megadose oral methylprednisolone
Fred Lublin
2003 Phase 3 NCT00418145 United States
Melatonin
Isfahan University of Medical Sciences
2012 Phase 2 NCT01718678 Iran, Islamic Republic of
North Bristol NHS Trust
2013 Phase 2 EUCTR2012-004183-21-GB United Kingdom
Tehran University of Medical Sciences
2012 - NCT02463318 Iran, Islamic Republic of
2010 Phase 2 NCT01279876 Iran, Islamic Republic of
University of California, San Francisco
2019 - NCT04035889 United States
Melphalan
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States
Memantine
AZ. OSPEDALIERA GARIBALDI, S.LUIGI CURRO , ASCOLI TOMASELLI
2007 - EUCTR2007-000503-15-IT Italy
Clinica Universidad de Navarra, Universidad de Navarra
2007 Phase 2 NCT00638833 Spain
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France
Hospices Civils de Lyon
2012 Phase 2 NCT01744444 France
OSPEDALE S. RAFFAELE
2008 Phase 2 EUCTR2008-000490-37-IT Italy
Oregon Health and Science University
2004 Phase 2/Phase 3 NCT00300716 United States
University Hospital, Caen
2005 Phase 3 NCT01074619 France
University of Rochester
2006 Phase 4 NCT00638027 United States
Menitorix
R & D, Cambridge University Hospitals
2009 - EUCTR2009-011523-31-GB United Kingdom
Menveo
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Mesenchymal stem cells
Dimitrios Karussis
2015 Phase 2 NCT02166021 Israel
Hadassah Medical Organization
2013 Phase 1/Phase 2 NCT04823000 -
Haukeland University Hospital
2021 Phase 2 EUCTR2020-002373-95-NO Norway
Imperial College London
2013 Phase 1/Phase 2 NCT01606215 United Kingdom
Ottawa Hospital Research Institute
2015 Phase 2 NCT02239393 Canada
Prof. Per Soelberg Sørensen
2012 Phase 2 EUCTR2012-000518-13-DK Denmark
University Hospital, Toulouse
2015 Phase 1/Phase 2 NCT02403947 France
Mesenchymal stem/stromal cells
Prof. Per Soelberg Sørensen
2012 Phase 2 EUCTR2012-000518-13-DK Denmark
Mesna
Baylor College of Medicine
1999 Phase 2 NCT00040482 United States
Indapta Therapeutics, INC.
2026 Phase 1 NCT06677710 United States
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States
2017 Phase 3 NCT03342638 United States
Metabolic fatigue
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France
Metex
Universitätsklinikum Heidelberg
2006 Phase 3 EUCTR2004-004403-37-DE Germany
Metformin
German University in Cairo
2022 Phase 2 NCT06812585 Egypt
State University of New York at Buffalo
2025 Phase 2 NCT06463743 -
The Hospital for Sick Children
2020 Phase 1/Phase 2 NCT04121468 Canada
Metformin 1000 MG oral tablet
German University in Cairo
2022 Phase 2 NCT05298670 Egypt
Metformin 500 MG oral tablet, UP TO 4 tablets A DAY
University of California, Los Angeles
2022 Early Phase 1 NCT05349474 United States
Metformin and clemastine IN combination
Cambridge University Hospitals NHS Foundation Trust
2022 Phase 2 NCT05131828 United Kingdom
Metformin hydrochloride 850 MG oral tablet
University Hospital, Antwerp
2023 Phase 2 NCT05893225 Belgium
Methelphenidate
Kessler Foundation
2014 Phase 2 NCT02286557 United States
Methotrexat
Universitätsklinikum Heidelberg
2006 Phase 3 EUCTR2004-004403-37-DE Germany
Methotrexate
Biogen Idec
2003 Phase 4 NCT00112034 United States
Heidelberg University
2006 Phase 3 NCT00344253 Germany
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
2002 Phase 4 NCT00037115 United States
2001 Phase 4 NCT00037102 United States
Methyl B12
University of Iowa
2010 Phase 1 NCT01381354 United States
Methyl folate
University of Iowa
2010 Phase 1 NCT01381354 United States
Methyl prednisolonate
University Hospital Muenster
2018 - NCT04450030 Germany
Methyloprednisolone
Genentech, Inc.
2016 Phase 3 NCT02688985 Canada;Germany;Sweden;United States
Methylphenidate
Johns Hopkins University
2017 Phase 3 NCT03185065 United States
Oregon Health and Science University
2013 Phase 2/Phase 3 NCT01896700 United States
Methylphenidate hydrochloride
Medizinische Universität Wien
2012 Phase 2 EUCTR2012-003418-15-AT Austria
Methylphenidate modified release
Medical University of Vienna
2012 Phase 2 NCT01879202 Austria
Methylphenidate modified release 20 MG
Medizinische Universität Wien
2012 Phase 2 EUCTR2012-003418-15-AT Austria
Methylphenidate modified release 30 MG
Medizinische Universität Wien
2012 Phase 2 EUCTR2012-003418-15-AT Austria
Methylphenidate modified release 40 MG
Medizinische Universität Wien
2012 Phase 2 EUCTR2012-003418-15-AT Austria
Methylprednisolon-21-hydrogensuccinat, natriumsalz
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany
Methylprednisolone
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
2008 - EUCTR2007-002179-15-FR France
Beijing Tongren Hospital
2020 - NCT04601142 China
Biogen
2010 Phase 2 NCT01071083 Germany;Spain;United States
Biogen Idec
2010 - EUCTR2009-017490-38-DE Germany;Spain
2003 Phase 4 NCT00493116 Australia;New Zealand
2003 Phase 4 NCT00492466 Finland
CHU Rennes
2007 - EUCTR2007-000590-37-FR France
Galapagos NV
2009 Phase 2 NCT01039103 Belgium;Germany;Poland
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 1 NCT02583594 Spain
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain
Germans Trias i Pujol Hospital
2008 Phase 4 NCT00753792 Spain
Hoffmann-La Roche
2020 Phase 3 NCT04548999 Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 NCT04544436 Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany
Merck KGaA, Darmstadt, Germany
2018 Phase 2 NCT03387046 Germany;Italy
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
2002 Phase 4 NCT00037115 United States
National Eye Institute (NEI)
1988 - NCT00000147 United States
1988 Phase 3 NCT00000146 United States
National Institute of Neurological Disorders and Stroke (NINDS)
2016 Phase 2 NCT02784210 United States
Neurologique Foundation, Inc.
2009 Phase 2/Phase 3 NCT00947895 United States
Northwestern Memorial Hospital
2001 Phase 1 NCT00017628 United States
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States
2017 Phase 3 NCT03342638 United States
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark
2011 Phase 2 NCT01305837 Denmark
Scleroseklinikken, Rigshospitalet
2011 - EUCTR2010-024561-43-DK Denmark
Servicio de Neurología
2008 - EUCTR2007-000888-15-ES Spain
Stanford University
2014 Phase 1 NCT02087813 United States
Sykehuset Innlandet HF
2009 - NCT00764413 Norway
Tomas Olsson
2018 Phase 2 NCT03674099 Denmark;Germany;Norway;Sweden
University Hospital, Bordeaux
2005 Phase 3 NCT00241254 France
University Hospital, Clermont-Ferrand
2019 Phase 4 NCT02769689 France
University Medical Center Hamburg Eppendorf
2013 Phase 2 EUCTR2012-004807-10-DE Germany
University of Southern California
2009 Phase 1 NCT01049451 United States
University of Texas Southwestern Medical Center
2013 Phase 2 NCT01710228 United States
Universität Leipzig
2018 Phase 3 EUCTR2017-000635-13-DE Germany
Methylprednisolone 1250 MG/24H X3 days
Germans Trias i Pujol Hospital
2013 Phase 4 NCT01986998 Spain
Methylprednisolone hemisuccinate
BBB-Therapeutics B.V.
2013 Phase 1 NCT02048358 Netherlands
Methylprednisolone IV
Centre Hospitalier de PAU
2015 Phase 2 NCT02545959 France
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Australia;Brazil;Canada;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
Rennes University Hospital
2008 Phase 3 NCT00984984 France
Methylprednisolone PO
Rennes University Hospital
2008 Phase 3 NCT00984984 France
Methylprednisolone sodium hemisuccinate
Servicio de Neurología, HU. Germans Trias i Pujol
2012 Phase 4 EUCTR2012-001965-34-ES Spain
Methylprednisolone sodium succinate
Danish Multiple Sclerosis Research Centre
2009 Phase 2 EUCTR2009-011516-37-DK Denmark
Department of Clinical Neuroscience, Karolinska Institutet
2020 Phase 2 EUCTR2018-000620-34-DE Germany;Sweden
2018 Phase 2 EUCTR2018-000620-34-SE Sweden
2018 Phase 2 EUCTR2018-000620-34-NO Germany;Norway;Sweden
Enceladus Pharmaceuticals BV
2010 - EUCTR2009-013884-21-PL Belgium;Germany;Poland
2009 - EUCTR2009-013884-21-DE Belgium;Germany;Poland
2009 Phase 2 EUCTR2009-013884-21-BE Belgium;Germany;Poland
Methylprednisolone succinate
Mazandaran University of Medical Sciences
2021 Phase 2 NCT04979650 Iran, Islamic Republic of
Metilprednisolone sodio succinato
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
Microgynon
Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2019 Phase 1 NCT04086225 Germany;Poland
Merck KGaA, Darmstadt, Germany
2019 Phase 1 NCT03745144 Germany;Poland
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands
Micropirin
Biogen Idec Research Limited
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom
Midazolam
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States
Johns Hopkins University
2023 Phase 2 NCT05378100 United States
2018 Phase 1/Phase 2 NCT03500289 United States
MIL62
Beijing Mabworks Biotech Co., Ltd.
2022 Phase 3 NCT05314010 China
Mild dose cannabis
University of California, Davis
2009 Phase 1/Phase 2 NCT01037088 United States
Minocycline
Dr. Luanne Metz
2009 Phase 3 NCT00666887 Canada
Merck KGaA
2006 Phase 2 NCT01134627 Denmark
University of Calgary
2010 Phase 2 NCT01073813 Canada
Minocycline 100 MG FILM-coated tablets
E. Merck AB
2005 - EUCTR2005-004289-18-DK Denmark;Finland;Sweden
Merck AB
2006 - EUCTR2005-004289-18-SE Finland;Sweden
2006 - EUCTR2005-004289-18-FI Finland;Sweden
Minocycline 100MG
University of Calgary
2020 Phase 3 NCT04291456 Canada
Minocycline hydrochloride
E. Merck AB
2005 - EUCTR2005-004289-18-DK Denmark;Finland;Sweden
Merck AB
2006 - EUCTR2005-004289-18-SE Finland;Sweden
2006 - EUCTR2005-004289-18-FI Finland;Sweden
Mirabegron
Theodore R. Brown, MD MPH
2014 Phase 4 NCT02086188 United States
Mirna
University of Gaziantep
2015 - NCT04772495 -
MIS416
Innate Immunotherapeutics
2014 Phase 2 NCT02228213 Australia;New Zealand
2010 Phase 1/Phase 2 NCT01191996 New Zealand
Mitoquinone
Oregon Health and Science University
2018 Phase 1/Phase 2 NCT03166800 United States
Mitoxantrone
AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA` DEGLI STUDI DI NAPOLI
2009 - EUCTR2009-010661-23-IT Italy
Fundación Española de Esclerosis Múltiple (FEDEM)
2006 - EUCTR2004-001286-17-PT Portugal
OSPEDALE S. RAFFAELE
2004 - EUCTR2004-001601-10-IT France;Italy
PD Dr. Andrew Chan
2012 Phase 2 NCT01627938 Germany
Queen Mary, University of London
2009 - EUCTR2008-000256-26-GB United Kingdom
Rennes University Hospital
2010 Phase 3 NCT02937285 France
1999 Phase 2 NCT00219908 France;Italy
State University of New York at Buffalo
2001 Phase 4 NCT00304291 United States
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom
University Medical Center Hamburg Eppendorf
2007 - EUCTR2007-001962-34-DE Germany
Wyeth is now a wholly owned subsidiary of Pfizer
2005 Phase 3 NCT00146159 Germany
Xuanwu Hospital, Beijing
2009 Phase 4 NCT02021825 China
Mitoxantrone - immunomodulator
Rennes University Hospital
2010 - NCT01065727 France
Mitoxantrone hydrochloride liposome injection
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
2022 Phase 2 NCT05551598 China
2022 Phase 2 NCT05496894 China
MK0812
Merck Sharp & Dohme Corp.
2004 Phase 2 NCT00239655 Canada;Finland;Germany;United Kingdom;United States
MLN1202
Millennium Pharmaceuticals, Inc.
2006 Phase 2 EUCTR2004-002567-24-GB Czech Republic;Hungary;United Kingdom
2005 Phase 2 NCT01199640 -
2005 - EUCTR2004-002567-24-HU Czech Republic;Hungary;United Kingdom
2005 - EUCTR2004-002567-24-CZ Czech Republic;Hungary;United Kingdom
MMF
Hoffmann-La Roche
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States
Modafinil
Institute for Clinical Research
2003 - NCT00210301 United States
Johns Hopkins University
2017 Phase 3 NCT03185065 United States
Kessler Foundation
2003 - NCT00142402 United States
University of Michigan
2018 Phase 4 NCT03621761 United States
Modafinil generis 100 MG
Clinical Academic Center (2CA-Braga)
2024 Phase 2 NCT06592352 Portugal
Moderna MRNA-1273, bivalent
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States
Modified paleolithic diet
University of Iowa
2010 Phase 1 NCT01381354 United States
Modified paleolithic elimination diet
Terry L. Wahls
2022 - NCT05007483 United States
MOG peptide
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland
Monoclonal antibody M-T412
National Center for Research Resources (NCRR)
1995 Phase 1 NCT00004816 -
Monomethyl fumarate
Banner Life Sciences LLC
2023 - NCT05978531 Puerto Rico;United States
2021 - NCT04925778 -
Monomethyl fumarate 190 MG
Banner Life Sciences LLC
2017 Phase 1 NCT04570670 -
Monovalent [B.1.351] COV2 pres DTM-AS03
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States
Montelukast
Biogen
2015 Phase 4 NCT02410278 United States
MOR103
MorphoSys AG
2012 Phase 1/Phase 2 NCT01517282 Germany;Poland;United Kingdom
Most recent vaccine TO seasonal influenza
Heinrich-Heine University, Duesseldorf
2020 - NCT05019248 Germany
Motivational interviewing
Oakland University
2015 - NCT02335450 United States
Motor imagery AS compared TO physical practice FOR balance tasks
Dominican University of New York
2023 - NCT05615207 United States
MPA
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States
MRI brain and cervical spine
University of Utah
2022 Early Phase 1 NCT05357833 United States
MRI contrast-enhancing agents
Sanofi
2023 Phase 3 NCT06141486 Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;France;Germany;Greece;Hungary;India;Italy;Japan;Korea, Republic of;Netherlands;Poland;Portugal;Puerto Rico;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2023 Phase 3 NCT06141473 Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
MRI contrast-enhancing preparations
Sanofi
2021 Phase 2 NCT04879628 Bulgaria;Canada;Czechia;France;Germany;Russian Federation;Spain;Turkey;Ukraine;United States
Mrna covid-19 vaccine
Novartis Pharmaceuticals
2021 Phase 4 NCT04878211 United States
MRNA-1195
ModernaTX, Inc.
2025 Phase 2 NCT06735248 -
MRNA-1273
Novartis Pharmaceuticals
2021 Phase 4 NCT04792567 Germany
MSC2015
SALK - Gemeinnützige Salzburger Landeskliniken Betriebsges. m.b.H., Christian-Doppler-Klinik, UK für Neurologie der PMU
- - EUCTR2015-000137-78-AT Austria
MSC2304479A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation
MSC2304480A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation
MSC2304481A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation
MSC2304482A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation
MSC2358825A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation
MSC2364447C
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
Merck Healthcare KGaA
2022 Phase 3 EUCTR2019-004980-36-CZ Belarus;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-SI Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-RO Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-SK Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PL Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-NO Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LV Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-GR Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-ES Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-DE Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-BG Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
MSC2491529A
Merck KGaA
2014 - EUCTR2013-002283-25-PL Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-GR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 Phase 2 EUCTR2013-002283-25-GB Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-ES Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-BG Bulgaria;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2013-002283-25-IT Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-HU Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-HR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-FI Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-CZ Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
Mscs
Haukeland University Hospital
2021 Phase 1/Phase 2 NCT04749667 Norway
Prof. Per Soelberg Sørensen
2012 Phase 2 EUCTR2012-000518-13-DK Denmark
MT-1303
MITSUBISHI PHARMA CORPORATION
2013 - EUCTR2012-002470-31-IT Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Hungary;Italy;Lithuania;Poland;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom
MITSUBISHI TANABE PHARMA CORPORATION
2013 Phase 2 EUCTR2012-002639-27-IT Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02293967 United Kingdom
Mitsubishi Tanabe Pharma Corporation (MTPC)
2013 Phase 2 EUCTR2012-002639-27-PL Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-002639-27-LT Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-002639-27-HU Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-002639-27-GB Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-002639-27-FI Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-002639-27-ES Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-002639-27-CZ Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-002639-27-BG Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 Phase 2 EUCTR2012-002639-27-BE Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 - EUCTR2012-002470-31-LT Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 - EUCTR2012-002470-31-FI Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 - EUCTR2012-002470-31-ES Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 - EUCTR2012-002470-31-BG Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2013 - EUCTR2012-002470-31-BE Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2012 - EUCTR2012-002470-31-PL Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2012 - EUCTR2012-002470-31-HU Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2012 - EUCTR2012-002470-31-GB Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
2012 - EUCTR2012-002470-31-CZ Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
MT-1303-forma
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02310048 United Kingdom
MT-1303-formb
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02310048 United Kingdom
MT-1303-high
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02193217 United Kingdom
2013 Phase 2 NCT01890655 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom
2013 Phase 2 NCT01742052 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom
MT-1303-LOW
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02193217 United Kingdom
2013 Phase 2 NCT01890655 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom
2013 Phase 2 NCT01742052 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom
MT-1303-middle
Mitsubishi Tanabe Pharma Corporation
2013 Phase 2 NCT01890655 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom
2013 Phase 2 NCT01742052 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom
MTR-601
Motric Bio
2023 Phase 1 NCT06117020 United States
MTX
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States
Multiferon
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark
Mutagrip
sanofi-aventis recherche & developpement
2011 - EUCTR2011-001160-21-DE Austria;Canada;Germany;Russian Federation;Ukraine
2011 - EUCTR2011-001160-21-AT Austria;Canada;Germany;Russian Federation;Ukraine
Mybetaapp
Bayer
2019 - NCT03808142 Germany
2017 - NCT03134573 Germany
Mycophenolate mofetil
Aaron Boster
2006 Phase 0 NCT00618527 United States
Hoffmann-La Roche
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Kobe University Hospital
2018 - JPRN-UMIN000031135 Japan
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
2023 Phase 1 ChiCTR2300076302 China
Sekiguchi Kenji
2018 Phase 2 JPRN-jRCTs051180080 -
Shandong University Qilu Hospital
2021 Phase 4 ChiCTR2100043013 China
The Ophthalmology Department of the Chinese Peoples Liberation Army Hospital
2019 Phase 4 ChiCTR1900025744 China
2014 - ChiCTR-ICR-15007177 China
The third affiliated hospital,Sun Yat-sen university
2016 - ChiCTR-OPB-16007730 China
Third Affiliated Hospital, Sun Yat-Sen University
2016 Phase 4 NCT02809079 -
University of Texas Southwestern Medical Center
2006 Phase 2 NCT00324506 United States
2004 Phase 2/Phase 3 NCT00223301 United States
Mycophenolate mofetil, MMF
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
2024 Phase 1/Phase 2 NCT06557174 -
Myelin
Fundació Institut Germans Trias i Pujol
2017 Phase 1 NCT02903537 Spain
Hadassah Medical Organization
2002 Phase 1/Phase 2 NCT01448252 Israel
University Medical Center Hamburg-Eppendorf
2009 - EUCTR2008-004408-29-DE Germany
Myeloablative regimen
Stanford University
2025 Phase 1 NCT06900192 -
Méthylprednisolone mylan
Centre Hospitalier de Pau
2015 Phase 2 EUCTR2014-005493-11-FR France
N acetylcysteine
University of Iowa
2010 Phase 1 NCT01381354 United States
N-acetyl cysteine
Emmanuelle Waubant, MD PhD
2022 Phase 2 NCT05122559 United States
Thomas Jefferson University
2017 - NCT03032601 United States
University of California, San Francisco
2016 Phase 2 NCT02804594 United States
N-acetylcysteine
ISTITUTO C. MONDINO
2007 - EUCTR2008-000955-90-IT Italy
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
2012 Phase 4 EUCTR2011-003775-11-BE Belgium
N. meningitidis group W135 oligosaccharide conjugated CRM197
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
N02bg10
JOSE MANUEL GARCIA DOMINGUEZ
2013 - EUCTR2011-000985-36-ES Spain
N03ax12
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France
N06dx01
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France
NA18F
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2016 Phase 2 EUCTR2015-001202-34-IT Italy
Nabilone
NEMA Research, Inc.
2006 Phase 4 NCT00381264 United States
University of Manitoba
2007 Phase 4 NCT00480181 Canada
Nabiximols
Jazz Pharmaceuticals
2021 Phase 3 NCT04984278 Czechia;Poland;Spain;United Kingdom;United States
2020 Phase 3 NCT04657666 Czechia;Poland
2020 Phase 3 NCT04203498 Czechia;Poland;Romania;United Kingdom;United States
Michael, Levy M.D.,Ph.D.
2025 Phase 2 NCT05974293 United States
Nabiximols - sativex
GW Pharma Limited
2022 Phase 3 EUCTR2020-004306-58-LT Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom
2021 Phase 3 EUCTR2020-003271-18-CZ Czech Republic;Czechia;Poland;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom
Naltrexone
OSPEDALE S. RAFFAELE
2006 - EUCTR2005-005679-13-IT Italy
Namisol
Echo Pharmaceuticals B.V.
2011 - EUCTR2010-022033-28-NL Netherlands
Nanocort
Enceladus Pharmaceuticals BV
2010 - EUCTR2009-013884-21-PL Belgium;Germany;Poland
2009 - EUCTR2009-013884-21-DE Belgium;Germany;Poland
2009 Phase 2 EUCTR2009-013884-21-BE Belgium;Germany;Poland
Nanocurcumin
Tabriz University of Medical Sciences
2016 Phase 2 NCT03150966 Iran, Islamic Republic of
Naproxen
Biogen
2013 Phase 3 NCT01939002 United States
Natalizumab
Amir Hadi Maghzi
2022 Phase 3 JPRN-jRCT2051210146 -
Amsterdam University Medical Center
2019 Phase 4 EUCTR2019-002566-13-NL Netherlands
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2007 - EUCTR2005-004061-41-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2007 - EUCTR2005-004061-41-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom
2006 - EUCTR2005-004061-41-IT Australia;Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-IE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Spain;Sweden;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-002145-11-IT Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
Biogen
2023 - NCT05925049 United States
2023 - NCT05701423 Germany
2023 Phase 4 NCT05532163 Germany
2022 Phase 3 NCT05265728 Japan
2021 - NCT05688436 United States
2021 - NCT05304520 Germany
2019 - NCT05236777 Czechia
2018 Phase 3 NCT03689972 Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;United Kingdom;United States
2015 - NCT02677077 Belgium;Czech Republic;Czechia
2015 - NCT02386566 Switzerland
2014 Phase 4 NCT02342704 Australia;Czech Republic;Czechia;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 NCT02241785 Germany;United States
2014 - NCT02159573 United States
2014 Phase 2 NCT02142192 Belgium;Denmark;Germany;Italy
2014 - NCT02137109 -
2013 - NCT04832399 Portugal
2013 Phase 1 NCT01884935 Italy
2012 - NCT01485003 United States
2011 - NCT01943526 Ireland
2011 Phase 3 NCT01416181 Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2010 Phase 2/Phase 3 NCT01440101 China;Japan
2010 Phase 2 NCT01416155 China;Japan
2010 Phase 2 NCT01071083 Germany;Spain;United States
2010 - NCT01070836 Puerto Rico;United States
2010 - NCT01070823 United States
2010 Phase 3 NCT01058005 Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States
2009 - NCT00884481 Austria;Denmark;Norway;Sweden;United States
2009 Phase 4 NCT00871780 Belgium;Mexico;Poland;Romania;Saudi Arabia;Ukraine;Venezuela
2008 Phase 4 NCT00536120 United States
2006 Phase 2 NCT00516893 United States
2006 Phase 3 NCT00306592 Canada;United States
2006 Phase 3 NCT00297232 Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2001 Phase 3 NCT00027300 Belgium;Canada;Czech Republic;France;Germany;Netherlands;United Kingdom;United States
Biogen Idec
2014 Phase 4 EUCTR2014-003669-97-BE Belgium
2010 - EUCTR2009-017490-38-DE Germany;Spain
2009 - NCT00818038 United States
2008 Phase 4 NCT00744679 United States
2007 Phase 1 NCT00559702 United States
2003 Phase 3 NCT00276172 United States
2003 Phase 2 NCT00097760 -
2002 Phase 3 NCT00030966 Austria;Belgium;France;Germany;Israel;Italy;United States
Biogen Idec GmbH
2005 - EUCTR2004-004130-14-AT Austria
Biogen Idec International GmbH
2010 Phase 4 EUCTR2009-009503-19-BE Belgium
Biogen Idec Limited
2012 Phase 3 EUCTR2010-021978-11-IE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2012 - EUCTR2010-021978-11-BE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-SE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-PL Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-GB Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-FI Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-ES Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-DK Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-DE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Iraq;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-CZ Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Biogen Idec Ltd.
2004 - EUCTR2004-000047-18-SE Sweden
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-002145-11-NL Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-GB Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-FR Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-ES Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-DE Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2015 - EUCTR2013-005586-39-DE Germany;Italy;United States
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2013 - EUCTR2012-005082-13-IT Italy
Claudio Gobbi
2010 Phase 4 NCT01144052 Switzerland
Cornerstone Health Care, PA
2012 Phase 4 NCT01591551 United States
Dansk Multipel Sclerose Center
2010 Phase 2 EUCTR2009-016703-35-DK Denmark
Hôpitaux Universitaires de Strasbourg
2014 - EUCTR2014-003209-14-FR France
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Multiple Sclerosis Center of Northeastern New York
2021 - NCT04964700 United States
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States
Novartis Pharma Services AG
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
Novartis Pharmaceuticals
2023 - NCT05627271 Switzerland
Polpharma Biologics S.A.
2019 Phase 3 EUCTR2018-004751-20-PL Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine
2019 Phase 3 EUCTR2018-004751-20-HR Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine
Rennes University Hospital
2010 - NCT01065727 France
Rigshospitalet, Denmark
2010 Phase 2 NCT01077466 Denmark
State University of New York at Buffalo
2015 Phase 4 NCT03046251 United States
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University Hospital Muenster
2014 Phase 4 NCT02325440 Germany
University Hospital, Caen
2020 - NCT04580381 France
University Hospital, Clermont-Ferrand
2019 Phase 4 NCT02769689 France
University Hospital, Toulouse
2009 Phase 4 NCT00942214 France
University of British Columbia
2003 - NCT06705608 -
University of South Florida
2011 - NCT01455220 United States
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany
Uppsala l?ns landsting
2011 Phase 2 EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States
VU University Medical Center
2016 Phase 4 NCT03516526 Netherlands
VU medical center
2016 Phase 4 EUCTR2016-000345-31-NL Netherlands
Natalizumab 300 MG IN 15 ML injection
Vanderbilt University Medical Center
2022 Phase 4 NCT05177718 United States
Natalizumab discontinuation
University at Buffalo
2012 Phase 4 NCT02775110 United States
Natalizumab FOR IV infusion
Biogen Idec Limited
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain
Natalizumab FOR subcutaneous injection
Biogen Idec Limited
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain
Biogen Idec Research Limited
2014 - EUCTR2014-000917-30-IT Belgium;Denmark;Italy
2014 - EUCTR2014-000917-30-DK Belgium;Denmark;Italy
2014 Phase 2 EUCTR2014-000917-30-DE Belgium;Denmark;Germany;Italy
2014 - EUCTR2014-000917-30-BE Belgium;Denmark;Italy
Natalizumab IV
Biogen
2011 Phase 2 NCT01405820 Belgium;France;Germany;Italy;Spain
Natalizumab SC
Biogen
2011 Phase 2 NCT01405820 Belgium;France;Germany;Italy;Spain
Natalizumab treatment
Biogen Idec
2007 Phase 0 NCT00424788 United States
Natalizumab/natalizumab-sztn, alemtuzumab, ocrelizumab, rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, cladribine, ofatumumab, ublituximab-xiiy, ocrelizumab and hyaluronidase-ocsq
Johns Hopkins University
2018 - NCT03500328 United States
NBI-5788
Neurocrine Biosciences
2003 Phase 2 NCT00079495 -
Nebido
Hôpitaux Universitaires de Strasbourg
2019 Phase 2 EUCTR2018-002648-10-FR France
Nebido® testosterone undecanoate 1000 MG/4 ML solution FOR injection
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France
Neorecormon
Danish Multiple Sclerosis Research Centre
2009 Phase 2 EUCTR2009-011516-37-DK Denmark
Walton Centre for Neurology and Neurosurgery
2008 - EUCTR2008-005125-11-GB United Kingdom
Neramexane mesylate
Merz Pharmaceuticals GmbH
2009 Phase 2 NCT00799942 United Kingdom
Nerispirdine
Sanofi
2008 Phase 2 NCT00811902 Canada;Finland;France;Germany;Norway;Spain;United States
2008 Phase 2 NCT00772525 United States
Nerispirdine hydrochloride
sanofi-aventis Recherche & Développement
2009 Phase 2 EUCTR2008-001999-67-FR Finland;France;Germany;Spain
2009 - EUCTR2008-001999-67-FI Finland;France;Germany;Spain
2009 Phase 2 EUCTR2008-001999-67-ES Finland;France;Germany;Spain
2009 - EUCTR2008-001999-67-DE Finland;France;Germany;Spain
Neupogen
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy
Uppsala l?ns landsting
2011 Phase 2 EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States
Neuromuscular electrical stimulation delivered using THE electrical therapy device empi 300 PV
University of Iowa
2010 Phase 1 NCT01381354 United States
Neuromuscular evaluation
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France
Neurontin
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France
Neurontin 300 MG hard capsule
Charité University Medicine Berlin
2010 Phase 4 EUCTR2008-005167-33-DE Germany
Neurovax
Immune Response BioPharma, Inc.
2020 Phase 1 NCT02200718 United States
2020 Phase 2 NCT02149706 United States
2020 Phase 2/Phase 3 NCT02057159 United States
Neurovax 300UG/ML dose FOR IM injection
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia
NEW formulation OF rebif - human interferon BETA-1A
EMD Serono
2006 Phase 3 NCT00428584 United States
NG01 - autologous bone marrow derived human stromal cells
NeuroGenesis Ltd.
2025 Phase 2 NCT06961383 Israel;United States
Niacinamide
University of Iowa
2010 Phase 1 NCT01381354 United States
Nicotinamid riboside
Haukeland University Hospital
2023 Phase 2 NCT05740722 Norway
Nicotine and cotinine serum levels
University of Jordan
2021 - NCT05046535 Jordan
Nicotine dependence
University of Jordan
2021 - NCT05046535 Jordan
Nintendo WII FIT balance board
University Hospital of Ferrara
2014 - NCT02287948 Italy
Nintendo WII FIT balance exercises
Biruni University
2016 - NCT03436927 -
Nirs after bosentan administration
Universitair Ziekenhuis Brussel
2014 - NCT02389426 Belgium
Nirs baseline
Universitair Ziekenhuis Brussel
2014 - NCT02389426 Belgium
Nitrofurantoin
University College London
2010 Phase 4 EUCTR2009-017939-18-GB United Kingdom
Nivolumab
Alliance Foundation Trials, LLC.
2019 Phase 1 NCT03656627 United States
National Cancer Institute (NCI)
2019 Phase 1 NCT03816345 Canada;United States
NO treatment ARM
New York University School of Medicine
2015 Phase 4 NCT02665221 United States
Nomegestrol
OSPEDALI CIVILI DI LIONE
2007 - EUCTR2006-005460-30-IT Italy
Nomegestrol acetate
Hospices Civils de Lyon
2005 Phase 3 NCT00127075 France
NON disponibile
FONDAZIONE ITALIANA SCLEROSI MULTIPLA ONLUS
2023 Phase 2 EUCTR2022-002654-95-IT Italy
NON-pegylated interferon
Biogen
2015 Phase 2 NCT02097849 United States
Norethindrone
University of California, Los Angeles
2011 Phase 2 NCT01466114 United States
Normal saline
Allergan
2012 Phase 3 NCT01600716 Belgium;Canada;Czech Republic;Czechia;France;Poland;Portugal;Russian Federation;United States
Mazandaran University of Medical Sciences
2021 Phase 2 NCT04979650 Iran, Islamic Republic of
National Institute of Neurological Disorders and Stroke (NINDS)
2010 Phase 1/Phase 2 NCT01212094 United States
Normal saline FOR injection
University of Manitoba
2013 Phase 2 NCT01911377 Canada
NOT applicable
Biogen Idec GmbH
2005 - EUCTR2004-004130-14-AT Austria
Cellerys AG
2023 Phase 1;Phase 2 EUCTR2022-000801-28-CZ Czech Republic;Czechia;Germany;Italy;Switzerland
MERCK KGAA
2021 Phase 4 EUCTR2020-003995-42-IT Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003874-30-IT Austria;Czech Republic;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain
2019 Phase 4 EUCTR2019-000069-19-IT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
Merck Healthcare KGaA
2021 Phase 4 EUCTR2020-003995-42-PL Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-HU Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-CZ Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003995-42-AT Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2021 Phase 4 EUCTR2020-003874-30-SK Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-HU Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-FR Austria;Czech Republic;Denmark;France;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-DK Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2021 Phase 4 EUCTR2020-003874-30-CZ Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
2020 Phase 4 EUCTR2020-003995-42-FI Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2020 Phase 4 EUCTR2020-003995-42-DE Australia;Austria;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland
2020 Phase 4 EUCTR2020-003874-30-AT Austria;Czech Republic;Denmark;Hungary;Italy;Slovakia
Merck KGaA
2020 Phase 4 EUCTR2019-000069-19-RO Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-SE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-PT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-PL Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-LT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-HR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-ES Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-EE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-CZ Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-BG Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 4 EUCTR2019-000069-19-BE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
Merck Serono International S.A.
2008 - EUCTR2007-000381-20-NL Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2008 - EUCTR2007-000381-20-GR Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2007 Phase 3 EUCTR2007-000381-20-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lithuania;Netherlands;Portugal;United Kingdom
2007 - EUCTR2006-002982-38-LT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2007 - EUCTR2006-002982-38-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-AT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2004-005148-28-LT Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-FI Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-EE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-DK Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-CZ Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Merck Serono International SA
2007 - EUCTR2006-003037-32-LT Estonia;Germany;Italy;Lithuania;Spain
2007 Phase 3 EUCTR2006-003037-32-ES Estonia;Germany;Italy;Lithuania;Spain
2007 - EUCTR2006-003037-32-EE Estonia;Germany;Italy;Lithuania;Spain
Merck Serono International, a branch of Laboratoires Serono S.A.
2005 Phase 3 EUCTR2004-005148-28-GB Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom
Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA
2007 Phase 3 EUCTR2006-002982-38-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain
2007 - EUCTR2006-002982-38-EE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
Merck Serono International, a branch of Laboratories Serono S.A.
2005 - EUCTR2004-005148-28-DE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Merck Serono S.A. - Geneva
2012 Phase 3 EUCTR2009-017978-21-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2012 Phase 3 EUCTR2009-017978-21-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2012 Phase 3 EUCTR2009-017978-21-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-SE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-LV Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 - EUCTR2009-017978-21-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-DK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 - EUCTR2009-017978-21-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2011 Phase 3 EUCTR2009-017978-21-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2010 Phase 3 EUCTR2009-017978-21-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - EUCTR2007-000381-20-PT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom
2008 - EUCTR2007-000381-20-LV Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-000381-20-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-EE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-DK Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-000381-20-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-000381-20-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2007-000381-20-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2007-000381-20-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2007 - EUCTR2006-002982-38-PT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2007 - EUCTR2006-002982-38-DE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-FI Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-CZ Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
Merck Serono S.A.-Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 Phase 3 EUCTR2006-002982-38-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain
Merck Serono SA
2007 - EUCTR2006-003037-32-DE Estonia;Germany;Italy;Lithuania;Spain
Merck, S.L.
2019 Phase 4 EUCTR2019-000069-19-AT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States
Sahlgrenska University Hospital
2005 Phase 4 EUCTR2005-001008-37-SE Sweden
Sanofi-Aventis Recherche et Développement
2021 Phase 2 EUCTR2020-004785-19-FR Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States
2021 Phase 2 EUCTR2020-004785-19-DE Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States
2021 Phase 2 EUCTR2020-004785-19-CZ Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States
2021 Phase 2 EUCTR2020-004785-19-BG Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Türkiye;Ukraine;United States
Serono International S.A.
2006 Phase 3 EUCTR2004-005148-28-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom
2006 - EUCTR2004-005148-28-LV Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
2005 - EUCTR2004-005148-28-AT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom
Serono International SA
2007 Phase 3 EUCTR2006-002982-38-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain
2005 - EUCTR2004-003799-13-SE Ireland;Lithuania;Spain;Sweden;United Kingdom
2005 - EUCTR2004-003799-13-LT Ireland;Lithuania;Spain;Sweden;United Kingdom
2005 Phase 3 EUCTR2004-003799-13-GB Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
2005 Phase 3 EUCTR2004-003799-13-ES Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
2005 Phase 3 EUCTR2004-003799-13-DK Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
2004 Phase 4 EUCTR2004-000337-12-HU Hungary
- Phase 3 EUCTR2004-003799-13-IE Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
Serono International, S.A.
2007 - EUCTR2006-003366-33-ES Italy;Spain
Teva Pharmaceutical Industries, Ltd
2016 Phase 4 EUCTR2015-000922-12-PL Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-FR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-DE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2016 Phase 4 EUCTR2015-000922-12-BE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-IE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-HR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-FI Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
2015 Phase 4 EUCTR2015-000922-12-AT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States
University College London
2020 Phase 2 EUCTR2017-003008-30-GB United Kingdom
Novantrone*INF 2MG/ML 5ML
OSPEDALE S. RAFFAELE
2004 - EUCTR2004-001601-10-IT France;Italy
Novartis pharmaceuticals corporation
Universitätsklinikum Hamburg-Eppendorf
2013 - NCT03216915 Germany
Novatrex
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
NPB-01
Nihon Pharmaceutical Co., Ltd
2013 Phase 2 NCT01845584 Japan
NT-KO-003
Neurotec Pharma
2011 Phase 2 NCT01428726 Germany;Spain
NU100
NURON BIOTECH INC.
2012 - EUCTR2011-002683-24-IT Belarus;Bulgaria;Hungary;Italy;Russian Federation;Spain
Nuron Biotech Inc.
2011 Phase 3 NCT01464905 Belarus;Bulgaria;Croatia;Georgia;Hungary;India;Italy;Lebanon;Poland;Russian Federation;Serbia;Spain;Ukraine
Nuron Biotech, Inc.
2012 - EUCTR2011-002683-24-HU Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine
2012 - EUCTR2011-002683-24-ES Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Poland;Russian Federation;Spain;Ukraine
2012 - EUCTR2011-002683-24-BG Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine
NVF233
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy
Obexelimab
Zenas BioPharma (USA), LLC
2024 Phase 2 NCT06564311 Austria;Belgium;China;Croatia;Czechia;Denmark;Greece;Italy;Poland;Spain;United Kingdom;United States
Observation OF ocrelizumab AS treatment IN rrms patients
Wayne State University
2021 - NCT04458688 United States
Observational control
Jeffrey Gelfand
2018 Phase 1 NCT03594487 United States
OCH-NCNP1
National Center of Neurology and Psychiatry, Japan
2019 Phase 2 NCT04211740 Japan
Oclelizumab
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
OCR
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States
Ocrelizumab
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
2018 Phase 3 EUCTR2017-004158-40-FR France
Amgen
2025 Phase 3 NCT06700343 Georgia;Serbia;Switzerland;United States
Amsterdam UMC, location VUmc
2022 Phase 4 NCT05296161 Netherlands
Assistance Publique - Hôpitaux de Paris
2018 Phase 3 NCT03691077 France
Biogen
2021 - NCT05688436 United States
Biogen Idec Research Limited
2020 Phase 2 EUCTR2019-001967-58-PL Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States
2020 Phase 2 EUCTR2019-001967-58-FR Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States
Brigham and Women's Hospital
2021 - NCT05131984 United States
Centre Hospitalier Universitaire de Nice
2022 Phase 3 NCT05210621 France
Cinnagen
2019 Phase 3 NCT04966338 Iran, Islamic Republic of
Claudio Gobbi
2020 - NCT04640818 Switzerland
Danish Multiple Sclerosis Center, Rigshospitalet
2020 Phase 3 EUCTR2020-002981-15-DK Denmark
Dr Recai Turkoglu
2021 - NCT04874597 Turkey
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2019-003919-53-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-005448-48-IT Brazil;Czech Republic;Czechia;France;Italy;Poland;Spain
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-IT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-IT Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 2 EUCTR2016-002667-34-IT Italy;Poland;United States
2018 Phase 3;Phase 4 EUCTR2017-004886-29-IT Belgium;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2017 Phase 3 EUCTR2016-002937-31-IT Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005597-38-IT Belgium;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
F. Hoffmann - La Roche
2010 Phase 3 EUCTR2010-020338-25-IT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Poland;Portugal;Spain;United Kingdom
F. Hoffmann-La Roche Ltd
2023 Phase 3 EUCTR2020-004128-41-RO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2023 Phase 3 EUCTR2020-004128-41-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-005448-48-FR Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2022 Phase 3 EUCTR2020-005448-48-CZ Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2022 Phase 3 EUCTR2020-004128-41-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 4 EUCTR2021-000063-79-ES Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000063-79-DE Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000062-14-ES Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000062-14-DE Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 3 EUCTR2020-005448-48-PL Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2020-004128-41-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-GR Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-DK Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-BG Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-BE Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000893-69-GR Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000893-69-DK Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2017-004886-29-SK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-SI Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-PT Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-PL Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-HU Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-HR Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-BG Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-BE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2020 Phase 3 EUCTR2020-000894-26-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-GB Argentina;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-FR Argentina;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-PT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-PL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-NL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-HU Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-GB Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-FR Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-DE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-BE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-003919-53-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-003919-53-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-RO Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-IE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-FR Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-DE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2017-001313-93-DE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2020 Phase 2 EUCTR2016-002667-34-PL Italy;Mexico;Poland;United States
2019 Phase 3 EUCTR2018-001511-73-PL Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-HU Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-HR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-GB Bulgaria;Croatia;Germany;Hungary;Ireland;Poland;Portugal;Spain;United Kingdom
2019 Phase 3 EUCTR2018-001511-73-ES Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2017-004886-29-IE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-SE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-NL Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-GB Czech Republic;Denmark;Estonia;Finland;France;Ireland;Netherlands;Spain;Sweden;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-FR Belgium;Bulgaria;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-FI Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-EE Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-DK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-001313-93-PL Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-IE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-HU Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Kuwait;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-FR Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Kuwait;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-DK Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-CZ Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2017 Phase 3 EUCTR2016-002937-31-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-SI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-SE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-NO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-FR Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005597-38-SE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-NL Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-IE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-GB Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-FR Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-FI Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-EE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-DK Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-DE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-CZ Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-BE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
- Phase 3 EUCTR2020-004128-41-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd.
2022 Phase 4 EUCTR2021-003296-33-GR Greece;Russian Federation
2022 Phase 3 EUCTR2020-004128-41-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020337-99-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020338-25-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Portugal;Spain;United Kingdom
2011 Phase 3 EUCTR2010-020338-25-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020337-99-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-FR Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020315-36-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2010 - EUCTR2010-020338-25-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2010-020338-25-ES Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Greece;Hungary;Italy;Lithuania;Portugal;Spain;United Kingdom
2010 - EUCTR2010-020337-99-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-FI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States
F.Hoffmann-La Roche Ltd.
2008 - EUCTR2007-006338-32-IT Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Russian Federation;Spain;Switzerland;Ukraine;United Kingdom;United States
FONDAZIONE ITALIANA SCLEROSI MULTIPLA ONLUS
2023 Phase 2 EUCTR2022-002654-95-IT Italy
Fondation Ophtalmologique Adolphe de Rothschild
2023 Phase 3 NCT05999604 France
Genentech, Inc.
2020 Phase 4 NCT04377555 Kenya;Puerto Rico;United States
2016 - NCT02807285 United States
2016 Phase 3 NCT02688985 Canada;Germany;Sweden;United States
2016 Phase 3 NCT02637856 Canada;United States
2008 Phase 2 NCT00676715 Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
Georgia State University
2021 Phase 4 NCT04387734 United States
Haukeland University Hospital
2020 Phase 3 NCT04578639 Norway;Sweden
2018 Phase 3 NCT03477500 Denmark;Netherlands;Norway;Sweden
Helse Bergen HF, Haukeland University Hospital
2022 Phase 3 EUCTR2020-001205-23-SE Norway;Sweden
2020 Phase 3 EUCTR2020-001205-23-NO Norway;Sweden
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-SE Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
Hoffman La Roche Ltd
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
Hoffmann-La Roche
2024 - NCT06780150 Germany
2024 Phase 3 NCT06675955 France;Germany;Ukraine
2023 Phase 4 NCT05208840 Russian Federation
2022 Phase 3 NCT05269004 Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 NCT05123703 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 4 NCT04998812 Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 NCT04998851 Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2020 Phase 3 NCT04548999 Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 NCT04544449 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czechia;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;New Zealand;North Macedonia;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 NCT04544436 Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 2 NCT04075266 Italy;Mexico;Poland;United States
2019 Phase 3 NCT04035005 Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Tunisia;Ukraine;United Kingdom;United States
2019 Phase 1 NCT03972306 Canada;United States
2018 Phase 3 NCT03599245 Argentina;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Kuwait;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 - NCT03593590 Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Dominican Republic;Egypt;Israel;Italy;Kuwait;Montenegro;Netherlands;Panama;Paraguay;Poland;Portugal;Qatar;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Turkey;United Arab Emirates;United Kingdom
2018 Phase 3 NCT03523858 Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates;United States
2017 Phase 3 NCT03085810 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2016 Phase 3 NCT02861014 Australia;Belgium;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Hong Kong;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2011 Phase 3 NCT01412333 Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;France;Germany;Ireland;Italy;Mexico;Morocco;Norway;Poland;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 NCT01247324 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Czechia;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 NCT01194570 Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;Uruguay
Hospital Italiano de Buenos Aires
2019 - NCT03784547 Argentina
Indapta Therapeutics, INC.
2026 Phase 1 NCT06677710 United States
Johns Hopkins University
2020 Phase 4 NCT04261790 United States
2019 - NCT03873389 United States
2019 Phase 4 NCT03853746 United States
NYU Langone Health
2020 - NCT04855617 United States
National Institute of Allergy and Infectious Diseases (NIAID)
2023 Phase 4 NCT05285891 United States
Novartis Pharmaceuticals
2025 Phase 3 NCT06846281 -
2023 - NCT06121349 United States
2023 - NCT05627271 Switzerland
2022 - NCT05266469 Oman;United Arab Emirates
2021 - NCT04676555 Australia;United Kingdom;United States
Peking Union Medical College Hospital
2025 Phase 4 ChiCTR2500102783 China
ROCHE
2018 Phase 4 EUCTR2018-000780-91-FR France
2011 Phase 3 EUCTR2010-020337-99-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IT Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark
Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-005448-48-ES Brazil;Czechia;France;Italy;Spain
Roche Farma S.A(Soc. Unipersonal) que realiza el ensayo en España y actúa como representante de F. Hoffmann-La Roche LTD
2018 Phase 3 EUCTR2017-001313-93-ES Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;France;Guatemala;Hungary;Ireland;Italy;Kuwait;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates
Roche Farma S.A. (Soc.unipersonal)que realiza el ensayo en España y que actúa como representante de F.Hoffmann-La Roche
2017 Phase 3 EUCTR2016-002937-31-ES Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Roche Farma S.A. que representa en España a F. Hoffmann-La Roche Ltd
2016 Phase 3 EUCTR2015-005597-38-ES Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
Roche Farma SA (Soc unipersonal) que realiza el ensayo en España y que actúa como representante F.Hoffmann-La Roche Ltd
2018 Phase 3 EUCTR2017-004886-29-ES Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom
State University of New York at Buffalo
2023 - NCT05974852 United States
2023 - NCT05974839 United States
University Nice Hospital
2022 Phase 3 EUCTR2021-006107-15-FR France
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany
University at Buffalo
2017 - NCT03025269 United States
University of California, San Francisco
2025 Phase 4 NCT06495593 United States
2020 Phase 4 NCT04466150 United States
2020 - NCT04387110 United States
University of Chicago
2017 - NCT03344094 United States
University of Colorado, Denver
2017 Phase 3 NCT02980042 United States
University of Michigan
2020 - NCT04459988 United States
University of South Florida
2018 - NCT03562975 United States
Universitätsklinikum Hamburg-Eppendorf
2021 Phase 2 NCT04971005 Germany
VU medical center
2022 Phase 4 EUCTR2021-004791-34-NL Netherlands
Yale University
2022 Phase 4 NCT04877457 United States
Ocrelizumab 300 MG
Hoffmann-La Roche
2018 Phase 4 NCT03589105 France
Ocrelizumab 300MG
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-SK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
Ocrelizumab 300MG/10 ML
F.Hoffmann-La Roche
2011 Phase 3 EUCTR2010-020338-25-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
Ocrelizumab 300MG/10ML
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2021-005746-15-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2021-005746-15-SK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-SE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-RO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-NO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-LT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-FI Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-CZ Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-AT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
F.Hoffmann-La Roche
2013 Phase 3 EUCTR2010-020338-25-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-GR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
GENENTECH Inc.
2016 Phase 3 EUCTR2015-004616-37-SE Germany;Sweden;Switzerland;United States
2016 Phase 3 EUCTR2015-004616-37-DE Germany;Sweden;Switzerland;United States
Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2021-005746-15-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
Ocrelizumab 600 MG
Hoffmann-La Roche
2018 Phase 4 NCT03589105 France
Ocrelizumab AT home
University of Colorado, Denver
2021 Phase 4 NCT04650321 United States
Ocrelizumab dose 1
Genentech, Inc.
2018 Phase 3 NCT03606460 United States
Ocrelizumab dose 2 and dose 3
Genentech, Inc.
2018 Phase 3 NCT03606460 United States
Ocrelizumab IV
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Australia;Brazil;Canada;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
Ocrelizumab SC
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Australia;Brazil;Canada;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
Ocrevus
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
2018 Phase 3 EUCTR2017-004158-40-FR France
Biogen Idec Research Limited
2020 Phase 2 EUCTR2019-001967-58-PL Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States
2020 Phase 2 EUCTR2019-001967-58-FR Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States
Danish Multiple Sclerosis Center, Rigshospitalet
2020 Phase 3 EUCTR2020-002981-15-DK Denmark
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2021-005746-15-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2019-003919-53-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-005448-48-IT Brazil;Czech Republic;Czechia;France;Italy;Poland;Spain
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-IT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-IT Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 2 EUCTR2016-002667-34-IT Italy;Poland;United States
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2023 Phase 3 EUCTR2020-004128-41-RO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2023 Phase 3 EUCTR2020-004128-41-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-SK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-SE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-RO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-NO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-LT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-FI Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-CZ Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-AT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-005448-48-FR Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2022 Phase 3 EUCTR2020-005448-48-CZ Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2022 Phase 3 EUCTR2020-004128-41-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 4 EUCTR2021-000063-79-ES Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000063-79-DE Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000062-14-ES Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000062-14-DE Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 3 EUCTR2020-005448-48-PL Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2020-004128-41-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-GR Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-DK Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-BG Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-BE Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000893-69-GR Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000893-69-DK Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2017-004886-29-SK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-SI Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-PT Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-PL Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-HU Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-HR Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-BG Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-BE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2020 Phase 3 EUCTR2020-000894-26-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-GB Argentina;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-FR Argentina;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-PT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-PL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-NL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-HU Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-GB Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-FR Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-DE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-BE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-003919-53-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-003919-53-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-RO Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-IE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-FR Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-DE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2017-001313-93-DE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2020 Phase 2 EUCTR2016-002667-34-PL Italy;Mexico;Poland;United States
2019 Phase 3 EUCTR2018-001511-73-PL Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-HU Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-HR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-GB Bulgaria;Croatia;Germany;Hungary;Ireland;Poland;Portugal;Spain;United Kingdom
2019 Phase 3 EUCTR2018-001511-73-ES Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2017-004886-29-IE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-SE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-NL Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-GB Czech Republic;Denmark;Estonia;Finland;France;Ireland;Netherlands;Spain;Sweden;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-FI Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-EE Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-DK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-001313-93-PL Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-IE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-DK Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-CZ Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2017 Phase 3 EUCTR2016-002937-31-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-SI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-SE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-NO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
- Phase 3 EUCTR2020-004128-41-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd.
2022 Phase 4 EUCTR2021-003296-33-GR Greece;Russian Federation
2022 Phase 3 EUCTR2020-004128-41-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F.Hoffmann-La Roche
2013 Phase 3 EUCTR2010-020338-25-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-GR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
FONDAZIONE ITALIANA SCLEROSI MULTIPLA ONLUS
2023 Phase 2 EUCTR2022-002654-95-IT Italy
Fondation Ophtalmologique Adolphe de Rothschild
2023 Phase 3 NCT05999604 France
GENENTECH Inc.
2016 Phase 3 EUCTR2015-004616-37-SE Germany;Sweden;Switzerland;United States
2016 Phase 3 EUCTR2015-004616-37-DE Germany;Sweden;Switzerland;United States
Helse Bergen HF, Haukeland University Hospital
2022 Phase 3 EUCTR2020-001205-23-SE Norway;Sweden
2020 Phase 3 EUCTR2020-001205-23-NO Norway;Sweden
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-SE Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-SK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
Kessler Foundation
2021 - NCT04448977 United States
Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2021-005746-15-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-005448-48-ES Brazil;Czechia;France;Italy;Spain
State University of New York at Buffalo
2021 Phase 2/Phase 3 NCT04925557 United States
University Nice Hospital
2022 Phase 3 EUCTR2021-006107-15-FR France
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany
VU medical center
2022 Phase 4 EUCTR2021-004791-34-NL Netherlands
Ocrevus 300 MG, solution à diluer pour perfusion
ROCHE
2018 Phase 4 EUCTR2018-000780-91-FR France
Ocrevus-EU
Sandoz
2025 Phase 3 NCT06847724 -
Ocrevus-US
Sandoz
2025 Phase 3 NCT06847724 -
Ocrrelizumab 300 MG
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
Octagam
Octapharma AG
2009 - EUCTR2008-004579-22-DE Austria;Germany
2008 - EUCTR2008-004579-22-AT Austria
Octagam 50 MG/ML
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Ocufolin
University of Miami
2007 - NCT03135327 United States
Ofatumumab
Biogen
2021 - NCT05688436 United States
Brigham and Women's Hospital
2020 Phase 3 NCT04510220 United States
Chinese PLA General Hospital & Chinese PLA Medical School
2022 Phase 4 ChiCTR2400086835 China
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD.
2012 - EUCTR2011-002333-19-IT Canada;Czech Republic;Germany;Italy;Netherlands;Russian Federation;Spain;United States
Genmab A/S
2008 Phase 2 EUCTR2007-004223-38-DE Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom
2008 - EUCTR2007-004223-38-BE Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom
GlaxoSmithKline
2008 - EUCTR2007-004223-38-DK Czech Republic;Denmark;Germany;Sweden;United Kingdom
GlaxoSmithKline AB
2008 - EUCTR2007-004223-38-SE Czech Republic;Denmark;Germany;Sweden;United Kingdom
GlaxoSmithKline Research and Development Limited
2012 - EUCTR2011-002333-19-CZ Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
2011 - EUCTR2011-002333-19-NL Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
2011 Phase 2 EUCTR2011-002333-19-DK Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
2011 - EUCTR2011-002333-19-DE Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
GlaxoSmithKline SA
2011 Phase 2 EUCTR2011-002333-19-ES Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
GlaxoSmithKline UK
2009 Phase 2 EUCTR2007-004223-38-GB Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom
GlaxoSmithKline s.r.o.
2008 - EUCTR2007-004223-38-CZ Czech Republic;Denmark;Germany;Sweden;United Kingdom
Johns Hopkins University
2023 - NCT06167642 United States
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States
Novartis Farmacéutica, S.A
2019 Phase 3 EUCTR2017-004703-51-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
Novartis Farmacéutica, S.A.
2018 Phase 2 EUCTR2017-004702-17-ES Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2016 Phase 3 EUCTR2015-005419-33-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-ES Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2016 Phase 3 EUCTR2015-005419-33-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;Italy
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;United Kingdom
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-SI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-NO Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-NO Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 2 EUCTR2017-004702-17-PL Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 3 EUCTR2017-004703-51-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 2 EUCTR2017-004702-17-LV Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-LT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-EE Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-CZ Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-BG Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-AT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2017 Phase 3 EUCTR2015-005418-31-FR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HU Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BE Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-RO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
Novartis Pharma K.K.
2018 Phase 2 JPRN-jRCT2080223655 Japan;Russia
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-NL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-CZ Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-PL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GB Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-EE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BG Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany
Novartis Pharma. K.K.
2019 Phase 3 JPRN-jRCT2080224590 Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russia;Slovakia(Slovak Republic);South Africa;Spain;United Kingdom;United States
Novartis Pharmaceuticals
2024 - NCT06551519 Germany
2024 - NCT06486779 Greece
2024 - NCT06345157 Italy
2024 - NCT06251986 Spain
2023 - NCT06157086 France
2023 - NCT06121349 United States
2023 - NCT05809986 Portugal
2023 - NCT05776888 Austria
2023 - NCT05627271 Switzerland
2022 - NCT05566756 Germany
2022 - NCT05344469 Germany
2022 - NCT05285904 Switzerland
2022 - NCT05266469 Oman;United Arab Emirates
2022 Phase 4 NCT05199571 China
2022 Phase 4 NCT05090371 Canada;United States
2022 - NCT05090033 Australia
2022 Phase 4 NCT05084638 Puerto Rico;United States
2021 Phase 3 NCT04926818 Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
2021 Phase 4 NCT04878211 United States
2021 Phase 4 NCT04869358 Germany
2021 - NCT04847596 Puerto Rico;United States
2021 Phase 3 NCT04788615 France;Germany;Italy;Spain;United Kingdom
2021 - NCT04676555 Australia;United Kingdom;United States
2021 Phase 4 NCT04667117 United States
2020 Phase 3 NCT04486716 Puerto Rico;United States
2020 Phase 3 NCT04353492 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 2 NCT03249714 Japan;Russian Federation
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
2023 Phase 1 ChiCTR2300076302 China
Tianjin Medical University General Hospital
2022 - NCT05414487 China
University of Southern California
2022 - NCT05171972 United States
Ofatumumab 100
GlaxoSmithKline
2008 Phase 2 NCT00640328 Belgium;Czech Republic;Denmark;Former Serbia and Montenegro;Germany;Poland;Serbia;Sweden;United Kingdom
Ofatumumab 300
GlaxoSmithKline
2008 Phase 2 NCT00640328 Belgium;Czech Republic;Denmark;Former Serbia and Montenegro;Germany;Poland;Serbia;Sweden;United Kingdom
Ofatumumab 30MG
GlaxoSmithKline
2011 Phase 2 NCT01457924 Bulgaria;Canada;Czech Republic;Czechia;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
Ofatumumab 3MG
GlaxoSmithKline
2011 Phase 2 NCT01457924 Bulgaria;Canada;Czech Republic;Czechia;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
Ofatumumab 60MG
GlaxoSmithKline
2011 Phase 2 NCT01457924 Bulgaria;Canada;Czech Republic;Czechia;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States
Ofatumumab 700
GlaxoSmithKline
2008 Phase 2 NCT00640328 Belgium;Czech Republic;Denmark;Former Serbia and Montenegro;Germany;Poland;Serbia;Sweden;United Kingdom
Ofatumumab approved dose
Novartis Pharmaceuticals
2025 Phase 3 NCT06869785 United States
Ofatumumab NEW dose
Novartis Pharmaceuticals
2025 Phase 3 NCT06869785 United States
Ofatumumab subcutaneous injection
Novartis Pharmaceuticals
2016 Phase 3 NCT02792231 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Finland;France;Germany;Hungary;India;Italy;Latvia;Lithuania;Mexico;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 NCT02792218 Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Ofatumumab with AI
Novartis Pharmaceuticals
2018 Phase 2 NCT03560739 Austria;Bulgaria;Czechia;Estonia;Latvia;Lithuania;Russian Federation;Spain;United States
Ofatumumab with PRF
Novartis Pharmaceuticals
2018 Phase 2 NCT03560739 Austria;Bulgaria;Czechia;Estonia;Latvia;Lithuania;Russian Federation;Spain;United States
Ofatunumab
Novartis Pharmaceuticals
2024 Phase 4 NCT06444113 Germany;Puerto Rico;United Kingdom;United States
Oleovit D3 14.400 IU/ML oral drops, solution
University medical centre Maribor
2017 Phase 4 EUCTR2017-004846-31-SI Slovenia
Olesoxime
Hoffmann-La Roche
2013 Phase 1 NCT01808885 France
OMB157
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States
Novartis Farmacéutica, S.A
2019 Phase 3 EUCTR2017-004703-51-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
Novartis Farmacéutica, S.A.
2018 Phase 2 EUCTR2017-004702-17-ES Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2016 Phase 3 EUCTR2015-005419-33-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-ES Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2016 Phase 3 EUCTR2015-005419-33-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;Italy
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;United Kingdom
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-SI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2019-001341-40-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-NO Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Türkiye;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-001341-40-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-NO Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2019 Phase 3 EUCTR2017-004703-51-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Türkiye;United Kingdom;United States
2019 Phase 2 EUCTR2017-004702-17-PL Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 3 EUCTR2017-004703-51-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 3 EUCTR2017-004703-51-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2018 Phase 2 EUCTR2017-004702-17-LV Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-LT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-EE Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-CZ Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-BG Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2018 Phase 2 EUCTR2017-004702-17-AT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
2017 Phase 3 EUCTR2015-005418-31-FR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HU Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BE Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-RO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-NL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-CZ Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-PL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GB Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-EE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BG Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
OMB157G
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany
Omega 3 fatty acids
University of Iowa
2010 Phase 1 NCT01381354 United States
Omega-3 fatty acids
Haukeland University Hospital
2004 Phase 2/Phase 3 NCT00360906 Norway
Omeprazole
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States
Onabotulinumtoxina
Allergan
2012 Phase 3 NCT01600716 Belgium;Canada;Czech Republic;Czechia;France;Poland;Portugal;Russian Federation;United States
ONE-LEG stance test
Gazi University
2018 - NCT03584672 -
ONO-4641
EMD Serono
2010 Phase 2 NCT01226745 Belgium;Canada;Czech Republic;Germany;Greece;Japan;Poland;Russian Federation;Spain;Ukraine;United States
Merck KGaA
2014 - EUCTR2013-003126-83-HU Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-GR Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-ES Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-003126-83-DE Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
ONO Pharmaceutical Co., Ltd.
2011 - EUCTR2010-018705-11-GR Belgium;Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States
2010 - EUCTR2010-018705-11-ES Belgium;Czech Republic;Germany;Greece;Spain
2010 - EUCTR2009-014339-19-GR Czech Republic;Germany;Greece;Spain
2010 Phase 2 EUCTR2009-014339-19-ES Czech Republic;Germany;Greece;Spain
2010 - EUCTR2009-014339-19-DE Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States
2010 - EUCTR2009-014339-19-CZ Czech Republic;Germany;Greece;Spain
Ono Pharma USA Inc
2010 Phase 2 NCT01081782 Belgium;Canada;Czech Republic;Germany;Greece;Japan;Poland;Russian Federation;Spain;Ukraine;United States
ONO-4641/ MSC2430913A
Merck KGaA
- - EUCTR2010-018705-11-DE Belgium;Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States
ONO-4641/MSC2430913A
Merck KGaA
2010 - EUCTR2010-018705-11-CZ Belgium;Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States
Merck Serono S.A. - Geneva
2010 - EUCTR2010-018705-11-BE Belgium;Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States
Opicinumab
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 2 EUCTR2017-001224-22-IT Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Biogen
2017 Phase 2 NCT03222973 Australia;Belgium;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
2016 Phase 1 NCT02833142 United States
Biogen Idec Research Limited
2018 Phase 2 EUCTR2017-001224-22-PL Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 2 EUCTR2017-001224-22-NL Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 2 EUCTR2017-001224-22-DE Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 2 EUCTR2017-001224-22-BE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2017 Phase 2 EUCTR2017-001224-22-HU Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2017 Phase 2 EUCTR2017-001224-22-GB Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2017 Phase 2 EUCTR2017-001224-22-ES Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2017 Phase 2 EUCTR2017-001224-22-CZ Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Oral corticosteroids
Hoffmann-La Roche
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Oral glucocorticoids
Guangzhou JOYO Pharma Co., Ltd
2023 Phase 2 NCT06697535 China
Oral glucose tolerance test
Slovak Academy of Sciences
2017 - NCT03052595 Slovakia
Oral immunosuppressant
Xuanwu Hospital, Beijing
2024 - NCT05891379 China
Oral methylprednisolone 625 MG/24H X3 days
Germans Trias i Pujol Hospital
2013 Phase 4 NCT01986998 Spain
Oral THC
University of California, Davis
2004 Phase 1/Phase 2 NCT00682929 United States
ORCA-Q
Stanford University
2025 Phase 1 NCT06900192 -
Orelabrutinib
Beijing InnoCare Pharma Tech Co., Ltd.
2021 Phase 2 NCT04711148 China;Poland;Ukraine;United States
InnoCare Pharma, Inc.
2021 Phase 2 EUCTR2020-005117-41-PL China;Poland;Ukraine;United States
Peking Union Medical College Hospital
2022 - NCT05284175 China
2022 Phase 1 ChiCTR2200057880 China
ORY2001
Oryzon Genomics S. A
2017 Phase 2 EUCTR2017-002838-23-ES Spain
OS440
Osmotica Pharmaceutical US LLC
2018 Phase 3 EUCTR2017-004101-40-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004101-40-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004101-40-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
2018 Phase 3 EUCTR2017-004100-22-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
Other analgesics and antipyretics
GW PHARMA LTD
2008 - EUCTR2006-005910-11-IT Germany;Italy;Spain;United Kingdom
Other disease modifying therapies
University of Maryland, Baltimore
2025 - NCT06864936 United States
Other disease-modifying therapy
Novartis Pharmaceuticals
2011 - NCT01442194 Argentina;Australia;Canada;Chile;Mexico;Puerto Rico;United States
Other H1 antagonist
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
Other nervous system drugs
NOVARTIS FARMA
2011 - EUCTR2011-000770-60-IT Italy
Ovastat 1000
medac Gesellschaft für klinische Spezialpräparate mbH
2007 - EUCTR2006-002856-14-DE Germany
Ovastat 5000
medac Gesellschaft für klinische Spezialpräparate mbH
2007 - EUCTR2006-002856-14-DE Germany
Oxcarbazepine
Queen Mary University London
2014 Phase 2 EUCTR2013-002419-87-GB United Kingdom
Queen Mary University of London
2014 Phase 2 NCT02104661 United Kingdom
Oxiklorin
Varsinais-Suomen sairaanhoitopiirin kuntayhtymä
2022 Phase 2 EUCTR2022-003170-23-FI Finland
Oxine
University of Alabama at Birmingham
2021 Phase 1 NCT03807973 United States
Oxybutynin hydrochloride
Astellas Pharma Inc
2008 Phase 4 NCT00629642 Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Portugal;Russian Federation;Spain;United Kingdom
Ozanimod
Biogen
2021 - NCT05688436 United States
Brigham and Women's Hospital
2022 - NCT05319093 -
Bristol-Myers Squibb
2021 - NCT05335031 Germany
Celgene
2025 Phase 3 NCT06408259 Australia;Italy;Mexico;Poland;Portugal;Romania;Spain;Taiwan;Turkey;United States
2014 Phase 3 NCT02294058 Argentina;Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2015-002500-91-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
I.R.C.C.S. FONDAZIONE S.LUCIA
2022 Phase 4 EUCTR2021-005860-24-IT Italy
Receptos, Inc.
2015 Phase 3 EUCTR2015-002500-91-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
The University of Texas at Dallas
2024 Phase 4 NCT06334094 United States
University of Colorado, Denver
2024 Phase 4 NCT06529406 United States
Ozanimod 0.5 MG
Celgene
2013 Phase 3 NCT02047734 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
Ozanimod 1 MG
Celgene
2013 Phase 3 NCT02047734 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
Ozanimod cloridrato
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2023 Phase 4 EUCTR2023-000018-16-IT Italy
OSPEDALE SAN RAFFAELE
2022 Phase 4 EUCTR2021-003577-63-IT Italy
Ozanimod HCI
Celgene International II Sàrl (CIS II)
2016 Phase 3 EUCTR2015-002500-91-PT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-GR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Ozanimod HCL
CELGENE INTERNATIONAL II SàRL
2016 Phase 3 EUCTR2015-002500-91-IT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Celgene International II Sàrl (CIS II)
2017 Phase 3 EUCTR2015-002500-91-SE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-PL Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-LV Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-LT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-EE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-002500-91-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2015-002500-91-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
Ozanimod hydrochloride
Celgene International II Sàrl
2016 Phase 1 EUCTR2016-003073-18-GB United Kingdom
Ozanimod oral capsule
I.R.C.C.S. Fondazione Santa Lucia
2023 Phase 4 NCT05777902 Italy
Pain
Ankara Yildirim Beyazit University
2019 - NCT04408742 Turkey
Palifermin
Cambridge University Hospitals NHS Foundation Trust
2012 Phase 1/Phase 2 NCT01712945 United Kingdom
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom
Pantoprazole
Merck KGaA
2008 Phase 1 NCT00938366 -
Paracetamol
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2015 Phase 1 NCT02583594 Spain
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark
Paracetamolo 500 MG
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
Paroxetine
University of Manitoba
2006 Phase 3 NCT00291148 Canada
Part A: 100 MG/ML GSK2618960
GlaxoSmithKline
2013 Phase 1 NCT01808482 United Kingdom
Part B: dose OF GSK2618960 decided from part A
GlaxoSmithKline
2013 Phase 1 NCT01808482 United Kingdom
Part C: dose OF GSK2618960 decided from part A and B
GlaxoSmithKline
2013 Phase 1 NCT01808482 United Kingdom
PB006
Polpharma Biologics S.A.
2019 Phase 3 EUCTR2018-004751-20-PL Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine
2019 Phase 3 EUCTR2018-004751-20-HR Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine
PCV
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
Peak
Bayer
2019 - NCT03808142 Germany
Peanut butter
Rocky Mountain MS Research Group, LLC
2014 Phase 4 NCT02217982 United States
PEG
Bayer
2024 - NCT06053749 Finland;Sweden
PEG-liposomal prednisolone sodium phosphate
Enceladus Pharmaceuticals BV
2010 - EUCTR2009-013884-21-PL Belgium;Germany;Poland
2009 - EUCTR2009-013884-21-DE Belgium;Germany;Poland
2009 Phase 2 EUCTR2009-013884-21-BE Belgium;Germany;Poland
Galapagos NV
2009 Phase 2 NCT01039103 Belgium;Germany;Poland
Peginterferon BETA-1A
Biogen
2021 - NCT05688436 United States
2019 Phase 3 NCT03958877 Argentina;Australia;Belgium;Bulgaria;Croatia;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 NCT03870763 Colombia;Estonia;Hungary;Jordan;Korea, Republic of;Malaysia;Mexico;Saudi Arabia;Taiwan;Thailand;Tunisia;Turkey;United States
2017 Phase 4 NCT03177083 Portugal
2016 Phase 4 NCT02587065 Italy
2016 Phase 4 NCT02568111 -
2014 - NCT02230969 Australia;Austria;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;Switzerland;United Kingdom;United States
2013 - NCT01911767 Australia;Canada;France;Germany;Ireland;Italy;Poland;Spain;United Kingdom;United States
2011 Phase 3 NCT01332019 Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2009 Phase 3 NCT00906399 Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Biogen Idec
2014 Phase 1 NCT02269930 United States
2014 Phase 4 NCT02234869 -
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Peginterferone beta 1A
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
Peginterferone BETA-1A
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Peginterferone lambda-1A
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Pegylated intereron BETA-1A
Biogen Idec Limited
2012 Phase 3 EUCTR2010-024477-39-GR Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2010-024477-39-GB Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2012 - EUCTR2010-024477-39-CZ Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-LV Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-EE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-024477-39-DE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-024477-39-BG Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-BE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Pegylated interferon BETA-1A
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Biogen Idec LTD
2009 - EUCTR2008-006333-27-LV Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom
Biogen Idec Limited
2012 Phase 3 EUCTR2010-024477-39-GR Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2010-024477-39-GB Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2012 - EUCTR2010-024477-39-CZ Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-LV Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-EE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-024477-39-DE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-024477-39-BG Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2011 - EUCTR2010-024477-39-BE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2010 - EUCTR2008-006333-27-GR Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom
2010 - EUCTR2008-006333-27-CZ Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-NL Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2008-006333-27-GB Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-EE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-BG Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2008-006333-27-BE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
- - EUCTR2008-006333-27-DE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
Cinnagen
2017 Phase 3 NCT05242133 Iran, Islamic Republic of
Pending
JOSE MANUEL GARCIA DOMINGUEZ
2013 - EUCTR2011-000985-36-ES Spain
Peptid coupled RED blood cells
Cellerys AG
2023 Phase 1;Phase 2 EUCTR2022-000801-28-CZ Czech Republic;Czechia;Germany;Italy;Switzerland
Peptide coupled RED blood cells
Cellerys AG
2023 Phase 1;Phase 2 EUCTR2022-000801-28-IT Czech Republic;Czechia;Germany;Italy;Switzerland
Perfusion OF treatment ocrelizumab
Rennes University Hospital
2023 Phase 3 NCT05758831 France
Perfusion OF treatment rituximab
Rennes University Hospital
2023 Phase 3 NCT05758831 France
Periodized exercise training
Hasselt University
2019 - NCT03803800 Belgium
Peripheral blood stem cell transplantation
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States
Peripheral blood withdrawal
Neuromed IRCCS
2023 - NCT05779449 Italy
Personalized extended interval dosing OF natalizumab
Amsterdam UMC, location VUmc
2020 Phase 4 NCT04225312 Netherlands
PET with 11C-flumazenil
Assistance Publique - Hôpitaux de Paris
2013 - NCT01651520 France
PET with [11C]flumazenil
Institut National de la Santé Et de la Recherche Médicale, France
2019 - NCT03825601 France
PET/CT scan
Mayo Clinic
2023 Phase 2 NCT05805839 United States
PF-06342674 0.25 MG/KG
Pfizer
2014 Phase 1 NCT02045732 United States
PF-06342674 1.5 MG/KG
Pfizer
2014 Phase 1 NCT02045732 United States
PF-06342674 6.0 MG/KG
Pfizer
2014 Phase 1 NCT02045732 United States
Phase 2
Supernus Pharmaceuticals, Inc.
2021 Phase 2/Phase 3 NCT04815967 Czechia;United States
Phase 3
Supernus Pharmaceuticals, Inc.
2021 Phase 2/Phase 3 NCT04815967 Czechia;United States
Phenylcyclopropylamine derivatives and dual LSD1/MAO-B (lysine-specific demethylase 1 and monoamine oxidase-B) inhibitor
Oryzon Genomics S. A
2017 Phase 2 EUCTR2017-002838-23-ES Spain
Phenytoin
University College, London
2011 Phase 2 NCT01451593 United Kingdom
Phosphate
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
PI-2301
PEPTIMMUNE Inc
2008 - EUCTR2007-007759-15-HU Hungary
Peptimmune Inc.
2010 Phase 2 EUCTR2009-012716-40-SK Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 Phase 2 EUCTR2009-012716-40-PL Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 - EUCTR2009-012716-40-FR Bulgaria;Czech Republic;Estonia;France;Germany;Poland
2010 Phase 2 EUCTR2009-012716-40-DE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 Phase 2 EUCTR2009-012716-40-CZ Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia
2010 - EUCTR2009-012716-40-BG Bulgaria;Czech Republic;Estonia;France;Germany;Poland
2009 - EUCTR2009-012716-40-EE Bulgaria;Czech Republic;Estonia;France;Germany;Poland
Pioglitazone
National Institute of Allergy and Infectious Diseases (NIAID)
2017 Phase 1/Phase 2 NCT03109288 United States
University of Illinois at Chicago
2003 Phase 1 NCT00242177 United States
PIPE-307
Pipeline Therapeutics, Inc.
2021 Phase 1 NCT04941781 United Kingdom
2021 Phase 1 NCT04725175 Australia
PIPE-307 dose A
Contineum Therapeutics
2023 Phase 2 NCT06083753 United States
PIPE-307 dose B
Contineum Therapeutics
2023 Phase 2 NCT06083753 United States
PIPE-791
Contineum Therapeutics
2024 Phase 1 NCT06683612 United Kingdom
2023 Phase 1 NCT05983939 United States
Pirfenidone
National Institute of Allergy and Infectious Diseases (NIAID)
2017 Phase 1/Phase 2 NCT03109288 United States
Pirtobrutinib
Loxo Oncology, Inc.
2024 Phase 2 NCT06104683 Puerto Rico;United States
Pixantrone
Fondation Charcot Stichting
2009 Phase 1;Phase 2 EUCTR2007-003086-40-BE Belgium;France
2008 - EUCTR2007-003086-40-FR France
PL 04515/0127
Queen Mary, University of London
2009 - EUCTR2008-000256-26-GB United Kingdom
PL 12762/0049
University College London
2010 Phase 4 EUCTR2009-017939-18-GB United Kingdom
Plasma exchange
Biogen Idec
2007 Phase 0 NCT00424788 United States
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
2023 Phase 1 ChiCTR2300076302 China
2020 Phase 0 ChiCTR2000036285 China
Plasticity-based computerized cognitive remediation program
Stony Brook University
2013 - NCT02141022 United States
Platelet transfusion
Region Skane
2016 - NCT02601131 Sweden
Platform
Georgia State University
2021 Phase 4 NCT04387734 United States
Pledigry
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Plegridy
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
Bayer
2024 - NCT06053749 Finland;Sweden
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Türkiye;United States
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
Holy Name Medical Center, Inc.
2017 Phase 4 NCT03424733 United States
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
Plegridy (peginterferon BETA-1A), biogen idec LTD
Bayer
2016 - NCT02749396 Finland
Plegridy - 125 MCG - soluzione iniettabile - USO sottocutaneo - penna preriempita - 0,5 ML - 6 penne preriempite
BIOGEN IDEC ITALIA S.R.L.
2015 Phase 4 EUCTR2015-002201-11-IT Italy
Plegridy 125 micrograms
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Plegridy 63 micrograms
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Pleneva TM BGC20-0134
Boston Scientific Corporation
2009 Phase 2 NCT01037907 Belgium;France;Germany;Italy;Poland;Russian Federation;Spain
Plovamer acetate
Merck KGaA
2014 - EUCTR2013-002283-25-PL Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-GR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 Phase 2 EUCTR2013-002283-25-GB Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-ES Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2014 - EUCTR2013-002283-25-BG Bulgaria;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
2013 - EUCTR2013-002283-25-IT Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-HU Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-HR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-FI Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
2013 - EUCTR2013-002283-25-CZ Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
Plovamer acetate 10 MG
EMD Serono
2013 Phase 2 NCT01963611 Bulgaria;Croatia;Czech Republic;Finland;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
Plovamer acetate 20 MG
EMD Serono
2013 Phase 2 NCT01963611 Bulgaria;Croatia;Czech Republic;Finland;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
Plovamer acetate 3 MG
EMD Serono
2013 Phase 2 NCT01963611 Bulgaria;Croatia;Czech Republic;Finland;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
PLP peptide
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland
Pneumococcal polysaccharide vaccine
Celgene
2021 Phase 3 NCT05028634 Germany;United States
Pneumovax II
R & D, Cambridge University Hospitals
2009 - EUCTR2009-011523-31-GB United Kingdom
PNF
Somogy Megyei Kaposi Mór Teaching Hospital
2018 - NCT04550650 Hungary
PNU-215062 sodium salt
Teva Pharmaceutical Industries Ltd
2006 Phase 2 EUCTR2005-004334-41-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 - EUCTR2004-003943-28-HU Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 Phase 2 EUCTR2004-003943-28-GB Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 Phase 2 EUCTR2004-003943-28-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 - EUCTR2004-003943-28-DE Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
2005 - EUCTR2004-003943-28-CZ Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
Polyphenon E
Louisiana State University Health Sciences Center in New Orleans
2011 Phase 2 NCT01451723 United States
2009 Phase 1 NCT00836719 United States
Ponesimod
ACTELION Pharmaceuticals Ltd
2010 Phase 2 EUCTR2009-011470-15-PL Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-NL Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-HU Australia;Austria;Bulgaria;Canada;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-GB Austria;Bulgaria;Canada;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-FI Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-DE Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-CZ Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-BG Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 2 EUCTR2009-011470-15-AT Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
ACTELION Pharmaceuticals Ltd.
2010 Phase 2 EUCTR2009-011470-15-SE Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Actelion
2017 Phase 3 NCT03232073 Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 NCT02907177 Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Mexico;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;United Kingdom;United States
2015 Phase 3 NCT02425644 Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Actelion Pharmaceuticals Ltd
2015 Phase 3 EUCTR2012-000540-10-SE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-PT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-PL Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LV Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-HU Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-HR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-GR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FI Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-ES Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-DE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-CZ Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Actelion Pharmaceuticals Ltd.
2019 Phase 3 EUCTR2012-000541-12-HR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Mexico;Poland;Portugal;Russian Federation;Spain;Switzerland;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-RO Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-PT Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-LV Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-HU Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-HR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-GR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-GB Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-FI Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-CZ Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2016-004719-10-BG Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3 EUCTR2012-000541-12-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2017 Phase 3 EUCTR2016-004719-10-SE Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2016-004719-10-PL Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2016-004719-10-LT Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2016-004719-10-ES Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2012-000541-12-PL Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2017 Phase 3 EUCTR2012-000541-12-FR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2017 Phase 3 EUCTR2012-000541-12-FI Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2017 Phase 3 EUCTR2012-000541-12-BG Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-PT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-HU Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-GR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-ES Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-DK Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-DE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-CZ Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
2016 Phase 3 EUCTR2012-000541-12-AT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States
Biogen
2021 - NCT05688436 United States
JANSSEN CILAG INTERNATIONAL NV
2023 Phase 3 EUCTR2020-004431-24-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
Janssen-Cilag International NV
2023 Phase 3 EUCTR2020-004431-24-PT Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2023 Phase 3 EUCTR2020-004431-24-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
2023 Phase 3 EUCTR2020-004431-24-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
2023 Phase 3 EUCTR2020-004431-24-DE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2023 Phase 3 EUCTR2020-004431-24-BG Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2022 Phase 3 EUCTR2020-004431-24-SE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
- Phase 3 EUCTR2020-004431-24-Outside-EU/EEA Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
- Phase 3 EUCTR2020-004431-24-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Peru;Poland;Portugal;Puerto Rico;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
Ponesimod 10 MG
Actelion
2010 Phase 2 NCT01093326 Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Ponesimod 20 MG
Actelion
2010 Phase 2 NCT01093326 Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Ponesimod 40 MG
Actelion
2010 Phase 2 NCT01093326 Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
Ponvory
Janssen-Cilag International NV
2023 Phase 3 EUCTR2020-004431-24-DE Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
2023 Phase 3 EUCTR2020-004431-24-BG Belgium;Bulgaria;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Portugal;Spain;Sweden;United Kingdom
Position sense
Ankara Yildirim Beyazit University
2019 - NCT04408742 Turkey
2019 - NCT04286828 Turkey
Pravastatin
Nantes University Hospital
2004 Phase 3 NCT00200655 France
PRD806998
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
Prebiotics and probiotics supplementation
Neuromed IRCCS
2023 - NCT05779449 Italy
Prednisolone
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
Tohoku University Hospital
2013 Phase 1,2 JPRN-UMIN000010094 Japan
Prednisone
Claudio Gobbi
2011 Phase 4 NCT01411514 Switzerland
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States
Holy Name Medical Center, Inc.
2017 Phase 4 NCT03424733 United States
National Eye Institute (NEI)
1988 - NCT00000147 United States
1988 Phase 3 NCT00000146 United States
National Institute of Neurological Disorders and Stroke (NINDS)
2016 Phase 2 NCT02784210 United States
Teva Pharmaceutical Industries
2005 Phase 4 NCT00203047 Canada;United States
The Affiliated Hospital of Guangdong Medical University
2024 Phase 3 ChiCTR2400087660 China
Third Affiliated Hospital, Sun Yat-Sen University
2016 Phase 4 NCT02809079 -
West China Hospital,Sichuan University
2024 Phase 4 ChiCTR2400087203 China
Pregabalin
Pfizer Japan Inc.
2010 Phase 3 JPRN-jRCT2080221298 -
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
2010 Phase 3 NCT01202227 Japan
University of Manitoba
2006 Phase 3 NCT00291148 Canada
Prepulsid
Department of Neurology UMCG
2006 - EUCTR2006-004318-42-NL Netherlands
Prevenar 13
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
PRN2246
GENZYME CORPORATION
2022 Phase 3 EUCTR2020-000644-55-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
Genzyme Corporation
2022 Phase 3 EUCTR2020-000644-55-EE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000647-30-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000647-30-FR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000647-30-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000647-30-RO Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-NO Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-FI Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-RO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-NO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-FR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-DK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-CZ Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-BG Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NO Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HR Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-BE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-RO Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-SK Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-NL Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-FR Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-ES Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-EE Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-CZ Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-SK Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-SE Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-NL Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-ES Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-EE Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
Procedure/surgery: implant procedure
SetPoint Medical Corporation
2025 - NCT06796504 -
Progressive exercise
University of Iowa
2010 Phase 1 NCT01381354 United States
Prolonged-release fampridine
University of Zurich
2012 Phase 2 NCT01576354 Switzerland
Propensity score
University Hospital, Clermont-Ferrand
2018 - NCT03552211 France
Propionic acid 1000 MG capsule
Salzburger Landeskliniken
2024 Phase 2/Phase 3 NCT06402487 Austria
Protein A immunoadsorption
The Third Affiliated Hospital Sun Yat-sen University
2025 - ChiCTR2500100495 China
Third Affiliated Hospital, Sun Yat-Sen University
2025 - NCT06763848 China
Provigil
Institute for Clinical Research
2003 - NCT00210301 United States
Sheba Medical Center
2005 - NCT00220506 Israel
Prucalopride
2010 Phase 4 EUCTR2010-023996-25-BE Belgium
Psilocybin therapy
University Medical Center Groningen
2025 Phase 2 NCT06782724 -
PSP
Biogen
2019 - NCT04221191 France
PTL201
PhytoTech Therapeutics, Ltd.
2018 Phase 2 NCT03005119 Israel
Qalcimum questionnaire
Centre Hospitalier Universitaire de Nimes
2016 - NCT02636829 France
Quadrivalent influenza vaccine
Novartis Pharmaceuticals
2021 Phase 4 NCT04667117 United States
Quality OF life
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France
Quality OF life questionnaires
University Hospital, Strasbourg, France
2025 Phase 3 NCT06663189 France
Questionnaires
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France
Quinidina sulfato
Avanir Pharmaceuticals, Inc.
2011 Phase 2 EUCTR2011-002178-22-ES Argentina;Bulgaria;Czech Republic;Poland;Spain;United Kingdom;United States
Quinidine sulfate
Avanir Pharmaceuticals, Inc.
2012 - EUCTR2011-002178-22-PL Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2012 Phase 2 EUCTR2011-002178-22-GB Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
2012 - EUCTR2011-002178-22-CZ Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States
R lipoic acid
Oregon Health and Science University
2005 Phase 1 NCT00676156 United States
RA15804589, C19061501-F, DNL788, DN2489, DN0002489
Sanofi-aventis recherche & développement
2022 Phase 2 EUCTR2022-000049-34-ES Belgium;Canada;China;Czechia;France;Germany;Italy;Poland;Spain;United States
Rabbit
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
Rabbit ANTI-human thymocyte immunoglobulin
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom
Rabbit human T lymphocyte immunoglobulin
Uppsala l?ns landsting
2011 Phase 2 EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States
Radiation therapy
Baylor College of Medicine
1999 Phase 2 NCT00040482 United States
Radiotracer [11C]-CS1p1
Washington University School of Medicine
2024 - NCT06591429 United States
Radiotracer [11C]-DPA-713
Washington University School of Medicine
2024 - NCT06591429 United States
Radiotracer [12F]-FDG
Washington University School of Medicine
2024 - NCT06591429 United States
Ralenova
University Medical Center Hamburg Eppendorf
2007 - EUCTR2007-001962-34-DE Germany
Raltegravir
Queen Mary University of London
2013 Phase 2 NCT01767701 United Kingdom
2013 - EUCTR2012-004847-61-GB United Kingdom
Ramatroban
Iou hospital
2008 - JPRN-UMIN000002725 Japan
Ranitidine
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain
Raptiva 100 MG/ML powder and solvent FOR solution FOR injection
Merck Serono International S.A.
2009 - EUCTR2007-001377-28-PT Austria;France;Germany;Netherlands;Portugal
2008 - EUCTR2007-001377-28-NL Austria;France;Germany;Netherlands;Portugal
2008 Phase 4 EUCTR2007-001377-28-FR Austria;France;Germany;Netherlands;Portugal
2008 - EUCTR2007-001377-28-DE Austria;France;Germany;Netherlands;Portugal
2008 - EUCTR2007-001377-28-AT Austria;France;Germany;Netherlands;Portugal
Ratg
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States
2017 Phase 3 NCT03342638 United States
Ravulizumab
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 3 EUCTR2019-003352-37-IT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
Alexion Pharma GK
2020 Phase 3 JPRN-jRCT2080225205 Asia except Japan;Europe;Japan;North America
Alexion Pharmaceuticals, Inc.
2022 Phase 2/Phase 3 NCT05346354 Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2022 Phase 2;Phase 3 EUCTR2021-006075-42-FR Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2022 Phase 2;Phase 3 EUCTR2021-006075-42-ES Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2020 Phase 3 EUCTR2019-003352-37-PL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-NL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-ES Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-DK Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-DE Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-AT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2019 Phase 3 NCT04201262 Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Poland;Spain;United Kingdom;United States
- Phase 2;Phase 3 EUCTR2021-006075-42-DE Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
University of Texas Southwestern Medical Center
2024 - NCT06398158 United States
Wuebbenhorst Hiroaki
2021 Phase 2-3 JPRN-jRCT2031220259 Japan;Spain;US
RC18 160 MG
RemeGen Co., Ltd.
2018 Phase 3 NCT03330418 China
RC18 160MG
RemeGen Co., Ltd.
2021 Phase 2 NCT04625153 China
RC18 240MG
RemeGen Co., Ltd.
2021 Phase 2 NCT04625153 China
RD06-05 cart cell injection
Nanjing Bioheng Biotech Co., Ltd.
2025 Early Phase 1 NCT06775912 China
Rebif
Aaron Boster
2006 Phase 0 NCT00618527 United States
Bayer
2024 - NCT06053749 Finland;Sweden
2006 Phase 4 NCT00317941 France
Biocad
2014 Phase 2/Phase 3 NCT02727907 Russian Federation
Biogen Idec
2014 Phase 1 NCT02269930 United States
Brigham and Women's Hospital
2015 - NCT02419638 United States
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark
EMD Serono
2014 Phase 4 NCT02117050 United States
2010 - NCT01207648 Argentina;Canada;France;Italy;Russian Federation;Tunisia;United States;Venezuela
2010 Phase 4 NCT01085318 United States
2004 Phase 4 NCT00101959 United States
1999 Phase 3 NCT00292266 -
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020337-99-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020337-99-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-FR Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020315-36-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 - EUCTR2010-020337-99-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-FI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
Genzyme Corporation
2008 - EUCTR2007-001162-32-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-NL Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-IT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-001162-32-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-001162-32-CZ Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 Phase 3 EUCTR2007-001162-32-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001162-32-AT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2008 - EUCTR2007-001161-14-SE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 - EUCTR2007-001161-14-PL Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 Phase 3 EUCTR2007-001161-14-FR Czech Republic;France;Germany;Poland;Sweden;United Kingdom
2008 - EUCTR2007-001161-14-DE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2008 - EUCTR2007-001161-14-CZ Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom
2007 Phase 3 EUCTR2007-001162-32-GB Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom
2007 - EUCTR2007-001161-14-GB Czech Republic;France;Germany;Poland;Sweden;United Kingdom
IMS HEALTH GmbH & Co. OHG
2016 - NCT02823951 Canada;United States
Karolinska Institutet
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
MERCK ROMANIA SRL
2014 Phase 4 EUCTR2014-001290-14-RO Romania
MERCK SERONO SA
2010 - EUCTR2009-016087-37-IT France;Ireland;Italy;Spain;United Kingdom
MERCK SERONO SPA
2009 - EUCTR2009-013333-24-IT Italy
Medizinische Universität Innsbruck
2014 - EUCTR2012-005450-30-SE Austria;Sweden
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden
Merck KGaA
2013 Phase 4 NCT01791244 Germany;Sweden
2012 - NCT01601119 United Kingdom
2010 - NCT01101776 Australia
2009 Phase 2 NCT01198132 France
2009 - NCT01075880 Czech Republic
2005 Phase 4 NCT01142466 -
2004 - NCT01142557 Germany
2004 Phase 4 NCT00367484 -
Merck KGaA, Darmstadt, Germany
2017 - NCT02949908 Germany
2016 - NCT02921035 Algeria;Argentina;Bahrain;Bulgaria;Egypt;Germany;Hungary;Iran, Islamic Republic of;Korea, Republic of;Kuwait;Lebanon;Morocco;Poland;Saudi Arabia;Tunisia;United Arab Emirates
2014 Phase 4 NCT02254304 Germany
2014 Phase 4 NCT02064816 Germany
Merck Serono International SA
2007 - EUCTR2006-003037-32-LT Estonia;Germany;Italy;Lithuania;Spain
2007 Phase 3 EUCTR2006-003037-32-ES Estonia;Germany;Italy;Lithuania;Spain
2007 - EUCTR2006-003037-32-EE Estonia;Germany;Italy;Lithuania;Spain
Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA
2007 Phase 3 EUCTR2006-002982-38-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain
2007 - EUCTR2006-002982-38-EE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
2009 - EUCTR2008-004954-34-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain
Merck Serono S.A. - Geneva
2010 - EUCTR2009-016087-37-GB France;Ireland;Italy;Spain;United Kingdom
2009 - EUCTR2009-016087-37-ES France;Ireland;Italy;Spain;United Kingdom
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2007 - EUCTR2006-002982-38-PT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2007 - EUCTR2006-002982-38-DE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-FI Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
2006 - EUCTR2006-002982-38-CZ Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2010 - EUCTR2008-004954-34-AT Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 Phase 3 EUCTR2008-004954-34-SK Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 Phase 3 EUCTR2008-004954-34-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain
2009 - EUCTR2008-004954-34-PL Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 - EUCTR2008-004954-34-LV Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain
2009 - EUCTR2008-004954-34-FI Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 - EUCTR2008-004954-34-EE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 - EUCTR2008-004954-34-DE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 - EUCTR2008-004954-34-BG Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2009 Phase 3 EUCTR2008-004954-34-BE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
2008 - EUCTR2008-004954-34-CZ Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey
Merck Serono S.A.- Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2009 Phase 3 EUCTR2008-004954-34-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain
Merck Serono S.A.-Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 Phase 3 EUCTR2006-002982-38-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain
Merck Serono SA
2007 - EUCTR2006-003037-32-DE Estonia;Germany;Italy;Lithuania;Spain
Merck Serono SA – Geneva
2010 - EUCTR2009-015502-19-GB Belgium;Finland;Germany;Sweden;United Kingdom
2010 - EUCTR2009-015502-19-DE Belgium;Finland;Germany;Sweden;United Kingdom
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy
PD Dr. Marcus Müller
2015 Phase 1 NCT02364986 Germany
Queen Mary, University of London
2009 - EUCTR2008-000256-26-GB United Kingdom
ROCHE
2011 Phase 3 EUCTR2010-020337-99-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IT Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Sahlgrenska University Hospital
2005 Phase 4 EUCTR2005-001008-37-SE Sweden
Serono International SA
2005 Phase 3 EUCTR2004-003799-13-ES Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom
2004 Phase 4 EUCTR2004-000337-12-HU Hungary
Teva Pharmaceutical Industries
2004 Phase 4 NCT00202995 Canada;United States
The Multiple Sclerosis Research Group, Department of Clinical Neuroscience
2009 - EUCTR2008-008554-23-SE Sweden
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University of North Carolina, Chapel Hill
2004 - NCT00137176 United States
Universitätsklinikum Heidelberg
2006 Phase 3 EUCTR2004-004403-37-DE Germany
VU University Medical Center
2011 - EUCTR2011-003570-89-NL Netherlands
Waukesha Memorial Hospital
2008 - NCT00391352 United States
sanofi-aventis Recherche & Dévelopment
2009 - EUCTR2008-006226-34-FR Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 Phase 3 EUCTR2008-006226-34-GR Belgium;Czech Republic;France;Germany;Greece;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis recherche et developpement
2010 - EUCTR2008-006226-34-GB Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-HU Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-CZ Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
Rebif (interferon BETA-1A), merck serono europe LTD
Bayer
2016 - NCT02749396 Finland
Rebif 22
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
Rebif 22 micrograms
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Rebif 22 Y 44 MCG
Merck, S.L.
2006 Phase 4 EUCTR2006-000606-23-ES Spain
Rebif 44
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic
Rebif 44 microgrammi/0.5ML soluzione iniettabile IN cartuccia
Merck Serono S.p.A.
2014 Phase 4 EUCTR2013-004450-21-IT Italy
Rebif 44 microgramos solucióN inyectable
Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
2009 Phase 3 EUCTR2008-004954-34-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 - EUCTR2006-002982-38-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
Rebif 44 microgramos solucióN inyectable EN jeringa precargada
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Rebif 44 micrograms
Biogen Idec GmbH
2005 - EUCTR2004-004130-14-AT Austria
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation
Rebif 44 micrograms solution FOR injection
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
Merck Serono S.A. - Geneva
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
Rebif 44 micrograms solution FOR injection IN PRE-filled syringe
Biogen Idec Limited
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Rebif 44 µG
Serono GmbH
2005 - EUCTR2005-001026-89-DE Germany
Rebif 8,8 µG, rebif 22µG
Serono GmbH
2005 - EUCTR2005-001026-89-DE Germany
Rebif 8.8 micrograms and 22 micrograms solution FOR injection IN PRE-filled syringe initiation pack
Biogen Idec Limited
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Rebif NEW formulation + ibuprofen PRN
Merck KGaA
2007 Phase 3 NCT00619307 France;Germany
Rebif NEW formulation + prophylactic ibuprofen
Merck KGaA
2007 Phase 3 NCT00619307 France;Germany
Rebif NEW formulation 44MCG multidose cartridge
Merck Serono International S.A.
2008 - EUCTR2008-000499-25-SE Germany;Italy;Spain;Sweden
2008 - EUCTR2008-000499-25-ES Germany;Italy;Spain;Sweden
- - EUCTR2008-000499-25-DE Germany;Italy;Spain;Sweden
Rebif NEW formulation NON titrated
EMD Serono
2007 Phase 3 NCT00472797 United States
Rebif NEW formulation titrated
EMD Serono
2007 Phase 3 NCT00472797 United States
Rebif SC 12SIR 12000000ui44MCG
Universita di Firenze
2006 Phase 3 EUCTR2006-004937-13-IT Italy
Rebif SC 12SIR 6000000UI 22MCG
Universita di Firenze
2006 Phase 3 EUCTR2006-004937-13-IT Italy
Rebif*SC 12SIR 12000000ui44MCG
MERCK SERONO INTERNATIONAL SA
2008 - EUCTR2006-003366-33-IT Italy;Spain
MERCK SERONO SA
2009 - EUCTR2008-004954-34-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain
2009 - EUCTR2008-003706-33-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom
OSPEDALE S. RAFFAELE
2004 - EUCTR2004-001601-10-IT France;Italy
Rebif*SC 12SIR 6000000UI 22MCG
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Rebif® NEW formulation
EMD Serono
2008 Phase 3 NCT00725985 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;India;Italy;Korea, Republic of;Lebanon;Macedonia, The Former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Merck KGaA
2008 - NCT01080027 Greece
2006 Phase 3 NCT00441103 Canada;Germany;Italy;Russian Federation;Spain;Switzerland
Rebif® NEW formulation (RNF) using rebismarttm
EMD Serono
2008 Phase 3 NCT00735007 Canada;Germany;Italy;Spain;Sweden;United States
Recombinant human alpha B-crystallin
Delta Crystallon B.V.
2012 - EUCTR2011-004475-36-BG Bulgaria
Delta Crystallon BV
2012 Phase 2 NCT02442570 Bulgaria
2009 Phase 1 NCT02442557 Netherlands
Recombinant human erythropoietin
Walton Centre for Neurology and Neurosurgery
2008 - EUCTR2008-005125-11-GB United Kingdom
Recombinant human IFN beta
Merck Serono International SA
2007 - EUCTR2006-005972-42-DE France;Germany
Recombinant human interferon beta
Serono International SA
2004 Phase 4 EUCTR2004-000337-12-HU Hungary
Recombinant humanized ANTI-alpha 4 integrin antibody
BIOGEN IDEC LTD
2007 - EUCTR2005-004061-41-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2007 - EUCTR2005-004061-41-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom
2006 - EUCTR2005-004061-41-IE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Spain;Sweden;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
Recombinant humanized ANTI-CD20 monoclonal antibody
F. Hoffmann-La Roche Ltd.
2022 Phase 4 EUCTR2021-003296-33-GR Greece;Russian Federation
Recombinant interferon BE
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Recombinant interferon BETA-1B
Bayer AG
2017 Phase 4 EUCTR2017-001176-31-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
Bayer HealthCare AG
2013 - EUCTR2012-005262-35-SI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-IT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 4 EUCTR2012-005262-35-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2012-005262-35-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal
Recombinant neisseria meningitidis group B nhba fusion protein
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Recombinant zoster vaccine
Prof Patrice Lalive
2022 Phase 4 NCT05596526 Switzerland
Remibrutinib
Iwasaki Ryohei
2023 Phase 3 JPRN-jRCT2071220034 France;Italy;Japan;Poland;Portugal;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;US
NOVARTIS PHARMA AG
2022 Phase 3 EUCTR2020-005929-89-IT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Japan;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-IT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Guatemala;Hong Kong;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
Novartis Farmacéutica S.A.
2022 Phase 3 EUCTR2020-005929-89-ES Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-ES Slovakia;Spain
Novartis Pharma AG
2023 Phase 3 EUCTR2020-005899-36-LT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2023 Phase 3 EUCTR2020-005899-36-DK Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2023 Phase 3 EUCTR2020-005899-36-AT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;Finland;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SK Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SI Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-RO Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Türkiye;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-PT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-PL Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Türkiye;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-HR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-GR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-FR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-EE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-BG Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-SK Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-NL Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-LV Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-HR Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-BG Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-BE Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
Novartis Pharmaceuticals
2021 Phase 3 NCT05156281 Argentina;Brazil;Bulgaria;Canada;China;Croatia;Estonia;France;Greece;India;Italy;Japan;Mexico;Poland;Portugal;Puerto Rico;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2021 Phase 3 NCT05147220 Argentina;Austria;Belgium;Brazil;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Georgia;Guatemala;Hong Kong;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Saudi Arabia;Slovakia;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
Remibrutinib oral treatment
Novartis Pharmaceuticals
2025 Phase 3 NCT06846281 -
Repository corticotropin injection
Mallinckrodt
2017 Phase 4 NCT03126760 United States
The University of Texas Health Science Center, Houston
2013 Phase 4 NCT01888354 United States
University at Buffalo
2009 Phase 2 NCT00986960 United States
Revaxis
R & D, Cambridge University Hospitals
2009 - EUCTR2009-011523-31-GB United Kingdom
University of Nottingham
2010 Phase 2 EUCTR2007-001496-11-GB United Kingdom
REX robotic assisted balance exercises
East Kent Hospitals University NHS Foundation Trust
2018 Phase 1 NCT06429085 United Kingdom
RHB-104
RedHill Biopharma Limited
2013 Phase 2 NCT01717664 Israel
Rhepo
Walton Centre for Neurology and Neurosurgery
2008 - EUCTR2008-005125-11-GB United Kingdom
Rhifn BETA-1B
Nuron Biotech Inc.
2011 Phase 3 NCT01464905 Belarus;Bulgaria;Croatia;Georgia;Hungary;India;Italy;Lebanon;Poland;Russian Federation;Serbia;Spain;Ukraine
Rhigm22
Acorda Therapeutics
2015 Phase 1 NCT02398461 United States
2013 Phase 1 NCT01803867 United States
Rhumab 2h7
Hoffman La Roche Ltd
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
Rhumab TO IL-17A IGG1-K-class
Novartis Pharma Services AG
2012 - EUCTR2011-001629-25-CZ Czech Republic;Russian Federation;Ukraine
Rhuph20
Hoffmann-La Roche
2019 Phase 1 NCT03972306 Canada;United States
Riboflavin
University of Iowa
2010 Phase 1 NCT01381354 United States
Rifampicin
Sanofi
2020 Phase 1 NCT06064539 United States
Rifampin
National Center for Research Resources (NCRR)
2001 Phase 2 NCT00043264 United States
Rilutek
UCL
2014 Phase 2 EUCTR2012-005394-31-GB United Kingdom
Riluzole
S. Andrea Hospital
2005 Phase 2 NCT00202397 Italy
UCL
2014 Phase 2 EUCTR2012-005394-31-GB United Kingdom
University College, London
2014 Phase 2 NCT01910259 United Kingdom
University of California, San Francisco
2006 Phase 2 NCT00501943 United States
RIPK1 inhibitor
Sanofi
2021 Phase 1 NCT04982991 United Kingdom
Ritalin
Sheba Medical Center
2003 Phase 1 NCT00220493 Israel
Ritalin LA 20MG capsules
Medizinische Universität Wien
2012 Phase 2 EUCTR2012-003418-15-AT Austria
Ritalin LA 30MG capsules
Medizinische Universität Wien
2012 Phase 2 EUCTR2012-003418-15-AT Austria
Ritalin LA 40MG capsules
Medizinische Universität Wien
2012 Phase 2 EUCTR2012-003418-15-AT Austria
Rituximab
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
Amsterdam UMC, location VUmc
2023 Phase 3 NCT05834855 Netherlands
Anders Svenningsson
2016 Phase 3 NCT02746744 Sweden
2009 Phase 2 NCT01719159 Sweden
Cairo University
2024 Phase 2 NCT06599307 Egypt
Centre Hospitalier de Pau
2015 Phase 2 EUCTR2014-005493-11-FR France
Claudio Gobbi
2020 - NCT04640818 Switzerland
Clinical Research Center, NHO Utano National Hospital
2014 Phase 2,3 JPRN-UMIN000013453 Japan
Clinical Research Center, Utano National Hospital, National Hospital Organization
2015 Phase 2,3 JPRN-UMIN000017217 Japan
Danish Multiple Sclerosis Center, Rigshospitalet
2020 Phase 3 EUCTR2020-002981-15-DK Denmark
Department of Clinical Sciences, Danderyd Hospital
2015 Phase 3 EUCTR2015-004116-38-SE Sweden
Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital
2018 Phase 2 EUCTR2018-000721-31-SE Sweden
Department of Pediatrics, Kobe Universtiy Graduate School of Medicine
2012 - JPRN-UMIN000009421 Japan
Dept of Neurology
2009 Phase 2 EUCTR2008-002626-11-SE Sweden
Dept of Neurology, Umeå University Hospital, Umeå, Sweden
2012 Phase 2 EUCTR2012-000721-53-SE Sweden
Feng Jinzhou
2023 - NCT06068829 -
Genentech, Inc.
2004 Phase 2 NCT00097188 United States
2004 Phase 2/Phase 3 NCT00087529 Canada;United States
Haukeland University Hospital
2020 Phase 3 NCT04578639 Norway;Sweden
Helse Bergen HF, Haukeland University Hospital
2022 Phase 3 EUCTR2020-001205-23-SE Norway;Sweden
2020 Phase 3 EUCTR2020-001205-23-NO Norway;Sweden
Isfahan University of Medical Sciences
2017 Phase 2/Phase 3 NCT03315923 Iran, Islamic Republic of
2015 Phase 2/Phase 3 NCT03002038 Iran, Islamic Republic of
Johns Hopkins University
2014 Phase 1 NCT02253264 United States
Karolinska Institutet
2018 Phase 3 NCT03979456 Sweden
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
National Institute of Neurological Disorders and Stroke (NINDS)
2010 Phase 1/Phase 2 NCT01212094 United States
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States
Odense University Hospital
2013 Phase 2 EUCTR2012-004436-36-DK Denmark
Oslo University Hospital
2019 Phase 3 NCT04121403 Norway
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark
Shandong University Qilu Hospital
2021 Phase 4 ChiCTR2100043013 China
Tang-Du Hospital
2014 Phase 4 NCT04256252 -
The Ophthalmology Department of the Chinese Peoples Liberation Army Hospital
2019 Phase 4 ChiCTR1900025744 China
2014 - ChiCTR-ICR-15007177 China
University of California, San Francisco
2004 Phase 1 NCT00501748 United States
University of Colorado, Denver
2017 Phase 3 NCT02980042 United States
2012 Phase 2 NCT01569451 United States
Västerbottens Läns Landsting
2014 Phase 2 EUCTR2013-002378-26-SE Sweden
Västerbottens läns landsting
2011 - EUCTR2010-023021-38-SE Sweden
Rituximab infusion
Wake Forest University Health Sciences
2013 Phase 4 NCT02040116 United States
Rituximab IT
Centre Hospitalier de PAU
2015 Phase 2 NCT02545959 France
Rituximab IV
Centre Hospitalier de PAU
2015 Phase 2 NCT02545959 France
Rituximab konsentrat TIL infusjonsvaeske oppløsning 10 MG/ML
Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital
2019 Phase 3 EUCTR2019-001505-24-NO Norway
Rivastigmin
Novartis Pharma GmbH
- - EUCTR2008-007015-32-DE Germany
Rivastigmine transdermal patch
Novartis Pharmaceuticals
2009 Phase 4 NCT00881205 Germany
Rixathon
Danish Multiple Sclerosis Center, Rigshospitalet
2020 Phase 3 EUCTR2020-002981-15-DK Denmark
RNF
EMD Serono
2008 Phase 3 NCT00725985 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;India;Italy;Korea, Republic of;Lebanon;Macedonia, The Former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
Merck KGaA
2008 Phase 3 NCT00813709 Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Turkey
2006 Phase 3 NCT00441103 Canada;Germany;Italy;Russian Federation;Spain;Switzerland
2006 Phase 3 NCT00404352 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Turkey
RNS60
University Hospital Zürich
2014 Phase 2 EUCTR2014-000221-20-AT Austria;Switzerland
RNS60 125 ML
Revalesio Corporation
2013 Phase 2 NCT01714089 United States
RNS60 250 ML
Revalesio Corporation
2013 Phase 2 NCT01714089 United States
RO 496-4913/F03
F.Hoffmann-La Roche
2011 Phase 3 EUCTR2010-020338-25-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2010-020338-25-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
RO 496-4913/F07
F.Hoffmann-La Roche
2013 Phase 3 EUCTR2010-020338-25-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-GR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
RO 533-3787/F01- 06
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2019-004092-39-IT Argentina;France;Italy;Mexico;Poland;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2019-004092-39-PL Argentina;France;Italy;Mexico;Poland;United Kingdom;United States
2022 Phase 3 EUCTR2019-004092-39-FR Argentina;France;Italy;Mexico;Poland;Ukraine;United Kingdom;United States
RO0506997
F. Hoffmann-La Roche Ltd
2007 Phase 2 EUCTR2004-004519-43-SK Czech Republic;Germany;Slovakia;Spain;United Kingdom
2007 - EUCTR2004-004519-43-GB Czech Republic;Germany;Spain;United Kingdom
2007 - EUCTR2004-004519-43-DE Czech Republic;Germany;Spain;United Kingdom
2005 Phase 2 EUCTR2004-004519-43-CZ Czech Republic;Germany;Slovakia;Spain;United Kingdom
RO4964913
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2019-003919-53-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-005448-48-IT Brazil;Czech Republic;Czechia;France;Italy;Poland;Spain
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2018 Phase 3;Phase 4 EUCTR2017-004886-29-IT Belgium;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
F. Hoffmann - La Roche
2010 Phase 3 EUCTR2010-020338-25-IT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Poland;Portugal;Spain;United Kingdom
F. Hoffmann-La Roche Ltd
2023 Phase 3 EUCTR2020-004128-41-RO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2023 Phase 3 EUCTR2020-004128-41-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-005448-48-FR Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2022 Phase 3 EUCTR2020-005448-48-CZ Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2022 Phase 3 EUCTR2020-004128-41-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2020-004128-41-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 4 EUCTR2021-000063-79-ES Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000063-79-DE Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000062-14-ES Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 4 EUCTR2021-000062-14-DE Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States
2021 Phase 3 EUCTR2020-005448-48-PL Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2020-004128-41-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Morocco;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-004128-41-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2019-003919-53-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2017-004886-29-SK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-SI Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-PT Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-PL Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-HU Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-HR Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-BG Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2021 Phase 3 EUCTR2017-004886-29-BE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2020 Phase 3 EUCTR2019-003919-53-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-003919-53-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2017-001313-93-DE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2019 Phase 3 EUCTR2017-004886-29-IE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-SE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-NL Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-GB Czech Republic;Denmark;Estonia;Finland;France;Ireland;Netherlands;Spain;Sweden;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-FR Belgium;Bulgaria;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-FI Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-EE Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-DK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-004886-29-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom
2018 Phase 3 EUCTR2017-001313-93-PL Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-IE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-HU Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Kuwait;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-FR Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Kuwait;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-DK Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
2018 Phase 3 EUCTR2017-001313-93-CZ Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates
- Phase 3 EUCTR2020-004128-41-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Latvia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd.
2022 Phase 4 EUCTR2021-003296-33-GR Greece;Russian Federation
2022 Phase 3 EUCTR2020-004128-41-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
F.Hoffmann-La Roche
2013 Phase 3 EUCTR2010-020338-25-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-GR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020338-25-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Portugal;Spain;United Kingdom
2011 Phase 3 EUCTR2010-020338-25-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020338-25-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020337-99-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-FR Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 - EUCTR2010-020315-36-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2010-020338-25-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020338-25-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2010 - EUCTR2010-020338-25-ES Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Greece;Hungary;Italy;Lithuania;Portugal;Spain;United Kingdom
2010 - EUCTR2010-020337-99-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-FI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States
F.Hoffmann-La Roche Ltd.
2008 - EUCTR2007-006338-32-IT Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Russian Federation;Spain;Switzerland;Ukraine;United Kingdom;United States
Hoffman La Roche Ltd
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
ROCHE
2018 Phase 4 EUCTR2018-000780-91-FR France
2011 Phase 3 EUCTR2010-020337-99-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IT Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-005448-48-ES Brazil;Czechia;France;Italy;Spain
Roche Farma S.A(Soc. Unipersonal) que realiza el ensayo en España y actúa como representante de F. Hoffmann-La Roche LTD
2018 Phase 3 EUCTR2017-001313-93-ES Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;France;Guatemala;Hungary;Ireland;Italy;Kuwait;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates
Roche Farma SA (Soc unipersonal) que realiza el ensayo en España y que actúa como representante F.Hoffmann-La Roche Ltd
2018 Phase 3 EUCTR2017-004886-29-ES Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom
University Nice Hospital
2022 Phase 3 EUCTR2021-006107-15-FR France
RO4964913 F07
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020337-99-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
RO4964913/F03
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom
RO4964913/F07
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2021-005746-15-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-005597-38-IT Belgium;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2021-005746-15-SK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-SE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-RO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-NO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-LT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-FI Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-CZ Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-005746-15-AT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Türkiye;Ukraine;United Kingdom;United States
2016 Phase 3 EUCTR2015-005597-38-SE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-NL Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-IE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-GB Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-FR Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-FI Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-EE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-DK Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-DE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-CZ Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
2016 Phase 3 EUCTR2015-005597-38-BE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2011 Phase 3 EUCTR2010-020315-36-BE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States
GENENTECH Inc.
2016 Phase 3 EUCTR2015-004616-37-SE Germany;Sweden;Switzerland;United States
2016 Phase 3 EUCTR2015-004616-37-DE Germany;Sweden;Switzerland;United States
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-SK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2021-005746-15-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States
Roche Farma S.A. que representa en España a F. Hoffmann-La Roche Ltd
2016 Phase 3 EUCTR2015-005597-38-ES Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom
RO4964913/F07-01
F. HOFFMANN - LA ROCHE LTD.
2020 Phase 3 EUCTR2020-000894-26-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-IT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-IT Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 2 EUCTR2016-002667-34-IT Italy;Poland;United States
2017 Phase 3 EUCTR2016-002937-31-IT Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-000894-26-GR Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-DK Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-BG Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000894-26-BE Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000893-69-GR Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000893-69-DK Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-GB Argentina;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-FR Argentina;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000894-26-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-PT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-PL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-NL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-HU Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-GB Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-FR Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-DE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000893-69-BE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-RO Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-IE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-FR Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-DE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2018-001511-73-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2020 Phase 2 EUCTR2016-002667-34-PL Italy;Mexico;Poland;United States
2019 Phase 3 EUCTR2018-001511-73-PL Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-HU Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-HR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-GB Bulgaria;Croatia;Germany;Hungary;Ireland;Poland;Portugal;Spain;United Kingdom
2019 Phase 3 EUCTR2018-001511-73-ES Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 3 EUCTR2018-001511-73-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-SI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-SE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-NO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-FR Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2016-002937-31-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Roche Farma S.A. (Soc.unipersonal)que realiza el ensayo en España y que actúa como representante de F.Hoffmann-La Roche
2017 Phase 3 EUCTR2016-002937-31-ES Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
RO5333787
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2019-004092-39-IT Argentina;France;Italy;Mexico;Poland;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-001088-26-IT Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States
2021 Phase 3 EUCTR2020-003413-35-IT Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2021-001088-26-DE Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States
2022 Phase 3 EUCTR2019-004092-39-PL Argentina;France;Italy;Mexico;Poland;United Kingdom;United States
2022 Phase 3 EUCTR2019-004092-39-FR Argentina;France;Italy;Mexico;Poland;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-PL Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-HU Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-HR Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-DE Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-BG Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd.
2017 Phase 3 EUCTR2015-005431-41-PL Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Russian Federation;Taiwan;Turkey;Ukraine;United States
2016 Phase 3 EUCTR2015-005431-41-HR Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Taiwan;Turkey;Ukraine;United States
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-GB France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-DE France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
RO7010939
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-001168-28-IT Austria;Bulgaria;Denmark;Finland;France;Greece;Italy;Netherlands;United States
2021 Phase 3 EUCTR2019-004857-10-IT Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
F. Hoffmann-La Roche Ltd
2022 Phase 2 EUCTR2021-003772-14-HR Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
2021 Phase 2 EUCTR2021-003772-14-SK Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
2021 Phase 2 EUCTR2021-003772-14-CZ Croatia;Czech Republic;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia
2021 Phase 3 EUCTR2020-001168-28-GR Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-DK Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-BG Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2019-004857-10-PT Algeria;Argentina;China;Dominican Republic;Egypt;Finland;France;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
2021 Phase 3 EUCTR2019-004857-10-NL Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2021 Phase 3 EUCTR2019-004857-10-HU Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2021 Phase 3 EUCTR2019-004857-10-DE Algeria;Argentina;China;Dominican Republic;Egypt;Finland;France;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
2020 Phase 3 EUCTR2020-001168-28-FR Austria;Bulgaria;Denmark;Finland;France;Greece;Italy;Netherlands;United States
2020 Phase 3 EUCTR2019-004857-10-FI Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
RO7121932 - MAD
Hoffmann-La Roche
2021 Phase 1 NCT05704361 Belgium;Canada;Germany;Israel;Italy;Moldova, Republic of;Poland;Portugal;Romania;Serbia;Spain;United States
RO7121932 IV - SAD
Hoffmann-La Roche
2021 Phase 1 NCT05704361 Belgium;Canada;Germany;Israel;Italy;Moldova, Republic of;Poland;Portugal;Romania;Serbia;Spain;United States
RO7121932 SC - SAD
Hoffmann-La Roche
2021 Phase 1 NCT05704361 Belgium;Canada;Germany;Israel;Italy;Moldova, Republic of;Poland;Portugal;Romania;Serbia;Spain;United States
Rolipram
National Institute of Neurological Disorders and Stroke (NINDS)
2001 Phase 2 NCT00011375 United States
RPC-1063
Celgene
2020 Phase 3 NCT04140305 Canada;Puerto Rico;United States
RPC1063
Celgene
2016 Phase 1 NCT02797015 United States
2015 Phase 3 NCT02576717 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
2012 Phase 2/Phase 3 NCT01628393 Belgium;Bulgaria;Georgia;Greece;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
Celgene International II Sàrl
2016 Phase 1 EUCTR2016-003073-18-GB United Kingdom
RTL1000
Artielle ImmunoTherapeutics
2006 Phase 1 NCT00411723 United States
RTX
Feng Jinzhou
2023 - NCT06068829 -
Ruxience
Danish Multiple Sclerosis Center, Rigshospitalet
2020 Phase 3 EUCTR2020-002981-15-DK Denmark
Ruxolitinib
Tianjin Medical University General Hospital
2024 Phase 1/Phase 2 NCT05909943 China
RVP-001
Reveal Pharmaceuticals Inc.
2024 Phase 2 NCT06322342 United States
RYAH-medtech inhaler
OMNI Medical Services, LLC
2018 Phase 2 NCT03944447 United States
S-warfarin
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States
SA237
Chugai Pharmaceutical Co. Ltd
2016 Phase 3 EUCTR2015-005431-41-RO Bulgaria;Canada;Croatia;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Turkey;Ukraine;United States
2015 Phase 3 EUCTR2013-003752-21-HU France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
2015 - EUCTR2013-003752-21-ES France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-IT France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom
Chugai Pharmaceutical Co., Ltd.
2019 - JPRN-jRCT2080225027 Japan
2014 Phase 3 JPRN-jRCT2080222347 Asia except Japan;Europe;Japan;North America
F. Hoffmann-La Roche Ltd.
2017 Phase 3 EUCTR2015-005431-41-PL Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Russian Federation;Taiwan;Turkey;Ukraine;United States
2016 Phase 3 EUCTR2015-005431-41-HR Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Taiwan;Turkey;Ukraine;United States
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-GB France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-DE France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
Saline
Cairo University
2024 Phase 2 NCT06599307 Egypt
GlaxoSmithKline
2011 Phase 1 NCT01435993 Germany;Italy;Norway
Haukeland University Hospital
2021 Phase 1/Phase 2 NCT04749667 Norway
Innate Immunotherapeutics
2014 Phase 2 NCT02228213 Australia;New Zealand
University at Buffalo
2009 Phase 2 NCT00986960 United States
Sapelizumab
Chugai Pharmaceutical Co. Ltd
2016 Phase 3 EUCTR2015-005431-41-RO Bulgaria;Canada;Croatia;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Turkey;Ukraine;United States
SAR339658
Genzyme Corporation
2015 Phase 2 EUCTR2014-003265-19-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-SE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-DE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
SAR441344
Sanofi-Aventis Recherche et Développement
2021 Phase 2 EUCTR2020-004785-19-FR Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States
2021 Phase 2 EUCTR2020-004785-19-DE Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States
2021 Phase 2 EUCTR2020-004785-19-CZ Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States
2021 Phase 2 EUCTR2020-004785-19-BG Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Türkiye;Ukraine;United States
SAR441344 IV
Sanofi
2021 Phase 2 NCT04879628 Bulgaria;Canada;Czechia;France;Germany;Russian Federation;Spain;Turkey;Ukraine;United States
SAR441344 SC
Sanofi
2021 Phase 2 NCT04879628 Bulgaria;Canada;Czechia;France;Germany;Russian Federation;Spain;Turkey;Ukraine;United States
SAR442168
GENZYME CORPORATION
2022 Phase 3 EUCTR2020-000644-55-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
Genzyme Corporation
2022 Phase 3 EUCTR2020-000644-55-EE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000647-30-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000647-30-FR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000647-30-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000645-14-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000647-30-RO Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-NO Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-FI Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000647-30-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-RO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-NO Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-FR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-DK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-CZ Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000645-14-BG Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Kuwait;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NO Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HR Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-BE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-RO Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-SK Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-NL Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-FR Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-ES Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-EE Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-004731-76-CZ Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-SK Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-SE Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-NL Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-ES Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
2019 Phase 2 EUCTR2018-003927-12-EE Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
Peking University Third Hospital
2020 - NCT04964791 China
Sanofi
2019 Phase 1 NCT04171310 United Kingdom
2019 Phase 2 NCT03889639 Canada;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States
Tanaka Tomoyuki
2024 Phase 3 JPRN-jRCT2031240058 China;Japan;Republic of Korea;Turkey;Ukraine;United States
2021 Phase 3 JPRN-jRCT2021200035 Austria;Belarus;Bulgaria;Canada;China;Czechia;Denmark;Estonia;Finland;Germany;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
SAR443820
Sanofi
2022 Phase 2 NCT05630547 Belgium;Bulgaria;Canada;Chile;China;France;Germany;Italy;Poland;Spain
Sanofi-aventis recherche & développement
2023 Phase 2 EUCTR2022-000049-34-DE Belgium;Bulgaria;Canada;Chile;China;France;Germany;Greece;Italy;Poland;Spain
2023 Phase 2 EUCTR2022-000049-34-BG Belgium;Bulgaria;Canada;Chile;China;France;Germany;Greece;Italy;Poland;Spain
2022 Phase 2 EUCTR2022-000049-34-PL Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Greece;Italy;Poland;Spain;United States
2022 Phase 2 EUCTR2022-000049-34-FR Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Greece;Italy;Poland;Spain;United States
2022 Phase 2 EUCTR2022-000049-34-ES Belgium;Canada;China;Czechia;France;Germany;Italy;Poland;Spain;United States
2022 Phase 2 EUCTR2022-000049-34-BE Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Greece;Italy;Poland;Spain;United States
SARS-COV-2 mrna vaccine
NYU Langone Health
2021 - NCT04843774 United States
Sativex
ALMIRALL PRODESFARMA
2011 - EUCTR2011-002258-30-IT Italy
AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
2004 - EUCTR2005-000393-47-IT Italy
Almirall Hermal GmbH
2016 Phase 4 EUCTR2015-004451-40-CZ Austria;Czech Republic
2016 Phase 4 EUCTR2015-004451-40-AT Austria;Czech Republic
Almirall, S.A.
2012 Phase 3 NCT01538225 Italy
GW PHARMA LTD
2008 - EUCTR2006-005910-11-IT Germany;Italy;Spain;United Kingdom
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-PL Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
2007 Phase 3 EUCTR2006-005910-11-CZ Czech Republic;Germany;Italy;Spain;United Kingdom
2006 Phase 3 EUCTR2005-005265-11-GB Czech Republic;France;United Kingdom
2006 Phase 3 EUCTR2005-005265-11-FR Czech Republic;France;United Kingdom
2006 - EUCTR2005-005265-11-CZ Czech Republic;France;United Kingdom
2005 Phase 3 EUCTR2004-002509-63-GB Czech Republic;United Kingdom
2005 - EUCTR2004-002509-63-CZ Czech Republic;United Kingdom
GW Pharma Ltd.
2008 Phase 3 EUCTR2006-005910-11-GB Czech Republic;Germany;Italy;Spain;United Kingdom
2008 - EUCTR2006-005910-11-DE Germany;Italy;Spain;United Kingdom
2007 - EUCTR2007-002138-13-GB United Kingdom
GW Pharmaceuticals Ltd.
2012 Phase 4 NCT01964547 Czech Republic
2008 Phase 3 NCT00681538 United Kingdom
2007 Phase 3 NCT00702468 United Kingdom
2006 Phase 3 NCT00391079 Canada
2005 Phase 3 NCT01599234 United Kingdom
2002 Phase 3 NCT01604265 United Kingdom
2002 Phase 3 NCT00711646 United Kingdom
2002 Phase 3 NCT00678795 United Kingdom
GW Research Ltd
2013 Phase 3 NCT01868048 -
IRCCS Centro Neurolesi Bonino-Pulejo
2016 - NCT03186664 Italy
JOSE MANUEL GARCIA DOMINGUEZ
2013 - EUCTR2011-000985-36-ES Spain
Jazz Pharmaceuticals
2011 - NCT02073474 -
S. Andrea Hospital
2005 Phase 2 NCT00202423 Italy
Sativex - spray PER mucosa orale 3 flaconi nebulizzatori CON pompa dosatrice DA 10 ML - 90 erogazioni
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2016 Phase 4 EUCTR2016-000840-32-IT Italy
Sativex 2,7MG/2,5 MG solucion para pulverizacion bucal
GW Pharma Limited
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom
Sativex oromucosal spray
GW Pharma Limited
2021 Phase 3 EUCTR2020-003271-18-CZ Czech Republic;Czechia;Poland;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-GB Poland;United Kingdom
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-CZ Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
GW Pharma Ltd.
2011 - EUCTR2011-000926-31-CZ Czech Republic
Satralizumab
Chugai Pharmaceutical Co., Ltd.
2019 - JPRN-jRCT2080225027 Japan
2014 Phase 3 JPRN-jRCT2080222347 Asia except Japan;Europe;Japan;North America
F. HOFFMANN - LA ROCHE LTD.
2022 Phase 3 EUCTR2019-004092-39-IT Argentina;France;Italy;Mexico;Poland;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-001088-26-IT Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States
2021 Phase 3 EUCTR2020-003413-35-IT Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2021-001088-26-DE Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States
2022 Phase 3 EUCTR2019-004092-39-PL Argentina;France;Italy;Mexico;Poland;United Kingdom;United States
2022 Phase 3 EUCTR2019-004092-39-FR Argentina;France;Italy;Mexico;Poland;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-PL Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-HU Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-HR Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-DE Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-003413-35-BG Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
F. Hoffmann-La Roche Ltd.
2017 Phase 3 EUCTR2015-005431-41-PL Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Russian Federation;Taiwan;Turkey;Ukraine;United States
2016 Phase 3 EUCTR2015-005431-41-HR Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Taiwan;Turkey;Ukraine;United States
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-GB France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
2014 Phase 3 EUCTR2013-003752-21-DE France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States
Hans-Christian von Buedingen
2021 Phase 4 JPRN-jRCT2031200333 Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Hoffmann-La Roche
2025 Phase 3 NCT05199688 Argentina;France;Italy;Mexico;Poland;Ukraine;United Kingdom;United States
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 NCT02073279 Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Philippines;Poland;Puerto Rico;Romania;Singapore;Taiwan;Turkey;Ukraine;United States
2014 Phase 3 NCT02028884 France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States
Huashan Hospital
2025 - NCT06829524 China
Huashan Hospital, Fudan University
2025 - ChiCTR2500099340 China
Okuno Tatsusada
2024 Phase 1 JPRN-jRCT2051230006 -
Regine Buffels
2022 Phase 4 JPRN-jRCT2021220014 Canada;France;Germany;India;Italy;Japan;Korea;Turkey;United States
Satralizumab 120 MG
Hoffmann-La Roche
2022 Phase 4 NCT05269667 Canada;France;Germany;India;Italy;Japan;Korea, Republic of;Turkey;United States
SB-683699
GlaxoSmithKline Research & Development Ltd
2007 - EUCTR2006-007057-42-SE Czech Republic;Denmark;Sweden
2007 - EUCTR2006-007057-42-DK Czech Republic;Denmark;Sweden
2007 Phase 2 EUCTR2006-007057-42-CZ Belgium;Czech Republic;Denmark;Sweden
2007 - EUCTR2006-007057-42-BE Belgium;Czech Republic;Denmark;Sweden
SB683699
GLAXO SMITHKLINE
2004 - EUCTR2004-000374-31-IT Italy
GlaxoSmithKline
2004 Phase 2 NCT00097331 Belgium;Canada;France;Germany;Italy;Poland;Romania;Russian Federation;Spain;United States
GlaxoSmithKline Research & Development Ltd
2007 - EUCTR2006-002633-20-LT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2007 - EUCTR2006-002633-20-IT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2007 Phase 2 EUCTR2006-002633-20-GB Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2007 Phase 2 EUCTR2006-002633-20-FR Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2006 - EUCTR2006-002633-20-NL Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2006 - EUCTR2006-002633-20-FI Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2006 - EUCTR2006-002633-20-DE Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
2006 - EUCTR2006-002633-20-AT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom
GlaxoSmithKline S.A
2006 Phase 2 EUCTR2006-002633-20-ES Australia;Austria;Canada;Finland;France;Germany;Italy;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Spain;United Kingdom
SC interferon BETA-1A
Biogen
2017 - NCT03347370 Germany
SC interferon BETA-1B
Biogen
2017 - NCT03347370 Germany
SC peginterferon BETA-1A
Biogen
2017 - NCT03347370 Germany
Sclerolym
ImCyse S.A
2014 Phase 1;Phase 2 EUCTR2014-001081-99-BE Belgium
SCM-010
Stem Cell Medicine Ltd.
2024 Phase 1/Phase 2 NCT03696485 Israel
Seasonal influenza vaccine
Celgene
2021 Phase 3 NCT05028634 Germany;United States
Novartis
2010 Phase 3 NCT01199861 Austria;Belgium;Canada;Finland;France;Guatemala;Poland;Spain;Switzerland;United Kingdom
Seasonal quadrivalent influenza vaccine
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
Second-generation fumaric acid
Biogen Idec Inc.
2004 - EUCTR2004-000663-99-SE Hungary;Sweden
2004 - EUCTR2004-000663-99-HU Hungary;Sweden
2004 - EUCTR2004-000663-99-CZ Czech Republic;Hungary;Sweden
Secukinumab
NOVARTIS FARMA
2013 - EUCTR2012-004019-29-IT Argentina;Canada;Colombia;Finland;Germany;Italy;Japan;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
Novartis Farmacéutica, S.A.
2013 - EUCTR2012-004019-29-ES Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
Novartis Pharma AG
2013 - EUCTR2012-004019-29-SE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 - EUCTR2012-004019-29-PT Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 - EUCTR2012-004019-29-PL Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 - EUCTR2012-004019-29-FI Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 - EUCTR2012-004019-29-DE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 Phase 2 EUCTR2012-004019-29-CZ Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
2013 Phase 2 EUCTR2012-004019-29-BE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States
Novartis Pharma K.K.
2013 Phase 2 JPRN-jRCT2080222132 -
Novartis Pharma Services AG
2012 - EUCTR2011-001629-25-CZ Czech Republic;Russian Federation;Ukraine
Select dmts other than ozanimod
Bristol-Myers Squibb
2021 - NCT06133049 United States
Selenium
National Center for Complementary and Integrative Health (NCCIH)
1999 Phase 1/Phase 2 NCT00010842 United States
Self massage
University of Iowa
2010 Phase 1 NCT01381354 United States
Sendoxan
Uppsala l?ns landsting
2011 Phase 2 EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States
Sendoxane
Helse Bergen HF, Haukeland University Hospital
2018 Phase 3 EUCTR2017-001362-25-SE Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
Serum containing avonex
Biogen Idec
2003 Phase 1 NCT00913250 -
Serum free avonex
Biogen Idec
2003 Phase 1 NCT00913250 -
SF-12 questionnaire
University Hospital, Lille
2020 - NCT04334031 France
SH U 555 C
C.H.U. de RENNES
2008 - EUCTR2007-005363-10-FR France
2008 - EUCTR2007-005362-12-FR France
Max-Planck-Institute of Psychiatry
2007 - EUCTR2006-001337-17-DE Germany
Short-course ocrelizumab
Johns Hopkins University
2021 Phase 2 NCT04767698 United States
Silodyx
Erasmus MC Dept. Urology
2016 Phase 3 EUCTR2015-002820-20-NL Netherlands
Simethicone
Rocky Mountain MS Research Group, LLC
2014 Phase 4 NCT02217982 United States
Simvahexal® 40 MG filmtabletten
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom
Simvastatin
Alabama Neurology Associates, PC
2005 Phase 3 NCT00242268 United States
Anna Tsakiri
2008 Phase 3 NCT00429442 Denmark
Biogen Idec
2006 Phase 4 NCT00492765 Denmark
Glostrup Hospital, Dep. of Neurology
2009 - EUCTR2006-001827-21-DK Denmark
Glostrup University Hospital, Copenhagen
2006 Phase 3 NCT00261326 Denmark
Imperial College London
2008 Phase 2 NCT00647348 United Kingdom
Tehran University of Medical Sciences
2005 Phase 3 NCT00668343 Iran, Islamic Republic of
University College, London
2019 Phase 2 NCT03896217 United Kingdom
2018 Phase 3 NCT03387670 Ireland;United Kingdom
VUmc Neurology Department
2020 Phase 2 EUCTR2019-003127-38-NL Netherlands
Simvastatin 40 MG FILM-coated tablets
University College London
2020 Phase 2 EUCTR2017-003008-30-GB United Kingdom
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom
Simvastatin alternova
Biogen Idec A/S
2006 - EUCTR2005-003930-16-SE Finland;Sweden
2006 - EUCTR2005-003930-16-FI Finland;Sweden
2005 - EUCTR2005-003930-16-DK Denmark;Finland;Sweden
Simvastatin IN relapsing remitting multiple sclerosis
Assiut University
2020 Phase 1 NCT04178980 -
Simvastatina sandoz 40 MG comprimidos recubiertos CON PELícula EFG
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom
Simvastatine
VUmc Neurology Department
2020 Phase 2 EUCTR2019-003127-38-NL Netherlands
Simvastatine sandoz 40 MG filmomhulde tabletten
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom
Simvastatine sandoz 40MG deelbare filmomhulde tabletten
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom
Single-USE autoinjector
Biogen Idec
2005 Phase 3 NCT00915577 -
Single-USE autoinjector with A prefilled liquid avonex syringe
Biogen
2009 Phase 3 NCT00828204 United States
Sinvastatina sandoz 40 MG comprimidos revestidos POR PELícula
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom
Siponimob
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Siponimod
Biogen
2021 - NCT05688436 United States
NOVARTIS FARMA
2012 Phase 3 EUCTR2012-003056-36-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Novartis Pharma K.K.
2014 Phase 3 JPRN-jRCT2080222397 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;United Kingdom;United States
Novartis Pharma Services AG
2010 Phase 2 EUCTR2009-014392-51-PL Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States
2010 Phase 2 EUCTR2009-014392-51-HU Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States
2010 Phase 2 EUCTR2009-014392-51-FI Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States
2010 - EUCTR2009-014392-51-DE Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States
Novartis Pharmaceuticals
2022 - NCT05376579 Italy
2021 - NCT04933552 United States
2021 Phase 3 NCT04926818 Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
2021 - NCT04895202 Switzerland
2021 - NCT04540861 -
2019 Phase 3 NCT03623243 Puerto Rico;United States
Siponimod 0,25 MG
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2021 Phase 4 EUCTR2020-005947-22-IT Italy
Siponimod 0.25 MG tablet
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Siponimod 0.5 MG tablet
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Siponimod 1 MG
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2021 Phase 4 EUCTR2020-005947-22-IT Italy
Siponimod 1 MG tablet
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Siponimod 2 MG
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2023 Phase 4 EUCTR2023-000142-42-IT Italy
2021 Phase 4 EUCTR2020-005947-22-IT Italy
Siponimod 2 MG tablet
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Siponimod fumarato
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2023 Phase 4 EUCTR2023-000142-42-IT Italy
Siponimod fumaric acid
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-RO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
Sirolimus
National Institute of Allergy and Infectious Diseases (NIAID)
2003 Phase 1/Phase 2 NCT00095329 United States
Sivatin 40 MG FILM-coated tablets
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom
Sivelestat
Tohoku University Hospital
2013 Phase 1,2 JPRN-UMIN000010094 Japan
Sleep assessment
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France
Sleep quality and physical activity
University of Jordan
2021 - NCT05046535 Jordan
Smderpept
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland
Smoked cannabis
Center for Medicinal Cannabis Research
2003 Phase 1/Phase 2 NCT00260741 United States
2001 Phase 1/Phase 2 NCT00248378 United States
Smoking
University of Jordan
2021 - NCT05046535 Jordan
Sodium chlorid
Sykehuset Innlandet HF
2009 - NCT00764413 Norway
Sodium chloride
NeuroGenesis Ltd.
2025 Phase 2 NCT06961383 Israel;United States
Sodium chloride solution
Anders Svenningsson
2016 Phase 3 NCT02746744 Sweden
Solifenacin succinate
Astellas Pharma Inc
2008 Phase 4 NCT00629642 Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Portugal;Russian Federation;Spain;United Kingdom
Soliris
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Alexion Pharmaceuticals Inc.
2020 Phase 2;Phase 3 EUCTR2019-001829-26-DE Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2019 Phase 2;Phase 3 EUCTR2019-001829-26-ES Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Alexion Pharmaceuticals, Inc.
2015 Phase 3 EUCTR2013-001151-12-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001151-12-DK Argentina;Australia;Austria;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Martinique;Romania;Russian Federation;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001151-12-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2015 Phase 3 EUCTR2013-001150-10-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Malaysia;Martinique;Peru;Romania;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001151-12-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hong Kong;Italy;Japan;Korea, Republic of;Netherlands;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2014 Phase 3 EUCTR2013-001150-10-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001151-12-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2013 Phase 3 EUCTR2013-001150-10-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Peru;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Arab Emirates;United Kingdom;United States
Solriamfetol
Johns Hopkins University
2024 Phase 2 NCT06170970 United States
Solu medrol - 125 MG/2 ML polvere E solvente PER soluzione iniettabile 1 flacone A doppia camera DA 125 MG/2 ML
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
SOLU-medrol
Danish Multiple Sclerosis Research Centre
2009 Phase 2 EUCTR2009-011516-37-DK Denmark
Department of Clinical Neuroscience, Karolinska Institutet
2018 Phase 2 EUCTR2018-000620-34-SE Sweden
2018 Phase 2 EUCTR2018-000620-34-NO Germany;Norway;Sweden
Enceladus Pharmaceuticals BV
2010 - EUCTR2009-013884-21-PL Belgium;Germany;Poland
2009 - EUCTR2009-013884-21-DE Belgium;Germany;Poland
2009 Phase 2 EUCTR2009-013884-21-BE Belgium;Germany;Poland
Uppsala l?ns landsting
2011 Phase 2 EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States
SOLU-moderin 1 G
Servicio de Neurología
2008 - EUCTR2007-000888-15-ES Spain
Solumedrol
University of Utah
2014 - NCT02296346 United States
Solumedrol IM 125MG/2ML
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
Somatorelin
UNIVERSITA' DEGLI STUDI DI NAPOLI FEDERICO II
2009 - EUCTR2008-007447-14-IT Italy
Sparc0921
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States
Specifically design 6 month resistance training program
University of Nebraska
2013 - NCT01816100 United States
Spikevax
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany
Spinning GRP
Somogy Megyei Kaposi Mór Teaching Hospital
2018 - NCT04550650 Hungary
Spiropent
Department of Neurology UMCG
2006 - EUCTR2006-004318-42-NL Netherlands
SR-fampridine
University of Southern Denmark
2014 Phase 4 NCT02143167 Denmark
Standard gadolinium contrast
National Center for Research Resources (NCRR)
1999 - NCT00006060 United States
Standard interval dosing
Amsterdam UMC, location VUmc
2020 Phase 4 NCT04225312 Netherlands
Standard lymphodepletion regimen
Kyverna Therapeutics
2024 Phase 2 NCT06384976 United States
Stanford University
2024 Phase 1 NCT06138132 United States
Standard MS DMT
Novartis Pharmaceuticals
2011 Phase 4 NCT01317004 Italy
Standard MS dmts
Novartis Pharmaceuticals
2010 Phase 4 NCT01216072 Canada;Puerto Rico;United States
Standard treatment with A conventional drug
Northwestern University
2005 Phase 2 NCT00273364 United States
Standard-OF-care
University Hospital, Antwerp
2025 Phase 2 NCT06715605 Belgium
Standardized cannabis extract
Institut fur Klinische Forschung, Germany
2006 Phase 3 NCT00552604 United Kingdom
Static balance test
Gazi University
2018 - NCT03584672 -
Statin
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy
Stem cell transplantation
Stem Cells Arabia
2016 Phase 1 NCT03069170 Jordan
Step tracking
Ohio State University
2017 - NCT03244696 United States
Strength training
University of Aarhus
2016 - NCT02870023 Denmark
Stretching
University of Illinois at Chicago
2025 - NCT06341023 United States
Stroop test
Slovak Academy of Sciences
2017 - NCT03052595 Slovakia
Study drug
Biogen
2014 Phase 1 NCT02201849 United States
SUB0750MIG
St. Vincent's University Hospital
2012 Phase 4 EUCTR2011-002561-38-IE Ireland
SUB175614
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
SUB22282
Biogen Idec Limited
2012 Phase 3 EUCTR2010-021978-11-IE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2012 - EUCTR2010-021978-11-BE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-SE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-PL Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-GB Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-FI Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-ES Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-DK Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-DE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Iraq;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-CZ Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
Sublingual tizanidine 12 MG
Teva GTC
2008 Phase 1/Phase 2 NCT00464958 Israel
Sunphenon
Charite University, Berlin, Germany
2007 Phase 1/Phase 2 NCT00525668 Germany
Sunphenon egcg
Charite Universitätsmedizin Berlin
- Phase 2;Phase 3 EUCTR2008-005213-22-DE Germany
Friedemann Paul
2009 Phase 2/Phase 3 NCT00799890 Germany
Sunphenon egcg TM
Charité-Universitätsmedizin Berlin
2007 - EUCTR2006-006323-39-DE Germany
Supervised physical therapy
University of Jordan
2017 Phase 1/Phase 2 NCT03326505 Jordan
Suspension media
University Hospital, Toulouse
2015 Phase 1/Phase 2 NCT02403947 France
Sustained-release oral dalfampridine
Sheba Medical Center
2014 Phase 4 NCT02259361 Israel
Suvorexant
Theodore R. Brown, MD MPH
2017 Phase 4 NCT03110315 United States
Syngeneic bone marrow transplantation
Fred Hutchinson Cancer Center
2008 Phase 2 NCT00716066 United States
T cell vaccination
Hadassah Medical Organization
2002 Phase 1/Phase 2 NCT01448252 Israel
Sheba Medical Center
2002 Phase 3 NCT00228228 Israel
T-cell vaccination
Sheba Medical Center
1998 Phase 1/Phase 2 NCT00220428 Israel
Tachipirina - 500 MG compresse20 compresse
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States
TACI-FC5
Merck Serono Geneva- an affiliate of Merck KGaA, Darmstadt Germany
2008 - EUCTR2007-003936-50-SE Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Merck Serono International
2009 - EUCTR2008-005021-11-SE Belgium;Czech Republic;France;Sweden
2009 Phase 2 EUCTR2008-005021-11-FR Belgium;Czech Republic;France;Sweden
2009 Phase 2 EUCTR2008-005021-11-CZ Belgium;Czech Republic;France;Sweden
Merck Serono International S.A.
2008 - EUCTR2007-003936-50-NL Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2008 Phase 2 EUCTR2007-003936-50-FR Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2008 Phase 2 EUCTR2007-003936-50-ES Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Merck Serono S.A. - Geneva
2008 - EUCTR2007-003936-50-GB Australia;Austria;Canada;Czech Republic;France;Lebanon;Lithuania;Netherlands;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States
2008 - EUCTR2007-003936-50-AT Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Merck Serono SA - Geneva, An affiliate of Merck KGaA, Darmstadt, Germany
2009 - EUCTR2008-005021-11-BE Belgium;Czech Republic;France;Sweden
Merck Serono SA - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2008 - EUCTR2007-003936-50-CZ Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2008 - EUCTR2007-003936-50-BE Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Merck Serono SA-Geneva
2008 - EUCTR2007-003936-50-LT Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Tamsulosin
Centre Hospitalier Universitaire de Nimes
2022 - NCT05439902 France
Tanakan
Ipsen
2003 Phase 3 NCT00276341 France
Tarenflurbil
Fraunhofer Gesellschaft for its Institute Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)
2015 Phase 2 EUCTR2014-004483-38-DE Germany
Targretin
Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge
2015 Phase 2 EUCTR2014-003145-99-GB United Kingdom
Taurine
University of Iowa
2010 Phase 1 NCT01381354 United States
TCD after bosentan administration
Universitair Ziekenhuis Brussel
2014 - NCT02389426 Belgium
TCD baseline
Universitair Ziekenhuis Brussel
2014 - NCT02389426 Belgium
Tcelna
Opexa Therapeutics, Inc.
2012 Phase 2 NCT01684761 Canada;United States
Tecfidera
Banner Life Sciences LLC
2019 Phase 1 NCT04022473 United States
Biogen GmbH
2015 Phase 4 EUCTR2014-000395-26-DE Germany
Biogen Idec Italia S.r.l.
2015 - EUCTR2015-000303-21-IT Italy
Biogen Idec Ltd.
2009 Phase 3 EUCTR2008-004753-14-DE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
Biogen Idec Norway
2015 Phase 4 EUCTR2015-001197-18-NO Norway
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States
2015 Phase 3 EUCTR2014-004562-22-DE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
2015 - EUCTR2013-001025-53-ES Denmark;Finland;Netherlands;Norway;Spain;United Kingdom
2015 Phase 4 EUCTR2013-001025-53-DK Denmark;Finland;Netherlands;Norway;Spain;United Kingdom
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom
2014 Phase 4 EUCTR2013-001656-35-SK Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-SI Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-PT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-IT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-HU Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-FR Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-ES Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-CZ Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-BE Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 Phase 4 EUCTR2013-001656-35-AT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain
2014 - EUCTR2013-001486-17-DE Germany
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
Department of Clinical Sciences, Danderyd Hospital
2015 Phase 3 EUCTR2015-004116-38-SE Sweden
EMD Serono Research & Development Institute, Inc.
2017 Phase 2 NCT02975349 Bulgaria;Czechia;Germany;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States
Finn Sellebjerg
2016 Phase 2 EUCTR2016-000283-41-DK Denmark
IMS HEALTH GmbH & Co. OHG
2016 - NCT02823951 Canada;United States
IRCCS Centro Neurolesi Bonino Pulejo
2021 - NCT05811949 Italy
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Merck KGaA
2017 Phase 2 EUCTR2016-001448-21-SK Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-PL Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-ES Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-CZ Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
2017 Phase 2 EUCTR2016-001448-21-BG Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
Multiple Sclerosis Center of Northeastern New York
2015 Phase 4 NCT02683863 United States
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom
University of Texas Southwestern Medical Center
2016 Phase 4 NCT02739542 United States
Yale University
2014 - NCT02218879 United States
Tecfidera - 240 MG - capsula rigida gastroresistente - USO orale - blister (PVC/PE/PVDC-PVC alluminio) - 56 capsule
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2017 Phase 4 EUCTR2017-000559-26-IT Israel;Italy;Switzerland;United States
Tecfidera 240MG CPS ETD
Fakultní nemocnice Ostrava
2021 Phase 4 EUCTR2021-003195-13-CZ Czech Republic
Tecfidera® 120 MG
Alkermes, Inc.
2019 Phase 3 EUCTR2017-001294-16-DE Germany;Poland;United States
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States
Tecfidera® 120MG magensaftresistente hartkapseln
Universitätsklinikum Münster
2015 Phase 4 EUCTR2014-003481-25-DE Germany
Tecfidera® 240 MG
Alkermes, Inc.
2019 Phase 3 EUCTR2017-001294-16-DE Germany;Poland;United States
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States
Tecfidera® 240MG magensaftresistente hartkapseln
Universitätsklinikum Münster
2015 Phase 4 EUCTR2014-003481-25-DE Germany
Telephone-based cognitive behavioral therapy
University of Michigan
2018 Phase 4 NCT03621761 United States
Telitacicept
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
2020 Phase 0 ChiCTR2000036285 China
Temelimab
GeNeuro Innovation SAS
2021 Phase 2 EUCTR2021-001973-21-SE Sweden
2020 Phase 2 EUCTR2019-004822-15-SE Sweden
Temsirolimus tablets
Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
2005 - EUCTR2005-000171-18-FI Finland
Tenofovir
Massachusetts General Hospital
2023 Phase 2 NCT05957913 United States
Tenofovir alafenamide
Massachusetts General Hospital
2022 Phase 2 NCT04880577 United States
Teriflunomide
Actelion
2015 Phase 3 NCT02425644 Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Actelion Pharmaceuticals Ltd
2015 Phase 3 EUCTR2012-000540-10-SE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-PT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-PL Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LV Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-LT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-HU Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-HR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-GR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-FI Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-ES Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-DE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
2015 Phase 3 EUCTR2012-000540-10-CZ Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
Aventis Pharmaceuticals Inc.
2006 - EUCTR2004-000555-42-PT Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
Biocad
2021 Phase 3 NCT05385744 Russian Federation
2019 Phase 2 NCT04056897 Russian Federation
Centre Hospitalier Universitaire de Nice
2015 Phase 3 NCT02587195 France
Centre hospitalier de l'Université de Montréal (CHUM)
2015 - NCT02490982 Canada
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-001168-28-IT Austria;Bulgaria;Denmark;Finland;France;Greece;Italy;Netherlands;United States
2021 Phase 3 EUCTR2019-004857-10-IT Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-001168-28-GR Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-DK Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2020-001168-28-BG Austria;Brazil;Bulgaria;Canada;Denmark;Finland;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Türkiye;United Kingdom;United States
2021 Phase 3 EUCTR2019-004857-10-PT Algeria;Argentina;China;Dominican Republic;Egypt;Finland;France;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
2021 Phase 3 EUCTR2019-004857-10-NL Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2021 Phase 3 EUCTR2019-004857-10-HU Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
2021 Phase 3 EUCTR2019-004857-10-DE Algeria;Argentina;China;Dominican Republic;Egypt;Finland;France;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
2020 Phase 3 EUCTR2020-001168-28-FR Austria;Bulgaria;Denmark;Finland;France;Greece;Italy;Netherlands;United States
2020 Phase 3 EUCTR2019-004857-10-FI Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States
Fakultní nemocnice Ostrava
2023 Phase 4 EUCTR2022-004331-23-CZ Czech Republic
2021 Phase 4 EUCTR2021-003195-13-CZ Czech Republic
GENZYME CORPORATION
2022 Phase 3 EUCTR2020-000644-55-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2017 Phase 3 EUCTR2011-005249-12-IT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States
Genzyme Corporation
2022 Phase 3 EUCTR2020-000644-55-EE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NO Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Türkiye;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-HR Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000644-55-BE Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-RO Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2017 Phase 3 EUCTR2011-005249-12-SI Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Egypt;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2011-005249-12-PT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Egypt;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2011-005249-12-NL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States
2015 Phase 3 EUCTR2011-005249-12-LT Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2014 Phase 4 EUCTR2013-001439-34-IT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States
2014 Phase 4 EUCTR2013-001439-34-GR Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 Phase 4 EUCTR2013-001439-34-GB Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-DE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-BE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 - EUCTR2013-001439-34-AT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2014 Phase 3 EUCTR2011-005249-12-GB Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2014 Phase 3 EUCTR2011-005249-12-ES Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2011-005249-12-EE Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States
2014 Phase 3 EUCTR2011-005249-12-BE Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-SE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-FI Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States
2013 Phase 4 EUCTR2013-001439-34-ES Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States
2013 - EUCTR2012-005324-16-NL Belgium;Germany;Netherlands
2013 - EUCTR2012-005324-16-DE Belgium;Germany;Netherlands
2013 - EUCTR2012-005324-16-BE Belgium;Germany;Netherlands
- Phase 3 EUCTR2011-005249-12-Outside-EU/EEA Australia;Bosnia and Herzegovina;Canada;China;Israel;Lebanon;Morocco;Russian Federation;Tunisia;Turkey;United States
- Phase 3 EUCTR2011-005249-12-FR Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States
- Phase 3 EUCTR2011-005249-12-BG Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
Genzyme, a Sanofi Company
2014 Phase 3 NCT02201108 Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Israel;Lebanon;Lithuania;Macedonia, The Former Yugoslav Republic of;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States
Hoffmann-La Roche
2021 Phase 3 NCT04586023 Austria;Brazil;Bulgaria;Canada;Denmark;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Poland;Puerto Rico;Russian Federation;Turkey;United Kingdom;United States
2021 Phase 3 NCT04586010 Algeria;Argentina;China;Dominican Republic;Finland;Georgia;Germany;Hong Kong;Hungary;Italy;Kenya;Mexico;Morocco;Netherlands;North Macedonia;Peru;Poland;Portugal;Russian Federation;Serbia;Spain;Switzerland;Taiwan;Tunisia;Ukraine;United States
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
MS Centrum, Department of Neurology, Sshlgrenska University Hospital
2018 Phase 4 EUCTR2016-004414-10-SE Sweden
McGill University
2016 - NCT03561402 Canada
Merck Healthcare KGaA
2022 Phase 3 EUCTR2019-004980-36-CZ Belarus;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-SI Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2021 Phase 3 EUCTR2019-004980-36-RO Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-SK Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PT Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-PL Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Türkiye;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-NO Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LV Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-LT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-GR Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-ES Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-DE Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004980-36-BG Belarus;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States
2020 Phase 3 EUCTR2019-004972-20-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
2020 Phase 3 EUCTR2019-004972-20-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2020 Phase 3 NCT04338061 Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Latvia;Lithuania;Malaysia;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United States
2020 Phase 3 NCT04338022 Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States
NOVARTIS PHARMA AG
2022 Phase 3 EUCTR2020-005929-89-IT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Japan;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-IT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Guatemala;Hong Kong;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Farmacéutica S.A.
2022 Phase 3 EUCTR2020-005929-89-ES Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-ES Slovakia;Spain
Novartis Farmacéutica, S.A.
2016 Phase 3 EUCTR2015-005419-33-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-ES Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma Services AG
2016 Phase 3 EUCTR2015-005419-33-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
Novartis Pharma AG
2023 Phase 3 EUCTR2020-005899-36-LT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2023 Phase 3 EUCTR2020-005899-36-DK Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2023 Phase 3 EUCTR2020-005899-36-AT Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;Finland;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SK Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SI Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-SE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-RO Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Türkiye;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-PT Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-PL Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Türkiye;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-HR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-GR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-FR Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-EE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005929-89-BG Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Morocco;Oman;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-SK Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Arab Emirates;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-NL Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-LV Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-HR Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-BG Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Ireland;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2022 Phase 3 EUCTR2020-005899-36-BE Argentina;Austria;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-FR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HU Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BE Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005419-33-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-NL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2017 Phase 3 EUCTR2015-005418-31-CZ Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-SE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-PL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-HR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-GB Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-EE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
2016 Phase 3 EUCTR2015-005418-31-BG Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Novartis Pharmaceuticals
2021 Phase 3 NCT05156281 Argentina;Brazil;Bulgaria;Canada;China;Croatia;Estonia;France;Greece;India;Italy;Japan;Mexico;Poland;Portugal;Puerto Rico;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States
2021 Phase 3 NCT05147220 Argentina;Austria;Belgium;Brazil;Bulgaria;Chile;China;Colombia;Croatia;Denmark;Georgia;Guatemala;Hong Kong;India;Ireland;Israel;Italy;Jordan;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Netherlands;Poland;Saudi Arabia;Slovakia;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States
Providence Health & Services
2013 Phase 4 NCT01970410 United States
Sanofi
2024 Phase 3 NCT06372145 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
2023 Phase 3 NCT06141473 Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
2020 Phase 4 NCT04410965 China
2013 - NCT03198351 Canada;United States
2013 Phase 4 NCT01895335 Austria;Belgium;Canada;Chile;Finland;France;Germany;Greece;Italy;Norway;Spain;Sweden;United Kingdom;United States
2011 Phase 2 NCT01403376 Austria;Canada;Germany;Russian Federation;Ukraine
2011 Phase 3 NCT01252355 Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2009 Phase 3 NCT00883337 Belgium;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Spain;Switzerland;Tunisia;United Kingdom
2008 Phase 3 NCT00751881 Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;South Africa;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 NCT00622700 Australia;Austria;Brazil;Bulgaria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Italy;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2007 Phase 2 NCT00811395 Austria;Canada;Germany;Italy;Spain;United Kingdom;United States
2007 Phase 2 NCT00489489 Canada;Germany;Italy;Poland;Spain;United States
2007 Phase 2 NCT00475865 Austria;Canada;Germany;Italy;United Kingdom;United States
2006 Phase 3 NCT00803049 Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2004 Phase 3 NCT00134563 Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2002 Phase 2 NCT00228163 Canada;France
2001 Phase 2 NCT01487096 Canada;France
Sanofi-Aventis US, Inc.
2004 - EUCTR2004-000555-42-AT Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
Sanofi-Aventis recherche & de'veloppement
2008 - EUCTR2007-003997-24-IT Austria;Italy;Spain;United Kingdom
Sanofi-Aventis recherche & développement
2008 - EUCTR2007-003997-24-GB Austria;Italy;Spain;United Kingdom
2007 - EUCTR2007-003997-24-ES Austria;Italy;Spain;United Kingdom
2007 - EUCTR2007-003997-24-AT Austria;Italy;Spain;United Kingdom
Sanofi-aventis U.S. Inc
2007 - EUCTR2006-003134-14-IT Germany;Italy;Spain
2007 - EUCTR2004-000555-42-EE Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
Sanofi-aventis U.S. Inc.
2007 - EUCTR2006-004893-29-IT Austria;Germany;Italy;United Kingdom
2007 Phase 2 EUCTR2006-004893-29-GB Austria;Germany;Italy;United Kingdom
2007 - EUCTR2006-004893-29-AT Austria;Germany;Italy;United Kingdom
2007 Phase 2 EUCTR2006-003134-14-ES Germany;Italy;Spain
2007 - EUCTR2006-003134-14-DE Germany;Italy;Spain
- - EUCTR2006-004893-29-DE Austria;Germany;Italy;United Kingdom
Sanofi-aventis US, Inc
2008 Phase 3 EUCTR2004-000555-42-GB Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
2005 - EUCTR2004-000555-42-DK Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
2004 - EUCTR2004-000555-42-SE Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
2004 - EUCTR2004-000555-42-NO Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
Sanofi-aventis recherche & développement
2010 - EUCTR2007-004452-36-SK Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-SE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-GR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2007-004452-36-GB Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2007-004452-36-FR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-ES Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-EE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2007-004452-36-DE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom
2008 - EUCTR2006-001152-12-SK Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2008 Phase 3 EUCTR2006-001152-12-FR Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
TG Therapeutics
2017 Phase 3 EUCTR2017-000639-15-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000639-15-GB Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000639-15-ES Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-GB Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-ES Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
TG Therapeutics, Inc.
2017 Phase 3 NCT03277261 United States
2017 Phase 3 NCT03277248 United States
2017 Phase 3 EUCTR2017-000639-15-PL Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-PL Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Turku University Hospital
2017 Phase 4 EUCTR2016-003622-16-FI Finland
UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
2016 Phase 4 EUCTR2016-001515-20-IT Italy
University at Buffalo
2018 - NCT03526224 United States
University of British Columbia
2003 - NCT06705608 -
University of Michigan
2018 - NCT03464448 United States
sanofi-aventis Recherche & De`veloppement
2004 - EUCTR2004-000555-42-IT Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
sanofi-aventis Recherche & Dévelopment
2009 - EUCTR2008-006226-34-FR Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis U.S Inc
2007 - EUCTR2004-000555-42-CZ Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom
sanofi-aventis group
2011 - EUCTR2010-023172-12-GR Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
sanofi-aventis recherche de veloppement
2007 - EUCTR2006-003361-14-IT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
sanofi-aventis recherche & developpement
2011 - EUCTR2011-001160-21-DE Austria;Canada;Germany;Russian Federation;Ukraine
2011 - EUCTR2011-001160-21-AT Austria;Canada;Germany;Russian Federation;Ukraine
sanofi-aventis recherche & développement
2009 - EUCTR2007-004452-36-AT Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2006-003361-14-EE Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2009 - EUCTR2006-003361-14-CZ Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2006-001152-12-LT Australia;Austria;Belarus;Bulgaria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2009 - EUCTR2006-001152-12-DE Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2008 - EUCTR2007-004452-36-NL Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-004452-36-CZ Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2007-004452-36-BE Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2006-003361-14-PT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2008 - EUCTR2006-003361-14-NL Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2006-003361-14-DK Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2008 - EUCTR2006-001152-12-HU Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2008 - EUCTR2006-001152-12-EE Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2008 Phase 3 EUCTR2006-001152-12-BG Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2007 Phase 3 EUCTR2006-003361-14-SE Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2007 Phase 3 EUCTR2006-003361-14-GB Austria;Canada;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2006-003361-14-DE Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Poland;Portugal;Russian Federation;Sweden;Switzerland;Ukraine;United Kingdom;United States
2007 Phase 3 EUCTR2006-001152-12-GB Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2007 Phase 3 EUCTR2006-001152-12-FI Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2007 - EUCTR2006-001152-12-DK Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2007 Phase 3 EUCTR2006-001152-12-CZ Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States
2007 - EUCTR2006-001152-12-AT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom
2006 Phase 3 EUCTR2006-003361-14-FI Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom
2006 - EUCTR2006-003361-14-AT Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
sanofi-aventis recherche et development
2012 - EUCTR2010-023172-12-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 Phase 3 EUCTR2010-023172-12-SK Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-PT Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-NO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-IT Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 Phase 3 EUCTR2010-023172-12-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-GB Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-ES Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 - EUCTR2010-023172-12-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2011 Phase 3 EUCTR2010-023172-12-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
2011 - EUCTR2010-023172-12-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States
2009 - EUCTR2008-006226-34-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 Phase 3 EUCTR2008-006226-34-GR Belgium;Czech Republic;France;Germany;Greece;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
sanofi-aventis recherche et developpement
2010 - EUCTR2008-006226-34-GB Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-HU Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
2009 - EUCTR2008-006226-34-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
2009 - EUCTR2008-006226-34-CZ Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom
Teriflunomide 14 MG
Centre Hospitalier Universitaire de Nice
2017 Phase 3 NCT03122652 France;Germany;Martinique;Sweden;Switzerland;Turkey;United Kingdom
Jan Lycke
2019 Phase 4 NCT04129736 Sweden
Tanaka Tomoyuki
2024 Phase 3 JPRN-jRCT2031240058 China;Japan;Republic of Korea;Turkey;Ukraine;United States
Teriflunomide capsule
Iwasaki Ryohei
2023 Phase 3 JPRN-jRCT2071220034 France;Italy;Japan;Poland;Portugal;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;US
Novartis Pharmaceuticals
2016 Phase 3 NCT02792231 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Finland;France;Germany;Hungary;India;Italy;Latvia;Lithuania;Mexico;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
2016 Phase 3 NCT02792218 Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States
Teriflunomide HMR1726
Sanofi
2020 Phase 3 NCT04410991 Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 NCT04410978 Austria;Belarus;Bulgaria;Canada;China;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2019 Phase 4 NCT03856619 India
2014 Phase 1 NCT02046629 China
2013 Phase 3 NCT01863888 Belgium;Germany;Netherlands
Tanaka Tomoyuki
2021 Phase 3 JPRN-jRCT2021200035 Austria;Belarus;Bulgaria;Canada;China;Czechia;Denmark;Estonia;Finland;Germany;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
Testing OF autonomous nervous system function
Slovak Academy of Sciences
2017 - NCT03052595 Slovakia
Testosterone
University of California, Los Angeles
2014 Phase 2 NCT02317263 -
Testosterone undecanoate
Health Sciences Centre, Winnipeg, Manitoba
2012 Phase 2 NCT01516554 Canada
Hôpitaux Universitaires de Strasbourg
2019 Phase 2 EUCTR2018-002648-10-FR France
Tetanus diphtheria toxoids vaccine
Biogen
2015 Phase 2 NCT02097849 United States
Tetanus toxoid
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States
Tetanus toxoid vaccine
Novartis
2010 Phase 3 NCT01199861 Austria;Belgium;Canada;Finland;France;Guatemala;Poland;Spain;Switzerland;United Kingdom
Tetanus, diphtheria, and acellular pertussis vaccine
Celgene
2021 Phase 3 NCT05028634 Germany;United States
Tetracycline
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy
Tetracycline - statin - antimycotic
Università Popolare Homo & Natura
2015 Phase 0 NCT02606929 Italy
Tetrahydrocannabinol
Tiffany J. Braley, MD, MS
2022 Phase 2 NCT05269628 United States
TG-1101
TG Therapeutics
2017 Phase 3 EUCTR2017-000639-15-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000639-15-GB Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000639-15-ES Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-GB Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-ES Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
TG Therapeutics, Inc.
2020 Phase 3 EUCTR2019-003625-16-PL Belarus;Croatia;Georgia;Poland;Russian Federation;Serbia;Ukraine;United States
2020 Phase 3 EUCTR2019-003625-16-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2017 Phase 3 EUCTR2017-000639-15-PL Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-PL Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
THC
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark
Almirall Hermal GmbH
2016 Phase 4 EUCTR2015-004451-40-AT Austria;Czech Republic
GW Pharma Limited
2022 Phase 3 EUCTR2020-004306-58-LT Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom
2021 Phase 3 EUCTR2020-003271-18-CZ Czech Republic;Czechia;Poland;Spain;United Kingdom;United States
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom
2020 Phase 3 EUCTR2019-002625-29-GB Poland;United Kingdom
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-PL Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
2020 Phase 3 EUCTR2019-002623-14-GB Czech Republic;Poland;Romania;United Kingdom;United States
2020 Phase 3 EUCTR2019-002623-14-CZ Czech Republic;Czechia;Poland;Romania;United Kingdom;United States
Tiffany J. Braley, MD, MS
2022 Phase 2 NCT05269628 United States
University of Calgary
2024 Phase 2 NCT06261489 -
Thiamine
University of Iowa
2010 Phase 1 NCT01381354 United States
Thioplex
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy
Thiotepa
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy
Thymoglobuline
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-SE Denmark;Netherlands;Sweden
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;Sweden
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom
Uppsala l?ns landsting
2011 Phase 2 EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States
Thymol
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2021 - JPRN-UMIN000043910 Japan
Time restricted olive OIL based (troo) ketogenic diet
Terry L. Wahls
2022 - NCT05007483 United States
Timed UP AN GO test
Gazi University
2018 - NCT03584672 -
Tissue selective estrogen complex
University of California, San Francisco
2016 Phase 2 NCT02710214 United States
Tizanidine
Teva GTC
2006 Phase 1/Phase 2 NCT00358293 Israel
Tizanidine hydrochloride capsule
Elan Pharmaceuticals
2002 Phase 3 NCT00047580 United States
TMP001
Dr. Frank Behrens
2015 Phase 2 NCT02686788 Germany
Fraunhofer Gesellschaft for its Institute Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)
2015 Phase 2 EUCTR2014-004483-38-DE Germany
Tocilizumab
Department of Immunology, National Institute of Neuroscience, NCNP
2014 - JPRN-UMIN000012705 Japan
2012 - JPRN-UMIN000007866 Japan
2011 - JPRN-UMIN000005889 Japan
Department of Neurology, Shimane University Hospital
2016 - JPRN-UMIN000022201 Japan
Fu-Dong Shi
2017 Phase 1/Phase 2 NCT03062579 China
Yamamura Takashi
2013 - JPRN-jRCTs031180346 -
2012 - JPRN-jRCTs031180152 -
Tocilizumab injection
Tianjin Medical University General Hospital
2017 Phase 2/Phase 3 NCT03350633 China
Toldc - intradermal
Antwerp University Hospital
2023 Phase 2 EUCTR2022-003465-38-BE Belgium;Spain
Toldc - intranodal
Antwerp University Hospital
2023 Phase 2 EUCTR2022-003465-38-BE Belgium;Spain
Tolebrutinib
Sanofi
2024 Phase 3 NCT06372145 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
2020 Phase 1 NCT06106074 United States
2020 Phase 1 NCT06064539 United States
2020 Phase 3 NCT04458051 Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Estonia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
2020 Phase 3 NCT04411641 Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 NCT04410991 Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
2020 Phase 3 NCT04410978 Austria;Belarus;Bulgaria;Canada;China;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
2019 Phase 2 NCT03996291 Canada;Czechia;Estonia;France;Netherlands;Russian Federation;Spain;Ukraine;United States
Tanaka Tomoyuki
2024 Phase 3 JPRN-jRCT2031240058 China;Japan;Republic of Korea;Turkey;Ukraine;United States
2021 Phase 3 JPRN-jRCT2021200035 Austria;Belarus;Bulgaria;Canada;China;Czechia;Denmark;Estonia;Finland;Germany;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
Tolebrutinib 120MG
National Institute of Neurological Disorders and Stroke (NINDS)
2021 Phase 2 NCT04742400 United States
Tolebrutinib 60MG
National Institute of Neurological Disorders and Stroke (NINDS)
2021 Phase 2 NCT04742400 United States
Tolerogenic dendritic cells loaded with myelin peptides
Sara Varea
2015 Phase 1 NCT02283671 Spain
Tolerogenic fibroblasts
FibroBiologics
2020 Early Phase 1 NCT05080270 Mexico
Tolperisone HC1
Avigen Inc
2007 - EUCTR2007-001031-63-DE Germany
2007 Phase 2 EUCTR2007-001031-63-CZ Czech Republic;Germany
Tolperisone HCL
Avigen
2007 Phase 2 NCT00532532 Czech Republic;Former Serbia and Montenegro;Germany;Russian Federation;Serbia;Ukraine
Tolpersan
Avigen Inc
2007 - EUCTR2007-001031-63-DE Germany
2007 Phase 2 EUCTR2007-001031-63-CZ Czech Republic;Germany
Tolposan
Avigen Inc
2007 - EUCTR2007-001031-63-DE Germany
2007 Phase 2 EUCTR2007-001031-63-CZ Czech Republic;Germany
Topical preparation H ARM
New York University School of Medicine
2015 Phase 4 NCT02665221 United States
Torvast*10CPR 10MG
DR DIMENSIONE RICERCA
2005 - EUCTR2005-001009-25-IT Italy
Tovaxin
Opexa Therapeutics, Inc.
2007 Phase 2 NCT00595920 United States
Tovaxin autologous T cell vaccine
Opexa Therapeutics, Inc.
2006 Phase 2 NCT00245622 United States
2002 Phase 1/Phase 2 NCT00587691 United States
Tracleer
UZ Brussel
2017 Phase 2 EUCTR2017-001253-13-BE Belgium
Traditional balance exercises
Halic University
2024 - NCT06387043 Turkey
Training groupe
Somogy Megyei Kaposi Mór Teaching Hospital
2018 - NCT04550650 Hungary
Trancopal dolo
Charité-Universitätsmedizin Berlin
2007 Phase 2 EUCTR2006-005262-39-DE Germany
Transcranial magnetic stimulation
Hospital San Carlos, Madrid
2022 Phase 3 NCT05809414 Spain
Maimónides Biomedical Research Institute of Córdoba
2019 Phase 1/Phase 2 NCT04062331 -
Neuromed IRCCS
2023 - NCT05779449 Italy
Trap myelin test
Nantes University Hospital
2012 - NCT01723631 France
Treatment withdrawal
University Hospital, Strasbourg, France
2025 Phase 3 NCT06663189 France
Treosulfan
medac Gesellschaft für klinische Spezialpräparate mbH
2007 - EUCTR2006-002856-14-DE Germany
Trichuris suis eggs
Danish Multiple Sclerosis Research Center
2009 Phase 2 EUCTR2008-007549-29-DK Denmark
Trichuris suis OVA
Charite University, Berlin, Germany
2012 Phase 2 NCT01413243 Germany
Danish Multiple Sclerosis Research Center
2009 Phase 2 EUCTR2008-007549-29-DK Denmark
Rigshospitalet, Denmark
2010 Phase 2 NCT01006941 Denmark
Trichuris suis OVA (eggs), embryonated, viable
Charite Universitätsmedizin Berlin
2011 Phase 2 EUCTR2009-015319-41-DE Germany
Trileptal
Queen Mary University London
2014 Phase 2 EUCTR2013-002419-87-GB United Kingdom
Trivalent seasonal influenza vaccine
Biogen
2010 Phase 2 NCT01051349 Czech Republic;Czechia;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom
Trulicity 0,75 MG injekcný roztok naplnený V injekcnom pere
Lekárska fakulta UK Bratislava
2019 Phase 2 EUCTR2019-003001-94-SK Slovakia
Trunk impairment
Ankara Yildirim Beyazit University
2019 - NCT03945006 Turkey
Trunk position sense
Ankara Yildirim Beyazit University
2016 - NCT03566251 Turkey
TSO
Charite Universitätsmedizin Berlin
2011 Phase 2 EUCTR2009-015319-41-DE Germany
Danish Multiple Sclerosis Research Center
2009 Phase 2 EUCTR2008-007549-29-DK Denmark
TT vaccine
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States
TV-5010
TEVA
2004 - EUCTR2004-000759-40-IT Italy
TEVA ITALIA srl
2004 Phase 2 EUCTR2004-000762-13-IT Italy
TV-5600
TEVA ITALIA srl
2008 - EUCTR2007-005450-23-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2007 - EUCTR2007-003226-19-IT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
TEVA PHARMACEUTICALS INDUSTRIES LTD
2013 Phase 3 EUCTR2012-003647-30-IT Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Puerto Rico;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
Teva Pharmaceutical Industries Ltd
2013 Phase 3 EUCTR2012-003647-30-PL Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-HU Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-ES Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-EE Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-CZ Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-BE Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
2013 Phase 3 EUCTR2012-003647-30-AT Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2012-003647-30-SK Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2012-003647-30-LV Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2012-003647-30-GR Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2012 Phase 3 EUCTR2012-003647-30-GB Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-015815-42-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain
2010 Phase 3 EUCTR2009-015815-42-PL Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-LT Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain
2010 Phase 3 EUCTR2009-015815-42-EE Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-CZ Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-015815-42-BG Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
2010 Phase 3 EUCTR2009-012989-30-SE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012989-30-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2010 Phase 3 EUCTR2009-012989-30-BG Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2010 Phase 3 EUCTR2009-012989-30-AT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-NL Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-LT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-IT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2009-012989-30-HU Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-GB Austria;Bulgaria;Canada;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
2009 Phase 3 EUCTR2009-012989-30-EE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 Phase 3 EUCTR2009-012989-30-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States
2009 - EUCTR2009-011234-99-DE Germany
2008 Phase 3 EUCTR2007-005450-23-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Slovakia;Spain
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-ES Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-DE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-CZ Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-005450-23-BG Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain
2008 - EUCTR2007-003226-19-PT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2007-003226-19-LT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2008 - EUCTR2007-003226-19-BG Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-SE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-NL Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-LV Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-HU Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-GB Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 Phase 3 EUCTR2007-003226-19-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 Phase 3 EUCTR2007-003226-19-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-EE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-DE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2007 - EUCTR2007-003226-19-AT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-GB Czech Republic;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-DE Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
2006 Phase 2 EUCTR2005-004334-41-CZ Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
2005 Phase 2 EUCTR2005-004334-41-HU Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom
Teva Pharmaceutical Industries Ltd.
2015 Phase 2 EUCTR2014-001579-30-NL Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
2015 Phase 2 EUCTR2014-001579-30-DE Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
2014 Phase 2 EUCTR2014-001579-30-IT Canada;Germany;Italy;Netherlands;Russian Federation;Spain;Ukraine;United Kingdom;United States
2014 Phase 2 EUCTR2014-001579-30-GB Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
2014 Phase 2 EUCTR2014-001579-30-ES Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States
Teva Pharmaceutical Industries, Ltd.
2014 - EUCTR2013-002082-19-NL Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
2014 - EUCTR2013-002082-19-ES Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-SE Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 EUCTR2013-002082-19-GB Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-FI Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 - EUCTR2013-002082-19-DK Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom
2013 Phase 3 EUCTR2013-002082-19-BE Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom
Tylenol pill
Holy Name Medical Center, Inc.
2017 Phase 4 NCT03424733 United States
Tysabri
Amsterdam University Medical Center
2019 Phase 4 EUCTR2019-002566-13-NL Netherlands
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2007 - EUCTR2005-004061-41-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-IT Australia;Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-IE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Spain;Sweden;United Kingdom
2006 - EUCTR2005-004061-41-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 - EUCTR2005-004061-41-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
2006 Phase 3 EUCTR2005-004061-41-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-002145-11-IT Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
Biogen
2023 - NCT05658497 Germany;Ireland;Spain;Switzerland;United States
2017 - NCT03399981 United States
2010 - NCT01070823 United States
2007 - NCT00493298 Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Italy;Mexico;Netherlands;Norway;Portugal;Slovakia;Spain;Switzerland;United Kingdom
Biogen Idec
2014 Phase 4 EUCTR2014-003669-97-BE Belgium
2010 - EUCTR2009-017490-38-DE Germany;Spain
Biogen Idec International GmbH
2010 Phase 4 EUCTR2009-009503-19-BE Belgium
Biogen Idec Limited
2012 Phase 3 EUCTR2010-021978-11-IE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2012 - EUCTR2010-021978-11-BE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain
2011 - EUCTR2010-021978-11-SE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-PL Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-GB Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-FI Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-ES Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-DK Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 - EUCTR2010-021978-11-DE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Iraq;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2011 Phase 3 EUCTR2010-021978-11-CZ Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-002145-11-NL Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-GB Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-FR Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-ES Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2019 Phase 3 EUCTR2018-002145-11-DE Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States
2015 - EUCTR2013-005586-39-DE Germany;Italy;United States
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States
2013 - EUCTR2012-005082-13-IT Italy
BiogenIdec A/S
2009 - EUCTR2008-008065-35-SE Sweden
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France
CHU de Toulouse
2009 - EUCTR2008-005906-38-FR France
Cornerstone Health Care, PA
2012 Phase 4 NCT01591551 United States
Dansk Multipel Sclerose Center
2010 Phase 2 EUCTR2009-016703-35-DK Denmark
Imperial College London
2008 Phase 4 EUCTR2007-007394-22-GB United Kingdom
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden
2017 Phase 4 EUCTR2016-003587-39-SE Sweden
Kessler Foundation
2021 - NCT04565431 United States
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States
Novartis Pharma Services AG
2012 Phase 3 EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
Polpharma Biologics S.A.
2019 Phase 3 EUCTR2018-004751-20-PL Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine
2019 Phase 3 EUCTR2018-004751-20-HR Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland
University Hospital, Caen
2020 - NCT04580381 France
University at Buffalo
2007 - NCT00937677 United States
University of Chicago
2010 - NCT01071512 United States
University of South Florida
2011 - NCT01455220 United States
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany
Uppsala l?ns landsting
2011 Phase 2 EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States
VU medical center
2016 Phase 4 EUCTR2016-000345-31-NL Netherlands
Tysabri 300 MG concentrado para solucióN para perfusióN
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom
Tysabri 300 MG concentrate FOR solution FOR infusion
BIOGEN IDEC LTD
2006 Phase 3 EUCTR2005-004061-41-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom
Tysabri 300 MG solution à diluer pour perfusion
Hôpitaux Universitaires de Strasbourg
2014 - EUCTR2014-003209-14-FR France
Tysabri and avonex
Biogen
2008 Phase 4 NCT00771043 United States
Tysabri injectable product
Queen Mary University of London
2022 Phase 2 NCT05418010 United Kingdom
Tysabri*IV 1FL 300MG 15ML
BIOGEN IDEC LTD
2011 - EUCTR2010-024000-10-IT Belgium;Germany;Italy;Spain
2011 - EUCTR2010-021978-11-IT Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Ireland;Italy;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States
Ublituximab
Georgia State University
2024 Early Phase 1 NCT06629428 United States
Johns Hopkins University
2016 Phase 1 NCT02276963 United States
Neurology Center of New England P.C.
2024 - NCT06681623 United States
TG Therapeutics
2017 Phase 3 EUCTR2017-000639-15-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000639-15-GB Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000639-15-ES Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-GB Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-ES Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
TG Therapeutics, Inc.
2023 Phase 3 NCT05877963 United States
2020 Phase 3 EUCTR2019-003625-16-PL Belarus;Croatia;Georgia;Poland;Russian Federation;Serbia;Ukraine;United States
2020 Phase 3 EUCTR2019-003625-16-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2019 Phase 3 NCT04130997 Belarus;Croatia;Georgia;Poland;Russian Federation;Serbia;Ukraine;United States
2017 Phase 2 NCT03381170 United States
2017 Phase 3 NCT03277261 United States
2017 Phase 3 NCT03277248 United States
2017 Phase 3 EUCTR2017-000639-15-PL Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
2017 Phase 3 EUCTR2017-000638-75-PL Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2016 Phase 2 NCT02738775 United States
University of Maryland, Baltimore
2025 - NCT06864936 United States
Ubltuximab
TG Therapeutics
2017 Phase 3 EUCTR2017-000639-15-GB Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
Ucar T-cell
Tianjin Huanhu Hospital
2025 Early Phase 1 NCT06939166 China
UCB L059
Søren H. Sindrup, Department of Neurology, Odense University Hospital
2006 - EUCTR2006-000397-71-DK Denmark
UK: sativex oromucosal spray
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-GB Czech Republic;Poland;Romania;United Kingdom;United States
Ultomiris
Alexion Pharmaceuticals, Inc.
2024 - NCT06312644 United States
2022 Phase 2;Phase 3 EUCTR2021-006075-42-FR Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2022 Phase 2;Phase 3 EUCTR2021-006075-42-ES Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
2020 Phase 3 EUCTR2019-003352-37-PL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-NL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-ES Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-DK Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-DE Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
2020 Phase 3 EUCTR2019-003352-37-AT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
- Phase 2;Phase 3 EUCTR2021-006075-42-DE Canada;France;Germany;Italy;Japan;Korea, Republic of;Spain;United States
Ultrasmall particles OF iron oxide
Max-Planck-Institute of Psychiatry
2007 - EUCTR2006-001337-17-DE Germany
Ultromiris
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 3 EUCTR2019-003352-37-IT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
Umbilical cord derived mesenchymal stem cells
University of Jordan
2017 Phase 1/Phase 2 NCT03326505 Jordan
Umbilical cord mesenchymal stem cells
Translational Biosciences
2014 Phase 1/Phase 2 NCT02034188 Panama
Uncoupled rbcs
Cellerys AG
2024 Phase 1/Phase 2 NCT06430671 Czech Republic;Czechia;Germany;Italy;Switzerland
Undifferentiated autologous mesenchymal stem cells
SALK - Gemeinnützige Salzburger Landeskliniken Betriebsges. m.b.H., Christian-Doppler-Klinik, UK für Neurologie der PMU
- - EUCTR2015-000137-78-AT Austria
Universal bcma CAR-T
Xuanwu Hospital, Beijing
2025 Early Phase 1 NCT06485232 China
Universal BCMA-CD19 cart
Bioray Laboratories
2024 Phase 1 NCT06633042 -
Universal CD19 CAR-T
Xuanwu Hospital, Beijing
2025 Early Phase 1 NCT06485232 China
Untreated TO atorvastatin treatment
Charite University, Berlin, Germany
2003 Phase 2 NCT00616187 -
Uplizna
Amgen
2025 - NCT05909761 United States
Urbason 40 MG
Servicio de Neurología, HU. Germans Trias i Pujol
2012 Phase 4 EUCTR2012-001965-34-ES Spain
Urbason 40 MG comprimidos
Servicio de Neurología
2008 - EUCTR2007-000888-15-ES Spain
Urbason forte
Biogen Idec
2010 - EUCTR2009-017490-38-DE Germany;Spain
Urbason solubile forte 1000MG
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany
Urbason® solubile forte 1000 MG
University Medical Center Hamburg Eppendorf
2013 Phase 2 EUCTR2012-004807-10-DE Germany
Urine samples
Centre Hospitalier Universitaire de Nimes
2013 Phase 3 NCT01817166 France;Martinique
US-ocrevus
Celltrion
2024 Phase 3 NCT05906992 Poland
Uspio MRI - gadolinium MRI
Rennes University Hospital
2009 - NCT01567553 France
Usual diet with dietary guidelines FOR americans diet information
Terry L. Wahls
2022 - NCT05007483 United States
Usual DMT continuation
University Hospital, Strasbourg, France
2025 Phase 3 NCT06663189 France
Uvedose
CHU de Nîmes
2022 Phase 4 EUCTR2022-002157-25-FR France
2013 Phase 4 EUCTR2013-000910-40-FR France
Uvedose 100 000 UI, solution buvable EN ampoule
MERCK SERONO s.a.s
2009 - EUCTR2009-013695-46-FR France
V08ca02
Universitätsklinikum Erlangen
2010 Phase 4 EUCTR2009-014857-34-DE Germany
V08ca09
Universitätsklinikum Erlangen
2010 Phase 4 EUCTR2009-014857-34-DE Germany
Vaginal estriol
Texas Tech University Health Sciences Center
2019 Phase 2/Phase 3 NCT03774407 United States
Vancomycin
Icahn School of Medicine at Mount Sinai
2023 Phase 1 NCT05539729 United States
Vardenafil
Unidad de Neuroinmunología
2005 Phase 4 EUCTR2004-003761-33-ES Spain
Vardenafilo hidrocloruro
Unidad de Neuroinmunología
2005 Phase 4 EUCTR2004-003761-33-ES Spain
Vatelizumab
Genzyme Corporation
2015 Phase 2 EUCTR2014-003265-19-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-SE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
2015 Phase 2 EUCTR2014-001643-20-DE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States
Genzyme, a Sanofi Company
2015 Phase 2 NCT02306811 Canada;Poland;Russian Federation;United States
2014 Phase 2 NCT02222948 Canada;Poland;Russian Federation;Sweden;United States
VAY736
Novartis Pharma Services AG
2014 Phase 2 EUCTR2013-002324-16-PL Czech Republic;Poland;Russian Federation;Ukraine;United States
2014 Phase 2 EUCTR2013-002324-16-CZ Czech Republic;Poland;Russian Federation;Ukraine;United States
Novartis Pharmaceuticals
2013 Phase 2 NCT02038049 Czech Republic;Czechia;Germany;Poland;Russian Federation;Ukraine;United States
VB13s1
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia
VB5s2
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia
VB6s5
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia
Vehicle GEL
Biogen
2016 Phase 4 NCT02568111 -
Venlafaxin hexal
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany
Venlafaxine
Novartis Pharmaceuticals
2011 Phase 4 NCT01436643 Germany
Venlafaxine hydrochloride
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany
Verum ARM receiving vitamin D OIL
Charite University, Berlin, Germany
2011 Phase 2 NCT01440062 Germany
Vesicare 10MG tablet
Brigitte Schürch
2021 Phase 4 NCT04819360 Switzerland
Vestibular habituation exercises
October 6 University
2017 - NCT03670459 Egypt
Vestibular rehabilitation: balance and EYE movement exercises
University of Colorado, Denver
2012 - NCT01698086 United States
VIB0551
Horizon Therapeutics Ireland DAC
2022 Phase 2 EUCTR2021-003528-33-SE Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
2022 Phase 2 EUCTR2021-003528-33-PL Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
2022 Phase 2 EUCTR2021-003528-33-FR Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
- Phase 2 EUCTR2021-003528-33-NL Argentina;Brazil;Canada;France;Netherlands;Poland;Serbia;Spain;Sweden;United Kingdom;United States
Video game therapy
University Hospital of Ferrara
2017 - NCT03353974 Italy
Vidofludimus calcium
Immunic AG
2023 Phase 3 EUCTR2021-000028-36-GR Albania;Belarus;Bulgaria;Colombia;Georgia;Germany;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2023 Phase 3 EUCTR2021-000028-36-ES Albania;Bulgaria;Colombia;Georgia;Germany;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Russian Federation;Spain;Ukraine;United States
2023 Phase 3 EUCTR2021-000028-36-DE Albania;Algeria;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2022 Phase 2 EUCTR2021-000048-23-NL Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
2022 Phase 2 EUCTR2021-000048-23-DE Bulgaria;Canada;Czechia;Georgia;Germany;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Serbia;Ukraine;United States
2022 Phase 3 EUCTR2021-000029-28-RO Armenia;Bosnia and Herzegovina;Estonia;Germany;India;Peru;Poland;Romania;Serbia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000029-28-PL Bosnia and Herzegovina;Estonia;India;Peru;Poland;Romania;Russian Federation;Serbia;Türkiye;Ukraine;United Kingdom;United States
2022 Phase 3 EUCTR2021-000028-36-LT Albania;Algeria;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-000028-36-BG Albania;Algeria;Belarus;Bulgaria;Colombia;Georgia;Germany;Greece;India;Jordan;Lebanon;Lithuania;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Russian Federation;Spain;Ukraine;United States
2022 Phase 2 EUCTR2018-001896-19-DE Bulgaria;Germany;Poland;Romania;Ukraine
2021 Phase 2 EUCTR2021-000048-23-RO Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine
2021 Phase 2 EUCTR2021-000048-23-PL Bulgaria;Canada;Czechia;Georgia;Germany;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Serbia;Ukraine;United States
2021 Phase 2 EUCTR2021-000048-23-BG Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine
2019 Phase 2 EUCTR2018-001896-19-RO Bulgaria;Germany;Poland;Romania;Ukraine
2018 Phase 2 EUCTR2018-001896-19-BG Bulgaria;Germany;Poland;Romania;Ukraine
Vigantol
University College Dublin
2012 Phase 2 EUCTR2012-000635-68-IE Ireland
Vigantol OEL
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-DE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
2011 - EUCTR2010-020328-23-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Vigantol OIL
MERCK SERONO SA
2011 - EUCTR2010-020328-23-IT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Merck KGaA
2011 Phase 2 NCT01285401 Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-LT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2011 - EUCTR2010-020328-23-DE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland
Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
2011 - EUCTR2010-020328-23-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal
Vigantol® OIL
Academic MS Center Limburg
- Phase 2 EUCTR2014-000728-97-NL Netherlands
Vigantol® ÖL 20.000 I.E./ML
Charité - Universitätsmedizin Berlin
2011 Phase 2 EUCTR2011-002785-20-DE Germany
Virtual reality group
Gazi University
2018 - NCT03501342 Turkey
Vitamin A
Tehran University of Medical Sciences
2011 Phase 4 NCT01407211 Iran, Islamic Republic of
2010 Phase 4 NCT01705457 Iran, Islamic Republic of
2010 Phase 4 NCT01417273 Iran, Islamic Republic of
2009 Phase 4 NCT01225289 Iran, Islamic Republic of
Vitamin D
Centre Hospitalier Universitaire de Nimes
2013 Phase 3 NCT01817166 France;Martinique
Mazandaran University of Medical Sciences
2013 Phase 3 NCT01768039 Iran, Islamic Republic of
University Medical Centre Maribor
2017 Phase 4 NCT03385356 Slovenia
Vitamin D3
AlJohara M AlQuaiz, M.D.
2013 Phase 2 NCT01753375 Saudi Arabia
American University of Beirut Medical Center
2018 - NCT03610139 Lebanon
Carmel Medical Center
2010 Phase 4 NCT01005095 Israel
Isfahan University of Medical Sciences
2015 - NCT02696590 Iran, Islamic Republic of
Johns Hopkins University
2012 Phase 3 NCT01490502 United States
2010 - NCT01667796 United States
Maastricht University Medical Center
2009 - NCT00940719 Netherlands
Merck KGaA
2009 Phase 2 NCT01198132 France
Tehran University of Medical Sciences
2022 Phase 4 NCT05340985 -
University of Toronto
2006 Phase 1/Phase 2 NCT00644904 Canada
Vitamin K
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States
Vitamin K cream
Biogen
2017 Phase 4 NCT03091569 Italy
Vitamina D3 kern pharma soluciÓN oleosa
Javier Olascoaga Urtaza
2013 Phase 2 EUCTR2012-004602-97-ES Spain
VSN16R
Canbex Therapeutics Ltd
2015 Phase 2 NCT02542787 United Kingdom
VSN16R 100MG
Canbex Therapeutics Ltd
2015 Phase 2 EUCTR2014-004412-11-GB United Kingdom
VX15/2503
Vaccinex Inc.
2012 Phase 1 NCT01764737 United States
Warm compress prior TO injection OF glatiramer acetate
Teva Neuroscience, Inc.
2005 Phase 4 NCT00239993 United States
Water
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2021 - JPRN-UMIN000043910 Japan
Kharazmi university
2024 - JPRN-UMIN000053947 Asia(except Japan)
Water tracking
Ohio State University
2017 - NCT03244696 United States
WAY-130799
Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
2005 - EUCTR2005-000171-18-FI Finland
Withdrawal OF dalfampridine-ER 10MG
Acorda Therapeutics
2012 - NCT01535664 United States
Wristband physical activity monitor
Oakland University
2015 - NCT02335450 United States
XBD173
Imperial College London
2018 - NCT03850301 United Kingdom
XCEL-MC-alpha
Banc de Sang i Teixits
2015 Phase 1/Phase 2 NCT02495766 Spain
2014 - EUCTR2012-000734-19-ES Spain
Xeomin
OSPEDALE S. RAFFAELE
2008 - EUCTR2007-006268-32-IT Italy
Xyosted 75 milligram (MG) IN 0.5 ML AUTO-injector
Tulane University
2025 Phase 4 NCT04601233 United States
Zanubrutinib
Xuanwu Hospital, Beijing
2022 Phase 2 NCT05356858 China
Zenapax
National Institute of Neurological Disorders and Stroke (NINDS)
1999 Phase 2 NCT00001934 United States
Zeposia
I.R.C.C.S. FONDAZIONE S.LUCIA
2022 Phase 4 EUCTR2021-005860-24-IT Italy
Kessler Foundation
2022 - NCT04885894 United States
Zeposia 0,92 MG capsule rigide
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2023 Phase 4 EUCTR2023-000018-16-IT Italy
Zeposia® indicated FOR THE treatment OF: relapsing forms OF multiple sclerosis, and active ulcerative colitis IN adults
Corium Innovations, Inc.
2025 - NCT06528665 Malaysia
Zinbryta
BIOGEN IDEC RESEARCH LIMITED
2017 Phase 3 EUCTR2016-002820-10-IT Canada;Denmark;France;Germany;Italy;United Kingdom;United States
Biogen Idec Research Limited
2017 Phase 3 EUCTR2016-002820-10-GB Canada;Denmark;France;Germany;Italy;United Kingdom;United States
2017 Phase 3 EUCTR2016-002820-10-DE Canada;Germany;Italy;United Kingdom;United States
2013 Phase 3 EUCTR2012-003176-39-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States
ZK 157046
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
SCHERING
2007 - EUCTR2006-005270-47-IT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
Schering AG
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-IE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden
ZOL446H
North Bristol Trust
2009 - EUCTR2008-005304-93-GB United Kingdom
Novartis Pharma GmbH
2010 - EUCTR2009-011888-37-DE Germany
Zoledronic acid
Novartis
2010 Phase 3 NCT01166178 Germany
Zoledronic acid monohydrate
Novartis Pharma GmbH
2010 - EUCTR2009-011888-37-DE Germany